<SEC-DOCUMENT>0000721371-20-000043.txt : 20200511
<SEC-HEADER>0000721371-20-000043.hdr.sgml : 20200511
<ACCEPTANCE-DATETIME>20200511091508
ACCESSION NUMBER:		0000721371-20-000043
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		91
CONFORMED PERIOD OF REPORT:	20200331
FILED AS OF DATE:		20200511
DATE AS OF CHANGE:		20200511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARDINAL HEALTH INC
		CENTRAL INDEX KEY:			0000721371
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				310958666
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11373
		FILM NUMBER:		20862888

	BUSINESS ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147573033

	MAIL ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDINAL DISTRIBUTION INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>a20q310q033120form10-q.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:6a4897146d6648e8b4a1004cfc7ae683,x:caa9c77c003c49d78de5f6fb5feffd17-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:sheci="http://fasb.org/stm/sheci/2020-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2020-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2020-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2020-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2020-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2020-01-31" xmlns:equity="http://fasb.org/dis/equity/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:ides="http://fasb.org/dis/ides/2020-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2020-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2020-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2020-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2020-01-31" xmlns:ei="http://fasb.org/dis/ei/2020-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2020-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2020-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2020-01-31" xmlns:srt-all="http://fasb.org/srt-all/2020-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2020-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2020-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2020-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2020-01-31" xmlns:se="http://fasb.org/dis/se/2020-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2020-01-31" xmlns:hco="http://fasb.org/dis/hco/2020-01-31" xmlns:soi="http://fasb.org/stm/soi/2020-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2020-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:debt="http://fasb.org/dis/debt/2020-01-31" xmlns:spc="http://fasb.org/stm/spc/2020-01-31" xmlns:ts="http://fasb.org/dis/ts/2020-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:rd="http://fasb.org/dis/rd/2020-01-31" xmlns:sr="http://fasb.org/dis/sr/2020-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:edco="http://fasb.org/dis/edco/2020-01-31" xmlns:guar="http://fasb.org/dis/guar/2020-01-31" xmlns:te="http://fasb.org/dis/te/2020-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2020-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:ni="http://fasb.org/dis/ni/2020-01-31" xmlns:dr="http://fasb.org/dis/dr/2020-01-31" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2020-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2020-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2020-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2020-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2020-01-31" xmlns:iago="http://fasb.org/dis/iago/2020-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2020-01-31" xmlns:con="http://fasb.org/dis/con/2020-01-31" xmlns:leas="http://fasb.org/dis/leas/2020-01-31" xmlns:com="http://fasb.org/stm/com/2020-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2020-01-31" xmlns:inv="http://fasb.org/dis/inv/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2020-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2020-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2020-01-31" xmlns:oi="http://fasb.org/dis/oi/2020-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2020-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2020-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:cn-part="http://fasb.org/cn-part/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2020-01-31" xmlns:srt-std="http://fasb.org/srt-std/2020-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2020-01-31" xmlns:re="http://fasb.org/dis/re/2020-01-31" xmlns:ir="http://fasb.org/dis/ir/2020-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2020-01-31" xmlns:soc="http://fasb.org/stm/soc/2020-01-31" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2020-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2020-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2020-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2020-01-31" xmlns:regop="http://fasb.org/dis/regop/2020-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2020-01-31" xmlns:ero="http://fasb.org/dis/ero/2020-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2020-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2020-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:invco="http://fasb.org/dis/invco/2020-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2020-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2020-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2020-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2020-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2020-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2020-01-31" xmlns:aro="http://fasb.org/dis/aro/2020-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2020-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2020-01-31" xmlns:pay="http://fasb.org/dis/pay/2020-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2020-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2020-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2020-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2020-01-31" xmlns:eps="http://fasb.org/dis/eps/2020-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2020-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2020-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:crcrb="http://fasb.org/dis/crcrb/2020-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2020-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2020-01-31" xmlns:lea="http://fasb.org/dis/lea/2020-01-31" xmlns:disops="http://fasb.org/dis/disops/2020-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2020-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2020-01-31" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2020-01-31" xmlns:nt="http://fasb.org/dis/nt/2020-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2020-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2020-01-31" xmlns:cce="http://fasb.org/dis/cce/2020-01-31" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2020-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2020-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2020-01-31" xmlns:acec="http://fasb.org/dis/acec/2020-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2020-01-31" xmlns:cah="http://www.cardinal.com/20200331" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2020-01-31" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2020-01-31" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:cc="http://fasb.org/dis/cc/2020-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2020-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2020-01-31" xmlns:ru="http://fasb.org/dis/ru/2020-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2020-01-31" xmlns:foct="http://fasb.org/dis/foct/2020-01-31" xmlns:sec-re="http://fasb.org/dis/sec-re/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2020-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2020-01-31" xmlns:diha="http://fasb.org/dis/diha/2020-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ap="http://fasb.org/dis/ap/2020-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2020-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:eui="http://fasb.org/dis/eui/2020-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="FD2020Q3YTD" name="dei:AmendmentFlag" id="Fact-9237862606A7BCA7298C54B51AE07017-wk-Fact-9237862606A7BCA7298C54B51AE07017" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q3YTD" name="dei:CurrentFiscalYearEndDate" id="Fact-F43BC75F0FEEA99FCC2B54B51ADD906E-wk-Fact-F43BC75F0FEEA99FCC2B54B51ADD906E">--06-30</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q3YTD" name="dei:DocumentFiscalPeriodFocus" id="Fact-6825393F2FDC51908B4954B51ADE3D4B-wk-Fact-6825393F2FDC51908B4954B51ADE3D4B">Q3</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q3YTD" name="dei:DocumentFiscalYearFocus" id="Fact-39ADC9C92D7DCE3D05CF54B51ADEFA5B-wk-Fact-39ADC9C92D7DCE3D05CF54B51ADEFA5B">2020</ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q3YTD" name="dei:EntityCentralIndexKey" id="Fact-2062A61CD15B024629D254B51AE0A31C-wk-Fact-2062A61CD15B024629D254B51AE0A31C">0000721371</ix:nonNumeric><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FD2019Q3YTD" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact-879C99B0F2503F832D5D54B51B102DC8-wk-Fact-879C99B0F2503F832D5D54B51B102DC8">6000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="usd" contextRef="FD2019Q3QTD" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" id="Fact-0EFF2BDBB542E828E0E854B51AE6A7B0-wk-Fact-0EFF2BDBB542E828E0E854B51AE6A7B0">0</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="usd" contextRef="FD2019Q3YTD" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" id="Fact-3F994A80D98FE166839E54B51AE557D6-wk-Fact-3F994A80D98FE166839E54B51AE557D6">0</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesAuthorized" id="Fact-BBAB922100EACD20D1A454B51AB76D80-wk-Fact-BBAB922100EACD20D1A454B51AB76D80">755000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FI2020Q3" name="us-gaap:CommonStockSharesAuthorized" id="Fact-8F54C790D5AB93D684C054B51AAF69E7-wk-Fact-8F54C790D5AB93D684C054B51AAF69E7">755000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:CommonStockSharesIssued" id="Fact-0F67C8D846509D56081754B51AAD9C11-wk-Fact-0F67C8D846509D56081754B51AAD9C11">327000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FI2020Q3" name="us-gaap:CommonStockSharesIssued" id="Fact-29AE64265F2AF29C555A54B51AAF3017-wk-Fact-29AE64265F2AF29C555A54B51AAF3017">327000000</ix:nonFraction><ix:nonFraction decimals="0" unitRef="segment" contextRef="FD2020Q3YTD" name="us-gaap:NumberOfReportableSegments" id="Fact-9AE083E3A9FB667853FF54B51AC2153D-wk-Fact-9AE083E3A9FB667853FF54B51AC2153D">2</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-60DA7A6D0AAC9E20CF1A54B51AADF650-wk-Fact-60DA7A6D0AAC9E20CF1A54B51AADF650">500000</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2020Q3" name="us-gaap:PreferredStockSharesAuthorized" id="Fact-4D0A8A5601A0C8A584AF54B51AAEADA7-wk-Fact-4D0A8A5601A0C8A584AF54B51AAEADA7">500000</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:PreferredStockSharesIssued" id="Fact-9D69251144C5272F051654B51AADCC87-wk-Fact-9D69251144C5272F051654B51AADCC87">0</ix:nonFraction><ix:nonFraction decimals="-3" unitRef="shares" contextRef="FI2020Q3" name="us-gaap:PreferredStockSharesIssued" id="Fact-08AF18ADEA6CAD384B3554B51AAC86F0-wk-Fact-08AF18ADEA6CAD384B3554B51AAC86F0">0</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FI2019Q4" name="us-gaap:TreasuryStockShares" id="Fact-7BF09B7B5CAD1A07E1B054B51AAF36B1-wk-Fact-7BF09B7B5CAD1A07E1B054B51AAF36B1">28000000</ix:nonFraction><ix:nonFraction decimals="-6" unitRef="shares" contextRef="FI2020Q3" name="us-gaap:TreasuryStockShares" id="Fact-F06165CBBED17D09494754B51AACA15D-wk-Fact-F06165CBBED17D09494754B51AACA15D">35000000</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:href="cah-20200331.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="FD2020Q3YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q3">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-04-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q3">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q1ASC842">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-07-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalReportingUnitMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalReportingUnitMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-08-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-08-01</xbrli:startDate>
			<xbrli:endDate>2018-08-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2018Q1navi_srt_OwnershipAxis_cah_NaviOwnershipInterestDivestedMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:OwnershipAxis">cah:NaviOwnershipInterestDivestedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-08-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_RangeAxis_srt_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_RangeAxis_srt_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q1SD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:FinanceLeaseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:OperatingLeaseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q1SD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cah_ASC842Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2019-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.4Notesdue2020Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.4Notesdue2020Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q2NotesPayable_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.4Notesdue2020Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-11-01</xbrli:startDate>
			<xbrli:endDate>2019-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:GownRecallAxis">cah:SterileSurgicalGownRecallMemberDomain</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q3SD_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-05-04</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q3SD_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-05-04</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q3Litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-05-04</xbrli:startDate>
			<xbrli:endDate>2020-05-04</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_LitigationCaseAxis_cah_OpioidLitigationCuyahogaandSummitCountiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationnetoftaxMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q3SD_srt_LitigationCaseAxis_cah_OpioidLawsuitsStateDomain_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsStateDomain</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-05-04</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_MajorCustomersAxis_cah_CVSHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationlessCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:GownRecallAxis">cah:SterileSurgicalGownRecallMemberDomain</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q3Litigation_us-gaap_LossContingenciesByNatureOfContingencyAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-05-04</xbrli:startDate>
			<xbrli:endDate>2020-05-04</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="I2020Q3SD_cah_LawsuitTypeAxis_cah_ClassActionLawsuitsMember_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:LawsuitTypeAxis">cah:ClassActionLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-05-04</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q3Litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:AlamedaCountyMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-05-04</xbrli:startDate>
			<xbrli:endDate>2020-05-04</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationlessCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="D2020Q3Litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:OtherJurisdictionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-05-04</xbrli:startDate>
			<xbrli:endDate>2020-05-04</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_cah_TaxMatterAxis_cah_CareFusionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_cah_TaxMatterAxis_cah_CareFusionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-01-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-01-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2020-03-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2020Q3YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2019-07-01</xbrli:startDate>
			<xbrli:endDate>2020-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-06-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-07-01</xbrli:startDate>
			<xbrli:endDate>2019-03-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context><xbrli:context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000721371</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2019-06-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context><xbrli:unit id="number">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit><xbrli:unit id="StateAG">
		<xbrli:measure>cah:StateAG</xbrli:measure>
	</xbrli:unit><xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit><xbrli:unit id="jpy">
		<xbrli:measure>iso4217:JPY</xbrli:measure>
	</xbrli:unit><xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit><xbrli:unit id="plaintiff">
		<xbrli:measure>cah:plaintiff</xbrli:measure>
	</xbrli:unit><xbrli:unit id="eur">
		<xbrli:measure>iso4217:EUR</xbrli:measure>
	</xbrli:unit><xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit><xbrli:unit id="lawsuit">
		<xbrli:measure>cah:lawsuit</xbrli:measure>
	</xbrli:unit><xbrli:unit id="segment">
		<xbrli:measure>cah:segment</xbrli:measure>
	</xbrli:unit></ix:resources></ix:header></div><div><a id="sFBECBEE56ABA5475BEA618E5118292D2"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;color:#0000ff;text-decoration:underline;" href="#s57FCB5EB633C53808B6CF224D8F4C555"><span style="font-family:Arial Narrow;font-size:8pt;color:#0000ff;text-decoration:underline;">Table of Contents</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:100%;padding-bottom:4px;text-align:center;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:100%;padding-bottom:4px;text-align:center;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:100%;padding-bottom:4px;padding-top:8px;text-align:center;font-size:11pt;"><span style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Washington,&#160;D.C. 20549</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:center;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Form </span><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;"><span><ix:nonNumeric id="d55290718e2756-wk-Fact-A5C2F86E3AA1AF5C57CA54B51B083BCB" name="dei:DocumentType" contextRef="FD2020Q3YTD">10-Q</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Wingdings;font-size:10pt;"><span><ix:nonNumeric id="d55290718e2773-wk-Fact-3B0812E189A157AE0C6654B51B07061E" name="dei:DocumentQuarterlyReport" contextRef="FD2020Q3YTD" format="ixt-sec:boolballotbox">&#9745;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">For the quarterly period ended </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d55290718e2783-wk-Fact-194F46A3F823EF98863A54B51B062094" name="dei:DocumentPeriodEndDate" contextRef="FD2020Q3YTD" format="ixt:datemonthdayyearen">March 31, 2020</ix:nonNumeric></span></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">or</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Wingdings;font-size:10pt;"><span><ix:nonNumeric id="d55290718e2803-wk-Fact-EA565CE478F626B6E29054B51AD9681E" name="dei:DocumentTransitionReport" contextRef="FD2020Q3YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">For the transition period from ________ to ________</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Commission File Number:&#160;</span><span><ix:nonNumeric id="d55290718e2816-wk-Fact-9AB61F136A9A9A0CA7A254B51A7E0935" name="dei:EntityFileNumber" contextRef="FD2020Q3YTD"><span style="font-family:Arial Narrow;">1-11373</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:24pt;"><span><ix:nonNumeric id="d55290718e2823-wk-Fact-8746B1620FE198E829C054B51AFD6F55" name="dei:EntityRegistrantName" contextRef="FD2020Q3YTD"><span style="font-family:Arial Narrow;font-size:24pt;font-weight:bold;">Cardinal Health, Inc.</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:24pt;font-weight:bold;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">(Exact name of registrant as specified in its charter)</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:26%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:50%;"></td></tr><tr><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d55290718e2849-wk-Fact-45392805751A6C675F4954B51ADAA499" name="dei:EntityIncorporationStateCountryCode" contextRef="FD2020Q3YTD" format="ixt-sec:stateprovnameen">Ohio</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d55290718e2879-wk-Fact-63609306CCEADCBDAFC654B51ADFE708" name="dei:EntityTaxIdentificationNumber" contextRef="FD2020Q3YTD">31-0958666</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;">(State or other jurisdiction of<br/>incorporation or organization)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;">(IRS Employer<br/>Identification No.)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d55290718e2957-wk-Fact-7F7AB032B60061F288D654B51ADF1CC6" name="dei:EntityAddressAddressLine1" contextRef="FD2020Q3YTD">7000 Cardinal Place</ix:nonNumeric></span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">,</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d55290718e2967-wk-Fact-291A356CF2AEFA00D77854B51ADE9E11" name="dei:EntityAddressCityOrTown" contextRef="FD2020Q3YTD">Dublin</ix:nonNumeric></span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">,</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d55290718e2977-wk-Fact-AD8BEDE4BD2128B3EBD554B51AD3A46F" name="dei:EntityAddressStateOrProvince" contextRef="FD2020Q3YTD" format="ixt-sec:stateprovnameen">Ohio</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d55290718e2987-wk-Fact-1C3EBFAAC500D828C1A254B51AD8623C" name="dei:EntityAddressPostalZipCode" contextRef="FD2020Q3YTD">43017</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;">(Address of principal executive offices)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;">(Zip Code)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d55290718e3085-wk-Fact-200B95C353A475BBCF7554B51ADF7B8C" name="dei:CityAreaCode" contextRef="FD2020Q3YTD">(614)</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d55290718e3095-wk-Fact-D341E35D62260A0EA63054B51ADB896F" name="dei:LocalPhoneNumber" contextRef="FD2020Q3YTD">757-5000</ix:nonNumeric></span></span></div></td></tr><tr><td colspan="7" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;font-style:italic;font-weight:bold;">(Registrant&#8217;s telephone number, including area code)</span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.36065573770492%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:37%;"></td><td style="width:26%;"></td><td style="width:37%;"></td></tr><tr><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Securities registered pursuant to Section 12(b) of the Act:</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Title of each class</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Trading Symbol(s)</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d55290718e3178-wk-Fact-CF100CBFE9D64709E18854B51AC8024B" name="dei:Security12bTitle" contextRef="FD2020Q3YTD">Common shares (without par value)</ix:nonNumeric></span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d55290718e3183-wk-Fact-0546DD73738FB3C51A9854B51AC778D6" name="dei:TradingSymbol" contextRef="FD2020Q3YTD">CAH</ix:nonNumeric></span></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d55290718e3188-wk-Fact-E09BFE8975167A1C978454B51AC759BC" name="dei:SecurityExchangeName" contextRef="FD2020Q3YTD" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;</span><span><ix:nonNumeric id="d55290718e3193-wk-Fact-99E0283978A2E811CBAF54B51B26495B" name="dei:EntityCurrentReportingStatus" contextRef="FD2020Q3YTD"><span style="font-family:Arial Narrow;">Yes</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;&#160;</span><span style="font-family:Wingdings;font-size:10pt;">&#254;</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="font-family:Wingdings;font-size:10pt;">o</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;</span><span><ix:nonNumeric id="d55290718e3207-wk-Fact-0E7140A906FC9B7762BB54B51A7F76E0" name="dei:EntityInteractiveDataCurrent" contextRef="FD2020Q3YTD"><span style="font-family:Arial Narrow;">Yes</span></ix:nonNumeric></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:inherit;font-size:10pt;">&#160;</span><span style="font-family:Wingdings;font-size:10pt;">&#254;</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="font-family:Wingdings;font-size:10pt;">o</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:19%;"></td><td style="width:3%;"></td><td style="width:27%;"></td><td style="width:18%;"></td><td style="width:3%;"></td><td style="width:30%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonNumeric id="d55290718e3240-wk-Fact-F748EE4E670BE20DEA9454B51B2A1E67" name="dei:EntityFilerCategory" contextRef="FD2020Q3YTD" format="ixt-sec:entityfilercategoryen">Large accelerated filer</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9745;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Accelerated filer</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9744;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Non-accelerated filer</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9744;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Smaller&#160;reporting&#160;company</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><span style="font-family:Arial Unicode MS;font-size:11pt;"><span><ix:nonNumeric id="d55290718e3291-wk-Fact-3531CC31569026AC2FFB54B51B2A888F" name="dei:EntitySmallBusiness" contextRef="FD2020Q3YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Emerging growth&#160;company</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><span style="font-family:Arial Unicode MS;font-size:11pt;"><span><ix:nonNumeric id="d55290718e3322-wk-Fact-93ECEFF218BD622191D354B51A7EE8E1" name="dei:EntityEmergingGrowthCompany" contextRef="FD2020Q3YTD" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act </span><span style="font-family:Wingdings;font-size:10pt;">o</span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). &#160;&#160;&#160;Yes&#160;&#160;</span><span><ix:nonNumeric id="d55290718e3364-wk-Fact-7AF0E7550DA025809BB654B51B02D589" name="dei:EntityShellCompany" contextRef="FD2020Q3YTD" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;font-size:11pt;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;">&#160;&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;&#160;No&#160;</span><span style="font-family:inherit;font-size:10pt;">&#160;</span><span style="font-family:Wingdings;font-size:10pt;">&#254;</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The number of the registrant&#8217;s common shares, without par value, outstanding as of </span><span style="font-family:Arial Narrow;font-size:10pt;">April&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, was the following: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d55290718e3382-wk-Fact-EF46847575DA4A041B3554B51B2377AA" name="dei:EntityCommonStockSharesOutstanding" contextRef="I2020Q3" unitRef="shares" decimals="0" scale="0" format="ixt:numdotdecimal">291,986,422</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div><br/></div><hr style="page-break-after:always"></hr><div><a id="s57FCB5EB633C53808B6CF224D8F4C555"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:22pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:22pt;"><span style="font-family:Arial Narrow;font-size:22pt;font-weight:bold;color:#ee2724;">Cardinal Health</span><span style="font-family:Arial Narrow;font-size:20pt;font-weight:bold;color:#ee2724;">&#160;</span><span style="font-family:Arial Narrow;font-size:18pt;font-weight:bold;color:#ee2724;">&#160;</span></div><div style="text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Q3 Fiscal 2020 Form 10-Q                                                                                                                                   </span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Table of Contents</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:92%;"></td><td style="width:8%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Page</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s37C5C8C8ACBC502094BFDC052C023541"><span style="font-family:Arial Narrow;font-size:10pt;">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s37C5C8C8ACBC502094BFDC052C023541">2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD432D95941E5536593F030C5B83DE887"><span style="font-family:Arial Narrow;font-size:10pt;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sD432D95941E5536593F030C5B83DE887">16</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s524C8134125A5F01AB88EEFF8006DD5A"><span style="font-family:Arial Narrow;font-size:10pt;">Quantitative and Qualitative Disclosures about Market Risk</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s524C8134125A5F01AB88EEFF8006DD5A">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s91B1FB400D41594EB9C06B28B18291C3"><span style="font-family:Arial Narrow;font-size:10pt;">Controls and Procedures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s91B1FB400D41594EB9C06B28B18291C3">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s9909505D248E51E48CF18A6646D92F4E"><span style="font-family:Arial Narrow;font-size:10pt;">Legal Proceedings</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s9909505D248E51E48CF18A6646D92F4E">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sE462DDDB9F695421BDF161325CCD492F"><span style="font-family:Arial Narrow;font-size:10pt;">Risk Factors</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sE462DDDB9F695421BDF161325CCD492F">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sA5369DE2A7B551D9A7BCDFADEF743FFC"><span style="font-family:Arial Narrow;font-size:10pt;">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sA5369DE2A7B551D9A7BCDFADEF743FFC">22</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s5134E92FB23E597F804A558EAB99AF7A"><span style="font-family:Arial Narrow;font-size:10pt;">Financial Statemen</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">ts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s5134E92FB23E597F804A558EAB99AF7A">23</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sDFDD1F6C85755EF6B29701A043855C03"><span style="font-family:Arial Narrow;font-size:10pt;">Exhibits</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sDFDD1F6C85755EF6B29701A043855C03">42</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sD1F76ACE1C2956F390E0231026E67A67"><span style="font-family:Arial Narrow;font-size:10pt;">Form 10-Q Cross Reference Index</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sD1F76ACE1C2956F390E0231026E67A67">43</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sE3E36FC784CC524CAB619BE0E27A7B8A"><span style="font-family:Arial Narrow;font-size:10pt;">Signatures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sE3E36FC784CC524CAB619BE0E27A7B8A">44</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">About Cardinal Health</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc. is an Ohio corporation formed in 1979 and is a globally integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. We provide medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. We connect patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. We manage our business and report our financial results in two segments: Pharmaceutical and Medical. As used in this report, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; and similar pronouns refer to Cardinal Health, Inc. and its subsidiaries, unless the context requires otherwise. Our fiscal year ends on June 30. References to fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> are to the fiscal years ending or ended June 30, </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and June 30, </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Forward-Looking Statements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">This Quarterly Report on Form 10-Q for the quarter ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (this "Form 10-Q") (including information incorporated by reference) includes "forward-looking statements" addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. Many forward-looking statements appear in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations ("MD&amp;A"), but there are others in this Form 10-Q, which may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results, trends or guidance, statements of outlook and expense accruals. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those made, projected or implied. The most significant of these risks and uncertainties are described in Exhibit 99.1 to this Form 10-Q and in "Risk Factors" in this Form 10-Q and the forms 10-Q for the quarters ended September 30, 2019 and December  31, 2020 and our Annual Report on Form 10-K for the fiscal year ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (our &#8220;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K&#8221;). Forward-looking statements in this Form 10-Q speak only as of the date of this document. Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Non-GAAP Financial Measures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In the "Overview of Consolidated Results" section of MD&amp;A, we use financial measures that are derived from our consolidated financial data but are not presented in our condensed consolidated financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP"). These measures are considered "non-GAAP financial measures" under the United States Securities and Exchange Commission ("SEC") rules. The reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures are included in the &#8220;Explanation and Reconciliation of Non-GAAP Financial Measures&#8221; section following MD&amp;A in this Form 10-Q. </span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s37C5C8C8ACBC502094BFDC052C023541"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.01574803149606%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div></div><div><a id="sDD4F9B80AF0D599EB464979E669C7C12"></a></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The discussion and analysis presented below is concerned with material changes in financial condition and results of operations between the periods specified in our condensed consolidated balance sheets at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and in our condensed consolidated statements of earnings/(loss) for the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. All comparisons presented are with respect to the prior-year period, unless stated otherwise. This discussion and analysis should be read in conjunction with the MD&amp;A included in our </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">2</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s3730FB2777D6549FB2DF886A07BAE9CC"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:17pt;"><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Overview of Consolidated Results</span></div><div style="line-height:120%;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Revenue</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;"><img src="chart-f71680c275d85d55b02.jpg" alt="chart-f71680c275d85d55b02.jpg" style="height:200px;width:266px;"></img></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, revenue increased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">11 percent</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$39.2 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">7 percent</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$116.2 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, primarily due to sales growth from pharmaceutical distribution and specialty solutions customers, including a temporary increase in pharmaceutical sales in March, which we believe to be related to accelerated purchasing by some customers in connection with the outbreak in the United States of the novel strain of coronavirus (&#8220;COVID-19&#8221;). We have experienced below average sales volume since the end of March. </span></div><div style="line-height:120%;padding-top:4px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">GAAP and Non-GAAP Operating Earnings/(Loss)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:47%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP operating earnings/(loss)</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">562</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">432</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">30</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4,368</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,752</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Surgical gown recall costs</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(1</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">95</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State opioid assessment related to prior fiscal years</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(6</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">53</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">80</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">97</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">130</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">154</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">395</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">468</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(1</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">11</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(492</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">35</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">17</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5,729</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">20</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP operating earnings</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">719</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">667</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">8</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,942</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,845</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The sum of the components may not equal the total due to rounding.</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in GAAP operating earnings during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was primarily due to lower restructuring and employee severance, the performance of our Pharmaceutical segment generics program, and an increase in products and distribution within our Medical segment, partially offset by the adverse impact of Pharmaceutical segment customer contract renewals. The increase in sales due to the COVID-19 pandemic had a modest positive impact on GAAP operating earnings during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The decrease in GAAP operating earnings during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was primarily due to a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax charge we recognized for the estimated liability associated with lawsuits and claims brought against us by states and political subdivisions relating to the distribution of prescription opioid pain medications as described in the Significant Developments in Fiscal 2020 and Trends section in this MD&amp;A and </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s054B3015E6505AB9825D03C656BE42ED"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements". GAAP operating earnings during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> also include the favorable impact from a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$508 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax gain from the divestiture of our naviHealth Holdings, LLC ("naviHealth") business.</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in non-GAAP operating earnings during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was primarily due to the performance of our Pharmaceutical segment generics program and an increase in products and distribution within our Medical segment, partially offset by the adverse impact of Pharmaceutical segment customer contract renewals. The increase in sales due to the COVID-19 pandemic had a modest positive impact on non-GAAP operating earnings during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The increase in non-GAAP operating earnings during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was primarily due to the beneficial impact of enterprise-wide cost-savings measures, the performance of our Pharmaceutical segment generics program and growth from Pharmaceutical specialty solutions, partially offset by the adverse impact of Pharmaceutical segment customer contract renewals.</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">GAAP and Non-GAAP Diluted EPS</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:47%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">($ per share)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020 </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019 </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020 </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2) (3)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;(2)</sup></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP diluted EPS </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1.19</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.99</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">20</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(14.84</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.88</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Surgical gown recall costs</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.24</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State opioid assessment related to prior fiscal years</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.01</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(0.01</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.13</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.21</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.24</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.34</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.39</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1.01</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.18</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.03</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.02</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1.20</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.09</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.03</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">17.80</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.04</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss on extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.01</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">0.02</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Transitional tax benefit, net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.02</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(0.04</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.03</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP diluted EPS </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1.62</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.59</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4.41</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.17</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The sum of the components may not equal the total due to rounding. </span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted earnings/(loss) per share attributable to Cardinal Health, Inc. ("diluted EPS" or "diluted loss per share")</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The reconciling items are presented within this table net of tax. See quantification of tax effect of each reconciling item in our GAAP to Non-GAAP Reconciliations in the "Explanation and Reconciliation of Non-GAAP Financial Measures." </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">For the nine months ended March 31, 2020, GAAP diluted loss per share attributable to Cardinal Health, Inc. and the EPS impact from the GAAP to non-GAAP per share reconciling items are calculated using a weighted average of 293 million common shares, which excludes potentially dilutive securities from the denominator due to their anti-dilutive effects resulting from our GAAP net loss for the period. Year-to-date fiscal 2020 non-GAAP diluted EPS is calculated using a weighted average of 295 million common shares, which includes potentially dilutive shares.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, GAAP diluted EPS increased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">20 percent</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> primarily due to factors discussed above impacting GAAP operating earnings, partially offset by a higher effective tax rate primarily due to changes in discrete tax items and jurisdictional mix. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$(14.84)</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> GAAP diluted loss per share due to the charge we recognized for the estimated liability associated with lawsuits and claims brought against us by states and political subdivisions relating to the distribution of prescription opioid pain medications. The charge had a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$(17.53)</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> per share after tax impact on GAAP diluted EPS during the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. GAAP diluted EPS during the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> also reflects a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1.25</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> per share gain from the divestiture of naviHealth.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, non-GAAP diluted EPS increased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2 percent</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1.62</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> per share. This increase was primarily due to the factors discussed above impacting non-GAAP operating earnings, mostly offset by a higher effective tax rate primarily due to changes in discrete tax items. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, non-GAAP diluted EPS increased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">6 percent</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$4.41</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> per share. This increase was primarily due to the factors discussed above impacting non-GAAP operating earnings, a lower share count as a result of share repurchases and lower interest expense due to</span><span style="font-family:Arial Narrow;font-size:10pt;"> less debt outstanding</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The year-over-year comparison was unfavorably impacted by a higher effective tax rate due to the benefit in the prior-year from discrete tax items, largely related to international legal entity changes.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash and Equivalents</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our cash and equivalents balance was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$2.3 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> compared to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$2.5 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span><span style="font-family:Arial Narrow;font-size:10pt;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, net cash provided by operating activities was </span><span style="font-family:Arial Narrow;font-size:10pt;">$1.7 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> and we deployed $</span><span style="font-family:Arial Narrow;font-size:10pt;">888 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> for long-term debt repayments, $</span><span style="font-family:Arial Narrow;font-size:10pt;">428 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> for cash dividends and </span><span style="font-family:Arial Narrow;font-size:10pt;">$350 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> for share repurchases.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">4</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:17pt;"><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Significant Developments in Fiscal </span><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">2020</span><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;"> and Trends</span></div><div style="line-height:120%;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">COVID-19</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As the COVID-19 pandemic continues to severely impact the U.S. and global economy, our businesses are being impacted in a variety of ways, beginning mostly in the last few weeks of the three months ended March 31, 2020 and continuing through the date of this filing, as discussed in the following paragraphs and under &#8220;Results of Operations&#8221;. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Within our manufacturing and distribution facilities, we have implemented preparedness plans that are designed to protect the safety of our employees and maintain continuity of our operations. Additionally, in line with various governmental recommendations to reduce large gatherings and practice social distancing, we have transitioned employees who can work remotely, to remote work locations. These measures have created additional burdens on our infrastructure and information technology systems and may result in decreased productivity. Furthermore, if a significant number of our employees are unable to perform their duties for a period of time, we may experience difficulties in operating one or more of our facilities which could adversely impact our financial results.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Within our Medical segment, we have seen dramatically increased demand for personal protective equipment (&#8220;PPE&#8221;), such as masks, gowns and gloves. We manufacture, source and distribute some of these PPE products and distribute PPE and other products manufactured by others. This increased demand resulted in an increase in sales volume for certain products in the three months ended March 31, 2020, but we do not expect continued increased sales due to supply shortages and disruptions for many of these products, which is likely to negatively impact our ability to meet customer demand. In addition, we may incur increased costs of PPE, which may adversely affect our results of operations. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Similarly, our Pharmaceutical Distribution and Specialty Solutions businesses experienced a temporary increase in sales volume toward the end of the three months ended March 31, 2020, which we believe to be related to accelerated purchasing by some customers due to the COVID-19 pandemic. We have experienced below average sales volume since the end of March and are uncertain when sales volume will return to expected levels.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Federal, state and local governmental policies and initiatives designed to reduce the transmission of COVID-19 also have resulted in, among other things, the cancellation or deferral of many elective medical procedures and some of our customers closing or severely curtailing their operations. To date, these policies and initiatives have resulted in a significant decrease in sales by our Nuclear and Precision Health Solutions division in our Pharmaceutical segment and reduced sales of certain Cardinal Health Brand products and Services in our Medical segment, among others. We cannot predict the duration of these policies and initiatives and expect that while they are in place, they will continue to have an adverse impact on the sales of these products and services.  </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Political, legal or regulatory actions as a result of the COVID-19 pandemic in jurisdictions where we manufacture, source or distribute products have created supply disruptions within both our Medical and, to a lesser extent, our Pharmaceutical segments and are likely to cause additional supply disruptions or shortages in the future. We cannot currently predict the frequency, duration or scope of these governmental actions and supply disruptions. For example, several countries, including India and China, have increased or instituted new restrictions on the export of medical or pharmaceutical products that we distribute or use in our businesses, including key components or raw materials. Governmental authorities in many countries, including the U.S., are enacting legislative or regulatory changes to address the impact of the pandemic, which may restrict or require changes in our operations, increase our costs, or otherwise adversely affect our operations.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">5</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Overview</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Opioid Lawsuits Development </span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2019, we agreed in principle to a global settlement framework with a leadership group of state attorneys general that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions (the "Settlement Framework"). This Settlement Framework is subject to contingencies and uncertainties as to final terms, but is the basis for our negotiation of definitive terms and documentation. The Settlement Framework includes (1) a cash component, pursuant to which we would pay up to </span><span style="font-family:Arial Narrow;font-size:10pt;">$5.56 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> over </span><span style="font-family:Arial Narrow;font-size:10pt;">eighteen years</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, (2) development and participation in a program for distribution of opioid abuse treatment medications for a period of ten years, and (3) industry-wide changes to be specified to controlled substance anti-diversion programs. We continue to negotiate the definitive terms of the Settlement Framework.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with this and with the October 2019 settlement to resolve all claims with two Ohio counties, we recorded a total pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.14 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> after tax) during the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in litigation (recoveries)/charges, net, in the condensed consolidated statement of earnings for the cash component. The amount of ultimate loss may differ materially from this accrual. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s054B3015E6505AB9825D03C656BE42ED"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements" for additional information. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Also in connection with these matters, we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$487 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$468 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid under the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> accrual taken in connection with the opioid litigation. The actual amount of tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sB7CDBCE5EBAC5E44B528F25DC21C6048"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the &#8220;Notes to the Condensed Consolidated Financial Statements&#8221; for additional information.</span></div><div style="line-height:120%;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">6</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sD60D612EF63A5932A7FB0B4DA5B68C95"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:17pt;"><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Results of Operations</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Revenue</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;"><img src="chart-63966054a2b856539df.jpg" alt="chart-63966054a2b856539df.jpg" style="height:200px;width:266px;"></img><img src="chart-c5eb687c6be4546d867.jpg" alt="chart-c5eb687c6be4546d867.jpg" style="height:200px;width:266px;"></img></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:47%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">35,112</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">31,361</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">12</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">104,254</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">96,516</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">8</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4,051</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3,871</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">11,991</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">11,678</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">39,163</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">35,232</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">11</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">116,245</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">108,194</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(6</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(4</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(12</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(13</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">39,157</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">35,228</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">11</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">116,233</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">108,181</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Pharmaceutical Segment </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Pharmaceutical segment revenue growth was primarily due to sales growth from pharmaceutical distribution and specialty solutions customers, which together increased revenue by </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$3.8 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$7.7 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. This growth included a temporary increase in pharmaceutical sales in March, which we believe to be related to accelerated purchasing by some customers in connection with the outbreak in the United States of the COVID-19 pandemic. We have experienced below average sales volume since the end of March.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Medical Segment</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Medical segment revenue increased during the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> primarily due to sales growth from products and distribution and Cardinal Health at-Home Solutions. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:4px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Cost of Products Sold</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cost of products sold f</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">or the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> increased </span><span style="font-family:Arial Narrow;font-size:10pt;">$3.8 billion</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">(</span><span style="font-family:Arial Narrow;font-size:10pt;">11 percent</span><span style="font-family:Arial Narrow;font-size:10pt;">) and </span><span style="font-family:Arial Narrow;font-size:10pt;">$7.9 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;">8 percent</span><span style="font-family:Arial Narrow;font-size:10pt;">) compared to the respective prior-year periods as a result of the factors affecting the changes in revenue and gross margin.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">7</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Gross Margin</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><img src="chart-90453b3d6ed050ecbdc.jpg" alt="chart-90453b3d6ed050ecbdc.jpg" style="height:200px;width:266px;"></img><img src="chart-84be621792a45ea38bb.jpg" alt="chart-84be621792a45ea38bb.jpg" style="height:200px;width:266px;"></img><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:47%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross margin</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,885</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,764</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5,278</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5,160</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gross margin during the three months ended&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> increased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$121 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> compared to the prior-year period primarily due to the performance from our Pharmaceutical segment generics program and Medical segment products and distribution sales growth.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gross margin during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> increased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$118 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> compared to the prior-year period primarily due to the performance from our Pharmaceutical segment generics program.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gross margin rate declined 20 basis points during the three months ended&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> mainly due to changes in pharmaceutical distribution product mix and the adverse impact of pharmaceutical customer contract renewals, partially offset by the performance of our Pharmaceutical segment generics program.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gross margin rate declined 23 basis points during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> mainly due to the adverse impact of pharmaceutical customer contract renewals, changes in pharmaceutical distribution product mix, and the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$55 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> charge in connection with a voluntary recall for Association for the Advancement of Medical Instrumentation ("AAMI") Level 3 surgical gowns and a voluntary recall and field actions for surgical procedure packs containing affected gowns (together, the "Recalls"), as described further within </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s054B3015E6505AB9825D03C656BE42ED"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements".</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:12px;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Distribution, Selling, General and Administrative ("SG&amp;A") Expenses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:47%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">SG&amp;A expenses</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,165</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,097</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3,435</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3,315</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, SG&amp;A expenses increased primarily due to enterprise-wide incentive compensation and higher costs to support sales growth. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, SG&amp;A expenses increased primarily due to higher costs to support sales growth and the&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$40 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;charge in connection with the Recalls as described further within </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s054B3015E6505AB9825D03C656BE42ED"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements."</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">8</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Segment Profit</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluate segment performance based on segment profit, among other measures. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sBB8F57EFBB3E56A1AB175224B7857442"><span style="font-family:Arial Narrow;font-size:10pt;">Note 13</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements" for additional information on segment profit.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><img src="chart-d47fafa037625ec1989.jpg" alt="chart-d47fafa037625ec1989.jpg" style="height:200px;width:266px;"></img><img src="chart-b4b418d5d2515afb95c.jpg" alt="chart-b4b418d5d2515afb95c.jpg" style="height:200px;width:266px;"></img><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">534</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">536</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,394</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,388</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">178</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">155</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">15</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">543</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">479</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">13</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">712</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">691</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">3</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,937</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,867</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(150</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(259</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(42</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(6,305</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(115</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total consolidated operating earnings/(loss)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">562</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">432</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">30</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4,368</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,752</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Pharmaceutical Segment Profit</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Pharmaceutical segment profit during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was essentially flat with the adverse impact of customer contract renewals offset by the favorable performance of our generics program. The increase in sales volume due to the COVID-19 pandemic had a modest positive impact on Pharmaceutical segment profit during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Pharmaceutical segment profit during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was essentially flat with the performance of our generics program and growth from specialty solutions, mostly offset by the adverse impact of customer contract renewals.</span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Medical Segment Profit</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Medical segment profit during the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> increased primarily due to the performance of products and distribution, including benefits from global manufacturing and cost-savings measures. The increase in sales volume due to the COVID-19 pandemic had a modest positive impact on Medical segment profit during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Medical segment financial results do not include the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$95 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> charge incurred during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in connection with the Recalls, as described further within </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s054B3015E6505AB9825D03C656BE42ED"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements".</span></div><div style="line-height:120%;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Corporate</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The changes in Corporate during the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;were due to the factors discussed in the Other Components of Consolidated Operating Earnings/(Loss) section that follows. </span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">9</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Other Components of Consolidated Operating Earnings/(Loss)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to revenue, gross margin and SG&amp;A expenses discussed previously, consolidated operating earnings/(loss) were impacted by the following:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:53%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(6</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">53</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">80</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">97</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">130</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">154</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">395</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">468</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(1</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">11</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">7</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(492</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">35</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">17</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5,729</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">20</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Restructuring and Employee Severance</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Restructuring and employee severance during both the three and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was primarily related to enterprise-wide cost-saving measures. The income during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was due to changes in estimates for accrued severance.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Amortization and Other Acquisition-Related Costs</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Amortization of acquisition-related intangible assets was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$129 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$133 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March 31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$385 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$399 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Transaction and integration costs associated with the acquisition of the Patient Recovery Business were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$1 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$17 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$62 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March 31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Impairments and (Gain)/Loss on Disposal of Assets, Net</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March 31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$508 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> related to the divestiture of our naviHealth business.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Litigation (Recoveries)/Charges, Net</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;">$5.14 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> after tax) associated with the opioid litigation. See Significant Developments in Fiscal 2020 and Trends section in this MD&amp;A for additional information.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The costs we recognized in connection with the IVC filter product liability claims during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$30 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$58 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$92 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$104 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> durin</span><span style="font-family:Arial Narrow;font-size:10pt;">g the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Recoveries in class action antitrust lawsuits recognized were </span><span style="font-family:Arial Narrow;font-size:10pt;">$46 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> during </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$16 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">$94 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> during</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March 31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Earnings/(Loss) Before Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition to the items discussed above, earnings/(loss) before income taxes were impacted by the following:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:47%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Change</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other (income)/expense, net</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">19</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(13</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">21</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">13</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Interest expense, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">60</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">75</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(20</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">189</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">227</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(17</span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss on extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">9</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other (Income)/Expense, Net</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">During the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, other (income)/expense, net was unfavorable compared to the respective prior-year periods primarily due to decreased returns from investments, which are used to offset fluctuations in deferred compensation liabilities that are included within SG&amp;A and discussed further in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s754FF11889B25B3797F9B44EE187CD4D"><span style="font-family:Arial Narrow;font-size:10pt;">Note 9</span></a><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Interest Expense, Net</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The decrease in interest expense during the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> was primarily due to less debt outstanding.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">10</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:25%;"></td><td style="width:52%;"></td><td style="width:23%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Results of Operations</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Provision for/(Benefit from) Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the effective tax rate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">26.8</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent and&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">20.0</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent, respectively. The increase in the effective tax rate for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> compared to the prior period was </span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">primarily due to changes in discrete tax items and jurisdictional mix.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the effective tax rate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">5.2</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;percent and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">22.6</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;percent, respectively. The decrease in the effective tax rate for the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> compared to the prior period was primarily due to the Settlement Framework, as described further in the Significant Developments in Fiscal 2020 and Trends section in this MD&amp;A.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">11</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s2BAC2A4211ED5DD6A929C5E929880169"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.40944881889764%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Liquidity and Capital Resources</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:17pt;"><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Liquidity and Capital Resources</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We currently believe that, based on available capital resources (cash on hand and committed credit facilities) and projected operating cash flow, we have adequate capital resources to fund working capital needs; currently anticipated capital expenditures; currently anticipated business growth and expansion; contractual obligations; tax payments; and current and projected debt service requirements, early extinguishment of debt, dividends and share repurchases as well as potential opioid litigation settlement payments associated with the Settlement Framework. If we decide to engage in one or more acquisitions, depending on the size and timing of such transactions, we may need to access capital markets for additional financing. We do not currently expect the impacts of the COVID-19 pandemic to result in material changes to our liquidity and capital resources or our ability to comply with financial commitments.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Cash and Equivalents</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Our cash and equivalents balance was </span><span style="font-family:Arial Narrow;font-size:10pt;">$2.3 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> compared to </span><span style="font-family:Arial Narrow;font-size:10pt;">$2.5 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">. At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, our cash and equivalents were held in cash depository accounts with major banks or invested in high quality, short-term liquid investments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, net cash provided by operating activities was </span><span style="font-family:Arial Narrow;font-size:10pt;">$1.7 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> and we deployed </span><span style="font-family:Arial Narrow;font-size:10pt;">$888 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> for long-term debt repayments, </span><span style="font-family:Arial Narrow;font-size:10pt;">$428 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> for cash dividends and </span><span style="font-family:Arial Narrow;font-size:10pt;">$350 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> for share repurchases.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Changes in working capital, which impact operating cash flow, can vary significantly depending on factors such as the timing of customer payments, inventory purchases and payments to vendors in the </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">regular course of business, as well as fluctuating working capital needs driven by customer and product mix. In addition, financial hardship to our customers or vendors as a result of the COVID-19 pandemic could adversely impact our working capital. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The cash and equivalents balance at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> includes </span><span style="font-family:Arial Narrow;font-size:10pt;">$805 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> of cash held by subsidiaries outside of the United States. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:16px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Other Financing Arrangements and Financial Instruments</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Credit Facilities and Commercial Paper</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to cash and equivalents and operating cash flow, other sources of liquidity at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> include a </span><span style="font-family:Arial Narrow;font-size:10pt;">$2.0 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> commercial paper program, backed by a </span><span style="font-family:Arial Narrow;font-size:10pt;">$2.0 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> revolving credit facility. We also have a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$1.0 billion</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;committed receivables sales facility. At&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had no amounts outstanding under our commercial paper program, revolving credit facility, or our committed receivables sales facility. During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had maximum amounts outstanding under our commercial paper program and our committed receivables program of </span><span style="font-family:Arial Narrow;font-size:10pt;">$1.7 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">$700 million</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively. The maximum combined total daily amounts outstanding was </span><span style="font-family:Arial Narrow;font-size:10pt;">$1.7 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> and the average daily amount outstanding was </span><span style="font-family:Arial Narrow;font-size:10pt;">$244 million</span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">Our revolving credit and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter through December 2020, a consolidated net leverage ratio of no more than 4.00-to-1. The maximum permitted ratio will reduce to 3.75-to-1 in March 2021 and as of the end of every quarter thereafter.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;">As of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;">, we were in compliance with this financial covenant.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Long-Term Debt and Other Short-Term Borrowings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had total long-term obligations</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, including the current portion and other short-term borrowings, of&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">$7.3 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. In November 2019, we repaid the full principal of the 2.4% Notes due 2019 at maturity for </span><span style="font-family:Arial Narrow;font-size:10pt;">$450 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span><span style="font-family:Arial Narrow;font-size:10pt;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;">we early repurchased</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">$247 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">2.616% </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Notes due 2022</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">$11 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">3.2% Notes due 2022</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">$20 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> of the  </span><span style="font-family:Arial Narrow;font-size:10pt;">Floating Rate Notes due 2022</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">$104 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">3.41% Notes due 2027</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">$6 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">4.6% Notes due 2043</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;">$5 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> of the  </span><span style="font-family:Arial Narrow;font-size:10pt;">4.9% Notes due 2045</span><span style="font-family:Arial Narrow;font-size:10pt;">, and </span><span style="font-family:Arial Narrow;font-size:10pt;">$35 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">4.368% Notes due 2047</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span><span style="font-family:Arial Narrow;">The repurchases were paid for with available cash and other short-term borrowings. In connection with the early debt repurchases, we recorded a</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">$9 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;">loss on extinguishment of debt.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">12</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.40944881889764%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Liquidity and Capital Resources</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:0px;padding-top:8px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Capital Deployment</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Opioid Settlement Framework</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In October 2019, we agreed in principle to a Settlement Framework which includes a cash component, pursuant to which we would pay up to </span><span style="font-family:Arial Narrow;font-size:10pt;">$5.56 billion</span><span style="font-family:Arial Narrow;font-size:10pt;"> over </span><span style="font-family:Arial Narrow;font-size:10pt;">eighteen years</span><span style="font-family:Arial Narrow;font-size:10pt;">. If a definitive agreement is reached, and subject to participation by states and political subdivisions, we expect payment amounts under the Settlement Framework to be spread through the 18-year period. We cannot currently predict when these payments will begin, and it is possible that they may ultimately be made over a different time period, or not at all. See </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Significant Developments in Fiscal 2020 and Trends section in this MD&amp;A </span><span style="font-family:Arial Narrow;font-size:10pt;">for additional information.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Capital Expenditures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Capital expenditures during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$239 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$192 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Dividends</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">On each of May 8, 2019, August 7, 2019, November 6, 2019 and February 11, 2020, our Board of Directors approved a quarterly dividend of $0.4811 per share, or $1.92 per share on an annualized basis, which were paid on July 15, 2019, October 15, 2019, January 15, 2020 and April 15, 2020, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Share Repurchases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;">$350 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of our common shares under an accelerated share repurchase ("ASR") program. We funded the ASR program with available cash and short-term borrowings. See </span><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#sC0D2D5319C8C576FB588B8F4B1EFA50D"><span style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">Note 11</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements" for additional information. At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$943 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> authorized for share repurchases. </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">13</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s6B7509F661EB5D2895483A6165FBD4B0"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.6328125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Items</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:17pt;"><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Other Items</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The MD&amp;A in our </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K addresses our contractual obligations and off-balance sheet arrangements, as of and for the fiscal year ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. There have been no subsequent material changes outside of the ordinary course of business to those items except for the agreement in principle on a global settlement framework designed to resolve all pending and future opioid lawsuits and claims brought by states and political subdivisions described in the Significant Developments in Fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and Trends section in this MD&amp;A and </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s054B3015E6505AB9825D03C656BE42ED"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements."</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">14</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sFFA39837D2CB554989E22F852FD8F121"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.01574803149606%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Critical Accounting Policies and Sensitive Accounting Estimates</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:17pt;"><span style="font-family:Arial Narrow;font-size:17pt;color:#ff0000;font-weight:bold;">Critical Accounting Policies and Sensitive Accounting Estimates</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The discussion and analysis presented below is a supplemental disclosure to the critical accounting policies and sensitive accounting estimates specified in our consolidated balance sheet at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. This discussion and analysis should be read in conjunction with the Critical Accounting Policies and Sensitive Accounting Estimates included in our </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K and our Forms 10-Q for the quarters ended September 30, 2019 and December 31, 2019.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Critical accounting policies are those accounting policies that (i) can have a significant impact on our financial condition and results of operations and (ii) require the use of complex and subjective estimates based upon past experience and management&#8217;s judgment. Other people applying reasonable judgment to the same facts and circumstances could develop different estimates. Because estimates are inherently uncertain, actual results may differ. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Goodwill</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Purchased goodwill is tested for impairment annually or when indicators of impairment exist. Goodwill impairment testing involves a comparison of the estimated fair value of reporting units to the respective carrying amount, which may be performed utilizing either a qualitative or quantitative assessment. Qualitative factors are first assessed to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There is an option to bypass the qualitative assessment for any reporting unit in any period and proceed directly to performing the quantitative goodwill impairment test. We elected to bypass the qualitative assessment for our annual impairment test in fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.  Additionally, we elected to bypass the qualitative assessment and perform an interim goodwill impairment test for our Medical Unit at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. A reporting unit is defined as an operating segment or one level below an operating segment (also known as a component).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Goodwill impairment testing involves judgment, including the identification of reporting units, qualitative evaluation of events and circumstances to determine if it is more likely than not that an impairment exists, and, if necessary, the estimation of the fair value of the applicable reporting unit. Our qualitative evaluation considers the weight of evidence and significance of all identified events and circumstances and most relevant drivers of fair value, both positive and negative, in determining whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount.</span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Medical Unit Goodwill </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As noted within </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s054B3015E6505AB9825D03C656BE42ED"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements", we recorded a charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$95 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> within Corporate during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in connection with the Recalls that is allocated to the Medical Unit for purposes of goodwill impairment testing. Primarily due to the risks and uncertainties to the business from both the Recalls and the COVID-19 pandemic, we elected to bypass the qualitative assessment and perform interim goodwill impairment testing for the Medical Unit during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The carrying value of this reporting unit at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$10.1</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> billion, of which </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$4.2</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> billion was goodwill. The fair value of the reporting unit was estimated to be approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">10</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent in excess of its carrying value, using a combination of the income-based approach (using a discount rate of 8.5 percent and a terminal growth rate of 2 percent), and the market-based approach.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Adverse changes in key assumptions, including related to our current assumptions about the impact of the Recalls and the COVID-19 pandemic which could cause a decrease in future cash flows; an increase in the discount rate; or a decrease in the terminal growth rate, among other things, could result in a goodwill impairment for the Medical Unit. For example, if we were to increase the discount rate by 1.0 percent, the carrying value would have exceeded the fair value for our Medical Unit by approximately 1 percent at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Loss Contingencies</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the opioid litigation as described further in the Significant Developments in Fiscal 2020 and Trends section in this MD&amp;A, we recorded a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;">$5.14 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> after tax) during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. We accrue for contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. Definitive terms of a settlement under the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. We will regularly review opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual.</span></div><div style="line-height:174%;padding-bottom:4px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">15</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.01574803149606%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">MD&amp;A</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Critical Accounting Policies and Sensitive Accounting Estimates</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:174%;padding-bottom:4px;text-align:justify;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">Provision for Income Taxes</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Tax benefits from uncertain tax positions are recognized when it is more likely than not that the position will be sustained upon examination of the technical merits of the position, including resolutions of any related appeals or litigation. The amount recognized is measured as the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. For tax benefits that do not qualify for recognition, we recognize a liability for unrecognized tax benefits. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax charge for the opioid litigation, during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$487 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$468 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">changed by the Tax Act. Further, it is possible that the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sB7CDBCE5EBAC5E44B528F25DC21C6048"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the Notes to the "Condensed Consolidated Financial Statements" for more information regarding these matters. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years 2008 through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including IRS challenges to our international transfer pricing for the periods from 2008 to 2014, and it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div></div><div><a id="sD432D95941E5536593F030C5B83DE887"></a></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ff0000;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The "Overview of Consolidated Results" section within MD&amp;A in this Form 10-Q contains financial measures that are not calculated in accordance with GAAP. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">In addition to analyzing our business based on financial information prepared in accordance with GAAP, we use these non-GAAP financial measures internally to evaluate our performance, engage in financial and operational planning, and, in most cases, determine incentive compensation because we believe that these measures provide additional perspective on and, in some circumstances are more closely correlated to, the performance of our underlying, ongoing business. We provide these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on our financial and operating results on a year-over-year basis and in comparing our performance to that of our competitors. However, the non-GAAP financial measures that we use may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. The non-GAAP financial measures disclosed by us should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth below should be carefully evaluated.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Exclusions from Non-GAAP Financial Measures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">Management believes it is useful to exclude the following items from the non-GAAP measures presented in this report for its own and for investors&#8217; assessment of the business for the reasons identified below:</span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">LIFO charges and credits</span><span style="font-family:Arial Narrow;"> are excluded because the factors that drive last-in first-out ("LIFO") inventory charges or credits, such as pharmaceutical manufacturer price appreciation or deflation and year-end inventory levels (which can be meaningfully influenced by customer buying behavior immediately preceding our fiscal year-end), are largely out of our control and cannot be accurately predicted. The exclusion of LIFO charges and credits from non-GAAP metrics facilitates comparison of our current financial results to our historical financial results and to our peer group companies&#8217; financial results.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Surgical gown recall costs</span><span style="font-family:Arial Narrow;"> includes inventory write-offs and certain remediation and supply disruption costs arising from the January 2020 recall of select Association for the Advancement of Medical Instrumentation ("AAMI") Level 3 surgical gowns and voluntary field actions (a recall of some packs and a corrective action allowing overlabeling of other packs) for Presource Procedure Packs containing affected gowns. We have excluded these costs from our non-GAAP metrics to allow investors to better understand the underlying operating results of the business and to facilitate comparison of our current financial results to our historical financial results and to our peer group companies&#8217; financial results.  </span><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">16</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:51%;"></td><td style="width:24%;"></td><td style="width:25%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">State opioid assessments related to prior fiscal years</span><span style="font-family:Arial Narrow;"> is the portion of state assessments for prescription opioid medications that were sold or distributed in periods prior to the fiscal year of the initial assessment. This portion is excluded from non-GAAP financial measures because it is retrospectively applied to sales in prior fiscal years and inclusion would obscure analysis of the current fiscal year results of our underlying, ongoing business. Additionally, while states' laws may require us to make payments on an ongoing basis, the portion of the assessment related to sales in prior periods are contemplated to be one-time, nonrecurring items. Reversals of these accruals have occurred when certain assessments were found by a Court unconstitutional.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Restructuring and employee severance costs</span><span style="font-family:Arial Narrow;"> are excluded because they are not part of the ongoing operations of our underlying business.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Amortization and other acquisition-related costs</span><span style="font-family:Arial Narrow;">, which include transaction costs, integration costs, and changes in the fair value of contingent consideration obligations, are excluded because they are not part of the ongoing operations of our underlying business and to facilitate comparison of our current financial results to our historical financial results and to our peer group companies' financial results. Additionally, costs for amortization of acquisition-related intangible assets are non-cash amounts, which are variable in amount and frequency and are significantly impacted by the timing and size of acquisitions, so their exclusion facilitates comparison of historical, current and forecasted financial results. We also exclude other acquisition-related costs, which are directly related to an acquisition but do not meet the criteria to be recognized on the acquired entity&#8217;s initial balance sheet as part of the purchase price allocation. These costs are also significantly impacted by the timing, complexity and size of acquisitions.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Impairments and gain or loss on disposal of assets</span><span style="font-family:Arial Narrow;">&#160;are excluded because they do not occur in or reflect the ordinary course of our ongoing business operations and are inherently unpredictable in timing and amount, and in the case of impairments, are non-cash amounts, so their exclusion facilitates comparison of historical, current and forecasted financial results.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Litigation recoveries or charges, net</span><span style="font-family:Arial Narrow;"> are excluded because they often relate to events that may have occurred in prior or multiple periods, do not occur in or reflect the ordinary course of our business and are inherently unpredictable in timing and amount.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Loss on extinguishment of debt</span><span style="font-family:Arial Narrow;"> is excluded because it does not typically occur in the normal course of business and may obscure analysis of trends and financial performance. Additionally, the amount and frequency of this type of charge is not consistent and is significantly impacted by the timing and size of debt extinguishment transactions.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#8226;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;text-decoration:underline;">Transitional tax benefit, net</span><span style="font-family:Arial Narrow;"> related to the Tax Cuts and Jobs Act is excluded because it results from the one-time impact of a very significant change in the U.S. federal corporate tax rate and, due to the significant size of the benefit, obscures analysis of trends and financial performance. The transitional tax benefit includes the initial estimate and subsequent adjustments for the re-measurement of deferred tax assets and liabilities due to the reduction of the U.S. federal corporate income tax rate and the repatriation tax on undistributed foreign earnings.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;">The tax effect for each of the items listed above, other than the transitional tax benefit item, is determined using the tax rate and other tax attributes applicable to the item and the jurisdiction(s) in which the item is recorded. The gross, tax and net impact of each item are presented with our GAAP to non-GAAP reconciliations.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:16pt;font-weight:bold;">Definitions</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Growth rate calculation:</span><span style="font-family:Arial Narrow;"> growth rates in this Form 10-Q are determined by dividing the difference between current-period results and prior-period results by prior-period results.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Non-GAAP operating earnings</span><span style="font-family:Arial Narrow;">: operating earnings/(loss) excluding (1) LIFO charges/(credits), (2) surgical gown recall costs, (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, and (7) litigation (recoveries)/charges, net.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Non-GAAP earnings before income taxes</span><span style="font-family:Arial Narrow;">: earnings/(loss) before income taxes excluding (1) LIFO charges/(credits), (2) surgical gown recall costs, (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, (7) litigation (recoveries)/charges, net, and (8) loss on extinguishment of debt.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Non-GAAP net earnings attributable to Cardinal Health, Inc.</span><span style="font-family:Arial Narrow;">: net earnings/(loss) attributable to Cardinal Health, Inc. excluding (1) LIFO charges/(credits), (2) surgical gown recall costs, (3) state opioid assessment related to prior fiscal years, (4) restructuring and employee severance, (5) amortization and other acquisition-related costs, (6) impairments and (gain)/loss on disposal of assets, (7) litigation (recoveries)/charges, net, (8) loss on extinguishment of debt, each net of tax, and (9) transitional tax benefit, net.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-weight:bold;">Non-GAAP diluted earnings per share attributable to Cardinal Health, Inc.</span><span style="font-family:Arial Narrow;">: non-GAAP net earnings attributable to Cardinal Health, Inc. divided by diluted weighted-average shares outstanding.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">17</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s011E49C33A125B46BC2272537A9A1EEA"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:51%;"></td><td style="width:24%;"></td><td style="width:25%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">GAAP to Non-GAAP Reconciliation</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:32%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Earnings/(Loss)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Earnings Growth Rate</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings/(Loss) Before Income Taxes</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Provision for/(Benefit from) Income Taxes</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net Earnings/(Loss)</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net Earnings/(Loss)</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;Growth Rate</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Diluted EPS</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1,2</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Diluted EPS</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;Growth Rate</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="21" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2020</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">562</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">30</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">478</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">127</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">350</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">18</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1.19</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">20</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Surgical gown recall costs</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(6</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(6</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(3</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(3</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(0.01</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">130</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">130</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">31</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">99</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.34</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">35</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">35</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">8</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">27</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.09</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss on extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.01</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Transitional tax benefit, net</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">719</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">8</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">639</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">164</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">474</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1.62</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="21" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Three Months Ended March 31, 2019</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">GAAP</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">432</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(21</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">370</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">74</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">296</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">16</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.99</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">22</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">53</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">53</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">14</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">39</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.13</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">154</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">154</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">38</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">116</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.39</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">11</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">11</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.03</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">17</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">17</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.03</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Transitional tax benefit, net</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(5</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.02</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-GAAP</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">667</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(15</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">605</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">130</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">475</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">9</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.59</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">14</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="21" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31, 2020</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">GAAP</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;</sup></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4,368</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4,587</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(237</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(4,352</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(14.84</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N.M</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Surgical gown recall costs</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">95</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">95</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">25</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">70</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.24</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">State opioid assessment related to prior fiscal years</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.01</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">80</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">80</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">18</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">62</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.21</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">395</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">395</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">98</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">297</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.01</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">6</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.02</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">3</sup></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5,729</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5,729</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">509</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5,220</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">17.80</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss on extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">9</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.02</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Transitional tax benefit, net</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">12</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(12</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(0.04</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Non-GAAP</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">&#160;</sup></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,942</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">5</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,732</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">429</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">1,300</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">4.41</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">6</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="21" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nine Months Ended March 31, 2019</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">GAAP</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,752</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">45</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,512</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">342</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,169</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(18</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.88</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(14</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">97</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">97</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">25</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">72</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.24</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">468</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">468</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">112</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">356</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1.18</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(492</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(492</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(129</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(363</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(1.20</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">20</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">20</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">13</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.04</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Transitional tax benefit, net</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(8</span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">8</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">0.03</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-GAAP</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,845</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">(13</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,605</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">349</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,255</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.17</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">5</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;%</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">18</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:51%;"></td><td style="width:24%;"></td><td style="width:25%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Explanation and Reconciliation of Non-GAAP Financial Measures</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">1</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Attributable to Cardinal Health, Inc.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">2</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">For the nine months ended March 31, 2020, GAAP diluted loss per share attributable to Cardinal Health, Inc. and the EPS impact from the GAAP to non-GAAP per share reconciling items are calculated using a weighted average of 293 million common shares, which excludes potentially dilutive securities from the denominator due to their anti-dilutive effects resulting from our GAAP net loss for the period. Year-to-date fiscal 2020 non-GAAP diluted EPS is calculated using a weighted average of 295 million common shares, which includes potentially dilutive shares.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">3</sup>&#160;</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;">Litigation (recoveries)/charges, net includes a pre-tax charge of</span><span style="font-family:Arial Narrow;font-size:9pt;"> </span><span style="font-family:Arial Narrow;font-size:9pt;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:9pt;"> </span><span style="font-family:Arial Narrow;font-size:9pt;">($5.14 billion after tax) recorded in the first quarter of fiscal 2020 related to the opioid litigation. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The sum of the components may not equal the total due to rounding.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We apply varying tax rates depending on the item's nature and tax jurisdiction where it is incurred.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:9pt;"><span style="font-family:Arial Narrow;font-size:9pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">19</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s1DF21AC68B9E50EA9ACA709B13C5739C"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:25%;"></td><td style="width:75%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:2pt;"><span style="font-family:inherit;font-size:2pt;"><br/></span></div></div></div><div><a id="s524C8134125A5F01AB88EEFF8006DD5A"></a></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">There have been no material changes in the quantitative and qualitative market risk disclosures included in our&#160;2019&#160;Form 10-K since the end of fiscal&#160;2019&#160;through&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div><a id="s91B1FB400D41594EB9C06B28B18291C3"></a></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Controls and Procedures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;font-weight:bold;">Evaluation of Disclosure Controls and Procedures</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluated, with the participation of our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")) as of</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Based on this evaluation, our principal executive officer and principal financial officer have concluded that as of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;font-weight:bold;">Changes in Internal Control Over Financial Reporting</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">There were no changes in our internal control over financial reporting during the quarter ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div><a id="s9909505D248E51E48CF18A6646D92F4E"></a></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ff0000;font-weight:bold;">Legal Proceedings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to the proceeding described below, the legal proceedings described in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s054B3015E6505AB9825D03C656BE42ED"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;"> of the "Notes to Condensed Consolidated Financial Statements" are incorporated in this "Legal Proceedings" section by reference.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In June 2019, Melissa Cohen, a purported shareholder, filed an action on behalf of Cardinal Health, Inc. in the U.S. District Court for the Southern District of Ohio against certain current and former members of our Board of Directors alleging that the defendants breached their fiduciary duties by failing to effectively monitor Cardinal Health's distribution of controlled substances. The derivative complaint seeks, among other things, unspecified money damages against the defendants and an award of attorneys' fees. In December 2019 and January 2020, similar complaints were filed in the U.S. District Court for the Southern District of Ohio by purported shareholders, Stanley M. Malone and Michael Splaine, respectively. In January, 2020, the court consolidated the derivative cases under the caption </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">In re Cardinal Health, Inc. Derivative Litigation</span><span style="font-family:Arial Narrow;font-size:10pt;"> and in March 2020, plaintiffs filed an amended complaint. The amended derivative complaint seeks, among other things, unspecified money damages against the defendants and an award of attorneys' fees.</span></div><div><a id="sE462DDDB9F695421BDF161325CCD492F"></a></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Risk Factors</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">You should carefully consider the information in this Form 10-Q, including the risk factors below, and the risk factors discussed in "Risk Factors" and other risks discussed in our </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K, our Forms 10-Q for the quarters ended September 30, 2019 and December 31, 2019, and other filings with the SEC since </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These risks could materially and adversely affect our results of operations, financial condition, liquidity, and cash flows. Our business also could be affected by risks that we are not presently aware of or that we currently consider immaterial to our operations.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">We have been and expect to continue to be negatively affected by the ongoing COVID-19 pandemic.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#212529;">In addition to the actual and possible effects of the COVID-19 pandemic and resulting disruptions on our business and operations discussed above in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; we face other possible adverse impacts from the COVID-19 pandemic. Among other possible consequences, we may become subject to claims or lawsuits by employees, customers, suppliers or other parties regarding actions we take in our operations in response to the pandemic. Financial hardship to our customers and others could adversely impact the timing and collectability of payments to us from customers and require an increase in reserves against our accounts </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#212529;">receivable. Additionally, the situation has and will likely continue to give rise to or amplify other risks that could adversely affect our results of operations, financial condition, liquidity or cash flows</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#212529;">As a critical player in the global healthcare supply chain, we are participating in industry-wide collaboration with the U.S. government and other distributors intended to increase the availability of PPE in the U.S and may participate in additional efforts relating to other products. In connection with these efforts, we have received information requests from several members of the U.S. Congress and could be investigated or have enforcement actions instituted against us by one or more agencies of the U.S., state or international governments and have and could receive negative publicity. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">20</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:25%;"></td><td style="width:75%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#212529;">We cannot estimate the length or severity of the COVID-19 pandemic or the related consequences on the U.S. and global economy and our business and operations, including whether and when normal economic and operating conditions will resume or the extent to which the disruption may impact our business, financial position, results of operations or cash flow. The COVID-19 pandemic also may give rise to or heighten many of the risks we have previously identified, including risks associated with supplier relationships, international operations, regulatory and licensing, changes to the U.S. healthcare environment, cyber security, access to capital markets, and goodwill impairment, discussed further in our Annual Report on Form 10-K for the fiscal year ended June 30, 2019, and our Quarterly Reports on Form 10-Q for the quarters ended September 30, 2019 and December 31, 2019. COVID-19 may also adversely affect our operating and financial results in a manner that is not currently known to us or that we do not currently consider a significant risk. </span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">The public health crisis involving the abuse of prescription opioid pain medication and our efforts to resolve related claims could have additional or unexpected material negative effects on our business</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Pharmaceutical segment distributes prescription opioid pain medications. In recent years, the abuse of prescription opioid pain medication has become a public health crisis.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">A significant number of counties, municipalities and other plaintiffs, including a number of state attorneys general, have filed lawsuits against pharmaceutical manufacturers, pharmaceutical wholesale distributors (including us), retail chains and others relating to the manufacturing, marketing or distribution of prescription opioid pain medications. In addition, we are currently being investigated or sued by other states for the same activities and could be named as a defendant in additional lawsuits. The defense and resolution of current and future lawsuits and events relating to these lawsuits are subject to uncertainty and could have a material adverse effect on our results of operations, financial condition, cash flows, liquidity, our ability to pay dividends or repurchase our shares, or have adverse reputational or operational effects on our business. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2019, we agreed in principle to a Settlement Framework and in connection with this development we recorded a pre-tax accrual of </span><span style="font-family:Arial Narrow;font-size:10pt;">$5.56 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in the nine months ended March 31, 2020. This Settlement Framework is subject to contingencies but is the basis for our negotiation of definitive terms and documentation. Definitive terms of a settlement under the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. We will regularly review opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual. See&#160;</span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s4E63F8E98BD858D2B62213E5E2185201"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;of the "Notes to Condensed Consolidated Financial Statements" for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Other legislative, regulatory or industry measures related to the public health crisis involving the abuse of prescription opioid pain </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">medication and the distribution of these medications could affect our business in ways that we may not be able to predict. For example, several states have now adopted taxes or other fees on the sale of opioids, and several other states have proposed similar legislative initiatives. These laws and proposals vary in the tax amounts imposed and the means of calculation. Liabilities for taxes or assessments under any such laws could have an adverse impact on our results of operations unless we are able to mitigate them through operational changes or commercial arrangements where permitted.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Ongoing unfavorable publicity regarding the abuse or misuse of prescription opioid pain medications and the role of wholesale distributors in the supply chain of such prescription medications, as well as the continued proliferation of the opioid lawsuits, investigations, regulations and legislative actions, and unfavorable publicity in relation to those lawsuits could have a material adverse effect on our reputation or results of operations.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">We could be subject to adverse changes in the tax laws or challenges to our tax positions. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are a large multinational corporation with operations in the United States and many foreign countries. As a result, we are subject to the tax laws of many jurisdictions. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">From time to time, initiatives are proposed in the United States and other jurisdictions in which we operate that could adversely affect our tax positions, effective tax rate or tax payments. Specific initiatives that may impact us include the repeal of the LIFO (last-in, first-out) method of inventory accounting for income tax purposes, the establishment or increase in taxation at the U.S. state level on the basis of gross revenues, recommendations of the recently completed base erosion and profit shifting project undertaken by the Organization for Economic Cooperation and Development and the European Commission&#8217;s investigation into illegal state aid. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Additionally, in connection with the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$5.63 billion</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax charge for the opioid litigation, in the nine months ended March 31, 2020, we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$487 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">$468 million</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the Tax Act.  Further, it is possible that the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s9C0D5CD6013852EF853A9B500CE008E1"><span style="font-family:Arial Narrow;font-size:10pt;">Note 8</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the "Notes to Condensed Consolidated Financial Statements" for more information regarding these matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">21</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:25%;"></td><td style="width:75%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">years 2008 through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including IRS challenges to our international transfer pricing for the periods from 2008 to 2014, and </span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.</span></div></div></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></div></div><div><a id="sA5369DE2A7B551D9A7BCDFADEF743FFC"></a></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Issuer Purchases of Equity Securities</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:15%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:20%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total Number<br/>of Shares<br/>Purchased&#160;(1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Average Price Paid&#160;per Share</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total Number of Shares<br/>Purchased<br/>as Part of Publicly Announced Programs&#160;(2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Approximate</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Dollar Value of</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Shares That May</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Yet be Purchased</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Under the Program&#160;(2)</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">(in millions)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">January 2020</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">1,678</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">53.60</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">943</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">February 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">223</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">58.58</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">943</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">March 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">216</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">47.41</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">943</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2,117</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">53.49</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">943</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Reflects </span><span style="font-family:Arial Narrow;font-size:8pt;">1,678</span><span style="font-family:Arial Narrow;font-size:8pt;">, </span><span style="font-family:Arial Narrow;font-size:8pt;">223</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">216</span><span style="font-family:Arial Narrow;font-size:8pt;"> common shares purchased in </span><span style="font-family:Arial Narrow;font-size:8pt;">January</span><span style="font-family:Arial Narrow;font-size:8pt;">, </span><span style="font-family:Arial Narrow;font-size:8pt;">February</span><span style="font-family:Arial Narrow;font-size:8pt;"> and </span><span style="font-family:Arial Narrow;font-size:8pt;">March</span><span style="font-family:Arial Narrow;font-size:8pt;"> </span><span style="font-family:Arial Narrow;font-size:8pt;">2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, respectively, through a rabbi trust as investments of participants in our Deferred Compensation Plan. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">On February 7, 2018, our Board of Directors approved a $1.0 billion share repurchase program that was completed in December 2019. On November 7, 2018, our Board of Directors approved a $1.0 billion share repurchase program that expires on December 31, 2021 and as of March 31, 2020, we have $943 million authorized for share repurchases remaining under this program.</span></div></td></tr></table><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;padding-left:24px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">22</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sB86F24C5EDD55920839EBB1BAE2C4546"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:14pt;"><span style="font-family:Arial Narrow;font-size:14pt;"><br/></span></div><div><a id="s5134E92FB23E597F804A558EAB99AF7A"></a></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Statements of Earnings/(Loss)</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">(Unaudited)</span></div><div style="line-height:120%;padding-bottom:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:53%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per common share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e2937-wk-Fact-B5678807817E002A2C5254B51ACDCA6C" name="us-gaap:Revenues" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39,157</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e2956-wk-Fact-1CCE01CC0FAB05B634D054B51AAD948A" name="us-gaap:Revenues" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,228</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e2975-wk-Fact-95BB44ACFE0A3C8D473654B51AA5FF98" name="us-gaap:Revenues" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">116,233</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e2995-wk-Fact-2D6DD524F1EBD75BAFA054B51AA8777B" name="us-gaap:Revenues" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">108,181</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cost of products sold</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3010-wk-Fact-C89690A278F35814348254B51AC2BB05" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37,272</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3029-wk-Fact-C58DF660935EDDFB43C954B51AA2B2DE" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33,464</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3048-wk-Fact-30A224BFBEC760DBBD1354B51ADA1114" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">110,955</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3068-wk-Fact-9E3FF4DDBFCA6B5CB7C954B51B012265" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">103,021</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross margin</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3088-wk-Fact-4118215C16A561B788EB54B51B19D085" name="us-gaap:GrossProfit" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,885</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3107-wk-Fact-3C213EABD9DBDAACA5D854B51AEC7BBE" name="us-gaap:GrossProfit" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,764</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3126-wk-Fact-AAD4CE138DEEEF77CC0F54B51A81630C" name="us-gaap:GrossProfit" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,278</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3146-wk-Fact-3F03E0677B006461518054B51B0ACB11" name="us-gaap:GrossProfit" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,160</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating expenses:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Distribution, selling, general and administrative expenses</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3330-wk-Fact-F1280C73126656C973ED54B51A9FBA9C" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,165</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3349-wk-Fact-3AB3B9B158C893B109A554B51AA62DA2" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,097</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3368-wk-Fact-C5F41C052A5CAA15D74754B51AE3A76E" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,435</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3388-wk-Fact-3718D3E045514DEA725354B51B073C49" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,315</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restructuring and employee severance</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55354548e3408-wk-Fact-CDD23AFADBFEF20CF0C854B51B130038" name="us-gaap:RestructuringCharges" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3428-wk-Fact-D12C27E0834E4710F68054B51ABA0B0B" name="us-gaap:RestructuringCharges" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3447-wk-Fact-9EF350966CEAF3367B0F54B51AF25715" name="us-gaap:RestructuringCharges" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">80</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3467-wk-Fact-DC1310CD717A52D67B3D54B51AEE96B6" name="us-gaap:RestructuringCharges" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">97</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization and other acquisition-related costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3487-wk-Fact-8D6AFCDF057859D9B6DE54B51B1A4C81" name="cah:Amortizationandotheracquisitionrelatedcosts" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">130</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3506-wk-Fact-FFACB6CEC5105828FB2254B51B2192F9" name="cah:Amortizationandotheracquisitionrelatedcosts" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">154</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3525-wk-Fact-4C18BD900DE70D5A57D354B51AABCDEA" name="cah:Amortizationandotheracquisitionrelatedcosts" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">395</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3545-wk-Fact-C74667F4FA2345E604B454B51AA48B27" name="cah:Amortizationandotheracquisitionrelatedcosts" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">468</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55354548e3565-wk-Fact-EA706E4D9F2D1B15B80654B51AEAA01C" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3585-wk-Fact-2FE6D337637D8F3E9D9254B51B0F4FD3" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3604-wk-Fact-3F237E8C094C4D20E87554B51AE6B03E" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55354548e3624-wk-Fact-4258B5E0825630CFC45754B51ABA8334" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">492</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Litigation (recoveries)/charges, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3646-wk-Fact-C58F46D1036CF11CB39554B51AA5A96B" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3665-wk-Fact-6B6D0B306B30DE64D5D154B51A7FD9A5" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3684-wk-Fact-8A4BC8D191A614D4B11C54B51AFFC113" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5,729</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3704-wk-Fact-D2372DF3B7903BCC3C9954B51AA78942" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3724-wk-Fact-214140D02A180F197B4954B51A8F21D9" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">562</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3743-wk-Fact-DF69602F2038573D567154B51B043599" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">432</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55354548e3762-wk-Fact-0D29BC4669F150A7E4BD54B51AA61445" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,368</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3783-wk-Fact-7336E4EDFE2DAA666FCC54B51A8823BF" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,752</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other (income)/expense, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3885-wk-Fact-ACB2BA5C8E31A83F001C54B51ABF49A7" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55354548e3904-wk-Fact-72628D183A60CB34B99F54B51AB7DBA8" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3924-wk-Fact-DCE43C99C2E08BF4E10054B51ABB0227" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">21</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3944-wk-Fact-34936A6785BAA8949D5254B51A9F33FB" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Interest expense, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e3964-wk-Fact-6B77C77920BAABD2A59054B51A80BD8B" name="us-gaap:InterestExpense" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">60</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e3983-wk-Fact-C7C543F2798DB575AB0054B51A8CEE79" name="us-gaap:InterestExpense" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">75</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e4002-wk-Fact-3CAE29399BE4FE27715754B51AA7C525" name="us-gaap:InterestExpense" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">189</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4022-wk-Fact-C846E2E1581C4AEC0E6B54B51A91E362" name="us-gaap:InterestExpense" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">227</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss on extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e4042-wk-Fact-FD435428437A218052EC54B51AA56CA2" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e4061-wk-Fact-CB1A0E64377CA6969A2C54B51AA9E7B8" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e4080-wk-Fact-5F9B3DE83DE70A97FD6454B51AA69642" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4100-wk-Fact-13EB6853A5D82CF9B36854B51B20E343" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Earnings/(loss) before income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e4120-wk-Fact-CB138D4E4575F46ED54A54B51B26B0E4" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">478</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4139-wk-Fact-3A6787092D6E9ABB9FF454B51A856FD6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">370</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55354548e4158-wk-Fact-57DA495F244616B33DFA54B51B1ABF6C" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,587</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4179-wk-Fact-9000324042B2C60A5A8A54B51AFEEE66" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,512</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Provision for/(benefit from) income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e4281-wk-Fact-2547B3EC90BC7B32789C54B51AF028B0" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">127</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4300-wk-Fact-43BDD7AE624BEA480B6C54B51AA288B2" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">74</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55354548e4319-wk-Fact-F243BE4C240FCCAAE51454B51B139C87" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">237</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4340-wk-Fact-DB9104E46BCF02DAC24E54B51AE4E1B1" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">342</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e4360-wk-Fact-EB709ACC766503B2370C54B51AC127E0" name="us-gaap:ProfitLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">351</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4379-wk-Fact-2DB02FE7A9D905403B8061C9D4E58E9A" name="us-gaap:ProfitLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">296</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55354548e4398-wk-Fact-F078490E78EE8F83C79754B51AA13A98" name="us-gaap:ProfitLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4419-wk-Fact-67590E840E811BAA718E54B51ABE7580" name="us-gaap:ProfitLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,170</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55354548e4522-wk-Fact-0E6B894266D67A681EA754B51B10F1D9" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4542-wk-Fact-A81364456FEA3E37EBBA54B51B0B1906" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55354548e4561-wk-Fact-69248AD84D3E8B62216254B51AC58F9B" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55354548e4582-wk-Fact-25C2752A6A28A1DCDD1954B51AC77D31" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Net earnings/(loss) attributable to Cardinal Health, Inc. </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e4608-wk-Fact-35EF6B3029BEDC008B5054B51AAECB0B" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4627-wk-Fact-33B1AB25C580C3A0D03454B51AFE9FFF" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">296</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55354548e4646-wk-Fact-105C2CDA654CB50A699A54B51AD31834" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,352</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4667-wk-Fact-42887B037229FD92376954B51A820B65" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,169</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Earnings/(loss) per common share attributable to Cardinal Health, Inc.:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e4851-wk-Fact-35B7388269F954955FFF54B51AA4B5E1" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="FD2020Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4870-wk-Fact-4DC02757D3A3F5D76FEA54B51AA69EA6" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="FD2019Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.99</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55354548e4889-wk-Fact-BAAE7044E8133D6FD2B854B51B1CC35D" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="FD2020Q3YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">14.84</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4910-wk-Fact-D079ABA865704BE9C72654B51B0BE160" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="FD2019Q3YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">3.89</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e4925-wk-Fact-31525DD9F24C571C700A54B51AC5418E" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="FD2020Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">1.19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4944-wk-Fact-663244E0C075DB4674D654B51AC5A554" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="FD2019Q3QTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">0.99</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55354548e4963-wk-Fact-347F63DCD1F9E111706354B51A86D6D7" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="FD2020Q3YTD" unitRef="usdPerShare" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">14.84</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e4984-wk-Fact-5EF65F8234B4FBC2137D54B51AB7236E" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="FD2019Q3YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">3.88</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average number of common shares outstanding:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Basic</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e5168-wk-Fact-0B26D6B638400FB2D18454B51B21CD14" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2020Q3QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">292</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e5187-wk-Fact-556A52112788EC9E118654B51A8B31D9" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q3QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">298</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e5206-wk-Fact-F2F36F531E2C061568FA54B51A8E1510" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">293</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e5226-wk-Fact-5535B20D9FD47662E0D254B51AAC6E51" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">301</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Diluted</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e5246-wk-Fact-3C5E39C3EF23C07BA0ED54B51A99B73A" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2020Q3QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">294</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e5265-wk-Fact-74BC951CA67E200BA9E754B51AFCDAED" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q3QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">299</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e5284-wk-Fact-F6D925A67782C67F989554B51A86E258" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">293</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e5304-wk-Fact-526E27FF304324D2092354B51B2388DA" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">302</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash dividends declared per common share</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e5412-wk-Fact-B0D5CE26FB5D366931C554B51ABB6EB2" name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="FD2020Q3QTD" unitRef="usdPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.4811</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e5431-wk-Fact-9213FD1FAE619687826054B51AA68A05" name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="FD2019Q3QTD" unitRef="usdPerShare" decimals="INF" scale="0" format="ixt:numdotdecimal">0.4763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55354548e5450-wk-Fact-93C72551129C7F04D8CF54B51AC0A27E" name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="FD2020Q3YTD" unitRef="usdPerShare" decimals="4" scale="0" format="ixt:numdotdecimal">1.4433</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55354548e5470-wk-Fact-97EDBBC7E9722965E88254B51B125FC8" name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="FD2019Q3YTD" unitRef="usdPerShare" decimals="4" scale="0" format="ixt:numdotdecimal">1.4289</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">23</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sC6D5F88712A058C2B560484004B29410"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Statements of Comprehensive Income/(Loss)</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">(Unaudited)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:53%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55363777e2936-wk-Fact-EB709ACC766503B2370C54B51AC127E0" name="us-gaap:ProfitLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">351</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55363777e2955-wk-Fact-2DB02FE7A9D905403B8061C9D4E58E9A" name="us-gaap:ProfitLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">296</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55363777e2974-wk-Fact-F078490E78EE8F83C79754B51AA13A98" name="us-gaap:ProfitLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55363777e2995-wk-Fact-67590E840E811BAA718E54B51ABE7580" name="us-gaap:ProfitLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,170</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Other comprehensive income/(loss):</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55363777e3174-wk-Fact-7D774844018D9680179A54B51AC4E30A" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55363777e3194-wk-Fact-09ACDDE1CD29B089F5CF54B51AC0D399" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55363777e3213-wk-Fact-A13CBA778A366EC741E254B51AC60D17" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55363777e3234-wk-Fact-B80BE59A5735A5E2F6DE54B51AC756F3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net unrealized loss on derivative instruments, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55363777e3255-wk-Fact-89E549543DFDB5A5B40654B51AC2C248" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">21</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55363777e3275-wk-Fact-38DAD721AF41EB04D52454B51ABD00C6" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55363777e3295-wk-Fact-3A5BBB66429EA44DFDD654B51AC168B4" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">27</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55363777e3316-wk-Fact-DEE5E053C64DD10019F354B51AC62235" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total other comprehensive income/(loss), net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55363777e3337-wk-Fact-3E440F9346445BDB592254B51AA4E8B0" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">38</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55363777e3357-wk-Fact-5093EFC34D0C3C462CD654B51AA4B7BC" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55363777e3376-wk-Fact-18042220F0F0E4E46DAE54B51AA504F4" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">62</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55363777e3397-wk-Fact-8F1CA99B30778D61112D54B51AC5ACD5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total comprehensive income/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55363777e3500-wk-Fact-C9779B5A61999B40C04B54B51AA5270E" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">313</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55363777e3519-wk-Fact-CAAA1D20E10EB2CB2E8254B51AA44A00" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">308</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55363777e3538-wk-Fact-23070D0FB1FFC7800A5D54B51AC648CE" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,412</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55363777e3559-wk-Fact-B0A3F743D5770BA7638E54B51AC796D1" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,151</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: comprehensive income attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55363777e3662-wk-Fact-0E6B894266D67A681EA754B51B10F1D9" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55363777e3682-wk-Fact-A81364456FEA3E37EBBA54B51B0B1906" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55363777e3701-wk-Fact-69248AD84D3E8B62216254B51AC58F9B" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55363777e3722-wk-Fact-25C2752A6A28A1DCDD1954B51AC77D31" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total comprehensive income/(loss) attributable to Cardinal Health, Inc. </span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55363777e3748-wk-Fact-3EE138256991C8DEEAE154B51AC65ED8" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">312</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55363777e3767-wk-Fact-950E900CBD816DDE5BA054B51AC44399" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">308</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55363777e3786-wk-Fact-594F72D11F950DFDCE0054B51AC517B7" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,414</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55363777e3807-wk-Fact-5C6FBCF5A2EDA00D8DBA54B51AC215D2" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,150</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">24</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s36A3DBDFE88E5418AF1CA215AC0CDADE"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Balance Sheets</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">(Unaudited)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Current assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash and equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e2888-wk-Fact-BD7C186A5B42F120F70A54B51AFD69A7" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,329</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e2907-wk-Fact-D0E1A50DDE1CDF6E806154B51AEF1C21" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,531</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trade receivables, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e2922-wk-Fact-26987694F7920A2C1C8154B51AEF107D" name="us-gaap:ReceivablesNetCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9,019</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e2941-wk-Fact-15866CC2F16CA7CAE9EB54B51B000A83" name="us-gaap:ReceivablesNetCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,448</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inventories, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e2961-wk-Fact-E5212BB22D8EA27AC4F554B51AF95410" name="us-gaap:InventoryNet" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12,808</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e2980-wk-Fact-39F782F57463F137835954B51AF094EB" name="us-gaap:InventoryNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12,822</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Prepaid expenses and other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3000-wk-Fact-8E54BA4D272CD872FEA954B51AF234A1" name="us-gaap:OtherAssetsCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,692</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3019-wk-Fact-AA3A15F110F1588AE1BC54B51AEA9993" name="us-gaap:OtherAssetsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,946</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3039-wk-Fact-B808FBBBE7A37082601F54B51AFA9FB5" name="us-gaap:AssetsCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">25,848</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3058-wk-Fact-B68643127FFD6C7DF87854B51AE8EF8D" name="us-gaap:AssetsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">25,747</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Property and equipment, net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3119-wk-Fact-03305930E7ADF95AD4E054B51AFF81C3" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,299</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3138-wk-Fact-BA15BAC9545515E7854954B51AF176B0" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,356</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill and other intangibles, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3158-wk-Fact-D04779526CB3D8BD087154B51AE70ED3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11,378</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3177-wk-Fact-5FF107B511EC235C95DC54B51AE47EEE" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11,808</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3198-wk-Fact-1BE368FF3E1E18FA60DB54B51AEBBFEE" name="us-gaap:OtherAssetsNoncurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,623</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3217-wk-Fact-D960C964B7B84A12CE4E54B51AE600E6" name="us-gaap:OtherAssetsNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,052</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3242-wk-Fact-79192C98474F73FFBB6B54B51AF8130A" name="us-gaap:Assets" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">41,148</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3261-wk-Fact-917DCA0680103C02A25754B51AFF2750" name="us-gaap:Assets" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40,963</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Liabilities and Shareholders&#8217; Equity</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Current liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accounts payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3404-wk-Fact-D1A68742AD7F613C6B6154B51AE7DDC5" name="us-gaap:AccountsPayableCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">21,984</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3423-wk-Fact-CA129F3B526FC941592F54B51AE6675E" name="us-gaap:AccountsPayableCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">21,535</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Current portion of long-term obligations and other short-term borrowings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3438-wk-Fact-F497BA391D56252F1F4E54B51AECCD3B" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">508</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3457-wk-Fact-4F45C093DE0583F7701154B51AFE64C8" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">452</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3477-wk-Fact-F91393ABDEFFB8070D8854B51AEF505B" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,179</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3496-wk-Fact-5E8A36BF6954F3A5CB0454B51AE42712" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,122</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3516-wk-Fact-50D5D07A35AEA5DD798854B51AF1ABC1" name="us-gaap:LiabilitiesCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">24,671</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3535-wk-Fact-C40225AF49A6AB17DFAF54B51AE67A39" name="us-gaap:LiabilitiesCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">24,109</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term obligations, less current portion</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3596-wk-Fact-576A5B650BA3491CB7A154B51AEBFBEF" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,754</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3615-wk-Fact-044D800023AE5C22DF8254B51B003CF2" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7,579</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Deferred income taxes and other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3636-wk-Fact-2A600DD5A9E4BFAC8A5954B51AF8C618" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,517</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3655-wk-Fact-6ED392447DEABC07A94A54B51AED3454" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,945</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Shareholders&#8217; equity:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Preferred shares, without par value:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Authorized&#8212;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">500&#160;thousand</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;shares, Issued&#8212;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">none</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3804-wk-Fact-CD866A916DC83598888C54B51AEE7D0F" name="us-gaap:PreferredStockValue" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3823-wk-Fact-F577A7066F5EB61E2A6554B51AEAF3C9" name="us-gaap:PreferredStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Common shares, without par value:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Authorized&#8212;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">755&#160;million</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;shares, Issued&#8212;</span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">327 million</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;shares at </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March 31, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;and June 30, 2019, respectively</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3896-wk-Fact-93B663D7958916A99DCC54B51AED2E25" name="us-gaap:CommonStockValue" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,774</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3915-wk-Fact-0B28CDE8C0990B0ED01254B51AFFDDFA" name="us-gaap:CommonStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Retained earnings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e3935-wk-Fact-1C8B0F6E877AFB616BAD54B51AE9E8FF" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">656</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e3954-wk-Fact-4D8F2C4C77E010FB294954B51AEBCE9D" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,434</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Common shares in treasury, at cost: </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">35 million </span><span style="font-family:Arial Narrow;font-size:8pt;">shares and 28&#160;million shares at </span><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March 31, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;and June 30, 2019, respectively</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55361983e3982-wk-Fact-FE94123580EB7859BF5454B51AFF83B1" name="us-gaap:TreasuryStockValue" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,086</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55361983e4002-wk-Fact-22670B103CB3CDF93B8854B51AE85B7D" name="us-gaap:TreasuryStockValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,790</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated other comprehensive loss</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55361983e4023-wk-Fact-DD48F6F2B68FA6273F1854B51AFFDBE6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">141</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55361983e4043-wk-Fact-6DDF835225D29A2EA00154B51AEC5CC5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total Cardinal Health, Inc. shareholders' equity</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e4064-wk-Fact-4959005A72B6A6AEEAD054B51AFF5CD4" name="us-gaap:StockholdersEquity" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,203</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e4083-wk-Fact-A6C46A9EE011C35AF05954B51AF80493" name="us-gaap:StockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,328</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e4104-wk-Fact-24EC0E0E2909CE943C1954B51AEEA465" name="us-gaap:MinorityInterest" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e4123-wk-Fact-D875E3AB39F0149E297154B51AEEFDD9" name="us-gaap:MinorityInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total shareholders&#8217; equity</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e4143-wk-Fact-CDE916D192DECAFCFB8B54B51AED2F88" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,206</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e4162-wk-Fact-CE3156BD577214A8851554B51AE7B0EE" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,330</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total liabilities and shareholders&#8217; equity</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55361983e4187-wk-Fact-85176B163BC170C900A854B51AEAFE90" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">41,148</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55361983e4206-wk-Fact-CA86463B26FF04489FF754B51AF95BC5" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40,963</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">25</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sCCFCB3DDA6B65023ABB0433747746173"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Statements of Shareholders' Equity</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">(Unaudited)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"></td></tr><tr><td style="width:32%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Common Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Treasury Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated Other<br/>Comprehensive<br/>Loss</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Noncontrolling Interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total<br/>Shareholders&#8217;<br/>Equity</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Shares Issued</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Retained<br/>Earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="29" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at December 31, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e3240-wk-Fact-DD562D82CB0C77CE143D54B51B078DEB" name="us-gaap:CommonStockSharesIssued" contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e3259-wk-Fact-9CA7A75C444F9CA1EE3454B51A9F5715" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,752</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e3278-wk-Fact-86A1B978EA8078F9678154B51A9C0637" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">449</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e3293-wk-Fact-2F86E23BC371B675671F54B51AA3DA8B" name="us-gaap:TreasuryStockShares" contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e3313-wk-Fact-52FC7BB269DDF874694F54B51B03D67A" name="us-gaap:TreasuryStockValue" contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2,099</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e3333-wk-Fact-15F84A46B97B6467D1F154B51AA205A1" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">103</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e3354-wk-Fact-BD8F2549F18F501FB1B854B51AA1DC53" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e3373-wk-Fact-240FC41A74E50611D38254B51A9FD9CA" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q2" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,002</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e3423-wk-Fact-35EF6B3029BEDC008B5054B51AAECB0B" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e3499-wk-Fact-F4BF95A589E7E5A0FA3C54B51B003B56" name="us-gaap:ProfitLoss" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e3518-wk-Fact-EB709ACC766503B2370C54B51AC127E0" name="us-gaap:ProfitLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">351</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e3629-wk-Fact-3E440F9346445BDB592254B51AA4E8B0" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">38</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e3670-wk-Fact-98058F24B57403A1D2A554B51AA14125" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">38</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock plans activity, net of shares withheld for employee taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e3705-wk-Fact-CC147F59BA55A1EAE1F454B51AA2E8DB" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e3758-wk-Fact-FF6CC19E3054286885EC54B51B045A84" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e3818-wk-Fact-1EB948E80544A399F68054B51A9FFFF5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividends declared</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e3873-wk-Fact-7377D6D650A37E9AE8E854B51A9B5A6D" name="us-gaap:Dividends" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">142</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e3970-wk-Fact-1D9697C4A7231DD498B554B51B040A6A" name="us-gaap:Dividends" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">142</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e4026-wk-Fact-61F58D55EE71DD1934F754B51AA0E634" name="us-gaap:StockholdersEquityOther" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e4103-wk-Fact-C1B1A2F9C0D7A909B89654B51AA1DB7A" name="us-gaap:StockholdersEquityOther" contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e4123-wk-Fact-C316279E628FD8ACB54254B51A9E3BCF" name="us-gaap:StockholdersEquityOther" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e4144-wk-Fact-2F03BAA068955DAFB57254B51A9E0D89" name="us-gaap:CommonStockSharesIssued" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e4163-wk-Fact-5D1633A1DB160AADACB654B51AA0BC1A" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,774</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e4182-wk-Fact-7254B4EA33B6AA05381D54B51A9D46E5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">656</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e4197-wk-Fact-8927D94E05ECFF64945054B51A9E6031" name="us-gaap:TreasuryStockShares" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e4217-wk-Fact-E7A21D525234B88AD08154B51AA1C4BC" name="us-gaap:TreasuryStockValue" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,086</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e4237-wk-Fact-C4594A4A3F705968274A54B51AA2F9B9" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">141</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e4258-wk-Fact-0A599A035C1050EA6D5154B51AA2F035" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e4277-wk-Fact-CDE916D192DECAFCFB8B54B51AED2F88" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,206</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"></td></tr><tr><td style="width:32%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="29" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Three Months Ended March 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e4484-wk-Fact-F2C1844C6B044D151D3A54B51ADEF9A2" name="us-gaap:CommonStockSharesIssued" contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e4503-wk-Fact-D2B520B24EDF13E96FCD54B51ADA71DE" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,728</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e4522-wk-Fact-F0EBFF255B567F32FF1D54B51ADCEA7A" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,233</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e4537-wk-Fact-2BDFF02382E3368BDBFA54B51AD2E8E6" name="us-gaap:TreasuryStockShares" contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">29</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e4557-wk-Fact-9F196462D9D101B9291454B51ADED637" name="us-gaap:TreasuryStockValue" contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,795</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e4577-wk-Fact-10A076A527A4CA16D92854B51AD96408" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">123</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e4598-wk-Fact-77307A87C431DBF3AC5C54B51AE30AB4" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e4617-wk-Fact-69F1B5F92E8FA1C966EE54B51AD9C690" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q2" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,043</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e4667-wk-Fact-33B1AB25C580C3A0D03454B51AFE9FFF" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">296</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e4743-wk-Fact-8CD3F083BFC9FDD02D4154B51AE01FEC" name="us-gaap:ProfitLoss" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e4762-wk-Fact-2DB02FE7A9D905403B8061C9D4E58E9A" name="us-gaap:ProfitLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">296</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive income, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e4873-wk-Fact-5972AE41296E201FA3E154B51ADFA25E" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e4913-wk-Fact-E52DD5239EA0A6A85B7F54B51AE2FDC9" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock plans activity, net of shares withheld for employee taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e4947-wk-Fact-D42A53F2411CA753CEC254B51AE3457D" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e4987-wk-Fact-3282C2AFC1E2DC63960F54B51ADBFAF6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" xsi:nil="true" scale="6" format="ixt:nocontent"></ix:nonFraction></span><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5000-wk-Fact-463D1DC5765EFA224EFE54B51AE2200C" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5060-wk-Fact-640C051BF781F0957AD454B51ADBBB12" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividends declared</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e5115-wk-Fact-2E3BE44C1A0E58BD319E54B51ADD0EAD" name="us-gaap:Dividends" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">143</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e5212-wk-Fact-0F725AB52B1B60CF479E54B51AE1B91A" name="us-gaap:Dividends" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">143</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5268-wk-Fact-DA9DC3CCA01A63A43C3B54B51ADD9DBE" name="us-gaap:StockholdersEquityOther" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5344-wk-Fact-AD912F65EC830C162B7654B51ADBB02B" name="us-gaap:StockholdersEquityOther" contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5363-wk-Fact-AF862B2B4D22AD801EAD54B51ADE10A7" name="us-gaap:StockholdersEquityOther" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at March 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5383-wk-Fact-245D4717586334139C1054B51ABD62A8" name="us-gaap:CommonStockSharesIssued" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5402-wk-Fact-850F0322FE427CCE3C9D54B51AB0F458" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,748</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5421-wk-Fact-1F6A194ECD8211D1774254B51ABBFAD0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,386</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e5436-wk-Fact-3BA664087DBE3EF7FFCC54B51AB83928" name="us-gaap:TreasuryStockShares" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">29</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e5456-wk-Fact-6E13B2F5DA6D6565B9FC54B51AB9AC33" name="us-gaap:TreasuryStockValue" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,793</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e5476-wk-Fact-A6A91FE527666F04C87354B51AAFA609" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">111</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5497-wk-Fact-ED1858A430E8A8EA7CDB54B51ABF1F0C" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5516-wk-Fact-17A626A1D528A488BC0254B51AB69F38" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,232</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"></td></tr><tr><td style="width:32%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="29" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5722-wk-Fact-013581B0FE00157B462F54B51B008921" name="us-gaap:CommonStockSharesIssued" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5741-wk-Fact-D1ABDCE5C2E420A992B154B51B0A482D" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5760-wk-Fact-E0E610827D00B8F0FFD654B51B0EC683" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,434</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e5775-wk-Fact-D7CF5207F2EADC82381F54B51B0CE70D" name="us-gaap:TreasuryStockShares" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">28</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e5795-wk-Fact-B298E012AA250F46144754B51B0A6FE6" name="us-gaap:TreasuryStockValue" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1,790</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e5815-wk-Fact-B8CF12806FC87C9F1A0B54B51B0D115A" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5836-wk-Fact-0D13DA5E17B25D84183754B51B0B922F" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e5855-wk-Fact-CE3156BD577214A8851554B51AE7B0EE" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,330</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e5905-wk-Fact-105C2CDA654CB50A699A54B51AD31834" name="us-gaap:NetIncomeLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,352</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e5982-wk-Fact-3CDE91D9155E99908FD754B51B05A0E5" name="us-gaap:ProfitLoss" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e6001-wk-Fact-F078490E78EE8F83C79754B51AA13A98" name="us-gaap:ProfitLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e6113-wk-Fact-E96553D6611AB0CA951B54B51B051314" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">62</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e6154-wk-Fact-72494495C740F7B9BE4354B51B01E840" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">62</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock plans activity, net of shares withheld for employee taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e6189-wk-Fact-44BB3B24C5F81FCF6CD654B51B023066" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e6242-wk-Fact-C89888EF6B3898F6C8A654B51B02D42C" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">54</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e6302-wk-Fact-0CFA1B30BFDF644E835D54B51B00B116" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">65</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share repurchase program activity</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e6337-wk-Fact-14AB8329CAD5365EE4F354B51B0F4F92" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e6375-wk-Fact-28AB96A847ED06D1C33554B51B0D6C36" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e6390-wk-Fact-75844EB611179C54B15D54B51B0D3D07" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e6451-wk-Fact-74D3B12AD2E710ABEBFA54B51B02D142" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividends declared</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e6507-wk-Fact-4B0A41F25245E55F503954B51B0DA9D0" name="us-gaap:Dividends" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">426</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e6604-wk-Fact-17B02B541B419A9E9D2654B51B0AAE7A" name="us-gaap:Dividends" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">426</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e6660-wk-Fact-3467C2984775A4E71E9054B51B05D1C8" name="us-gaap:StockholdersEquityOther" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e6736-wk-Fact-E780FE7D34A745CBC82454B51B0513A0" name="us-gaap:StockholdersEquityOther" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e6756-wk-Fact-949F08435683B2D52E5954B51B09C897" name="us-gaap:StockholdersEquityOther" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e6777-wk-Fact-2F03BAA068955DAFB57254B51A9E0D89" name="us-gaap:CommonStockSharesIssued" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e6796-wk-Fact-5D1633A1DB160AADACB654B51AA0BC1A" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,774</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e6815-wk-Fact-7254B4EA33B6AA05381D54B51A9D46E5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">656</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e6830-wk-Fact-8927D94E05ECFF64945054B51A9E6031" name="us-gaap:TreasuryStockShares" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e6850-wk-Fact-E7A21D525234B88AD08154B51AA1C4BC" name="us-gaap:TreasuryStockValue" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,086</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388091e6870-wk-Fact-C4594A4A3F705968274A54B51AA2F9B9" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">141</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e6891-wk-Fact-0A599A035C1050EA6D5154B51AA2F035" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388091e6910-wk-Fact-CDE916D192DECAFCFB8B54B51AED2F88" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,206</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"></td></tr><tr><td style="width:32%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:4%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="29" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nine Months Ended March 31, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e7117-wk-Fact-AB556C772901698D4C9054B51AC0E9DE" name="us-gaap:CommonStockSharesIssued" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e7136-wk-Fact-6DCEAE7555A18B1925CB54B51AB0AB51" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,730</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e7155-wk-Fact-B69B00E063982FABD25454B51AAF90D7" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4,645</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e7170-wk-Fact-D06F50FC648919C1AC7654B51AB68520" name="us-gaap:TreasuryStockShares" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e7190-wk-Fact-7A58CEDABF7AC285095254B51ABDDCEC" name="us-gaap:TreasuryStockValue" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,224</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e7210-wk-Fact-6D4A0BC4E0C70393868C54B51AACE936" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">92</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e7231-wk-Fact-5811541612ABD1C1ECCE54B51ABA5EFD" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e7250-wk-Fact-00C142A5D3ADEC768C6C54B51ABBFC37" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,059</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e7300-wk-Fact-42887B037229FD92376954B51A820B65" name="us-gaap:NetIncomeLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,169</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e7376-wk-Fact-E6FA7D98926C449C9D3754B51AB7C8CA" name="us-gaap:ProfitLoss" contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e7395-wk-Fact-67590E840E811BAA718E54B51ABE7580" name="us-gaap:ProfitLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,170</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e7506-wk-Fact-8FDDDF603D57A741920154B51AAC7CB6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e7547-wk-Fact-719B9B2B8B7ACA6C6B6154B51AC1CFA7" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">19</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock plans activity, net of shares withheld for employee taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e7582-wk-Fact-D38973670C8C03D597EC54B51ABC6AA3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e7622-wk-Fact-DB3B9967EFCF1E55156354B51AADB03C" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e7636-wk-Fact-D8D4E5D1E33FA11F45A854B51AC19E9D" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">31</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e7696-wk-Fact-53DA43E1A9BCC2BF45B054B51AB91321" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">49</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share repurchase program activity</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e7771-wk-Fact-67B50102B67EDEEF3EC354B51AB813DF" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e7786-wk-Fact-A18C9E8CA1955F4501F954B51ABE9A2B" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e7847-wk-Fact-D90329078A87441BCC3254B51ABCA990" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividends declared</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e7903-wk-Fact-A262364F8D7386D83A0B54B51AAC8983" name="us-gaap:Dividends" contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">429</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e8000-wk-Fact-FCAC390DE628BB5ECB2054B51ABC88BD" name="us-gaap:Dividends" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">429</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e8056-wk-Fact-26F9C275287F14986E8754B51AAEFE6A" name="us-gaap:StockholdersEquityOther" contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e8132-wk-Fact-3E27135BE35AB5DEDE1D54B51AB5601B" name="us-gaap:StockholdersEquityOther" contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e8151-wk-Fact-672F4EE66C9F8C26EDFE54B51AAC61AB" name="us-gaap:StockholdersEquityOther" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at March 31, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e8171-wk-Fact-245D4717586334139C1054B51ABD62A8" name="us-gaap:CommonStockSharesIssued" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">327</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e8190-wk-Fact-850F0322FE427CCE3C9D54B51AB0F458" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,748</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e8209-wk-Fact-1F6A194ECD8211D1774254B51ABBFAD0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,386</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e8224-wk-Fact-3BA664087DBE3EF7FFCC54B51AB83928" name="us-gaap:TreasuryStockShares" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">29</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e8244-wk-Fact-6E13B2F5DA6D6565B9FC54B51AB9AC33" name="us-gaap:TreasuryStockValue" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,793</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388091e8264-wk-Fact-A6A91FE527666F04C87354B51AAFA609" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">111</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e8285-wk-Fact-ED1858A430E8A8EA7CDB54B51ABF1F0C" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388091e8304-wk-Fact-17A626A1D528A488BC0254B51AB69F38" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,232</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">26</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s457BC7C52E1F53F6BAF5723F6A1BB52C"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Condensed Consolidated Statements of Cash Flows</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">(Unaudited)</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash flows from operating activities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net earnings/(loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e2887-wk-Fact-F078490E78EE8F83C79754B51AA13A98" name="us-gaap:ProfitLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e2907-wk-Fact-67590E840E811BAA718E54B51ABE7580" name="us-gaap:ProfitLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,170</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e3004-wk-Fact-AB10504BC20D202C007054B51B24ABF8" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">688</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e3023-wk-Fact-378C032EEE30E328F77A54B51AC80CF1" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">759</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and loss on sale of other investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e3043-wk-Fact-D6C1A865C1D170A83F3554B51AD23183" name="us-gaap:LossOnSaleOfInvestments" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e3062-wk-Fact-60C9378BD5D570DC4B6954B51B1EB6C3" name="us-gaap:LossOnSaleOfInvestments" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Impairments and (gain)/loss on disposal of assets, net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e3082-wk-Fact-3F237E8C094C4D20E87554B51AE6B03E" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55373487e3101-wk-Fact-4258B5E0825630CFC45754B51ABA8334" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">492</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss on extinguishment of debt</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e3122-wk-Fact-5F9B3DE83DE70A97FD6454B51AA69642" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e3141-wk-Fact-13EB6853A5D82CF9B36854B51B20E343" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e3161-wk-Fact-44B495E6052B0036080154B51AC86701" name="us-gaap:ShareBasedCompensation" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">68</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e3180-wk-Fact-48956753B0718B00419254B51B2A81AB" name="us-gaap:ShareBasedCompensation" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">64</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Provision for bad debts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e3201-wk-Fact-82411A5B74B8CE11D2AF54B51ACBA196" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">86</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e3220-wk-Fact-661A93DE87A3CDF49D5C54B51B230F8D" name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">59</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Increase in trade receivables</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e3281-wk-Fact-C475A01364865A8F52DD54B51ACDC9E0" name="us-gaap:IncreaseDecreaseInReceivables" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">653</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55373487e3301-wk-Fact-CD93C7D5EE3A7E9A3DCC54B51B1FDF94" name="us-gaap:IncreaseDecreaseInReceivables" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">156</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Increase in inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e3322-wk-Fact-2559D6A037C48C30070E54B51ACB7A4B" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55373487e3342-wk-Fact-B21EF344325BCC48807C54B51ACF964A" name="us-gaap:IncreaseDecreaseInInventories" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">345</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Increase in accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e3363-wk-Fact-4A95DD12A709CD4051F554B51AD08397" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">448</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e3382-wk-Fact-A7E73438BCCF1D8E7D4D54B51AD0D6BE" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">846</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other accrued liabilities and operating items, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e3402-wk-Fact-C9A6C83D0C57DB60030B54B51AC9EC44" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5,425</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e3421-wk-Fact-04C80DA9BB4264E63B9254B51B27CD90" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">309</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net cash provided by operating activities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e3441-wk-Fact-5036AAA5DBADB76585F854B51AD19825" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,720</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e3460-wk-Fact-E22C1DB80AD19B8B658754B51B2A527E" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,216</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash flows from investing activities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Acquisition of subsidiaries, net of cash acquired</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e3562-wk-Fact-C97B54C1515B976F247954B51B21A09F" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55373487e3581-wk-Fact-F1B80EBD33EBA375E40C54B51ACBF693" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">38</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions to property and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e3602-wk-Fact-BE3F43ADEA2F650A1AC854B51ACE9235" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">239</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55373487e3622-wk-Fact-F5FBE63559E3A6A07AF654B51B2A0715" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">192</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Purchase of investments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e3644-wk-Fact-7A413CF7DC50F269630B54B51B1D0E2B" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">18</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55373487e3664-wk-Fact-B86DDE486B12CC239E1654B51B25DA3A" name="cah:Purchaseofavailableforsalesecuritiesandotherinvestments" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Proceeds from return of investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e3685-wk-Fact-101E8D21FA197DEF097354B51B2467D2" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e3704-wk-Fact-F393066FAB2780F1077554B51B1DE7B0" name="cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Proceeds from divestitures, net of cash sold, and disposal of property and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e3724-wk-Fact-D9F0DD6BF00F4A77317454B51ACE2199" name="cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e3743-wk-Fact-3B12EB17030908350D7F54B51B203547" name="cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">749</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net cash provided by/(used in) investing activities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e3763-wk-Fact-E16094A6EC2127CED04554B51B20A76B" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">249</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e3783-wk-Fact-C56A935D6934EE83E31A54B51B26382C" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">511</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash flows from financing activities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net change in short-term borrowings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e3885-wk-Fact-45B87C94ABE60FC96C9B54B51B222DF9" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e3905-wk-Fact-66FCBB99EB4C3AE2453354B51B210599" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Reduction of long-term obligations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e3925-wk-Fact-972708A0473D504BE1D054B51B1F52D8" name="us-gaap:RepaymentsOfLongTermDebt" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">888</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55373487e3945-wk-Fact-1F5FCD85313EEF9C854154B51ACFAA68" name="us-gaap:RepaymentsOfLongTermDebt" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net tax withholdings from share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e3966-wk-Fact-2F45A97FF4CDC882D4AD54B51A8160C7" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55373487e3986-wk-Fact-CAD091C65CFB0F9E82B754B51ACC4E05" name="cah:Netproceedstaxwithholdingsfromsharebasedcompensation" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Dividends on common shares</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e4007-wk-Fact-5078A2FE6F1EAB822AAF54B51B26414E" name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">428</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55373487e4027-wk-Fact-EFA0CE3249D21EDBD15F54B51B1D6564" name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">435</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Purchase of treasury shares</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e4048-wk-Fact-74D3B12AD2E710ABEBFA54B51B02D142" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55373487e4068-wk-Fact-D90329078A87441BCC3254B51ABCA990" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net cash used in financing activities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e4090-wk-Fact-6B71FC5490BB490CDC4B54B51B293E73" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1,672</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55373487e4110-wk-Fact-2B2CB097D5BDCDDB993B54B51ACC5B2D" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1,050</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Effect of exchange rates changes on cash and equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e4172-wk-Fact-A4A3660014780D04E1E254B51AD13CED" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55373487e4192-wk-Fact-728D27ED6E72E5B9F1CA54B51B21D97A" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net increase/(decrease) in cash and equivalents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55373487e4254-wk-Fact-27A962EC96EB31A2AE2954B51B20F872" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">202</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e4274-wk-Fact-13429B6EDBCC43F2625554B51B22F1D4" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,675</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash and equivalents at beginning of period</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e4294-wk-Fact-D0E1A50DDE1CDF6E806154B51AEF1C21" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,531</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e4313-wk-Fact-0ABF0DEA7E181F12A18754B51AC74C13" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2018Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,763</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Cash and equivalents at end of period</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55373487e4338-wk-Fact-BD7C186A5B42F120F70A54B51AFD69A7" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,329</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55373487e4357-wk-Fact-D51BA1D542000AB5560F54B51B1DDBA8" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="FI2019Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,438</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">See notes to condensed consolidated financial statements.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">27</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s264133521AF35C1396805251DC84D5EC"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Notes to Condensed Consolidated Financial Statements</span></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div><a id="sCDFF4A6CF60F51ABA5110DB568251E3E"></a></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="TextSelection-3B2CD0A042E450EB379E54B51B4DC504-0-wk-Fact-C23337D5E250A7D8134554B51A9A0235" continuedAt="TextSelection-3B2CD0A042E450EB379E54B51B4DC504-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">1. Basis of Presentation and Summary of Significant Accounting Policies</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="TextSelection-FC0CC9F5436B0CF59D9D54B51B4DD211-0-wk-Fact-7D3C2DDAE5CB14D9F34F54B51A9B022A" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis of Presentation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">References to "we," "our," and similar pronouns is in this Quarterly Report on Form 10-Q for the quarter ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our fiscal year ends on June 30. References to fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in these condensed consolidated financial statements are to the fiscal years ending or ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements have been prepared in accordance with the United States Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. To conform to the current year presentation, certain prior year amounts have been reclassified.&#160;In addition, financial results presented for this fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (the "</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K"). </span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="TextSelection-18B451B2F1E1E77922FE54B51B4DF5EE-0-wk-Fact-0ECBB04057259D59F25654B51A9A5D48" continuedAt="TextSelection-18B451B2F1E1E77922FE54B51B4DF5EE-1" escape="true"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Adopted Financial Accounting Standards</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Derivatives and Hedging </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2018, the </span><span style="font-family:Arial Narrow;font-size:10pt;">Financial Accounting Standards Board ("FASB")</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a benchmark interest rate for hedge accounting purposes. This guidance is effective beginning the first quarter of fiscal 2020 and must be applied on a prospective basis. The adoption did not have a material impact on our consolidated financial statements.</span></div></ix:nonNumeric></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-18B451B2F1E1E77922FE54B51B4DF5EE-1"><ix:continuation id="TextSelection-3B2CD0A042E450EB379E54B51B4DC504-1"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Leases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal 2020 and elected the transition option which allows us to apply the guidance prospectively. The adoption resulted in the recognition of lease liabilities in the amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55375279e2834-wk-Fact-893FDD43AA38FC6C4CAA54B51A9BAFAB" name="cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" contextRef="I2020Q1ASC842" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">422</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s37977FB1689852A6888EFF6B57032648"><span style="font-family:Arial Narrow;font-size:10pt;">Note 5</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for additional information regarding leases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Issued Financial Accounting Standards Not Yet Adopted</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This&#160;guidance will be effective for us in the first quarter of fiscal 2021. We are currently evaluating the impact of this amended guidance but do not expect the adoption to have a material impact on our consolidated financial statements or disclosures.</span></div></ix:continuation></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">28</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s9E0AC935367F55999225DFF920671BFF"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="TextSelection-2035394A40273F2E8D3054B51B4DB3BA-0-wk-Fact-72F70BD1F3AF7F573F0154B51A8CAFAD" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">2. Restructuring and Employee Severance</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="TextSelection-036B3693A63687D8F6F154B51B4DD8C7-0-wk-Fact-3EF5A221EBC3A489692E54B51A8B9998" continuedAt="TextSelection-036B3693A63687D8F6F154B51B4DD8C7-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes restructuring and employee severance:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388671e2900-wk-Fact-8E1432A2D9B36B53031754B51A93C814" name="us-gaap:SeveranceCosts1" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">15</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388671e2920-wk-Fact-30E748BE5B754031A15B54B51A94DA1D" name="us-gaap:SeveranceCosts1" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">29</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388671e2935-wk-Fact-7DB7E5F3CA0D9D6939DE54B51A9966AA" name="cah:FacilityExitAndOtherCosts" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388671e2954-wk-Fact-7E97D700EB46BC531C8F54B51A93EC99" name="cah:FacilityExitAndOtherCosts" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">24</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388671e2979-wk-Fact-CDD23AFADBFEF20CF0C854B51B130038" name="us-gaap:RestructuringCharges" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388671e2999-wk-Fact-D12C27E0834E4710F68054B51ABA0B0B" name="us-gaap:RestructuringCharges" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388671e3141-wk-Fact-2485CB1FF0F32D6BD35954B51ACA11C2" name="us-gaap:SeveranceCosts1" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">47</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388671e3160-wk-Fact-69F8B74A653B01BCA27B54B51AC908F0" name="us-gaap:SeveranceCosts1" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">70</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388671e3175-wk-Fact-8C1847879FAE0061B62F54B51ACA0482" name="cah:FacilityExitAndOtherCosts" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388671e3194-wk-Fact-C9E2BEFBB5AFFDA645F254B51ACBA305" name="cah:FacilityExitAndOtherCosts" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">27</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388671e3219-wk-Fact-9EF350966CEAF3367B0F54B51AF25715" name="us-gaap:RestructuringCharges" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">80</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388671e3238-wk-Fact-DC1310CD717A52D67B3D54B51AEE96B6" name="us-gaap:RestructuringCharges" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">97</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods.</span></div></td></tr></table></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-036B3693A63687D8F6F154B51B4DD8C7-1" continuedAt="TextSelection-036B3693A63687D8F6F154B51B4DD8C7-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-036B3693A63687D8F6F154B51B4DD8C7-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, vendor transition fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.</span></div></ix:continuation></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Restructuring and employee severance during both the three and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was primarily related to enterprise-wide cost-saving measures. The income during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was due to changes in estimates for severance previously accrued.</span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="TextSelection-2E8D4C6EC2FC0F11396054B51B48129D-0-wk-Fact-7EBC2C8310843AD5BF2754B51A8B3101" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Related Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility Exit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">and Other Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388671e3403-wk-Fact-9374612369B64518B56C54B51AEA95A9" name="us-gaap:RestructuringReserve" contextRef="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">64</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388671e3422-wk-Fact-1EC0606BD071E079F13D54B51AECD835" name="us-gaap:RestructuringReserve" contextRef="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388671e3441-wk-Fact-200209B7EFF702F1744654B51AE89CEC" name="us-gaap:RestructuringReserve" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">72</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388671e3457-wk-Fact-64FD1944C2F72AFFF44854B51AE92653" name="us-gaap:RestructuringCosts" contextRef="FD2020Q3YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">57</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55388671e3476-wk-Fact-A478B474AD324F0E997D54B51AEA35A2" name="us-gaap:RestructuringCosts" contextRef="FD2020Q3YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388671e3495-wk-Fact-605448ADFBA0727B91E654B51AECF951" name="us-gaap:RestructuringCosts" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">67</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388671e3516-wk-Fact-C62FBA4A3DEEFC3F409154B51AEBCD6E" name="us-gaap:PaymentsForRestructuring" contextRef="FD2020Q3YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">55</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55388671e3536-wk-Fact-6EAF200CDF97F8AB9A1C54B51AEA02D9" name="us-gaap:PaymentsForRestructuring" contextRef="FD2020Q3YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55388671e3556-wk-Fact-F013728926B003766D4E54B51AE94E0F" name="us-gaap:PaymentsForRestructuring" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">58</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388671e3583-wk-Fact-1FAA037A3C0C2D58318B54B51AEB66CB" name="us-gaap:RestructuringReserve" contextRef="FI2020Q3_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">66</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388671e3602-wk-Fact-C396340CA2A70933B0B554B51AE8CB34" name="us-gaap:RestructuringReserve" contextRef="FI2020Q3_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55388671e3621-wk-Fact-9A40EC4BF9E19C7100B054B51AED9BAC" name="us-gaap:RestructuringReserve" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">81</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a id="s2FDD6C2AF39D5CFABDF5988E2E6765A9"></a></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="TextSelection-B9AAA695C3EF59E20A7454B51B4ED97A-0-wk-Fact-9C042C70FA1EDB21769554B51B21A6C4" continuedAt="TextSelection-B9AAA695C3EF59E20A7454B51B4ED97A-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">3. Goodwill and Other Intangible Assets</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Goodwill</span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfGoodwillTextBlock" id="TextSelection-428EC5B21E53D0B0807054B51B4DDA13-0-wk-Fact-AE8D5293857D00EB7A1554B51B270653" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:47%;"></td><td style="width:1%;"></td><td style="width:20%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e2860-wk-Fact-9E2D5463F5BD7135147754B51ABC3795" name="us-gaap:Goodwill" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,663</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e2879-wk-Fact-BE15B290B5EF4C7D7DE154B51ABA9519" name="us-gaap:Goodwill" contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,715</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e2898-wk-Fact-9D36BB887BD0C84BFA7054B51ABBB4F7" name="us-gaap:Goodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,378</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55397340e2914-wk-Fact-B4704929F44957BC1E8A54B51AB90260" name="us-gaap:GoodwillTransfers" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e2934-wk-Fact-FB513EB8578B0F8CDC1F54B51AB9295B" name="us-gaap:GoodwillTransfers" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55397340e2953-wk-Fact-2B4F456CE8032017719954B51AB9E390" name="us-gaap:GoodwillTransfers" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e2975-wk-Fact-272A62F0C4D1F9BA58AB54B51AAEF20F" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55397340e2994-wk-Fact-4B4E69E6F4B81AA6407C54B51AAEF953" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">34</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55397340e3014-wk-Fact-0E11A8143120509BD94F54B51AB9DE44" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">34</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3041-wk-Fact-683C5AF325D76D696C9654B51ABA7C04" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,658</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3060-wk-Fact-66859FDEF84036089A7E54B51AB6826E" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,681</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3079-wk-Fact-C7E07246F08963044A3354B51ABAEA3A" name="us-gaap:Goodwill" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,339</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Primarily due to the risks and uncertainties to the business from both the Recalls and the COVID-19 pandemic, we elected to bypass the qualitative assessment and perform interim goodwill impairment testing for the Medical Unit during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The carrying value of this reporting unit at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55397340e3111-wk-Fact-C8E849B25B94BFC96605EB0B1E8CE237" name="cah:CarryingValue" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalReportingUnitMember" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">10.1</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, of which </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55397340e3115-wk-Fact-4595A8473CEB32428559EAD956F63347" name="us-gaap:Goodwill" contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalReportingUnitMember" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">4.2</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was goodwill. The fair value of the reporting unit was estimated to be approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55397340e3119-wk-Fact-AD32C5B19431B525FE43E62BC85AE0C4" name="us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" contextRef="FI2020Q3" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent in excess of its carrying value, using a combination of the income-based approach (using a discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55397340e3124-wk-Fact-DA55A9A8B57DF763F811EB0CBD071602" name="cah:DiscountRatefairvalueinputs" contextRef="FD2020Q3YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">8.5</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent and a terminal growth rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55397340e3128-wk-Fact-A2598F2A2DE6A3CADC8CF0ACB9EB1DB8" name="cah:TerminalGrowthRatefairvalueinputs" contextRef="FD2020Q3YTD" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent), and the market-based approach.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Intangible Assets</span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="TextSelection-2D37680A57CE5FBD6F3C54B51B4E5E07-0-wk-Fact-DF5096EA23AC28F4DE7C54B51AA85AE0" continuedAt="TextSelection-2D37680A57CE5FBD6F3C54B51B4E5E07-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"></td></tr><tr><td style="width:25%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:19%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted- Average Remaining Amortization Period (Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3413-wk-Fact-A960D2CC4B7C7A74E97F54B51A9C91F4" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3451-wk-Fact-A960D2CC4B7C7A74E97F54B51A9C91F4" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3477-wk-Fact-189E51B2AEA682835DEC54B51A9A3217" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3515-wk-Fact-189E51B2AEA682835DEC54B51A9A3217" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3690-wk-Fact-BF0B5C2292362B4F4D1A54B51A9CEC6E" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,544</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3709-wk-Fact-7EAF3BBF98752DDD878C54B51A9D980F" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,746</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3728-wk-Fact-31A55655725AF10248AE54B51A9E87CF" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,798</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d55397340e3748-wk-Fact-814510111174754E0DCC54B51A933062" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="FD2020Q3YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear">13</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3759-wk-Fact-A318E469B916D15FF60F54B51A9DF05D" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">674</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3778-wk-Fact-46C272FC37D8E470F05E54B51A9ED954" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">329</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3797-wk-Fact-6FCDAE74B3ADC6B6240F54B51A9EF6A5" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">345</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d55397340e3817-wk-Fact-C2D32B164ACA254D65D354B51A94242B" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="FD2020Q3YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" format="ixt-sec:duryear">13</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3828-wk-Fact-FE6112E9F5BF4413223F54B51A9C9D4B" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,604</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3847-wk-Fact-6C056C4E95A47F8A31C354B51A9A2802" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">730</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3866-wk-Fact-E43316CBDF1F39579B2454B51A9D69FC" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">874</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d55397340e3886-wk-Fact-A4CD034E49FF2CB0F9A054B51A9B3A39" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="FD2020Q3YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" format="ixt-sec:duryear">11</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3897-wk-Fact-F6418AD1C9C5928792C554B51A9C016B" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,822</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3916-wk-Fact-7DA35B595EC9DDCF929F54B51A936FD7" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,805</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3935-wk-Fact-375229C4F5C05C9F403E54B51A94A431" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,017</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d55397340e3955-wk-Fact-0388697F6B0A16A6617E54B51A9BFD30" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" contextRef="FD2020Q3YTD" format="ixt-sec:duryear">12</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3972-wk-Fact-B58B650EC206FE4BF32154B51A92FFE9" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,844</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e3991-wk-Fact-7DA35B595EC9DDCF929F54B51A936FD7" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,805</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55397340e4010-wk-Fact-DF9023B3C900129EC19254B51A9BBAAE" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,039</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr></table></div></div></ix:nonNumeric></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">29</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-B9AAA695C3EF59E20A7454B51B4ED97A-1"><ix:continuation id="TextSelection-2D37680A57CE5FBD6F3C54B51B4E5E07-1"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4255-wk-Fact-CBB2E79823FF155209FF54B51AAC6F40" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4293-wk-Fact-CBB2E79823FF155209FF54B51AAC6F40" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4309-wk-Fact-E61530679C07470AF70354B51AC07FC4" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4347-wk-Fact-E61530679C07470AF70354B51AC07FC4" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4492-wk-Fact-F75EE4315EC2FD1BBC2154B51AC0D7B0" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,562</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4511-wk-Fact-6C2B259DA0A633E2836554B51AAE6439" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,517</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4530-wk-Fact-69CA400469FD20C71A3A54B51AABBA5F" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,045</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4551-wk-Fact-0FA43F71938C97E50CE254B51ABD449F" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">672</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4570-wk-Fact-D0858B709AA071A32ADD54B51AAD594A" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">295</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4589-wk-Fact-5FBB1BC47741F2C2C8A654B51ABCED8B" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">377</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4610-wk-Fact-6CEB79941F3FFF0CE69A54B51AC04EB9" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,602</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4629-wk-Fact-8B3BBA792D9680BA225754B51ABCCFD3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">616</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4648-wk-Fact-76B8884B359940E3032554B51ABDA437" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">986</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4669-wk-Fact-2EC53CFC62D2BA6E4C3C54B51ABD96CD" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,836</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4688-wk-Fact-18EAE26518A0B50C9F2454B51AC4FB7E" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,428</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4707-wk-Fact-585DA04721449349DA8254B51AAD39C5" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,408</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4734-wk-Fact-9CA9ED538358611A696F54B51ABDA8F2" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5,858</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4753-wk-Fact-18EAE26518A0B50C9F2454B51AC4FB7E" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2,428</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55397340e4772-wk-Fact-1A7362C68134E6FC48EF54B51ABAF87C" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,430</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:continuation><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Total amortization of intangible assets was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55397340e4800-wk-Fact-DD35D15212C44B59990F54B51B235092" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">129</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55397340e4804-wk-Fact-C2D7DA6FD1EB6C0D53E754B51B20AB43" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">133</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March 31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55397340e4816-wk-Fact-709D1581693A22214C4A54B51AA75015" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">385</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55397340e4821-wk-Fact-0F0BE5BFB1F2C07B2E7A54B51B22BEB3" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">399</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. Estimated annual amortization of intangible assets for the remainder of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> through </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2024</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> is as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55397340e4846-wk-Fact-90B0DBACB4EF0F342FCC54B51AA8D888" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">134</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55397340e4850-wk-Fact-93A1F8C4D63A789ED03854B51AA9F1C8" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">442</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55397340e4854-wk-Fact-232F19BC72A2C7F2F22A54B51B21C0D3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">408</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55397340e4858-wk-Fact-054C35274AE3B0F6FE3754B51B1FA7F3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">358</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55397340e4862-wk-Fact-83615130CA238216CBA054B51AA88A5C" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">328</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div></ix:continuation><div><a id="s278C8D151C2F53ABAC5819E0A5352EFA"></a></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock" id="TextSelection-0B8FAF2D61B103EAE81D54B51B4EABFA-0-wk-Fact-6FCEC92FAA2868333EA054B51A904DDC" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">4. Investments</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In August 2018, we sold our </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55391894e2758-wk-Fact-8DD8A040D7113622D0EC54B51A8E5F61" name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="I2018Q1navi_srt_OwnershipAxis_cah_NaviOwnershipInterestDivestedMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">98</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> ownership interest in naviHealth Holdings, LLC ("naviHealth") to investor entities controlled by Clayton, Dubilier &amp; Rice in exchange for cash proceeds of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55391894e2762-wk-Fact-A5CE0920F58E27AD659854B51A900787" name="us-gaap:ProceedsFromDivestitureOfBusinesses" contextRef="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">737</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (after adjusting for certain fees and expenses) and a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55391894e2766-wk-Fact-B1F83B5133096EA51E5454B51A8E5EC0" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">44</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> equity interest in a partnership that owns </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55391894e2770-wk-Fact-C597732D506FC98536D554B51A91E5FE" name="cah:PartnershipIndirectOwnership" contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the equity interest of naviHealth. We also have certain call rights to reacquire naviHealth. We are accounting for this investment using the equity method of accounting and on a one-month reporting lag.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55391894e2785-wk-Fact-A66B8111D0F733B8A69454B51A8F2287" name="cah:PreTaxGainonDivestiture" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">508</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> related to this divestiture in impairments and (gain)/loss on disposal of assets in our condensed consolidated statements of earnings/(loss).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The carrying value of this investment was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55391894e2792-wk-Fact-1CAE451EDC56DC615D1154B51A90B2B5" name="us-gaap:EquityMethodInvestments" contextRef="FI2020Q3_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">330</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55391894e2796-wk-Fact-CF742F295EEB6A2ABC2E54B51A8FF8D4" name="us-gaap:EquityMethodInvestments" contextRef="FI2019Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">334</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> as of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. During the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, our proportionate share of naviHealth&#8217;s net loss, which was recorded in other (income)/ expense, net in the condensed consolidated statements of earnings/(loss), was immaterial.</span></div></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a id="s37977FB1689852A6888EFF6B57032648"></a></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="cah:LeasesTextBlock" id="TextSelection-0F700B5A6822366EC7EC54B51B4EFBAE-0-wk-Fact-340B2B904ED4F86574E154B51B23B5BB" continuedAt="TextSelection-0F700B5A6822366EC7EC54B51B4EFBAE-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">5. Leases</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We primarily have operating leases for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Beginning July 1, 2019, operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our condensed consolidated balance sheet at commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our lease agreements include leases that contain lease components and non-lease components. For all asset classes, we have elected to account for both of these provisions as a single lease component.  We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the condensed consolidated financial statements at or for the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was not material. In addition, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing 1) whether any contracts are leases or contain leases, 2) lease classification and 3) initial direct costs. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our leases have remaining lease terms from less than </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d55406474e2768-wk-Fact-149523CBE92BA64CFB3254B51B242160" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="FI2020Q3_srt_RangeAxis_srt_MinimumMember" format="ixt-sec:duryear">1</ix:nonNumeric> year</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> up to approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d55406474e2772-wk-Fact-E8E00571A7B505E3669754B51B27014C" name="us-gaap:LesseeOperatingLeaseTermOfContract" contextRef="FI2020Q3_srt_RangeAxis_srt_MaximumMember" format="ixt-sec:duryear">23</ix:nonNumeric> years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">30</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-0F700B5A6822366EC7EC54B51B4EFBAE-1" continuedAt="TextSelection-0F700B5A6822366EC7EC54B51B4EFBAE-2"><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:LeaseCostTableTextBlock" id="TextSelection-173B01AD0315A2C8802B54B51B4E0AB6-0-wk-Fact-3CB09E2252B753A3E44054B51B2A9CE4" continuedAt="TextSelection-173B01AD0315A2C8802B54B51B4E0AB6-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the components of lease cost:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:51%;"></td><td style="width:1%;"></td><td style="width:22%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e2883-wk-Fact-60673AC53C7D7E063E0A54B51AF26177" name="us-gaap:OperatingLeaseCost" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">31</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e2897-wk-Fact-6D2A1BE124587A0C8A8A54B51AF28194" name="us-gaap:OperatingLeaseCost" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">92</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization of right-of-use assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e2944-wk-Fact-2910123C93A15ADF34C454B51AF1FC12" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e2958-wk-Fact-109E63D3E2B1EB4FD6D154B51AEF5598" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e2978-wk-Fact-0001F669F3AF4796886F54B51AF15983" name="cah:TotalFinanceLeaseCost" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e2992-wk-Fact-15072FFC704E8C11E4EA54B51AEFBCE5" name="cah:TotalFinanceLeaseCost" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Variable lease cost</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3014-wk-Fact-154676E5356448B8F9EE54B51AEE77F4" name="us-gaap:VariableLeaseCost" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3028-wk-Fact-FC996E61CD02653BAA7954B51AF2571D" name="us-gaap:VariableLeaseCost" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3053-wk-Fact-C34538FA49F58E176A3A54B51AF1C0DB" name="us-gaap:LeaseCost" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3067-wk-Fact-5D23F7A609635D58681154B51AEF444F" name="us-gaap:LeaseCost" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">118</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-173B01AD0315A2C8802B54B51B4E0AB6-1" continuedAt="TextSelection-173B01AD0315A2C8802B54B51B4E0AB6-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-173B01AD0315A2C8802B54B51B4E0AB6-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Primarily includes payments for property taxes, maintenance and insurance. </span></div></ix:continuation></td></tr></table><ix:nonNumeric contextRef="FD2020Q3YTD" name="cah:LeasesSupplementalBalanceSheetInformationTableTextBlock" id="TextSelection-31777E1D67404630656F54B51B4FDE38-0-wk-Fact-A3E671A5D8A88CCC496354B51B0D13C5" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes supplemental balance sheet information related to leases:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:27%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3155-wk-Fact-717C12B21F6CC4D08566E01224936888" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">469</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Current portion of operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3191-wk-Fact-0707FDF1136E865C82F6E012253F4A6A" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">109</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Long-term operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3211-wk-Fact-55BCF7AEBCF69F22D4F8E01224BD3082" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">381</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3231-wk-Fact-A1E6C17FD87D760DDF4C54B51AC01451" name="us-gaap:OperatingLeaseLiability" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">490</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease right-of-use assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3293-wk-Fact-8A0177B6EAD626BDBB32E01224E6D8EA" name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Current portion of finance lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3335-wk-Fact-5B45F313784567877AA7E01224558581" name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term finance lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3355-wk-Fact-6ED37342CDF3736A3826E0122514D1F1" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3380-wk-Fact-16D4A11AAE04C2725E0C54B51AC336FC" name="us-gaap:FinanceLeaseLiability" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">14</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our condensed consolidated balance sheet. Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our condensed consolidated balance sheet. </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-0F700B5A6822366EC7EC54B51B4EFBAE-2"><ix:nonNumeric contextRef="FD2020Q3YTD" name="cah:LeasePaymentsTableTextBlock" id="TextSelection-19A865949873EB0B44B054B51B4E79E8-0-wk-Fact-2B698AA366CCC04AA4FA54B51B043611" continuedAt="TextSelection-19A865949873EB0B44B054B51B4E79E8-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarizes supplemental cash flow information related to leases:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:71%;"></td><td style="width:1%;"></td><td style="width:27%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating cash flows paid for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3486-wk-Fact-1FF6F6E0A65E7283B5AB54B51AA0412B" name="us-gaap:OperatingLeasePayments" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">95</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Financing cash flows paid for finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3501-wk-Fact-F3DBE81607A7C36F018254B51AA0E82B" name="us-gaap:FinanceLeasePrincipalPayments" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3541-wk-Fact-F6918C6F7F45CCF78A6254B51AA10B05" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">154</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3561-wk-Fact-A05332FCCE9C0940EEFF54B51AA05D5E" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amended lease standard adoption impact as of July 1, 2019 </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3585-wk-Fact-35283208ABA32FDFFBF754B51AA0D695" name="cah:Impactofadoptionofnewaccountingstandard" contextRef="D2020Q1SD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cah_ASC842Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">400</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-19A865949873EB0B44B054B51B4E79E8-1" continuedAt="TextSelection-19A865949873EB0B44B054B51B4E79E8-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-19A865949873EB0B44B054B51B4E79E8-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes the effect of </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$<ix:nonFraction id="d55406474e3603-wk-Fact-70D0394C1E5C3C142E1A54B51A7F1779" name="cah:ReclassificationofdeferredrentinaccordancewithASC842" contextRef="D2020Q1SD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance. </span></div></ix:continuation></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operating leases had a weighted-average remaining lease term of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d55406474e3612-wk-Fact-8456AA7248535BF5C2D354B51B23CBBE" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="FI2020Q3" format="ixt-sec:duryear">6.5</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> years and a weighted-average discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55406474e3616-wk-Fact-11BD9F8570C224DFE87F54B51A7F7899" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="FI2020Q3" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">2.8</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="TextSelection-D86209777F7DD08B59C754B51B4E92E3-0-wk-Fact-29163A09E7757811515A54B51B278092" continuedAt="TextSelection-D86209777F7DD08B59C754B51B4E92E3-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Future lease payments under non-cancellable leases as of </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> were as follows:</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">                          </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:51%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Remainder of 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e3727-wk-Fact-CB1DFFA82AB74F8B212D54B51AE0F329" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">29</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e3746-wk-Fact-FC6DF462D71A78F04DFE54B51AE15759" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3765-wk-Fact-DC44398BB148A7D93D6A54B51AE3DBC9" name="cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">30</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e3781-wk-Fact-67C49839B414199908B854B51AE230F4" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">113</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e3800-wk-Fact-82A76946AEF0993CD68E54B51AE41D9D" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3819-wk-Fact-7CA435206A8950632C6154B51AE46A4B" name="cah:LesseeLeaseLiabilityPaymentsDueYearTwo" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">119</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e3840-wk-Fact-5CF450A201BBAB8DFA5C54B51AE0A5BE" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">95</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e3859-wk-Fact-C82D947322B193E6D20454B51ADF26D2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3878-wk-Fact-D440E73262ACE2CB40C854B51AE53FBF" name="cah:LesseeLeaseLiabilityPaymentsDueYearThree" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">99</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e3899-wk-Fact-F9C630E400069C0235FD54B51AE7C8D9" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">73</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e3918-wk-Fact-D45F80C4DB048F41D66D54B51AE3A965" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3937-wk-Fact-F0188ED92B9DA9D4779754B51ADC034E" name="cah:LesseeLeaseLiabilityPaymentsDueYearFour" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">77</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e3958-wk-Fact-034BEA3F04C525CAE40454B51AE0392D" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">54</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e3977-wk-Fact-007E5C80364F77129E0954B51ADD925C" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e3996-wk-Fact-7BC4920E9C20B71B36C354B51ADBD270" name="cah:LesseeLeaseLiabilityPaymentsDueYearFive" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">55</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e4017-wk-Fact-24E4F19326D9D2F938BF54B51AE291A7" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">173</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e4036-wk-Fact-0F82301524221228422254B51AE75E03" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e4055-wk-Fact-2A5E641B2F179A578A6E54B51AE56C0C" name="cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">173</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e4076-wk-Fact-A838CC9ED69DAC73709754B51AE1710E" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">537</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e4095-wk-Fact-92DA04C43388454478DF54B51AE71902" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e4114-wk-Fact-339B6E40FCAFD57C337B54B51AE31AE1" name="cah:TotalLeaseLiabilityPaymentsDue" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">553</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: leases not yet commenced </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e4139-wk-Fact-7BA2981E23928BEAA86954B51AE44323" name="cah:LesseeOperatingLeaseLiabilityNotYetCommencedAmount" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e4158-wk-Fact-F4371FDFEA2295E1EAFF54B51ADD2288" name="cah:LesseeFinanceLeaseLiabilityNotYetCommencedAmount" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e4177-wk-Fact-7C41E5D57C3758FEE4A454B51AE8B204" name="cah:TotalLeaseLiabilityNotYetCommencedAmount" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e4198-wk-Fact-9A9211425AC0F961306E54B51AE87871" name="cah:OperatingLeaseImputedInterest" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">43</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e4217-wk-Fact-18E6865F1525974CDE1A54B51ADDF7C5" name="cah:FinanceLeaseImputedInterest" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e4236-wk-Fact-21B003D0AAC15C69CEFE54B51AE3914A" name="cah:TotalLeaseLiabilityUndiscountedExcessAmount" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">45</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e4262-wk-Fact-5134E564BC1EB77B714D54B51ADC70D2" name="us-gaap:OperatingLeaseLiability" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">490</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55406474e4281-wk-Fact-D69B5329534D9DA2B6D954B51AE2E314" name="us-gaap:FinanceLeaseLiability" contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">14</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55406474e4300-wk-Fact-F24DC858FCB7D0EEFBD854B51AE34933" name="cah:TotalLeaseLiability" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">504</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-D86209777F7DD08B59C754B51B4E92E3-1" continuedAt="TextSelection-D86209777F7DD08B59C754B51B4E92E3-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-D86209777F7DD08B59C754B51B4E92E3-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">As of </span><span style="font-family:Arial Narrow;font-size:8pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the condensed consolidated balance sheets. </span></div></ix:continuation></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The future minimum rental payments for operating leases&#160;having initial or remaining non-cancelable lease terms in excess of one year at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> through </span><span style="font-family:Arial Narrow;font-size:10pt;">2024</span><span style="font-family:Arial Narrow;font-size:10pt;"> and thereafter were as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55406474e4335-wk-Fact-5BDFC3A1686B1ED760B054B51A7FFD9A" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">126</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55406474e4339-wk-Fact-57F12B10BCAEDFFFB8D654B51B2989E4" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">100</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55406474e4344-wk-Fact-DCE5995520BBE9E2F97954B51B22107F" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">76</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55406474e4348-wk-Fact-2E8E6B739775003C52BC54B51B0D31F1" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">54</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55406474e4352-wk-Fact-C8FB2AABFA729C12234A54B51B2413F5" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">33</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55406474e4356-wk-Fact-0E28B44946A3B30B2EAE54B51A81ADCE" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">94</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sC01B26F4270953278E0B2F0FA5E5852A"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:DebtDisclosureTextBlock" id="TextSelection-DCA53FBDCD5F146A651D54B51B4F3130-0-wk-Fact-784723F619F9FCAF720654B51A889747" continuedAt="TextSelection-DCA53FBDCD5F146A651D54B51B4F3130-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-weight:bold;">6. Long-Term Obligations and Other Short-Term Borrowings</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Long-Term Debt and Other Short-Term Borrowings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had total long-term obligations, including the current portion and other short-term borrowings, of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;text-align:right;vertical-align:bottom;"><span>$<ix:nonFraction id="d55401591e2751-wk-Fact-0BC2E3599948DA6740B954B51A895C8E" name="cah:TotalLongTermandShortTermObligations" contextRef="FI2020Q3" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">7.3</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;text-align:right;vertical-align:bottom;"><span>$<ix:nonFraction id="d55401591e2755-wk-Fact-7C934709BB9D643F238254B51A8F0334" name="cah:TotalLongTermandShortTermObligations" contextRef="FI2019Q4" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">8.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </span><span style="font-family:Arial Narrow;font-size:10pt;">All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. Interest is paid pursuant to the terms of the obligations. These obligations are effectively subordinated to the liabilities of our subsidiaries, including trade payables of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e2761-wk-Fact-46E9531AEBC449D692BD54B51A89DD83" name="us-gaap:AccountsPayableCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">22.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e2766-wk-Fact-20C1DD835ED6A7DD3DCEF1DCF74B8C21" name="us-gaap:AccountsPayableCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-8" scale="9" format="ixt:numdotdecimal">21.5</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In November 2019, we repaid the full principal of the 2.4% Notes due 2019 at maturity for </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e2781-wk-Fact-E24DF376B679FCCF4D5E54B51A8A6EAE" name="us-gaap:RepaymentsOfNotesPayable" contextRef="D2020Q2NotesPayable_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">450</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span><span style="font-family:Arial Narrow;font-size:10pt;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;">we early repurchased</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e2800-wk-Fact-53B8739CC66E373345ED54B51A89BC7F" name="cah:NotesPayableRepurchased" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">247</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">2.616% Notes due 2022</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e2809-wk-Fact-DFD8179652FF6D5B5F2954B51A8BAE70" name="cah:NotesPayableRepurchased" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">  of the </span><span style="font-family:Arial Narrow;font-size:10pt;">3.2% Notes due 2022</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e2817-wk-Fact-EADC97498F00DBEFBEE054B51A8D0DAA" name="cah:NotesPayableRepurchased" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the  </span><span style="font-family:Arial Narrow;font-size:10pt;">Floating Rate Notes due 2022</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e2826-wk-Fact-E2861A83CEB441726BD754B51A8E652E" name="cah:NotesPayableRepurchased" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">104</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">3.41% Notes due 2027</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e2834-wk-Fact-ABCBE72BAAAC001D57C554B51A8C4356" name="cah:NotesPayableRepurchased" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">4.6% Notes due 2043</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e2842-wk-Fact-F31F37ABFFC5EF52E2AA54B51A8D4E7A" name="cah:NotesPayableRepurchased" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the  </span><span style="font-family:Arial Narrow;font-size:10pt;">4.9% Notes due 2045</span><span style="font-family:Arial Narrow;font-size:10pt;">, and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e2851-wk-Fact-176107B635169649FB3754B51A8D22E7" name="cah:NotesPayableRepurchased" contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">4.368% Notes due 2047</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span><span style="font-family:Arial Narrow;">The repurchases were paid for with available cash and other short-term borrowings. In connection with the early debt repurchases, we recorded a</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e2864-wk-Fact-5F9B3DE83DE70A97FD6454B51AA69642" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">9</ix:nonFraction> million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;">loss on extinguishment of debt.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-DCA53FBDCD5F146A651D54B51B4F3130-1" continuedAt="TextSelection-DCA53FBDCD5F146A651D54B51B4F3130-2"><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfDebtTableTextBlock" id="TextSelection-42519092354AF2CA3B7154B51B4F542F-0-wk-Fact-A2D73F9C957D01F1784D54B51A8BDD07" continuedAt="TextSelection-42519092354AF2CA3B7154B51B4F542F-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes long-term obligations and other short-term borrowings at:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.76543209876543%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:59%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions) (1)</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.4% Notes due 2019</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e2950-wk-Fact-69DF84C99F3E481D632A54B51AF8ACB9" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e2969-wk-Fact-6D9D7D6C8CF545C8705A54B51A7FABB3" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">450</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.625%&#160;Notes due 2020</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e2984-wk-Fact-C126CF7120E4EB5D880954B51A83B8C9" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">504</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3003-wk-Fact-56A514E8AC59AC67896A54B51AF83DA5" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">508</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.616% Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3023-wk-Fact-B8D3F9C58044035623DA54B51AEFCDE3" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">834</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3042-wk-Fact-D37A30A4490DDB811C9554B51AF0E94E" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,079</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2% Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3062-wk-Fact-B7D8AFF0B5E77C786A0D54B51A85F85D" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">236</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3081-wk-Fact-640A56A99B867DC5811A54B51AEE397F" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">247</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Floating Rate Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3101-wk-Fact-2A24B6294227CF8EE68654B51AFA7AE0" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">321</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3120-wk-Fact-9F7C9FF898024EFF47F054B51AFA8DE1" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">340</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2% Notes due 2023</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3140-wk-Fact-83CFA5DA0356624A7C0754B51AF08702" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">573</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3159-wk-Fact-99BBA8FBAC77694E871954B51AF10F5A" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">551</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.079% Notes due 2024</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3179-wk-Fact-138996D5A02CEA08E19E54B51AEDB5A4" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">815</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3198-wk-Fact-E94B95BEFBAA234B4DBF54B51A848133" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">781</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.5% Notes due 2024</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3218-wk-Fact-0BC7871F75E0A9A4E6E554B51A81164B" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">413</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3237-wk-Fact-5EB9DEA1C648E8FF453254B51A856926" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">402</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.75% Notes due 2025</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3257-wk-Fact-D30E214F960C1088B05854B51AEE88F1" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">530</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3276-wk-Fact-15597F4F683F2CD27A8054B51AFC9373" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">494</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.41% Notes due 2027</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3296-wk-Fact-C2AA5C33E75A02BCEB3454B51AF28C09" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,215</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3315-wk-Fact-CF7FE6B5EFCF39B8E16454B51A84165D" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,318</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.6% Notes due 2043</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3336-wk-Fact-45C1F7BBA5B6C5C8AEE154B51AFAC586" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">340</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3355-wk-Fact-3AC82D6FB37124BC7EC954B51AF2C4D5" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">346</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.5% Notes due 2044</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3375-wk-Fact-C5A9EF27AA16BF4B34ED54B51AF9E8CE" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">342</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3394-wk-Fact-32D9E3E7D9A406FC488F54B51AF94747" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">342</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.9% Notes due 2045</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3414-wk-Fact-F7855EA8B0E17321759454B51A8435D7" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">441</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3433-wk-Fact-02E7E9C8EEF993D8CAD654B51A839722" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">445</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.368% Notes due 2047</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3453-wk-Fact-F674C763678F593FE08254B51AEEADEA" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">560</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3472-wk-Fact-7EF12C52947C74501B7954B51AEE73CF" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">594</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7.0%&#160;Debentures due 2026</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3492-wk-Fact-9699D5007CD5EAF4394754B51A849AA3" name="us-gaap:NotesPayable" contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">124</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3511-wk-Fact-CACE11EBA70119B41B2F54B51A81436C" name="us-gaap:NotesPayable" contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">124</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other Obligations</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3531-wk-Fact-F92A91457FE871234BDD54B51AF8B733" name="us-gaap:OtherBorrowings" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">14</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3550-wk-Fact-7047502C41F68032420254B51A8034F7" name="us-gaap:OtherBorrowings" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3570-wk-Fact-876E2D6CDB4B8D100E8154B51A833BDA" name="cah:TotalLongTermandShortTermObligations" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7,262</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3589-wk-Fact-BADC2BDBA626C0961C4554B51A82B842" name="cah:TotalLongTermandShortTermObligations" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,031</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: current portion of long-term obligations and other short-term borrowings</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3609-wk-Fact-F497BA391D56252F1F4E54B51AECCD3B" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">508</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3628-wk-Fact-4F45C093DE0583F7701154B51AFE64C8" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">452</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;&#160;&#160;Long-term obligations, less current portion</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55401591e3653-wk-Fact-576A5B650BA3491CB7A154B51AEBFBEF" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6,754</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55401591e3672-wk-Fact-044D800023AE5C22DF8254B51B003CF2" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7,579</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Maturities are presented on a calendar year basis. </span></div></td></tr></table></ix:nonNumeric><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"><ix:continuation id="TextSelection-42519092354AF2CA3B7154B51B4F542F-1"></ix:continuation>Other Financing Arrangements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e3693-wk-Fact-F2DECE937EB8F0EA036B54B51A892FC0" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2020Q3_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">2.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;commercial paper program backed by a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e3697-wk-Fact-F6D1E663806E8024631954B51A8AA975" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2020Q3_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">2.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;revolving credit facility. We also have a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55401591e3701-wk-Fact-6D80E77A338B3C75D1E054B51A8DCBBC" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="FI2020Q3_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember" unitRef="usd" decimals="-6" scale="9" format="ixt:numdotdecimal">1.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;committed receivables sales facility. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through September 30, 2022. CHF was organized for</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. </span></div></ix:continuation><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><ix:continuation id="TextSelection-DCA53FBDCD5F146A651D54B51B4F3130-2"><span style="font-family:Arial Narrow;">Our revolving credit and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter through December 2020, a consolidated net leverage ratio of no more than 4.00-to-1. The maximum permitted ratio will reduce to 3.75-to-1 in March 2021 and as of the end of every quarter thereafter.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;">As of </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;">, we were in compliance with this financial covenant.</span></ix:continuation><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">32</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s054B3015E6505AB9825D03C656BE42ED"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="TextSelection-AEA7B073026C37E0D25354B51B4F4DD5-0-wk-Fact-CD4937FC2CBFC67A0E5854B51B109149" continuedAt="TextSelection-AEA7B073026C37E0D25354B51B4F4DD5-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">7. Commitments, Contingent Liabilities and Litigation</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commitments</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Generic Sourcing Venture with CVS Health Corporation ("CVS Health")</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In July 2014, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d55409962e2756-wk-Fact-B0D0493B0E52079CE4B454B51B0C85D0" name="us-gaap:LongtermPurchaseCommitmentPeriod" contextRef="FD2020Q3YTD_srt_MajorCustomersAxis_cah_CVSHealthMember" format="ixt-sec:duryear">10</ix:nonNumeric> years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. Due to the achievement of predetermined milestones, we are required to make quarterly payments of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55409962e2760-wk-Fact-94C2A466E1C9E6EEDCF354B51B0FAA97" name="cah:MaximumQuarterlyPayment" contextRef="FD2020Q3YTD_srt_MajorCustomersAxis_cah_CVSHealthMember" unitRef="usd" decimals="-5" scale="6" format="ixt:numdotdecimal">45.6</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to CVS Health for the remainder of the initial term.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Legal Proceedings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We become involved from time to time in disputes, litigation and regulatory matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are named from time to time in </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information have led, and may in the future lead, to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we determine that products we manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions can lead to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, action by regulators and product liability claims and lawsuits, including class actions. Even absent an </span></div></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-AEA7B073026C37E0D25354B51B4F4DD5-1" continuedAt="TextSelection-AEA7B073026C37E0D25354B51B4F4DD5-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates. Except as otherwise disclosed in this footnote, it is not possible for us to reasonably estimate the amount of any possible loss or range of possible losses in the matters described below. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our condensed consolidated statements of earnings.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Opioid Lawsuits and Investigations</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Pharmaceutical wholesale distributors, including us, have been named as defendants in over </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d55409962e2806-wk-Fact-E021A5FFC4929D5C255C54B51B0C39A0" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q3SD_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="number" decimals="0" scale="0" format="ixt:numdotdecimal">3,000</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits relating to the distribution of prescription opioid pain medications. The lawsuits seek equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as public nuisance, negligence and unjust enrichment as well as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. These lawsuits also name pharmaceutical manufacturers, retail pharmacy chains and other entities as defendants.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">States &amp; Political Subdivisions</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d55409962e2816-wk-Fact-E2472C2FD2C5370D83A554B51B0DEA93" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q3SD_srt_LitigationCaseAxis_cah_OpioidLawsuitsStateDomain_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="number" decimals="0" scale="0" format="ixt:numdotdecimal">2,700</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of these lawsuits have been filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The vast majority of these lawsuits were filed in U.S. federal court and have been transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#8220;MDL&#8221;).  </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In January 2020, the complaints of the Cabell County, West Virginia and the City of Huntington, West Virginia were remanded to U.S. District Court in West Virginia.  A trial date has been set in August 2020.  In addition, the complaints of San Francisco, California and the Cherokee Nation have been remanded to their original district courts, but no trial dates have been set.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d55409962e2826-wk-Fact-8D5EDA93E8E6FF8E037C54B51B10A78D" name="cah:NumberofStateAttorneysGeneralfilinglawsuits" contextRef="I2020Q3SD_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="StateAG" decimals="0" scale="0" format="ixt:numdotdecimal">25</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> state attorneys general have filed lawsuits against distributors, including us, in various state courts.  A trial in New York for cases brought by the New York State Attorney General and Nassau and Suffolk counties was scheduled to begin in March 2020, but was deferred due to the COVID-19 pandemic. Trial is scheduled to begin in October 2020 for a case brought by the Ohio State Attorney General and trial on a case brought by certain West Virginia political subdivisions is scheduled for March 2021. </span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">33</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-AEA7B073026C37E0D25354B51B4F4DD5-2" continuedAt="TextSelection-AEA7B073026C37E0D25354B51B4F4DD5-3"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Additionally, we have received requests from a multi-state task force of state attorneys general, as well as separate civil investigative demands, subpoenas or requests for information from these and other state attorneys general offices and governmental authorities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In October 2019, we agreed in principle to a global settlement framework with a leadership group of state attorneys general that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions (the "Settlement Framework"). This Settlement Framework is subject to contingencies and uncertainties as to final terms, but is the basis for our negotiation of definitive terms and documentation.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Settlement Framework includes (1) a cash </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">component</span><span style="font-family:Arial Narrow;font-size:10pt;">, pursuant to which we would pay up to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2843-wk-Fact-5FFC1971F9D31BF771EB54B51B07910D" name="us-gaap:LitigationReserve" contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" unitRef="usd" decimals="-7" scale="9" format="ixt:numdotdecimal">5.56</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d55409962e2847-wk-Fact-CA8E8EEC260DEBF35FD654B51B0E13F1" name="cah:CashComponentForSettlementFrameworkTerm" contextRef="FD2020Q3YTD_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" format="ixt-sec:durwordsen">eighteen years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;">, (2) development and participation in a program for  distribution of opioid abuse treatment medications for a period of ten years, and (3) industry-wide changes to be specified to controlled substance anti-diversion programs. Definitive terms for a settlement pursuant to the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. In connection with these matters, we have </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2851-wk-Fact-5FFC1971F9D31BF771EB54B51B07910D" name="us-gaap:LitigationReserve" contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" unitRef="usd" decimals="-7" scale="9" format="ixt:numdotdecimal">5.56</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> accrued at March 31, 2020, included in deferred income taxes and other liabilities in the condensed consolidated balance sheets, which represents the cash component. We are unable to reasonably estimate the liability or cost associated with the other components of the Settlement Framework, the potential distribution of treatment medications and any incremental costs for changes to our controlled substance anti-diversion program that we may agree to. We continue to negotiate the definitive terms of the Settlement Framework. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the nine months ended March 31, 2020, we along with two other national distributors entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2859-wk-Fact-D1765D640457DB68A4AA54B51B0EA1DE" name="cah:OpioidTotalSettlementCuyahogaandSummitCounties" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">215</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> settlement with two Ohio counties, Cuyahoga and Summit, to resolve all claims in the first bellwether trial in the MDL, which had been set for trial for October 2019. In connection with this settlement, we incurred </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2863-wk-Fact-71F828C2464664426B8654B51B108A43" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q3YTD_srt_LitigationCaseAxis_cah_OpioidLitigationCuyahogaandSummitCountiesMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">66</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> within litigation (recoveries)/charges, net during the nine months ended March 31, 2020. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with these matters, we recorded a total pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2870-wk-Fact-4074F71F4572CF3082B854B51B0B8528" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q3YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-6" scale="9" sign="-" format="ixt:numdotdecimal">5.63</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2874-wk-Fact-4BD128957D98CF90040D54B51B10F8A1" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q3YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember" unitRef="usd" decimals="-6" scale="9" sign="-" format="ixt:numdotdecimal">5.14</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> after tax) during the nine months ended March 31, 2020 in litigation (recoveries)/charges, net, in the condensed consolidated statement of earnings for the cash component. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We will regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual. We continue to strongly dispute the allegations made in these lawsuits and reaching an agreement in principle on a global settlement framework is not an admission of liability or wrongdoing.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Private Plaintiffs</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Settlement Framework does not address claims by private plaintiffs, which includes unions and other health and welfare funds, </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-AEA7B073026C37E0D25354B51B4F4DD5-3" continuedAt="TextSelection-AEA7B073026C37E0D25354B51B4F4DD5-4"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">hospital systems and other healthcare providers, businesses and individuals. Private plaintiffs had brought approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d55409962e2887-wk-Fact-F05CE517D6D623308ED3E1811BEADAE9" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q3SD_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="lawsuit" decimals="0" scale="0" format="ixt:numdotdecimal">400</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits as of May 4, 2020. Of these, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d55409962e2891-wk-Fact-DC67CE161EA97FB0275054B51B0F830E" name="cah:LossContingencyLawsuitsNumber" contextRef="I2020Q3SD_cah_LawsuitTypeAxis_cah_ClassActionLawsuitsMember_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="lawsuit" decimals="0" scale="0" format="ixt:numdotdecimal">105</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs. We will continue to vigorously defend ourselves in these matters.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Department of Justice Investigations</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have received grand jury subpoenas issued on behalf of the District Courts for the Eastern District of New York and the District of Columbia seeking documents and, in the District of Columbia, testimony, related to our anti-diversion policies and procedures, and our distribution of certain controlled substances. We are cooperating with these requests.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Cordis Product Liability Lawsuits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As of May 4, 2020, we are named as a defendant in </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d55409962e2907-wk-Fact-96B6FFB7B4816969D9D454B51B116B33" name="us-gaap:LossContingencyNewClaimsFiledNumber" contextRef="D2020Q3Litigation_us-gaap_LossContingenciesByNatureOfContingencyAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="lawsuit" decimals="0" scale="0" format="ixt:numdotdecimal">309</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d55409962e2911-wk-Fact-BE9949E7B9A82BDDE6CA54B51B0AE624" name="us-gaap:LossContingencyNumberOfPlaintiffs" contextRef="D2020Q3Litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="plaintiff" decimals="0" scale="0" format="ixt:numdotdecimal">3,924</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. Another </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d55409962e2915-wk-Fact-4237C7DE4C97FEBE8C7F54B51B104343" name="us-gaap:LossContingencyNewClaimsFiledNumber" contextRef="D2020Q3Litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="lawsuit" decimals="0" scale="0" format="ixt:numdotdecimal">29</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits involving similar claims by approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d55409962e2919-wk-Fact-B77F475FE5D176CD2AA754B51B0A5F97" name="us-gaap:LossContingencyNumberOfPlaintiffs" contextRef="D2020Q3Litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="plaintiff" decimals="0" scale="0" format="ixt:numdotdecimal">34</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. We are vigorously defending ourselves in these lawsuits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had a total of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2930-wk-Fact-256CF8EC9955AA71165954B51B0D764B" name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="FI2020Q3_srt_RangeAxis_srt_MinimumMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">466</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> accrued for losses and legal defense costs related to the Cordis IVC filter lawsuits, net of estimated insurance recoveries. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range to be approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2934-wk-Fact-5598CA08763CAE642D0E54B51B105474" name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="FI2020Q3_srt_RangeAxis_srt_MaximumMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">900</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, net of estimated insurance recoveries.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Shareholder Securities Litigation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In August 2019, the Louisiana Sheriffs' Pension &amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. The complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. We believe that the claims asserted in this complaint are without merit and intend to vigorously defend against them. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Surgical Gown Recalls</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In January 2020, we issued a voluntary recall for </span><span style="font-family:Arial Narrow;font-size:10pt;">9.1 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> AAMI Level 3 surgical gowns and two voluntary field actions (a recall of some packs and a corrective action allowing overlabeling of other packs) for 2.9 million Presource Procedure Packs containing affected gowns (together, the "Recalls"). These Recalls were necessary </span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">34</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-AEA7B073026C37E0D25354B51B4F4DD5-4"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">because we discovered in December 2019 that one of our FDA-registered suppliers in China had shifted production of some gowns to unapproved sites with uncontrolled manufacturing environments. Because of this, we could not assure sterility of the gowns. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with these Recalls, in the nine months ended </span><span style="font-family:Arial Narrow;font-size:10pt;">March 31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we recorded total charges of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2965-wk-Fact-1A86236C670FA586A29154B51B0ED102" name="us-gaap:InventoryRecallExpense" contextRef="FD2020Q3YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">95</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, of which </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2969-wk-Fact-99336BCAC5265656600654B51B0ABF85" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="FD2020Q3YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">55</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> is within cost of products sold and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2973-wk-Fact-DBDEE4599B890F4E355954B51B0FE685" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="FD2020Q3YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> is within SG&amp;A in the condensed consolidated statements of earnings/(loss). In our condensed consolidated balance sheet at March 31, 2020, we had </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2977-wk-Fact-AFD49B57CB98132521F354B51B0C7047" name="us-gaap:InventoryNet" contextRef="FI2020Q3_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">38</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> reserved within inventories, net, and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$<ix:nonFraction id="d55409962e2982-wk-Fact-B5FAE13621BBCF652EC854B51B094256" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="FI2020Q3_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">55</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> included in other accrued liabilities related to this charge.  This charge represents our best estimate of costs for the Recalls and includes inventory write-off costs and certain remediation and supply disruption costs, such as costs to replace recalled products. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. The amount of ultimate loss may differ materially from this accrual. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to the charge for the nine months ended March 31, 2020, the Recalls may have other negative impacts, which could include: government investigations and enforcement actions by the U.S. Food and Drug Administration or other regulators or U.S. or international governmental bodies (possibly resulting in the suspension or revocation of the authority to produce, distribute and sell products and other civil or criminal sanctions); losses due to patient claims, including product liability claims and lawsuits; and customer claims unrelated to their direct costs from the supply disruption. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Civil Litigation </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Generic Pharmaceutical Antitrust Litigation </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In December 2019, pharmaceutical distributors including us were added as defendants in a civil multidistrict litigation consisting of multiple individual and class action lawsuits filed by indirect purchasers of generic drugs, such as hospitals and retail pharmacies. The plaintiffs allege that pharmaceutical distributors encouraged manufacturers to increase prices, provided anti-competitive pricing information to manufacturers and informed manufacturers that they wished to maintain current customer allocations for the purpose of avoiding price erosion. We intend to vigorously defend ourselves in these matters. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Blood Pressure Medication Recall Litigation </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Many participants in the pharmaceutical supply chain, including manufacturers, repackagers (including us), distributors (including us), and retailers have been named as defendants in Multidistrict Litigation in the U.S. District Court for the District of New Jersey (the &#8220;Blood Pressure Medication Recall MDL&#8221;), which was created in February 2019. The claims arise out of a series of recalls of generic blood pressure medications due to alleged impurities in active pharmaceutical ingredients. We intend to vigorously defend ourselves in these matters.</span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a id="sB7CDBCE5EBAC5E44B528F25DC21C6048"></a></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:IncomeTaxDisclosureTextBlock" id="TextSelection-EEEB26D000FD0FF6C5EA54B51B4F85C5-0-wk-Fact-C7BFCDAEDDEE8941DA9754B51A893ED8" continuedAt="TextSelection-EEEB26D000FD0FF6C5EA54B51B4F85C5-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">8. Income Taxes</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Fluctuations in our provision for/(benefit from) income taxes as a percentage of pretax earnings (&#8220;effective tax rate&#8221;) are generally due to changes in international and U.S. state effective tax rates resulting from our business mix and discrete items. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Opioid Settlement Framework</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2749-wk-Fact-C827D709C763425D03DB54B51A88875B" name="us-gaap:LitigationReserve" contextRef="FI2020Q3_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-7" scale="9" format="ixt:numdotdecimal">5.63</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax charge for the opioid litigation, during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2761-wk-Fact-7230EA700241F1F8918C54B51A87BD2B" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="FD2020Q3YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">487</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2765-wk-Fact-4FCB10BF91AD0D13034054B51A87502E" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextRef="FI2020Q3_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">468</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the U.S. Tax Cuts and Jobs Act ("Tax Act"). Further, it is possible that the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s8AD44EFDC5135A2C93CB707A0F4CCE02"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for more information regarding these matters.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Effective Tax Rate</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;and&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the effective tax rate was&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55413243e2789-wk-Fact-01BA2776369D9207C6BE54B51A8816D3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2020Q3QTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">26.8</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent and&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55413243e2793-wk-Fact-DD56625A8904CED45E6054B51A8AFEBE" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2019Q3QTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">20.0</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;percent, respectively. The increase in the effective tax rate from the prior period was </span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">primarily due to changes in discrete tax items and jurisdictional mix.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;and&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the effective tax rate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55413243e2815-wk-Fact-82538175F53CC6D699BA54B51A8A6D48" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2020Q3YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">5.2</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;percent and&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55413243e2819-wk-Fact-E251B4E4C6963D13977D54B51A8BB32A" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="FD2019Q3YTD" unitRef="number" decimals="3" scale="-2" format="ixt:numdotdecimal">22.6</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;percent, respectively.  The decrease in the effective tax rate from fiscal 2019 to fiscal 2020 was primarily due to the net tax effects of </span><span style="font-family:Arial Narrow;font-size:10pt;">the Settlement Framework.  </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Unrecognized Tax Benefits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2840-wk-Fact-B85D73606C7939B57FE954B51A8EBEAD" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">919</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2844-wk-Fact-6EBF8C0B00379729DEF2E1285D422880" name="us-gaap:UnrecognizedTaxBenefits" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">456</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of unrecognized tax benefits, respectively. The </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> balances include </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2857-wk-Fact-C88C341DFB9362BA9E1D54B51A88023D" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">772</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2861-wk-Fact-98458148AC76AFA9363BE128D24823EE" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">303</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of unrecognized tax benefits, respectively, that if recognized, would have an impact on the effective tax rate. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2876-wk-Fact-40FCE5C055A1AEFFA81A54B51A8B2C57" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">137</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2880-wk-Fact-FD7E8DB15020819F909354B51A8A2DF6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">122</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, accrued for the payment of interest and penalties related to unrecognized tax benefits, which we recognize in the provision for/(benefit from) income taxes in the condensed consolidated statements of earnings/(loss). These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the condensed consolidated balance sheets. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of IRS and other audit issues, </span></div></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">35</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-EEEB26D000FD0FF6C5EA54B51B4F85C5-1"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is between </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55413243e2891-wk-Fact-C2705F220CD3515ECB3054B51A89B5EA" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" contextRef="FI2020Q3_srt_RangeAxis_srt_MinimumMember" unitRef="usd" decimals="-6" scale="6" format="ixt-sec:numwordsen">zero</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and a net decrease of up to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2895-wk-Fact-A3F93B9831A9998A560954B51A87031E" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" contextRef="FI2020Q3_srt_RangeAxis_srt_MaximumMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, exclusive of penalties and interest.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Tax Matters</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d55413243e2905-wk-Fact-02410FD87281CEBF97F054B51A8CD491" name="us-gaap:OpenTaxYear" contextRef="FD2020Q3QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember">2008</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including IRS challenges to our international transfer pricing for the periods from 2008 to 2014, and it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), a subsidiary of Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2912-wk-Fact-DA4A0939B682249FBE4054B51A8A6419" name="cah:IndemnificationReceivable" contextRef="FI2020Q3_cah_TaxMatterAxis_cah_CareFusionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">173</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2916-wk-Fact-F578E75BE509975E08FA54B51A879A7B" name="cah:IndemnificationReceivable" contextRef="FI2019Q4_cah_TaxMatterAxis_cah_CareFusionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">165</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and is included in other assets in the condensed consolidated balance sheets.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition under the purchase agreement. The indemnification receivable was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2931-wk-Fact-E4970FDF0EEB181977C454B51A8A894C" name="cah:IndemnificationReceivable" contextRef="FI2020Q3_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">18</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55413243e2935-wk-Fact-21514D2926A043637CE354B51A87E127" name="cah:IndemnificationReceivable" contextRef="FI2019Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and is included in other assets in the condensed consolidated balance sheet.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Future adjustments to the financial statements may be necessary as final tax regulations related to U.S. Tax Reform are issued. We will assess any impact as additional guidance is issued.</span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a id="sE6475692C3385FD2AA9628E7E912331E"></a></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="TextSelection-3F862220C2F0F3511DC254B51B4F2568-0-wk-Fact-2CB425C6EB7D863CE86954B51A9A7D30" continuedAt="TextSelection-3F862220C2F0F3511DC254B51B4F2568-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">9. Fair Value Measurements</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="TextSelection-63C2F2612879A6E0161454B51B4F48E3-0-wk-Fact-2703BAD0E8206E26477454B51A9E43CE" continuedAt="TextSelection-63C2F2612879A6E0161454B51B4F48E3-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55421030e3044-wk-Fact-4177FE15403B2396930D54B51ACF5DF7" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">647</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55421030e3063-wk-Fact-F8AE24940C2BB0BBF13154B51ACD99BC" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55421030e3082-wk-Fact-A531C885AE0854C4C7B054B51ACEC2E6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55421030e3102-wk-Fact-B07DD9D2484518F3CB3954B51ACE133D" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">647</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55421030e3117-wk-Fact-739AFDDABCE1CC45641454B51ACC6F30" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">96</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55421030e3136-wk-Fact-A12910F2D5457BBD73E054B51AC965D1" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55421030e3155-wk-Fact-B26E0E38D4E6BBF4422B54B51ACC8679" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55421030e3175-wk-Fact-AC74E3BB9261595DE62354B51ACD23DD" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">96</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55421030e3195-wk-Fact-9E606EB3C7C5F052FB0C54B51AC98A73" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55421030e3214-wk-Fact-223A62BA8E65C7F1F5A854B51ACA4FA3" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">170</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55421030e3233-wk-Fact-874D2CB42B657D6159B454B51ACC884F" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55421030e3253-wk-Fact-3355794C6F41C663B8F454B51ACBBED7" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">170</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55421030e3548-wk-Fact-0F84D4DD99AE3296A07154B51A80FE8F" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">297</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55421030e3567-wk-Fact-596BC5A2C56521B73ABA54B51B19625D" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55421030e3586-wk-Fact-9B536B22A45AB70E80A454B51B218A00" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55421030e3606-wk-Fact-FF3D1C921AB3BAE69E7C54B51B24779E" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="FI2018Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">297</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55421030e3621-wk-Fact-C57DBE0667B5A449A5E054B51A910000" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">118</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55421030e3640-wk-Fact-DD2B6905E86F3DBDC47854B51A91E324" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55421030e3659-wk-Fact-2D9492C6527B92B44AD754B51A8FE14C" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55421030e3679-wk-Fact-C13B0FD54FF2B38E803254B51A922444" name="us-gaap:InvestmentsFairValueDisclosure" contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">118</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55421030e3699-wk-Fact-73D8D1B46D584134544654B51A909E27" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55421030e3718-wk-Fact-9657D4A53587C630C62454B51A8F57B7" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55421030e3737-wk-Fact-667F475675469E29F98954B51A912D3C" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55421030e3757-wk-Fact-1B88FD3D6E189A1E9CCD54B51A91C734" name="us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet" contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div></td></tr></table></ix:nonNumeric></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-63C2F2612879A6E0161454B51B4F48E3-1" continuedAt="TextSelection-63C2F2612879A6E0161454B51B4F48E3-2"><ix:continuation id="TextSelection-3F862220C2F0F3511DC254B51B4F2568-1" continuedAt="TextSelection-3F862220C2F0F3511DC254B51B4F2568-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></ix:continuation></ix:continuation></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><ix:continuation id="TextSelection-63C2F2612879A6E0161454B51B4F48E3-2"><ix:continuation id="TextSelection-3F862220C2F0F3511DC254B51B4F2568-2">The fair value of interest rate swaps, foreign currency contracts, commodity contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the condensed consolidated balance sheets.</ix:continuation></ix:continuation> </span></div></td></tr></table><div><a id="s754FF11889B25B3797F9B44EE187CD4D"></a></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="TextSelection-70E496C87DD5F1C7F30A54B51B4F7F55-0-wk-Fact-914DC504A1829D3CCC5D54B51AD24F98" continuedAt="TextSelection-70E496C87DD5F1C7F30A54B51B4F7F55-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">10. Financial Instruments</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to fair value through earnings at the end of each period. We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are rated investment grade or better. We do not have significant exposure to any one counterparty and we believe the risk of loss is remote. Additionally, we do not require collateral under these agreements.</span></div></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">36</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-70E496C87DD5F1C7F30A54B51B4F7F55-1" continuedAt="TextSelection-70E496C87DD5F1C7F30A54B51B4F7F55-2"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Interest Rate Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes in interest rates. In addition, we enter into interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Currency Exchange Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce volatility in earnings, cash flow and net investments in certain subsidiaries to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commodity Price Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense in the condensed consolidated statements of earnings. For the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, there was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span><ix:nonFraction id="d55416729e2780-wk-Fact-AD19C04A41A94AEC80AC54B51AA57EC3" name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> gain or loss recorded to interest expense as changes in the market value of our derivative instruments offset changes in the market value of the underlying debt.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, no new pay-floating interest rate swaps were executed. In connection with the debt redemption  as described in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#sC01B26F4270953278E0B2F0FA5E5852A"><span style="font-family:Arial Narrow;font-size:10pt;">Note 6</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, two pay-floating interest rate swaps with notional amounts of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55416729e2804-wk-Fact-1053ED9A8CA33FEAC1C054B51AD28D24" name="cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">200</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> matured in the second quarter of fiscal 2020. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash Flow Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of other comprehensive income/(loss) and reclassified into earnings in the </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-70E496C87DD5F1C7F30A54B51B4F7F55-2" continuedAt="TextSelection-70E496C87DD5F1C7F30A54B51B4F7F55-3"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered into forward interest rate swaps with a total notional amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55416729e2829-wk-Fact-522E21F8F49AD4E220EE54B51ACEE1EA" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">200</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to hedge probable, but not firmly committed, future transactions associated with our debt.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gains and losses recognized in accumulated other comprehensive loss and reclassified into earnings were immaterial for the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. All gains and losses currently included within accumulated other comprehensive loss associated with our foreign exchange forward contracts that are expected to be reclassified into net earnings within the next 12 months are immaterial.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Net Investment Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In August 2019, we entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>&#165;<ix:nonFraction id="d55416729e2857-wk-Fact-C7638E4E29FD4AE84E6B54B51ACF6CB6" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="jpy" decimals="-6" scale="9" format="ixt:numdotdecimal">64.0</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55416729e2861-wk-Fact-83A15CB947A060B6B89F54B51AD187B2" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">) cross-currency swap maturing in 2022.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In September 2018, we entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>&#8364;<ix:nonFraction id="d55416729e2868-wk-Fact-D526AE510231D806874454B51AA3ECDB" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="eur" decimals="-6" scale="6" format="ixt:numdotdecimal">200</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55416729e2872-wk-Fact-9D70F4DC0981FA9BAC8054B51AC8AADF" name="us-gaap:DerivativeLiabilityNotionalAmount" contextRef="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">233</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">) cross-currency swap maturing in 2023.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive loss until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Economic (Non-Designated) Hedges</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. We recorded a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55416729e2888-wk-Fact-9F8AEBC21689F245E51054B51AD0770B" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">7</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55416729e2892-wk-Fact-A029E17225F1F55C753C54B51AA3FA9F" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">8</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> expense during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. The principal currencies managed through foreign currency contracts are the euro, Canadian dollar, British pound, Japanese yen, and Chinese renminbi.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value of Financial Instruments</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The carrying amounts of cash and equivalents, trade receivables, accounts payable and other accrued liabilities at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> approximate fair value due to their short-term maturities.</span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">37</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-70E496C87DD5F1C7F30A54B51B4F7F55-3"><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="TextSelection-19DA682266FFD3F0868254B51B508DB4-0-wk-Fact-7BCE65CE307DE6BE530154B51ACF7878" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:43%;"></td><td style="width:1%;"></td><td style="width:26%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Estimated fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55416729e3000-wk-Fact-9D30B9B2ECE9975B501D54B51AC1E146" name="us-gaap:DebtInstrumentFairValue" contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7,211</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55416729e3019-wk-Fact-5E5AFAC1D3BC81CE4FB654B51AB08D15" name="us-gaap:DebtInstrumentFairValue" contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,065</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Carrying amount</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55416729e3034-wk-Fact-F06326DCBCE66A30CB8454B51AB088D3" name="cah:CarryingAmountofLongTermandotherShortTermBorrowings" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">7,262</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55416729e3053-wk-Fact-5852226AE5E3DDC3B94854B51AAF0C91" name="cah:CarryingAmountofLongTermandotherShortTermBorrowings" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8,031</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.</span></div></ix:continuation><div><a id="sC0D2D5319C8C576FB588B8F4B1EFA50D"></a></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="TextSelection-2243CEB78CC4CB88476854B51B500922-0-wk-Fact-B1982CA5FA460EBF9D0454B51AFBE75B" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">11. Shareholders' Equity</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55424723e2762-wk-Fact-E49486C423693175141B54B51AE4649C" name="us-gaap:TreasuryStockSharesAcquired" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">7.3</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55424723e2766-wk-Fact-74D3B12AD2E710ABEBFA54B51B02D142" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">350</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.  The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55424723e2770-wk-Fact-C596FCC85962378A16DB54B51AE127C8" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">48.00</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These repurchases were made under an accelerated share repurchase ("ASR") program, which began on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">August&#160;20, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and was completed on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">December&#160;4, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55424723e2794-wk-Fact-56A34E8B7DACC10294FC54B51AE2E26D" name="cah:TreasuryStockAcquiredShares" contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">11.5</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55424723e2798-wk-Fact-D90329078A87441BCC3254B51ABCA990" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">600</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55424723e2802-wk-Fact-9C231AF5B47D86A4C69D54B51AE51258" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">52.32</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We funded the repurchases with available cash and short-term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Accumulated Other Comprehensive Loss</span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="TextSelection-FF6EF8A2FEA500E32B9054B51B50B3CF-0-wk-Fact-827497D03AA82817CB0A54B51AE4C57B" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:38%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Currency</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Translation</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain/(Loss) on</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Derivatives,</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprehensive</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55424723e2941-wk-Fact-5B54A947EFBD717E673D54B51B118A90" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">95</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55424723e2961-wk-Fact-AAD30A35F05C7429185C54B51B126855" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">16</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55424723e2980-wk-Fact-A3EB249D21ED5C6323B854B51B2633BF" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">79</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55424723e2997-wk-Fact-CCBBA030CB3FF1DFBA9554B51AA275CA" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55424723e3017-wk-Fact-1C1C9629427C1F98B33A54B51AA4F8B7" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">22</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55424723e3037-wk-Fact-86A7BBA93AFFF759A7CE54B51B1BA19F" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">57</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55424723e3059-wk-Fact-D4635A2A07CF52A2853554B51A88C440" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55424723e3078-wk-Fact-243C80AEE697367C1A7654B51AA4F50D" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55424723e3098-wk-Fact-7BB592B87C926646CB5F54B51A87704D" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55424723e3120-wk-Fact-AF04F91587175ACDDF1754B51A8723C6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">35</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55424723e3140-wk-Fact-5E701692EAFEFC172F9354B51B1223CC" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">27</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55424723e3160-wk-Fact-E8D56A7FA19C524BBEB054B51A900516" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">62</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55424723e3187-wk-Fact-D816F62218451721D23D54B51AA6878C" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">130</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55424723e3207-wk-Fact-80FF37689761E59475A854B51A8E909E" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">11</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55424723e3227-wk-Fact-2FAB4B569AB9C979248A54B51B13A8CF" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">141</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div></ix:nonNumeric></ix:nonNumeric></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div><a id="sC00F50FD9947595F8C8B22E799BF7FD1"></a></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:EarningsPerShareTextBlock" id="TextSelection-1FA098C00422BFC8EE2554B51B50122A-0-wk-Fact-9D8129D2C5DABCEA320F54B51B030AD3" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">12. Earnings Per Share Attributable to Cardinal Health, Inc.</span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="TextSelection-248DC63518384E29A52854B51B50AD83-0-wk-Fact-4B22FF1CBB4628F4F48554B51B04E8AE" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:70%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55428392e2830-wk-Fact-0B26D6B638400FB2D18454B51B21CD14" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2020Q3QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">292</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55428392e2844-wk-Fact-556A52112788EC9E118654B51A8B31D9" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q3QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">298</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units and performance share units</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55428392e2890-wk-Fact-40BF9DB5D5A0E28A68E654B51A868F2C" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="FD2020Q3QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55428392e2904-wk-Fact-D49C018021FF1964259E54B51A858CE5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="FD2019Q3QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55428392e2919-wk-Fact-3C5E39C3EF23C07BA0ED54B51A99B73A" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2020Q3QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">294</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55428392e2933-wk-Fact-74BC951CA67E200BA9E754B51AFCDAED" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q3QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">299</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:70%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55428392e3022-wk-Fact-F2F36F531E2C061568FA54B51A8E1510" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">293</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55428392e3036-wk-Fact-5535B20D9FD47662E0D254B51AAC6E51" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="FD2019Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">301</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units and performance share units</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55428392e3082-wk-Fact-C10882DD0B920FFC2F9754B51AFCEB69" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55428392e3096-wk-Fact-257B3B89F8587BA6054B54B51AFE1DC0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="FD2019Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55428392e3111-wk-Fact-F6D925A67782C67F989554B51A86E258" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">293</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55428392e3125-wk-Fact-526E27FF304324D2092354B51B2388DA" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="FD2019Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">302</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55428392e3140-wk-Fact-48D455F9A31C6FF315FD54B51B039F3E" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2020Q3QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55428392e3148-wk-Fact-693F81673B332CCC726754B51B04EDBE" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">7</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55428392e3161-wk-Fact-D4F22345D5D7B7E632DE54B51B034379" name="cah:Sharesthatwouldbeantidilutiveasaresultofnetloss" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of which were anti-dilutive as a result of the year-to-date net loss).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55428392e3168-wk-Fact-6325C9A92A956A26788154B51B06A135" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="FD2019Q3QTD" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during both the three months and the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div></ix:nonNumeric><div><a id="sBB8F57EFBB3E56A1AB175224B7857442"></a></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:SegmentReportingDisclosureTextBlock" id="TextSelection-E665B3A49B67D80F1C1254B51B50AA3C-0-wk-Fact-9072B05275E067C849BF54B51B286C33" continuedAt="TextSelection-E665B3A49B67D80F1C1254B51B50AA3C-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">13. Segment Information</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operations are principally managed on a products and services basis and are comprised of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55446147e2741-wk-Fact-D631E556B9E4628A959C54B51B269C22" name="us-gaap:NumberOfOperatingSegments" contextRef="FD2020Q3YTD" unitRef="segment" decimals="0" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.</span></div></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">38</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-E665B3A49B67D80F1C1254B51B50AA3C-1" continuedAt="TextSelection-E665B3A49B67D80F1C1254B51B50AA3C-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, this segment also distributes a broad range of national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Revenue</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:</span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="TextSelection-3582EC9A3968ED118D3E54B51B504461-0-wk-Fact-C0E8F7578BC3D19F78AB54B51ACBAE39" continuedAt="TextSelection-3582EC9A3968ED118D3E54B51B504461-1" escape="true"><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e2878-wk-Fact-FE6E48F8FA9170174CFD54B51AA89F54" name="us-gaap:Revenues" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">34,899</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e2897-wk-Fact-0702439432E07F81379754B51AAB7B16" name="us-gaap:Revenues" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">31,146</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e2912-wk-Fact-B1C60E9B690B1A18A1FA54B51AA92169" name="us-gaap:Revenues" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">213</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e2931-wk-Fact-30FA082C5458E10B606754B51AAE75F1" name="us-gaap:Revenues" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">215</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e2951-wk-Fact-DBAC790408518EF5ACD954B51AA96752" name="us-gaap:Revenues" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,112</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e2970-wk-Fact-46479CF5E898CBE02A6254B51AAB5867" name="us-gaap:Revenues" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">31,361</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (3)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e2990-wk-Fact-24E13E820102EF5C3C8654B51AABDA94" name="us-gaap:Revenues" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,539</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3009-wk-Fact-44134564C9EABE7E938654B51AA9E31D" name="us-gaap:Revenues" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,431</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3029-wk-Fact-31FF3C900127A0AEAF2E54B51AA98730" name="us-gaap:Revenues" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">512</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3048-wk-Fact-7FB1FF074D060720F07D54B51AA9A2BC" name="us-gaap:Revenues" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">440</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3068-wk-Fact-FFC5B1459CC785A51D7054B51AA8828A" name="us-gaap:Revenues" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4,051</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3087-wk-Fact-2DDFD0A4834E8430651F54B51AAB71F6" name="us-gaap:Revenues" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,871</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3107-wk-Fact-38556B57205319D998F354B51AAEAC2F" name="us-gaap:Revenues" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39,163</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3126-wk-Fact-FC4B0B47AB536C8C4C3754B51AAA7EC2" name="us-gaap:Revenues" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,232</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55446147e3146-wk-Fact-2F7D81D8B9DBC5D66F5454B51AAFCB38" name="us-gaap:Revenues" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55446147e3166-wk-Fact-C9D1F2F69E015692955F54B51AAE7B39" name="us-gaap:Revenues" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3192-wk-Fact-B5678807817E002A2C5254B51ACDCA6C" name="us-gaap:Revenues" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39,157</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3211-wk-Fact-1CCE01CC0FAB05B634D054B51AAD948A" name="us-gaap:Revenues" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,228</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-E665B3A49B67D80F1C1254B51B50AA3C-2" continuedAt="TextSelection-E665B3A49B67D80F1C1254B51B50AA3C-3"><ix:continuation id="TextSelection-3582EC9A3968ED118D3E54B51B504461-1" continuedAt="TextSelection-3582EC9A3968ED118D3E54B51B504461-2"><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:48%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3327-wk-Fact-B2FCE6406AA7F56A141554B51AE6D7DC" name="us-gaap:Revenues" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">103,612</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3346-wk-Fact-0081754E6BE7145D466354B51B1AD527" name="us-gaap:Revenues" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">95,888</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3361-wk-Fact-3382591D5CCDBAC219D554B51A9D0310" name="us-gaap:Revenues" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">642</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3380-wk-Fact-C4004E11024DBC88C01054B51AC01AB1" name="us-gaap:Revenues" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">628</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3400-wk-Fact-DCEA624298CD56FDC4F354B51B1AB304" name="us-gaap:Revenues" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">104,254</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3419-wk-Fact-D44E8637AEE1CCB480105FBD13F4439B" name="us-gaap:Revenues" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">96,516</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (3)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3439-wk-Fact-5A7688B9CAB4E47E96CF54B51A9B5D75" name="us-gaap:Revenues" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10,483</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3458-wk-Fact-EFB2BB865981886822DD54B51AC562AE" name="us-gaap:Revenues" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10,339</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3478-wk-Fact-7B6B6BF3E6C3562358B954B51B1D83C0" name="us-gaap:Revenues" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,508</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3497-wk-Fact-9E07AA89C7BDA1D4728D54B51B1D0D13" name="us-gaap:Revenues" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,339</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3517-wk-Fact-C786DEC2E9B577D2A14154B51B1C8C00" name="us-gaap:Revenues" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11,991</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3536-wk-Fact-540BC91BDF23EA619B025FBD13E97CCB" name="us-gaap:Revenues" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">11,678</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3556-wk-Fact-0B4D03A0D4234274C53E54B51AA0B01E" name="us-gaap:Revenues" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">116,245</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3575-wk-Fact-F63C16D145731C60EDAB54B51A9D575A" name="us-gaap:Revenues" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">108,194</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55446147e3595-wk-Fact-B8C17E2C80FB84FF7BDF54B51A9F8121" name="us-gaap:Revenues" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55446147e3615-wk-Fact-7D33EA3DC209B17A73DF54B51A9E015E" name="us-gaap:Revenues" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3641-wk-Fact-95BB44ACFE0A3C8D473654B51AA5FF98" name="us-gaap:Revenues" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">116,233</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3660-wk-Fact-2D6DD524F1EBD75BAFA054B51AA8777B" name="us-gaap:Revenues" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">108,181</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services."</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.</span></div></td></tr></table></ix:continuation><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-3582EC9A3968ED118D3E54B51B504461-2" continuedAt="TextSelection-3582EC9A3968ED118D3E54B51B504461-3"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-3582EC9A3968ED118D3E54B51B504461-3"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:continuation></td></tr></table><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="TextSelection-46948AC38F093158875054B51B503826-0-wk-Fact-7D8536D4F56C36EBB1B354B51B26681A" continuedAt="TextSelection-46948AC38F093158875054B51B503826-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present revenue by geographic area:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3817-wk-Fact-0F32505F1BFA5363425754B51AD0B00E" name="us-gaap:Revenues" contextRef="FD2020Q3QTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">38,073</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3836-wk-Fact-B9908D823ADAE0E8EF4D54B51AD2168A" name="us-gaap:Revenues" contextRef="FD2019Q3QTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">34,230</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3851-wk-Fact-1D43CA95F55FFF46F44D54B51AD0606A" name="us-gaap:Revenues" contextRef="FD2020Q3QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,090</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3870-wk-Fact-9CB0ACCCF02FD9B66D5054B51AAAD4E8" name="us-gaap:Revenues" contextRef="FD2019Q3QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,002</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3890-wk-Fact-38556B57205319D998F354B51AAEAC2F" name="us-gaap:Revenues" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39,163</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3909-wk-Fact-FC4B0B47AB536C8C4C3754B51AAA7EC2" name="us-gaap:Revenues" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,232</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55446147e3929-wk-Fact-2F7D81D8B9DBC5D66F5454B51AAFCB38" name="us-gaap:Revenues" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55446147e3949-wk-Fact-C9D1F2F69E015692955F54B51AAE7B39" name="us-gaap:Revenues" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3975-wk-Fact-B5678807817E002A2C5254B51ACDCA6C" name="us-gaap:Revenues" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">39,157</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e3994-wk-Fact-1CCE01CC0FAB05B634D054B51AAD948A" name="us-gaap:Revenues" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">35,228</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4111-wk-Fact-C12E5C5142A13631F5F454B51A9CB3F8" name="us-gaap:Revenues" contextRef="FD2020Q3YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">113,053</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4130-wk-Fact-F65DFAE1BE566186F00254B51AA298CE" name="us-gaap:Revenues" contextRef="FD2019Q3YTD_srt_StatementGeographicalAxis_country_US" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">105,190</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4145-wk-Fact-B28087BA80A2FD4E718C54B51A9FDCB4" name="us-gaap:Revenues" contextRef="FD2020Q3YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,192</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4164-wk-Fact-1BAEC1A20D6EE1B9584654B51A9F926F" name="us-gaap:Revenues" contextRef="FD2019Q3YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,004</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4184-wk-Fact-0B4D03A0D4234274C53E54B51AA0B01E" name="us-gaap:Revenues" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">116,245</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4203-wk-Fact-F63C16D145731C60EDAB54B51A9D575A" name="us-gaap:Revenues" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">108,194</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55446147e4223-wk-Fact-B8C17E2C80FB84FF7BDF54B51A9F8121" name="us-gaap:Revenues" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55446147e4243-wk-Fact-7D33EA3DC209B17A73DF54B51A9E015E" name="us-gaap:Revenues" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4269-wk-Fact-95BB44ACFE0A3C8D473654B51AA5FF98" name="us-gaap:Revenues" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">116,233</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4288-wk-Fact-2D6DD524F1EBD75BAFA054B51AA8777B" name="us-gaap:Revenues" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">108,181</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><ix:continuation id="TextSelection-46948AC38F093158875054B51B503826-1" continuedAt="TextSelection-46948AC38F093158875054B51B503826-2"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></ix:continuation></td><td style="vertical-align:top;"><ix:continuation id="TextSelection-46948AC38F093158875054B51B503826-2"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></ix:continuation></td></tr></table></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">39</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-E665B3A49B67D80F1C1254B51B50AA3C-3" continuedAt="TextSelection-E665B3A49B67D80F1C1254B51B50AA3C-4"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Segment Profit</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general and administrative ("SG&amp;A") expenses. Segment SG&amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial, and customer care shared services, human resources, information technology, and legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We do not allocate the following items to our segments: last-in first-out, or ("LIFO"), inventory charges/(credits); surgical gown recall costs; restructuring and employee severance; amortization and other acquisition-related costs; impairments and (gain)/loss on disposal of assets; litigation (recoveries)/charges, net; state opioid assessment related to prior fiscal years; other (income)/expense, net; interest expense, net; loss on extinguishment of debt; and provision for income taxes. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55446147e4316-wk-Fact-C6FBC924F04260EBEFE754B51ACA7A3D" name="cah:ProjectCostsOnInvestmentAndOtherSpending" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">17</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for both the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55446147e4328-wk-Fact-78D5EE6340EE20121BA454B51ACF664D" name="cah:ProjectCostsOnInvestmentAndOtherSpending" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">37</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55446147e4332-wk-Fact-B526CF4C12F7493E870D54B51A849685" name="cah:ProjectCostsOnInvestmentAndOtherSpending" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">36</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the opioid litigation as discussed further in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s054B3015E6505AB9825D03C656BE42ED"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55446147e4357-wk-Fact-4074F71F4572CF3082B854B51B0B8528" name="us-gaap:GainLossRelatedToLitigationSettlement" contextRef="FD2020Q3YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember" unitRef="usd" decimals="-6" scale="9" sign="-" format="ixt:numdotdecimal">5.63</ix:nonFraction> billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which was retained at Corporate. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the surgical gown recall as discussed further in </span><a style="font-family:Arial Narrow;font-size:10pt;" href="#s054B3015E6505AB9825D03C656BE42ED"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55446147e4377-wk-Fact-1A86236C670FA586A29154B51B0ED102" name="us-gaap:InventoryRecallExpense" contextRef="FD2020Q3YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">95</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> which was retained at Corporate. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the naviHealth divestiture, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55446147e4393-wk-Fact-A66B8111D0F733B8A69454B51A8F2287" name="cah:PreTaxGainonDivestiture" contextRef="FD2019Q3YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">508</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which was retained at Corporate. </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-E665B3A49B67D80F1C1254B51B50AA3C-4"><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="TextSelection-468CE5C2553002CCDAE054B51B50AA12-0-wk-Fact-47365AF44E28366F383F54B51AC959E0" escape="true"><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present segment profit by reportable segment and Corporate:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4523-wk-Fact-D12C08DE622B935FFD5854B51AE80C24" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">534</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55446147e4542-wk-Fact-DBCA9DC3185A0E61633F54B51AFED1FA" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">536</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4557-wk-Fact-716A3963185A8AD3EF4954B51AFF26C3" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">178</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55446147e4576-wk-Fact-B9EBA376E0298DEE252654B51AEC2DAB" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">155</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4596-wk-Fact-CADF19DC7DE5D6D6AF0554B51AFADD2B" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">712</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55446147e4615-wk-Fact-38551D860599E9EF357354B51AE7AC8B" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">691</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55446147e4635-wk-Fact-A274487488E9F94F03B354B51B0253FA" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">150</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55446147e4655-wk-Fact-D5396A5873232190429954B51AFCCBE6" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">259</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4681-wk-Fact-214140D02A180F197B4954B51A8F21D9" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">562</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55446147e4700-wk-Fact-DF69602F2038573D567154B51B043599" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">432</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4815-wk-Fact-D4100987A70F33F10B7954B51AE13747" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,394</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55446147e4834-wk-Fact-ADA9F2645AF9E6FAB81254B51ADD6690" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,388</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4849-wk-Fact-FA7847D2928B6A3A3A5954B51ADE38B6" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">543</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55446147e4868-wk-Fact-F04C54AB50FEB563DC8B54B51ADC9A20" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">479</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e4888-wk-Fact-8457B98EFC1A0DBCFF4654B51AEB960A" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,937</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55446147e4907-wk-Fact-CEB224BE84042A2B067154B51AE077F6" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,867</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55446147e4927-wk-Fact-6ECDE70A77EC76EB700E54B51AE2BCFE" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">6,305</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55446147e4947-wk-Fact-CF1E89CADB9D87EA91A054B51ADEE500" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">115</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings/(loss)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(<ix:nonFraction id="d55446147e4973-wk-Fact-0D29BC4669F150A7E4BD54B51AA61445" name="us-gaap:OperatingIncomeLoss" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" sign="-" format="ixt:numdotdecimal">4,368</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55446147e4993-wk-Fact-7336E4EDFE2DAA666FCC54B51A8823BF" name="us-gaap:OperatingIncomeLoss" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1,752</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="TextSelection-2CE2FCA7EB50243553A554B51B51D529-0-wk-Fact-0651B07792AA9E48526054B51B2AA684" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents total assets for each reportable segment and Corporate at: </span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:16pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, <br/>2020</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#d1d1d1;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e5083-wk-Fact-3FF201C6DC8FBC28919054B51A9B3BB6" name="us-gaap:Assets" contextRef="FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22,508</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#d1d1d1;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55446147e5102-wk-Fact-D9EC9D09347EDCD797C054B51A9B0FE3" name="us-gaap:Assets" contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">22,446</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e5117-wk-Fact-52167F23051D344B3E1954B51A930184" name="us-gaap:Assets" contextRef="FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15,445</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55446147e5136-wk-Fact-DB5DA84A1B021A5266F654B51A929B86" name="us-gaap:Assets" contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">15,284</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e5156-wk-Fact-7790429EB6F161D7607B54B51A932CEA" name="us-gaap:Assets" contextRef="FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,195</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55446147e5175-wk-Fact-0A6FAF7026FDD43497CD54B51A949154" name="us-gaap:Assets" contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3,233</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55446147e5200-wk-Fact-79192C98474F73FFBB6B54B51AF8130A" name="us-gaap:Assets" contextRef="FI2020Q3" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">41,148</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55446147e5219-wk-Fact-917DCA0680103C02A25754B51AFF2750" name="us-gaap:Assets" contextRef="FI2019Q4" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">40,963</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div></ix:nonNumeric></ix:continuation><div><a id="s45BD55B22A915C4FBDF301F1173B76A9"></a></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="TextSelection-7D7CB86523F846B3350754B51B51B055-0-wk-Fact-425B74E90FB73467B07754B51A82EC53" continuedAt="TextSelection-7D7CB86523F846B3350754B51B51B055-1" escape="true"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">14. Share-Based Compensation</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We maintain stock incentive plans (collectively, the &#8220;Plans&#8221;) for the benefit of certain of our officers, directors and employees. </span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="TextSelection-D791A697838E7563DC2154B51B5201F4-0-wk-Fact-45E9B20C878702FE11CE54B51B1AA3BB" continuedAt="TextSelection-D791A697838E7563DC2154B51B5201F4-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides total share-based compensation expense by type of award:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e2880-wk-Fact-81BDCA2081AD2A1D417254B51A8F438A" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q3QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">20</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e2899-wk-Fact-7770A060B29D96AF7F0A54B51A8F08C2" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q3QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">17</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e2914-wk-Fact-606FB73F0146AD86A89B54B51A922327" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q3QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e2933-wk-Fact-96A3BF1896316BE91AB654B51A91FABC" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q3QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e2953-wk-Fact-251862DAA90ACA327AC754B51A92D65D" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q3QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e2972-wk-Fact-5DF7EF1F5AF57275179754B51A8E5C68" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q3QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e2997-wk-Fact-F31A720F5D778B8496DB54B51A923820" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">27</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3016-wk-Fact-D638018CEAC7A5BDB7F554B51A8E9843" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">23</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e3135-wk-Fact-D43318356557120D36DB54B51AC4AFD7" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">53</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3154-wk-Fact-0890EE0DA48300176DD254B51AACD487" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">47</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e3169-wk-Fact-0FDD741EF47221630CE154B51AAA9208" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3188-wk-Fact-0A2A9DC7BDBBD1B4798D54B51AAB1356" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">8</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e3208-wk-Fact-26E89E6BDED25570A0CF54B51AC2A14E" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3227-wk-Fact-89C73458E74E7E2508CC54B51AC5BEC2" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e3252-wk-Fact-13EE0878A2F70C64904C54B51AC4EF32" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">68</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3271-wk-Fact-B951A0AE54C54ABA0A5E54B51AC4EFB2" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">64</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-D791A697838E7563DC2154B51B5201F4-1"></ix:continuation>The total tax benefit related to share-based compensation was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55443014e3287-wk-Fact-DB01B3D2C6910C722A6654B51ADA6E8B" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" contextRef="FD2020Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55443014e3291-wk-Fact-EB8D9E3A61F200AA5CBF54B51ADBCDD6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" contextRef="FD2019Q3QTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">4</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div></ix:nonNumeric></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">40</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8015873015873%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Notes to Financial Statements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><ix:continuation id="TextSelection-7D7CB86523F846B3350754B51B51B055-1" continuedAt="TextSelection-7D7CB86523F846B3350754B51B51B055-2"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55443014e3306-wk-Fact-4597EFC27239149A309154B51ADAFDB3" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" contextRef="FD2020Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">12</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55443014e3310-wk-Fact-7D4CCA082D2A6515F2C254B51AD90572" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" contextRef="FD2019Q3YTD" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Restricted Share Units</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Restricted share units granted under the Plans generally vest in equal annual installments over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d55443014e3333-wk-Fact-795D6DDE0C81DCD708B354B51AD956C9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="TextSelection-3797D492C5F7D5DC755154B51B512033-0-wk-Fact-8197A2B73BC62D19CDC154B51B19DD19" continuedAt="TextSelection-3797D492C5F7D5DC755154B51B512033-1" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:52%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:24%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Restricted Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3410-wk-Fact-98CC13635E877D0BF95454B51B1C9267" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3429-wk-Fact-E3BF258BD1A88B0694F754B51B1E562A" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">51.65</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3444-wk-Fact-BBBB5AB2B76EDEC2565C54B51B1EB33E" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">2</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3458-wk-Fact-8DF0E0D97F54292E0A0554B51B1F040F" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">42.58</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55443014e3478-wk-Fact-395C073D201B6E0CAC5854B51B1CDFCE" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3493-wk-Fact-87A203F7B1566E2D502C54B51B1EAD2B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">60.13</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3513-wk-Fact-38B6EEB9FD3B90B4F8AB54B51B1C3415" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3527-wk-Fact-22ED5EE499B5F49F4B2554B51B1BB868" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" xsi:nil="true" scale="0" format="ixt:nocontent"></ix:nonFraction></span><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e3546-wk-Fact-6B93F3112992DF97C76A54B51B1C4664" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e3565-wk-Fact-4A158FE95D6680F6E35854B51B1EAF70" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">45.88</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><ix:continuation id="TextSelection-3797D492C5F7D5DC755154B51B512033-1"></ix:continuation>At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55443014e3584-wk-Fact-7607A631780891474FE454B51AD36D6B" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">93</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d55443014e3588-wk-Fact-FCB0BC93E3E44946062554B51B1320D4" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" format="ixt-sec:durwordsen">two years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Stock Options</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Employee stock options granted under the Plans generally vest in equal annual installments over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d55443014e3598-wk-Fact-D97A6DBDD88DF6DB329054B51AD22372" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen">three years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and are exercisable for </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d55443014e3602-wk-Fact-6D32A3BB41D11C58403254B51AD36815" name="cah:ExercisablePeriodOfPlansInYears" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen">ten years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.</span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="TextSelection-5B9F84347EB9C7AD37BE54B51B514B41-0-wk-Fact-0926BDCA8BE50C824E0E54B51A824F2A" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all stock option transactions under the Plans:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:57%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Stock</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercise Price per</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Common Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3689-wk-Fact-0E3D6DB281224BEF14B554B51B0FF53B" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="FI2019Q4" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3708-wk-Fact-B48D171DF33B72A0F77254B51B0E3414" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="FI2019Q4" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">63.78</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3723-wk-Fact-CD4F947DA5C0B83E0AB954B51B03D6DA" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3737-wk-Fact-63ECACAD020D7CAB427954B51B1178E7" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="FD2020Q3YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Exercised</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3757-wk-Fact-790C59687B1E890B776954B51AFCEBBF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3771-wk-Fact-F6E2361E73F5EBB3C20654B51AFA78B5" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="FD2020Q3YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3791-wk-Fact-B08427703308ADA6FC1154B51B12F48E" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="FD2020Q3YTD" unitRef="shares" decimals="-6" scale="6" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e3805-wk-Fact-7E5501013664A376E15F54B51B066ADD" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="FD2020Q3YTD" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Outstanding at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e3825-wk-Fact-154E80348E64A5B03E6954B51B13B204" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="FI2020Q3" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e3844-wk-Fact-240D406ED9BE78AA84C054B51AFA80E0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="FI2020Q3" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">64.02</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercisable at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e3859-wk-Fact-69EFDB8E3DE6208703FF54B51B0F6DD4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="FI2020Q3" unitRef="shares" decimals="-6" scale="6" format="ixt:numdotdecimal">5</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e3878-wk-Fact-4FA3E2C206322260BCB554B51AFE2791" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="FI2020Q3" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">63.96</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55443014e3905-wk-Fact-0FE0A1D84FC05F63E2B854B51AD98F26" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">1</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of less than </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d55443014e3909-wk-Fact-F51D2576739F5A1618ED54B51B19D99D" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen">one year</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div></ix:continuation></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><ix:continuation id="TextSelection-7D7CB86523F846B3350754B51B51B055-2"><ix:nonNumeric contextRef="FD2020Q3YTD" name="cah:AdditionalStockOptionPlanDataTableTextBlock" id="TextSelection-A7D6AACD9935863F4F6454B51B510723-0-wk-Fact-FF3415E6615F4DB42D9C54B51A7FC104" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables provide additional detail related to stock options:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:58%;"></td><td style="width:1%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of outstanding options at period end</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e3992-wk-Fact-65C65E28515B84669A3654B51A8676B4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e4011-wk-Fact-E12E9C5928E4C3675A4754B51ADA6E87" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercisable options at period end</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e4026-wk-Fact-83E5B4CCE9FE45B1B3D954B51A82A8FD" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e4045-wk-Fact-B2A55AD186A35D0D6E8C54B51AD82BE2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:58%;"></td><td style="width:21%;"></td><td style="width:2%;"></td><td style="width:19%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in years)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of outstanding options</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d55443014e4125-wk-Fact-A7E1B27E7F0CF3BAF9DA54B51B19BBCC" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d55443014e4135-wk-Fact-9922B56A821AB718127254B51B138D2A" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of exercisable options</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonNumeric id="d55443014e4146-wk-Fact-A39FF8B836CC56DA857454B51B13CAC1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonNumeric id="d55443014e4156-wk-Fact-2C8227FC2DD153F64D9C54B51B193575" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">5</ix:nonNumeric></span></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Performance Share Units</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Performance share units vest over a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55443014e4201-wk-Fact-4544F660527CB1DA1BBC54B51ADB6E0D" name="cah:VestingPeriodinyearsforShares" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="number" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55443014e4205-wk-Fact-FF697DE9623D5209C79354B51A815E47" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="FD2020Q3YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="number" decimals="2" scale="-2" format="ixt-sec:numwordsen">zero</ix:nonFraction></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonFraction id="d55443014e4209-wk-Fact-786A321FA80375C3CD3154B51B13635E" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="FD2020Q3YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="number" decimals="2" scale="-2" format="ixt:numdotdecimal">240</ix:nonFraction> percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><ix:nonNumeric contextRef="FD2020Q3YTD" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="TextSelection-65D46D637BCE9A83572454B51B51337F-0-wk-Fact-1695DE7C8F83BB6A7A9454B51AD07161" escape="true"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:51%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:25%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Performance</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e4319-wk-Fact-6A64A8CA5EA1DB8984B254B51AC52664" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e4338-wk-Fact-EE358B7852C45EEFB06454B51AD20365" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">51.45</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e4353-wk-Fact-BD86E6607175E751EDE654B51AA7B1CB" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e4367-wk-Fact-052BC0CE470B87A0C6E254B51B0BED62" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">43.68</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55443014e4387-wk-Fact-F5BF4C66AED0618E187854B51AC4C49C" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e4402-wk-Fact-A5D77F3F37C30B36CD2954B51A912EA4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">48.40</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(<ix:nonFraction id="d55443014e4422-wk-Fact-B0E2E9DE4FFDBB3CFBB254B51B1F7260" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span><ix:nonFraction id="d55443014e4437-wk-Fact-F79ED58B169B150BC47A54B51AC385A2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">50.76</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e4457-wk-Fact-E39F92C2EE8D08E1BD8B54B51AABA9DE" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="shares" decimals="-5" scale="6" format="ixt:numdotdecimal">1.3</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span><ix:nonFraction id="d55443014e4476-wk-Fact-B80F42C575DA7DDAC0FF54B51AE69533" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usdPerShare" decimals="2" scale="0" format="ixt:numdotdecimal">51.94</ix:nonFraction></span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div></ix:nonNumeric><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$<ix:nonFraction id="d55443014e4512-wk-Fact-138733F917EEC78BD56154B51AD26FEA" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="usd" decimals="-6" scale="6" format="ixt:numdotdecimal">29</ix:nonFraction> million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span><ix:nonNumeric id="d55443014e4516-wk-Fact-24DB0572748EE776365A54B51AD12EFB" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" format="ixt-sec:durwordsen">two years</ix:nonNumeric></span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> if targets are achieved.</span></div></ix:continuation></div></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">41</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sDFDD1F6C85755EF6B29701A043855C03"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;-sec-extract:summary;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Exhibits</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;text-align:left;-sec-extract:summary;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-weight:bold;">Exhibits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;text-align:justify;">Exhibit</span></div><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;text-align:justify;">Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;text-decoration:underline;">Exhibit Description</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000119312508230011/dex31.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Amended and Restated Articles of Incorporation of Cardinal Health, Inc., as amended (incorporated by reference to Exhibit 3.1 to Cardinal Health&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/721371/000072137119000129/exhibit32-restatedcode.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health, Inc. Restated Code of Regulations (incorporated by reference to Exhibit 3.2 to Cardinal Health&#8217;s Current Report on Form 8-K filed on November 12, 2019, File No. 1-11373)</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000023/a20q210q123119exhibit1.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health Deferred Compensation Plan, Amended and Restated effective January 1, 2020 (incorporated by reference to Exhibit 10.4 to Cardinal Health's Quarterly Report for the quarter ended December 31, 2019, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.2</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000033/exhibit101cfoofferlett.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Letter Agreement, dated March 9, 2020, between Cardinal Health, Inc. and Jason Hollar (incorporated by reference to Exhibit 10.1 to Cardinal Health's Current Report on Form 8-K filed on March 19, 2020, File No. 1-11373)*</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">10.3</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="https://www.sec.gov/Archives/edgar/data/721371/000072137120000033/exhibit102cfocbpagreem.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Confidentiality and Business Protection Agreement, effective as of April 27, 2020, between Cardinal Health, Inc. and Jason Hollar (incorporated by reference to Exhibit 10.2 to Cardinal Health's Current Report on Form 8-K filed on March 19, 2020, File No. 1-11373)* </span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">31.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q310q33120exhibit311.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">31.2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q310q33120exhibit312.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">32.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q310q33120exhibit321.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">99.1</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="a20q310q33120exhibit991.htm"><span style="font-family:Arial Narrow;font-size:8pt;">Statement Regarding Forward-Looking Information</span></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.INS</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Instance Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.SCH</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Extension Schema Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.CAL</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.DEF</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Definition Linkbase Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.LAB</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">101.PRE</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">104</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cover Page Interactive Data File - formatted in Inline XBRL (included as Exhibit 101)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ff0000;font-weight:bold;">Cardinal Health Website</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Cardinal Health&#160;uses its website as a channel of distribution for material company information. Important information, including news releases, financial information, earnings and analyst presentations and information about upcoming presentations and events is routinely posted and accessible at ir.cardinalhealth.com. In addition, the website allows investors and other interested persons to sign up automatically to receive e-mail alerts when the company posts news releases,&#160;SEC filings and certain other information on its website.</span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">42</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sD1F76ACE1C2956F390E0231026E67A67"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:29%;"></td><td style="width:47%;"></td><td style="width:24%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Form 10-Q Cross Reference Index</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Form 10-Q Cross Reference Index</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:85%;"></td><td style="width:7%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Item Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Page</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Part I. Financial Information</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s5134E92FB23E597F804A558EAB99AF7A"><span style="font-family:Arial Narrow;font-size:10pt;">Financial Statements </span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s5134E92FB23E597F804A558EAB99AF7A">23</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s37C5C8C8ACBC502094BFDC052C023541"><span style="font-family:Arial Narrow;font-size:10pt;">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s37C5C8C8ACBC502094BFDC052C023541">2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s524C8134125A5F01AB88EEFF8006DD5A"><span style="font-family:Arial Narrow;font-size:10pt;">Quantitative and Qualitative Disclosures about Market Risk </span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s524C8134125A5F01AB88EEFF8006DD5A">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 4</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s91B1FB400D41594EB9C06B28B18291C3"><span style="font-family:Arial Narrow;font-size:10pt;">Controls and Procedures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s91B1FB400D41594EB9C06B28B18291C3">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Part II. Other Information</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#s9909505D248E51E48CF18A6646D92F4E"><span style="font-family:Arial Narrow;font-size:10pt;">Legal Proceedings</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s9909505D248E51E48CF18A6646D92F4E">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 1A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sE462DDDB9F695421BDF161325CCD492F"><span style="font-family:Arial Narrow;font-size:10pt;">Risk Factors</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sE462DDDB9F695421BDF161325CCD492F">20</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sA5369DE2A7B551D9A7BCDFADEF743FFC"><span style="font-family:Arial Narrow;font-size:10pt;">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sA5369DE2A7B551D9A7BCDFADEF743FFC">22</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Defaults Upon Senior Securities </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 4</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Mine Safety Disclosures </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 5</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Other Information</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Item 6</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sDFDD1F6C85755EF6B29701A043855C03"><span style="font-family:Arial Narrow;font-size:10pt;">Exhibits</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sDFDD1F6C85755EF6B29701A043855C03">42</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;" href="#sE3E36FC784CC524CAB619BE0E27A7B8A"><span style="font-family:Arial Narrow;font-size:10pt;">Signatures</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sE3E36FC784CC524CAB619BE0E27A7B8A">44</a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:4%;"></td><td style="width:48%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Not applicable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">43</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">| </span><span style="font-family:Arial Narrow;font-size:10pt;">Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sE3E36FC784CC524CAB619BE0E27A7B8A"></a></div><div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.70731707317073%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:26%;"></td><td style="width:52%;"></td><td style="width:22%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;background-color:#e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#ffffff;font-weight:bold;">Additional Information</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #e41f35;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr></table></div></div></div><div><br/></div><div style="line-height:120%;padding-bottom:4px;font-size:20pt;"><span style="font-family:Arial Narrow;font-size:20pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">Signatures</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.04761904761905%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:6%;"></td><td style="width:50%;"></td><td style="width:44%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Date:</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">May&#160;11, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;MICHAEL C. KAUFMANN</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Michael C. Kaufmann</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Chief Executive Officer</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;DAVID C. EVANS</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">David C. Evans</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Chief Financial Officer</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:34%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #ee2724;"><div style="overflow:hidden;height:6px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health </span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">|</span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;Q3</span><span style="font-family:Arial Narrow;font-size:10pt;color:#ee2724;font-weight:bold;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;">Fiscal 2020 Form 10-Q</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">44</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>a20q310q33120exhibit311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s60F94E20AC5856EC89610855A726AC79"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 31.1</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I, </font><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann</font><font style="font-family:Arial Narrow;font-size:10pt;">, certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I have reviewed this Form 10-Q of Cardinal Health, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Date: </font><font style="font-family:Arial Narrow;font-size:10pt;">May&#160;11, 2020</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:627px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:198px;"></td><td style="width:428px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ MICHAEL C. KAUFMANN</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Executive Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>a20q310q33120exhibit312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sF232D29C0DC25EDD9CF41AC096C10677"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 31.2</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I, David C. Evans, certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I have reviewed this Form 10-Q of Cardinal Health, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:72px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Date: </font><font style="font-family:Arial Narrow;font-size:10pt;">May&#160;11, 2020</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:184px;"></td><td style="width:498px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/</font><font style="font-family:Arial Narrow;font-size:9pt;">&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">D</font><font style="font-family:Arial Narrow;font-size:9pt;">AVID </font><font style="font-family:Arial Narrow;font-size:10pt;">C</font><font style="font-family:Arial Narrow;font-size:9pt;">. </font><font style="font-family:Arial Narrow;font-size:10pt;">E</font><font style="font-family:Arial Narrow;font-size:9pt;">VANS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">David C. Evans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Financial Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>a20q310q33120exhibit321.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s199A04347A1A5C3FBCB3F7776F29DF94"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 32.1</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Certification of the Chief Executive Officer and the Chief Financial Officer Pursuant to 18 U.S.C. Section&#160;1350, as Adopted </font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann, Chief Executive Officer of Cardinal Health, Inc. (the &#8220;Company&#8221;) and David C. Evans, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the Periodic Report on Form 10-Q for the quarter ended March 31, 2020 containing the financial statements of the Company (the &#8220;Periodic Report&#8221;), which this statement accompanies, fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Dated: </font><font style="font-family:Arial Narrow;font-size:10pt;">May&#160;11, 2020</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:70%;"></td><td style="width:30%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ MICHAEL C. KAUFMANN</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Michael C. Kaufmann</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Executive Officer </font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:70%;"></td><td style="width:30%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ D</font><font style="font-family:Arial Narrow;font-size:9pt;">AVID</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;C. E</font><font style="font-family:Arial Narrow;font-size:9pt;">VANS</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">David C. Evans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>a20q310q33120exhibit991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sB0B9DE20A0295DD6AFEFABD8763E4ED9"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:33%;"></td><td style="width:33%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 99.1</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:13pt;"><font style="font-family:Arial Narrow;font-size:13pt;font-weight:bold;">Statement Regarding Forward-Looking Information </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">As used in this exhibit, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and similar pronouns refer to Cardinal Health, Inc. and its subsidiaries, unless the context requires otherwise. Our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended June&#160;30, 2019 (the &#8220;2019 Form 10-K&#8221;), our quarterly reports on Form 10-Q, including this one, and our current reports on Form 8-K (along with any exhibits and amendments to such reports), as well as our news releases or any other written or oral statements made by or on behalf of us, including materials posted on our website, may include, directly or by incorporation by reference, forward-looking statements that reflect our current view (as of the date the forward-looking statement is first made) about future events, prospects, projections or financial performance. The matters discussed in these forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied in or by such statements. These risks and uncertainties include:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">competitive pressures in the markets in which we operate, including pricing pressures;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to the pricing of generic pharmaceuticals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to the timing, frequency and profitability of generic pharmaceutical launches;  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to maintain the benefits of our generic pharmaceutical sourcing venture with CVS Health Corporation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">with respect to our distribution services agreements with branded pharmaceutical manufacturers, changes in the amount of service fees we receive or, in cases where part of our compensation under these agreements is based on branded pharmaceutical price appreciation, changes in the frequency or magnitude of such price appreciation; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in manufacturer approaches to pricing branded pharmaceutical products and risks related to our compensation under contractual arrangements with manufacturers being set as a percentage of the wholesale acquisition cost of branded pharmaceuticals; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in the timing or frequency of the introduction of branded pharmaceuticals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with the resolution and defense of the lawsuits and investigations in which we have been or will be named relating to the distribution of prescription opioid pain medication, including the risk that the outcome of these lawsuits and investigations could have a material adverse effect on our results of operations, financial condition, cash flows or liquidity;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">potential damage to our reputation, adverse operational impacts or other effects that may result from the national opioid epidemic, the allegations that have been made about our role in such epidemic and the ongoing unfavorable publicity surrounding the lawsuits and investigations against us;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with the ongoing discussions regarding a potential global settlement of certain opioid lawsuits and investigations against us, including the risk that we could fail to reach a final settlement, that any final settlement reached could require us to pay more than we currently anticipate or could have a negative effect on our liquidity or ability to return money to shareholders and the risk that any injunctive or non-monetary remedies we may agree to could have unintended consequences;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from the COVID-19 pandemic, including the possibility that our manufacturing or distribution facilities will be required to cease operations, whether from government regulation in the United States or internationally, or from reduction in available workforce due to illness; the possibility that we could experience significant delays or disruptions in our supply of medical or pharmaceutical products resulting in an inability to fulfill customer demand; the possibility that the widespread required cancellation or deferral of elective medical procedures will result in a sustained reduction in demand for our products; and the potential for us to receive negative publicity resulting from prolonged supply shortages or our participation in industry-wide collaboration to increase the supply of personal protective equipment in the United States; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">potential adverse impact to our financial results resulting from enacted and proposed state taxes or other assessments on the sale or distribution of opioid medications;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our high sales concentration with certain key customers, including CVS Health Corporation and OptumRx;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">costs or claims resulting from a quality issue related to the manufacture of some of our sterile surgical downs, or other potential errors or defects in our manufacturing of medical devices or other products or in our compounding, repackaging, information systems or pharmacy management services that may injure persons or damage property or operations, including costs from recalls, remediation efforts, and related product liability claims and lawsuits, including class action lawsuits;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">actions of regulatory bodies and other governmental authorities, including the U.S. Drug Enforcement Administration, certain agencies within the U.S. Department of Health and Human Services (including the U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services, the Office of Inspector General and the Office for Civil Rights), the U.S. Nuclear Regulatory Commission, the U.S. Federal Trade Commission, the U.S. Customs and Border Protection, various state boards of pharmacy, state controlled substance authorities, state health departments, state insurance departments, state Medicaid departments or comparable regulatory bodies or governmental authorities or foreign equivalents that, in each case, could delay, limit or suspend product development, manufacturing, distribution, importation or sales or result in warning letters, recalls, seizures, injunctions or monetary sanctions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any compromise of our information systems or of those of a third-party service provider, including unauthorized access to or use or disclosure of company or customer information, disruption of access and ancillary risks associated with our ability to effectively manage any issues arising from any such compromise or disruption;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties related to our Medical segment's Cardinal Health Brand products, including our ability to manage infrastructure and cost challenges, and to improve its performance;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with the realignment of our Medical segment's supply chain and other businesses, including our ability to achieve the expected benefits from such realignment; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties with respect to our cost-savings initiatives or other restructuring activities, including the ability to achieve the expected benefits from such initiatives, the risk that we could incur unexpected charges, and the risk that we may fail to retain key personnel; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">difficulties or delays in the development, production, manufacturing, sourcing and marketing of new or existing products and services, including difficulties or delays associated with obtaining requisite regulatory consents or approvals associated with those activities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">manufacturing disruptions, whether due to regulatory action, production quality deviations, safety issues or raw material shortages or defects, or because a key product is manufactured at a single manufacturing facility with limited alternate facilities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from possible violations of healthcare fraud and abuse laws;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from possible violations of the U.S. Foreign Corrupt Practices Act and other similar anti-corruption laws in other jurisdictions and U.S. and foreign export control, trade embargo and customs laws;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from our collecting, handling and maintaining patient-identifiable health information and other sensitive personal and financial information, which are subject to federal, state and foreign laws that regulate the use and disclosure of such information;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from certain of our businesses being Medicare-certified suppliers or participating in other federal and state healthcare programs, such as state Medicaid programs and the federal 340B drug pricing program, which businesses are subject to accreditation and quality standards and other rules and regulations, including applicable reporting, billing, payment and record-keeping requirements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from certain of our businesses manufacturing pharmaceutical and medical products or repackaging pharmaceuticals that are purchased or reimbursed through, or are otherwise governed by, federal or state healthcare programs, which businesses are subject to federal and state laws that establish eligibility for reimbursement by such programs and other applicable standards and regulations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in laws or changes in the interpretation or application of laws or regulations, as well as possible failures to comply with applicable laws or regulations, including as a result of possible misinterpretations or misapplications;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">material reductions in purchases, pricing changes, non-renewal, early termination, or delinquencies or defaults under contracts with key customers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">unfavorable changes to the terms or with our ability to meet contractual obligations of key customer or supplier relationships, or changes in customer mix;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from changes in U.S. or foreign tax laws and unfavorable challenges to our tax positions and payments to settle these challenges, which may adversely affect our effective tax rate or tax payments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties due to possible government healthcare reform, including proposals related to Medicare drug rebate arrangements, possible repeal or replacement of major parts of the Patient Protection and Affordable Care Act, proposals related to prescription drug pricing transparency and the possible adoption of Medicare-For-All;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">reductions or limitations on governmental funding at the state or federal level or efforts by healthcare insurance companies to limit payments for products and services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in manufacturers' pricing, selling, inventory, distribution or supply policies or practices;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in legislation or regulations governing prescription drug pricing, healthcare services or mandated benefits;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in hospital buying groups or hospital buying practices;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in distribution or sourcing models for pharmaceutical and medical and surgical products, including an increase in direct and limited distribution;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes to the prescription drug reimbursement formula and related reporting requirements for generic pharmaceuticals under Medicaid;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">continuing consolidation in the healthcare industry, which could give the resulting enterprises greater bargaining power and may increase pressure on prices for our products and services or result in the loss of customers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">disruption, damage or lack of access to, or failure of, our or our third-party service providers' information systems, our critical facilities, including our national logistics center, or our distribution networks;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks to our business and information and controls systems in the event that business process improvements, infrastructure modernizations or initiatives to use third-party service providers for key systems and processes are not effectively implemented;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the results, costs, effects or timing of any commercial disputes, government contract compliance matters, patent infringement claims, </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;actions, government investigations, shareholder lawsuits or other legal proceedings;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">possible losses relating to product liability lawsuits and claims regarding products for which we cannot obtain product liability insurance or for which such insurance may not be adequate to cover our losses, including the product liability lawsuits we are currently defending relating to alleged personal injuries associated with the use of Cordis inferior vena cava filter products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to maintain adequate intellectual property protections;</font></div></td></tr></table><div><br></div><hr style="page-break-after:always"><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the costs, difficulties and uncertainties related to the integration of acquired businesses, including liabilities relating to the operations or activities of such businesses prior to their acquisition, and uncertainties relating to our ability to achieve the anticipated results from acquisitions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to manage and complete divestitures or other strategic business combination transactions, including our ability to find buyers or other strategic exit opportunities and risks associated with the possibility that we could experience greater dis-synergies than anticipated or otherwise fail to achieve our strategic objectives;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">increased costs for commodities and other materials used in the Medical segment manufacturing, including various components, compounds, raw materials or energy such as oil-based resins, pulp, cotton, latex and other commodities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">shortages in commodities, components, compounds, raw materials or energy used by our businesses, including supply disruptions of radioisotopes;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the loss of, or default by, one or more key suppliers for which alternative suppliers may not be readily available;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">bankruptcy, insolvency or other credit failure of a customer or supplier that owes us a substantial amount;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with global operations, including the effect of local economic environments, inflation, recession, currency volatility and global competition, in addition to risks associated with compliance with U.S. and international laws relating to global operations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties with respect to U.S. or international trade policies, tariffs, excise or border taxes and their impact on our ability to source products or materials that we need to conduct our business;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with our use of and reliance on the global capital and credit markets, including our ability to access credit and our cost of credit, which may adversely affect our ability to efficiently fund our operations or undertake certain expenditures;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to introduce and market new products and our ability to keep pace with advances in technology;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">significant charges to earnings if goodwill or intangible assets become impaired; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to general political, business, industry, regulatory and market conditions; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">other factors described in the &#8220;Risk Factors&#8221; section of the 2019 Form 10-K and Forms 10-Q for the three-months ended September 30, 2019 and December 31, 2019.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The words &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; and similar expressions generally identify &#8220;forward-looking statements,&#8221; which speak only as of the date the statements were made, and also include statements reflecting future results or guidance, statements of outlook and expense accruals. We undertake no obligation to update or revise any forward-looking statements, except to the extent required by applicable law.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cah-20200331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cardinal.com/20200331" xmlns:cah="http://www.cardinal.com/20200331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20200331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20200331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20200331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cah-20200331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies">
        <link:definition>2101100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails">
        <link:definition>2401402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>2201201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingentLiabilitiesAndLitigation" roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation">
        <link:definition>2111100 - Disclosure - Commitments, Contingent Liabilities and Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingentLiabilitiesAndLitigationDetails" roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails">
        <link:definition>2411401 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1003000 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1003501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows">
        <link:definition>1005000 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfComprehensiveIncome" roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome">
        <link:definition>1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfComprehensiveIncomeCalc2" roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeCalc2">
        <link:definition>1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfEarnings" roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings">
        <link:definition>1001000 - Statement - Condensed Consolidated Statements of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsOfShareholdersEquity" roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity">
        <link:definition>1004000 - Statement - Condensed Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CoverPage" roleURI="http://www.cardinal.com/role/CoverPage">
        <link:definition>0001000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthInc" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc">
        <link:definition>2117100 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails">
        <link:definition>2417402 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails">
        <link:definition>2417403 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAttributableToCardinalHealthIncTables" roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables">
        <link:definition>2317301 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.cardinal.com/role/FairValueMeasurements">
        <link:definition>2113100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails">
        <link:definition>2413402 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables">
        <link:definition>2313301 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.cardinal.com/role/FinancialInstruments">
        <link:definition>2115100 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>2415402 - Disclosure - Financial Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails">
        <link:definition>2415403 - Disclosure - Financial Instruments Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables">
        <link:definition>2315301 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssets" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets">
        <link:definition>2105100 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsNarrativeDetails" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails">
        <link:definition>2405404 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails">
        <link:definition>2405402 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails">
        <link:definition>2405403 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndOtherIntangibleAssetsTables" roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables">
        <link:definition>2305301 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cardinal.com/role/IncomeTaxes">
        <link:definition>2112100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2412401 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.cardinal.com/role/Investments">
        <link:definition>2107100 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsInvestmentsDetails" roleURI="http://www.cardinal.com/role/InvestmentsInvestmentsDetails">
        <link:definition>2407401 - Disclosure - Investments Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.cardinal.com/role/Leases">
        <link:definition>2108100 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.cardinal.com/role/LeasesDetails">
        <link:definition>2408402 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleOfFutureLeasePaymentsDetails" roleURI="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails">
        <link:definition>2408406 - Disclosure - Leases Schedule of Future Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleOfLeaseCostsDetails" roleURI="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails">
        <link:definition>2408403 - Disclosure - Leases Schedule of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>2408404 - Disclosure - Leases Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>2408405 - Disclosure - Leases Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.cardinal.com/role/LeasesTables">
        <link:definition>2308301 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowings" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings">
        <link:definition>2110100 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowingsDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails">
        <link:definition>2410402 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails">
        <link:definition>2410403 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsAndOtherShortTermBorrowingsTables" roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables">
        <link:definition>2310301 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeverance" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance">
        <link:definition>2103100 - Disclosure - Restructuring and Employee Severance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails">
        <link:definition>2403402 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails">
        <link:definition>2403403 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceNarativeDetails" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails">
        <link:definition>2403404 - Disclosure - Restructuring and Employee Severance Narative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringAndEmployeeSeveranceTables" roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables">
        <link:definition>2303301 - Disclosure - Restructuring and Employee Severance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.cardinal.com/role/SegmentInformation">
        <link:definition>2118100 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationAssetsByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails">
        <link:definition>2418406 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails">
        <link:definition>2418402 - Disclosure - Segment Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationRevenueByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails">
        <link:definition>2418403 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails" roleURI="http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails">
        <link:definition>2418405 - Disclosure - Segment Information Revenue From External Customers By Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentProfitByReportableSegmentDetails" roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails">
        <link:definition>2418404 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.cardinal.com/role/SegmentInformationTables">
        <link:definition>2318301 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.cardinal.com/role/ShareBasedCompensation">
        <link:definition>2119100 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>2419402 - Disclosure - Share-Based Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails">
        <link:definition>2419405 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails">
        <link:definition>2419404 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails">
        <link:definition>2419407 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails">
        <link:definition>2419406 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails">
        <link:definition>2419403 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables">
        <link:definition>2319301 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cardinal.com/role/ShareholdersEquity">
        <link:definition>2116100 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2416403 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>2416402 - Disclosure - Shareholders' Equity (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.cardinal.com/role/ShareholdersEquityTables">
        <link:definition>2316301 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="cah_A2.4Notesdue2020Member" name="A2.4Notesdue2020Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A2.616Notesdue2022Member" name="A2.616Notesdue2022Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.079Notesdue2024Member" name="A3.079Notesdue2024Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.2Notesdue2022Member" name="A3.2Notesdue2022Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.2Notesdue2023Member" name="A3.2Notesdue2023Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.41Notesdue2027Member" name="A3.41Notesdue2027Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.5Notesdue2025Member" name="A3.5Notesdue2025Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A3.75Notesdue2026Member" name="A3.75Notesdue2026Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A4.368Notesdue2047Member" name="A4.368Notesdue2047Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A4.5Notesdue2044Member" name="A4.5Notesdue2044Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A4.625Notesdue2021Member" name="A4.625Notesdue2021Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A4.6Notesdue2043Member" name="A4.6Notesdue2043Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A4.9Notesdue2045Member" name="A4.9Notesdue2045Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_A7.0Debenturesduefiscal2027Member" name="A7.0Debenturesduefiscal2027Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ASC842Member" name="ASC842Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_AdditionalStockOptionPlanDataTableTextBlock" name="AdditionalStockOptionPlanDataTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_AlamedaCountyMember" name="AlamedaCountyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Amortizationandotheracquisitionrelatedcosts" name="Amortizationandotheracquisitionrelatedcosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CVSHealthMember" name="CVSHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CardinalHealthAtHomeMember" name="CardinalHealthAtHomeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CareFusionMember" name="CareFusionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_CarryingAmountofLongTermandotherShortTermBorrowings" name="CarryingAmountofLongTermandotherShortTermBorrowings" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_CarryingValue" name="CarryingValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cah_CashComponentForSettlementFrameworkTerm" name="CashComponentForSettlementFrameworkTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ClassActionLawsuitsMember" name="ClassActionLawsuitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_CommittedReceivablesSalesFacilityProgramMember" name="CommittedReceivablesSalesFacilityProgramMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" name="DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="cah_DiscountRatefairvalueinputs" name="DiscountRatefairvalueinputs" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ExercisablePeriodOfPlansInYears" name="ExercisablePeriodOfPlansInYears" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_FacilityExitAndOtherCosts" name="FacilityExitAndOtherCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_FinanceLeaseImputedInterest" name="FinanceLeaseImputedInterest" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_FinanceLeaseMember" name="FinanceLeaseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_FloatingRateNotesdue2022Member" name="FloatingRateNotesdue2022Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_GownRecallAxis" name="GownRecallAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_GownRecallDomain" name="GownRecallDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_IPRDTrademarksandOtherMember" name="IPRDTrademarksandOtherMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Impactofadoptionofnewaccountingstandard" name="Impactofadoptionofnewaccountingstandard" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cah_IndemnificationReceivable" name="IndemnificationReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_LawsuitTypeAxis" name="LawsuitTypeAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_LawsuitTypeDomain" name="LawsuitTypeDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" name="LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LeasePaymentsTableTextBlock" name="LeasePaymentsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" name="LeasesSupplementalBalanceSheetInformationTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LeasesTextBlock" name="LeasesTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" name="LesseeFinanceLeaseLiabilityNotYetCommencedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" name="LesseeLeaseLiabilityPaymentsDueAfterYearFive" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueYearFive" name="LesseeLeaseLiabilityPaymentsDueYearFive" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueYearFour" name="LesseeLeaseLiabilityPaymentsDueYearFour" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueYearThree" name="LesseeLeaseLiabilityPaymentsDueYearThree" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsDueYearTwo" name="LesseeLeaseLiabilityPaymentsDueYearTwo" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" name="LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" name="LesseeOperatingLeaseLiabilityNotYetCommencedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_LongTermObligationsandOtherShortTermBorrowingsAbstract" name="LongTermObligationsandOtherShortTermBorrowingsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_LossContingencyLawsuitsNumber" name="LossContingencyLawsuitsNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="cah_MaximumQuarterlyPayment" name="MaximumQuarterlyPayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_MedicalMember" name="MedicalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_MedicalReportingUnitMember" name="MedicalReportingUnitMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_MedicaldistributionandproductsMember" name="MedicaldistributionandproductsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_NarativeAbstract" name="NarativeAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_NaviHealthMember" name="NaviHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_NaviOwnershipInterestDivestedMember" name="NaviOwnershipInterestDivestedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Netproceedstaxwithholdingsfromsharebasedcompensation" name="Netproceedstaxwithholdingsfromsharebasedcompensation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_NotesPayableRepurchased" name="NotesPayableRepurchased" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_NuclearPrecisionHealthServicesMember" name="NuclearPrecisionHealthServicesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_NumberofStateAttorneysGeneralfilinglawsuits" name="NumberofStateAttorneysGeneralfilinglawsuits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="cah_OperatingLeaseImputedInterest" name="OperatingLeaseImputedInterest" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_OperatingLeaseMember" name="OperatingLeaseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLawsuitsMember" name="OpioidLawsuitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLawsuitsStateDomain" name="OpioidLawsuitsStateDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLitigationAxis" name="OpioidLitigationAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLitigationCuyahogaandSummitCountiesMember" name="OpioidLitigationCuyahogaandSummitCountiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLitigationDomain" name="OpioidLitigationDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" name="OpioidLitigationlessCuyahogaandSummitCountiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_OpioidTotalSettlementCuyahogaandSummitCounties" name="OpioidTotalSettlementCuyahogaandSummitCounties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_OtherJurisdictionsMember" name="OtherJurisdictionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_PartnershipIndirectOwnership" name="PartnershipIndirectOwnership" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_PatientRecoveryBusinessMember" name="PatientRecoveryBusinessMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PharmaceuticalDistributionandSpecialtyMember" name="PharmaceuticalDistributionandSpecialtyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PharmaceuticalMember" name="PharmaceuticalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PlaintiffTypeAxis" name="PlaintiffTypeAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PlaintiffTypeDomain" name="PlaintiffTypeDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_PreTaxGainonDivestiture" name="PreTaxGainonDivestiture" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_PrivatePartiesMember" name="PrivatePartiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" name="Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" name="Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ProductLiabilityLawsuitsMember" name="ProductLiabilityLawsuitsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_ProjectCostsOnInvestmentAndOtherSpending" name="ProjectCostsOnInvestmentAndOtherSpending" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_Purchaseofavailableforsalesecuritiesandotherinvestments" name="Purchaseofavailableforsalesecuritiesandotherinvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="cah_ReclassificationofdeferredrentinaccordancewithASC842" name="ReclassificationofdeferredrentinaccordancewithASC842" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems" name="SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable" name="SegmentRevenuefromExternalCustomersbyGeographicAreaTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" name="Sharesthatwouldbeantidilutiveasaresultofnetloss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_ShortTermCreditFacilitiesMember" name="ShortTermCreditFacilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_SterileSurgicalGownRecallAxis" name="SterileSurgicalGownRecallAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_SterileSurgicalGownRecallDomain" name="SterileSurgicalGownRecallDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_SterileSurgicalGownRecallMemberDomain" name="SterileSurgicalGownRecallMemberDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TaxMatterAxis" name="TaxMatterAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TaxMatterDomain" name="TaxMatterDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TaxMattersAgreementAxis" name="TaxMattersAgreementAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TaxMattersAgreementDomain" name="TaxMattersAgreementDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_TerminalGrowthRatefairvalueinputs" name="TerminalGrowthRatefairvalueinputs" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_TotalFinanceLeaseCost" name="TotalFinanceLeaseCost" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="cah_TotalLeaseLiability" name="TotalLeaseLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_TotalLeaseLiabilityNotYetCommencedAmount" name="TotalLeaseLiabilityNotYetCommencedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_TotalLeaseLiabilityPaymentsDue" name="TotalLeaseLiabilityPaymentsDue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_TotalLeaseLiabilityUndiscountedExcessAmount" name="TotalLeaseLiabilityUndiscountedExcessAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="cah_TotalLongTermandShortTermObligations" name="TotalLongTermandShortTermObligations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="cah_TotalOpioidLitigationMember" name="TotalOpioidLitigationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TotalOpioidLitigationnetoftaxMember" name="TotalOpioidLitigationnetoftaxMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="cah_TrademarksAndPatentsMember" name="TrademarksAndPatentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_TreasuryStockAcquiredShares" name="TreasuryStockAcquiredShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="cah_VestingPeriodinyearsforShares" name="VestingPeriodinyearsforShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>cah-20200331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="cah-20200331.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:href="cah-20200331.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cah-20200331.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:href="cah-20200331.xsd#CommitmentsContingentLiabilitiesAndLitigation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:href="cah-20200331.xsd#CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets" xlink:href="cah-20200331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="cah-20200331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeCalc2" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfComprehensiveIncomeCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfEarnings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CoverPage" xlink:href="cah-20200331.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:href="cah-20200331.xsd#EarningsPerShareAttributableToCardinalHealthInc" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:href="cah-20200331.xsd#EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:href="cah-20200331.xsd#EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:href="cah-20200331.xsd#EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:href="cah-20200331.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="cah-20200331.xsd#FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:href="cah-20200331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:href="cah-20200331.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="cah-20200331.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20200331.xsd#FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:href="cah-20200331.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:href="cah-20200331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:href="cah-20200331.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Investments" xlink:href="cah-20200331.xsd#Investments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/InvestmentsInvestmentsDetails" xlink:href="cah-20200331.xsd#InvestmentsInvestmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Leases" xlink:href="cah-20200331.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesDetails" xlink:href="cah-20200331.xsd#LeasesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" xlink:href="cah-20200331.xsd#LeasesScheduleOfFutureLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails" xlink:href="cah-20200331.xsd#LeasesScheduleOfLeaseCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="cah-20200331.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:href="cah-20200331.xsd#LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesTables" xlink:href="cah-20200331.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:href="cah-20200331.xsd#LongTermObligationsAndOtherShortTermBorrowings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20200331.xsd#LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:href="cah-20200331.xsd#LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:href="cah-20200331.xsd#LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeverance" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeveranceNarativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeveranceTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:href="cah-20200331.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:href="cah-20200331.xsd#SegmentInformationAssetsByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:href="cah-20200331.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:href="cah-20200331.xsd#SegmentInformationRevenueByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails" xlink:href="cah-20200331.xsd#SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:href="cah-20200331.xsd#SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:href="cah-20200331.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:href="cah-20200331.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:href="cah-20200331.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:href="cah-20200331.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="cah-20200331.xsd#ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:href="cah-20200331.xsd#ShareholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:href="cah-20200331.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:to="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26247a2d-7bac-8834-3dc5-06c993b10b2c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_26247a2d-7bac-8834-3dc5-06c993b10b2c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_02eb9f27-cc70-d84a-60be-0ebfa9ad27e5" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:to="loc_us-gaap_ReceivablesNetCurrent_02eb9f27-cc70-d84a-60be-0ebfa9ad27e5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_aa7cc103-d668-cf3b-6875-81c99ffeac19" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:to="loc_us-gaap_InventoryNet_aa7cc103-d668-cf3b-6875-81c99ffeac19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_be6829f0-538a-891f-48bc-46140655594e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bceb5e86-dcaf-e940-c004-d20dda9b81f2" xlink:to="loc_us-gaap_OtherAssetsCurrent_be6829f0-538a-891f-48bc-46140655594e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bf545d72-755b-f46c-4176-2eeaac0328d1" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_bf545d72-755b-f46c-4176-2eeaac0328d1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_459a5f08-8f16-fffd-523f-f6e6ee19e90a" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_459a5f08-8f16-fffd-523f-f6e6ee19e90a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_17a41c51-6fe7-c037-64c3-3ef6c9692a94" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d88b9019-0bd3-d7de-96eb-5cd69c504c2c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_17a41c51-6fe7-c037-64c3-3ef6c9692a94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:to="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c8e34a68-78cf-1f0f-d260-cfd03835a0ac" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c8e34a68-78cf-1f0f-d260-cfd03835a0ac" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_13159f86-b20a-f641-5cfd-65a0553fc694" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_13159f86-b20a-f641-5cfd-65a0553fc694" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_95fe5c6d-e90e-6d2c-8e9a-8339666be1b8" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_723c74a6-b3c0-ab21-b11a-8bd4ce4806f0" xlink:to="loc_us-gaap_AccountsPayableCurrent_95fe5c6d-e90e-6d2c-8e9a-8339666be1b8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_18cd02df-c342-1135-80a4-128981b71541" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_18cd02df-c342-1135-80a4-128981b71541" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_585ced85-cbc5-11e0-dac8-d6a197e5d990" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_585ced85-cbc5-11e0-dac8-d6a197e5d990" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ae7d1998-6654-2677-8e9f-f36b62210000" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_130b8997-2f7a-8192-a853-ff9fb4629d95" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:to="loc_us-gaap_CommonStockValue_130b8997-2f7a-8192-a853-ff9fb4629d95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_18ff0284-4873-6ef0-806f-4fb76051c01f" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_18ff0284-4873-6ef0-806f-4fb76051c01f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_af531fdd-0099-f49a-729d-64bccce3d7cd" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:to="loc_us-gaap_TreasuryStockValue_af531fdd-0099-f49a-729d-64bccce3d7cd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_355fc088-038d-3905-0784-91db0d020a77" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_355fc088-038d-3905-0784-91db0d020a77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_02ec7b38-4afa-636c-3b62-de1bd1bf96c1" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ac757736-b2b3-41b4-5596-13d65c8f73d5" xlink:to="loc_us-gaap_MinorityInterest_02ec7b38-4afa-636c-3b62-de1bd1bf96c1" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_b27d9ca4-ae01-5f3a-6835-014c96994fe9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_b27d9ca4-ae01-5f3a-6835-014c96994fe9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_9574e099-407d-f499-a4f7-37e06c5ca226" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_LossOnSaleOfInvestments_9574e099-407d-f499-a4f7-37e06c5ca226" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_fb4a1534-3ea3-3150-f601-42486b71bc63" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_fb4a1534-3ea3-3150-f601-42486b71bc63" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0d10caa9-02ca-dfff-16b0-b48af0dbe41a" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0d10caa9-02ca-dfff-16b0-b48af0dbe41a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11843925-b604-1b74-cbbb-bea6e3ba6b7e" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11843925-b604-1b74-cbbb-bea6e3ba6b7e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_8e70545b-e41a-5c88-3aeb-15f273c05266" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_ShareBasedCompensation_8e70545b-e41a-5c88-3aeb-15f273c05266" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_62c92b83-f76e-68ff-4453-8ab3478d0029" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_62c92b83-f76e-68ff-4453-8ab3478d0029" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_2720b568-6d18-ebd1-f8c5-59e8401a86fb" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_2720b568-6d18-ebd1-f8c5-59e8401a86fb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_660d037d-5031-2fde-c0d3-d2b6978292ac" xlink:type="locator" />
    <link:calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_660d037d-5031-2fde-c0d3-d2b6978292ac" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1aefa3b7-6b7a-d481-5bdc-6b8b587c627e" xlink:type="locator" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1aefa3b7-6b7a-d481-5bdc-6b8b587c627e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4392a9aa-12d6-0a02-3bb4-a001e4753188" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13d5d34e-e391-ca89-d84d-71b1e1c2a78c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4392a9aa-12d6-0a02-3bb4-a001e4753188" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_b27d9ca4-ae01-5f3a-6835-014c96994fe9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c7e64fd7-0b56-e309-1408-1e90657554b0" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c7e64fd7-0b56-e309-1408-1e90657554b0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ca48a49a-2cde-cf3d-6904-e8f08b6e1fbb" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ca48a49a-2cde-cf3d-6904-e8f08b6e1fbb" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_cab8a6dd-a29f-61af-763a-54b5341882f1" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_cab8a6dd-a29f-61af-763a-54b5341882f1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_56b5177b-1beb-5c9c-aed9-54b532fdd715" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_56b5177b-1beb-5c9c-aed9-54b532fdd715" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" xlink:label="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_48e461f9-21ca-d5f9-b102-54b535786f26" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2794b8a8-762d-d243-a2f5-a00d52d74432" xlink:to="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_48e461f9-21ca-d5f9-b102-54b535786f26" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_b27d9ca4-ae01-5f3a-6835-014c96994fe9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_9fc9e483-8e3b-7514-ceac-50d930424fe0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_9fc9e483-8e3b-7514-ceac-50d930424fe0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_7f9580a9-3805-cc3a-42fd-74ab6d116d7a" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_7f9580a9-3805-cc3a-42fd-74ab6d116d7a" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_b2cc977c-eaa3-c1f6-1b9f-54b535bd7fad" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_b2cc977c-eaa3-c1f6-1b9f-54b535bd7fad" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_d5388628-04a8-f9f2-f1f1-9af34cf68c6b" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_d5388628-04a8-f9f2-f1f1-9af34cf68c6b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5438f733-2c2e-cb8b-518a-eb0b0108364e" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a7e00ec-a1a5-81e8-5255-8844ac6fe87f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5438f733-2c2e-cb8b-518a-eb0b0108364e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5a50c8d2-c551-fe84-870a-29975db72587" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_b27d9ca4-ae01-5f3a-6835-014c96994fe9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_5a50c8d2-c551-fe84-870a-29975db72587" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_61cff5eb-6380-0a99-0b9f-2aa494c88658" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b648d0ef-16fe-7d60-a025-6e0cc8ac751c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_61cff5eb-6380-0a99-0b9f-2aa494c88658" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b648d0ef-16fe-7d60-a025-6e0cc8ac751c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b648d0ef-16fe-7d60-a025-6e0cc8ac751c" xlink:to="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec9c3aab-da5b-a831-3f37-62a3ea3b00ff" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b648d0ef-16fe-7d60-a025-6e0cc8ac751c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec9c3aab-da5b-a831-3f37-62a3ea3b00ff" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d954d1a3-69c6-9ed8-87ac-70ab0eca24d0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec9c3aab-da5b-a831-3f37-62a3ea3b00ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d954d1a3-69c6-9ed8-87ac-70ab0eca24d0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_b6d34176-e5c4-1bea-2919-8d8743b54529" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec9c3aab-da5b-a831-3f37-62a3ea3b00ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_b6d34176-e5c4-1bea-2919-8d8743b54529" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_63bbe84c-b938-87b9-5103-68b80738d584" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_61cff5eb-6380-0a99-0b9f-2aa494c88658" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_63bbe84c-b938-87b9-5103-68b80738d584" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeCalc2" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_aaf4fade-f652-62f8-cf02-c59447905641" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aaf4fade-f652-62f8-cf02-c59447905641" xlink:to="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:to="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_da1a9111-3960-6334-38ac-32be56368293" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_us-gaap_GrossProfit_da1a9111-3960-6334-38ac-32be56368293" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_0bbe8f4f-d085-9302-fa93-9512411ebfc0" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_da1a9111-3960-6334-38ac-32be56368293" xlink:to="loc_us-gaap_Revenues_0bbe8f4f-d085-9302-fa93-9512411ebfc0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_01f4f849-ade5-f04f-1204-64d74a0c2886" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_da1a9111-3960-6334-38ac-32be56368293" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_01f4f849-ade5-f04f-1204-64d74a0c2886" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89404ae6-0808-876c-4ac7-0c429ea9ed38" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89404ae6-0808-876c-4ac7-0c429ea9ed38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_0e117598-5e59-61cf-d7cd-38957b1c7098" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_us-gaap_RestructuringCharges_0e117598-5e59-61cf-d7cd-38957b1c7098" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Amortizationandotheracquisitionrelatedcosts" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_ff8c1a7b-e054-a484-6efc-54b532e5bca3" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_cah_Amortizationandotheracquisitionrelatedcosts_ff8c1a7b-e054-a484-6efc-54b532e5bca3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0d10caa9-02ca-dfff-16b0-b48af0dbe41a" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_0d10caa9-02ca-dfff-16b0-b48af0dbe41a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_f8b165ba-23a3-ed13-0d25-fe63b9165d30" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86cfb7da-c050-ac7c-919e-7f811affb4ae" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_f8b165ba-23a3-ed13-0d25-fe63b9165d30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_497f98e6-8a11-3c53-7076-ee6aaae664ce" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_497f98e6-8a11-3c53-7076-ee6aaae664ce" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_70961961-6a13-30f4-732a-8e29cef0bea0" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:to="loc_us-gaap_InterestExpense_70961961-6a13-30f4-732a-8e29cef0bea0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11843925-b604-1b74-cbbb-bea6e3ba6b7e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3b4fb19e-0ab3-73fa-6824-0c5022a00349" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_11843925-b604-1b74-cbbb-bea6e3ba6b7e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6a75c878-dfaf-e368-936e-ce293fe86f6f" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_82a1dba8-8b5a-130a-edce-afbb0d3a199c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6a75c878-dfaf-e368-936e-ce293fe86f6f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_63bbe84c-b938-87b9-5103-68b80738d584" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_aaf4fade-f652-62f8-cf02-c59447905641" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_63bbe84c-b938-87b9-5103-68b80738d584" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/CoverPage" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3b4f95d0-4de5-2b2f-e2ec-91daf63ca50c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f60858b4-cb31-daa2-3699-140a0e3df912" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3b4f95d0-4de5-2b2f-e2ec-91daf63ca50c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f60858b4-cb31-daa2-3699-140a0e3df912" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7595492d-e98c-ec24-3583-0c7237508f48" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3b4f95d0-4de5-2b2f-e2ec-91daf63ca50c" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7595492d-e98c-ec24-3583-0c7237508f48" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/Investments" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/InvestmentsInvestmentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/Leases" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_77713e2c-39c0-2928-ada1-44468992f16e" xlink:type="locator" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalFinanceLeaseCost" xlink:label="loc_cah_TotalFinanceLeaseCost_4678319d-939e-8155-452d-54b535cdbbc5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_77713e2c-39c0-2928-ada1-44468992f16e" xlink:to="loc_cah_TotalFinanceLeaseCost_4678319d-939e-8155-452d-54b535cdbbc5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7f54c327-2f55-648a-30dd-b75d1935dcb8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cah_TotalFinanceLeaseCost_4678319d-939e-8155-452d-54b535cdbbc5" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7f54c327-2f55-648a-30dd-b75d1935dcb8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_255ac63d-d319-d16f-1081-3af76186230c" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_77713e2c-39c0-2928-ada1-44468992f16e" xlink:to="loc_us-gaap_VariableLeaseCost_255ac63d-d319-d16f-1081-3af76186230c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_33693773-864e-1cc1-3236-0c5155be3c52" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_77713e2c-39c0-2928-ada1-44468992f16e" xlink:to="loc_us-gaap_OperatingLeaseCost_33693773-864e-1cc1-3236-0c5155be3c52" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LeasesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_0e117598-5e59-61cf-d7cd-38957b1c7098" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_bc82456d-8f04-6add-4452-4fd7d3855aa8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_0e117598-5e59-61cf-d7cd-38957b1c7098" xlink:to="loc_us-gaap_SeveranceCosts1_bc82456d-8f04-6add-4452-4fd7d3855aa8" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_c70e8c4d-38ea-e44f-6db5-54b535c9d208" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_0e117598-5e59-61cf-d7cd-38957b1c7098" xlink:to="loc_cah_FacilityExitAndOtherCosts_c70e8c4d-38ea-e44f-6db5-54b535c9d208" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec9c3aab-da5b-a831-3f37-62a3ea3b00ff" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_172bc63a-ba62-e56a-f5ee-176e880a1b99" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec9c3aab-da5b-a831-3f37-62a3ea3b00ff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_172bc63a-ba62-e56a-f5ee-176e880a1b99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_cebe8cd2-dfa5-f0b2-fced-53d6c831f16c" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ec9c3aab-da5b-a831-3f37-62a3ea3b00ff" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_cebe8cd2-dfa5-f0b2-fced-53d6c831f16c" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>cah-20200331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="cah-20200331.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:href="cah-20200331.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cah-20200331.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:href="cah-20200331.xsd#CommitmentsContingentLiabilitiesAndLitigation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:href="cah-20200331.xsd#CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets" xlink:href="cah-20200331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="cah-20200331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfEarnings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CoverPage" xlink:href="cah-20200331.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:href="cah-20200331.xsd#EarningsPerShareAttributableToCardinalHealthInc" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:href="cah-20200331.xsd#EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:href="cah-20200331.xsd#EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:href="cah-20200331.xsd#EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:href="cah-20200331.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="cah-20200331.xsd#FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:href="cah-20200331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:href="cah-20200331.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="cah-20200331.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20200331.xsd#FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:href="cah-20200331.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:href="cah-20200331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:href="cah-20200331.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Investments" xlink:href="cah-20200331.xsd#Investments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/InvestmentsInvestmentsDetails" xlink:href="cah-20200331.xsd#InvestmentsInvestmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Leases" xlink:href="cah-20200331.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesDetails" xlink:href="cah-20200331.xsd#LeasesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" xlink:href="cah-20200331.xsd#LeasesScheduleOfFutureLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails" xlink:href="cah-20200331.xsd#LeasesScheduleOfLeaseCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="cah-20200331.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:href="cah-20200331.xsd#LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesTables" xlink:href="cah-20200331.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:href="cah-20200331.xsd#LongTermObligationsAndOtherShortTermBorrowings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20200331.xsd#LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:href="cah-20200331.xsd#LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:href="cah-20200331.xsd#LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeverance" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeveranceNarativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeveranceTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:href="cah-20200331.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:href="cah-20200331.xsd#SegmentInformationAssetsByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:href="cah-20200331.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:href="cah-20200331.xsd#SegmentInformationRevenueByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails" xlink:href="cah-20200331.xsd#SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:href="cah-20200331.xsd#SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:href="cah-20200331.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:href="cah-20200331.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:href="cah-20200331.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:href="cah-20200331.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="cah-20200331.xsd#ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:href="cah-20200331.xsd#ShareholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:href="cah-20200331.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE" xlink:to="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" xlink:label="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15" xlink:to="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20200331.xsd#cah_GownRecallAxis" xlink:label="loc_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:to="loc_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:to="loc_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallMemberDomain" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:to="loc_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:to="loc_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:to="loc_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:to="loc_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LawsuitTypeAxis" xlink:label="loc_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LawsuitTypeDomain" xlink:label="loc_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:to="loc_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LawsuitTypeDomain" xlink:label="loc_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:to="loc_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ClassActionLawsuitsMember" xlink:label="loc_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41" xlink:to="loc_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PlaintiffTypeAxis" xlink:label="loc_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PlaintiffTypeDomain" xlink:label="loc_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:to="loc_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PlaintiffTypeDomain" xlink:label="loc_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:to="loc_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PrivatePartiesMember" xlink:label="loc_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A" xlink:to="loc_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMattersAgreementAxis" xlink:label="loc_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:to="loc_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:to="loc_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_71B918F27D9B3C2B95E4F5E148D51A11" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:to="loc_cah_TotalOpioidLitigationMember_71B918F27D9B3C2B95E4F5E148D51A11" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_2413DCEA3A42A18A1858F5E148D6DFB5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:to="loc_cah_TotalOpioidLitigationnetoftaxMember_2413DCEA3A42A18A1858F5E148D6DFB5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA" xlink:to="loc_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA" xlink:to="loc_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_AlamedaCountyMember" xlink:label="loc_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:to="loc_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OtherJurisdictionsMember" xlink:label="loc_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:to="loc_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9" xlink:to="loc_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9" xlink:to="loc_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_DD0155DDF9750AB20D57F5E148D7359C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:to="loc_srt_MinimumMember_DD0155DDF9750AB20D57F5E148D7359C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_196F4318D19F3C206017F5E148D86ED0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:to="loc_srt_MaximumMember_196F4318D19F3C206017F5E148D86ED0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43" xlink:to="loc_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43" xlink:to="loc_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:to="loc_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73" xlink:to="loc_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73" xlink:to="loc_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605" xlink:to="loc_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D" xlink:to="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D" xlink:to="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLawsuitsStateDomain" xlink:label="loc_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="loc_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_180960914913F614AEB3F5E148E10D98" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="loc_cah_OpioidLawsuitsMember_180960914913F614AEB3F5E148E10D98" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallMemberDomain" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_CF7D9C57992E12DF0E61F5E148E1E361" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_CF7D9C57992E12DF0E61F5E148E1E361" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_46F2667E2DCED3A5CFB0F5E148E1ADEA" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_46F2667E2DCED3A5CFB0F5E148E1ADEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_E4895499992AE68FB1D2F5E148E21EF8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09" xlink:to="loc_us-gaap_SubsequentEventMember_E4895499992AE68FB1D2F5E148E21EF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_BD4D4DC9A3076B9A1A55F5E148E37738" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_InventoryNet_BD4D4DC9A3076B9A1A55F5E148E37738" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_0BF62F4B2ED5E9236254F5E148E3F336" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_LongtermPurchaseCommitmentPeriod_0BF62F4B2ED5E9236254F5E148E3F336" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MaximumQuarterlyPayment" xlink:label="loc_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LossContingencyLawsuitsNumber" xlink:label="loc_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:label="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CashComponentForSettlementFrameworkTerm" xlink:label="loc_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidTotalSettlementCuyahogaandSummitCounties" xlink:label="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_1348E8E38F1257CC181AF5E14DF2BE1A" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_1348E8E38F1257CC181AF5E14DF2BE1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_A47C0010A960059DD977F5E148E57EEB" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_LitigationReserve_A47C0010A960059DD977F5E148E57EEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_3BF47C00D1158D3E10D9F5E148E5F53C" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_3BF47C00D1158D3E10D9F5E148E5F53C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_6F79A0C190292C805A9EF5E148E6F815" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_6F79A0C190292C805A9EF5E148E6F815" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_A5FFAFB0428159338092F5E148E6D442" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_A5FFAFB0428159338092F5E148E6D442" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRecallExpense" xlink:label="loc_us-gaap_InventoryRecallExpense_AB0FA8FC50B77D6AC4E6F5E148E6AF5B" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_InventoryRecallExpense_AB0FA8FC50B77D6AC4E6F5E148E6AF5B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_93ADDF2C90EE69B6B2BFF5E148E72032" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_93ADDF2C90EE69B6B2BFF5E148E72032" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_822A32DFCB3DC6FF9721F5E148E7D3FF" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_822A32DFCB3DC6FF9721F5E148E7D3FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_B807203D2802DA0C4A91F5E148E7907E" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_B807203D2802DA0C4A91F5E148E7907E" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_744AD22119BF75BADFE9DFCE37547AF0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_StatementTable_744AD22119BF75BADFE9DFCE37547AF0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1FC4D5163E7E52DBB7B1DFCE37542450" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_744AD22119BF75BADFE9DFCE37547AF0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1FC4D5163E7E52DBB7B1DFCE37542450" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1FC4D5163E7E52DBB7B1DFCE37542450" xlink:to="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1FC4D5163E7E52DBB7B1DFCE37542450" xlink:to="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_D6E2D7303BF37034D9D2DFCE37556628" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:to="loc_us-gaap_CommonStockMember_D6E2D7303BF37034D9D2DFCE37556628" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_6E00BF17987EF4914406DFCE3755A5AC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:to="loc_us-gaap_RetainedEarningsMember_6E00BF17987EF4914406DFCE3755A5AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_341712EB20D7B035B589DFCE3756CB3C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:to="loc_us-gaap_TreasuryStockMember_341712EB20D7B035B589DFCE3756CB3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A771459543EBB0482EC8DFCE3756042C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A771459543EBB0482EC8DFCE3756042C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ED7C7DFAD8ECFD6F0192DFCE37561E6D" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ED7C7DFAD8ECFD6F0192DFCE37561E6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_CE51D0CDEFF6B0256163DFCE3757A191" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_CommonStockSharesIssued_CE51D0CDEFF6B0256163DFCE3757A191" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5FEEBC2CBA29163D08E1DFCE3757451D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5FEEBC2CBA29163D08E1DFCE3757451D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_E5680FD2C62E03183474DFCE37578884" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_TreasuryStockShares_E5680FD2C62E03183474DFCE37578884" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_52DD935B8ABA283E7535DFCE37573B7C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_TreasuryStockValue_52DD935B8ABA283E7535DFCE37573B7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_19A30678FD9272217C3DDFCE37572F41" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_ProfitLoss_19A30678FD9272217C3DDFCE37572F41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_A95CC2C65DA98C155A6EDFCE3757D5DD" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_NetIncomeLoss_A95CC2C65DA98C155A6EDFCE3757D5DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91EA59B3AF77E7CCBACEDFCE3758EC2A" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91EA59B3AF77E7CCBACEDFCE3758EC2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9605DE00460407B804D6DFCE375884F2" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9605DE00460407B804D6DFCE375884F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8663C8160C90999B2063DFCE37585882" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8663C8160C90999B2063DFCE37585882" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9E51EC60BE54D1962A51DFCE37592C52" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9E51EC60BE54D1962A51DFCE37592C52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_E96788A48827864F846FDFCE3759E03F" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_E96788A48827864F846FDFCE3759E03F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_106978E340915798E272DFCE3759A860" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_106978E340915798E272DFCE3759A860" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_DF0B8F558607CED0DDFFDFCE37593BE9" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_Dividends_DF0B8F558607CED0DDFFDFCE37593BE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="loc_us-gaap_StockholdersEquityOther_C4A1A9C6B0C27F5BF69DDFCE3759B1FB" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_StockholdersEquityOther_C4A1A9C6B0C27F5BF69DDFCE3759B1FB" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/CoverPage" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_F0A0817B09088F9ABBC654B5727F13FA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_F0A0817B09088F9ABBC654B5727F13FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_585F678F62B295F5B9F054B572805196" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_585F678F62B295F5B9F054B572805196" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3296D7DDDDEA0E2CEF7654B57281C3B4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3296D7DDDDEA0E2CEF7654B57281C3B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_E747AC5CAC182524ED0D54B57281C007" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_E747AC5CAC182524ED0D54B57281C007" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_67F140D2D1EE3CAB220854B57283F7D8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_67F140D2D1EE3CAB220854B57283F7D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_9A82C1F2C4976B44EFBF54B57283F6C5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_9A82C1F2C4976B44EFBF54B57283F6C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_4B031AAAB9FD2B9ED87654B572831A0D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_4B031AAAB9FD2B9ED87654B572831A0D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:to="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_10A75033F1FC00BFC40B54B572CFB01D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_10A75033F1FC00BFC40B54B572CFB01D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6B3B781587EA1FEF077454B572CF07B6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_10A75033F1FC00BFC40B54B572CFB01D" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6B3B781587EA1FEF077454B572CF07B6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6B3B781587EA1FEF077454B572CF07B6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_10A75033F1FC00BFC40B54B572CFB01D" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6B3B781587EA1FEF077454B572CF07B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_417004C8512B0D0195B154B572D0DB33" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6B3B781587EA1FEF077454B572CF07B6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_417004C8512B0D0195B154B572D0DB33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_F73C8AF31BC601D94C6254B572D0F897" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_F73C8AF31BC601D94C6254B572D0F897" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C8467E132BDEC4B49B7A54B572D06D87_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_F73C8AF31BC601D94C6254B572D0F897" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C8467E132BDEC4B49B7A54B572D06D87_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C8467E132BDEC4B49B7A54B572D06D87" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_F73C8AF31BC601D94C6254B572D0F897" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C8467E132BDEC4B49B7A54B572D06D87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_BE8470325B1AB40EECE854B572D1F121" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C8467E132BDEC4B49B7A54B572D06D87" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_BE8470325B1AB40EECE854B572D1F121" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:to="loc_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287" xlink:to="loc_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287" xlink:to="loc_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_CDFC0EC3A9D3FC90839A54B572D26666" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_CDFC0EC3A9D3FC90839A54B572D26666" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_B11680B8DDDBD5A30FAE54B572D2D070" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:to="loc_us-gaap_NondesignatedMember_B11680B8DDDBD5A30FAE54B572D2D070" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_7163664D6DBCAB61954154B572D3EAF0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91" xlink:to="loc_us-gaap_FairValueHedgingMember_7163664D6DBCAB61954154B572D3EAF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_EA581F2D3BFD4305108F54B572D405D2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:to="loc_us-gaap_CashFlowHedgingMember_EA581F2D3BFD4305108F54B572D405D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_A80E9BFADD1292FBB3E454B572D5F3CC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:to="loc_us-gaap_InterestRateSwapMember_A80E9BFADD1292FBB3E454B572D5F3CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_62305F5E250636FF8E3754B572D51C6B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:to="loc_us-gaap_CurrencySwapMember_62305F5E250636FF8E3754B572D51C6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_49A6C1DB2DC3D742A82054B572D562CB" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:to="loc_us-gaap_ForeignExchangeContractMember_49A6C1DB2DC3D742A82054B572D562CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_F23358CAB151FE4468C354B572D620D6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_F23358CAB151FE4468C354B572D620D6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_EDDEA57C150646C4701154B572D61EF9" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_EDDEA57C150646C4701154B572D61EF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_027FCAB760445BDA4A4654B572D6E201" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_027FCAB760445BDA4A4654B572D6E201" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C41499C036FB826AE20E54B574508C3E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_F89E7644125DBF26919554B5744F00F0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C41499C036FB826AE20E54B574508C3E" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_F89E7644125DBF26919554B5744F00F0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2B8F411218906B198C6E54B5744F6054" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_F89E7644125DBF26919554B5744F00F0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2B8F411218906B198C6E54B5744F6054" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_05E87A1756FE7FB11A8A54B5744F7D7F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2B8F411218906B198C6E54B5744F6054" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_05E87A1756FE7FB11A8A54B5744F7D7F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_05E87A1756FE7FB11A8A54B5744F7D7F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2B8F411218906B198C6E54B5744F6054" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_05E87A1756FE7FB11A8A54B5744F7D7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_D65CFA6B90F5DC98CC5754B57450F8AF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_05E87A1756FE7FB11A8A54B5744F7D7F" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_D65CFA6B90F5DC98CC5754B57450F8AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_446059672E6054EF84AA54B57450FE0C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C41499C036FB826AE20E54B574508C3E" xlink:to="loc_us-gaap_DebtInstrumentFairValue_446059672E6054EF84AA54B57450FE0C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:label="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C41499C036FB826AE20E54B574508C3E" xlink:to="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_F00475425CD5D8A9097FF0AC3B8BDF20" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_F00475425CD5D8A9097FF0AC3B8BDF20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3E702828E07EBD2E5D98F0AC3B8B7D4B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_F00475425CD5D8A9097FF0AC3B8BDF20" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3E702828E07EBD2E5D98F0AC3B8B7D4B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3E702828E07EBD2E5D98F0AC3B8B7D4B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_F00475425CD5D8A9097FF0AC3B8BDF20" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3E702828E07EBD2E5D98F0AC3B8B7D4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_325C8A3B9AD7E509A107F0AC3B8CAD88" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:to="loc_srt_ConsolidationItemsAxis_325C8A3B9AD7E509A107F0AC3B8CAD88" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_8471062D3E0CBB9B0CA5F0AC3B8C9034_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_325C8A3B9AD7E509A107F0AC3B8CAD88" xlink:to="loc_srt_ConsolidationItemsDomain_8471062D3E0CBB9B0CA5F0AC3B8C9034_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_8471062D3E0CBB9B0CA5F0AC3B8C9034" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_325C8A3B9AD7E509A107F0AC3B8CAD88" xlink:to="loc_srt_ConsolidationItemsDomain_8471062D3E0CBB9B0CA5F0AC3B8C9034" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9A1D419E9363194E3598F0AC3B8C8F1B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9A1D419E9363194E3598F0AC3B8C8F1B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_AE8156376C869A7FDB22F0AC3B8CF4F2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9A1D419E9363194E3598F0AC3B8C8F1B" xlink:to="loc_us-gaap_SegmentDomain_AE8156376C869A7FDB22F0AC3B8CF4F2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_AE8156376C869A7FDB22F0AC3B8CF4F2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9A1D419E9363194E3598F0AC3B8C8F1B" xlink:to="loc_us-gaap_SegmentDomain_AE8156376C869A7FDB22F0AC3B8CF4F2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalReportingUnitMember" xlink:label="loc_cah_MedicalReportingUnitMember_9038D1B8C91CCA596BB3F0BEA5BD82B3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_AE8156376C869A7FDB22F0AC3B8CF4F2" xlink:to="loc_cah_MedicalReportingUnitMember_9038D1B8C91CCA596BB3F0BEA5BD82B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_E12FD85DE6D92265C185F0AC3B8D14E7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:to="loc_srt_RangeAxis_E12FD85DE6D92265C185F0AC3B8D14E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_F8B566D73D4F8FBF29A6F0AC3B8D26BB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_E12FD85DE6D92265C185F0AC3B8D14E7" xlink:to="loc_srt_RangeMember_F8B566D73D4F8FBF29A6F0AC3B8D26BB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_F8B566D73D4F8FBF29A6F0AC3B8D26BB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_E12FD85DE6D92265C185F0AC3B8D14E7" xlink:to="loc_srt_RangeMember_F8B566D73D4F8FBF29A6F0AC3B8D26BB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CarryingValue" xlink:label="loc_cah_CarryingValue_C1E981E0988DE3BB5E0AF0BEA52F767C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:to="loc_cah_CarryingValue_C1E981E0988DE3BB5E0AF0BEA52F767C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_53DAF65F576AC869C1F5F0BEC76354EB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:to="loc_us-gaap_Goodwill_53DAF65F576AC869C1F5F0BEC76354EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_5E3361F39B878C618EF6F0BEED26E114" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_5E3361F39B878C618EF6F0BEED26E114" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_DiscountRatefairvalueinputs" xlink:label="loc_cah_DiscountRatefairvalueinputs_4624195FED7275A03531F0BF295D5B55" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:to="loc_cah_DiscountRatefairvalueinputs_4624195FED7275A03531F0BF295D5B55" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TerminalGrowthRatefairvalueinputs" xlink:label="loc_cah_TerminalGrowthRatefairvalueinputs_BBED1F57FA2101FA7C17F0BF53848EAE" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:to="loc_cah_TerminalGrowthRatefairvalueinputs_BBED1F57FA2101FA7C17F0BF53848EAE" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2" xlink:to="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2" xlink:to="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:to="loc_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:to="loc_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalReportingUnitMember" xlink:label="loc_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:to="loc_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CarryingValue" xlink:label="loc_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:to="loc_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_F2588BCF283992674D37F0AC3BB78969" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_F2588BCF283992674D37F0AC3BB78969" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:to="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_13BA183C7983F364309BF0AC3BB73B28" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:to="loc_us-gaap_Goodwill_13BA183C7983F364309BF0AC3BB73B28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers" xlink:label="loc_us-gaap_GoodwillTransfers_6FFD764F5AECF55AD9CAF0AC3BB8434B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:to="loc_us-gaap_GoodwillTransfers_6FFD764F5AECF55AD9CAF0AC3BB8434B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2E6D3078EE7A025B6970F0AC3BB81219" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2E6D3078EE7A025B6970F0AC3BB81219" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_DiscountRatefairvalueinputs" xlink:label="loc_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:to="loc_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TerminalGrowthRatefairvalueinputs" xlink:label="loc_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:to="loc_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_IPRDTrademarksandOtherMember" xlink:label="loc_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D" xlink:to="loc_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_341C13AB83AE4DE2EB9754B57248994F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_341C13AB83AE4DE2EB9754B57248994F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6935F7EDA742F276EEF954B5724AFDBF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6935F7EDA742F276EEF954B5724AFDBF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TrademarksAndPatentsMember" xlink:label="loc_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:to="loc_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_157FADE0780FC02F1A7454B5724B2D0D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_157FADE0780FC02F1A7454B5724B2D0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5FAF8F17962A69E0189C54B5724C5F61" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5FAF8F17962A69E0189C54B5724C5F61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6F052AF0DDF7B2B2883C54B5724E32FF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6F052AF0DDF7B2B2883C54B5724E32FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4B46954CB61C7BECD73554B5724F160D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4B46954CB61C7BECD73554B5724F160D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_877DFACB3A755A1A397C54B5724FAB85" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_877DFACB3A755A1A397C54B5724FAB85" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_A4CEA02549C0D604C72BF41CEEC55061" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_cah_OpioidLitigationAxis_A4CEA02549C0D604C72BF41CEEC55061" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_DBB1C8B8DBFB3A466304F41CEEC6E0DC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_A4CEA02549C0D604C72BF41CEEC55061" xlink:to="loc_cah_OpioidLitigationDomain_DBB1C8B8DBFB3A466304F41CEEC6E0DC_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_DBB1C8B8DBFB3A466304F41CEEC6E0DC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_A4CEA02549C0D604C72BF41CEEC55061" xlink:to="loc_cah_OpioidLitigationDomain_DBB1C8B8DBFB3A466304F41CEEC6E0DC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_A58116AAB9848210452AF41CEEC62CAB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_DBB1C8B8DBFB3A466304F41CEEC6E0DC" xlink:to="loc_cah_TotalOpioidLitigationMember_A58116AAB9848210452AF41CEEC62CAB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMatterAxis" xlink:label="loc_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMatterDomain" xlink:label="loc_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:to="loc_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMatterDomain" xlink:label="loc_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:to="loc_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:to="loc_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CareFusionMember" xlink:label="loc_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:to="loc_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_8D534F88215B80680455F41CEEC9F519" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0" xlink:to="loc_cah_PatientRecoveryBusinessMember_8D534F88215B80680455F41CEEC9F519" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMattersAgreementAxis" xlink:label="loc_cah_TaxMattersAgreementAxis_79B8617B0215946E4221F41CEEC91C73" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_cah_TaxMattersAgreementAxis_79B8617B0215946E4221F41CEEC91C73" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_2DE9FFE839CF4C0A1EE9F41CEEC94AA0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_TaxMattersAgreementAxis_79B8617B0215946E4221F41CEEC91C73" xlink:to="loc_cah_TaxMattersAgreementDomain_2DE9FFE839CF4C0A1EE9F41CEEC94AA0_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_2DE9FFE839CF4C0A1EE9F41CEEC94AA0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_TaxMattersAgreementAxis_79B8617B0215946E4221F41CEEC91C73" xlink:to="loc_cah_TaxMattersAgreementDomain_2DE9FFE839CF4C0A1EE9F41CEEC94AA0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CareFusionMember" xlink:label="loc_cah_CareFusionMember_B61048149033821C1E0EF41CEECA719D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_TaxMattersAgreementDomain_2DE9FFE839CF4C0A1EE9F41CEEC94AA0" xlink:to="loc_cah_CareFusionMember_B61048149033821C1E0EF41CEECA719D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_526B6B1BA8E2A82392E4F41CEECB42CC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_526B6B1BA8E2A82392E4F41CEECB42CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_465B1C11F8D3E3866C82F41CEECB7F8A" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_srt_RangeAxis_465B1C11F8D3E3866C82F41CEECB7F8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_4738CD2EF688A7096354F41CEECB29C4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_465B1C11F8D3E3866C82F41CEECB7F8A" xlink:to="loc_srt_RangeMember_4738CD2EF688A7096354F41CEECB29C4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_4738CD2EF688A7096354F41CEECB29C4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_465B1C11F8D3E3866C82F41CEECB7F8A" xlink:to="loc_srt_RangeMember_4738CD2EF688A7096354F41CEECB29C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_183AEE2810F44A3B8630F41CEECB55B0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4738CD2EF688A7096354F41CEECB29C4" xlink:to="loc_srt_MinimumMember_183AEE2810F44A3B8630F41CEECB55B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9405C8C142DC57DFB5F5F41CEECC39B6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4738CD2EF688A7096354F41CEECB29C4" xlink:to="loc_srt_MaximumMember_9405C8C142DC57DFB5F5F41CEECC39B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_478C05D095A546A78ADDF41CEECC9279" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_LitigationReserve_478C05D095A546A78ADDF41CEECC9279" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1CF479CE97515B47AEEFF41CEECCAEAC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1CF479CE97515B47AEEFF41CEECCAEAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_3D1884B79031C48C95DEF41CEECD4660" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_3D1884B79031C48C95DEF41CEECD4660" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_C2C62C6CE734F8D9AEE1F41CEECD8599" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_C2C62C6CE734F8D9AEE1F41CEECD8599" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_B0B9B79BD0A3063F3C0FF41CEECDA0DE" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_B0B9B79BD0A3063F3C0FF41CEECDA0DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_403D0D324005B631B7A6F41CEECD8FFE" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_403D0D324005B631B7A6F41CEECD8FFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaap_OpenTaxYear_41102EB5AA992F5F14A4F41CEECD28BC" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_OpenTaxYear_41102EB5AA992F5F14A4F41CEECD28BC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_IndemnificationReceivable" xlink:label="loc_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6D825953BC34692EF6A8F41CEECE75CF" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6D825953BC34692EF6A8F41CEECE75CF" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/Investments" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/InvestmentsInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="loc_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:to="loc_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E" xlink:to="loc_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E" xlink:to="loc_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_NaviOwnershipInterestDivestedMember" xlink:label="loc_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B" xlink:to="loc_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0802C9C5291E5B4D56E5E5395EA708EE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0802C9C5291E5B4D56E5E5395EA708EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_E030BC4AEF15BF1A37FFE5395EA7109C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0802C9C5291E5B4D56E5E5395EA708EE" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_E030BC4AEF15BF1A37FFE5395EA7109C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_E030BC4AEF15BF1A37FFE5395EA7109C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0802C9C5291E5B4D56E5E5395EA708EE" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_E030BC4AEF15BF1A37FFE5395EA7109C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_F4CBDCB8065A7471BE52E5395EA845DA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_E030BC4AEF15BF1A37FFE5395EA7109C" xlink:to="loc_cah_NaviHealthMember_F4CBDCB8065A7471BE52E5395EA845DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_F921F7405EB8C5540632E5395EA81586" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_F921F7405EB8C5540632E5395EA81586" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PartnershipIndirectOwnership" xlink:label="loc_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_61ED4C04EAE3743A08AAE5395EA9C6B4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_cah_PreTaxGainonDivestiture_61ED4C04EAE3743A08AAE5395EA9C6B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_49F65EF5B083BFEBC581E5395EA9037D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_49F65EF5B083BFEBC581E5395EA9037D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_16372A0C61EFB0D5A5B6E5395EA9479F" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_16372A0C61EFB0D5A5B6E5395EA9479F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_7706631CEF96B984FCCFE5395EA9ACD3" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_us-gaap_EquityMethodInvestments_7706631CEF96B984FCCFE5395EA9ACD3" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/Leases" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_A1EDC58AD8087F60A5C254B5741287E0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_StatementTable_A1EDC58AD8087F60A5C254B5741287E0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_037D7A6FEC299A79953454B5741360DA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_A1EDC58AD8087F60A5C254B5741287E0" xlink:to="loc_srt_RangeAxis_037D7A6FEC299A79953454B5741360DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_BE1B6377675E30BB87EE54B574132AFC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_037D7A6FEC299A79953454B5741360DA" xlink:to="loc_srt_RangeMember_BE1B6377675E30BB87EE54B574132AFC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_BE1B6377675E30BB87EE54B574132AFC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_037D7A6FEC299A79953454B5741360DA" xlink:to="loc_srt_RangeMember_BE1B6377675E30BB87EE54B574132AFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_41D7018FC9CFC02DB34554B574134397" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_BE1B6377675E30BB87EE54B574132AFC" xlink:to="loc_srt_MinimumMember_41D7018FC9CFC02DB34554B574134397" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9E4CBE35B1751755A2F754B57414DD2B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_BE1B6377675E30BB87EE54B574132AFC" xlink:to="loc_srt_MaximumMember_9E4CBE35B1751755A2F754B57414DD2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_FCCF175EC352F5326FF454B57414738A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_FCCF175EC352F5326FF454B57414738A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_F7B6D405D2B014A39D2154B57414CE94" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_F7B6D405D2B014A39D2154B57414CE94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_3DA1EE631F009CB2C74054B574153B56" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_3DA1EE631F009CB2C74054B574153B56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2F5AAA372653C88F4BC854B574155D50" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2F5AAA372653C88F4BC854B574155D50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9142D1EFC988F5D39B8E54B5741582CB" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9142D1EFC988F5D39B8E54B5741582CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_4E2AB8DFA2FDAD492BCB54B574159D3F" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_4E2AB8DFA2FDAD492BCB54B574159D3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_BA8E7B1AA40DD6F059EA54B574162FFD" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_BA8E7B1AA40DD6F059EA54B574162FFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_FDB21F279BA129DCB85B54B57416174C" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_FDB21F279BA129DCB85B54B57416174C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_664BCAC05EF0148BA37654B574169625" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_664BCAC05EF0148BA37654B574169625" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_AEC1055506F264546AC0DFCE3685E7D0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_StatementTable_AEC1055506F264546AC0DFCE3685E7D0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_AEC1055506F264546AC0DFCE3685E7D0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OperatingLeaseMember" xlink:label="loc_cah_OperatingLeaseMember_F70AA12591A8671BC1BBDFD3CF04AF88" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:to="loc_cah_OperatingLeaseMember_F70AA12591A8671BC1BBDFD3CF04AF88" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_FinanceLeaseMember" xlink:label="loc_cah_FinanceLeaseMember_4C744B473B119F233D5ADFD3CF05431C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:to="loc_cah_FinanceLeaseMember_4C744B473B119F233D5ADFD3CF05431C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_74D5C3CB637D9330808ADFCE3686F4F3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_74D5C3CB637D9330808ADFCE3686F4F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0A311B57F67D3A468219DFCE3687895B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0A311B57F67D3A468219DFCE3687895B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_BF47C274771D90F4B9A4DFCE3687C467" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_BF47C274771D90F4B9A4DFCE3687C467" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_81536AC8ACE2C8707394DFCE3687822C" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_81536AC8ACE2C8707394DFCE3687822C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2BF3CD0269BFEAC885A9DFCE36874B0D" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2BF3CD0269BFEAC885A9DFCE36874B0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_732CA9DAEF4C50B9DC15DFCE3688DD10" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_732CA9DAEF4C50B9DC15DFCE3688DD10" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_F5BC9EA3A12107F2BEB1DFCE3688F056" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_F5BC9EA3A12107F2BEB1DFCE3688F056" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1CE0721BA2AF5D6A89D5DFCE3688AAA3" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1CE0721BA2AF5D6A89D5DFCE3688AAA3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4DB07100E60E208FC760DFCE368930F9" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4DB07100E60E208FC760DFCE368930F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_12282AB053528E31E669DFCE36896DAE" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_12282AB053528E31E669DFCE36896DAE" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1E850B123630AAC20BBADFCE3689E57C" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1E850B123630AAC20BBADFCE3689E57C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5A0E50F281FF088179EDDFCE368923E8" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5A0E50F281FF088179EDDFCE368923E8" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1B6718F45A2E24E7A4DADFCE368A4010" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1B6718F45A2E24E7A4DADFCE368A4010" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_59707F8F8145EE4142B0DFCE368A3854" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_59707F8F8145EE4142B0DFCE368A3854" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLeaseLiabilityPaymentsDue" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78" xlink:type="locator" />
    <link:definitionArc order="23" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B" xlink:type="locator" />
    <link:definitionArc order="24" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OperatingLeaseImputedInterest" xlink:label="loc_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF" xlink:type="locator" />
    <link:definitionArc order="25" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_FinanceLeaseImputedInterest" xlink:label="loc_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC" xlink:type="locator" />
    <link:definitionArc order="26" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA" xlink:type="locator" />
    <link:definitionArc order="27" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_C1EE3F16678C6E96571BDFCE368C22AA" xlink:type="locator" />
    <link:definitionArc order="28" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_OperatingLeaseLiability_C1EE3F16678C6E96571BDFCE368C22AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_D9EBE2D6419FBCC40EAEDFCE368C8FAC" xlink:type="locator" />
    <link:definitionArc order="29" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiability_D9EBE2D6419FBCC40EAEDFCE368C8FAC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLeaseLiability" xlink:label="loc_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57" xlink:type="locator" />
    <link:definitionArc order="30" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF" xlink:to="loc_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045" xlink:to="loc_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045" xlink:to="loc_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ASC842Member" xlink:label="loc_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD" xlink:to="loc_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Impactofadoptionofnewaccountingstandard" xlink:label="loc_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF" xlink:to="loc_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LeasesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:to="loc_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:to="loc_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A2.4Notesdue2020Member" xlink:label="loc_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A2.616Notesdue2022Member" xlink:label="loc_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.41Notesdue2027Member" xlink:label="loc_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.6Notesdue2043Member" xlink:label="loc_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.9Notesdue2045Member" xlink:label="loc_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.368Notesdue2047Member" xlink:label="loc_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.2Notesdue2023Member" xlink:label="loc_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_FloatingRateNotesdue2022Member" xlink:label="loc_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:to="loc_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D" xlink:to="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D" xlink:to="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_102C09CDDA82463BB622F431BDF6398C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:to="loc_us-gaap_CommercialPaperMember_102C09CDDA82463BB622F431BDF6398C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_C17C591F641ED29844C7F431BDF6A5A1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_C17C591F641ED29844C7F431BDF6A5A1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_294F632C2441F130F349F431BDF76C9D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_294F632C2441F130F349F431BDF76C9D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLongTermandShortTermObligations" xlink:label="loc_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:to="loc_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_42E1866A0C4889BE85A2F431BDF8CFAD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_42E1866A0C4889BE85A2F431BDF8CFAD" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_NotesPayableRepurchased" xlink:label="loc_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:to="loc_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_C76C2D52C6090AE00C66F431BDF8899B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_C76C2D52C6090AE00C66F431BDF8899B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_A3AAABE8255DB2D0731BF431BDF85E23" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_A3AAABE8255DB2D0731BF431BDF85E23" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_0ADA0A97F6B407D68DBE54B572EE146C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:to="loc_us-gaap_DebtInstrumentTable_0ADA0A97F6B407D68DBE54B572EE146C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0ADA0A97F6B407D68DBE54B572EE146C" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_D75C1C72C2A9C0F5E63B54B572EFD829" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0ADA0A97F6B407D68DBE54B572EE146C" xlink:to="loc_us-gaap_DebtInstrumentAxis_D75C1C72C2A9C0F5E63B54B572EFD829" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_D75C1C72C2A9C0F5E63B54B572EFD829" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_D75C1C72C2A9C0F5E63B54B572EFD829" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A2.4Notesdue2020Member" xlink:label="loc_cah_A2.4Notesdue2020Member_FC9FAFF9C1D873060F6E54B572F0BFA2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A2.4Notesdue2020Member_FC9FAFF9C1D873060F6E54B572F0BFA2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.625Notesdue2021Member" xlink:label="loc_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A2.616Notesdue2022Member" xlink:label="loc_cah_A2.616Notesdue2022Member_30E1914BFA7B23EB818654B572F046F3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A2.616Notesdue2022Member_30E1914BFA7B23EB818654B572F046F3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.2Notesdue2022Member" xlink:label="loc_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_FloatingRateNotesdue2022Member" xlink:label="loc_cah_FloatingRateNotesdue2022Member_E765FF24DB0FD577FFD654B572F18056" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_FloatingRateNotesdue2022Member_E765FF24DB0FD577FFD654B572F18056" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.2Notesdue2023Member" xlink:label="loc_cah_A3.2Notesdue2023Member_C8AA75CB0C83B397A0F454B572F1FDED" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A3.2Notesdue2023Member_C8AA75CB0C83B397A0F454B572F1FDED" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.079Notesdue2024Member" xlink:label="loc_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.5Notesdue2025Member" xlink:label="loc_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.75Notesdue2026Member" xlink:label="loc_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.41Notesdue2027Member" xlink:label="loc_cah_A3.41Notesdue2027Member_BF4B36A073A9FC98277454B572F1A651" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A3.41Notesdue2027Member_BF4B36A073A9FC98277454B572F1A651" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.6Notesdue2043Member" xlink:label="loc_cah_A4.6Notesdue2043Member_13A1A0EC9FD087439C9154B572F2E472" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A4.6Notesdue2043Member_13A1A0EC9FD087439C9154B572F2E472" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.5Notesdue2044Member" xlink:label="loc_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.9Notesdue2045Member" xlink:label="loc_cah_A4.9Notesdue2045Member_224ECEE59CBC32B28BF854B572F237CB" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A4.9Notesdue2045Member_224ECEE59CBC32B28BF854B572F237CB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.368Notesdue2047Member" xlink:label="loc_cah_A4.368Notesdue2047Member_1C5097DA638F5BF4809E54B572F29E56" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A4.368Notesdue2047Member_1C5097DA638F5BF4809E54B572F29E56" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A7.0Debenturesduefiscal2027Member" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_C7ECB9634C734C695E2754B572F39640" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:to="loc_us-gaap_NotesPayable_C7ECB9634C734C695E2754B572F39640" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaap_OtherBorrowings_4417D77D0723449A240354B572F36BF6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:to="loc_us-gaap_OtherBorrowings_4417D77D0723449A240354B572F36BF6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLongTermandShortTermObligations" xlink:label="loc_cah_TotalLongTermandShortTermObligations_2A25A96E0C651C34ED3D54B572F3C5B4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:to="loc_cah_TotalLongTermandShortTermObligations_2A25A96E0C651C34ED3D54B572F3C5B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_BC9CD27C4D51BFAFB00254B572F334B8" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_BC9CD27C4D51BFAFB00254B572F334B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_315C698DB158DF0412C654B572F3D146" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_315C698DB158DF0412C654B572F3D146" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_E7311B1092A0B59157C654B573BE3121" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_010C7BA8EE528A9C1A3F54B573BC9653" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_E7311B1092A0B59157C654B573BE3121" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_010C7BA8EE528A9C1A3F54B573BC9653" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_010C7BA8EE528A9C1A3F54B573BC9653" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_6F419679033CEF0DC53E54B573BEEDC5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:to="loc_us-gaap_EmployeeSeveranceMember_6F419679033CEF0DC53E54B573BEEDC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_44451552D5961426377F54B573BE82C9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:to="loc_us-gaap_FacilityClosingMember_44451552D5961426377F54B573BE82C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_E7311B1092A0B59157C654B573BE3121" xlink:to="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_0A43E9224AA4F10B739554B573BFEFC9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:to="loc_us-gaap_RestructuringReserve_0A43E9224AA4F10B739554B573BFEFC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_E59B59EAE07CA0A8C51754B573BF0369" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:to="loc_us-gaap_RestructuringCosts_E59B59EAE07CA0A8C51754B573BF0369" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_909254ABE38CE9F044D754B573C23CCF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:to="loc_us-gaap_PaymentsForRestructuring_909254ABE38CE9F044D754B573C23CCF" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:to="loc_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC" xlink:to="loc_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC" xlink:to="loc_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_DEE46D26AE1A661D779DE54904DF3E0E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:to="loc_us-gaap_RestructuringCosts_DEE46D26AE1A661D779DE54904DF3E0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_E936532B5239FB46B6D6E54904E0C8EF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:to="loc_us-gaap_SeveranceCosts1_E936532B5239FB46B6D6E54904E0C8EF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_FD21F4D57465CE7A260AE54904E099EF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:to="loc_cah_FacilityExitAndOtherCosts_FD21F4D57465CE7A260AE54904E099EF" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2F3AE1C0F35A2E7284C754B5738FB109" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_BA8F8A995E3107EB0BB854B5738B1A71" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2F3AE1C0F35A2E7284C754B5738FB109" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_BA8F8A995E3107EB0BB854B5738B1A71" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_BA8F8A995E3107EB0BB854B5738B1A71" xlink:to="loc_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6" xlink:to="loc_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6" xlink:to="loc_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_199F4D76491B1EBD53A854B5738C0EFC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:to="loc_us-gaap_OperatingSegmentsMember_199F4D76491B1EBD53A854B5738C0EFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_0FEEDB9E29B4C9EECC6554B5738D84FA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:to="loc_us-gaap_CorporateNonSegmentMember_0FEEDB9E29B4C9EECC6554B5738D84FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_02D1632F0EC41C31C64E54B5738D8B74" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_BA8F8A995E3107EB0BB854B5738B1A71" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_02D1632F0EC41C31C64E54B5738D8B74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8DF7FA24C9868575277954B5738E2AD4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_02D1632F0EC41C31C64E54B5738D8B74" xlink:to="loc_us-gaap_SegmentDomain_8DF7FA24C9868575277954B5738E2AD4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8DF7FA24C9868575277954B5738E2AD4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_02D1632F0EC41C31C64E54B5738D8B74" xlink:to="loc_us-gaap_SegmentDomain_8DF7FA24C9868575277954B5738E2AD4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_F6A60870A13D9D2C6D1454B5738EBCAC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8DF7FA24C9868575277954B5738E2AD4" xlink:to="loc_cah_PharmaceuticalMember_F6A60870A13D9D2C6D1454B5738EBCAC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_F0C17FD9FC9D7F3D9ECD54B5738EEB46" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8DF7FA24C9868575277954B5738E2AD4" xlink:to="loc_cah_MedicalMember_F0C17FD9FC9D7F3D9ECD54B5738EEB46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_1E9BE57AEA100886DD0D54B5738FAC7C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2F3AE1C0F35A2E7284C754B5738FB109" xlink:to="loc_us-gaap_Assets_1E9BE57AEA100886DD0D54B5738FAC7C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="cah-20200331.xsd#cah_GownRecallAxis" xlink:label="loc_cah_GownRecallAxis_86D171530DAA8D7D92FDFFE671604FF0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:to="loc_cah_GownRecallAxis_86D171530DAA8D7D92FDFFE671604FF0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_4D59EACF887DFFD8E553FFE67160BE3C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_GownRecallAxis_86D171530DAA8D7D92FDFFE671604FF0" xlink:to="loc_cah_GownRecallDomain_4D59EACF887DFFD8E553FFE67160BE3C_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_4D59EACF887DFFD8E553FFE67160BE3C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_GownRecallAxis_86D171530DAA8D7D92FDFFE671604FF0" xlink:to="loc_cah_GownRecallDomain_4D59EACF887DFFD8E553FFE67160BE3C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallMemberDomain" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_82F545B334D9414C6A1EFFE671617689" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_GownRecallAxis_86D171530DAA8D7D92FDFFE671604FF0" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_82F545B334D9414C6A1EFFE671617689" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallAxis" xlink:label="loc_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:to="loc_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallDomain" xlink:label="loc_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:to="loc_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallDomain" xlink:label="loc_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:to="loc_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallMemberDomain" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_43BCF31318CEDF97150FFFE67161A58B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_43BCF31318CEDF97150FFFE67161A58B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_48BD150E7BBE0D483692FFE67162CC71" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:to="loc_cah_OpioidLitigationAxis_48BD150E7BBE0D483692FFE67162CC71" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_5D453D224BACDF6228FCFFE671625E29_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cah_OpioidLitigationAxis_48BD150E7BBE0D483692FFE67162CC71" xlink:to="loc_cah_OpioidLitigationDomain_5D453D224BACDF6228FCFFE671625E29_default" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_5D453D224BACDF6228FCFFE671625E29" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cah_OpioidLitigationAxis_48BD150E7BBE0D483692FFE67162CC71" xlink:to="loc_cah_OpioidLitigationDomain_5D453D224BACDF6228FCFFE671625E29" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_5D35312F6606291A6099FFE67162C321" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_OpioidLitigationDomain_5D453D224BACDF6228FCFFE671625E29" xlink:to="loc_cah_TotalOpioidLitigationMember_5D35312F6606291A6099FFE67162C321" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC" xlink:to="loc_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_5D74690D9B0BCA1A5BA5FFE6727CA99D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_5D74690D9B0BCA1A5BA5FFE6727CA99D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRecallExpense" xlink:label="loc_us-gaap_InventoryRecallExpense_9F9B46AAB25E9D04C77DFFE671643860" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:to="loc_us-gaap_InventoryRecallExpense_9F9B46AAB25E9D04C77DFFE671643860" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:to="loc_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_D121979964B0ED5BDA3E54B572FF83EF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_D121979964B0ED5BDA3E54B572FF83EF" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:to="loc_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B" xlink:to="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B" xlink:to="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PharmaceuticalDistributionandSpecialtyMember" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_NuclearPrecisionHealthServicesMember" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicaldistributionandproductsMember" xlink:label="loc_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:to="loc_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CardinalHealthAtHomeMember" xlink:label="loc_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:to="loc_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_8D5DFA567CFAA6BEA5BA54B572FC9F3E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:to="loc_srt_ConsolidationItemsAxis_8D5DFA567CFAA6BEA5BA54B572FC9F3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_E8903B72DDF342852C3554B572FCE846_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_8D5DFA567CFAA6BEA5BA54B572FC9F3E" xlink:to="loc_srt_ConsolidationItemsDomain_E8903B72DDF342852C3554B572FCE846_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_E8903B72DDF342852C3554B572FCE846" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_8D5DFA567CFAA6BEA5BA54B572FC9F3E" xlink:to="loc_srt_ConsolidationItemsDomain_E8903B72DDF342852C3554B572FCE846" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_3B510D895AD21B702F1F54B572FD3F2B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_E8903B72DDF342852C3554B572FCE846" xlink:to="loc_us-gaap_OperatingSegmentsMember_3B510D895AD21B702F1F54B572FD3F2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4AFB280C2BDBEE85DBC454B572FDD44E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_E8903B72DDF342852C3554B572FCE846" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4AFB280C2BDBEE85DBC454B572FDD44E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_D1C0F14460D636B819CD54B572FD870A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_D1C0F14460D636B819CD54B572FD870A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_E8E8F1BBDA5A2470F22754B572FEBAC6_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_D1C0F14460D636B819CD54B572FD870A" xlink:to="loc_us-gaap_SegmentDomain_E8E8F1BBDA5A2470F22754B572FEBAC6_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_E8E8F1BBDA5A2470F22754B572FEBAC6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_D1C0F14460D636B819CD54B572FD870A" xlink:to="loc_us-gaap_SegmentDomain_E8E8F1BBDA5A2470F22754B572FEBAC6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_4FB7E28BF217E7669ADD54B572FE52F1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_E8E8F1BBDA5A2470F22754B572FEBAC6" xlink:to="loc_cah_PharmaceuticalMember_4FB7E28BF217E7669ADD54B572FE52F1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_E140E185A1750224F02954B572FF4CAB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_E8E8F1BBDA5A2470F22754B572FEBAC6" xlink:to="loc_cah_MedicalMember_E140E185A1750224F02954B572FF4CAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_A5C3853D1A1C2635448854B572FF1E10" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_D121979964B0ED5BDA3E54B572FF83EF" xlink:to="loc_us-gaap_Revenues_A5C3853D1A1C2635448854B572FF1E10" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:href="cah-20200331.xsd#cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems" xlink:label="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E" xlink:type="locator" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable" xlink:label="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E" xlink:to="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_5D8AC3BC449AA6E2C5F654B573CA7A8A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:to="loc_srt_ConsolidationItemsAxis_5D8AC3BC449AA6E2C5F654B573CA7A8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_D44B0226EB5695D34F1A54B573CA71B5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5D8AC3BC449AA6E2C5F654B573CA7A8A" xlink:to="loc_srt_ConsolidationItemsDomain_D44B0226EB5695D34F1A54B573CA71B5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_D44B0226EB5695D34F1A54B573CA71B5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5D8AC3BC449AA6E2C5F654B573CA7A8A" xlink:to="loc_srt_ConsolidationItemsDomain_D44B0226EB5695D34F1A54B573CA71B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_669D71B85888A42E5C4554B573CAEB20" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_D44B0226EB5695D34F1A54B573CA71B5" xlink:to="loc_us-gaap_OperatingSegmentsMember_669D71B85888A42E5C4554B573CAEB20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_18E324CAEB7D6454BD2154B573CB8638" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_D44B0226EB5695D34F1A54B573CA71B5" xlink:to="loc_us-gaap_CorporateNonSegmentMember_18E324CAEB7D6454BD2154B573CB8638" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_285B66E4F591B80A449E54B573CB2FA0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:to="loc_srt_StatementGeographicalAxis_285B66E4F591B80A449E54B573CB2FA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_F5F94D8705F09F8D60B354B573CB0681_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_285B66E4F591B80A449E54B573CB2FA0" xlink:to="loc_srt_SegmentGeographicalDomain_F5F94D8705F09F8D60B354B573CB0681_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_F5F94D8705F09F8D60B354B573CB0681" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_285B66E4F591B80A449E54B573CB2FA0" xlink:to="loc_srt_SegmentGeographicalDomain_F5F94D8705F09F8D60B354B573CB0681" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_country_US_AAB354A69C6256CB74C454B573CCE43D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_F5F94D8705F09F8D60B354B573CB0681" xlink:to="loc_country_US_AAB354A69C6256CB74C454B573CCE43D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_26B4A6CFBA6DF9853A3554B573CC89E6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_F5F94D8705F09F8D60B354B573CB0681" xlink:to="loc_us-gaap_NonUsMember_26B4A6CFBA6DF9853A3554B573CC89E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_7FDF5254F723F8B3BE1054B573CCC5CD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E" xlink:to="loc_us-gaap_Revenues_7FDF5254F723F8B3BE1054B573CCC5CD" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5A617C7D6366D6E148C454B5731BCCDB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5A617C7D6366D6E148C454B5731BCCDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_105A3EDEBECF482607CD54B5731B7764_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5A617C7D6366D6E148C454B5731BCCDB" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_105A3EDEBECF482607CD54B5731B7764_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_105A3EDEBECF482607CD54B5731B7764" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5A617C7D6366D6E148C454B5731BCCDB" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_105A3EDEBECF482607CD54B5731B7764" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_C49765D7076EE9A69EBE54B5731C5B37" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:to="loc_srt_ConsolidationItemsAxis_C49765D7076EE9A69EBE54B5731C5B37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_8E9ABDAA9839F7829B3754B5731C5E3D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_C49765D7076EE9A69EBE54B5731C5B37" xlink:to="loc_srt_ConsolidationItemsDomain_8E9ABDAA9839F7829B3754B5731C5E3D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_8E9ABDAA9839F7829B3754B5731C5E3D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_C49765D7076EE9A69EBE54B5731C5B37" xlink:to="loc_srt_ConsolidationItemsDomain_8E9ABDAA9839F7829B3754B5731C5E3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_41A0C3D208EDD8632BAB54B5731C9DD7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_8E9ABDAA9839F7829B3754B5731C5E3D" xlink:to="loc_us-gaap_OperatingSegmentsMember_41A0C3D208EDD8632BAB54B5731C9DD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_D5CC591FD9D32830B9E454B5731CA7F7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_8E9ABDAA9839F7829B3754B5731C5E3D" xlink:to="loc_us-gaap_CorporateNonSegmentMember_D5CC591FD9D32830B9E454B5731CA7F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_F80452500E1D7E2476E354B5731C104A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_F80452500E1D7E2476E354B5731C104A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_9D7D788291CB906D175E54B5731DF26B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_F80452500E1D7E2476E354B5731C104A" xlink:to="loc_us-gaap_SegmentDomain_9D7D788291CB906D175E54B5731DF26B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_9D7D788291CB906D175E54B5731DF26B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_F80452500E1D7E2476E354B5731C104A" xlink:to="loc_us-gaap_SegmentDomain_9D7D788291CB906D175E54B5731DF26B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_0E252F95F1B54A38D9E754B5731DBFA0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9D7D788291CB906D175E54B5731DF26B" xlink:to="loc_cah_PharmaceuticalMember_0E252F95F1B54A38D9E754B5731DBFA0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_8BF2850BC3DD3DDA905054B5731DE807" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9D7D788291CB906D175E54B5731DF26B" xlink:to="loc_cah_MedicalMember_8BF2850BC3DD3DDA905054B5731DE807" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_C2191181F373BD7F2F9954B5731D91DA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D" xlink:to="loc_us-gaap_OperatingIncomeLoss_C2191181F373BD7F2F9954B5731D91DA" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0FD42F0284AA24EFA1CF54B572341D97" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0FD42F0284AA24EFA1CF54B572341D97" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_4C7141C629126F6D90CD54B572351CFD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0FD42F0284AA24EFA1CF54B572341D97" xlink:to="loc_us-gaap_AwardTypeAxis_4C7141C629126F6D90CD54B572351CFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DF55E393E5B5162266E054B5723523DD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4C7141C629126F6D90CD54B572351CFD" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DF55E393E5B5162266E054B5723523DD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DF55E393E5B5162266E054B5723523DD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4C7141C629126F6D90CD54B572351CFD" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DF55E393E5B5162266E054B5723523DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_A155E3A35FB7E688834354B57236BB86" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DF55E393E5B5162266E054B5723523DD" xlink:to="loc_us-gaap_EmployeeStockOptionMember_A155E3A35FB7E688834354B57236BB86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2E68C935903C64DEC90254B5723636A7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DF55E393E5B5162266E054B5723523DD" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2E68C935903C64DEC90254B5723636A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_48B8B5E0C2B48C27982854B5723646FD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DF55E393E5B5162266E054B5723523DD" xlink:to="loc_us-gaap_PerformanceSharesMember_48B8B5E0C2B48C27982854B5723646FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_DB157F47705650D894F254B57236DCC8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0FD42F0284AA24EFA1CF54B572341D97" xlink:to="loc_srt_RangeAxis_DB157F47705650D894F254B57236DCC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_3764A05CA431B195D1C854B572374B85_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_DB157F47705650D894F254B57236DCC8" xlink:to="loc_srt_RangeMember_3764A05CA431B195D1C854B572374B85_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_3764A05CA431B195D1C854B572374B85" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_DB157F47705650D894F254B57236DCC8" xlink:to="loc_srt_RangeMember_3764A05CA431B195D1C854B572374B85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_79C57E6D1A933DE48D4F54B572370C90" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3764A05CA431B195D1C854B572374B85" xlink:to="loc_srt_MinimumMember_79C57E6D1A933DE48D4F54B572370C90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_CCC9EE75F4A34369941E54B5723704CD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3764A05CA431B195D1C854B572374B85" xlink:to="loc_srt_MaximumMember_CCC9EE75F4A34369941E54B5723704CD" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_VestingPeriodinyearsforShares" xlink:label="loc_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_054DA05A0FDCD448C6C054B5723896BB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_054DA05A0FDCD448C6C054B5723896BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_02EC143328DA47675B8554B57238E121" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_02EC143328DA47675B8554B57238E121" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1B58DF4E816EFC0F956054B572398D78" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1B58DF4E816EFC0F956054B572398D78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_EFB1CFDF211EA29AA24A54B572394068" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_EFB1CFDF211EA29AA24A54B572394068" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ExercisablePeriodOfPlansInYears" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1B7A0DE3E93FA891DB6154B5723AAC02" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1B7A0DE3E93FA891DB6154B5723AAC02" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BA8052E2CF04CE20BD2A54B573E95FF5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BA8052E2CF04CE20BD2A54B573E95FF5" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_BB7EDB546B106A73A80554B573E9C4CF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BA8052E2CF04CE20BD2A54B573E95FF5" xlink:to="loc_us-gaap_AwardTypeAxis_BB7EDB546B106A73A80554B573E9C4CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65879B2351871DFDE57854B573E93AD4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_BB7EDB546B106A73A80554B573E9C4CF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65879B2351871DFDE57854B573E93AD4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65879B2351871DFDE57854B573E93AD4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_BB7EDB546B106A73A80554B573E9C4CF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65879B2351871DFDE57854B573E93AD4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_58212119842F6E6A6EE354B573EA9754" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65879B2351871DFDE57854B573E93AD4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_58212119842F6E6A6EE354B573EA9754" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_93753D0E6E083CE9B72854B573EAF5CA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_93753D0E6E083CE9B72854B573EAF5CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0057E2485D617F3BE16454B573EA114E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0057E2485D617F3BE16454B573EA114E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60C5D3939408812594EB54B573EB2C0F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60C5D3939408812594EB54B573EB2C0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_472CED317DCE97C429B354B573EB4AE1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_472CED317DCE97C429B354B573EB4AE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_36C9C01D539AF720C75254B573EBC407" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_36C9C01D539AF720C75254B573EBC407" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_462B6E3D998D260B3FA854B5722019EE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_462B6E3D998D260B3FA854B5722019EE" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_54135A12AA3C4FF51A1654B5722000BA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_462B6E3D998D260B3FA854B5722019EE" xlink:to="loc_us-gaap_AwardTypeAxis_54135A12AA3C4FF51A1654B5722000BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F718DA7685EC3CC0BC1154B57220B591_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_54135A12AA3C4FF51A1654B5722000BA" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F718DA7685EC3CC0BC1154B57220B591_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F718DA7685EC3CC0BC1154B57220B591" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_54135A12AA3C4FF51A1654B5722000BA" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F718DA7685EC3CC0BC1154B57220B591" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_06A2F6A293A1851C7A4E54B57221A867" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F718DA7685EC3CC0BC1154B57220B591" xlink:to="loc_us-gaap_PerformanceSharesMember_06A2F6A293A1851C7A4E54B57221A867" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_C9D9A121D26898E6B40254B572228BF3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_C9D9A121D26898E6B40254B572228BF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7A68E48636BC1D38815A54B5722322AA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7A68E48636BC1D38815A54B5722322AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F3428041D22685DC69754B572236F6B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F3428041D22685DC69754B572236F6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_B494025A34EDB61E86E454B57224697B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_B494025A34EDB61E86E454B57224697B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D3325994D23BC206A6BC54B5722469A7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D3325994D23BC206A6BC54B5722469A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4704093ACDCBC1CB49BB54B5722594A4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4704093ACDCBC1CB49BB54B5722594A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_FCECC6B08AF38667BEE954B572261033" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_FCECC6B08AF38667BEE954B572261033" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_23C867DD3BBBBECCCD4F54B57226A895" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_23C867DD3BBBBECCCD4F54B57226A895" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_FB185533383BE84B3C5C54B5722652A7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_FB185533383BE84B3C5C54B5722652A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D6A98376C152C192E56254B57227B97C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D6A98376C152C192E56254B57227B97C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0447D92BF695E6CEC59B54B572284422" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0447D92BF695E6CEC59B54B572284422" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_B3E2A19C12533A899C1554B572283248" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_B3E2A19C12533A899C1554B572283248" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6671A968DDE312C2B91154B572ACD46E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7B268795E5365EEE4A6054B572AAB30E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6671A968DDE312C2B91154B572ACD46E" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7B268795E5365EEE4A6054B572AAB30E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_C2720E84975FF2716F5254B572AB01B9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7B268795E5365EEE4A6054B572AAB30E" xlink:to="loc_us-gaap_AwardTypeAxis_C2720E84975FF2716F5254B572AB01B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7F6B4DA2FF4E4244260254B572AB58FA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_C2720E84975FF2716F5254B572AB01B9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7F6B4DA2FF4E4244260254B572AB58FA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7F6B4DA2FF4E4244260254B572AB58FA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_C2720E84975FF2716F5254B572AB01B9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7F6B4DA2FF4E4244260254B572AB58FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_615031608A7F86D4ABEB54B572AB620B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7F6B4DA2FF4E4244260254B572AB58FA" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_615031608A7F86D4ABEB54B572AB620B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_398DF7A77C8B2B14EB6954B572AB6151" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7F6B4DA2FF4E4244260254B572AB58FA" xlink:to="loc_us-gaap_EmployeeStockOptionMember_398DF7A77C8B2B14EB6954B572AB6151" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_DD92188B8A6F62AEEE2E54B572ACA17B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6671A968DDE312C2B91154B572ACD46E" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_DD92188B8A6F62AEEE2E54B572ACA17B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_14F7EA1DA3901B3FE5C654B572AC8B5E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6671A968DDE312C2B91154B572ACD46E" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_14F7EA1DA3901B3FE5C654B572AC8B5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6671A968DDE312C2B91154B572ACD46E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5A0272CD08257C50E23754B572ADAF14" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5A0272CD08257C50E23754B572ADAF14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7E17B0078728FDBA1F0354B572ADDD99" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7E17B0078728FDBA1F0354B572ADDD99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_06E2CAF7A030E9A3BC8254B572AEAEAF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_06E2CAF7A030E9A3BC8254B572AEAEAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_B70DE556EFE57A33942854B572AE2FF1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_B70DE556EFE57A33942854B572AE2FF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6671A968DDE312C2B91154B572ACD46E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0B700A689F53464F356654B572AF7090" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0B700A689F53464F356654B572AF7090" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_27C2A133CC21AA51787F54B572AF5D37" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_27C2A133CC21AA51787F54B572AF5D37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3FD4503EFFB44C74FDE454B572AF3444" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3FD4503EFFB44C74FDE454B572AF3444" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2D67339673A9F0E01FB454B572AFF61D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2D67339673A9F0E01FB454B572AFF61D" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF" xlink:to="loc_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ADD284ADD83BD5B2B4A854B572910583" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ADD284ADD83BD5B2B4A854B572910583" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_072DAA107E78A25ADCD254B57292F1E7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:to="loc_us-gaap_EmployeeStockOptionMember_072DAA107E78A25ADCD254B57292F1E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_90CD2ABA7453EDE8E0CF54B572920B58" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:to="loc_us-gaap_PerformanceSharesMember_90CD2ABA7453EDE8E0CF54B572920B58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_973C13C0899F0850ADD954B57293647A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_973C13C0899F0850ADD954B57293647A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B" xlink:to="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B" xlink:to="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2815251BDBBDD36AC13A54B7CE242F65" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2815251BDBBDD36AC13A54B7CE242F65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_066C67D4399E2CCE092F54B7CE2530AC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_066C67D4399E2CCE092F54B7CE2530AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8C5C635E03234F16D7D654B7CE25976B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8C5C635E03234F16D7D654B7CE25976B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F114CAC7833A47AAC20D54B7CE2537A3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F114CAC7833A47AAC20D54B7CE2537A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EEDAB9457CFDAF44029454B7CE260F07" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EEDAB9457CFDAF44029454B7CE260F07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D88FFB71B158066FCAAB54B7CE263B03" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D88FFB71B158066FCAAB54B7CE263B03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_DDF007A8B79F35BE993154B7CE2B5EF8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_DDF007A8B79F35BE993154B7CE2B5EF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7CAC2F317B1FCD0A883D54B7CE2CF90A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7CAC2F317B1FCD0A883D54B7CE2CF90A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6109B93260FF17B1F6E654B574C7AEEA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6109B93260FF17B1F6E654B574C7AEEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_56FEBB3F462EFC49598A54B574C8F099_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6109B93260FF17B1F6E654B574C7AEEA" xlink:to="loc_us-gaap_EquityComponentDomain_56FEBB3F462EFC49598A54B574C8F099_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_56FEBB3F462EFC49598A54B574C8F099" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6109B93260FF17B1F6E654B574C7AEEA" xlink:to="loc_us-gaap_EquityComponentDomain_56FEBB3F462EFC49598A54B574C8F099" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_58301B1564AE68AEE22754B574C820CC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_56FEBB3F462EFC49598A54B574C8F099" xlink:to="loc_us-gaap_TreasuryStockMember_58301B1564AE68AEE22754B574C820CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_045D18BFB8DC2EB5C28354B574C92B98" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_045D18BFB8DC2EB5C28354B574C92B98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_D4CF059169F01009598454B574CA5332" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_D4CF059169F01009598454B574CA5332" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38655F808B7037A10D8754B574CA5EAE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38655F808B7037A10D8754B574CA5EAE" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TreasuryStockAcquiredShares" xlink:label="loc_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:to="loc_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cah-20200331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BA76E6A1CD71EF1E8B03F5E148CB3FCA_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BA76E6A1CD71EF1E8B03F5E148CB3FCA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BA76E6A1CD71EF1E8B03F5E148CB3FCA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BA76E6A1CD71EF1E8B03F5E148CB3FCA" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BA76E6A1CD71EF1E8B03F5E148CB3FCA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="lab_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:type="arc" />
    <link:label id="lab_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5_terseLabel_en-US" xlink:label="lab_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5_label_en-US" xlink:label="lab_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5_documentation_en-US" xlink:label="lab_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gown Recall [Axis]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_GownRecallAxis" xlink:label="loc_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:to="lab_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:type="arc" />
    <link:label id="lab_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081_terseLabel_en-US" xlink:label="lab_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081_label_en-US" xlink:label="lab_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081_documentation_en-US" xlink:label="lab_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Gown Recall [Axis]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081" xlink:to="lab_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081" xlink:type="arc" />
    <link:label id="lab_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD_terseLabel_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Member] [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD_label_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Member] [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD_documentation_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Member] [Domain]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallMemberDomain" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD" xlink:to="lab_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29" xlink:to="lab_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D" xlink:to="lab_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Litigation [Axis]</link:label>
    <link:label id="lab_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26_label_en-US" xlink:label="lab_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Litigation [Axis]</link:label>
    <link:label id="lab_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26_documentation_en-US" xlink:label="lab_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Litigation</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:to="lab_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Litigation [Domain]</link:label>
    <link:label id="lab_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B_label_en-US" xlink:label="lab_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Litigation [Domain]</link:label>
    <link:label id="lab_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B_documentation_en-US" xlink:label="lab_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Litigation [Domain]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:to="lab_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:type="arc" />
    <link:label id="lab_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7_terseLabel_en-US" xlink:label="lab_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation, net of tax [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7_label_en-US" xlink:label="lab_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation, net of tax [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7_documentation_en-US" xlink:label="lab_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation, net of tax</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7" xlink:to="lab_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7" xlink:type="arc" />
    <link:label id="lab_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2_terseLabel_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2_label_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation [Member]</link:label>
    <link:label id="lab_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2_documentation_en-US" xlink:label="lab_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Opioid Litigation</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2" xlink:to="lab_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2" xlink:type="arc" />
    <link:label id="lab_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1_terseLabel_en-US" xlink:label="lab_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:label id="lab_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1_label_en-US" xlink:label="lab_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:label id="lab_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1_documentation_en-US" xlink:label="lab_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Axis]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LawsuitTypeAxis" xlink:label="loc_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:to="lab_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:type="arc" />
    <link:label id="lab_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41_terseLabel_en-US" xlink:label="lab_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Domain]</link:label>
    <link:label id="lab_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41_label_en-US" xlink:label="lab_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lawsuit Type [Domain]</link:label>
    <link:label id="lab_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41_documentation_en-US" xlink:label="lab_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Lawsuit Type [Axis]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LawsuitTypeDomain" xlink:label="loc_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41" xlink:to="lab_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41" xlink:type="arc" />
    <link:label id="lab_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78_terseLabel_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78_label_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78_documentation_en-US" xlink:label="lab_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Action Lawsuits [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_ClassActionLawsuitsMember" xlink:label="loc_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78" xlink:to="lab_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78" xlink:type="arc" />
    <link:label id="lab_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3_terseLabel_en-US" xlink:label="lab_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:label id="lab_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3_label_en-US" xlink:label="lab_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:label id="lab_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3_documentation_en-US" xlink:label="lab_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Axis]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_PlaintiffTypeAxis" xlink:label="loc_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:to="lab_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:type="arc" />
    <link:label id="lab_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A_terseLabel_en-US" xlink:label="lab_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Domain]</link:label>
    <link:label id="lab_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A_label_en-US" xlink:label="lab_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plaintiff Type [Domain]</link:label>
    <link:label id="lab_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A_documentation_en-US" xlink:label="lab_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Plaintiff Type [Axis]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_PlaintiffTypeDomain" xlink:label="loc_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A" xlink:to="lab_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A" xlink:type="arc" />
    <link:label id="lab_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5_terseLabel_en-US" xlink:label="lab_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:label id="lab_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5_label_en-US" xlink:label="lab_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:label id="lab_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5_documentation_en-US" xlink:label="lab_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Private Parties [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_PrivatePartiesMember" xlink:label="loc_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5" xlink:to="lab_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5" xlink:type="arc" />
    <link:label id="lab_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A_terseLabel_en-US" xlink:label="lab_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Matters Agreement [Axis]</link:label>
    <link:label id="lab_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A_label_en-US" xlink:label="lab_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Matters Agreement [Axis]</link:label>
    <link:label id="lab_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A_documentation_en-US" xlink:label="lab_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Matters Agreement [Axis]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMattersAgreementAxis" xlink:label="loc_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:to="lab_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:type="arc" />
    <link:label id="lab_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2_terseLabel_en-US" xlink:label="lab_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Matters Agreement [Domain]</link:label>
    <link:label id="lab_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2_label_en-US" xlink:label="lab_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Matters Agreement [Domain]</link:label>
    <link:label id="lab_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2_documentation_en-US" xlink:label="lab_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Tax Matters Agreement [Axis]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:to="lab_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:type="arc" />
    <link:label id="lab_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA" xlink:to="lab_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA" xlink:type="arc" />
    <link:label id="lab_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:to="lab_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:type="arc" />
    <link:label id="lab_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1_terseLabel_en-US" xlink:label="lab_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:label id="lab_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1_label_en-US" xlink:label="lab_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:label id="lab_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1_documentation_en-US" xlink:label="lab_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Alameda County [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_AlamedaCountyMember" xlink:label="loc_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1" xlink:to="lab_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1" xlink:type="arc" />
    <link:label id="lab_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E_terseLabel_en-US" xlink:label="lab_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:label id="lab_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E_label_en-US" xlink:label="lab_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:label id="lab_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E_documentation_en-US" xlink:label="lab_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Jurisdictions [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_OtherJurisdictionsMember" xlink:label="loc_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E" xlink:to="lab_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E" xlink:type="arc" />
    <link:label id="lab_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9_terseLabel_en-US" xlink:label="lab_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9_label_en-US" xlink:label="lab_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9" xlink:to="lab_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9" xlink:type="arc" />
    <link:label id="lab_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2_terseLabel_en-US" xlink:label="lab_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2_label_en-US" xlink:label="lab_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:to="lab_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:type="arc" />
    <link:label id="lab_srt_MinimumMember_DD0155DDF9750AB20D57F5E148D7359C_terseLabel_en-US" xlink:label="lab_srt_MinimumMember_DD0155DDF9750AB20D57F5E148D7359C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_DD0155DDF9750AB20D57F5E148D7359C_label_en-US" xlink:label="lab_srt_MinimumMember_DD0155DDF9750AB20D57F5E148D7359C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_DD0155DDF9750AB20D57F5E148D7359C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_DD0155DDF9750AB20D57F5E148D7359C" xlink:to="lab_srt_MinimumMember_DD0155DDF9750AB20D57F5E148D7359C" xlink:type="arc" />
    <link:label id="lab_srt_MaximumMember_196F4318D19F3C206017F5E148D86ED0_terseLabel_en-US" xlink:label="lab_srt_MaximumMember_196F4318D19F3C206017F5E148D86ED0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_196F4318D19F3C206017F5E148D86ED0_label_en-US" xlink:label="lab_srt_MaximumMember_196F4318D19F3C206017F5E148D86ED0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_196F4318D19F3C206017F5E148D86ED0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_196F4318D19F3C206017F5E148D86ED0" xlink:to="lab_srt_MaximumMember_196F4318D19F3C206017F5E148D86ED0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:to="lab_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E_terseLabel_en-US" xlink:label="lab_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E_label_en-US" xlink:label="lab_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E_documentation_en-US" xlink:label="lab_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E" xlink:to="lab_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E" xlink:type="arc" />
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61_terseLabel_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Liability Lawsuits</link:label>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61_label_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:label id="lab_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61_documentation_en-US" xlink:label="lab_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Product Liability Lawsuits [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61" xlink:to="lab_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61" xlink:type="arc" />
    <link:label id="lab_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73_label_en-US" xlink:label="lab_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73" xlink:to="lab_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73" xlink:type="arc" />
    <link:label id="lab_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605" xlink:to="lab_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605" xlink:type="arc" />
    <link:label id="lab_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25_terseLabel_en-US" xlink:label="lab_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CVS Health</link:label>
    <link:label id="lab_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25_label_en-US" xlink:label="lab_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CVS Health [Member]</link:label>
    <link:label id="lab_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25_documentation_en-US" xlink:label="lab_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CVS Health [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25" xlink:to="lab_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25" xlink:type="arc" />
    <link:label id="lab_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D_label_en-US" xlink:label="lab_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D" xlink:to="lab_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D" xlink:type="arc" />
    <link:label id="lab_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case Type</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="lab_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12_terseLabel_en-US" xlink:label="lab_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits State [Domain]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12_label_en-US" xlink:label="lab_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits State [Domain]</link:label>
    <link:label id="lab_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12_documentation_en-US" xlink:label="lab_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Lawsuits State and Political Subdivisions [Domain]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLawsuitsStateDomain" xlink:label="loc_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12" xlink:to="lab_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Litigation, less Cuyahoga and Summit Counties [Member]</link:label>
    <link:label id="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013_label_en-US" xlink:label="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Litigation, less Cuyahoga and Summit Counties [Member]</link:label>
    <link:label id="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013_documentation_en-US" xlink:label="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Litigation, less Cuyahoga and Summit Counties</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013" xlink:to="lab_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013" xlink:type="arc" />
    <link:label id="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B_terseLabel_en-US" xlink:label="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Litigation, Cuyahoga and Summit Counties [Member]</link:label>
    <link:label id="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B_label_en-US" xlink:label="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Litigation, Cuyahoga and Summit Counties [Member]</link:label>
    <link:label id="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B_documentation_en-US" xlink:label="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Litigation, Cuyahoga and Summit Counties</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B" xlink:to="lab_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventMember_E4895499992AE68FB1D2F5E148E21EF8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_E4895499992AE68FB1D2F5E148E21EF8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_E4895499992AE68FB1D2F5E148E21EF8_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_E4895499992AE68FB1D2F5E148E21EF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_E4895499992AE68FB1D2F5E148E21EF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_E4895499992AE68FB1D2F5E148E21EF8" xlink:to="lab_us-gaap_SubsequentEventMember_E4895499992AE68FB1D2F5E148E21EF8" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="lab_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_BD4D4DC9A3076B9A1A55F5E148E37738_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_BD4D4DC9A3076B9A1A55F5E148E37738" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_BD4D4DC9A3076B9A1A55F5E148E37738_label_en-US" xlink:label="lab_us-gaap_InventoryNet_BD4D4DC9A3076B9A1A55F5E148E37738" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_BD4D4DC9A3076B9A1A55F5E148E37738" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_BD4D4DC9A3076B9A1A55F5E148E37738" xlink:to="lab_us-gaap_InventoryNet_BD4D4DC9A3076B9A1A55F5E148E37738" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermPurchaseCommitmentPeriod_0BF62F4B2ED5E9236254F5E148E3F336_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermPurchaseCommitmentPeriod_0BF62F4B2ED5E9236254F5E148E3F336" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment, Period</link:label>
    <link:label id="lab_us-gaap_LongtermPurchaseCommitmentPeriod_0BF62F4B2ED5E9236254F5E148E3F336_label_en-US" xlink:label="lab_us-gaap_LongtermPurchaseCommitmentPeriod_0BF62F4B2ED5E9236254F5E148E3F336" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Purchase Commitment, Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_0BF62F4B2ED5E9236254F5E148E3F336" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermPurchaseCommitmentPeriod_0BF62F4B2ED5E9236254F5E148E3F336" xlink:to="lab_us-gaap_LongtermPurchaseCommitmentPeriod_0BF62F4B2ED5E9236254F5E148E3F336" xlink:type="arc" />
    <link:label id="lab_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF_terseLabel_en-US" xlink:label="lab_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum quarterly payment</link:label>
    <link:label id="lab_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF_label_en-US" xlink:label="lab_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Quarterly Payment</link:label>
    <link:label id="lab_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF_documentation_en-US" xlink:label="lab_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved.</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_MaximumQuarterlyPayment" xlink:label="loc_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF" xlink:to="lab_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF" xlink:type="arc" />
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18_verboseLabel_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18_label_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:label id="lab_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18_documentation_en-US" xlink:label="lab_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Lawsuits, Number</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LossContingencyLawsuitsNumber" xlink:label="loc_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18" xlink:to="lab_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18" xlink:type="arc" />
    <link:label id="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4_terseLabel_en-US" xlink:label="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of State Attorneys General filing lawsuits</link:label>
    <link:label id="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4_label_en-US" xlink:label="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of State Attorneys General filing lawsuits</link:label>
    <link:label id="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4_documentation_en-US" xlink:label="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of State Attorneys General filing lawsuits</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:label="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4" xlink:to="lab_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4" xlink:type="arc" />
    <link:label id="lab_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F_terseLabel_en-US" xlink:label="lab_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Component For Settlement Framework, Term</link:label>
    <link:label id="lab_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F_label_en-US" xlink:label="lab_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Component For Settlement Framework, Term</link:label>
    <link:label id="lab_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F_documentation_en-US" xlink:label="lab_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Component For Settlement Framework, Term</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_CashComponentForSettlementFrameworkTerm" xlink:label="loc_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F" xlink:to="lab_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F" xlink:type="arc" />
    <link:label id="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F_terseLabel_en-US" xlink:label="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Opioid Total Settlement, Cuyahoga and Summit Counties</link:label>
    <link:label id="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F_label_en-US" xlink:label="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Opioid Total Settlement, Cuyahoga and Summit Counties</link:label>
    <link:label id="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F_documentation_en-US" xlink:label="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Opioid Total Settlement, Cuyahoga and Summit Counties</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidTotalSettlementCuyahogaandSummitCounties" xlink:label="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F" xlink:to="lab_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_1348E8E38F1257CC181AF5E14DF2BE1A_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement_1348E8E38F1257CC181AF5E14DF2BE1A" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_1348E8E38F1257CC181AF5E14DF2BE1A_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement_1348E8E38F1257CC181AF5E14DF2BE1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_1348E8E38F1257CC181AF5E14DF2BE1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement_1348E8E38F1257CC181AF5E14DF2BE1A" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement_1348E8E38F1257CC181AF5E14DF2BE1A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationReserve_A47C0010A960059DD977F5E148E57EEB_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve_A47C0010A960059DD977F5E148E57EEB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_A47C0010A960059DD977F5E148E57EEB_label_en-US" xlink:label="lab_us-gaap_LitigationReserve_A47C0010A960059DD977F5E148E57EEB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_A47C0010A960059DD977F5E148E57EEB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve_A47C0010A960059DD977F5E148E57EEB" xlink:to="lab_us-gaap_LitigationReserve_A47C0010A960059DD977F5E148E57EEB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_3BF47C00D1158D3E10D9F5E148E5F53C_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber_3BF47C00D1158D3E10D9F5E148E5F53C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_3BF47C00D1158D3E10D9F5E148E5F53C_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber_3BF47C00D1158D3E10D9F5E148E5F53C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_3BF47C00D1158D3E10D9F5E148E5F53C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber_3BF47C00D1158D3E10D9F5E148E5F53C" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber_3BF47C00D1158D3E10D9F5E148E5F53C" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_6F79A0C190292C805A9EF5E148E6F815_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs_6F79A0C190292C805A9EF5E148E6F815" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_6F79A0C190292C805A9EF5E148E6F815_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs_6F79A0C190292C805A9EF5E148E6F815" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_6F79A0C190292C805A9EF5E148E6F815" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs_6F79A0C190292C805A9EF5E148E6F815" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs_6F79A0C190292C805A9EF5E148E6F815" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_A5FFAFB0428159338092F5E148E6D442_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue_A5FFAFB0428159338092F5E148E6D442" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_A5FFAFB0428159338092F5E148E6D442_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue_A5FFAFB0428159338092F5E148E6D442" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_A5FFAFB0428159338092F5E148E6D442" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_A5FFAFB0428159338092F5E148E6D442" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue_A5FFAFB0428159338092F5E148E6D442" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryRecallExpense_AB0FA8FC50B77D6AC4E6F5E148E6AF5B_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense_AB0FA8FC50B77D6AC4E6F5E148E6AF5B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:label id="lab_us-gaap_InventoryRecallExpense_AB0FA8FC50B77D6AC4E6F5E148E6AF5B_label_en-US" xlink:label="lab_us-gaap_InventoryRecallExpense_AB0FA8FC50B77D6AC4E6F5E148E6AF5B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Recall Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRecallExpense" xlink:label="loc_us-gaap_InventoryRecallExpense_AB0FA8FC50B77D6AC4E6F5E148E6AF5B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRecallExpense_AB0FA8FC50B77D6AC4E6F5E148E6AF5B" xlink:to="lab_us-gaap_InventoryRecallExpense_AB0FA8FC50B77D6AC4E6F5E148E6AF5B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_93ADDF2C90EE69B6B2BFF5E148E72032_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_93ADDF2C90EE69B6B2BFF5E148E72032" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_93ADDF2C90EE69B6B2BFF5E148E72032_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_93ADDF2C90EE69B6B2BFF5E148E72032" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_93ADDF2C90EE69B6B2BFF5E148E72032" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_93ADDF2C90EE69B6B2BFF5E148E72032" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold_93ADDF2C90EE69B6B2BFF5E148E72032" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_822A32DFCB3DC6FF9721F5E148E7D3FF_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_822A32DFCB3DC6FF9721F5E148E7D3FF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_822A32DFCB3DC6FF9721F5E148E7D3FF_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_822A32DFCB3DC6FF9721F5E148E7D3FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_822A32DFCB3DC6FF9721F5E148E7D3FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_822A32DFCB3DC6FF9721F5E148E7D3FF" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense_822A32DFCB3DC6FF9721F5E148E7D3FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_B807203D2802DA0C4A91F5E148E7907E_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_B807203D2802DA0C4A91F5E148E7907E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_B807203D2802DA0C4A91F5E148E7907E_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_B807203D2802DA0C4A91F5E148E7907E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_B807203D2802DA0C4A91F5E148E7907E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_B807203D2802DA0C4A91F5E148E7907E" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent_B807203D2802DA0C4A91F5E148E7907E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_3A556EC99D495071C11E54B5720F1DAE_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_3A556EC99D495071C11E54B5720F1DAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3A556EC99D495071C11E54B5720F1DAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3A556EC99D495071C11E54B5720F1DAE" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_3A556EC99D495071C11E54B5720F1DAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_799817CC0289FFB8FC8654B5720FE01D_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_799817CC0289FFB8FC8654B5720FE01D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_799817CC0289FFB8FC8654B5720FE01D_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_799817CC0289FFB8FC8654B5720FE01D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_799817CC0289FFB8FC8654B5720FE01D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized_799817CC0289FFB8FC8654B5720FE01D" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized_799817CC0289FFB8FC8654B5720FE01D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_6ED8709DFD4D6021DBD354B57210B1B7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_6ED8709DFD4D6021DBD354B57210B1B7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_6ED8709DFD4D6021DBD354B57210B1B7_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_6ED8709DFD4D6021DBD354B57210B1B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6ED8709DFD4D6021DBD354B57210B1B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued_6ED8709DFD4D6021DBD354B57210B1B7" xlink:to="lab_us-gaap_PreferredStockSharesIssued_6ED8709DFD4D6021DBD354B57210B1B7" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_00C1DFB1F29E10E1F0B854B572107B0D_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_00C1DFB1F29E10E1F0B854B572107B0D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares, authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_00C1DFB1F29E10E1F0B854B572107B0D_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_00C1DFB1F29E10E1F0B854B572107B0D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_00C1DFB1F29E10E1F0B854B572107B0D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_00C1DFB1F29E10E1F0B854B572107B0D" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_00C1DFB1F29E10E1F0B854B572107B0D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_88BFB4A77F7A26B30B0254B57210E809_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_88BFB4A77F7A26B30B0254B57210E809" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares, issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_88BFB4A77F7A26B30B0254B57210E809_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_88BFB4A77F7A26B30B0254B57210E809" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_88BFB4A77F7A26B30B0254B57210E809" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_88BFB4A77F7A26B30B0254B57210E809" xlink:to="lab_us-gaap_CommonStockSharesIssued_88BFB4A77F7A26B30B0254B57210E809" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_9B23FDEA7393E18EBCCB54B57211C330_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_9B23FDEA7393E18EBCCB54B57211C330" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares in treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_9B23FDEA7393E18EBCCB54B57211C330_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_9B23FDEA7393E18EBCCB54B57211C330" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_9B23FDEA7393E18EBCCB54B57211C330" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_9B23FDEA7393E18EBCCB54B57211C330" xlink:to="lab_us-gaap_TreasuryStockShares_9B23FDEA7393E18EBCCB54B57211C330" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_4012E43AE6E029B1F1E854B57323E398_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract_4012E43AE6E029B1F1E854B57323E398" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_4012E43AE6E029B1F1E854B57323E398" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract_4012E43AE6E029B1F1E854B57323E398" xlink:to="lab_us-gaap_RestructuringChargesAbstract_4012E43AE6E029B1F1E854B57323E398" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeveranceCosts1_C6F7B385E0D8F295BDB554B5732435DD_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1_C6F7B385E0D8F295BDB554B5732435DD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee-related costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_C6F7B385E0D8F295BDB554B5732435DD_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1_C6F7B385E0D8F295BDB554B5732435DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_C6F7B385E0D8F295BDB554B5732435DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1_C6F7B385E0D8F295BDB554B5732435DD" xlink:to="lab_us-gaap_SeveranceCosts1_C6F7B385E0D8F295BDB554B5732435DD" xlink:type="arc" />
    <link:label id="lab_cah_FacilityExitAndOtherCosts_EE55AEC1E6A8D053169A54B57324F99E_terseLabel_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts_EE55AEC1E6A8D053169A54B57324F99E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_EE55AEC1E6A8D053169A54B57324F99E_label_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts_EE55AEC1E6A8D053169A54B57324F99E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_cah_FacilityExitAndOtherCosts_EE55AEC1E6A8D053169A54B57324F99E_documentation_en-US" xlink:label="lab_cah_FacilityExitAndOtherCosts_EE55AEC1E6A8D053169A54B57324F99E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_EE55AEC1E6A8D053169A54B57324F99E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FacilityExitAndOtherCosts_EE55AEC1E6A8D053169A54B57324F99E" xlink:to="lab_cah_FacilityExitAndOtherCosts_EE55AEC1E6A8D053169A54B57324F99E" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_4AF93B481539780DB8D154B57324EA22_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_4AF93B481539780DB8D154B57324EA22" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total restructuring and employee severance</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_4AF93B481539780DB8D154B57324EA22_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges_4AF93B481539780DB8D154B57324EA22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_4AF93B481539780DB8D154B57324EA22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_4AF93B481539780DB8D154B57324EA22" xlink:to="lab_us-gaap_RestructuringCharges_4AF93B481539780DB8D154B57324EA22" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_9634A6C22510659F115954B5742B80B6_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_9634A6C22510659F115954B5742B80B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9634A6C22510659F115954B5742B80B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9634A6C22510659F115954B5742B80B6" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_9634A6C22510659F115954B5742B80B6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DCDC19BC61D7A79CB84854B5742B40F1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DCDC19BC61D7A79CB84854B5742B40F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DCDC19BC61D7A79CB84854B5742B40F1_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DCDC19BC61D7A79CB84854B5742B40F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DCDC19BC61D7A79CB84854B5742B40F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DCDC19BC61D7A79CB84854B5742B40F1" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DCDC19BC61D7A79CB84854B5742B40F1" xlink:type="arc" />
    <link:label id="lab_cah_NarativeAbstract_3F7E6CC6F73167DF204BE54904D2504C_label_en-US" xlink:label="lab_cah_NarativeAbstract_3F7E6CC6F73167DF204BE54904D2504C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Narative [Abstract]</link:label>
    <link:label id="lab_cah_NarativeAbstract_3F7E6CC6F73167DF204BE54904D2504C_documentation_en-US" xlink:label="lab_cah_NarativeAbstract_3F7E6CC6F73167DF204BE54904D2504C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Narative [Abstract]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_NarativeAbstract" xlink:label="loc_cah_NarativeAbstract_3F7E6CC6F73167DF204BE54904D2504C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NarativeAbstract_3F7E6CC6F73167DF204BE54904D2504C" xlink:to="lab_cah_NarativeAbstract_3F7E6CC6F73167DF204BE54904D2504C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC" xlink:to="lab_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183" xlink:to="lab_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCosts_DEE46D26AE1A661D779DE54904DF3E0E_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts_DEE46D26AE1A661D779DE54904DF3E0E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_DEE46D26AE1A661D779DE54904DF3E0E_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts_DEE46D26AE1A661D779DE54904DF3E0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_DEE46D26AE1A661D779DE54904DF3E0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts_DEE46D26AE1A661D779DE54904DF3E0E" xlink:to="lab_us-gaap_RestructuringCosts_DEE46D26AE1A661D779DE54904DF3E0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingAbstract_AE2B78A5BB79BE534CD254B574BE0FE1_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract_AE2B78A5BB79BE534CD254B574BE0FE1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_AE2B78A5BB79BE534CD254B574BE0FE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_AE2B78A5BB79BE534CD254B574BE0FE1" xlink:to="lab_us-gaap_SegmentReportingAbstract_AE2B78A5BB79BE534CD254B574BE0FE1" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_240FC838588340E85E2E54B574BEB2AF_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_240FC838588340E85E2E54B574BEB2AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_240FC838588340E85E2E54B574BEB2AF_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_240FC838588340E85E2E54B574BEB2AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_240FC838588340E85E2E54B574BEB2AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_240FC838588340E85E2E54B574BEB2AF" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_240FC838588340E85E2E54B574BEB2AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_132D312FFF3E57E2BBBD54B574CD2E16_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_132D312FFF3E57E2BBBD54B574CD2E16" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_132D312FFF3E57E2BBBD54B574CD2E16" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_132D312FFF3E57E2BBBD54B574CD2E16" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_132D312FFF3E57E2BBBD54B574CD2E16" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9498E95F8CB1E59C04CC54B574CDA084_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9498E95F8CB1E59C04CC54B574CDA084" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9498E95F8CB1E59C04CC54B574CDA084_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9498E95F8CB1E59C04CC54B574CDA084" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9498E95F8CB1E59C04CC54B574CDA084" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9498E95F8CB1E59C04CC54B574CDA084" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9498E95F8CB1E59C04CC54B574CDA084" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityAbstract_185EA6F495254252DCEE54B7CE23131D_label_en-US" xlink:label="lab_us-gaap_EquityAbstract_185EA6F495254252DCEE54B7CE23131D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_185EA6F495254252DCEE54B7CE23131D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract_185EA6F495254252DCEE54B7CE23131D" xlink:to="lab_us-gaap_EquityAbstract_185EA6F495254252DCEE54B7CE23131D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Loss [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:to="lab_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2815251BDBBDD36AC13A54B7CE242F65_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2815251BDBBDD36AC13A54B7CE242F65" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2815251BDBBDD36AC13A54B7CE242F65_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2815251BDBBDD36AC13A54B7CE242F65" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2815251BDBBDD36AC13A54B7CE242F65" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2815251BDBBDD36AC13A54B7CE242F65" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2815251BDBBDD36AC13A54B7CE242F65" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_066C67D4399E2CCE092F54B7CE2530AC_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_066C67D4399E2CCE092F54B7CE2530AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Gain/(Loss) on Derivatives, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_066C67D4399E2CCE092F54B7CE2530AC_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_066C67D4399E2CCE092F54B7CE2530AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_066C67D4399E2CCE092F54B7CE2530AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_066C67D4399E2CCE092F54B7CE2530AC" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_066C67D4399E2CCE092F54B7CE2530AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8C5C635E03234F16D7D654B7CE25976B_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8C5C635E03234F16D7D654B7CE25976B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8C5C635E03234F16D7D654B7CE25976B_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8C5C635E03234F16D7D654B7CE25976B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8C5C635E03234F16D7D654B7CE25976B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8C5C635E03234F16D7D654B7CE25976B" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8C5C635E03234F16D7D654B7CE25976B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F114CAC7833A47AAC20D54B7CE2537A3_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F114CAC7833A47AAC20D54B7CE2537A3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F114CAC7833A47AAC20D54B7CE2537A3_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F114CAC7833A47AAC20D54B7CE2537A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F114CAC7833A47AAC20D54B7CE2537A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F114CAC7833A47AAC20D54B7CE2537A3" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F114CAC7833A47AAC20D54B7CE2537A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Loss [Rollforward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EEDAB9457CFDAF44029454B7CE260F07_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EEDAB9457CFDAF44029454B7CE260F07" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EEDAB9457CFDAF44029454B7CE260F07_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EEDAB9457CFDAF44029454B7CE260F07" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EEDAB9457CFDAF44029454B7CE260F07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EEDAB9457CFDAF44029454B7CE260F07" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EEDAB9457CFDAF44029454B7CE260F07" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D88FFB71B158066FCAAB54B7CE263B03_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D88FFB71B158066FCAAB54B7CE263B03" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive loss, before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D88FFB71B158066FCAAB54B7CE263B03_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D88FFB71B158066FCAAB54B7CE263B03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D88FFB71B158066FCAAB54B7CE263B03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D88FFB71B158066FCAAB54B7CE263B03" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D88FFB71B158066FCAAB54B7CE263B03" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_DDF007A8B79F35BE993154B7CE2B5EF8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_DDF007A8B79F35BE993154B7CE2B5EF8" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amounts reclassified to earnings</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_DDF007A8B79F35BE993154B7CE2B5EF8_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_DDF007A8B79F35BE993154B7CE2B5EF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_DDF007A8B79F35BE993154B7CE2B5EF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_DDF007A8B79F35BE993154B7CE2B5EF8" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_DDF007A8B79F35BE993154B7CE2B5EF8" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7CAC2F317B1FCD0A883D54B7CE2CF90A_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7CAC2F317B1FCD0A883D54B7CE2CF90A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other comprehensive income/(loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7CAC2F317B1FCD0A883D54B7CE2CF90A_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7CAC2F317B1FCD0A883D54B7CE2CF90A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7CAC2F317B1FCD0A883D54B7CE2CF90A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7CAC2F317B1FCD0A883D54B7CE2CF90A" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7CAC2F317B1FCD0A883D54B7CE2CF90A" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_D2C92B576076480C005A54B7CE2C0C51_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_D2C92B576076480C005A54B7CE2C0C51" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_D2C92B576076480C005A54B7CE2C0C51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_D2C92B576076480C005A54B7CE2C0C51" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_D2C92B576076480C005A54B7CE2C0C51" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeasesAbstract_CCA74F3ED8C3C9C2E443E54A8E63AED3_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract_CCA74F3ED8C3C9C2E443E54A8E63AED3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_CCA74F3ED8C3C9C2E443E54A8E63AED3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract_CCA74F3ED8C3C9C2E443E54A8E63AED3" xlink:to="lab_us-gaap_LeasesAbstract_CCA74F3ED8C3C9C2E443E54A8E63AED3" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30_label_en-US" xlink:label="lab_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30" xlink:to="lab_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD" xlink:to="lab_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD" xlink:type="arc" />
    <link:label id="lab_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B_terseLabel_en-US" xlink:label="lab_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASC 842</link:label>
    <link:label id="lab_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B_label_en-US" xlink:label="lab_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ASC 842 [Member]</link:label>
    <link:label id="lab_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B_documentation_en-US" xlink:label="lab_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ASC 842</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_ASC842Member" xlink:label="loc_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B" xlink:to="lab_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF_label_en-US" xlink:label="lab_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF" xlink:to="lab_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF" xlink:type="arc" />
    <link:label id="lab_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC_terseLabel_en-US" xlink:label="lab_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31)</link:label>
    <link:label id="lab_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC_label_en-US" xlink:label="lab_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">impact of adoption of new accounting standard</link:label>
    <link:label id="lab_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC_documentation_en-US" xlink:label="lab_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">impact of adoption of new accounting standard</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_Impactofadoptionofnewaccountingstandard" xlink:label="loc_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC" xlink:to="lab_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasePayments_112C8196F5AE25EC7937E54A8E6B954F_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments_112C8196F5AE25EC7937E54A8E6B954F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_112C8196F5AE25EC7937E54A8E6B954F_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments_112C8196F5AE25EC7937E54A8E6B954F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_112C8196F5AE25EC7937E54A8E6B954F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments_112C8196F5AE25EC7937E54A8E6B954F" xlink:to="lab_us-gaap_OperatingLeasePayments_112C8196F5AE25EC7937E54A8E6B954F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_874BE262747B11205060E54A8E6BBF42_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments_874BE262747B11205060E54A8E6BBF42" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_874BE262747B11205060E54A8E6BBF42_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments_874BE262747B11205060E54A8E6BBF42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_874BE262747B11205060E54A8E6BBF42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments_874BE262747B11205060E54A8E6BBF42" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments_874BE262747B11205060E54A8E6BBF42" xlink:type="arc" />
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_055D48742928B34DE06FE54A8E6BD77C_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_055D48742928B34DE06FE54A8E6BD77C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_055D48742928B34DE06FE54A8E6BD77C_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_055D48742928B34DE06FE54A8E6BD77C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_055D48742928B34DE06FE54A8E6BD77C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_055D48742928B34DE06FE54A8E6BD77C" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_055D48742928B34DE06FE54A8E6BD77C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1E549B6F897231CF24E8E54A8E6CC3A5_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1E549B6F897231CF24E8E54A8E6CC3A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1E549B6F897231CF24E8E54A8E6CC3A5_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1E549B6F897231CF24E8E54A8E6CC3A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1E549B6F897231CF24E8E54A8E6CC3A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1E549B6F897231CF24E8E54A8E6CC3A5" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1E549B6F897231CF24E8E54A8E6CC3A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3" xlink:to="lab_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7" xlink:to="lab_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_E562DE8544F3684957FEF0AC3C4EDD15_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_E562DE8544F3684957FEF0AC3C4EDD15" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_E562DE8544F3684957FEF0AC3C4EDD15_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_E562DE8544F3684957FEF0AC3C4EDD15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_E562DE8544F3684957FEF0AC3C4EDD15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_E562DE8544F3684957FEF0AC3C4EDD15" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_E562DE8544F3684957FEF0AC3C4EDD15" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_190DBAE9F7AB77A4DDFEF0AC3C4E24DC_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent_190DBAE9F7AB77A4DDFEF0AC3C4E24DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_190DBAE9F7AB77A4DDFEF0AC3C4E24DC_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent_190DBAE9F7AB77A4DDFEF0AC3C4E24DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_190DBAE9F7AB77A4DDFEF0AC3C4E24DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent_190DBAE9F7AB77A4DDFEF0AC3C4E24DC" xlink:to="lab_us-gaap_ReceivablesNetCurrent_190DBAE9F7AB77A4DDFEF0AC3C4E24DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_5B2A16771DB665F3721CF0AC3C4EF0E3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_5B2A16771DB665F3721CF0AC3C4EF0E3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_5B2A16771DB665F3721CF0AC3C4EF0E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_5B2A16771DB665F3721CF0AC3C4EF0E3" xlink:to="lab_us-gaap_InventoryNet_5B2A16771DB665F3721CF0AC3C4EF0E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsCurrent_B7F7F5C1AC8D750FA62DF0AC3C4F3965_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_B7F7F5C1AC8D750FA62DF0AC3C4F3965" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_B7F7F5C1AC8D750FA62DF0AC3C4F3965_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent_B7F7F5C1AC8D750FA62DF0AC3C4F3965" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_B7F7F5C1AC8D750FA62DF0AC3C4F3965" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent_B7F7F5C1AC8D750FA62DF0AC3C4F3965" xlink:to="lab_us-gaap_OtherAssetsCurrent_B7F7F5C1AC8D750FA62DF0AC3C4F3965" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_D2AFE21E4F7304876923F0AC3C4F5A00_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_D2AFE21E4F7304876923F0AC3C4F5A00" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_D2AFE21E4F7304876923F0AC3C4F5A00_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_D2AFE21E4F7304876923F0AC3C4F5A00" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_D2AFE21E4F7304876923F0AC3C4F5A00" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_D2AFE21E4F7304876923F0AC3C4F5A00" xlink:to="lab_us-gaap_AssetsCurrent_D2AFE21E4F7304876923F0AC3C4F5A00" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_E0AED599A56A2B6E3008F0AC3C4F134D_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_E0AED599A56A2B6E3008F0AC3C4F134D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_E0AED599A56A2B6E3008F0AC3C4F134D_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_E0AED599A56A2B6E3008F0AC3C4F134D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_E0AED599A56A2B6E3008F0AC3C4F134D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_E0AED599A56A2B6E3008F0AC3C4F134D" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_E0AED599A56A2B6E3008F0AC3C4F134D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_248801F3CBC697B5FB9EF0AC3C4FB1A9_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_248801F3CBC697B5FB9EF0AC3C4FB1A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and other intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_248801F3CBC697B5FB9EF0AC3C4FB1A9_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_248801F3CBC697B5FB9EF0AC3C4FB1A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_248801F3CBC697B5FB9EF0AC3C4FB1A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_248801F3CBC697B5FB9EF0AC3C4FB1A9" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_248801F3CBC697B5FB9EF0AC3C4FB1A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_801BBA32DDF4C79A6953F0AC3C4FF1B9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_801BBA32DDF4C79A6953F0AC3C4FF1B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_801BBA32DDF4C79A6953F0AC3C4FF1B9_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_801BBA32DDF4C79A6953F0AC3C4FF1B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_801BBA32DDF4C79A6953F0AC3C4FF1B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_801BBA32DDF4C79A6953F0AC3C4FF1B9" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_801BBA32DDF4C79A6953F0AC3C4FF1B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_A365456516D86BF6C37EF0AC3C4FDF51_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_A365456516D86BF6C37EF0AC3C4FDF51" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_A365456516D86BF6C37EF0AC3C4FDF51_label_en-US" xlink:label="lab_us-gaap_Assets_A365456516D86BF6C37EF0AC3C4FDF51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_A365456516D86BF6C37EF0AC3C4FDF51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_A365456516D86BF6C37EF0AC3C4FDF51" xlink:to="lab_us-gaap_Assets_A365456516D86BF6C37EF0AC3C4FDF51" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableCurrent_F132B2C3AD55FF3A3BDBF0AC3C500FBB_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_F132B2C3AD55FF3A3BDBF0AC3C500FBB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_F132B2C3AD55FF3A3BDBF0AC3C500FBB_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_F132B2C3AD55FF3A3BDBF0AC3C500FBB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_F132B2C3AD55FF3A3BDBF0AC3C500FBB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_F132B2C3AD55FF3A3BDBF0AC3C500FBB" xlink:to="lab_us-gaap_AccountsPayableCurrent_F132B2C3AD55FF3A3BDBF0AC3C500FBB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1FB699D4674954296AD3F0AC3C501579_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1FB699D4674954296AD3F0AC3C501579" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of long-term obligations and other short-term borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1FB699D4674954296AD3F0AC3C501579_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1FB699D4674954296AD3F0AC3C501579" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1FB699D4674954296AD3F0AC3C501579" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1FB699D4674954296AD3F0AC3C501579" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1FB699D4674954296AD3F0AC3C501579" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_04C2327FC7AF52C690B9F0AC3C518FFD_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_04C2327FC7AF52C690B9F0AC3C518FFD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_04C2327FC7AF52C690B9F0AC3C518FFD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_04C2327FC7AF52C690B9F0AC3C518FFD" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent_04C2327FC7AF52C690B9F0AC3C518FFD" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_6E03FEFEA7D4E00B80F5F0AC3C51A4D6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_6E03FEFEA7D4E00B80F5F0AC3C51A4D6" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_6E03FEFEA7D4E00B80F5F0AC3C51A4D6_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_6E03FEFEA7D4E00B80F5F0AC3C51A4D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_6E03FEFEA7D4E00B80F5F0AC3C51A4D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_6E03FEFEA7D4E00B80F5F0AC3C51A4D6" xlink:to="lab_us-gaap_LiabilitiesCurrent_6E03FEFEA7D4E00B80F5F0AC3C51A4D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_4B7FB5D343734E183499F0AC3C51A450_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_4B7FB5D343734E183499F0AC3C51A450" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term obligations, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_4B7FB5D343734E183499F0AC3C51A450_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_4B7FB5D343734E183499F0AC3C51A450" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4B7FB5D343734E183499F0AC3C51A450" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4B7FB5D343734E183499F0AC3C51A450" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_4B7FB5D343734E183499F0AC3C51A450" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_50D6AEEC8366BAC9B3FFF0AC3C51B4CF_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_50D6AEEC8366BAC9B3FFF0AC3C51B4CF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes and other liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_50D6AEEC8366BAC9B3FFF0AC3C51B4CF_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_50D6AEEC8366BAC9B3FFF0AC3C51B4CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax and Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_50D6AEEC8366BAC9B3FFF0AC3C51B4CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_50D6AEEC8366BAC9B3FFF0AC3C51B4CF" xlink:to="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_50D6AEEC8366BAC9B3FFF0AC3C51B4CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:to="lab_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_F91540A800ABA777EA4FF0AC3C5223D0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_F91540A800ABA777EA4FF0AC3C5223D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred shares, without par value:</link:label>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_F91540A800ABA777EA4FF0AC3C5223D0_label_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_F91540A800ABA777EA4FF0AC3C5223D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_F91540A800ABA777EA4FF0AC3C5223D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_F91540A800ABA777EA4FF0AC3C5223D0" xlink:to="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_F91540A800ABA777EA4FF0AC3C5223D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockValue_05D245FF940F2974AA91F0AC3C5285E1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue_05D245FF940F2974AA91F0AC3C5285E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized&#8212;500 thousand shares, Issued&#8212;none</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_05D245FF940F2974AA91F0AC3C5285E1_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue_05D245FF940F2974AA91F0AC3C5285E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_05D245FF940F2974AA91F0AC3C5285E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue_05D245FF940F2974AA91F0AC3C5285E1" xlink:to="lab_us-gaap_PreferredStockValue_05D245FF940F2974AA91F0AC3C5285E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_EEC1378000E299666013F0AC3C522232_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_EEC1378000E299666013F0AC3C522232" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares, without par value:</link:label>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_EEC1378000E299666013F0AC3C522232_label_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_EEC1378000E299666013F0AC3C522232" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_EEC1378000E299666013F0AC3C522232" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_EEC1378000E299666013F0AC3C522232" xlink:to="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_EEC1378000E299666013F0AC3C522232" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValue_98D2CB6C5CAB15B0E4BCF0AC3C52C344_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue_98D2CB6C5CAB15B0E4BCF0AC3C52C344" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized&#8212;755 million shares, Issued&#8212;327 million shares at March 31, 2020 and June 30, 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_98D2CB6C5CAB15B0E4BCF0AC3C52C344_label_en-US" xlink:label="lab_us-gaap_CommonStockValue_98D2CB6C5CAB15B0E4BCF0AC3C52C344" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_98D2CB6C5CAB15B0E4BCF0AC3C52C344" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_98D2CB6C5CAB15B0E4BCF0AC3C52C344" xlink:to="lab_us-gaap_CommonStockValue_98D2CB6C5CAB15B0E4BCF0AC3C52C344" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3F30731A8CA8E37AF625F0AC3C5331F5_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3F30731A8CA8E37AF625F0AC3C5331F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3F30731A8CA8E37AF625F0AC3C5331F5_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3F30731A8CA8E37AF625F0AC3C5331F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3F30731A8CA8E37AF625F0AC3C5331F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3F30731A8CA8E37AF625F0AC3C5331F5" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3F30731A8CA8E37AF625F0AC3C5331F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_37E3DC30F555F7FBD031F0AC3C537FB2_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_37E3DC30F555F7FBD031F0AC3C537FB2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Common shares in treasury, at cost: 35 million shares and 28 million shares at March 31, 2020 and June 30, 2019, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_37E3DC30F555F7FBD031F0AC3C537FB2_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_37E3DC30F555F7FBD031F0AC3C537FB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_37E3DC30F555F7FBD031F0AC3C537FB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_37E3DC30F555F7FBD031F0AC3C537FB2" xlink:to="lab_us-gaap_TreasuryStockValue_37E3DC30F555F7FBD031F0AC3C537FB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_F9FFBF785F029E495B80F0AC3C53611B_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_F9FFBF785F029E495B80F0AC3C53611B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_F9FFBF785F029E495B80F0AC3C53611B_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_F9FFBF785F029E495B80F0AC3C53611B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_F9FFBF785F029E495B80F0AC3C53611B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_F9FFBF785F029E495B80F0AC3C53611B" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_F9FFBF785F029E495B80F0AC3C53611B" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_CAC03BF78D654C79871FF0AC3C535DDC_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_CAC03BF78D654C79871FF0AC3C535DDC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Cardinal Health, Inc. shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_CAC03BF78D654C79871FF0AC3C535DDC_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity_CAC03BF78D654C79871FF0AC3C535DDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_CAC03BF78D654C79871FF0AC3C535DDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_CAC03BF78D654C79871FF0AC3C535DDC" xlink:to="lab_us-gaap_StockholdersEquity_CAC03BF78D654C79871FF0AC3C535DDC" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterest_F34B6D8E129A799F0092F0AC3C5379BC_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest_F34B6D8E129A799F0092F0AC3C5379BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_F34B6D8E129A799F0092F0AC3C5379BC_label_en-US" xlink:label="lab_us-gaap_MinorityInterest_F34B6D8E129A799F0092F0AC3C5379BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_F34B6D8E129A799F0092F0AC3C5379BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest_F34B6D8E129A799F0092F0AC3C5379BC" xlink:to="lab_us-gaap_MinorityInterest_F34B6D8E129A799F0092F0AC3C5379BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_A79E85744B6BA89B3610F0AC3C536BA2_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_A79E85744B6BA89B3610F0AC3C536BA2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_A79E85744B6BA89B3610F0AC3C536BA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_A79E85744B6BA89B3610F0AC3C536BA2" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_A79E85744B6BA89B3610F0AC3C536BA2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_A802DC3FBFACD7FEE474F0AC3C549B58_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_A802DC3FBFACD7FEE474F0AC3C549B58" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_A802DC3FBFACD7FEE474F0AC3C549B58_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_A802DC3FBFACD7FEE474F0AC3C549B58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_A802DC3FBFACD7FEE474F0AC3C549B58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_A802DC3FBFACD7FEE474F0AC3C549B58" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_A802DC3FBFACD7FEE474F0AC3C549B58" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:type="arc" />
    <link:label id="lab_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277_terseLabel_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277_label_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Axis]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277_documentation_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Axis] [Axis]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallAxis" xlink:label="loc_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:to="lab_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:type="arc" />
    <link:label id="lab_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D_terseLabel_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D_label_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sterile Surgical Gown Recall [Domain]</link:label>
    <link:label id="lab_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D_documentation_en-US" xlink:label="lab_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Sterile Surgical Gown Recall [Axis] [Axis]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallDomain" xlink:label="loc_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D" xlink:to="lab_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC" xlink:type="arc" />
    <link:label id="lab_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06_terseLabel_en-US" xlink:label="lab_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:label id="lab_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06_label_en-US" xlink:label="lab_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:label id="lab_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06_documentation_en-US" xlink:label="lab_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">naviHealth [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06" xlink:to="lab_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:type="arc" />
    <link:label id="lab_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595_terseLabel_en-US" xlink:label="lab_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-Tax Gain on Divestiture</link:label>
    <link:label id="lab_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595_label_en-US" xlink:label="lab_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Tax Gain on Divestiture</link:label>
    <link:label id="lab_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595_documentation_en-US" xlink:label="lab_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Tax Gain on Divestiture</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595" xlink:to="lab_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_259B721DA53B18F9406CFFE6716968BC_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_259B721DA53B18F9406CFFE6716968BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_259B721DA53B18F9406CFFE6716968BC_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_259B721DA53B18F9406CFFE6716968BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_259B721DA53B18F9406CFFE6716968BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments_259B721DA53B18F9406CFFE6716968BC" xlink:to="lab_us-gaap_NumberOfOperatingSegments_259B721DA53B18F9406CFFE6716968BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfReportableSegments_B50276A8E96752CFBB12FFE671690B4D_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_B50276A8E96752CFBB12FFE671690B4D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_B50276A8E96752CFBB12FFE671690B4D_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_B50276A8E96752CFBB12FFE671690B4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_B50276A8E96752CFBB12FFE671690B4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments_B50276A8E96752CFBB12FFE671690B4D" xlink:to="lab_us-gaap_NumberOfReportableSegments_B50276A8E96752CFBB12FFE671690B4D" xlink:type="arc" />
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_78902826542842099364FFE6716A6511_terseLabel_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_78902826542842099364FFE6716A6511" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Project costs on investment and other spending</link:label>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_78902826542842099364FFE6716A6511_label_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_78902826542842099364FFE6716A6511" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Project Costs On Investment And Other Spending</link:label>
    <link:label id="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_78902826542842099364FFE6716A6511_documentation_en-US" xlink:label="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_78902826542842099364FFE6716A6511" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_78902826542842099364FFE6716A6511" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_78902826542842099364FFE6716A6511" xlink:to="lab_cah_ProjectCostsOnInvestmentAndOtherSpending_78902826542842099364FFE6716A6511" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_DDAB2277A27B817FBFD7E5395EA542B1_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_DDAB2277A27B817FBFD7E5395EA542B1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_DDAB2277A27B817FBFD7E5395EA542B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_DDAB2277A27B817FBFD7E5395EA542B1" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_DDAB2277A27B817FBFD7E5395EA542B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="loc_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:to="lab_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:type="arc" />
    <link:label id="lab_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E_label_en-US" xlink:label="lab_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E" xlink:to="lab_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E" xlink:type="arc" />
    <link:label id="lab_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B_label_en-US" xlink:label="lab_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B" xlink:to="lab_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B" xlink:type="arc" />
    <link:label id="lab_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963_terseLabel_en-US" xlink:label="lab_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963_label_en-US" xlink:label="lab_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Navi Ownership Interest Divested [Member]</link:label>
    <link:label id="lab_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963_documentation_en-US" xlink:label="lab_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Navi Ownership Interest Divested [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_NaviOwnershipInterestDivestedMember" xlink:label="loc_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963" xlink:to="lab_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="lab_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_F921F7405EB8C5540632E5395EA81586_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_F921F7405EB8C5540632E5395EA81586" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_F921F7405EB8C5540632E5395EA81586_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_F921F7405EB8C5540632E5395EA81586" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_F921F7405EB8C5540632E5395EA81586" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_F921F7405EB8C5540632E5395EA81586" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_F921F7405EB8C5540632E5395EA81586" xlink:type="arc" />
    <link:label id="lab_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E_terseLabel_en-US" xlink:label="lab_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Partnership Indirect Ownership</link:label>
    <link:label id="lab_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E_label_en-US" xlink:label="lab_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Partnership Indirect Ownership</link:label>
    <link:label id="lab_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E_documentation_en-US" xlink:label="lab_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Partnership Indirect Ownership</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_PartnershipIndirectOwnership" xlink:label="loc_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E" xlink:to="lab_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_49F65EF5B083BFEBC581E5395EA9037D_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_49F65EF5B083BFEBC581E5395EA9037D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_49F65EF5B083BFEBC581E5395EA9037D_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_49F65EF5B083BFEBC581E5395EA9037D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_49F65EF5B083BFEBC581E5395EA9037D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_49F65EF5B083BFEBC581E5395EA9037D" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_49F65EF5B083BFEBC581E5395EA9037D" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_16372A0C61EFB0D5A5B6E5395EA9479F_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_16372A0C61EFB0D5A5B6E5395EA9479F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_16372A0C61EFB0D5A5B6E5395EA9479F_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_16372A0C61EFB0D5A5B6E5395EA9479F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_16372A0C61EFB0D5A5B6E5395EA9479F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_16372A0C61EFB0D5A5B6E5395EA9479F" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_16372A0C61EFB0D5A5B6E5395EA9479F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityMethodInvestments_7706631CEF96B984FCCFE5395EA9ACD3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments_7706631CEF96B984FCCFE5395EA9ACD3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_7706631CEF96B984FCCFE5395EA9ACD3_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments_7706631CEF96B984FCCFE5395EA9ACD3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_7706631CEF96B984FCCFE5395EA9ACD3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments_7706631CEF96B984FCCFE5395EA9ACD3" xlink:to="lab_us-gaap_EquityMethodInvestments_7706631CEF96B984FCCFE5395EA9ACD3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BE63940D77704F58B42354B5742EF3C1_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BE63940D77704F58B42354B5742EF3C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BE63940D77704F58B42354B5742EF3C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BE63940D77704F58B42354B5742EF3C1" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BE63940D77704F58B42354B5742EF3C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_891A6886E12F06396CD254B5742F82CB_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_891A6886E12F06396CD254B5742F82CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Total Share-based Compensation Expense by Type of Award</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_891A6886E12F06396CD254B5742F82CB_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_891A6886E12F06396CD254B5742F82CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_891A6886E12F06396CD254B5742F82CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_891A6886E12F06396CD254B5742F82CB" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_891A6886E12F06396CD254B5742F82CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B254308C2DB12D56C9D754B5742F12E9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B254308C2DB12D56C9D754B5742F12E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Transactions Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B254308C2DB12D56C9D754B5742F12E9_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B254308C2DB12D56C9D754B5742F12E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B254308C2DB12D56C9D754B5742F12E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B254308C2DB12D56C9D754B5742F12E9" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B254308C2DB12D56C9D754B5742F12E9" xlink:type="arc" />
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_C9F035C67ED3DD3D4D8354B5742FE521_terseLabel_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_C9F035C67ED3DD3D4D8354B5742FE521" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Additional Data Related to Stock Option Activity</link:label>
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_C9F035C67ED3DD3D4D8354B5742FE521_label_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_C9F035C67ED3DD3D4D8354B5742FE521" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Stock Option Plan Data [Table Text Block]</link:label>
    <link:label id="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_C9F035C67ED3DD3D4D8354B5742FE521_documentation_en-US" xlink:label="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_C9F035C67ED3DD3D4D8354B5742FE521" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">A disclosure of additional data related to all stock option activity</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:label="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_C9F035C67ED3DD3D4D8354B5742FE521" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_C9F035C67ED3DD3D4D8354B5742FE521" xlink:to="lab_cah_AdditionalStockOptionPlanDataTableTextBlock_C9F035C67ED3DD3D4D8354B5742FE521" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_AC43B8F7D226B444484C54B5742F95DD_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_AC43B8F7D226B444484C54B5742F95DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Transactions Related to Restricted Share Units Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_AC43B8F7D226B444484C54B5742F95DD_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_AC43B8F7D226B444484C54B5742F95DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_AC43B8F7D226B444484C54B5742F95DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_AC43B8F7D226B444484C54B5742F95DD" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_AC43B8F7D226B444484C54B5742F95DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_7085F3EA8C92B45F5D1E54B5742F6F9D_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_7085F3EA8C92B45F5D1E54B5742F6F9D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Transactions Related to Performance Share Units Under the Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_7085F3EA8C92B45F5D1E54B5742F6F9D_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_7085F3EA8C92B45F5D1E54B5742F6F9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_7085F3EA8C92B45F5D1E54B5742F6F9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_7085F3EA8C92B45F5D1E54B5742F6F9D" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_7085F3EA8C92B45F5D1E54B5742F6F9D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_F0A0817B09088F9ABBC654B5727F13FA_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_F0A0817B09088F9ABBC654B5727F13FA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_F0A0817B09088F9ABBC654B5727F13FA_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_F0A0817B09088F9ABBC654B5727F13FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_F0A0817B09088F9ABBC654B5727F13FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember_F0A0817B09088F9ABBC654B5727F13FA" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember_F0A0817B09088F9ABBC654B5727F13FA" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_585F678F62B295F5B9F054B572805196_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_585F678F62B295F5B9F054B572805196" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_585F678F62B295F5B9F054B572805196_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_585F678F62B295F5B9F054B572805196" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_585F678F62B295F5B9F054B572805196" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_585F678F62B295F5B9F054B572805196" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_585F678F62B295F5B9F054B572805196" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3296D7DDDDEA0E2CEF7654B57281C3B4_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_3296D7DDDDEA0E2CEF7654B57281C3B4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3296D7DDDDEA0E2CEF7654B57281C3B4_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_3296D7DDDDEA0E2CEF7654B57281C3B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3296D7DDDDEA0E2CEF7654B57281C3B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_3296D7DDDDEA0E2CEF7654B57281C3B4" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_3296D7DDDDEA0E2CEF7654B57281C3B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_E747AC5CAC182524ED0D54B57281C007_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_E747AC5CAC182524ED0D54B57281C007" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_E747AC5CAC182524ED0D54B57281C007_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_E747AC5CAC182524ED0D54B57281C007" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_E747AC5CAC182524ED0D54B57281C007" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_E747AC5CAC182524ED0D54B57281C007" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_E747AC5CAC182524ED0D54B57281C007" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_67F140D2D1EE3CAB220854B57283F7D8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_67F140D2D1EE3CAB220854B57283F7D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_67F140D2D1EE3CAB220854B57283F7D8_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_67F140D2D1EE3CAB220854B57283F7D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_67F140D2D1EE3CAB220854B57283F7D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_67F140D2D1EE3CAB220854B57283F7D8" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_67F140D2D1EE3CAB220854B57283F7D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_9A82C1F2C4976B44EFBF54B57283F6C5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_9A82C1F2C4976B44EFBF54B57283F6C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_9A82C1F2C4976B44EFBF54B57283F6C5_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_9A82C1F2C4976B44EFBF54B57283F6C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_9A82C1F2C4976B44EFBF54B57283F6C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure_9A82C1F2C4976B44EFBF54B57283F6C5" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure_9A82C1F2C4976B44EFBF54B57283F6C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_4B031AAAB9FD2B9ED87654B572831A0D_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_4B031AAAB9FD2B9ED87654B572831A0D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forward contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_4B031AAAB9FD2B9ED87654B572831A0D_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_4B031AAAB9FD2B9ED87654B572831A0D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_4B031AAAB9FD2B9ED87654B572831A0D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_4B031AAAB9FD2B9ED87654B572831A0D" xlink:to="lab_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_4B031AAAB9FD2B9ED87654B572831A0D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_11F265EB0FBFAEBE34B154B57296965C_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_11F265EB0FBFAEBE34B154B57296965C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_11F265EB0FBFAEBE34B154B57296965C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_11F265EB0FBFAEBE34B154B57296965C" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_11F265EB0FBFAEBE34B154B57296965C" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9131E61F3A3AB711824154B5729757E0_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9131E61F3A3AB711824154B5729757E0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9131E61F3A3AB711824154B5729757E0_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9131E61F3A3AB711824154B5729757E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9131E61F3A3AB711824154B5729757E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9131E61F3A3AB711824154B5729757E0" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9131E61F3A3AB711824154B5729757E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02B006E87C729154207854B57312079C_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02B006E87C729154207854B57312079C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02B006E87C729154207854B57312079C_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02B006E87C729154207854B57312079C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02B006E87C729154207854B57312079C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02B006E87C729154207854B57312079C" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02B006E87C729154207854B57312079C" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BC109AE447BDA349C99E54B572466213_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BC109AE447BDA349C99E54B572466213" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BC109AE447BDA349C99E54B572466213" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BC109AE447BDA349C99E54B572466213" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BC109AE447BDA349C99E54B572466213" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D" xlink:type="arc" />
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923_terseLabel_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IPR&amp;D, trademarks and other</link:label>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923_label_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IPR&amp;D,TrademarksandOther [Member]</link:label>
    <link:label id="lab_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923_documentation_en-US" xlink:label="lab_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Includes in process investigation of new knowledge useful in developing new product or service or new process or techniques or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for the improvements to existing product or process and rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_IPRDTrademarksandOtherMember" xlink:label="loc_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923" xlink:to="lab_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_341C13AB83AE4DE2EB9754B57248994F_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_341C13AB83AE4DE2EB9754B57248994F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Intangible</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_341C13AB83AE4DE2EB9754B57248994F_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_341C13AB83AE4DE2EB9754B57248994F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_341C13AB83AE4DE2EB9754B57248994F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_341C13AB83AE4DE2EB9754B57248994F" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_341C13AB83AE4DE2EB9754B57248994F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_6935F7EDA742F276EEF954B5724AFDBF_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_6935F7EDA742F276EEF954B5724AFDBF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_6935F7EDA742F276EEF954B5724AFDBF_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_6935F7EDA742F276EEF954B5724AFDBF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6935F7EDA742F276EEF954B5724AFDBF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_6935F7EDA742F276EEF954B5724AFDBF" xlink:to="lab_us-gaap_CustomerRelationshipsMember_6935F7EDA742F276EEF954B5724AFDBF" xlink:type="arc" />
    <link:label id="lab_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D_terseLabel_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks, trade names and patents</link:label>
    <link:label id="lab_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D_label_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks And Patents Member</link:label>
    <link:label id="lab_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D_documentation_en-US" xlink:label="lab_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TrademarksAndPatentsMember" xlink:label="loc_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D" xlink:to="lab_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_157FADE0780FC02F1A7454B5724B2D0D_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_157FADE0780FC02F1A7454B5724B2D0D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Developed technology and other</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_157FADE0780FC02F1A7454B5724B2D0D_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_157FADE0780FC02F1A7454B5724B2D0D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_157FADE0780FC02F1A7454B5724B2D0D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember_157FADE0780FC02F1A7454B5724B2D0D" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember_157FADE0780FC02F1A7454B5724B2D0D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5FAF8F17962A69E0189C54B5724C5F61_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5FAF8F17962A69E0189C54B5724C5F61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Intangible</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5FAF8F17962A69E0189C54B5724C5F61_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5FAF8F17962A69E0189C54B5724C5F61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5FAF8F17962A69E0189C54B5724C5F61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5FAF8F17962A69E0189C54B5724C5F61" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5FAF8F17962A69E0189C54B5724C5F61" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6F052AF0DDF7B2B2883C54B5724E32FF_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6F052AF0DDF7B2B2883C54B5724E32FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6F052AF0DDF7B2B2883C54B5724E32FF_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6F052AF0DDF7B2B2883C54B5724E32FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6F052AF0DDF7B2B2883C54B5724E32FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6F052AF0DDF7B2B2883C54B5724E32FF" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6F052AF0DDF7B2B2883C54B5724E32FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_4B46954CB61C7BECD73554B5724F160D_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_4B46954CB61C7BECD73554B5724F160D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Intangible</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_4B46954CB61C7BECD73554B5724F160D_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_4B46954CB61C7BECD73554B5724F160D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4B46954CB61C7BECD73554B5724F160D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4B46954CB61C7BECD73554B5724F160D" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_4B46954CB61C7BECD73554B5724F160D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_877DFACB3A755A1A397C54B5724FAB85_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_877DFACB3A755A1A397C54B5724FAB85" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_877DFACB3A755A1A397C54B5724FAB85_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_877DFACB3A755A1A397C54B5724FAB85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_877DFACB3A755A1A397C54B5724FAB85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_877DFACB3A755A1A397C54B5724FAB85" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_877DFACB3A755A1A397C54B5724FAB85" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7AC511E9E6E439FF746354B572502B7F_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7AC511E9E6E439FF746354B572502B7F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Intangible, Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7AC511E9E6E439FF746354B572502B7F_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7AC511E9E6E439FF746354B572502B7F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7AC511E9E6E439FF746354B572502B7F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7AC511E9E6E439FF746354B572502B7F" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7AC511E9E6E439FF746354B572502B7F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6419374624E47BCF85E154B57250B0F1_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6419374624E47BCF85E154B57250B0F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Intangible, Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6419374624E47BCF85E154B57250B0F1_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6419374624E47BCF85E154B57250B0F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6419374624E47BCF85E154B57250B0F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6419374624E47BCF85E154B57250B0F1" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6419374624E47BCF85E154B57250B0F1" xlink:type="arc" />
    <link:label id="lab_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_716A8B8EEE12896F9C0AF431BDF24B38_label_en-US" xlink:label="lab_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_716A8B8EEE12896F9C0AF431BDF24B38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Obligations and Other Short-Term Borrowings [Abstract]</link:label>
    <link:label id="lab_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_716A8B8EEE12896F9C0AF431BDF24B38_documentation_en-US" xlink:label="lab_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_716A8B8EEE12896F9C0AF431BDF24B38" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long-Term Obligations and Other Short-Term Borrowings [Abstract]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LongTermObligationsandOtherShortTermBorrowingsAbstract" xlink:label="loc_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_716A8B8EEE12896F9C0AF431BDF24B38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_716A8B8EEE12896F9C0AF431BDF24B38" xlink:to="lab_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_716A8B8EEE12896F9C0AF431BDF24B38" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:to="lab_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7" xlink:to="lab_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:type="arc" />
    <link:label id="lab_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D_terseLabel_en-US" xlink:label="lab_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2.4% Notes due 2020 [Member]</link:label>
    <link:label id="lab_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D_label_en-US" xlink:label="lab_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2.4% Notes due 2020 [Member]</link:label>
    <link:label id="lab_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D_documentation_en-US" xlink:label="lab_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2.4% Notes due 2020</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A2.4Notesdue2020Member" xlink:label="loc_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D" xlink:to="lab_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D" xlink:type="arc" />
    <link:label id="lab_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845_terseLabel_en-US" xlink:label="lab_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2.616% Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845_label_en-US" xlink:label="lab_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2.616% Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845_documentation_en-US" xlink:label="lab_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2.616% Notes due 2022</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A2.616Notesdue2022Member" xlink:label="loc_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845" xlink:to="lab_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845" xlink:type="arc" />
    <link:label id="lab_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D_terseLabel_en-US" xlink:label="lab_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.41% Notes due 2027 [Member]</link:label>
    <link:label id="lab_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D_label_en-US" xlink:label="lab_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.41% Notes due 2027 [Member]</link:label>
    <link:label id="lab_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D_documentation_en-US" xlink:label="lab_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.41% Notes due 2027</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.41Notesdue2027Member" xlink:label="loc_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D" xlink:to="lab_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D" xlink:type="arc" />
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57_terseLabel_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Committed Receivables Sales Facility Program [Member]</link:label>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57_label_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Committed Receivables Sales Facility Program [Member]</link:label>
    <link:label id="lab_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57_documentation_en-US" xlink:label="lab_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Committed receivables sales facility program that exists largely to provide liquidity by selling interests in trade receivables.</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57" xlink:to="lab_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57" xlink:type="arc" />
    <link:label id="lab_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42_terseLabel_en-US" xlink:label="lab_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.6% Notes due 2043 [Member]</link:label>
    <link:label id="lab_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42_label_en-US" xlink:label="lab_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.6% Notes due 2043 [Member]</link:label>
    <link:label id="lab_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42_documentation_en-US" xlink:label="lab_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.6% Notes due 2043</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.6Notesdue2043Member" xlink:label="loc_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42" xlink:to="lab_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42" xlink:type="arc" />
    <link:label id="lab_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC_terseLabel_en-US" xlink:label="lab_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.9% Notes due 2045 [Member]</link:label>
    <link:label id="lab_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC_label_en-US" xlink:label="lab_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.9% Notes due 2045 [Member]</link:label>
    <link:label id="lab_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC_documentation_en-US" xlink:label="lab_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.9% Notes due 2045</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.9Notesdue2045Member" xlink:label="loc_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC" xlink:to="lab_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC" xlink:type="arc" />
    <link:label id="lab_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498_terseLabel_en-US" xlink:label="lab_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.368% Notes due 2047 [Member]</link:label>
    <link:label id="lab_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498_label_en-US" xlink:label="lab_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.368% Notes due 2047 [Member]</link:label>
    <link:label id="lab_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498_documentation_en-US" xlink:label="lab_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.368% Notes due 2047</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.368Notesdue2047Member" xlink:label="loc_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498" xlink:to="lab_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498" xlink:type="arc" />
    <link:label id="lab_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9_terseLabel_en-US" xlink:label="lab_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.2% Notes due 2023 [Member]</link:label>
    <link:label id="lab_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9_label_en-US" xlink:label="lab_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.2% Notes due 2023 [Member]</link:label>
    <link:label id="lab_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9_documentation_en-US" xlink:label="lab_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.2% Notes due 2023</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.2Notesdue2023Member" xlink:label="loc_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9" xlink:to="lab_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9" xlink:type="arc" />
    <link:label id="lab_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F_terseLabel_en-US" xlink:label="lab_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Floating Rate Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F_label_en-US" xlink:label="lab_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Floating Rate Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F_documentation_en-US" xlink:label="lab_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Floating Rate Notes due 2022</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_FloatingRateNotesdue2022Member" xlink:label="loc_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F" xlink:to="lab_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D" xlink:to="lab_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:to="lab_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommercialPaperMember_102C09CDDA82463BB622F431BDF6398C_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember_102C09CDDA82463BB622F431BDF6398C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_102C09CDDA82463BB622F431BDF6398C_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember_102C09CDDA82463BB622F431BDF6398C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_102C09CDDA82463BB622F431BDF6398C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember_102C09CDDA82463BB622F431BDF6398C" xlink:to="lab_us-gaap_CommercialPaperMember_102C09CDDA82463BB622F431BDF6398C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_C17C591F641ED29844C7F431BDF6A5A1_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_C17C591F641ED29844C7F431BDF6A5A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_C17C591F641ED29844C7F431BDF6A5A1_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_C17C591F641ED29844C7F431BDF6A5A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_C17C591F641ED29844C7F431BDF6A5A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_C17C591F641ED29844C7F431BDF6A5A1" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember_C17C591F641ED29844C7F431BDF6A5A1" xlink:type="arc" />
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F_terseLabel_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short Term Credit Facilities Member</link:label>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F_label_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short Term Credit Facilities Member</link:label>
    <link:label id="lab_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F_documentation_en-US" xlink:label="lab_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other short-term credit facilities and an unsecured line of credit</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F" xlink:to="lab_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:to="lab_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:type="arc" />
    <link:label id="lab_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC_terseLabel_en-US" xlink:label="lab_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Long-Term and Short-Term Obligations</link:label>
    <link:label id="lab_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC_label_en-US" xlink:label="lab_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Long-Term and Short-Term Obligations</link:label>
    <link:label id="lab_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC_documentation_en-US" xlink:label="lab_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Long-Term and Short-Term Obligations</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLongTermandShortTermObligations" xlink:label="loc_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC" xlink:to="lab_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_42E1866A0C4889BE85A2F431BDF8CFAD_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_42E1866A0C4889BE85A2F431BDF8CFAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_42E1866A0C4889BE85A2F431BDF8CFAD_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_42E1866A0C4889BE85A2F431BDF8CFAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_42E1866A0C4889BE85A2F431BDF8CFAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_42E1866A0C4889BE85A2F431BDF8CFAD" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_42E1866A0C4889BE85A2F431BDF8CFAD" xlink:type="arc" />
    <link:label id="lab_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333_terseLabel_en-US" xlink:label="lab_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable Repurchased</link:label>
    <link:label id="lab_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333_label_en-US" xlink:label="lab_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable Repurchased</link:label>
    <link:label id="lab_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333_documentation_en-US" xlink:label="lab_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Principal Amount of Notes Payable Repurchased during the year</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_NotesPayableRepurchased" xlink:label="loc_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333" xlink:to="lab_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_C76C2D52C6090AE00C66F431BDF8899B_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable_C76C2D52C6090AE00C66F431BDF8899B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_C76C2D52C6090AE00C66F431BDF8899B_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable_C76C2D52C6090AE00C66F431BDF8899B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_C76C2D52C6090AE00C66F431BDF8899B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable_C76C2D52C6090AE00C66F431BDF8899B" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable_C76C2D52C6090AE00C66F431BDF8899B" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_A3AAABE8255DB2D0731BF431BDF85E23_verboseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_A3AAABE8255DB2D0731BF431BDF85E23" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_A3AAABE8255DB2D0731BF431BDF85E23_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_A3AAABE8255DB2D0731BF431BDF85E23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_A3AAABE8255DB2D0731BF431BDF85E23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_A3AAABE8255DB2D0731BF431BDF85E23" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_A3AAABE8255DB2D0731BF431BDF85E23" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_198D3A31E29D27495BA354B5746581D6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_198D3A31E29D27495BA354B5746581D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_198D3A31E29D27495BA354B5746581D6_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_198D3A31E29D27495BA354B5746581D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_198D3A31E29D27495BA354B5746581D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_198D3A31E29D27495BA354B5746581D6" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_198D3A31E29D27495BA354B5746581D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57_label_en-US" xlink:label="lab_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:to="lab_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_417004C8512B0D0195B154B572D0DB33_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_417004C8512B0D0195B154B572D0DB33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_417004C8512B0D0195B154B572D0DB33_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_417004C8512B0D0195B154B572D0DB33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_417004C8512B0D0195B154B572D0DB33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_417004C8512B0D0195B154B572D0DB33" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_417004C8512B0D0195B154B572D0DB33" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_BE8470325B1AB40EECE854B572D1F121_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_BE8470325B1AB40EECE854B572D1F121" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_BE8470325B1AB40EECE854B572D1F121" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_BE8470325B1AB40EECE854B572D1F121" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_BE8470325B1AB40EECE854B572D1F121" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287" xlink:to="lab_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:to="lab_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_CDFC0EC3A9D3FC90839A54B572D26666_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_CDFC0EC3A9D3FC90839A54B572D26666" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_CDFC0EC3A9D3FC90839A54B572D26666_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_CDFC0EC3A9D3FC90839A54B572D26666" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_CDFC0EC3A9D3FC90839A54B572D26666" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember_CDFC0EC3A9D3FC90839A54B572D26666" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember_CDFC0EC3A9D3FC90839A54B572D26666" xlink:type="arc" />
    <link:label id="lab_us-gaap_NondesignatedMember_B11680B8DDDBD5A30FAE54B572D2D070_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember_B11680B8DDDBD5A30FAE54B572D2D070" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_B11680B8DDDBD5A30FAE54B572D2D070_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember_B11680B8DDDBD5A30FAE54B572D2D070" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_B11680B8DDDBD5A30FAE54B572D2D070" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember_B11680B8DDDBD5A30FAE54B572D2D070" xlink:to="lab_us-gaap_NondesignatedMember_B11680B8DDDBD5A30FAE54B572D2D070" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91" xlink:to="lab_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueHedgingMember_7163664D6DBCAB61954154B572D3EAF0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember_7163664D6DBCAB61954154B572D3EAF0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_7163664D6DBCAB61954154B572D3EAF0_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember_7163664D6DBCAB61954154B572D3EAF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_7163664D6DBCAB61954154B572D3EAF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember_7163664D6DBCAB61954154B572D3EAF0" xlink:to="lab_us-gaap_FairValueHedgingMember_7163664D6DBCAB61954154B572D3EAF0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:to="lab_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashFlowHedgingMember_EA581F2D3BFD4305108F54B572D405D2_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember_EA581F2D3BFD4305108F54B572D405D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_EA581F2D3BFD4305108F54B572D405D2_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember_EA581F2D3BFD4305108F54B572D405D2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_EA581F2D3BFD4305108F54B572D405D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember_EA581F2D3BFD4305108F54B572D405D2" xlink:to="lab_us-gaap_CashFlowHedgingMember_EA581F2D3BFD4305108F54B572D405D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestRateSwapMember_A80E9BFADD1292FBB3E454B572D5F3CC_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember_A80E9BFADD1292FBB3E454B572D5F3CC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_A80E9BFADD1292FBB3E454B572D5F3CC_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember_A80E9BFADD1292FBB3E454B572D5F3CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_A80E9BFADD1292FBB3E454B572D5F3CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember_A80E9BFADD1292FBB3E454B572D5F3CC" xlink:to="lab_us-gaap_InterestRateSwapMember_A80E9BFADD1292FBB3E454B572D5F3CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrencySwapMember_62305F5E250636FF8E3754B572D51C6B_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember_62305F5E250636FF8E3754B572D51C6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_62305F5E250636FF8E3754B572D51C6B_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember_62305F5E250636FF8E3754B572D51C6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_62305F5E250636FF8E3754B572D51C6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember_62305F5E250636FF8E3754B572D51C6B" xlink:to="lab_us-gaap_CurrencySwapMember_62305F5E250636FF8E3754B572D51C6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_49A6C1DB2DC3D742A82054B572D562CB_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember_49A6C1DB2DC3D742A82054B572D562CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_49A6C1DB2DC3D742A82054B572D562CB_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember_49A6C1DB2DC3D742A82054B572D562CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_49A6C1DB2DC3D742A82054B572D562CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember_49A6C1DB2DC3D742A82054B572D562CB" xlink:to="lab_us-gaap_ForeignExchangeContractMember_49A6C1DB2DC3D742A82054B572D562CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:to="lab_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_F23358CAB151FE4468C354B572D620D6_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_F23358CAB151FE4468C354B572D620D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_F23358CAB151FE4468C354B572D620D6_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_F23358CAB151FE4468C354B572D620D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_F23358CAB151FE4468C354B572D620D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_F23358CAB151FE4468C354B572D620D6" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_F23358CAB151FE4468C354B572D620D6" xlink:type="arc" />
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D_terseLabel_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</link:label>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D_label_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</link:label>
    <link:label id="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D_documentation_en-US" xlink:label="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D" xlink:to="lab_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_EDDEA57C150646C4701154B572D61EF9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_EDDEA57C150646C4701154B572D61EF9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_EDDEA57C150646C4701154B572D61EF9_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_EDDEA57C150646C4701154B572D61EF9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_EDDEA57C150646C4701154B572D61EF9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_EDDEA57C150646C4701154B572D61EF9" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_EDDEA57C150646C4701154B572D61EF9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_027FCAB760445BDA4A4654B572D6E201_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount_027FCAB760445BDA4A4654B572D6E201" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_027FCAB760445BDA4A4654B572D6E201_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount_027FCAB760445BDA4A4654B572D6E201" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_027FCAB760445BDA4A4654B572D6E201" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount_027FCAB760445BDA4A4654B572D6E201" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount_027FCAB760445BDA4A4654B572D6E201" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_DA340920142EF32733C654B57437F958_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_DA340920142EF32733C654B57437F958" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_DA340920142EF32733C654B57437F958_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_DA340920142EF32733C654B57437F958" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_DA340920142EF32733C654B57437F958" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_DA340920142EF32733C654B57437F958" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_DA340920142EF32733C654B57437F958" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_FAAE087FBD03E659681054B573D1CB04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_FAAE087FBD03E659681054B573D1CB04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_FAAE087FBD03E659681054B573D1CB04_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_FAAE087FBD03E659681054B573D1CB04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_FAAE087FBD03E659681054B573D1CB04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_FAAE087FBD03E659681054B573D1CB04" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_FAAE087FBD03E659681054B573D1CB04" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_BABA3C256D192E597E1954B573D165FF_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_BABA3C256D192E597E1954B573D165FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_BABA3C256D192E597E1954B573D165FF_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_BABA3C256D192E597E1954B573D165FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_BABA3C256D192E597E1954B573D165FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_BABA3C256D192E597E1954B573D165FF" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_BABA3C256D192E597E1954B573D165FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_AB6D6F96E6BADB4BCBB754B574AFDFA9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_AB6D6F96E6BADB4BCBB754B574AFDFA9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_AB6D6F96E6BADB4BCBB754B574AFDFA9_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_AB6D6F96E6BADB4BCBB754B574AFDFA9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_AB6D6F96E6BADB4BCBB754B574AFDFA9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_AB6D6F96E6BADB4BCBB754B574AFDFA9" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_AB6D6F96E6BADB4BCBB754B574AFDFA9" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_7B1C1071141F7CB1121F54B574AFCF8C_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_7B1C1071141F7CB1121F54B574AFCF8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_7B1C1071141F7CB1121F54B574AFCF8C_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_7B1C1071141F7CB1121F54B574AFCF8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_7B1C1071141F7CB1121F54B574AFCF8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_7B1C1071141F7CB1121F54B574AFCF8C" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_7B1C1071141F7CB1121F54B574AFCF8C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6A25D45750B214223F1F54B574AF0B43_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6A25D45750B214223F1F54B574AF0B43" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Profit by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6A25D45750B214223F1F54B574AF0B43_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6A25D45750B214223F1F54B574AF0B43" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6A25D45750B214223F1F54B574AF0B43" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6A25D45750B214223F1F54B574AF0B43" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6A25D45750B214223F1F54B574AF0B43" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_90D5AC20E95589A8588C54B574AFCBB2_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_90D5AC20E95589A8588C54B574AFCBB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_90D5AC20E95589A8588C54B574AFCBB2_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_90D5AC20E95589A8588C54B574AFCBB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_90D5AC20E95589A8588C54B574AFCBB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_90D5AC20E95589A8588C54B574AFCBB2" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_90D5AC20E95589A8588C54B574AFCBB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_EC69A0A5BBA2A85F6A5A54B574328A9A_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_EC69A0A5BBA2A85F6A5A54B574328A9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_EC69A0A5BBA2A85F6A5A54B574328A9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_EC69A0A5BBA2A85F6A5A54B574328A9A" xlink:to="lab_us-gaap_EarningsPerShareAbstract_EC69A0A5BBA2A85F6A5A54B574328A9A" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5E35FBC3B9E15B0083E254B574321F64_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5E35FBC3B9E15B0083E254B574321F64" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5E35FBC3B9E15B0083E254B574321F64_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5E35FBC3B9E15B0083E254B574321F64" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5E35FBC3B9E15B0083E254B574321F64" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5E35FBC3B9E15B0083E254B574321F64" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5E35FBC3B9E15B0083E254B574321F64" xlink:type="arc" />
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_4C401A8A33693551E94554B57432E78D_terseLabel_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_4C401A8A33693551E94554B57432E78D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_4C401A8A33693551E94554B57432E78D_label_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_4C401A8A33693551E94554B57432E78D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:label id="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_4C401A8A33693551E94554B57432E78D_documentation_en-US" xlink:label="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_4C401A8A33693551E94554B57432E78D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">shares that would be antidilutive as a result of net loss</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:label="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_4C401A8A33693551E94554B57432E78D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_4C401A8A33693551E94554B57432E78D" xlink:to="lab_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_4C401A8A33693551E94554B57432E78D" xlink:type="arc" />
    <link:label id="lab_cah_LeasesTextBlock_2F3D5DAC78548145F8C754B5722C6318_terseLabel_en-US" xlink:label="lab_cah_LeasesTextBlock_2F3D5DAC78548145F8C754B5722C6318" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_cah_LeasesTextBlock_2F3D5DAC78548145F8C754B5722C6318_label_en-US" xlink:label="lab_cah_LeasesTextBlock_2F3D5DAC78548145F8C754B5722C6318" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Text Block]</link:label>
    <link:label id="lab_cah_LeasesTextBlock_2F3D5DAC78548145F8C754B5722C6318_documentation_en-US" xlink:label="lab_cah_LeasesTextBlock_2F3D5DAC78548145F8C754B5722C6318" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leases [Text Block]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LeasesTextBlock" xlink:label="loc_cah_LeasesTextBlock_2F3D5DAC78548145F8C754B5722C6318" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasesTextBlock_2F3D5DAC78548145F8C754B5722C6318" xlink:to="lab_cah_LeasesTextBlock_2F3D5DAC78548145F8C754B5722C6318" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_B8035502C39C8B32EF8254B574468AD0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_B8035502C39C8B32EF8254B574468AD0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_B8035502C39C8B32EF8254B574468AD0_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_B8035502C39C8B32EF8254B574468AD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_B8035502C39C8B32EF8254B574468AD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_B8035502C39C8B32EF8254B574468AD0" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_B8035502C39C8B32EF8254B574468AD0" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_FF8101CFA94940A682D554B573217150_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_FF8101CFA94940A682D554B573217150" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share Attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_FF8101CFA94940A682D554B573217150_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_FF8101CFA94940A682D554B573217150" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_FF8101CFA94940A682D554B573217150" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_FF8101CFA94940A682D554B573217150" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_FF8101CFA94940A682D554B573217150" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating and Reportable Segment</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF_label_en-US" xlink:label="lab_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:to="lab_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:type="arc" />
    <link:label id="lab_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pharmaceutical</link:label>
    <link:label id="lab_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4_label_en-US" xlink:label="lab_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmaceutical Member</link:label>
    <link:label id="lab_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4_documentation_en-US" xlink:label="lab_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharmaceutical [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4" xlink:to="lab_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4" xlink:type="arc" />
    <link:label id="lab_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B_terseLabel_en-US" xlink:label="lab_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B_label_en-US" xlink:label="lab_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Member</link:label>
    <link:label id="lab_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B_documentation_en-US" xlink:label="lab_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B" xlink:to="lab_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B" xlink:type="arc" />
    <link:label id="lab_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0_terseLabel_en-US" xlink:label="lab_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical Reporting Unit [Member]</link:label>
    <link:label id="lab_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0_label_en-US" xlink:label="lab_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Reporting Unit [Member]</link:label>
    <link:label id="lab_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0_documentation_en-US" xlink:label="lab_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical Reporting Unit [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalReportingUnitMember" xlink:label="loc_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0" xlink:to="lab_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:to="lab_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:type="arc" />
    <link:label id="lab_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9_terseLabel_en-US" xlink:label="lab_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9_label_en-US" xlink:label="lab_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9_documentation_en-US" xlink:label="lab_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying Value of Reporting Unit</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_CarryingValue" xlink:label="loc_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9" xlink:to="lab_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_F2588BCF283992674D37F0AC3BB78969_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_F2588BCF283992674D37F0AC3BB78969" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_F2588BCF283992674D37F0AC3BB78969_label_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_F2588BCF283992674D37F0AC3BB78969" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_F2588BCF283992674D37F0AC3BB78969" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_F2588BCF283992674D37F0AC3BB78969" xlink:to="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_F2588BCF283992674D37F0AC3BB78969" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:to="lab_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_13BA183C7983F364309BF0AC3BB73B28_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill_13BA183C7983F364309BF0AC3BB73B28" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_13BA183C7983F364309BF0AC3BB73B28_label_en-US" xlink:label="lab_us-gaap_Goodwill_13BA183C7983F364309BF0AC3BB73B28" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_13BA183C7983F364309BF0AC3BB73B28" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_13BA183C7983F364309BF0AC3BB73B28" xlink:to="lab_us-gaap_Goodwill_13BA183C7983F364309BF0AC3BB73B28" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillTransfers_6FFD764F5AECF55AD9CAF0AC3BB8434B_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers_6FFD764F5AECF55AD9CAF0AC3BB8434B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_6FFD764F5AECF55AD9CAF0AC3BB8434B_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers_6FFD764F5AECF55AD9CAF0AC3BB8434B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers" xlink:label="loc_us-gaap_GoodwillTransfers_6FFD764F5AECF55AD9CAF0AC3BB8434B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers_6FFD764F5AECF55AD9CAF0AC3BB8434B" xlink:to="lab_us-gaap_GoodwillTransfers_6FFD764F5AECF55AD9CAF0AC3BB8434B" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2E6D3078EE7A025B6970F0AC3BB81219_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2E6D3078EE7A025B6970F0AC3BB81219" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2E6D3078EE7A025B6970F0AC3BB81219_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2E6D3078EE7A025B6970F0AC3BB81219" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2E6D3078EE7A025B6970F0AC3BB81219" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2E6D3078EE7A025B6970F0AC3BB81219" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2E6D3078EE7A025B6970F0AC3BB81219" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_C09182A99B662F1ACE43F0AC3BB8CD08_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill_C09182A99B662F1ACE43F0AC3BB8CD08" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_C09182A99B662F1ACE43F0AC3BB8CD08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_C09182A99B662F1ACE43F0AC3BB8CD08" xlink:to="lab_us-gaap_Goodwill_C09182A99B662F1ACE43F0AC3BB8CD08" xlink:type="arc" />
    <link:label id="lab_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F_terseLabel_en-US" xlink:label="lab_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount Rate, fair value inputs</link:label>
    <link:label id="lab_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F_label_en-US" xlink:label="lab_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discount Rate, fair value inputs</link:label>
    <link:label id="lab_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F_documentation_en-US" xlink:label="lab_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discount Rate, fair value inputs</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_DiscountRatefairvalueinputs" xlink:label="loc_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F" xlink:to="lab_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F" xlink:type="arc" />
    <link:label id="lab_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D_terseLabel_en-US" xlink:label="lab_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Terminal Growth Rate, fair value inputs</link:label>
    <link:label id="lab_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D_label_en-US" xlink:label="lab_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Terminal Growth Rate, fair value inputs</link:label>
    <link:label id="lab_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D_documentation_en-US" xlink:label="lab_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Terminal Growth Rate, fair value inputs</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TerminalGrowthRatefairvalueinputs" xlink:label="loc_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D" xlink:to="lab_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_C18656C5D0114EAEBA0D54B572EE0502_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract_C18656C5D0114EAEBA0D54B572EE0502" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_C18656C5D0114EAEBA0D54B572EE0502" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_C18656C5D0114EAEBA0D54B572EE0502" xlink:to="lab_us-gaap_DebtDisclosureAbstract_C18656C5D0114EAEBA0D54B572EE0502" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665" xlink:to="lab_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1" xlink:to="lab_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1" xlink:type="arc" />
    <link:label id="lab_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61_terseLabel_en-US" xlink:label="lab_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.625% Notes due 2021 [Member]</link:label>
    <link:label id="lab_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61_label_en-US" xlink:label="lab_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.625% Notes due 2021 [Member]</link:label>
    <link:label id="lab_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61_documentation_en-US" xlink:label="lab_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.625% Notes due 2021</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.625Notesdue2021Member" xlink:label="loc_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61" xlink:to="lab_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61" xlink:type="arc" />
    <link:label id="lab_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139_terseLabel_en-US" xlink:label="lab_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.2% Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139_label_en-US" xlink:label="lab_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.2% Notes due 2022 [Member]</link:label>
    <link:label id="lab_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139_documentation_en-US" xlink:label="lab_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.2% Notes due 2022</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.2Notesdue2022Member" xlink:label="loc_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139" xlink:to="lab_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139" xlink:type="arc" />
    <link:label id="lab_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230_terseLabel_en-US" xlink:label="lab_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.079% Notes due 2024 [Member]</link:label>
    <link:label id="lab_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230_label_en-US" xlink:label="lab_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.079% Notes due 2024 [Member]</link:label>
    <link:label id="lab_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230_documentation_en-US" xlink:label="lab_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.079% Notes due 2024</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.079Notesdue2024Member" xlink:label="loc_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230" xlink:to="lab_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230" xlink:type="arc" />
    <link:label id="lab_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B_terseLabel_en-US" xlink:label="lab_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.5% Notes due 2025 [Member]</link:label>
    <link:label id="lab_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B_label_en-US" xlink:label="lab_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.5% Notes due 2025 [Member]</link:label>
    <link:label id="lab_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B_documentation_en-US" xlink:label="lab_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.5% Notes due 2025</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.5Notesdue2025Member" xlink:label="loc_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B" xlink:to="lab_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B" xlink:type="arc" />
    <link:label id="lab_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109_terseLabel_en-US" xlink:label="lab_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">3.75% Notes due 2026 [Member]</link:label>
    <link:label id="lab_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109_label_en-US" xlink:label="lab_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.75% Notes due 2026 [Member]</link:label>
    <link:label id="lab_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109_documentation_en-US" xlink:label="lab_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">3.75% Notes due 2026</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.75Notesdue2026Member" xlink:label="loc_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109" xlink:to="lab_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109" xlink:type="arc" />
    <link:label id="lab_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3_terseLabel_en-US" xlink:label="lab_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">4.5% Notes due 2044 [Member]</link:label>
    <link:label id="lab_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3_label_en-US" xlink:label="lab_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.5% Notes due 2044 [Member]</link:label>
    <link:label id="lab_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3_documentation_en-US" xlink:label="lab_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">4.5% Notes due 2044</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.5Notesdue2044Member" xlink:label="loc_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3" xlink:to="lab_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3" xlink:type="arc" />
    <link:label id="lab_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D_terseLabel_en-US" xlink:label="lab_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">7.0% Debentures due fiscal 2027 [Member]</link:label>
    <link:label id="lab_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D_label_en-US" xlink:label="lab_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">7.0% Debentures due fiscal 2027 [Member]</link:label>
    <link:label id="lab_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D_documentation_en-US" xlink:label="lab_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">7.0% Debentures due fiscal 2027</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_A7.0Debenturesduefiscal2027Member" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D" xlink:to="lab_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D" xlink:type="arc" />
    <link:label id="lab_us-gaap_NotesPayable_C7ECB9634C734C695E2754B572F39640_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayable_C7ECB9634C734C695E2754B572F39640" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayable_C7ECB9634C734C695E2754B572F39640_label_en-US" xlink:label="lab_us-gaap_NotesPayable_C7ECB9634C734C695E2754B572F39640" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_C7ECB9634C734C695E2754B572F39640" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayable_C7ECB9634C734C695E2754B572F39640" xlink:to="lab_us-gaap_NotesPayable_C7ECB9634C734C695E2754B572F39640" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherBorrowings_4417D77D0723449A240354B572F36BF6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherBorrowings_4417D77D0723449A240354B572F36BF6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Borrowings</link:label>
    <link:label id="lab_us-gaap_OtherBorrowings_4417D77D0723449A240354B572F36BF6_label_en-US" xlink:label="lab_us-gaap_OtherBorrowings_4417D77D0723449A240354B572F36BF6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Borrowings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaap_OtherBorrowings_4417D77D0723449A240354B572F36BF6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherBorrowings_4417D77D0723449A240354B572F36BF6" xlink:to="lab_us-gaap_OtherBorrowings_4417D77D0723449A240354B572F36BF6" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_BC9CD27C4D51BFAFB00254B572F334B8_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_BC9CD27C4D51BFAFB00254B572F334B8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_BC9CD27C4D51BFAFB00254B572F334B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_BC9CD27C4D51BFAFB00254B572F334B8" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_BC9CD27C4D51BFAFB00254B572F334B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_315C698DB158DF0412C654B572F3D146_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_315C698DB158DF0412C654B572F3D146" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_315C698DB158DF0412C654B572F3D146" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_315C698DB158DF0412C654B572F3D146" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_315C698DB158DF0412C654B572F3D146" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135" xlink:to="lab_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_ADD284ADD83BD5B2B4A854B572910583_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_ADD284ADD83BD5B2B4A854B572910583" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted Share Unit</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_ADD284ADD83BD5B2B4A854B572910583_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_ADD284ADD83BD5B2B4A854B572910583" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ADD284ADD83BD5B2B4A854B572910583" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_ADD284ADD83BD5B2B4A854B572910583" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_ADD284ADD83BD5B2B4A854B572910583" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_072DAA107E78A25ADCD254B57292F1E7_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_072DAA107E78A25ADCD254B57292F1E7" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_072DAA107E78A25ADCD254B57292F1E7_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_072DAA107E78A25ADCD254B57292F1E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_072DAA107E78A25ADCD254B57292F1E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_072DAA107E78A25ADCD254B57292F1E7" xlink:to="lab_us-gaap_EmployeeStockOptionMember_072DAA107E78A25ADCD254B57292F1E7" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_90CD2ABA7453EDE8E0CF54B572920B58_verboseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_90CD2ABA7453EDE8E0CF54B572920B58" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Unit</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_90CD2ABA7453EDE8E0CF54B572920B58_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_90CD2ABA7453EDE8E0CF54B572920B58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_90CD2ABA7453EDE8E0CF54B572920B58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_90CD2ABA7453EDE8E0CF54B572920B58" xlink:to="lab_us-gaap_PerformanceSharesMember_90CD2ABA7453EDE8E0CF54B572920B58" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_973C13C0899F0850ADD954B57293647A_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_973C13C0899F0850ADD954B57293647A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total share-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_973C13C0899F0850ADD954B57293647A_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_973C13C0899F0850ADD954B57293647A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_973C13C0899F0850ADD954B57293647A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_973C13C0899F0850ADD954B57293647A" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_973C13C0899F0850ADD954B57293647A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_F89E7644125DBF26919554B5744F00F0_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_F89E7644125DBF26919554B5744F00F0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_F89E7644125DBF26919554B5744F00F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_F89E7644125DBF26919554B5744F00F0" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_F89E7644125DBF26919554B5744F00F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_446059672E6054EF84AA54B57450FE0C_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_446059672E6054EF84AA54B57450FE0C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_446059672E6054EF84AA54B57450FE0C_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_446059672E6054EF84AA54B57450FE0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_446059672E6054EF84AA54B57450FE0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue_446059672E6054EF84AA54B57450FE0C" xlink:to="lab_us-gaap_DebtInstrumentFairValue_446059672E6054EF84AA54B57450FE0C" xlink:type="arc" />
    <link:label id="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9_terseLabel_en-US" xlink:label="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying Amount of Long-Term and other Short-Term Borrowings</link:label>
    <link:label id="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9_label_en-US" xlink:label="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying Amount of Long-Term and other Short-Term Borrowings</link:label>
    <link:label id="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9_documentation_en-US" xlink:label="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying Amount of Long-Term and other Short-Term Borrowings</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:label="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9" xlink:to="lab_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_5714B8C36B499D26349554B57306E5E4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_5714B8C36B499D26349554B57306E5E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_5714B8C36B499D26349554B57306E5E4_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_5714B8C36B499D26349554B57306E5E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_5714B8C36B499D26349554B57306E5E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock_5714B8C36B499D26349554B57306E5E4" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock_5714B8C36B499D26349554B57306E5E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_7350CA2D1E17D6752278DFCE37542B6B_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract_7350CA2D1E17D6752278DFCE37542B6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7350CA2D1E17D6752278DFCE37542B6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7350CA2D1E17D6752278DFCE37542B6B" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract_7350CA2D1E17D6752278DFCE37542B6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockMember_D6E2D7303BF37034D9D2DFCE37556628_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember_D6E2D7303BF37034D9D2DFCE37556628" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_D6E2D7303BF37034D9D2DFCE37556628_label_en-US" xlink:label="lab_us-gaap_CommonStockMember_D6E2D7303BF37034D9D2DFCE37556628" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_D6E2D7303BF37034D9D2DFCE37556628" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_D6E2D7303BF37034D9D2DFCE37556628" xlink:to="lab_us-gaap_CommonStockMember_D6E2D7303BF37034D9D2DFCE37556628" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsMember_6E00BF17987EF4914406DFCE3755A5AC_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_6E00BF17987EF4914406DFCE3755A5AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_6E00BF17987EF4914406DFCE3755A5AC_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_6E00BF17987EF4914406DFCE3755A5AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_6E00BF17987EF4914406DFCE3755A5AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_6E00BF17987EF4914406DFCE3755A5AC" xlink:to="lab_us-gaap_RetainedEarningsMember_6E00BF17987EF4914406DFCE3755A5AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockMember_341712EB20D7B035B589DFCE3756CB3C_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_341712EB20D7B035B589DFCE3756CB3C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_341712EB20D7B035B589DFCE3756CB3C_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_341712EB20D7B035B589DFCE3756CB3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_341712EB20D7B035B589DFCE3756CB3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember_341712EB20D7B035B589DFCE3756CB3C" xlink:to="lab_us-gaap_TreasuryStockMember_341712EB20D7B035B589DFCE3756CB3C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A771459543EBB0482EC8DFCE3756042C_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A771459543EBB0482EC8DFCE3756042C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income/(Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A771459543EBB0482EC8DFCE3756042C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A771459543EBB0482EC8DFCE3756042C" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A771459543EBB0482EC8DFCE3756042C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_ED7C7DFAD8ECFD6F0192DFCE37561E6D_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember_ED7C7DFAD8ECFD6F0192DFCE37561E6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_ED7C7DFAD8ECFD6F0192DFCE37561E6D_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember_ED7C7DFAD8ECFD6F0192DFCE37561E6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ED7C7DFAD8ECFD6F0192DFCE37561E6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember_ED7C7DFAD8ECFD6F0192DFCE37561E6D" xlink:to="lab_us-gaap_NoncontrollingInterestMember_ED7C7DFAD8ECFD6F0192DFCE37561E6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="lab_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_CE51D0CDEFF6B0256163DFCE3757A191_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_CE51D0CDEFF6B0256163DFCE3757A191" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_CE51D0CDEFF6B0256163DFCE3757A191" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_CE51D0CDEFF6B0256163DFCE3757A191" xlink:to="lab_us-gaap_CommonStockSharesIssued_CE51D0CDEFF6B0256163DFCE3757A191" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_E5680FD2C62E03183474DFCE37578884_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_E5680FD2C62E03183474DFCE37578884" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury, balance at beginning of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_E5680FD2C62E03183474DFCE37578884" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_E5680FD2C62E03183474DFCE37578884" xlink:to="lab_us-gaap_TreasuryStockShares_E5680FD2C62E03183474DFCE37578884" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_52DD935B8ABA283E7535DFCE37573B7C_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_52DD935B8ABA283E7535DFCE37573B7C" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury, balance at beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_52DD935B8ABA283E7535DFCE37573B7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_52DD935B8ABA283E7535DFCE37573B7C" xlink:to="lab_us-gaap_TreasuryStockValue_52DD935B8ABA283E7535DFCE37573B7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_19A30678FD9272217C3DDFCE37572F41_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_19A30678FD9272217C3DDFCE37572F41" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_19A30678FD9272217C3DDFCE37572F41_label_en-US" xlink:label="lab_us-gaap_ProfitLoss_19A30678FD9272217C3DDFCE37572F41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_19A30678FD9272217C3DDFCE37572F41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_19A30678FD9272217C3DDFCE37572F41" xlink:to="lab_us-gaap_ProfitLoss_19A30678FD9272217C3DDFCE37572F41" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_A95CC2C65DA98C155A6EDFCE3757D5DD_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_A95CC2C65DA98C155A6EDFCE3757D5DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_A95CC2C65DA98C155A6EDFCE3757D5DD_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_A95CC2C65DA98C155A6EDFCE3757D5DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_A95CC2C65DA98C155A6EDFCE3757D5DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_A95CC2C65DA98C155A6EDFCE3757D5DD" xlink:to="lab_us-gaap_NetIncomeLoss_A95CC2C65DA98C155A6EDFCE3757D5DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91EA59B3AF77E7CCBACEDFCE3758EC2A_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91EA59B3AF77E7CCBACEDFCE3758EC2A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91EA59B3AF77E7CCBACEDFCE3758EC2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91EA59B3AF77E7CCBACEDFCE3758EC2A" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91EA59B3AF77E7CCBACEDFCE3758EC2A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9605DE00460407B804D6DFCE375884F2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9605DE00460407B804D6DFCE375884F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9605DE00460407B804D6DFCE375884F2_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9605DE00460407B804D6DFCE375884F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9605DE00460407B804D6DFCE375884F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9605DE00460407B804D6DFCE375884F2" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9605DE00460407B804D6DFCE375884F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8663C8160C90999B2063DFCE37585882_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8663C8160C90999B2063DFCE37585882" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8663C8160C90999B2063DFCE37585882_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8663C8160C90999B2063DFCE37585882" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8663C8160C90999B2063DFCE37585882" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8663C8160C90999B2063DFCE37585882" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8663C8160C90999B2063DFCE37585882" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9E51EC60BE54D1962A51DFCE37592C52_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9E51EC60BE54D1962A51DFCE37592C52" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9E51EC60BE54D1962A51DFCE37592C52_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9E51EC60BE54D1962A51DFCE37592C52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9E51EC60BE54D1962A51DFCE37592C52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9E51EC60BE54D1962A51DFCE37592C52" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9E51EC60BE54D1962A51DFCE37592C52" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_E96788A48827864F846FDFCE3759E03F_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_E96788A48827864F846FDFCE3759E03F" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_E96788A48827864F846FDFCE3759E03F_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_E96788A48827864F846FDFCE3759E03F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_E96788A48827864F846FDFCE3759E03F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_E96788A48827864F846FDFCE3759E03F" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_E96788A48827864F846FDFCE3759E03F" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_106978E340915798E272DFCE3759A860_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_106978E340915798E272DFCE3759A860" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury shares acquired (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_106978E340915798E272DFCE3759A860_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_106978E340915798E272DFCE3759A860" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_106978E340915798E272DFCE3759A860" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_106978E340915798E272DFCE3759A860" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_106978E340915798E272DFCE3759A860" xlink:type="arc" />
    <link:label id="lab_us-gaap_Dividends_DF0B8F558607CED0DDFFDFCE37593BE9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_Dividends_DF0B8F558607CED0DDFFDFCE37593BE9" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_Dividends_DF0B8F558607CED0DDFFDFCE37593BE9_label_en-US" xlink:label="lab_us-gaap_Dividends_DF0B8F558607CED0DDFFDFCE37593BE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_DF0B8F558607CED0DDFFDFCE37593BE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends_DF0B8F558607CED0DDFFDFCE37593BE9" xlink:to="lab_us-gaap_Dividends_DF0B8F558607CED0DDFFDFCE37593BE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityOther_C4A1A9C6B0C27F5BF69DDFCE3759B1FB_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther_C4A1A9C6B0C27F5BF69DDFCE3759B1FB" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_C4A1A9C6B0C27F5BF69DDFCE3759B1FB_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther_C4A1A9C6B0C27F5BF69DDFCE3759B1FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="loc_us-gaap_StockholdersEquityOther_C4A1A9C6B0C27F5BF69DDFCE3759B1FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther_C4A1A9C6B0C27F5BF69DDFCE3759B1FB" xlink:to="lab_us-gaap_StockholdersEquityOther_C4A1A9C6B0C27F5BF69DDFCE3759B1FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_0439A87331DB529F58B5DFCE375AA7F9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_0439A87331DB529F58B5DFCE375AA7F9" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_0439A87331DB529F58B5DFCE375AA7F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_0439A87331DB529F58B5DFCE375AA7F9" xlink:to="lab_us-gaap_CommonStockSharesIssued_0439A87331DB529F58B5DFCE375AA7F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_BD81C907193634A3A498DFCE375A0734_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_BD81C907193634A3A498DFCE375A0734" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury, balance at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_BD81C907193634A3A498DFCE375A0734" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_BD81C907193634A3A498DFCE375A0734" xlink:to="lab_us-gaap_TreasuryStockShares_BD81C907193634A3A498DFCE375A0734" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_E68875997574EF033049DFCE375A3374_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_E68875997574EF033049DFCE375A3374" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury, balance at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_E68875997574EF033049DFCE375A3374" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_E68875997574EF033049DFCE375A3374" xlink:to="lab_us-gaap_TreasuryStockValue_E68875997574EF033049DFCE375A3374" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_F8A16CC3A45C284FB5E2F41CEEC4F13A_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_F8A16CC3A45C284FB5E2F41CEEC4F13A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_F8A16CC3A45C284FB5E2F41CEEC4F13A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F8A16CC3A45C284FB5E2F41CEEC4F13A" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_F8A16CC3A45C284FB5E2F41CEEC4F13A" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="lab_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:type="arc" />
    <link:label id="lab_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E_terseLabel_en-US" xlink:label="lab_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:label id="lab_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E_label_en-US" xlink:label="lab_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:label id="lab_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E_documentation_en-US" xlink:label="lab_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Matter [Axis]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMatterAxis" xlink:label="loc_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:to="lab_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:type="arc" />
    <link:label id="lab_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7_terseLabel_en-US" xlink:label="lab_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Matter [Domain]</link:label>
    <link:label id="lab_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7_label_en-US" xlink:label="lab_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Matter [Domain]</link:label>
    <link:label id="lab_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7_documentation_en-US" xlink:label="lab_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Tax Matter [Axis]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMatterDomain" xlink:label="loc_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:to="lab_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:type="arc" />
    <link:label id="lab_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7_terseLabel_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patient Recovery Business</link:label>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7_label_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:label id="lab_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7_documentation_en-US" xlink:label="lab_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Patient Recovery Business [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7" xlink:to="lab_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7" xlink:type="arc" />
    <link:label id="lab_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376_terseLabel_en-US" xlink:label="lab_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:label id="lab_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376_label_en-US" xlink:label="lab_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:label id="lab_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376_documentation_en-US" xlink:label="lab_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CareFusion [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_CareFusionMember" xlink:label="loc_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376" xlink:to="lab_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02" xlink:type="arc" />
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_526B6B1BA8E2A82392E4F41CEECB42CC_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember_526B6B1BA8E2A82392E4F41CEECB42CC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_526B6B1BA8E2A82392E4F41CEECB42CC_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember_526B6B1BA8E2A82392E4F41CEECB42CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_526B6B1BA8E2A82392E4F41CEECB42CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember_526B6B1BA8E2A82392E4F41CEECB42CC" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember_526B6B1BA8E2A82392E4F41CEECB42CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="lab_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1CF479CE97515B47AEEFF41CEECCAEAC_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_1CF479CE97515B47AEEFF41CEECCAEAC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1CF479CE97515B47AEEFF41CEECCAEAC_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_1CF479CE97515B47AEEFF41CEECCAEAC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1CF479CE97515B47AEEFF41CEECCAEAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1CF479CE97515B47AEEFF41CEECCAEAC" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_1CF479CE97515B47AEEFF41CEECCAEAC" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_3D1884B79031C48C95DEF41CEECD4660_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_3D1884B79031C48C95DEF41CEECD4660" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_3D1884B79031C48C95DEF41CEECD4660_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_3D1884B79031C48C95DEF41CEECD4660" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_3D1884B79031C48C95DEF41CEECD4660" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_3D1884B79031C48C95DEF41CEECD4660" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_3D1884B79031C48C95DEF41CEECD4660" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_C2C62C6CE734F8D9AEE1F41CEECD8599_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_C2C62C6CE734F8D9AEE1F41CEECD8599" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_C2C62C6CE734F8D9AEE1F41CEECD8599_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_C2C62C6CE734F8D9AEE1F41CEECD8599" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_C2C62C6CE734F8D9AEE1F41CEECD8599" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_C2C62C6CE734F8D9AEE1F41CEECD8599" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_C2C62C6CE734F8D9AEE1F41CEECD8599" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_B0B9B79BD0A3063F3C0FF41CEECDA0DE_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_B0B9B79BD0A3063F3C0FF41CEECDA0DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, interest and penalties accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_B0B9B79BD0A3063F3C0FF41CEECDA0DE_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_B0B9B79BD0A3063F3C0FF41CEECDA0DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_B0B9B79BD0A3063F3C0FF41CEECDA0DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_B0B9B79BD0A3063F3C0FF41CEECDA0DE" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_B0B9B79BD0A3063F3C0FF41CEECDA0DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_403D0D324005B631B7A6F41CEECD8FFE_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_403D0D324005B631B7A6F41CEECD8FFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated range of decrease in unrecognized tax benefits within the next 12 months</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_403D0D324005B631B7A6F41CEECD8FFE_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_403D0D324005B631B7A6F41CEECD8FFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_403D0D324005B631B7A6F41CEECD8FFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_403D0D324005B631B7A6F41CEECD8FFE" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_403D0D324005B631B7A6F41CEECD8FFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OpenTaxYear_41102EB5AA992F5F14A4F41CEECD28BC_terseLabel_en-US" xlink:label="lab_us-gaap_OpenTaxYear_41102EB5AA992F5F14A4F41CEECD28BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Open Tax Year</link:label>
    <link:label id="lab_us-gaap_OpenTaxYear_41102EB5AA992F5F14A4F41CEECD28BC_label_en-US" xlink:label="lab_us-gaap_OpenTaxYear_41102EB5AA992F5F14A4F41CEECD28BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Open Tax Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaap_OpenTaxYear_41102EB5AA992F5F14A4F41CEECD28BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OpenTaxYear_41102EB5AA992F5F14A4F41CEECD28BC" xlink:to="lab_us-gaap_OpenTaxYear_41102EB5AA992F5F14A4F41CEECD28BC" xlink:type="arc" />
    <link:label id="lab_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017_terseLabel_en-US" xlink:label="lab_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indemnification Receivable</link:label>
    <link:label id="lab_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017_label_en-US" xlink:label="lab_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indemnification Receivable</link:label>
    <link:label id="lab_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017_documentation_en-US" xlink:label="lab_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_IndemnificationReceivable" xlink:label="loc_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017" xlink:to="lab_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6D825953BC34692EF6A8F41CEECE75CF_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6D825953BC34692EF6A8F41CEECE75CF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6D825953BC34692EF6A8F41CEECE75CF_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6D825953BC34692EF6A8F41CEECE75CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6D825953BC34692EF6A8F41CEECE75CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6D825953BC34692EF6A8F41CEECE75CF" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6D825953BC34692EF6A8F41CEECE75CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_BC33C967B8B8496F6E1C54B57435267C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_BC33C967B8B8496F6E1C54B57435267C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_BC33C967B8B8496F6E1C54B57435267C_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_BC33C967B8B8496F6E1C54B57435267C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_BC33C967B8B8496F6E1C54B57435267C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_BC33C967B8B8496F6E1C54B57435267C" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_BC33C967B8B8496F6E1C54B57435267C" xlink:type="arc" />
    <link:label id="lab_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6" xlink:to="lab_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6" xlink:type="arc" />
    <link:label id="lab_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:to="lab_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingSegmentsMember_199F4D76491B1EBD53A854B5738C0EFC_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember_199F4D76491B1EBD53A854B5738C0EFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_199F4D76491B1EBD53A854B5738C0EFC_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember_199F4D76491B1EBD53A854B5738C0EFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_199F4D76491B1EBD53A854B5738C0EFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember_199F4D76491B1EBD53A854B5738C0EFC" xlink:to="lab_us-gaap_OperatingSegmentsMember_199F4D76491B1EBD53A854B5738C0EFC" xlink:type="arc" />
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_0FEEDB9E29B4C9EECC6554B5738D84FA_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember_0FEEDB9E29B4C9EECC6554B5738D84FA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_0FEEDB9E29B4C9EECC6554B5738D84FA_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember_0FEEDB9E29B4C9EECC6554B5738D84FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_0FEEDB9E29B4C9EECC6554B5738D84FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember_0FEEDB9E29B4C9EECC6554B5738D84FA" xlink:to="lab_us-gaap_CorporateNonSegmentMember_0FEEDB9E29B4C9EECC6554B5738D84FA" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_02D1632F0EC41C31C64E54B5738D8B74_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_02D1632F0EC41C31C64E54B5738D8B74" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_02D1632F0EC41C31C64E54B5738D8B74" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_02D1632F0EC41C31C64E54B5738D8B74" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_02D1632F0EC41C31C64E54B5738D8B74" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_1E9BE57AEA100886DD0D54B5738FAC7C_terseLabel_en-US" xlink:label="lab_us-gaap_Assets_1E9BE57AEA100886DD0D54B5738FAC7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_1E9BE57AEA100886DD0D54B5738FAC7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_1E9BE57AEA100886DD0D54B5738FAC7C" xlink:to="lab_us-gaap_Assets_1E9BE57AEA100886DD0D54B5738FAC7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_82E3B0CBDDD291D67FFD54B5729A84D3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_82E3B0CBDDD291D67FFD54B5729A84D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_82E3B0CBDDD291D67FFD54B5729A84D3_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_82E3B0CBDDD291D67FFD54B5729A84D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_82E3B0CBDDD291D67FFD54B5729A84D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_82E3B0CBDDD291D67FFD54B5729A84D3" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_82E3B0CBDDD291D67FFD54B5729A84D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16332F89CE56772ECD7BF0AC3BF5E2CC_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16332F89CE56772ECD7BF0AC3BF5E2CC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16332F89CE56772ECD7BF0AC3BF5E2CC_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16332F89CE56772ECD7BF0AC3BF5E2CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16332F89CE56772ECD7BF0AC3BF5E2CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16332F89CE56772ECD7BF0AC3BF5E2CC" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16332F89CE56772ECD7BF0AC3BF5E2CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_BA4BBFEEE7101D12AD1DF0AC3BF5CC98_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_BA4BBFEEE7101D12AD1DF0AC3BF5CC98" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net earnings/(loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_BA4BBFEEE7101D12AD1DF0AC3BF5CC98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_BA4BBFEEE7101D12AD1DF0AC3BF5CC98" xlink:to="lab_us-gaap_ProfitLoss_BA4BBFEEE7101D12AD1DF0AC3BF5CC98" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_84C5440366AA67F047C0F0AC3BF6FD75_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_84C5440366AA67F047C0F0AC3BF6FD75" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_84C5440366AA67F047C0F0AC3BF6FD75_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization_84C5440366AA67F047C0F0AC3BF6FD75" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_84C5440366AA67F047C0F0AC3BF6FD75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_84C5440366AA67F047C0F0AC3BF6FD75" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization_84C5440366AA67F047C0F0AC3BF6FD75" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossOnSaleOfInvestments_AD2F6D0449A4FDFC6994F0AC3BF63828_terseLabel_en-US" xlink:label="lab_us-gaap_LossOnSaleOfInvestments_AD2F6D0449A4FDFC6994F0AC3BF63828" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_LossOnSaleOfInvestments_AD2F6D0449A4FDFC6994F0AC3BF63828_label_en-US" xlink:label="lab_us-gaap_LossOnSaleOfInvestments_AD2F6D0449A4FDFC6994F0AC3BF63828" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss on Sale of Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_AD2F6D0449A4FDFC6994F0AC3BF63828" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossOnSaleOfInvestments_AD2F6D0449A4FDFC6994F0AC3BF63828" xlink:to="lab_us-gaap_LossOnSaleOfInvestments_AD2F6D0449A4FDFC6994F0AC3BF63828" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_A31603C3BB89DC0E11FBF0AC3BF6B3C0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_A31603C3BB89DC0E11FBF0AC3BF6B3C0" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairments and (gain)/loss on disposal of assets, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_A31603C3BB89DC0E11FBF0AC3BF6B3C0_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_A31603C3BB89DC0E11FBF0AC3BF6B3C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_A31603C3BB89DC0E11FBF0AC3BF6B3C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_A31603C3BB89DC0E11FBF0AC3BF6B3C0" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_A31603C3BB89DC0E11FBF0AC3BF6B3C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_F9477A28B8A0E18130EAF0AC3BF6B332_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_F9477A28B8A0E18130EAF0AC3BF6B332" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on Extinguishment of Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_F9477A28B8A0E18130EAF0AC3BF6B332" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_F9477A28B8A0E18130EAF0AC3BF6B332" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_F9477A28B8A0E18130EAF0AC3BF6B332" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_76FEB8C026F4C8E7AA04F0AC3BF69336_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_76FEB8C026F4C8E7AA04F0AC3BF69336" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_76FEB8C026F4C8E7AA04F0AC3BF69336_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_76FEB8C026F4C8E7AA04F0AC3BF69336" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_76FEB8C026F4C8E7AA04F0AC3BF69336" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_76FEB8C026F4C8E7AA04F0AC3BF69336" xlink:to="lab_us-gaap_ShareBasedCompensation_76FEB8C026F4C8E7AA04F0AC3BF69336" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_F70F504A87139A4CE942F0AC3BF7104B_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_F70F504A87139A4CE942F0AC3BF7104B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for bad debts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_F70F504A87139A4CE942F0AC3BF7104B_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_F70F504A87139A4CE942F0AC3BF7104B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_F70F504A87139A4CE942F0AC3BF7104B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts_F70F504A87139A4CE942F0AC3BF7104B" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts_F70F504A87139A4CE942F0AC3BF7104B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_281F7401132DEA2EB5EEF0AC3BF70357_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables_281F7401132DEA2EB5EEF0AC3BF70357" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase in trade receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_281F7401132DEA2EB5EEF0AC3BF70357_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables_281F7401132DEA2EB5EEF0AC3BF70357" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_281F7401132DEA2EB5EEF0AC3BF70357" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables_281F7401132DEA2EB5EEF0AC3BF70357" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables_281F7401132DEA2EB5EEF0AC3BF70357" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_679B7488D8764686699EF0AC3BF7230E_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_679B7488D8764686699EF0AC3BF7230E" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_679B7488D8764686699EF0AC3BF7230E_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_679B7488D8764686699EF0AC3BF7230E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_679B7488D8764686699EF0AC3BF7230E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_679B7488D8764686699EF0AC3BF7230E" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_679B7488D8764686699EF0AC3BF7230E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_97F75241A5E9E611171DF0AC3BF89375_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_97F75241A5E9E611171DF0AC3BF89375" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_97F75241A5E9E611171DF0AC3BF89375_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_97F75241A5E9E611171DF0AC3BF89375" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_97F75241A5E9E611171DF0AC3BF89375" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable_97F75241A5E9E611171DF0AC3BF89375" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable_97F75241A5E9E611171DF0AC3BF89375" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9694AA8BD50FE22142F2F0AC3BF8325D_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9694AA8BD50FE22142F2F0AC3BF8325D" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities and operating items, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9694AA8BD50FE22142F2F0AC3BF8325D_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9694AA8BD50FE22142F2F0AC3BF8325D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9694AA8BD50FE22142F2F0AC3BF8325D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9694AA8BD50FE22142F2F0AC3BF8325D" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9694AA8BD50FE22142F2F0AC3BF8325D" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_B040BFB1D2D0E7EA3E11F0AC3BF86B72_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_B040BFB1D2D0E7EA3E11F0AC3BF86B72" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_B040BFB1D2D0E7EA3E11F0AC3BF86B72_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_B040BFB1D2D0E7EA3E11F0AC3BF86B72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_B040BFB1D2D0E7EA3E11F0AC3BF86B72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_B040BFB1D2D0E7EA3E11F0AC3BF86B72" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_B040BFB1D2D0E7EA3E11F0AC3BF86B72" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EA1C9A15902B9275FED1F0AC3BF843CA_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EA1C9A15902B9275FED1F0AC3BF843CA" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Acquisition of subsidiaries, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EA1C9A15902B9275FED1F0AC3BF843CA_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EA1C9A15902B9275FED1F0AC3BF843CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EA1C9A15902B9275FED1F0AC3BF843CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EA1C9A15902B9275FED1F0AC3BF843CA" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EA1C9A15902B9275FED1F0AC3BF843CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6CF34B15C54F8F60DDE4F0AC3BF86984_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6CF34B15C54F8F60DDE4F0AC3BF86984" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Additions to property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6CF34B15C54F8F60DDE4F0AC3BF86984_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6CF34B15C54F8F60DDE4F0AC3BF86984" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6CF34B15C54F8F60DDE4F0AC3BF86984" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6CF34B15C54F8F60DDE4F0AC3BF86984" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6CF34B15C54F8F60DDE4F0AC3BF86984" xlink:type="arc" />
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_2A081ACA180DB0B495B4F0AC3BF9C965_negatedLabel_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_2A081ACA180DB0B495B4F0AC3BF9C965" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of investments</link:label>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_2A081ACA180DB0B495B4F0AC3BF9C965_label_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_2A081ACA180DB0B495B4F0AC3BF9C965" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_2A081ACA180DB0B495B4F0AC3BF9C965_documentation_en-US" xlink:label="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_2A081ACA180DB0B495B4F0AC3BF9C965" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow from purchases of available-for-sale securities and other investments.</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_2A081ACA180DB0B495B4F0AC3BF9C965" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_2A081ACA180DB0B495B4F0AC3BF9C965" xlink:to="lab_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_2A081ACA180DB0B495B4F0AC3BF9C965" xlink:type="arc" />
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_E3A575AA609C57175D27F0AC3BF96C19_terseLabel_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_E3A575AA609C57175D27F0AC3BF96C19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from return of investments</link:label>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_E3A575AA609C57175D27F0AC3BF96C19_label_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_E3A575AA609C57175D27F0AC3BF96C19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sale of available-for-sale securities and other investments</link:label>
    <link:label id="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_E3A575AA609C57175D27F0AC3BF96C19_documentation_en-US" xlink:label="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_E3A575AA609C57175D27F0AC3BF96C19" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash inflow from sales of available-for-sale securities and other investments.</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_E3A575AA609C57175D27F0AC3BF96C19" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_E3A575AA609C57175D27F0AC3BF96C19" xlink:to="lab_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_E3A575AA609C57175D27F0AC3BF96C19" xlink:type="arc" />
    <link:label id="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_73C9281D1558BD7FE34AF0AC3BF9EB7C_terseLabel_en-US" xlink:label="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_73C9281D1558BD7FE34AF0AC3BF9EB7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from divestitures and disposal of property and equipment and held for sale assets</link:label>
    <link:label id="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_73C9281D1558BD7FE34AF0AC3BF9EB7C_label_en-US" xlink:label="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_73C9281D1558BD7FE34AF0AC3BF9EB7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from divestitures and disposal of property and equipment and held for sale assets</link:label>
    <link:label id="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_73C9281D1558BD7FE34AF0AC3BF9EB7C_documentation_en-US" xlink:label="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_73C9281D1558BD7FE34AF0AC3BF9EB7C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds from divestitures and disposal of property and equipment and held for sale assets</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" xlink:label="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_73C9281D1558BD7FE34AF0AC3BF9EB7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_73C9281D1558BD7FE34AF0AC3BF9EB7C" xlink:to="lab_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_73C9281D1558BD7FE34AF0AC3BF9EB7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_FAE274A360D4BF934C7FF0AC3BF9002B_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_FAE274A360D4BF934C7FF0AC3BF9002B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by/(used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_FAE274A360D4BF934C7FF0AC3BF9002B_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_FAE274A360D4BF934C7FF0AC3BF9002B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_FAE274A360D4BF934C7FF0AC3BF9002B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_FAE274A360D4BF934C7FF0AC3BF9002B" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_FAE274A360D4BF934C7FF0AC3BF9002B" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_FF8A5E57B6B65F0A77A4F0AC3BF962FA_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_FF8A5E57B6B65F0A77A4F0AC3BF962FA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net change in short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_FF8A5E57B6B65F0A77A4F0AC3BF962FA_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_FF8A5E57B6B65F0A77A4F0AC3BF962FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_FF8A5E57B6B65F0A77A4F0AC3BF962FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_FF8A5E57B6B65F0A77A4F0AC3BF962FA" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_FF8A5E57B6B65F0A77A4F0AC3BF962FA" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_15498F95646917A0B685F0AC3BFA4C1F_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_15498F95646917A0B685F0AC3BFA4C1F" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reduction of long-term obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_15498F95646917A0B685F0AC3BFA4C1F_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_15498F95646917A0B685F0AC3BFA4C1F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_15498F95646917A0B685F0AC3BFA4C1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt_15498F95646917A0B685F0AC3BFA4C1F" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt_15498F95646917A0B685F0AC3BFA4C1F" xlink:type="arc" />
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_803A554BC56169779D77F0AC3BFA4443_terseLabel_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_803A554BC56169779D77F0AC3BFA4443" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds/(tax withholdings) from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_803A554BC56169779D77F0AC3BFA4443_label_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_803A554BC56169779D77F0AC3BFA4443" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net proceeds/(tax withholdings) from share-based compensation</link:label>
    <link:label id="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_803A554BC56169779D77F0AC3BFA4443_documentation_en-US" xlink:label="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_803A554BC56169779D77F0AC3BFA4443" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_803A554BC56169779D77F0AC3BFA4443" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_803A554BC56169779D77F0AC3BFA4443" xlink:to="lab_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_803A554BC56169779D77F0AC3BFA4443" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_B034B66FCA3F9D7F476AF0AC3BFA3AAF_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock_B034B66FCA3F9D7F476AF0AC3BFA3AAF" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Dividends on common shares</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_B034B66FCA3F9D7F476AF0AC3BFA3AAF_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock_B034B66FCA3F9D7F476AF0AC3BFA3AAF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_B034B66FCA3F9D7F476AF0AC3BFA3AAF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock_B034B66FCA3F9D7F476AF0AC3BFA3AAF" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock_B034B66FCA3F9D7F476AF0AC3BFA3AAF" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_DA4CD893B0BE5A5990BFF0AC3BFA348F_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_DA4CD893B0BE5A5990BFF0AC3BFA348F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_DA4CD893B0BE5A5990BFF0AC3BFA348F_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_DA4CD893B0BE5A5990BFF0AC3BFA348F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_DA4CD893B0BE5A5990BFF0AC3BFA348F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_DA4CD893B0BE5A5990BFF0AC3BFA348F" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_DA4CD893B0BE5A5990BFF0AC3BFA348F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D0C949E34A5CE0B7B245F0AC3BFB5466_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D0C949E34A5CE0B7B245F0AC3BFB5466" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rates changes on cash and equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D0C949E34A5CE0B7B245F0AC3BFB5466_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D0C949E34A5CE0B7B245F0AC3BFB5466" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D0C949E34A5CE0B7B245F0AC3BFB5466" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D0C949E34A5CE0B7B245F0AC3BFB5466" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D0C949E34A5CE0B7B245F0AC3BFB5466" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6FEC69E1102765FD371BF0AC3BFB0A37_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6FEC69E1102765FD371BF0AC3BFB0A37" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase/(decrease) in cash and equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6FEC69E1102765FD371BF0AC3BFB0A37_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6FEC69E1102765FD371BF0AC3BFB0A37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6FEC69E1102765FD371BF0AC3BFB0A37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6FEC69E1102765FD371BF0AC3BFB0A37" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6FEC69E1102765FD371BF0AC3BFB0A37" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7F9FFFD17ABF49164002F0AC3BFBA7F5_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7F9FFFD17ABF49164002F0AC3BFBA7F5" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents at beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7F9FFFD17ABF49164002F0AC3BFBA7F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7F9FFFD17ABF49164002F0AC3BFBA7F5" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7F9FFFD17ABF49164002F0AC3BFBA7F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_DCCB1CF924142CB05635F0AC3BFB4840_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_DCCB1CF924142CB05635F0AC3BFB4840" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and equivalents at end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_DCCB1CF924142CB05635F0AC3BFB4840" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_DCCB1CF924142CB05635F0AC3BFB4840" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_DCCB1CF924142CB05635F0AC3BFB4840" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6A51BA808B14BE5CB5F154B5730F5C42_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_6A51BA808B14BE5CB5F154B5730F5C42" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6A51BA808B14BE5CB5F154B5730F5C42_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock_6A51BA808B14BE5CB5F154B5730F5C42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_6A51BA808B14BE5CB5F154B5730F5C42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock_6A51BA808B14BE5CB5F154B5730F5C42" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock_6A51BA808B14BE5CB5F154B5730F5C42" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3918E50312581254CE5C54B5730F00F2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3918E50312581254CE5C54B5730F00F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3918E50312581254CE5C54B5730F00F2_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3918E50312581254CE5C54B5730F00F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3918E50312581254CE5C54B5730F00F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3918E50312581254CE5C54B5730F00F2" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3918E50312581254CE5C54B5730F00F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_959C61B0FEC9B57FEC6654B5743E8380_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_959C61B0FEC9B57FEC6654B5743E8380" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_959C61B0FEC9B57FEC6654B5743E8380_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_959C61B0FEC9B57FEC6654B5743E8380" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_959C61B0FEC9B57FEC6654B5743E8380" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_959C61B0FEC9B57FEC6654B5743E8380" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_959C61B0FEC9B57FEC6654B5743E8380" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9D1331D44B6224384DD454B5743FA729_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9D1331D44B6224384DD454B5743FA729" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9D1331D44B6224384DD454B5743FA729_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9D1331D44B6224384DD454B5743FA729" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9D1331D44B6224384DD454B5743FA729" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9D1331D44B6224384DD454B5743FA729" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9D1331D44B6224384DD454B5743FA729" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_E00A1BB4A56281BDB73D54B5743F1139_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_E00A1BB4A56281BDB73D54B5743F1139" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_E00A1BB4A56281BDB73D54B5743F1139_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_E00A1BB4A56281BDB73D54B5743F1139" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_E00A1BB4A56281BDB73D54B5743F1139" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_E00A1BB4A56281BDB73D54B5743F1139" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_E00A1BB4A56281BDB73D54B5743F1139" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5F04EFD6C86939DC056354B5743F4D1B_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5F04EFD6C86939DC056354B5743F4D1B" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5F04EFD6C86939DC056354B5743F4D1B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5F04EFD6C86939DC056354B5743F4D1B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5F04EFD6C86939DC056354B5743F4D1B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5F04EFD6C86939DC056354B5743F4D1B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5F04EFD6C86939DC056354B5743F4D1B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3B36B2A55F49DA91809454B5743F5E87_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3B36B2A55F49DA91809454B5743F5E87" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3B36B2A55F49DA91809454B5743F5E87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3B36B2A55F49DA91809454B5743F5E87" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3B36B2A55F49DA91809454B5743F5E87" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1F5DC52850DEA19039BC54B574408048_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1F5DC52850DEA19039BC54B574408048" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1F5DC52850DEA19039BC54B574408048_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1F5DC52850DEA19039BC54B574408048" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1F5DC52850DEA19039BC54B574408048" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1F5DC52850DEA19039BC54B574408048" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1F5DC52850DEA19039BC54B574408048" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price per Common Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CF3A5527D81F72CCFA7654B57440B58A_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CF3A5527D81F72CCFA7654B57440B58A" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CF3A5527D81F72CCFA7654B57440B58A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CF3A5527D81F72CCFA7654B57440B58A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CF3A5527D81F72CCFA7654B57440B58A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CF3A5527D81F72CCFA7654B57440B58A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CF3A5527D81F72CCFA7654B57440B58A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_D7408C3CBE290C55F78454B57441BFE2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_D7408C3CBE290C55F78454B57441BFE2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_D7408C3CBE290C55F78454B57441BFE2_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_D7408C3CBE290C55F78454B57441BFE2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_D7408C3CBE290C55F78454B57441BFE2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_D7408C3CBE290C55F78454B57441BFE2" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_D7408C3CBE290C55F78454B57441BFE2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3380B0B724BD6C10A51554B57441D033_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3380B0B724BD6C10A51554B57441D033" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3380B0B724BD6C10A51554B57441D033_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3380B0B724BD6C10A51554B57441D033" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3380B0B724BD6C10A51554B57441D033" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3380B0B724BD6C10A51554B57441D033" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3380B0B724BD6C10A51554B57441D033" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_A6A75555A3675868E53654B57441C745_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_A6A75555A3675868E53654B57441C745" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_A6A75555A3675868E53654B57441C745_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_A6A75555A3675868E53654B57441C745" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_A6A75555A3675868E53654B57441C745" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_A6A75555A3675868E53654B57441C745" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_A6A75555A3675868E53654B57441C745" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9281E6ACEA0CE745AFD254B5744213B1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9281E6ACEA0CE745AFD254B5744213B1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9281E6ACEA0CE745AFD254B5744213B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9281E6ACEA0CE745AFD254B5744213B1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9281E6ACEA0CE745AFD254B5744213B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C85A98BB83AF4D8C7A1554B574422A8D_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C85A98BB83AF4D8C7A1554B574422A8D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C85A98BB83AF4D8C7A1554B574422A8D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C85A98BB83AF4D8C7A1554B574422A8D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C85A98BB83AF4D8C7A1554B574422A8D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C85A98BB83AF4D8C7A1554B574422A8D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C85A98BB83AF4D8C7A1554B574422A8D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9918B25200D0B3B2EB8554B5723D3818_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9918B25200D0B3B2EB8554B5723D3818" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments, Contingent Liabilities and Litigation</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9918B25200D0B3B2EB8554B5723D3818_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9918B25200D0B3B2EB8554B5723D3818" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9918B25200D0B3B2EB8554B5723D3818" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9918B25200D0B3B2EB8554B5723D3818" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9918B25200D0B3B2EB8554B5723D3818" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_803A4876ECE4034BBE6154B57302C092_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_803A4876ECE4034BBE6154B57302C092" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_803A4876ECE4034BBE6154B57302C092_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_803A4876ECE4034BBE6154B57302C092" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_803A4876ECE4034BBE6154B57302C092" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_803A4876ECE4034BBE6154B57302C092" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_803A4876ECE4034BBE6154B57302C092" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_E93F4B4DE28306F30A7C54B5730BEA34_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_E93F4B4DE28306F30A7C54B5730BEA34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_E93F4B4DE28306F30A7C54B5730BEA34_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock_E93F4B4DE28306F30A7C54B5730BEA34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_E93F4B4DE28306F30A7C54B5730BEA34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock_E93F4B4DE28306F30A7C54B5730BEA34" xlink:to="lab_us-gaap_LeaseCostTableTextBlock_E93F4B4DE28306F30A7C54B5730BEA34" xlink:type="arc" />
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_C4613A309E78FDD6831E54B5730C17A8_terseLabel_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_C4613A309E78FDD6831E54B5730C17A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_C4613A309E78FDD6831E54B5730C17A8_label_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_C4613A309E78FDD6831E54B5730C17A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">LeasesSupplementalBalanceSheetInformation [Table Text Block]</link:label>
    <link:label id="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_C4613A309E78FDD6831E54B5730C17A8_documentation_en-US" xlink:label="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_C4613A309E78FDD6831E54B5730C17A8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:label="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_C4613A309E78FDD6831E54B5730C17A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_C4613A309E78FDD6831E54B5730C17A8" xlink:to="lab_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_C4613A309E78FDD6831E54B5730C17A8" xlink:type="arc" />
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_45C9E05255D38D5F724354B5730C0221_terseLabel_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock_45C9E05255D38D5F724354B5730C0221" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases Supplemental Cash Flow Information</link:label>
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_45C9E05255D38D5F724354B5730C0221_label_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock_45C9E05255D38D5F724354B5730C0221" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Payments [Table Text Block]</link:label>
    <link:label id="lab_cah_LeasePaymentsTableTextBlock_45C9E05255D38D5F724354B5730C0221_documentation_en-US" xlink:label="lab_cah_LeasePaymentsTableTextBlock_45C9E05255D38D5F724354B5730C0221" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Table Text Block] for Lease Payments [Table]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LeasePaymentsTableTextBlock" xlink:label="loc_cah_LeasePaymentsTableTextBlock_45C9E05255D38D5F724354B5730C0221" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeasePaymentsTableTextBlock_45C9E05255D38D5F724354B5730C0221" xlink:to="lab_cah_LeasePaymentsTableTextBlock_45C9E05255D38D5F724354B5730C0221" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_C4B929E72E459EB5495054B5730C2869_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_C4B929E72E459EB5495054B5730C2869" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Future Lease Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_C4B929E72E459EB5495054B5730C2869_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_C4B929E72E459EB5495054B5730C2869" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_C4B929E72E459EB5495054B5730C2869" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_C4B929E72E459EB5495054B5730C2869" xlink:to="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_C4B929E72E459EB5495054B5730C2869" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E6B91BBD1237C9AF1CCD54B5729E6139_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E6B91BBD1237C9AF1CCD54B5729E6139" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E6B91BBD1237C9AF1CCD54B5729E6139_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E6B91BBD1237C9AF1CCD54B5729E6139" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E6B91BBD1237C9AF1CCD54B5729E6139" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E6B91BBD1237C9AF1CCD54B5729E6139" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E6B91BBD1237C9AF1CCD54B5729E6139" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="lab_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_2E8C9EBC5811EFA85B9154B572DF3EF3_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues_2E8C9EBC5811EFA85B9154B572DF3EF3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_2E8C9EBC5811EFA85B9154B572DF3EF3_label_en-US" xlink:label="lab_us-gaap_Revenues_2E8C9EBC5811EFA85B9154B572DF3EF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_2E8C9EBC5811EFA85B9154B572DF3EF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_2E8C9EBC5811EFA85B9154B572DF3EF3" xlink:to="lab_us-gaap_Revenues_2E8C9EBC5811EFA85B9154B572DF3EF3" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_61692A7D54AC8064022D54B572DF8F1A_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_61692A7D54AC8064022D54B572DF8F1A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of products sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_61692A7D54AC8064022D54B572DF8F1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_61692A7D54AC8064022D54B572DF8F1A" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold_61692A7D54AC8064022D54B572DF8F1A" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_8D7772478641AFC17D0254B572E0C216_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_8D7772478641AFC17D0254B572E0C216" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_8D7772478641AFC17D0254B572E0C216_label_en-US" xlink:label="lab_us-gaap_GrossProfit_8D7772478641AFC17D0254B572E0C216" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_8D7772478641AFC17D0254B572E0C216" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_8D7772478641AFC17D0254B572E0C216" xlink:to="lab_us-gaap_GrossProfit_8D7772478641AFC17D0254B572E0C216" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017" xlink:to="lab_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_D72EC1C491205A7DCBAF54B572E013CD_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense_D72EC1C491205A7DCBAF54B572E013CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution, selling, general and administrative expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_D72EC1C491205A7DCBAF54B572E013CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_D72EC1C491205A7DCBAF54B572E013CD" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense_D72EC1C491205A7DCBAF54B572E013CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_CDF4B21AC14F8F96DE3F54B572E0C768_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_CDF4B21AC14F8F96DE3F54B572E0C768" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and employee severance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_CDF4B21AC14F8F96DE3F54B572E0C768" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_CDF4B21AC14F8F96DE3F54B572E0C768" xlink:to="lab_us-gaap_RestructuringCharges_CDF4B21AC14F8F96DE3F54B572E0C768" xlink:type="arc" />
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_CCBBB2BCA9BFB863915254B572E1EBCE_terseLabel_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts_CCBBB2BCA9BFB863915254B572E1EBCE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization and other acquisition-related costs</link:label>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_CCBBB2BCA9BFB863915254B572E1EBCE_label_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts_CCBBB2BCA9BFB863915254B572E1EBCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization and other acquisition-related costs</link:label>
    <link:label id="lab_cah_Amortizationandotheracquisitionrelatedcosts_CCBBB2BCA9BFB863915254B572E1EBCE_documentation_en-US" xlink:label="lab_cah_Amortizationandotheracquisitionrelatedcosts_CCBBB2BCA9BFB863915254B572E1EBCE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_Amortizationandotheracquisitionrelatedcosts" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_CCBBB2BCA9BFB863915254B572E1EBCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_Amortizationandotheracquisitionrelatedcosts_CCBBB2BCA9BFB863915254B572E1EBCE" xlink:to="lab_cah_Amortizationandotheracquisitionrelatedcosts_CCBBB2BCA9BFB863915254B572E1EBCE" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_683739BF136091A0A11754B572E11FAD_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement_683739BF136091A0A11754B572E11FAD" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Litigation (recoveries)/charges, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_683739BF136091A0A11754B572E11FAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement_683739BF136091A0A11754B572E11FAD" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement_683739BF136091A0A11754B572E11FAD" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_B46CC140C19BE76FC26754B572E10220_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_B46CC140C19BE76FC26754B572E10220" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating earnings/(loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_B46CC140C19BE76FC26754B572E10220_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_B46CC140C19BE76FC26754B572E10220" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_B46CC140C19BE76FC26754B572E10220" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_B46CC140C19BE76FC26754B572E10220" xlink:to="lab_us-gaap_OperatingIncomeLoss_B46CC140C19BE76FC26754B572E10220" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_FCCABECB22D05CAE2F7154B572E1DF5D_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_FCCABECB22D05CAE2F7154B572E1DF5D" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_FCCABECB22D05CAE2F7154B572E1DF5D_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_FCCABECB22D05CAE2F7154B572E1DF5D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_FCCABECB22D05CAE2F7154B572E1DF5D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_FCCABECB22D05CAE2F7154B572E1DF5D" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense_FCCABECB22D05CAE2F7154B572E1DF5D" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpense_D1D4F2D423C33A61E61354B572E1C663_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense_D1D4F2D423C33A61E61354B572E1C663" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_D1D4F2D423C33A61E61354B572E1C663_label_en-US" xlink:label="lab_us-gaap_InterestExpense_D1D4F2D423C33A61E61354B572E1C663" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_D1D4F2D423C33A61E61354B572E1C663" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_D1D4F2D423C33A61E61354B572E1C663" xlink:to="lab_us-gaap_InterestExpense_D1D4F2D423C33A61E61354B572E1C663" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_526F87E9985AA8C5E40754B572E2D035_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_526F87E9985AA8C5E40754B572E2D035" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Earnings/(loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_526F87E9985AA8C5E40754B572E2D035_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_526F87E9985AA8C5E40754B572E2D035" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_526F87E9985AA8C5E40754B572E2D035" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_526F87E9985AA8C5E40754B572E2D035" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_526F87E9985AA8C5E40754B572E2D035" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_C4B0F9FC61395FCAE96654B572E20108_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_C4B0F9FC61395FCAE96654B572E20108" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Provision for/(benefit from) income taxes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_C4B0F9FC61395FCAE96654B572E20108" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_C4B0F9FC61395FCAE96654B572E20108" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_C4B0F9FC61395FCAE96654B572E20108" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProfitLoss_8F5BA48AFE5C97397F3054B572E26201_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss_8F5BA48AFE5C97397F3054B572E26201" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net earnings/(loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_8F5BA48AFE5C97397F3054B572E26201" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_8F5BA48AFE5C97397F3054B572E26201" xlink:to="lab_us-gaap_ProfitLoss_8F5BA48AFE5C97397F3054B572E26201" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_D2EF79A80191AED231DB54B572E2BE98_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_D2EF79A80191AED231DB54B572E2BE98" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Net earnings attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_D2EF79A80191AED231DB54B572E2BE98_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_D2EF79A80191AED231DB54B572E2BE98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_D2EF79A80191AED231DB54B572E2BE98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_D2EF79A80191AED231DB54B572E2BE98" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_D2EF79A80191AED231DB54B572E2BE98" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_5E8E1A3194B6378D2D7654B572E3D4A7_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_5E8E1A3194B6378D2D7654B572E3D4A7" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net earnings/(loss) attributable to Cardinal Health, Inc.</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_5E8E1A3194B6378D2D7654B572E3D4A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_5E8E1A3194B6378D2D7654B572E3D4A7" xlink:to="lab_us-gaap_NetIncomeLoss_5E8E1A3194B6378D2D7654B572E3D4A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_666F8EEDEA0A52186C0F54B572E32277_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract_666F8EEDEA0A52186C0F54B572E32277" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings/(loss) per common share attributable to Cardinal Health, Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_666F8EEDEA0A52186C0F54B572E32277_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract_666F8EEDEA0A52186C0F54B572E32277" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_666F8EEDEA0A52186C0F54B572E32277" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_666F8EEDEA0A52186C0F54B572E32277" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract_666F8EEDEA0A52186C0F54B572E32277" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3633077D56AB9C33FC4154B572E36929_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3633077D56AB9C33FC4154B572E36929" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3633077D56AB9C33FC4154B572E36929_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3633077D56AB9C33FC4154B572E36929" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3633077D56AB9C33FC4154B572E36929" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3633077D56AB9C33FC4154B572E36929" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3633077D56AB9C33FC4154B572E36929" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4661682005A9B9551DA454B572E3572D_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4661682005A9B9551DA454B572E3572D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4661682005A9B9551DA454B572E3572D_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4661682005A9B9551DA454B572E3572D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4661682005A9B9551DA454B572E3572D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4661682005A9B9551DA454B572E3572D" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4661682005A9B9551DA454B572E3572D" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3CF4632F7F0E76234A6A54B572E4D553_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3CF4632F7F0E76234A6A54B572E4D553" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3CF4632F7F0E76234A6A54B572E4D553_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3CF4632F7F0E76234A6A54B572E4D553" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3CF4632F7F0E76234A6A54B572E4D553" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3CF4632F7F0E76234A6A54B572E4D553" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3CF4632F7F0E76234A6A54B572E4D553" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_C349EA4BE008CE4A777254B572E43696_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_C349EA4BE008CE4A777254B572E43696" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_C349EA4BE008CE4A777254B572E43696_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_C349EA4BE008CE4A777254B572E43696" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_C349EA4BE008CE4A777254B572E43696" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_C349EA4BE008CE4A777254B572E43696" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_C349EA4BE008CE4A777254B572E43696" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_E419CA82BE4F1B5D835554B572E48001_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_E419CA82BE4F1B5D835554B572E48001" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_E419CA82BE4F1B5D835554B572E48001_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_E419CA82BE4F1B5D835554B572E48001" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_E419CA82BE4F1B5D835554B572E48001" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_E419CA82BE4F1B5D835554B572E48001" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_E419CA82BE4F1B5D835554B572E48001" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79D4D658883010C9F20954B572E48463_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79D4D658883010C9F20954B572E48463" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79D4D658883010C9F20954B572E48463_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79D4D658883010C9F20954B572E48463" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79D4D658883010C9F20954B572E48463" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79D4D658883010C9F20954B572E48463" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79D4D658883010C9F20954B572E48463" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_156D6B5C9A20386DEB8454B572E48B1F_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared_156D6B5C9A20386DEB8454B572E48B1F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash dividends declared per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_156D6B5C9A20386DEB8454B572E48B1F_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared_156D6B5C9A20386DEB8454B572E48B1F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_156D6B5C9A20386DEB8454B572E48B1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared_156D6B5C9A20386DEB8454B572E48B1F" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared_156D6B5C9A20386DEB8454B572E48B1F" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncement, Early Adoption [Axis]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncement, Early Adoption [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9" xlink:to="lab_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Principles, Early Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8_label_en-US" xlink:label="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Principles, Early Adoption [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8" xlink:to="lab_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15" xlink:type="arc" />
    <link:label id="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90_terseLabel_en-US" xlink:label="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Liabilities established as a Result of the adoption of ASC 842</link:label>
    <link:label id="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90_label_en-US" xlink:label="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Liabilities established as a Result of the adoption of ASC 842</link:label>
    <link:label id="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90_documentation_en-US" xlink:label="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Liabilities established as a Result of the adoption of ASC 842</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" xlink:label="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90" xlink:to="lab_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_360EE37B8B010574EAD454B572B35119_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_360EE37B8B010574EAD454B572B35119" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_360EE37B8B010574EAD454B572B35119_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_360EE37B8B010574EAD454B572B35119" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Holdings, Schedule of Investments [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_360EE37B8B010574EAD454B572B35119" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_360EE37B8B010574EAD454B572B35119" xlink:to="lab_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_360EE37B8B010574EAD454B572B35119" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_472B96828B52758FE44F54B573E164AF_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_472B96828B52758FE44F54B573E164AF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_472B96828B52758FE44F54B573E164AF_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_472B96828B52758FE44F54B573E164AF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_472B96828B52758FE44F54B573E164AF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_472B96828B52758FE44F54B573E164AF" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_472B96828B52758FE44F54B573E164AF" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_C09CDD1B36031B9920DA54B573E262BC_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_C09CDD1B36031B9920DA54B573E262BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Financial Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_C09CDD1B36031B9920DA54B573E262BC_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_C09CDD1B36031B9920DA54B573E262BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_C09CDD1B36031B9920DA54B573E262BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_C09CDD1B36031B9920DA54B573E262BC" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_C09CDD1B36031B9920DA54B573E262BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Arrangement, Type [Axis] (Deprecated 2020-01-31)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Arrangement, Type [Domain] (Deprecated 2020-01-31)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:type="arc" />
    <link:label id="lab_cah_OperatingLeaseMember_F70AA12591A8671BC1BBDFD3CF04AF88_terseLabel_en-US" xlink:label="lab_cah_OperatingLeaseMember_F70AA12591A8671BC1BBDFD3CF04AF88" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_cah_OperatingLeaseMember_F70AA12591A8671BC1BBDFD3CF04AF88_label_en-US" xlink:label="lab_cah_OperatingLeaseMember_F70AA12591A8671BC1BBDFD3CF04AF88" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease [Member]</link:label>
    <link:label id="lab_cah_OperatingLeaseMember_F70AA12591A8671BC1BBDFD3CF04AF88_documentation_en-US" xlink:label="lab_cah_OperatingLeaseMember_F70AA12591A8671BC1BBDFD3CF04AF88" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_OperatingLeaseMember" xlink:label="loc_cah_OperatingLeaseMember_F70AA12591A8671BC1BBDFD3CF04AF88" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OperatingLeaseMember_F70AA12591A8671BC1BBDFD3CF04AF88" xlink:to="lab_cah_OperatingLeaseMember_F70AA12591A8671BC1BBDFD3CF04AF88" xlink:type="arc" />
    <link:label id="lab_cah_FinanceLeaseMember_4C744B473B119F233D5ADFD3CF05431C_terseLabel_en-US" xlink:label="lab_cah_FinanceLeaseMember_4C744B473B119F233D5ADFD3CF05431C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_cah_FinanceLeaseMember_4C744B473B119F233D5ADFD3CF05431C_label_en-US" xlink:label="lab_cah_FinanceLeaseMember_4C744B473B119F233D5ADFD3CF05431C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:label id="lab_cah_FinanceLeaseMember_4C744B473B119F233D5ADFD3CF05431C_documentation_en-US" xlink:label="lab_cah_FinanceLeaseMember_4C744B473B119F233D5ADFD3CF05431C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_FinanceLeaseMember" xlink:label="loc_cah_FinanceLeaseMember_4C744B473B119F233D5ADFD3CF05431C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FinanceLeaseMember_4C744B473B119F233D5ADFD3CF05431C" xlink:to="lab_cah_FinanceLeaseMember_4C744B473B119F233D5ADFD3CF05431C" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_74D5C3CB637D9330808ADFCE3686F4F3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_74D5C3CB637D9330808ADFCE3686F4F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2020</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_74D5C3CB637D9330808ADFCE3686F4F3_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_74D5C3CB637D9330808ADFCE3686F4F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_74D5C3CB637D9330808ADFCE3686F4F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_74D5C3CB637D9330808ADFCE3686F4F3" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_74D5C3CB637D9330808ADFCE3686F4F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0A311B57F67D3A468219DFCE3687895B_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0A311B57F67D3A468219DFCE3687895B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2020</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0A311B57F67D3A468219DFCE3687895B_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0A311B57F67D3A468219DFCE3687895B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0A311B57F67D3A468219DFCE3687895B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0A311B57F67D3A468219DFCE3687895B" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0A311B57F67D3A468219DFCE3687895B" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2020</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Remainder Of Fiscal Year</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Remainder Of Fiscal Year</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_BF47C274771D90F4B9A4DFCE3687C467_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_BF47C274771D90F4B9A4DFCE3687C467" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_BF47C274771D90F4B9A4DFCE3687C467_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_BF47C274771D90F4B9A4DFCE3687C467" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_BF47C274771D90F4B9A4DFCE3687C467" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_BF47C274771D90F4B9A4DFCE3687C467" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_BF47C274771D90F4B9A4DFCE3687C467" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_81536AC8ACE2C8707394DFCE3687822C_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_81536AC8ACE2C8707394DFCE3687822C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_81536AC8ACE2C8707394DFCE3687822C_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_81536AC8ACE2C8707394DFCE3687822C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_81536AC8ACE2C8707394DFCE3687822C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_81536AC8ACE2C8707394DFCE3687822C" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_81536AC8ACE2C8707394DFCE3687822C" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Two</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Two</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2BF3CD0269BFEAC885A9DFCE36874B0D_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2BF3CD0269BFEAC885A9DFCE36874B0D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2BF3CD0269BFEAC885A9DFCE36874B0D_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2BF3CD0269BFEAC885A9DFCE36874B0D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2BF3CD0269BFEAC885A9DFCE36874B0D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2BF3CD0269BFEAC885A9DFCE36874B0D" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2BF3CD0269BFEAC885A9DFCE36874B0D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_732CA9DAEF4C50B9DC15DFCE3688DD10_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_732CA9DAEF4C50B9DC15DFCE3688DD10" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_732CA9DAEF4C50B9DC15DFCE3688DD10_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_732CA9DAEF4C50B9DC15DFCE3688DD10" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_732CA9DAEF4C50B9DC15DFCE3688DD10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_732CA9DAEF4C50B9DC15DFCE3688DD10" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_732CA9DAEF4C50B9DC15DFCE3688DD10" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Three</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Three</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_F5BC9EA3A12107F2BEB1DFCE3688F056_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_F5BC9EA3A12107F2BEB1DFCE3688F056" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_F5BC9EA3A12107F2BEB1DFCE3688F056_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_F5BC9EA3A12107F2BEB1DFCE3688F056" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_F5BC9EA3A12107F2BEB1DFCE3688F056" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_F5BC9EA3A12107F2BEB1DFCE3688F056" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_F5BC9EA3A12107F2BEB1DFCE3688F056" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1CE0721BA2AF5D6A89D5DFCE3688AAA3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1CE0721BA2AF5D6A89D5DFCE3688AAA3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1CE0721BA2AF5D6A89D5DFCE3688AAA3_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1CE0721BA2AF5D6A89D5DFCE3688AAA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1CE0721BA2AF5D6A89D5DFCE3688AAA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1CE0721BA2AF5D6A89D5DFCE3688AAA3" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1CE0721BA2AF5D6A89D5DFCE3688AAA3" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Four</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Four</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4DB07100E60E208FC760DFCE368930F9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4DB07100E60E208FC760DFCE368930F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4DB07100E60E208FC760DFCE368930F9_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4DB07100E60E208FC760DFCE368930F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4DB07100E60E208FC760DFCE368930F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4DB07100E60E208FC760DFCE368930F9" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4DB07100E60E208FC760DFCE368930F9" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_12282AB053528E31E669DFCE36896DAE_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_12282AB053528E31E669DFCE36896DAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_12282AB053528E31E669DFCE36896DAE_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_12282AB053528E31E669DFCE36896DAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_12282AB053528E31E669DFCE36896DAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_12282AB053528E31E669DFCE36896DAE" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_12282AB053528E31E669DFCE36896DAE" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Five</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due Year Five</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1E850B123630AAC20BBADFCE3689E57C_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1E850B123630AAC20BBADFCE3689E57C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1E850B123630AAC20BBADFCE3689E57C_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1E850B123630AAC20BBADFCE3689E57C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1E850B123630AAC20BBADFCE3689E57C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1E850B123630AAC20BBADFCE3689E57C" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1E850B123630AAC20BBADFCE3689E57C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5A0E50F281FF088179EDDFCE368923E8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5A0E50F281FF088179EDDFCE368923E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5A0E50F281FF088179EDDFCE368923E8_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5A0E50F281FF088179EDDFCE368923E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5A0E50F281FF088179EDDFCE368923E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5A0E50F281FF088179EDDFCE368923E8" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5A0E50F281FF088179EDDFCE368923E8" xlink:type="arc" />
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6_terseLabel_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6_label_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due After Year Five</link:label>
    <link:label id="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6_documentation_en-US" xlink:label="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Lease Liability Payments Due After Year Five</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6" xlink:to="lab_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1B6718F45A2E24E7A4DADFCE368A4010_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1B6718F45A2E24E7A4DADFCE368A4010" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1B6718F45A2E24E7A4DADFCE368A4010_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1B6718F45A2E24E7A4DADFCE368A4010" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1B6718F45A2E24E7A4DADFCE368A4010" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1B6718F45A2E24E7A4DADFCE368A4010" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1B6718F45A2E24E7A4DADFCE368A4010" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_59707F8F8145EE4142B0DFCE368A3854_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_59707F8F8145EE4142B0DFCE368A3854" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_59707F8F8145EE4142B0DFCE368A3854_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_59707F8F8145EE4142B0DFCE368A3854" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_59707F8F8145EE4142B0DFCE368A3854" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_59707F8F8145EE4142B0DFCE368A3854" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_59707F8F8145EE4142B0DFCE368A3854" xlink:type="arc" />
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Lease Liability Payments Due</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total undiscounted Lease Liability Payments Due for both operating and financing leases</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLeaseLiabilityPaymentsDue" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71" xlink:to="lab_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71" xlink:type="arc" />
    <link:label id="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5_terseLabel_en-US" xlink:label="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: leases not yet commenced (1)</link:label>
    <link:label id="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5_label_en-US" xlink:label="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Operating Lease Liability Not Yet Commenced, Amount</link:label>
    <link:label id="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5_documentation_en-US" xlink:label="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Operating Lease Liability Not Yet Commenced, Amount</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5" xlink:to="lab_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5" xlink:type="arc" />
    <link:label id="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78_terseLabel_en-US" xlink:label="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: leases not yet commenced (1)</link:label>
    <link:label id="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78_label_en-US" xlink:label="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Finance Lease Liability Not Yet Commenced, Amount</link:label>
    <link:label id="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78_documentation_en-US" xlink:label="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Finance Lease Liability Not Yet Commenced, Amount</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78" xlink:to="lab_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78" xlink:type="arc" />
    <link:label id="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: leases not yet commenced (1)</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Lease Liability Not Yet Commenced, Amount</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Lease Liability Not Yet Commenced, Amount</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B" xlink:to="lab_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B" xlink:type="arc" />
    <link:label id="lab_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF_terseLabel_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF_label_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease Imputed Interest</link:label>
    <link:label id="lab_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF_documentation_en-US" xlink:label="lab_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease Imputed Interest</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_OperatingLeaseImputedInterest" xlink:label="loc_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF" xlink:to="lab_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF" xlink:type="arc" />
    <link:label id="lab_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC_terseLabel_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC_label_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease Imputed Interest</link:label>
    <link:label id="lab_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC_documentation_en-US" xlink:label="lab_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finance Lease Imputed Interest</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_FinanceLeaseImputedInterest" xlink:label="loc_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC" xlink:to="lab_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC" xlink:type="arc" />
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA_label_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:label id="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Lease Liability Undiscounted Excess Amount</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA" xlink:to="lab_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_C1EE3F16678C6E96571BDFCE368C22AA_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_C1EE3F16678C6E96571BDFCE368C22AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_C1EE3F16678C6E96571BDFCE368C22AA_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_C1EE3F16678C6E96571BDFCE368C22AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_C1EE3F16678C6E96571BDFCE368C22AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_C1EE3F16678C6E96571BDFCE368C22AA" xlink:to="lab_us-gaap_OperatingLeaseLiability_C1EE3F16678C6E96571BDFCE368C22AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiability_D9EBE2D6419FBCC40EAEDFCE368C8FAC_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_D9EBE2D6419FBCC40EAEDFCE368C8FAC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_D9EBE2D6419FBCC40EAEDFCE368C8FAC_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_D9EBE2D6419FBCC40EAEDFCE368C8FAC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_D9EBE2D6419FBCC40EAEDFCE368C8FAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability_D9EBE2D6419FBCC40EAEDFCE368C8FAC" xlink:to="lab_us-gaap_FinanceLeaseLiability_D9EBE2D6419FBCC40EAEDFCE368C8FAC" xlink:type="arc" />
    <link:label id="lab_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57_terseLabel_en-US" xlink:label="lab_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Lease Liability</link:label>
    <link:label id="lab_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57_label_en-US" xlink:label="lab_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Lease Liability</link:label>
    <link:label id="lab_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57_documentation_en-US" xlink:label="lab_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Lease Liability</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLeaseLiability" xlink:label="loc_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57" xlink:to="lab_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_06A2F6A293A1851C7A4E54B57221A867_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_06A2F6A293A1851C7A4E54B57221A867" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Units</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_06A2F6A293A1851C7A4E54B57221A867" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_06A2F6A293A1851C7A4E54B57221A867" xlink:to="lab_us-gaap_PerformanceSharesMember_06A2F6A293A1851C7A4E54B57221A867" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_C9D9A121D26898E6B40254B572228BF3_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_C9D9A121D26898E6B40254B572228BF3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_C9D9A121D26898E6B40254B572228BF3_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_C9D9A121D26898E6B40254B572228BF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_C9D9A121D26898E6B40254B572228BF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_C9D9A121D26898E6B40254B572228BF3" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_C9D9A121D26898E6B40254B572228BF3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7A68E48636BC1D38815A54B5722322AA_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7A68E48636BC1D38815A54B5722322AA" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7A68E48636BC1D38815A54B5722322AA_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7A68E48636BC1D38815A54B5722322AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7A68E48636BC1D38815A54B5722322AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7A68E48636BC1D38815A54B5722322AA" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7A68E48636BC1D38815A54B5722322AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F3428041D22685DC69754B572236F6B_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F3428041D22685DC69754B572236F6B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F3428041D22685DC69754B572236F6B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F3428041D22685DC69754B572236F6B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F3428041D22685DC69754B572236F6B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F3428041D22685DC69754B572236F6B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F3428041D22685DC69754B572236F6B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_B494025A34EDB61E86E454B57224697B_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_B494025A34EDB61E86E454B57224697B" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_B494025A34EDB61E86E454B57224697B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_B494025A34EDB61E86E454B57224697B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_B494025A34EDB61E86E454B57224697B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_B494025A34EDB61E86E454B57224697B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_B494025A34EDB61E86E454B57224697B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D3325994D23BC206A6BC54B5722469A7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D3325994D23BC206A6BC54B5722469A7" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D3325994D23BC206A6BC54B5722469A7_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D3325994D23BC206A6BC54B5722469A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D3325994D23BC206A6BC54B5722469A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D3325994D23BC206A6BC54B5722469A7" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D3325994D23BC206A6BC54B5722469A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_CA53AA5D5441A31010FE54B57225662F_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_CA53AA5D5441A31010FE54B57225662F" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_CA53AA5D5441A31010FE54B57225662F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_CA53AA5D5441A31010FE54B57225662F" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_CA53AA5D5441A31010FE54B57225662F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4704093ACDCBC1CB49BB54B5722594A4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4704093ACDCBC1CB49BB54B5722594A4" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4704093ACDCBC1CB49BB54B5722594A4_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4704093ACDCBC1CB49BB54B5722594A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4704093ACDCBC1CB49BB54B5722594A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4704093ACDCBC1CB49BB54B5722594A4" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4704093ACDCBC1CB49BB54B5722594A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_FCECC6B08AF38667BEE954B572261033_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_FCECC6B08AF38667BEE954B572261033" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_FCECC6B08AF38667BEE954B572261033_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_FCECC6B08AF38667BEE954B572261033" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_FCECC6B08AF38667BEE954B572261033" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_FCECC6B08AF38667BEE954B572261033" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_FCECC6B08AF38667BEE954B572261033" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_23C867DD3BBBBECCCD4F54B57226A895_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_23C867DD3BBBBECCCD4F54B57226A895" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_23C867DD3BBBBECCCD4F54B57226A895_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_23C867DD3BBBBECCCD4F54B57226A895" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_23C867DD3BBBBECCCD4F54B57226A895" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_23C867DD3BBBBECCCD4F54B57226A895" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_23C867DD3BBBBECCCD4F54B57226A895" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_FB185533383BE84B3C5C54B5722652A7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_FB185533383BE84B3C5C54B5722652A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canceled and forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_FB185533383BE84B3C5C54B5722652A7_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_FB185533383BE84B3C5C54B5722652A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_FB185533383BE84B3C5C54B5722652A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_FB185533383BE84B3C5C54B5722652A7" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_FB185533383BE84B3C5C54B5722652A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C3A4565473AE6AF4B4C154B57227A2B1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C3A4565473AE6AF4B4C154B57227A2B1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (in usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C3A4565473AE6AF4B4C154B57227A2B1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C3A4565473AE6AF4B4C154B57227A2B1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C3A4565473AE6AF4B4C154B57227A2B1" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D6A98376C152C192E56254B57227B97C_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D6A98376C152C192E56254B57227B97C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D6A98376C152C192E56254B57227B97C_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D6A98376C152C192E56254B57227B97C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D6A98376C152C192E56254B57227B97C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D6A98376C152C192E56254B57227B97C" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D6A98376C152C192E56254B57227B97C" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0447D92BF695E6CEC59B54B572284422_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0447D92BF695E6CEC59B54B572284422" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0447D92BF695E6CEC59B54B572284422_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0447D92BF695E6CEC59B54B572284422" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0447D92BF695E6CEC59B54B572284422" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0447D92BF695E6CEC59B54B572284422" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0447D92BF695E6CEC59B54B572284422" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_B3E2A19C12533A899C1554B572283248_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_B3E2A19C12533A899C1554B572283248" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_B3E2A19C12533A899C1554B572283248_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_B3E2A19C12533A899C1554B572283248" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_B3E2A19C12533A899C1554B572283248" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_B3E2A19C12533A899C1554B572283248" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_B3E2A19C12533A899C1554B572283248" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3E702828E07EBD2E5D98F0AC3B8B7D4B_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3E702828E07EBD2E5D98F0AC3B8B7D4B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3E702828E07EBD2E5D98F0AC3B8B7D4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3E702828E07EBD2E5D98F0AC3B8B7D4B" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3E702828E07EBD2E5D98F0AC3B8B7D4B" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_53DAF65F576AC869C1F5F0BEC76354EB_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_53DAF65F576AC869C1F5F0BEC76354EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_53DAF65F576AC869C1F5F0BEC76354EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_53DAF65F576AC869C1F5F0BEC76354EB" xlink:to="lab_us-gaap_Goodwill_53DAF65F576AC869C1F5F0BEC76354EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_CD23C2AD4EA5D9210342F0AC3B8D5185_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_CD23C2AD4EA5D9210342F0AC3B8D5185" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_CD23C2AD4EA5D9210342F0AC3B8D5185_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_CD23C2AD4EA5D9210342F0AC3B8D5185" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_CD23C2AD4EA5D9210342F0AC3B8D5185" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_CD23C2AD4EA5D9210342F0AC3B8D5185" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_CD23C2AD4EA5D9210342F0AC3B8D5185" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_CC902528F885FE408289F0AC3B8EABD5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_CC902528F885FE408289F0AC3B8EABD5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_CC902528F885FE408289F0AC3B8EABD5_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_CC902528F885FE408289F0AC3B8EABD5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_CC902528F885FE408289F0AC3B8EABD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_CC902528F885FE408289F0AC3B8EABD5" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_CC902528F885FE408289F0AC3B8EABD5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3C9B4B70BAF755C3E8B6F0AC3B8E649B_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3C9B4B70BAF755C3E8B6F0AC3B8E649B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated annual amortization of intangible assets - Year Two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3C9B4B70BAF755C3E8B6F0AC3B8E649B_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3C9B4B70BAF755C3E8B6F0AC3B8E649B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3C9B4B70BAF755C3E8B6F0AC3B8E649B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3C9B4B70BAF755C3E8B6F0AC3B8E649B" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3C9B4B70BAF755C3E8B6F0AC3B8E649B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6852269481554733D78BF0AC3B8E1933_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6852269481554733D78BF0AC3B8E1933" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated annual amortization of intangible assets - Year Three</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6852269481554733D78BF0AC3B8E1933_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6852269481554733D78BF0AC3B8E1933" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6852269481554733D78BF0AC3B8E1933" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6852269481554733D78BF0AC3B8E1933" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6852269481554733D78BF0AC3B8E1933" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DB75F51ECE7CDE4DC088F0AC3B8EDC1B_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DB75F51ECE7CDE4DC088F0AC3B8EDC1B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated annual amortization of intangible assets - Year Four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DB75F51ECE7CDE4DC088F0AC3B8EDC1B_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DB75F51ECE7CDE4DC088F0AC3B8EDC1B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DB75F51ECE7CDE4DC088F0AC3B8EDC1B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DB75F51ECE7CDE4DC088F0AC3B8EDC1B" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DB75F51ECE7CDE4DC088F0AC3B8EDC1B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_62E524DAED6EF2D5E7BDF0AC3B8EF2E5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_62E524DAED6EF2D5E7BDF0AC3B8EF2E5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated annual amortization of intangible assets - Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_62E524DAED6EF2D5E7BDF0AC3B8EF2E5_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_62E524DAED6EF2D5E7BDF0AC3B8EF2E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_62E524DAED6EF2D5E7BDF0AC3B8EF2E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_62E524DAED6EF2D5E7BDF0AC3B8EF2E5" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_62E524DAED6EF2D5E7BDF0AC3B8EF2E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_C2191181F373BD7F2F9954B5731D91DA_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_C2191181F373BD7F2F9954B5731D91DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total operating earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_C2191181F373BD7F2F9954B5731D91DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_C2191181F373BD7F2F9954B5731D91DA" xlink:to="lab_us-gaap_OperatingIncomeLoss_C2191181F373BD7F2F9954B5731D91DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_58212119842F6E6A6EE354B573EA9754_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_58212119842F6E6A6EE354B573EA9754" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_58212119842F6E6A6EE354B573EA9754" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_58212119842F6E6A6EE354B573EA9754" xlink:to="lab_us-gaap_EmployeeStockOptionMember_58212119842F6E6A6EE354B573EA9754" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0057E2485D617F3BE16454B573EA114E_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0057E2485D617F3BE16454B573EA114E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of outstanding options at period end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0057E2485D617F3BE16454B573EA114E_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0057E2485D617F3BE16454B573EA114E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0057E2485D617F3BE16454B573EA114E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0057E2485D617F3BE16454B573EA114E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0057E2485D617F3BE16454B573EA114E" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60C5D3939408812594EB54B573EB2C0F_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60C5D3939408812594EB54B573EB2C0F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of exercisable options at period end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60C5D3939408812594EB54B573EB2C0F_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60C5D3939408812594EB54B573EB2C0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60C5D3939408812594EB54B573EB2C0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60C5D3939408812594EB54B573EB2C0F" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60C5D3939408812594EB54B573EB2C0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_472CED317DCE97C429B354B573EB4AE1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_472CED317DCE97C429B354B573EB4AE1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_472CED317DCE97C429B354B573EB4AE1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_472CED317DCE97C429B354B573EB4AE1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_472CED317DCE97C429B354B573EB4AE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_472CED317DCE97C429B354B573EB4AE1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_472CED317DCE97C429B354B573EB4AE1" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_36C9C01D539AF720C75254B573EBC407_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_36C9C01D539AF720C75254B573EBC407" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_36C9C01D539AF720C75254B573EBC407_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_36C9C01D539AF720C75254B573EBC407" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_36C9C01D539AF720C75254B573EBC407" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_36C9C01D539AF720C75254B573EBC407" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_36C9C01D539AF720C75254B573EBC407" xlink:type="arc" />
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_FCCF175EC352F5326FF454B57414738A_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_FCCF175EC352F5326FF454B57414738A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_FCCF175EC352F5326FF454B57414738A_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract_FCCF175EC352F5326FF454B57414738A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_FCCF175EC352F5326FF454B57414738A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract_FCCF175EC352F5326FF454B57414738A" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract_FCCF175EC352F5326FF454B57414738A" xlink:type="arc" />
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B_terseLabel_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B_label_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:label id="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B_documentation_en-US" xlink:label="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reclassification of deferred rent in accordance with ASC 842</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B" xlink:to="lab_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_F7B6D405D2B014A39D2154B57414CE94_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_F7B6D405D2B014A39D2154B57414CE94" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_F7B6D405D2B014A39D2154B57414CE94_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_F7B6D405D2B014A39D2154B57414CE94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_F7B6D405D2B014A39D2154B57414CE94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_F7B6D405D2B014A39D2154B57414CE94" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_F7B6D405D2B014A39D2154B57414CE94" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_3DA1EE631F009CB2C74054B574153B56_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_3DA1EE631F009CB2C74054B574153B56" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_3DA1EE631F009CB2C74054B574153B56_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_3DA1EE631F009CB2C74054B574153B56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_3DA1EE631F009CB2C74054B574153B56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_3DA1EE631F009CB2C74054B574153B56" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_3DA1EE631F009CB2C74054B574153B56" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2F5AAA372653C88F4BC854B574155D50_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2F5AAA372653C88F4BC854B574155D50" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2F5AAA372653C88F4BC854B574155D50_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2F5AAA372653C88F4BC854B574155D50" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2F5AAA372653C88F4BC854B574155D50" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2F5AAA372653C88F4BC854B574155D50" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2F5AAA372653C88F4BC854B574155D50" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9142D1EFC988F5D39B8E54B5741582CB_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9142D1EFC988F5D39B8E54B5741582CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9142D1EFC988F5D39B8E54B5741582CB_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9142D1EFC988F5D39B8E54B5741582CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9142D1EFC988F5D39B8E54B5741582CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9142D1EFC988F5D39B8E54B5741582CB" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9142D1EFC988F5D39B8E54B5741582CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_4E2AB8DFA2FDAD492BCB54B574159D3F_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_4E2AB8DFA2FDAD492BCB54B574159D3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_4E2AB8DFA2FDAD492BCB54B574159D3F_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_4E2AB8DFA2FDAD492BCB54B574159D3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_4E2AB8DFA2FDAD492BCB54B574159D3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_4E2AB8DFA2FDAD492BCB54B574159D3F" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_4E2AB8DFA2FDAD492BCB54B574159D3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_BA8E7B1AA40DD6F059EA54B574162FFD_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_BA8E7B1AA40DD6F059EA54B574162FFD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_BA8E7B1AA40DD6F059EA54B574162FFD_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_BA8E7B1AA40DD6F059EA54B574162FFD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_BA8E7B1AA40DD6F059EA54B574162FFD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_BA8E7B1AA40DD6F059EA54B574162FFD" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_BA8E7B1AA40DD6F059EA54B574162FFD" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_FDB21F279BA129DCB85B54B57416174C_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_FDB21F279BA129DCB85B54B57416174C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_FDB21F279BA129DCB85B54B57416174C_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_FDB21F279BA129DCB85B54B57416174C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_FDB21F279BA129DCB85B54B57416174C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_FDB21F279BA129DCB85B54B57416174C" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_FDB21F279BA129DCB85B54B57416174C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_664BCAC05EF0148BA37654B574169625_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_664BCAC05EF0148BA37654B574169625" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_664BCAC05EF0148BA37654B574169625_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_664BCAC05EF0148BA37654B574169625" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_664BCAC05EF0148BA37654B574169625" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_664BCAC05EF0148BA37654B574169625" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_664BCAC05EF0148BA37654B574169625" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseCost_94AFB79F8C0E184A92A054B5744A36D8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost_94AFB79F8C0E184A92A054B5744A36D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_94AFB79F8C0E184A92A054B5744A36D8_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost_94AFB79F8C0E184A92A054B5744A36D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_94AFB79F8C0E184A92A054B5744A36D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost_94AFB79F8C0E184A92A054B5744A36D8" xlink:to="lab_us-gaap_OperatingLeaseCost_94AFB79F8C0E184A92A054B5744A36D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_39EC19F0065690383A4654B5744A1E3B_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_39EC19F0065690383A4654B5744A1E3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_39EC19F0065690383A4654B5744A1E3B_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_39EC19F0065690383A4654B5744A1E3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_39EC19F0065690383A4654B5744A1E3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_39EC19F0065690383A4654B5744A1E3B" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_39EC19F0065690383A4654B5744A1E3B" xlink:type="arc" />
    <link:label id="lab_cah_TotalFinanceLeaseCost_08E918EDD992C5AEC7BE54B5744BFFA6_totalLabel_en-US" xlink:label="lab_cah_TotalFinanceLeaseCost_08E918EDD992C5AEC7BE54B5744BFFA6" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total finance lease cost</link:label>
    <link:label id="lab_cah_TotalFinanceLeaseCost_08E918EDD992C5AEC7BE54B5744BFFA6_label_en-US" xlink:label="lab_cah_TotalFinanceLeaseCost_08E918EDD992C5AEC7BE54B5744BFFA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Finance Lease Cost</link:label>
    <link:label id="lab_cah_TotalFinanceLeaseCost_08E918EDD992C5AEC7BE54B5744BFFA6_documentation_en-US" xlink:label="lab_cah_TotalFinanceLeaseCost_08E918EDD992C5AEC7BE54B5744BFFA6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Finance Lease Cost</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalFinanceLeaseCost" xlink:label="loc_cah_TotalFinanceLeaseCost_08E918EDD992C5AEC7BE54B5744BFFA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TotalFinanceLeaseCost_08E918EDD992C5AEC7BE54B5744BFFA6" xlink:to="lab_cah_TotalFinanceLeaseCost_08E918EDD992C5AEC7BE54B5744BFFA6" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableLeaseCost_075384FA59BBB7C218AB54B5744BBB56_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost_075384FA59BBB7C218AB54B5744BBB56" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_075384FA59BBB7C218AB54B5744BBB56_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost_075384FA59BBB7C218AB54B5744BBB56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_075384FA59BBB7C218AB54B5744BBB56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost_075384FA59BBB7C218AB54B5744BBB56" xlink:to="lab_us-gaap_VariableLeaseCost_075384FA59BBB7C218AB54B5744BBB56" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseCost_01C2A963775A3C23B7FD54B5744B4B4D_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost_01C2A963775A3C23B7FD54B5744B4B4D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_01C2A963775A3C23B7FD54B5744B4B4D_label_en-US" xlink:label="lab_us-gaap_LeaseCost_01C2A963775A3C23B7FD54B5744B4B4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_01C2A963775A3C23B7FD54B5744B4B4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost_01C2A963775A3C23B7FD54B5744B4B4D" xlink:to="lab_us-gaap_LeaseCost_01C2A963775A3C23B7FD54B5744B4B4D" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_2E68C935903C64DEC90254B5723636A7_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_2E68C935903C64DEC90254B5723636A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Share Units</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2E68C935903C64DEC90254B5723636A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_2E68C935903C64DEC90254B5723636A7" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_2E68C935903C64DEC90254B5723636A7" xlink:type="arc" />
    <link:label id="lab_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306_terseLabel_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:label id="lab_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306_label_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:label id="lab_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306_documentation_en-US" xlink:label="lab_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Period in years for Shares</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_VestingPeriodinyearsforShares" xlink:label="loc_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306" xlink:to="lab_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_054DA05A0FDCD448C6C054B5723896BB_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_054DA05A0FDCD448C6C054B5723896BB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax benefit related to share-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_054DA05A0FDCD448C6C054B5723896BB_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_054DA05A0FDCD448C6C054B5723896BB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_054DA05A0FDCD448C6C054B5723896BB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_054DA05A0FDCD448C6C054B5723896BB" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_054DA05A0FDCD448C6C054B5723896BB" xlink:type="arc" />
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568_terseLabel_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable period of plans (in years)</link:label>
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568_label_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercisable period of plans, in years</link:label>
    <link:label id="lab_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568_documentation_en-US" xlink:label="lab_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The instrument's contractual term.</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_ExercisablePeriodOfPlansInYears" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568" xlink:to="lab_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1B7A0DE3E93FA891DB6154B5723AAC02_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1B7A0DE3E93FA891DB6154B5723AAC02" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Target performance goal (as a percent)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1B7A0DE3E93FA891DB6154B5723AAC02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1B7A0DE3E93FA891DB6154B5723AAC02" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1B7A0DE3E93FA891DB6154B5723AAC02" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B" xlink:to="lab_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:to="lab_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:type="arc" />
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4_terseLabel_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4_label_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:label id="lab_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4_documentation_en-US" xlink:label="lab_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharmaceutical Distribution and Specialty [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_PharmaceuticalDistributionandSpecialtyMember" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4" xlink:to="lab_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4" xlink:type="arc" />
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C_terseLabel_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C_label_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:label id="lab_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C_documentation_en-US" xlink:label="lab_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Nuclear Precision Health Services [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_NuclearPrecisionHealthServicesMember" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C" xlink:to="lab_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C" xlink:type="arc" />
    <link:label id="lab_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953_terseLabel_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:label id="lab_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953_label_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:label id="lab_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953_documentation_en-US" xlink:label="lab_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical distribution and products [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicaldistributionandproductsMember" xlink:label="loc_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953" xlink:to="lab_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953" xlink:type="arc" />
    <link:label id="lab_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50_terseLabel_en-US" xlink:label="lab_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cardinal Health At Home [Member]</link:label>
    <link:label id="lab_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50_label_en-US" xlink:label="lab_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cardinal Health At Home [Member]</link:label>
    <link:label id="lab_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50_documentation_en-US" xlink:label="lab_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cardinal Health At Home [Member]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_CardinalHealthAtHomeMember" xlink:label="loc_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50" xlink:to="lab_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_A5C3853D1A1C2635448854B572FF1E10_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues_A5C3853D1A1C2635448854B572FF1E10" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_A5C3853D1A1C2635448854B572FF1E10" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_A5C3853D1A1C2635448854B572FF1E10" xlink:to="lab_us-gaap_Revenues_A5C3853D1A1C2635448854B572FF1E10" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Share Units</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:to="lab_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_6F419679033CEF0DC53E54B573BEEDC5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember_6F419679033CEF0DC53E54B573BEEDC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee- Related Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_6F419679033CEF0DC53E54B573BEEDC5_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember_6F419679033CEF0DC53E54B573BEEDC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_6F419679033CEF0DC53E54B573BEEDC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember_6F419679033CEF0DC53E54B573BEEDC5" xlink:to="lab_us-gaap_EmployeeSeveranceMember_6F419679033CEF0DC53E54B573BEEDC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FacilityClosingMember_44451552D5961426377F54B573BE82C9_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember_44451552D5961426377F54B573BE82C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility Exit and Other Costs</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_44451552D5961426377F54B573BE82C9_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember_44451552D5961426377F54B573BE82C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_44451552D5961426377F54B573BE82C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember_44451552D5961426377F54B573BE82C9" xlink:to="lab_us-gaap_FacilityClosingMember_44451552D5961426377F54B573BE82C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:to="lab_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_0A43E9224AA4F10B739554B573BFEFC9_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_0A43E9224AA4F10B739554B573BFEFC9" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_0A43E9224AA4F10B739554B573BFEFC9_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve_0A43E9224AA4F10B739554B573BFEFC9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_0A43E9224AA4F10B739554B573BFEFC9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_0A43E9224AA4F10B739554B573BFEFC9" xlink:to="lab_us-gaap_RestructuringReserve_0A43E9224AA4F10B739554B573BFEFC9" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCosts_E59B59EAE07CA0A8C51754B573BF0369_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts_E59B59EAE07CA0A8C51754B573BF0369" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_E59B59EAE07CA0A8C51754B573BF0369" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts_E59B59EAE07CA0A8C51754B573BF0369" xlink:to="lab_us-gaap_RestructuringCosts_E59B59EAE07CA0A8C51754B573BF0369" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRestructuring_909254ABE38CE9F044D754B573C23CCF_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_909254ABE38CE9F044D754B573C23CCF" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments and other adjustments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_909254ABE38CE9F044D754B573C23CCF_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_909254ABE38CE9F044D754B573C23CCF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_909254ABE38CE9F044D754B573C23CCF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring_909254ABE38CE9F044D754B573C23CCF" xlink:to="lab_us-gaap_PaymentsForRestructuring_909254ABE38CE9F044D754B573C23CCF" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_8B1863C8287F7F22265D54B573C25A04_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_8B1863C8287F7F22265D54B573C25A04" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_8B1863C8287F7F22265D54B573C25A04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_8B1863C8287F7F22265D54B573C25A04" xlink:to="lab_us-gaap_RestructuringReserve_8B1863C8287F7F22265D54B573C25A04" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1245D4A192F09A84B81F54B572C388D4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1245D4A192F09A84B81F54B572C388D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1245D4A192F09A84B81F54B572C388D4_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1245D4A192F09A84B81F54B572C388D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1245D4A192F09A84B81F54B572C388D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1245D4A192F09A84B81F54B572C388D4" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1245D4A192F09A84B81F54B572C388D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5F4434E4E7F3D8F1A84454B574625BAD_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5F4434E4E7F3D8F1A84454B574625BAD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares&#8211;basic (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5F4434E4E7F3D8F1A84454B574625BAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5F4434E4E7F3D8F1A84454B574625BAD" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5F4434E4E7F3D8F1A84454B574625BAD" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_49593BA867DA43FF605054B574629DC5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_49593BA867DA43FF605054B574629DC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_49593BA867DA43FF605054B574629DC5_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_49593BA867DA43FF605054B574629DC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_49593BA867DA43FF605054B574629DC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_49593BA867DA43FF605054B574629DC5" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_49593BA867DA43FF605054B574629DC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_085311D51B03BA80C50F54B57462332C_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_085311D51B03BA80C50F54B57462332C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee stock options, restricted share units, and performance share units (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_085311D51B03BA80C50F54B57462332C_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_085311D51B03BA80C50F54B57462332C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_085311D51B03BA80C50F54B57462332C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_085311D51B03BA80C50F54B57462332C" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_085311D51B03BA80C50F54B57462332C" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9213D4A3999F4106841654B574629037_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9213D4A3999F4106841654B574629037" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted-average common shares&#8211;diluted (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9213D4A3999F4106841654B574629037" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9213D4A3999F4106841654B574629037" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9213D4A3999F4106841654B574629037" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9DC42AADE10B905F4B3FE018CD1FAFD8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9DC42AADE10B905F4B3FE018CD1FAFD8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9DC42AADE10B905F4B3FE018CD1FAFD8_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9DC42AADE10B905F4B3FE018CD1FAFD8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9DC42AADE10B905F4B3FE018CD1FAFD8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9DC42AADE10B905F4B3FE018CD1FAFD8" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9DC42AADE10B905F4B3FE018CD1FAFD8" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_025214D2EF1B987AACAEE0186FB84CDC_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_025214D2EF1B987AACAEE0186FB84CDC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_025214D2EF1B987AACAEE0186FB84CDC_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_025214D2EF1B987AACAEE0186FB84CDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_025214D2EF1B987AACAEE0186FB84CDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_025214D2EF1B987AACAEE0186FB84CDC" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_025214D2EF1B987AACAEE0186FB84CDC" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_D1A0AAE37C08E5FDD5A6E019ADDC2615_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_D1A0AAE37C08E5FDD5A6E019ADDC2615" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_D1A0AAE37C08E5FDD5A6E019ADDC2615_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_D1A0AAE37C08E5FDD5A6E019ADDC2615" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_D1A0AAE37C08E5FDD5A6E019ADDC2615" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_D1A0AAE37C08E5FDD5A6E019ADDC2615" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_D1A0AAE37C08E5FDD5A6E019ADDC2615" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeaseLiability_F12BD083BC0163E1851DDFCE369C726D_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability_F12BD083BC0163E1851DDFCE369C726D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_F12BD083BC0163E1851DDFCE369C726D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability_F12BD083BC0163E1851DDFCE369C726D" xlink:to="lab_us-gaap_OperatingLeaseLiability_F12BD083BC0163E1851DDFCE369C726D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6F00892AD59E88CB4608DFCE369D62CE_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability_6F00892AD59E88CB4608DFCE369D62CE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_6F00892AD59E88CB4608DFCE369D62CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability_6F00892AD59E88CB4608DFCE369D62CE" xlink:to="lab_us-gaap_FinanceLeaseLiability_6F00892AD59E88CB4608DFCE369D62CE" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_C8FE86708ABEE7064167E017BB43843E_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset_C8FE86708ABEE7064167E017BB43843E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_C8FE86708ABEE7064167E017BB43843E_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset_C8FE86708ABEE7064167E017BB43843E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_C8FE86708ABEE7064167E017BB43843E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_C8FE86708ABEE7064167E017BB43843E" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset_C8FE86708ABEE7064167E017BB43843E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_88A24DE02377AE112637E018013545B9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent_88A24DE02377AE112637E018013545B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_88A24DE02377AE112637E018013545B9_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent_88A24DE02377AE112637E018013545B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_88A24DE02377AE112637E018013545B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent_88A24DE02377AE112637E018013545B9" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent_88A24DE02377AE112637E018013545B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_4DC80B5C67A3ACA82DA3E01918DC74B2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_4DC80B5C67A3ACA82DA3E01918DC74B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_4DC80B5C67A3ACA82DA3E01918DC74B2_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_4DC80B5C67A3ACA82DA3E01918DC74B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4DC80B5C67A3ACA82DA3E01918DC74B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4DC80B5C67A3ACA82DA3E01918DC74B2" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_4DC80B5C67A3ACA82DA3E01918DC74B2" xlink:type="arc" />
    <link:label id="lab_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5_label_en-US" xlink:label="lab_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="lab_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_545E18FEB374466214B754B5732EC423_terseLabel_en-US" xlink:label="lab_dei_DocumentType_545E18FEB374466214B754B5732EC423" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_545E18FEB374466214B754B5732EC423_label_en-US" xlink:label="lab_dei_DocumentType_545E18FEB374466214B754B5732EC423" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_545E18FEB374466214B754B5732EC423" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_545E18FEB374466214B754B5732EC423" xlink:to="lab_dei_DocumentType_545E18FEB374466214B754B5732EC423" xlink:type="arc" />
    <link:label id="lab_dei_DocumentQuarterlyReport_F8D7602D7758E0F0B97A54B5732E9A08_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport_F8D7602D7758E0F0B97A54B5732E9A08" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_F8D7602D7758E0F0B97A54B5732E9A08_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport_F8D7602D7758E0F0B97A54B5732E9A08" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_F8D7602D7758E0F0B97A54B5732E9A08" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport_F8D7602D7758E0F0B97A54B5732E9A08" xlink:to="lab_dei_DocumentQuarterlyReport_F8D7602D7758E0F0B97A54B5732E9A08" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_12D5317699A13667A0EA54B5732FE6C1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_12D5317699A13667A0EA54B5732FE6C1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_12D5317699A13667A0EA54B5732FE6C1_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_12D5317699A13667A0EA54B5732FE6C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_12D5317699A13667A0EA54B5732FE6C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_12D5317699A13667A0EA54B5732FE6C1" xlink:to="lab_dei_DocumentPeriodEndDate_12D5317699A13667A0EA54B5732FE6C1" xlink:type="arc" />
    <link:label id="lab_dei_DocumentTransitionReport_4443CC2B63E5632BE07454B573302DE0_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport_4443CC2B63E5632BE07454B573302DE0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_4443CC2B63E5632BE07454B573302DE0_label_en-US" xlink:label="lab_dei_DocumentTransitionReport_4443CC2B63E5632BE07454B573302DE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_4443CC2B63E5632BE07454B573302DE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_4443CC2B63E5632BE07454B573302DE0" xlink:to="lab_dei_DocumentTransitionReport_4443CC2B63E5632BE07454B573302DE0" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_D48B236B3C29ABEAE9B654B573301802_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_D48B236B3C29ABEAE9B654B573301802" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_D48B236B3C29ABEAE9B654B573301802_label_en-US" xlink:label="lab_dei_EntityFileNumber_D48B236B3C29ABEAE9B654B573301802" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_D48B236B3C29ABEAE9B654B573301802" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_D48B236B3C29ABEAE9B654B573301802" xlink:to="lab_dei_EntityFileNumber_D48B236B3C29ABEAE9B654B573301802" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_598893DD9C9AA089244454B573303F1B_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_598893DD9C9AA089244454B573303F1B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_598893DD9C9AA089244454B573303F1B_label_en-US" xlink:label="lab_dei_EntityRegistrantName_598893DD9C9AA089244454B573303F1B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_598893DD9C9AA089244454B573303F1B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_598893DD9C9AA089244454B573303F1B" xlink:to="lab_dei_EntityRegistrantName_598893DD9C9AA089244454B573303F1B" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_C6E7317B1E12C8FF368E54B57330B851_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_C6E7317B1E12C8FF368E54B57330B851" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_C6E7317B1E12C8FF368E54B57330B851_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_C6E7317B1E12C8FF368E54B57330B851" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_C6E7317B1E12C8FF368E54B57330B851" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_C6E7317B1E12C8FF368E54B57330B851" xlink:to="lab_dei_EntityCentralIndexKey_C6E7317B1E12C8FF368E54B57330B851" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_167BAA2F876675D5884854B573303558_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_167BAA2F876675D5884854B573303558" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_167BAA2F876675D5884854B573303558_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_167BAA2F876675D5884854B573303558" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_167BAA2F876675D5884854B573303558" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_167BAA2F876675D5884854B573303558" xlink:to="lab_dei_CurrentFiscalYearEndDate_167BAA2F876675D5884854B573303558" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_9AD6F8DD3A451322DDF954B573319933_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_9AD6F8DD3A451322DDF954B573319933" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_9AD6F8DD3A451322DDF954B573319933_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_9AD6F8DD3A451322DDF954B573319933" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_9AD6F8DD3A451322DDF954B573319933" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_9AD6F8DD3A451322DDF954B573319933" xlink:to="lab_dei_DocumentFiscalYearFocus_9AD6F8DD3A451322DDF954B573319933" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_0632926104DA7ED2ABEF54B573316BD3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0632926104DA7ED2ABEF54B573316BD3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_0632926104DA7ED2ABEF54B573316BD3_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0632926104DA7ED2ABEF54B573316BD3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_0632926104DA7ED2ABEF54B573316BD3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_0632926104DA7ED2ABEF54B573316BD3" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0632926104DA7ED2ABEF54B573316BD3" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_DD31B7188967288671B354B573314745_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_DD31B7188967288671B354B573314745" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_DD31B7188967288671B354B573314745_label_en-US" xlink:label="lab_dei_AmendmentFlag_DD31B7188967288671B354B573314745" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_DD31B7188967288671B354B573314745" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_DD31B7188967288671B354B573314745" xlink:to="lab_dei_AmendmentFlag_DD31B7188967288671B354B573314745" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_9D613F48069E8DA19FBB54B57331E27C_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_9D613F48069E8DA19FBB54B57331E27C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_9D613F48069E8DA19FBB54B57331E27C_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_9D613F48069E8DA19FBB54B57331E27C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9D613F48069E8DA19FBB54B57331E27C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_9D613F48069E8DA19FBB54B57331E27C" xlink:to="lab_dei_EntityIncorporationStateCountryCode_9D613F48069E8DA19FBB54B57331E27C" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_90C7F27512CB9FC0057754B57332B99F_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_90C7F27512CB9FC0057754B57332B99F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_90C7F27512CB9FC0057754B57332B99F_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_90C7F27512CB9FC0057754B57332B99F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_90C7F27512CB9FC0057754B57332B99F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_90C7F27512CB9FC0057754B57332B99F" xlink:to="lab_dei_EntityTaxIdentificationNumber_90C7F27512CB9FC0057754B57332B99F" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_10B4D5AACBE9739B30C354B57332A837_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_10B4D5AACBE9739B30C354B57332A837" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_10B4D5AACBE9739B30C354B57332A837_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_10B4D5AACBE9739B30C354B57332A837" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_10B4D5AACBE9739B30C354B57332A837" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_10B4D5AACBE9739B30C354B57332A837" xlink:to="lab_dei_EntityAddressAddressLine1_10B4D5AACBE9739B30C354B57332A837" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_8FCFECD793D8203C87B754B573321A6F_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_8FCFECD793D8203C87B754B573321A6F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_8FCFECD793D8203C87B754B573321A6F_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_8FCFECD793D8203C87B754B573321A6F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_8FCFECD793D8203C87B754B573321A6F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_8FCFECD793D8203C87B754B573321A6F" xlink:to="lab_dei_EntityAddressCityOrTown_8FCFECD793D8203C87B754B573321A6F" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_F9F86F36BED75C3A876D54B573334E8F_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_F9F86F36BED75C3A876D54B573334E8F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_F9F86F36BED75C3A876D54B573334E8F_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_F9F86F36BED75C3A876D54B573334E8F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_F9F86F36BED75C3A876D54B573334E8F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_F9F86F36BED75C3A876D54B573334E8F" xlink:to="lab_dei_EntityAddressStateOrProvince_F9F86F36BED75C3A876D54B573334E8F" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_2B44BE9C6009AA5AF77E54B573338DEC_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_2B44BE9C6009AA5AF77E54B573338DEC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2B44BE9C6009AA5AF77E54B573338DEC_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_2B44BE9C6009AA5AF77E54B573338DEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_2B44BE9C6009AA5AF77E54B573338DEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_2B44BE9C6009AA5AF77E54B573338DEC" xlink:to="lab_dei_EntityAddressPostalZipCode_2B44BE9C6009AA5AF77E54B573338DEC" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_A8DA60D101BD01EE45DE54B573332C24_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_A8DA60D101BD01EE45DE54B573332C24" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_A8DA60D101BD01EE45DE54B573332C24_label_en-US" xlink:label="lab_dei_CityAreaCode_A8DA60D101BD01EE45DE54B573332C24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_A8DA60D101BD01EE45DE54B573332C24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_A8DA60D101BD01EE45DE54B573332C24" xlink:to="lab_dei_CityAreaCode_A8DA60D101BD01EE45DE54B573332C24" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_4B7B17F9532C38BFBDC454B573331506_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_4B7B17F9532C38BFBDC454B573331506" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_4B7B17F9532C38BFBDC454B573331506_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_4B7B17F9532C38BFBDC454B573331506" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_4B7B17F9532C38BFBDC454B573331506" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_4B7B17F9532C38BFBDC454B573331506" xlink:to="lab_dei_LocalPhoneNumber_4B7B17F9532C38BFBDC454B573331506" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_EA5E0671F68013B2D02554B573348EF0_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_EA5E0671F68013B2D02554B573348EF0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_EA5E0671F68013B2D02554B573348EF0_label_en-US" xlink:label="lab_dei_Security12bTitle_EA5E0671F68013B2D02554B573348EF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_EA5E0671F68013B2D02554B573348EF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_EA5E0671F68013B2D02554B573348EF0" xlink:to="lab_dei_Security12bTitle_EA5E0671F68013B2D02554B573348EF0" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_5BBEB9E8D025489EB48F54B573342FBE_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_5BBEB9E8D025489EB48F54B573342FBE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_5BBEB9E8D025489EB48F54B573342FBE_label_en-US" xlink:label="lab_dei_TradingSymbol_5BBEB9E8D025489EB48F54B573342FBE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_5BBEB9E8D025489EB48F54B573342FBE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_5BBEB9E8D025489EB48F54B573342FBE" xlink:to="lab_dei_TradingSymbol_5BBEB9E8D025489EB48F54B573342FBE" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_3253AD4BE17B461F801354B573341700_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_3253AD4BE17B461F801354B573341700" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_3253AD4BE17B461F801354B573341700_label_en-US" xlink:label="lab_dei_SecurityExchangeName_3253AD4BE17B461F801354B573341700" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_3253AD4BE17B461F801354B573341700" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_3253AD4BE17B461F801354B573341700" xlink:to="lab_dei_SecurityExchangeName_3253AD4BE17B461F801354B573341700" xlink:type="arc" />
    <link:label id="lab_dei_EntityCurrentReportingStatus_691CC8936F3F3098AF8954B57335A656_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_691CC8936F3F3098AF8954B57335A656" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_691CC8936F3F3098AF8954B57335A656_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_691CC8936F3F3098AF8954B57335A656" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_691CC8936F3F3098AF8954B57335A656" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_691CC8936F3F3098AF8954B57335A656" xlink:to="lab_dei_EntityCurrentReportingStatus_691CC8936F3F3098AF8954B57335A656" xlink:type="arc" />
    <link:label id="lab_dei_EntityInteractiveDataCurrent_3171812F09931BE1120054B57335031E_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent_3171812F09931BE1120054B57335031E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_3171812F09931BE1120054B57335031E_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent_3171812F09931BE1120054B57335031E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_3171812F09931BE1120054B57335031E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_3171812F09931BE1120054B57335031E" xlink:to="lab_dei_EntityInteractiveDataCurrent_3171812F09931BE1120054B57335031E" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_D883CE3F722D9CB08A5254B573354584_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory_D883CE3F722D9CB08A5254B573354584" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_D883CE3F722D9CB08A5254B573354584_label_en-US" xlink:label="lab_dei_EntityFilerCategory_D883CE3F722D9CB08A5254B573354584" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_D883CE3F722D9CB08A5254B573354584" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_D883CE3F722D9CB08A5254B573354584" xlink:to="lab_dei_EntityFilerCategory_D883CE3F722D9CB08A5254B573354584" xlink:type="arc" />
    <link:label id="lab_dei_EntitySmallBusiness_8D392ACFE2626AA5856D54B57335F321_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness_8D392ACFE2626AA5856D54B57335F321" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_8D392ACFE2626AA5856D54B57335F321_label_en-US" xlink:label="lab_dei_EntitySmallBusiness_8D392ACFE2626AA5856D54B57335F321" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_8D392ACFE2626AA5856D54B57335F321" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_8D392ACFE2626AA5856D54B57335F321" xlink:to="lab_dei_EntitySmallBusiness_8D392ACFE2626AA5856D54B57335F321" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_163A38302CB05C7A4C7854B5733546EC_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_163A38302CB05C7A4C7854B5733546EC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_163A38302CB05C7A4C7854B5733546EC_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_163A38302CB05C7A4C7854B5733546EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_163A38302CB05C7A4C7854B5733546EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_163A38302CB05C7A4C7854B5733546EC" xlink:to="lab_dei_EntityEmergingGrowthCompany_163A38302CB05C7A4C7854B5733546EC" xlink:type="arc" />
    <link:label id="lab_dei_EntityShellCompany_DDE241E8A1C7E6D3752954B5733544BF_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany_DDE241E8A1C7E6D3752954B5733544BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_DDE241E8A1C7E6D3752954B5733544BF_label_en-US" xlink:label="lab_dei_EntityShellCompany_DDE241E8A1C7E6D3752954B5733544BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_DDE241E8A1C7E6D3752954B5733544BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_DDE241E8A1C7E6D3752954B5733544BF" xlink:to="lab_dei_EntityShellCompany_DDE241E8A1C7E6D3752954B5733544BF" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_D03844073265C321ED7A54B57336F4BE_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_D03844073265C321ED7A54B57336F4BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_D03844073265C321ED7A54B57336F4BE_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_D03844073265C321ED7A54B57336F4BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_D03844073265C321ED7A54B57336F4BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_D03844073265C321ED7A54B57336F4BE" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_D03844073265C321ED7A54B57336F4BE" xlink:type="arc" />
    <link:label id="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013_terseLabel_en-US" xlink:label="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Revenue from External Customers by Geographic Area [Table]</link:label>
    <link:label id="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013_label_en-US" xlink:label="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Revenue from External Customers by Geographic Area [Table]</link:label>
    <link:label id="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013_documentation_en-US" xlink:label="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Segment Revenue from External Customers by Geographic Area [Table]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable" xlink:label="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:to="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:type="arc" />
    <link:label id="lab_country_US_AAB354A69C6256CB74C454B573CCE43D_terseLabel_en-US" xlink:label="lab_country_US_AAB354A69C6256CB74C454B573CCE43D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_AAB354A69C6256CB74C454B573CCE43D_label_en-US" xlink:label="lab_country_US_AAB354A69C6256CB74C454B573CCE43D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_country_US_AAB354A69C6256CB74C454B573CCE43D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_AAB354A69C6256CB74C454B573CCE43D" xlink:to="lab_country_US_AAB354A69C6256CB74C454B573CCE43D" xlink:type="arc" />
    <link:label id="lab_us-gaap_NonUsMember_26B4A6CFBA6DF9853A3554B573CC89E6_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember_26B4A6CFBA6DF9853A3554B573CC89E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:label id="lab_us-gaap_NonUsMember_26B4A6CFBA6DF9853A3554B573CC89E6_label_en-US" xlink:label="lab_us-gaap_NonUsMember_26B4A6CFBA6DF9853A3554B573CC89E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_26B4A6CFBA6DF9853A3554B573CC89E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember_26B4A6CFBA6DF9853A3554B573CC89E6" xlink:to="lab_us-gaap_NonUsMember_26B4A6CFBA6DF9853A3554B573CC89E6" xlink:type="arc" />
    <link:label id="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E_terseLabel_en-US" xlink:label="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Revenue from External Customers by Geographic Area [Line Items]</link:label>
    <link:label id="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E_label_en-US" xlink:label="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Revenue from External Customers by Geographic Area [Line Items]</link:label>
    <link:label id="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E_documentation_en-US" xlink:label="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Line Items] for Segment Revenue from External Customers by Geographic Area [Table]</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems" xlink:label="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E" xlink:to="lab_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_CF848043C4BDA48A275F54B57287A0D5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_CF848043C4BDA48A275F54B57287A0D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Obligations and Other Short-Term Borrowings</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_CF848043C4BDA48A275F54B57287A0D5_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_CF848043C4BDA48A275F54B57287A0D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_CF848043C4BDA48A275F54B57287A0D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock_CF848043C4BDA48A275F54B57287A0D5" xlink:to="lab_us-gaap_DebtDisclosureTextBlock_CF848043C4BDA48A275F54B57287A0D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_271342994C2F8A9E741854B7D1496D7B_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_271342994C2F8A9E741854B7D1496D7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_271342994C2F8A9E741854B7D1496D7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_271342994C2F8A9E741854B7D1496D7B" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_271342994C2F8A9E741854B7D1496D7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9AD97541805E27C1C7C954B7D14AB84D_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9AD97541805E27C1C7C954B7D14AB84D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income/(loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9AD97541805E27C1C7C954B7D14AB84D_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9AD97541805E27C1C7C954B7D14AB84D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9AD97541805E27C1C7C954B7D14AB84D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9AD97541805E27C1C7C954B7D14AB84D" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9AD97541805E27C1C7C954B7D14AB84D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_484052C922119F83DF4454B7D14ACFAE_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_484052C922119F83DF4454B7D14ACFAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_484052C922119F83DF4454B7D14ACFAE_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_484052C922119F83DF4454B7D14ACFAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_484052C922119F83DF4454B7D14ACFAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_484052C922119F83DF4454B7D14ACFAE" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_484052C922119F83DF4454B7D14ACFAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_00C437D0BBA986F065B954B7D14A6049_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_00C437D0BBA986F065B954B7D14A6049" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net unrealized loss on derivative instruments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_00C437D0BBA986F065B954B7D14A6049_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_00C437D0BBA986F065B954B7D14A6049" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_00C437D0BBA986F065B954B7D14A6049" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_00C437D0BBA986F065B954B7D14A6049" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_00C437D0BBA986F065B954B7D14A6049" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_C6728DCBEF90157DC2FC54B7D14B7D99_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_C6728DCBEF90157DC2FC54B7D14B7D99" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income/(loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_C6728DCBEF90157DC2FC54B7D14B7D99_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_C6728DCBEF90157DC2FC54B7D14B7D99" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_C6728DCBEF90157DC2FC54B7D14B7D99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_C6728DCBEF90157DC2FC54B7D14B7D99" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_C6728DCBEF90157DC2FC54B7D14B7D99" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_1FB06163768D5AC9613B54B7D14B0F6A_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_1FB06163768D5AC9613B54B7D14B0F6A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income attributable to Cardinal Health, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_1FB06163768D5AC9613B54B7D14B0F6A_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_1FB06163768D5AC9613B54B7D14B0F6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1FB06163768D5AC9613B54B7D14B0F6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1FB06163768D5AC9613B54B7D14B0F6A" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_1FB06163768D5AC9613B54B7D14B0F6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockMember_58301B1564AE68AEE22754B574C820CC_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_58301B1564AE68AEE22754B574C820CC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Treasury Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_58301B1564AE68AEE22754B574C820CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember_58301B1564AE68AEE22754B574C820CC" xlink:to="lab_us-gaap_TreasuryStockMember_58301B1564AE68AEE22754B574C820CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:to="lab_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_045D18BFB8DC2EB5C28354B574C92B98_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_045D18BFB8DC2EB5C28354B574C92B98" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_045D18BFB8DC2EB5C28354B574C92B98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_045D18BFB8DC2EB5C28354B574C92B98" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_045D18BFB8DC2EB5C28354B574C92B98" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_D4CF059169F01009598454B574CA5332_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_D4CF059169F01009598454B574CA5332" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_D4CF059169F01009598454B574CA5332" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_D4CF059169F01009598454B574CA5332" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_D4CF059169F01009598454B574CA5332" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38655F808B7037A10D8754B574CA5EAE_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38655F808B7037A10D8754B574CA5EAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares acquired, average price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38655F808B7037A10D8754B574CA5EAE_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38655F808B7037A10D8754B574CA5EAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38655F808B7037A10D8754B574CA5EAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38655F808B7037A10D8754B574CA5EAE" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38655F808B7037A10D8754B574CA5EAE" xlink:type="arc" />
    <link:label id="lab_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0_terseLabel_en-US" xlink:label="lab_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock Acquired Shares</link:label>
    <link:label id="lab_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0_label_en-US" xlink:label="lab_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock Acquired Shares</link:label>
    <link:label id="lab_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0_documentation_en-US" xlink:label="lab_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Treasury Stock Acquired Shares</link:label>
    <link:loc xlink:href="cah-20200331.xsd#cah_TreasuryStockAcquiredShares" xlink:label="loc_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0" xlink:to="lab_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cah-20200331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="cah-20200331.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:href="cah-20200331.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cah-20200331.xsd#BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:href="cah-20200331.xsd#CommitmentsContingentLiabilitiesAndLitigation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:href="cah-20200331.xsd#CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets" xlink:href="cah-20200331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="cah-20200331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfEarnings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity" xlink:href="cah-20200331.xsd#CondensedConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/CoverPage" xlink:href="cah-20200331.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:href="cah-20200331.xsd#EarningsPerShareAttributableToCardinalHealthInc" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:href="cah-20200331.xsd#EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:href="cah-20200331.xsd#EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:href="cah-20200331.xsd#EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurements" xlink:href="cah-20200331.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:href="cah-20200331.xsd#FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:href="cah-20200331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstruments" xlink:href="cah-20200331.xsd#FinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:href="cah-20200331.xsd#FinancialInstrumentsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20200331.xsd#FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:href="cah-20200331.xsd#FinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:href="cah-20200331.xsd#GoodwillAndOtherIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxes" xlink:href="cah-20200331.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:href="cah-20200331.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Investments" xlink:href="cah-20200331.xsd#Investments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/InvestmentsInvestmentsDetails" xlink:href="cah-20200331.xsd#InvestmentsInvestmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/Leases" xlink:href="cah-20200331.xsd#Leases" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesDetails" xlink:href="cah-20200331.xsd#LeasesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" xlink:href="cah-20200331.xsd#LeasesScheduleOfFutureLeasePaymentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails" xlink:href="cah-20200331.xsd#LeasesScheduleOfLeaseCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:href="cah-20200331.xsd#LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:href="cah-20200331.xsd#LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LeasesTables" xlink:href="cah-20200331.xsd#LeasesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:href="cah-20200331.xsd#LongTermObligationsAndOtherShortTermBorrowings" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:href="cah-20200331.xsd#LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:href="cah-20200331.xsd#LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:href="cah-20200331.xsd#LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeverance" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeveranceNarativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:href="cah-20200331.xsd#RestructuringAndEmployeeSeveranceTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformation" xlink:href="cah-20200331.xsd#SegmentInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:href="cah-20200331.xsd#SegmentInformationAssetsByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:href="cah-20200331.xsd#SegmentInformationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:href="cah-20200331.xsd#SegmentInformationRevenueByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails" xlink:href="cah-20200331.xsd#SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:href="cah-20200331.xsd#SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/SegmentInformationTables" xlink:href="cah-20200331.xsd#SegmentInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensation" xlink:href="cah-20200331.xsd#ShareBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:href="cah-20200331.xsd#ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:href="cah-20200331.xsd#ShareBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquity" xlink:href="cah-20200331.xsd#ShareholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="cah-20200331.xsd#ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:href="cah-20200331.xsd#ShareholdersEquityNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:href="cah-20200331.xsd#ShareholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_11F265EB0FBFAEBE34B154B57296965C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9131E61F3A3AB711824154B5729757E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_11F265EB0FBFAEBE34B154B57296965C" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9131E61F3A3AB711824154B5729757E0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_87845F2F17AEDFF4EB7654B574B68FCB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_87845F2F17AEDFF4EB7654B574B68FCB" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE" xlink:to="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CFC2732D7548C40059DA54B574B879C9" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_56824DEAFE9B180E62EE54B574B87CE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5BA86DAB9470476E49D354B574B7CCFE" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842" xlink:label="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_019C069314028EE22B1354B574B81A15" xlink:to="loc_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842_32A302083114E090435354B574BA0C90" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_56618B2F7EC7746A278754B573E13BFF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_472B96828B52758FE44F54B573E164AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56618B2F7EC7746A278754B573E13BFF" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_472B96828B52758FE44F54B573E164AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_C09CDD1B36031B9920DA54B573E262BC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56618B2F7EC7746A278754B573E13BFF" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_C09CDD1B36031B9920DA54B573E262BC" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_F539E553F59455C7C2C854B5723D6A98" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9918B25200D0B3B2EB8554B5723D3818" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_F539E553F59455C7C2C854B5723D6A98" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9918B25200D0B3B2EB8554B5723D3818" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BA76E6A1CD71EF1E8B03F5E148CB3FCA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_BA76E6A1CD71EF1E8B03F5E148CB3FCA" xlink:to="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_GownRecallAxis" xlink:label="loc_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GownRecallAxis_E9204AA40F29BD133C4CF5E148CB40F5" xlink:to="loc_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallMemberDomain" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GownRecallDomain_80421BB4E3D837289B96F5E148CC6081" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3CE7E8DADBDB727438B3F5E148CCCC29" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6FD1F70E062174C575A5F5E148CD487D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_00570DEB136BE016853CF5E148CD9EAB" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_B68769866057D0AFD815F5E148CD902C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_7EAE618E90C25876BDF9F5E148CDBB26" xlink:to="loc_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalOpioidLitigationnetoftaxMember" xlink:label="loc_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:to="loc_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_9F509B13BF17C7ADAF02F5E148CD723B" xlink:to="loc_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LawsuitTypeAxis" xlink:label="loc_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LawsuitTypeDomain" xlink:label="loc_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LawsuitTypeAxis_18A2CCDF9F6D4195490FF5E148D328D1" xlink:to="loc_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ClassActionLawsuitsMember" xlink:label="loc_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LawsuitTypeDomain_C61D437E28E0925992FDF5E148D37A41" xlink:to="loc_cah_ClassActionLawsuitsMember_CAE7D24C37C8E18FDA3CF5E148D40B78" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PlaintiffTypeAxis" xlink:label="loc_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PlaintiffTypeDomain" xlink:label="loc_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PlaintiffTypeAxis_D485FE037A97F42F5C17F5E148D40AF3" xlink:to="loc_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PrivatePartiesMember" xlink:label="loc_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_PlaintiffTypeDomain_776D5943EEDAC86E4465F5E148D4417A" xlink:to="loc_cah_PrivatePartiesMember_016517230FEC640C6A52F5E148D5D4D5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMattersAgreementAxis" xlink:label="loc_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMattersAgreementAxis_92C3FCDB7F0673C11547F5E148D50C3A" xlink:to="loc_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:to="loc_cah_TotalOpioidLitigationMember_2F0B8DBF7294A5C3665AF5E148CE19C2" xlink:type="arc" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMattersAgreementDomain_0DE08216A7152B465109F5E148D586D2" xlink:to="loc_cah_TotalOpioidLitigationnetoftaxMember_0E93F569E4C1572EA684F5E148CE76F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_243227641DA402AF62D1F5E148D697DA" xlink:to="loc_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_AlamedaCountyMember" xlink:label="loc_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:to="loc_cah_AlamedaCountyMember_FDBF179793D243CB3EE1F5E148D6BBE1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OtherJurisdictionsMember" xlink:label="loc_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_52B69FF089E0E4131D2DF5E148D6D600" xlink:to="loc_cah_OtherJurisdictionsMember_9321B2AA61F06CF8DD3CF5E148D7841E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1E4314418E89C5474FAEF5E148D70AE9" xlink:to="loc_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_DD0155DDF9750AB20D57F5E148D7359C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:to="loc_srt_MinimumMember_DD0155DDF9750AB20D57F5E148D7359C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_196F4318D19F3C206017F5E148D86ED0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2B415C1FDA0048EC31A7F5E148D76CF2" xlink:to="loc_srt_MaximumMember_196F4318D19F3C206017F5E148D86ED0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_64676EDEBC4242891017F5E148D87C43" xlink:to="loc_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLawsuitsMember" xlink:label="loc_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:to="loc_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ProductLiabilityLawsuitsMember" xlink:label="loc_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_1F458F4DAD0139431A29F5E148D842CC" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_2E4E78E8664E86AA2DC9F5E148D96C73" xlink:to="loc_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CVSHealthMember" xlink:label="loc_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_E9ACCD07165EC9719CB1F5E148D91605" xlink:to="loc_cah_CVSHealthMember_0047982BE73081DE6060F5E148DA8C25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_1ABBE33601A1AE270C91F5E148DA559D" xlink:to="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLawsuitsStateDomain" xlink:label="loc_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="loc_cah_OpioidLawsuitsStateDomain_E66AF45083ABEEF9E8F0F5E148DBED12" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationlessCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="loc_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember_7ACF505140E2B29355D4F5E148DB8013" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationCuyahogaandSummitCountiesMember" xlink:label="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="loc_cah_OpioidLitigationCuyahogaandSummitCountiesMember_031D834947A8442FB42CF5E148DB726B" xlink:type="arc" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="loc_cah_OpioidLawsuitsMember_5D3C97A0370367A3C3A3F5E148D9597E" xlink:type="arc" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_1292FE6B83C41FB696AFF5E148CC6DBD" xlink:type="arc" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9E7DB68DE8620BE3E78EF5E148DB1FFF" xlink:to="loc_cah_ProductLiabilityLawsuitsMember_FFCF3419C3828BDBDE24F5E148D9DE61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_B314C11C531AC8B1C6A9F5E148E1BAF4" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_E4895499992AE68FB1D2F5E148E21EF8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_15FB461AA1693D4817A5F5E148E28E09" xlink:to="loc_us-gaap_SubsequentEventMember_E4895499992AE68FB1D2F5E148E21EF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_55EF5F22671151F6F482F5E148CB90C0" xlink:to="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_BD4D4DC9A3076B9A1A55F5E148E37738" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_InventoryNet_BD4D4DC9A3076B9A1A55F5E148E37738" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_0BF62F4B2ED5E9236254F5E148E3F336" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_LongtermPurchaseCommitmentPeriod_0BF62F4B2ED5E9236254F5E148E3F336" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MaximumQuarterlyPayment" xlink:label="loc_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_cah_MaximumQuarterlyPayment_4A431A41130065C8DA46F5E148E378FF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LossContingencyLawsuitsNumber" xlink:label="loc_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_cah_LossContingencyLawsuitsNumber_D67542E621124DD3311AF5E148E39D18" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_NumberofStateAttorneysGeneralfilinglawsuits" xlink:label="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_cah_NumberofStateAttorneysGeneralfilinglawsuits_1FB0855DB143D1CC536CF5E148E489F4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CashComponentForSettlementFrameworkTerm" xlink:label="loc_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_cah_CashComponentForSettlementFrameworkTerm_E40CB9BC7D7A0BD29667F5E148E58A4F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidTotalSettlementCuyahogaandSummitCounties" xlink:label="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_cah_OpioidTotalSettlementCuyahogaandSummitCounties_EB2CF813033BDD740104F5E148E56F4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_1348E8E38F1257CC181AF5E14DF2BE1A" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_1348E8E38F1257CC181AF5E14DF2BE1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_A47C0010A960059DD977F5E148E57EEB" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_LitigationReserve_A47C0010A960059DD977F5E148E57EEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_3BF47C00D1158D3E10D9F5E148E5F53C" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_3BF47C00D1158D3E10D9F5E148E5F53C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_6F79A0C190292C805A9EF5E148E6F815" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_6F79A0C190292C805A9EF5E148E6F815" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_A5FFAFB0428159338092F5E148E6D442" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_A5FFAFB0428159338092F5E148E6D442" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRecallExpense" xlink:label="loc_us-gaap_InventoryRecallExpense_AB0FA8FC50B77D6AC4E6F5E148E6AF5B" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_InventoryRecallExpense_AB0FA8FC50B77D6AC4E6F5E148E6AF5B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_93ADDF2C90EE69B6B2BFF5E148E72032" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_93ADDF2C90EE69B6B2BFF5E148E72032" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_822A32DFCB3DC6FF9721F5E148E7D3FF" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_822A32DFCB3DC6FF9721F5E148E7D3FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_B807203D2802DA0C4A91F5E148E7907E" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_06DE901CF6C7A8F51FFBF5E148E288AF" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_B807203D2802DA0C4A91F5E148E7907E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_93ED125BE5DA92C81AE4F0AC3C4DB90B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_93ED125BE5DA92C81AE4F0AC3C4DB90B" xlink:to="loc_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_E562DE8544F3684957FEF0AC3C4EDD15" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_E562DE8544F3684957FEF0AC3C4EDD15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_190DBAE9F7AB77A4DDFEF0AC3C4E24DC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7" xlink:to="loc_us-gaap_ReceivablesNetCurrent_190DBAE9F7AB77A4DDFEF0AC3C4E24DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_5B2A16771DB665F3721CF0AC3C4EF0E3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7" xlink:to="loc_us-gaap_InventoryNet_5B2A16771DB665F3721CF0AC3C4EF0E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_B7F7F5C1AC8D750FA62DF0AC3C4F3965" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7" xlink:to="loc_us-gaap_OtherAssetsCurrent_B7F7F5C1AC8D750FA62DF0AC3C4F3965" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_D2AFE21E4F7304876923F0AC3C4F5A00" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_CF8EE0E8E0C9570C5857F0AC3C4EB6F7" xlink:to="loc_us-gaap_AssetsCurrent_D2AFE21E4F7304876923F0AC3C4F5A00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_E0AED599A56A2B6E3008F0AC3C4F134D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_E0AED599A56A2B6E3008F0AC3C4F134D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_248801F3CBC697B5FB9EF0AC3C4FB1A9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_248801F3CBC697B5FB9EF0AC3C4FB1A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_801BBA32DDF4C79A6953F0AC3C4FF1B9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_801BBA32DDF4C79A6953F0AC3C4FF1B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_A365456516D86BF6C37EF0AC3C4FDF51" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_85E54CCA21F73533B3EEF0AC3C4D1FD3" xlink:to="loc_us-gaap_Assets_A365456516D86BF6C37EF0AC3C4FDF51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_93ED125BE5DA92C81AE4F0AC3C4DB90B" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_F132B2C3AD55FF3A3BDBF0AC3C500FBB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8" xlink:to="loc_us-gaap_AccountsPayableCurrent_F132B2C3AD55FF3A3BDBF0AC3C500FBB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1FB699D4674954296AD3F0AC3C501579" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1FB699D4674954296AD3F0AC3C501579" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_04C2327FC7AF52C690B9F0AC3C518FFD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_04C2327FC7AF52C690B9F0AC3C518FFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_6E03FEFEA7D4E00B80F5F0AC3C51A4D6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_C20582875C1F581C5142F0AC3C5058B8" xlink:to="loc_us-gaap_LiabilitiesCurrent_6E03FEFEA7D4E00B80F5F0AC3C51A4D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4B7FB5D343734E183499F0AC3C51A450" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4B7FB5D343734E183499F0AC3C51A450" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_50D6AEEC8366BAC9B3FFF0AC3C51B4CF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_50D6AEEC8366BAC9B3FFF0AC3C51B4CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0" xlink:to="loc_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_F91540A800ABA777EA4FF0AC3C5223D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:to="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_F91540A800ABA777EA4FF0AC3C5223D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_05D245FF940F2974AA91F0AC3C5285E1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_F91540A800ABA777EA4FF0AC3C5223D0" xlink:to="loc_us-gaap_PreferredStockValue_05D245FF940F2974AA91F0AC3C5285E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_EEC1378000E299666013F0AC3C522232" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_EEC1378000E299666013F0AC3C522232" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_98D2CB6C5CAB15B0E4BCF0AC3C52C344" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_EEC1378000E299666013F0AC3C522232" xlink:to="loc_us-gaap_CommonStockValue_98D2CB6C5CAB15B0E4BCF0AC3C52C344" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3F30731A8CA8E37AF625F0AC3C5331F5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3F30731A8CA8E37AF625F0AC3C5331F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_37E3DC30F555F7FBD031F0AC3C537FB2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:to="loc_us-gaap_TreasuryStockValue_37E3DC30F555F7FBD031F0AC3C537FB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_F9FFBF785F029E495B80F0AC3C53611B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_F9FFBF785F029E495B80F0AC3C53611B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_CAC03BF78D654C79871FF0AC3C535DDC" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:to="loc_us-gaap_StockholdersEquity_CAC03BF78D654C79871FF0AC3C535DDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_F34B6D8E129A799F0092F0AC3C5379BC" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:to="loc_us-gaap_MinorityInterest_F34B6D8E129A799F0092F0AC3C5379BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_A79E85744B6BA89B3610F0AC3C536BA2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5FB711AC6C250278B22BF0AC3C51D066" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_A79E85744B6BA89B3610F0AC3C536BA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_A802DC3FBFACD7FEE474F0AC3C549B58" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_DDA5CFC3EA13D9D70FEBF0AC3C50D7E0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_A802DC3FBFACD7FEE474F0AC3C549B58" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3A556EC99D495071C11E54B5720F1DAE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_799817CC0289FFB8FC8654B5720FE01D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3A556EC99D495071C11E54B5720F1DAE" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_799817CC0289FFB8FC8654B5720FE01D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6ED8709DFD4D6021DBD354B57210B1B7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3A556EC99D495071C11E54B5720F1DAE" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6ED8709DFD4D6021DBD354B57210B1B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_00C1DFB1F29E10E1F0B854B572107B0D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3A556EC99D495071C11E54B5720F1DAE" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_00C1DFB1F29E10E1F0B854B572107B0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_88BFB4A77F7A26B30B0254B57210E809" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3A556EC99D495071C11E54B5720F1DAE" xlink:to="loc_us-gaap_CommonStockSharesIssued_88BFB4A77F7A26B30B0254B57210E809" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_9B23FDEA7393E18EBCCB54B57211C330" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3A556EC99D495071C11E54B5720F1DAE" xlink:to="loc_us-gaap_TreasuryStockShares_9B23FDEA7393E18EBCCB54B57211C330" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16332F89CE56772ECD7BF0AC3BF5E2CC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16332F89CE56772ECD7BF0AC3BF5E2CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_BA4BBFEEE7101D12AD1DF0AC3BF5CC98" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16332F89CE56772ECD7BF0AC3BF5E2CC" xlink:to="loc_us-gaap_ProfitLoss_BA4BBFEEE7101D12AD1DF0AC3BF5CC98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16332F89CE56772ECD7BF0AC3BF5E2CC" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_84C5440366AA67F047C0F0AC3BF6FD75" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_84C5440366AA67F047C0F0AC3BF6FD75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_AD2F6D0449A4FDFC6994F0AC3BF63828" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:to="loc_us-gaap_LossOnSaleOfInvestments_AD2F6D0449A4FDFC6994F0AC3BF63828" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_A31603C3BB89DC0E11FBF0AC3BF6B3C0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_A31603C3BB89DC0E11FBF0AC3BF6B3C0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_F9477A28B8A0E18130EAF0AC3BF6B332" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_F9477A28B8A0E18130EAF0AC3BF6B332" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_76FEB8C026F4C8E7AA04F0AC3BF69336" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:to="loc_us-gaap_ShareBasedCompensation_76FEB8C026F4C8E7AA04F0AC3BF69336" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_F70F504A87139A4CE942F0AC3BF7104B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_F70F504A87139A4CE942F0AC3BF7104B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8B848A3A6084D91B8604F0AC3BF6CDC4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_281F7401132DEA2EB5EEF0AC3BF70357" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_281F7401132DEA2EB5EEF0AC3BF70357" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_679B7488D8764686699EF0AC3BF7230E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_679B7488D8764686699EF0AC3BF7230E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_97F75241A5E9E611171DF0AC3BF89375" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_97F75241A5E9E611171DF0AC3BF89375" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9694AA8BD50FE22142F2F0AC3BF8325D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FA02069F03F78283274EF0AC3BF73831" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9694AA8BD50FE22142F2F0AC3BF8325D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_B040BFB1D2D0E7EA3E11F0AC3BF86B72" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_16332F89CE56772ECD7BF0AC3BF5E2CC" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_B040BFB1D2D0E7EA3E11F0AC3BF86B72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EA1C9A15902B9275FED1F0AC3BF843CA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EA1C9A15902B9275FED1F0AC3BF843CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6CF34B15C54F8F60DDE4F0AC3BF86984" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6CF34B15C54F8F60DDE4F0AC3BF86984" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Purchaseofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_2A081ACA180DB0B495B4F0AC3BF9C965" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:to="loc_cah_Purchaseofavailableforsalesecuritiesandotherinvestments_2A081ACA180DB0B495B4F0AC3BF9C965" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments" xlink:label="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_E3A575AA609C57175D27F0AC3BF96C19" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:to="loc_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments_E3A575AA609C57175D27F0AC3BF96C19" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets" xlink:label="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_73C9281D1558BD7FE34AF0AC3BF9EB7C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:to="loc_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets_73C9281D1558BD7FE34AF0AC3BF9EB7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_FAE274A360D4BF934C7FF0AC3BF9002B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_FA18BA725CCDE6E3AB46F0AC3BF81860" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_FAE274A360D4BF934C7FF0AC3BF9002B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_FF8A5E57B6B65F0A77A4F0AC3BF962FA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_FF8A5E57B6B65F0A77A4F0AC3BF962FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_15498F95646917A0B685F0AC3BFA4C1F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_15498F95646917A0B685F0AC3BFA4C1F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Netproceedstaxwithholdingsfromsharebasedcompensation" xlink:label="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_803A554BC56169779D77F0AC3BFA4443" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:to="loc_cah_Netproceedstaxwithholdingsfromsharebasedcompensation_803A554BC56169779D77F0AC3BFA4443" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_B034B66FCA3F9D7F476AF0AC3BFA3AAF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_B034B66FCA3F9D7F476AF0AC3BFA3AAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_B772A81C88F3FFF65113F0AC3BFAB159" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_B772A81C88F3FFF65113F0AC3BFAB159" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_DA4CD893B0BE5A5990BFF0AC3BFA348F" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6355FDA0D7D53B8911DAF0AC3BF95A5C" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_DA4CD893B0BE5A5990BFF0AC3BFA348F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D0C949E34A5CE0B7B245F0AC3BFB5466" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_D0C949E34A5CE0B7B245F0AC3BFB5466" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6FEC69E1102765FD371BF0AC3BFB0A37" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6FEC69E1102765FD371BF0AC3BFB0A37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7F9FFFD17ABF49164002F0AC3BFBA7F5" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7F9FFFD17ABF49164002F0AC3BFBA7F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_DCCB1CF924142CB05635F0AC3BFB4840" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2CD2289ADD2F016B9C7DF0AC3BF5BE98" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_DCCB1CF924142CB05635F0AC3BFB4840" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_271342994C2F8A9E741854B7D1496D7B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_C0EB63FDFEFC760180F754B7D1497EBB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_271342994C2F8A9E741854B7D1496D7B" xlink:to="loc_us-gaap_ProfitLoss_C0EB63FDFEFC760180F754B7D1497EBB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9AD97541805E27C1C7C954B7D14AB84D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_271342994C2F8A9E741854B7D1496D7B" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9AD97541805E27C1C7C954B7D14AB84D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_484052C922119F83DF4454B7D14ACFAE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9AD97541805E27C1C7C954B7D14AB84D" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_484052C922119F83DF4454B7D14ACFAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_00C437D0BBA986F065B954B7D14A6049" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9AD97541805E27C1C7C954B7D14AB84D" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_00C437D0BBA986F065B954B7D14A6049" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0209CE4F57D60BC224C454B7D14B8718" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9AD97541805E27C1C7C954B7D14AB84D" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0209CE4F57D60BC224C454B7D14B8718" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_C6728DCBEF90157DC2FC54B7D14B7D99" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_271342994C2F8A9E741854B7D1496D7B" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_C6728DCBEF90157DC2FC54B7D14B7D99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_B56618203819C88C982B54B7D14B8708" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_271342994C2F8A9E741854B7D1496D7B" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_B56618203819C88C982B54B7D14B8708" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1FB06163768D5AC9613B54B7D14B0F6A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_271342994C2F8A9E741854B7D1496D7B" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1FB06163768D5AC9613B54B7D14B0F6A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_2E8C9EBC5811EFA85B9154B572DF3EF3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_Revenues_2E8C9EBC5811EFA85B9154B572DF3EF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_61692A7D54AC8064022D54B572DF8F1A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_61692A7D54AC8064022D54B572DF8F1A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_8D7772478641AFC17D0254B572E0C216" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_GrossProfit_8D7772478641AFC17D0254B572E0C216" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_D72EC1C491205A7DCBAF54B572E013CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_D72EC1C491205A7DCBAF54B572E013CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_CDF4B21AC14F8F96DE3F54B572E0C768" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017" xlink:to="loc_us-gaap_RestructuringCharges_CDF4B21AC14F8F96DE3F54B572E0C768" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Amortizationandotheracquisitionrelatedcosts" xlink:label="loc_cah_Amortizationandotheracquisitionrelatedcosts_CCBBB2BCA9BFB863915254B572E1EBCE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017" xlink:to="loc_cah_Amortizationandotheracquisitionrelatedcosts_CCBBB2BCA9BFB863915254B572E1EBCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_6E46ABC8B2C3A10D464654B572E16070" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_6E46ABC8B2C3A10D464654B572E16070" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_683739BF136091A0A11754B572E11FAD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87F281B1260A76D7C0A154B572E03017" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_683739BF136091A0A11754B572E11FAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_B46CC140C19BE76FC26754B572E10220" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_OperatingIncomeLoss_B46CC140C19BE76FC26754B572E10220" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_FCCABECB22D05CAE2F7154B572E1DF5D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_FCCABECB22D05CAE2F7154B572E1DF5D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_D1D4F2D423C33A61E61354B572E1C663" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_InterestExpense_D1D4F2D423C33A61E61354B572E1C663" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_75D953B0697BB1354ECF54B572E2DC22" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_75D953B0697BB1354ECF54B572E2DC22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_526F87E9985AA8C5E40754B572E2D035" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_526F87E9985AA8C5E40754B572E2D035" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_C4B0F9FC61395FCAE96654B572E20108" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_C4B0F9FC61395FCAE96654B572E20108" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_8F5BA48AFE5C97397F3054B572E26201" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_ProfitLoss_8F5BA48AFE5C97397F3054B572E26201" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_D2EF79A80191AED231DB54B572E2BE98" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_D2EF79A80191AED231DB54B572E2BE98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_5E8E1A3194B6378D2D7654B572E3D4A7" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_NetIncomeLoss_5E8E1A3194B6378D2D7654B572E3D4A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_666F8EEDEA0A52186C0F54B572E32277" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_666F8EEDEA0A52186C0F54B572E32277" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3633077D56AB9C33FC4154B572E36929" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_666F8EEDEA0A52186C0F54B572E32277" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_3633077D56AB9C33FC4154B572E36929" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4661682005A9B9551DA454B572E3572D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_666F8EEDEA0A52186C0F54B572E32277" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4661682005A9B9551DA454B572E3572D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3CF4632F7F0E76234A6A54B572E4D553" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3CF4632F7F0E76234A6A54B572E4D553" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_C349EA4BE008CE4A777254B572E43696" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_C349EA4BE008CE4A777254B572E43696" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_E419CA82BE4F1B5D835554B572E48001" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_C349EA4BE008CE4A777254B572E43696" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_E419CA82BE4F1B5D835554B572E48001" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79D4D658883010C9F20954B572E48463" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_C349EA4BE008CE4A777254B572E43696" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79D4D658883010C9F20954B572E48463" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_156D6B5C9A20386DEB8454B572E48B1F" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6E1073589D3C1754CC7554B572DF9577" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_156D6B5C9A20386DEB8454B572E48B1F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7350CA2D1E17D6752278DFCE37542B6B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_744AD22119BF75BADFE9DFCE37547AF0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7350CA2D1E17D6752278DFCE37542B6B" xlink:to="loc_us-gaap_StatementTable_744AD22119BF75BADFE9DFCE37547AF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1FC4D5163E7E52DBB7B1DFCE37542450" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_744AD22119BF75BADFE9DFCE37547AF0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1FC4D5163E7E52DBB7B1DFCE37542450" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1FC4D5163E7E52DBB7B1DFCE37542450" xlink:to="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_D6E2D7303BF37034D9D2DFCE37556628" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:to="loc_us-gaap_CommonStockMember_D6E2D7303BF37034D9D2DFCE37556628" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_6E00BF17987EF4914406DFCE3755A5AC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:to="loc_us-gaap_RetainedEarningsMember_6E00BF17987EF4914406DFCE3755A5AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_341712EB20D7B035B589DFCE3756CB3C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:to="loc_us-gaap_TreasuryStockMember_341712EB20D7B035B589DFCE3756CB3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A771459543EBB0482EC8DFCE3756042C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_A771459543EBB0482EC8DFCE3756042C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ED7C7DFAD8ECFD6F0192DFCE37561E6D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_68DDA3E06479E2341C4EDFCE375525C6" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ED7C7DFAD8ECFD6F0192DFCE37561E6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_744AD22119BF75BADFE9DFCE37547AF0" xlink:to="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_CE51D0CDEFF6B0256163DFCE3757A191" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_CommonStockSharesIssued_CE51D0CDEFF6B0256163DFCE3757A191" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5FEEBC2CBA29163D08E1DFCE3757451D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5FEEBC2CBA29163D08E1DFCE3757451D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_E5680FD2C62E03183474DFCE37578884" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_TreasuryStockShares_E5680FD2C62E03183474DFCE37578884" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_52DD935B8ABA283E7535DFCE37573B7C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_TreasuryStockValue_52DD935B8ABA283E7535DFCE37573B7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_19A30678FD9272217C3DDFCE37572F41" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_ProfitLoss_19A30678FD9272217C3DDFCE37572F41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_A95CC2C65DA98C155A6EDFCE3757D5DD" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_NetIncomeLoss_A95CC2C65DA98C155A6EDFCE3757D5DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91EA59B3AF77E7CCBACEDFCE3758EC2A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91EA59B3AF77E7CCBACEDFCE3758EC2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9605DE00460407B804D6DFCE375884F2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9605DE00460407B804D6DFCE375884F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8663C8160C90999B2063DFCE37585882" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8663C8160C90999B2063DFCE37585882" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9E51EC60BE54D1962A51DFCE37592C52" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9E51EC60BE54D1962A51DFCE37592C52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_E96788A48827864F846FDFCE3759E03F" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_E96788A48827864F846FDFCE3759E03F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_106978E340915798E272DFCE3759A860" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_106978E340915798E272DFCE3759A860" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_DF0B8F558607CED0DDFFDFCE37593BE9" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_Dividends_DF0B8F558607CED0DDFFDFCE37593BE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="loc_us-gaap_StockholdersEquityOther_C4A1A9C6B0C27F5BF69DDFCE3759B1FB" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_StockholdersEquityOther_C4A1A9C6B0C27F5BF69DDFCE3759B1FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_0439A87331DB529F58B5DFCE375AA7F9" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_CommonStockSharesIssued_0439A87331DB529F58B5DFCE375AA7F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1FDCFFDFF455FBF2FE80DFCE375A1135" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1FDCFFDFF455FBF2FE80DFCE375A1135" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_BD81C907193634A3A498DFCE375A0734" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_TreasuryStockShares_BD81C907193634A3A498DFCE375A0734" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_E68875997574EF033049DFCE375A3374" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_76A1487DE602DB37F962DFCE3756357A" xlink:to="loc_us-gaap_TreasuryStockValue_E68875997574EF033049DFCE375A3374" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_545E18FEB374466214B754B5732EC423" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_DocumentType_545E18FEB374466214B754B5732EC423" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_F8D7602D7758E0F0B97A54B5732E9A08" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_DocumentQuarterlyReport_F8D7602D7758E0F0B97A54B5732E9A08" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_12D5317699A13667A0EA54B5732FE6C1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_DocumentPeriodEndDate_12D5317699A13667A0EA54B5732FE6C1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_4443CC2B63E5632BE07454B573302DE0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_DocumentTransitionReport_4443CC2B63E5632BE07454B573302DE0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_D48B236B3C29ABEAE9B654B573301802" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityFileNumber_D48B236B3C29ABEAE9B654B573301802" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_598893DD9C9AA089244454B573303F1B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityRegistrantName_598893DD9C9AA089244454B573303F1B" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_C6E7317B1E12C8FF368E54B57330B851" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityCentralIndexKey_C6E7317B1E12C8FF368E54B57330B851" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_167BAA2F876675D5884854B573303558" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_CurrentFiscalYearEndDate_167BAA2F876675D5884854B573303558" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_9AD6F8DD3A451322DDF954B573319933" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_DocumentFiscalYearFocus_9AD6F8DD3A451322DDF954B573319933" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_0632926104DA7ED2ABEF54B573316BD3" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_0632926104DA7ED2ABEF54B573316BD3" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_DD31B7188967288671B354B573314745" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_AmendmentFlag_DD31B7188967288671B354B573314745" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9D613F48069E8DA19FBB54B57331E27C" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_9D613F48069E8DA19FBB54B57331E27C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_90C7F27512CB9FC0057754B57332B99F" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityTaxIdentificationNumber_90C7F27512CB9FC0057754B57332B99F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_10B4D5AACBE9739B30C354B57332A837" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityAddressAddressLine1_10B4D5AACBE9739B30C354B57332A837" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_8FCFECD793D8203C87B754B573321A6F" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityAddressCityOrTown_8FCFECD793D8203C87B754B573321A6F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_F9F86F36BED75C3A876D54B573334E8F" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityAddressStateOrProvince_F9F86F36BED75C3A876D54B573334E8F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_2B44BE9C6009AA5AF77E54B573338DEC" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityAddressPostalZipCode_2B44BE9C6009AA5AF77E54B573338DEC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_A8DA60D101BD01EE45DE54B573332C24" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_CityAreaCode_A8DA60D101BD01EE45DE54B573332C24" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_4B7B17F9532C38BFBDC454B573331506" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_LocalPhoneNumber_4B7B17F9532C38BFBDC454B573331506" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_EA5E0671F68013B2D02554B573348EF0" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_Security12bTitle_EA5E0671F68013B2D02554B573348EF0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_5BBEB9E8D025489EB48F54B573342FBE" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_TradingSymbol_5BBEB9E8D025489EB48F54B573342FBE" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_3253AD4BE17B461F801354B573341700" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_SecurityExchangeName_3253AD4BE17B461F801354B573341700" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_691CC8936F3F3098AF8954B57335A656" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityCurrentReportingStatus_691CC8936F3F3098AF8954B57335A656" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_3171812F09931BE1120054B57335031E" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityInteractiveDataCurrent_3171812F09931BE1120054B57335031E" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_D883CE3F722D9CB08A5254B573354584" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityFilerCategory_D883CE3F722D9CB08A5254B573354584" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_8D392ACFE2626AA5856D54B57335F321" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntitySmallBusiness_8D392ACFE2626AA5856D54B57335F321" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_163A38302CB05C7A4C7854B5733546EC" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityEmergingGrowthCompany_163A38302CB05C7A4C7854B5733546EC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_DDE241E8A1C7E6D3752954B5733544BF" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityShellCompany_DDE241E8A1C7E6D3752954B5733544BF" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_D03844073265C321ED7A54B57336F4BE" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_C9D257975A4EDEC45B0454B5732E54E5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_D03844073265C321ED7A54B57336F4BE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_BCE615BF3E5B28C9C6B354B57320F5B2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_FF8101CFA94940A682D554B573217150" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_BCE615BF3E5B28C9C6B354B57320F5B2" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_FF8101CFA94940A682D554B573217150" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_EC69A0A5BBA2A85F6A5A54B574328A9A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5E35FBC3B9E15B0083E254B574321F64" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_EC69A0A5BBA2A85F6A5A54B574328A9A" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5E35FBC3B9E15B0083E254B574321F64" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Sharesthatwouldbeantidilutiveasaresultofnetloss" xlink:label="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_4C401A8A33693551E94554B57432E78D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_EC69A0A5BBA2A85F6A5A54B574328A9A" xlink:to="loc_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss_4C401A8A33693551E94554B57432E78D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_54CAAEFACAC81346490854B574614864" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5F4434E4E7F3D8F1A84454B574625BAD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_54CAAEFACAC81346490854B574614864" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5F4434E4E7F3D8F1A84454B574625BAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_49593BA867DA43FF605054B574629DC5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_54CAAEFACAC81346490854B574614864" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_49593BA867DA43FF605054B574629DC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_085311D51B03BA80C50F54B57462332C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_49593BA867DA43FF605054B574629DC5" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_085311D51B03BA80C50F54B57462332C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9213D4A3999F4106841654B574629037" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_54CAAEFACAC81346490854B574614864" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9213D4A3999F4106841654B574629037" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6A55130340D34E86B97754B5744680F8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_B8035502C39C8B32EF8254B574468AD0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6A55130340D34E86B97754B5744680F8" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_B8035502C39C8B32EF8254B574468AD0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_682AE2E188F654E7838D54B574354D1F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_BC33C967B8B8496F6E1C54B57435267C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_682AE2E188F654E7838D54B574354D1F" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_BC33C967B8B8496F6E1C54B57435267C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_BA98EFC4EC2D52E5559754B5727DD77B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_BA98EFC4EC2D52E5559754B5727DD77B" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_A2477E79A29D3ECD25D154B5727EE842" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_F0A0817B09088F9ABBC654B5727F13FA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6E4472BF8282D642580F54B5727EEABD" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_F0A0817B09088F9ABBC654B5727F13FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5CC4D4FC865A69E86AB154B5728007B3" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_585F678F62B295F5B9F054B572805196" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_585F678F62B295F5B9F054B572805196" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3296D7DDDDEA0E2CEF7654B57281C3B4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3296D7DDDDEA0E2CEF7654B57281C3B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_E747AC5CAC182524ED0D54B57281C007" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A7D8912DE3CF8EFD4B4C54B572808FAD" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_E747AC5CAC182524ED0D54B57281C007" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_EE044E261B82D46A341654B5727ECC73" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_941FFDB22DA7C6A545B654B5728107E9" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_67F140D2D1EE3CAB220854B57283F7D8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_67F140D2D1EE3CAB220854B57283F7D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_9A82C1F2C4976B44EFBF54B57283F6C5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_9A82C1F2C4976B44EFBF54B57283F6C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:label="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_4B031AAAB9FD2B9ED87654B572831A0D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_F123FE8740B1648C0D7254B572821CC8" xlink:to="loc_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet_4B031AAAB9FD2B9ED87654B572831A0D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9634A6C22510659F115954B5742B80B6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DCDC19BC61D7A79CB84854B5742B40F1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9634A6C22510659F115954B5742B80B6" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_DCDC19BC61D7A79CB84854B5742B40F1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3CB1B8931DB2246D511A54B57302729E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_803A4876ECE4034BBE6154B57302C092" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3CB1B8931DB2246D511A54B57302729E" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_803A4876ECE4034BBE6154B57302C092" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_57111D2D5A2786ED990D54B572CEF5A7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_57111D2D5A2786ED990D54B572CEF5A7" xlink:to="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_10A75033F1FC00BFC40B54B572CFB01D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_10A75033F1FC00BFC40B54B572CFB01D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6B3B781587EA1FEF077454B572CF07B6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_10A75033F1FC00BFC40B54B572CFB01D" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6B3B781587EA1FEF077454B572CF07B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_417004C8512B0D0195B154B572D0DB33" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6B3B781587EA1FEF077454B572CF07B6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_417004C8512B0D0195B154B572D0DB33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_F73C8AF31BC601D94C6254B572D0F897" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_F73C8AF31BC601D94C6254B572D0F897" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C8467E132BDEC4B49B7A54B572D06D87" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_F73C8AF31BC601D94C6254B572D0F897" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C8467E132BDEC4B49B7A54B572D06D87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_BE8470325B1AB40EECE854B572D1F121" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_C8467E132BDEC4B49B7A54B572D06D87" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_BE8470325B1AB40EECE854B572D1F121" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:to="loc_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_B1D5A1D1E8B630C8AB7E54B572D14287" xlink:to="loc_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_CDFC0EC3A9D3FC90839A54B572D26666" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_CDFC0EC3A9D3FC90839A54B572D26666" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_B11680B8DDDBD5A30FAE54B572D2D070" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8DE3B2DD77B9A2ED833654B572D1F27E" xlink:to="loc_us-gaap_NondesignatedMember_B11680B8DDDBD5A30FAE54B572D2D070" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3B10FE4EB026F7EBC65C54B572D3C9A7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:label="loc_us-gaap_FairValueHedgingMember_7163664D6DBCAB61954154B572D3EAF0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_0C5659194F9EA0A8180554B572D39A91" xlink:to="loc_us-gaap_FairValueHedgingMember_7163664D6DBCAB61954154B572D3EAF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_C17F71652BDA46CFE42154B572D31D96" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_EA581F2D3BFD4305108F54B572D405D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:to="loc_us-gaap_CashFlowHedgingMember_EA581F2D3BFD4305108F54B572D405D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_A80E9BFADD1292FBB3E454B572D5F3CC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:to="loc_us-gaap_InterestRateSwapMember_A80E9BFADD1292FBB3E454B572D5F3CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrencySwapMember" xlink:label="loc_us-gaap_CurrencySwapMember_62305F5E250636FF8E3754B572D51C6B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:to="loc_us-gaap_CurrencySwapMember_62305F5E250636FF8E3754B572D51C6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_49A6C1DB2DC3D742A82054B572D562CB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5940DD83A168C626077954B572D472EC" xlink:to="loc_us-gaap_ForeignExchangeContractMember_49A6C1DB2DC3D742A82054B572D562CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_83A82C4975A75C98489054B572CE6C57" xlink:to="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_F23358CAB151FE4468C354B572D620D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_F23358CAB151FE4468C354B572D620D6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount" xlink:label="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:to="loc_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount_A9CD04AA276492769CB254B572D68D0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_EDDEA57C150646C4701154B572D61EF9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_EDDEA57C150646C4701154B572D61EF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_027FCAB760445BDA4A4654B572D6E201" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_96146E4D319ECF299B0F54B572D54FA2" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_027FCAB760445BDA4A4654B572D6E201" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0C7E7779CCFDAFC0C00F54B5744FA885" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_F89E7644125DBF26919554B5744F00F0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0C7E7779CCFDAFC0C00F54B5744FA885" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_F89E7644125DBF26919554B5744F00F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2B8F411218906B198C6E54B5744F6054" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_F89E7644125DBF26919554B5744F00F0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2B8F411218906B198C6E54B5744F6054" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_05E87A1756FE7FB11A8A54B5744F7D7F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2B8F411218906B198C6E54B5744F6054" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_05E87A1756FE7FB11A8A54B5744F7D7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_D65CFA6B90F5DC98CC5754B57450F8AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_05E87A1756FE7FB11A8A54B5744F7D7F" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_D65CFA6B90F5DC98CC5754B57450F8AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C41499C036FB826AE20E54B574508C3E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_F89E7644125DBF26919554B5744F00F0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C41499C036FB826AE20E54B574508C3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_446059672E6054EF84AA54B57450FE0C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C41499C036FB826AE20E54B574508C3E" xlink:to="loc_us-gaap_DebtInstrumentFairValue_446059672E6054EF84AA54B57450FE0C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CarryingAmountofLongTermandotherShortTermBorrowings" xlink:label="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_C41499C036FB826AE20E54B574508C3E" xlink:to="loc_cah_CarryingAmountofLongTermandotherShortTermBorrowings_39A41B4630E34144C60F54B574517EE9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_132D312FFF3E57E2BBBD54B574CD2E16" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9498E95F8CB1E59C04CC54B574CDA084" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_132D312FFF3E57E2BBBD54B574CD2E16" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_9498E95F8CB1E59C04CC54B574CDA084" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C7C8472C21FE545F939654B57465D489" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_198D3A31E29D27495BA354B5746581D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_C7C8472C21FE545F939654B57465D489" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_198D3A31E29D27495BA354B5746581D6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0054BB8DB4C83882A955F0AC3B8BFA10" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0054BB8DB4C83882A955F0AC3B8BFA10" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_F00475425CD5D8A9097FF0AC3B8BDF20" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_F00475425CD5D8A9097FF0AC3B8BDF20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3E702828E07EBD2E5D98F0AC3B8B7D4B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_F00475425CD5D8A9097FF0AC3B8BDF20" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3E702828E07EBD2E5D98F0AC3B8B7D4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_325C8A3B9AD7E509A107F0AC3B8CAD88" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:to="loc_srt_ConsolidationItemsAxis_325C8A3B9AD7E509A107F0AC3B8CAD88" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_8471062D3E0CBB9B0CA5F0AC3B8C9034" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_325C8A3B9AD7E509A107F0AC3B8CAD88" xlink:to="loc_srt_ConsolidationItemsDomain_8471062D3E0CBB9B0CA5F0AC3B8C9034" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9A1D419E9363194E3598F0AC3B8C8F1B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9A1D419E9363194E3598F0AC3B8C8F1B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_AE8156376C869A7FDB22F0AC3B8CF4F2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9A1D419E9363194E3598F0AC3B8C8F1B" xlink:to="loc_us-gaap_SegmentDomain_AE8156376C869A7FDB22F0AC3B8CF4F2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalReportingUnitMember" xlink:label="loc_cah_MedicalReportingUnitMember_9038D1B8C91CCA596BB3F0BEA5BD82B3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_AE8156376C869A7FDB22F0AC3B8CF4F2" xlink:to="loc_cah_MedicalReportingUnitMember_9038D1B8C91CCA596BB3F0BEA5BD82B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_E12FD85DE6D92265C185F0AC3B8D14E7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:to="loc_srt_RangeAxis_E12FD85DE6D92265C185F0AC3B8D14E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_F8B566D73D4F8FBF29A6F0AC3B8D26BB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_E12FD85DE6D92265C185F0AC3B8D14E7" xlink:to="loc_srt_RangeMember_F8B566D73D4F8FBF29A6F0AC3B8D26BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_B8D05E525BFA990F5B6CF0AC3B8BF73C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CarryingValue" xlink:label="loc_cah_CarryingValue_C1E981E0988DE3BB5E0AF0BEA52F767C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:to="loc_cah_CarryingValue_C1E981E0988DE3BB5E0AF0BEA52F767C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_53DAF65F576AC869C1F5F0BEC76354EB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:to="loc_us-gaap_Goodwill_53DAF65F576AC869C1F5F0BEC76354EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_5E3361F39B878C618EF6F0BEED26E114" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_5E3361F39B878C618EF6F0BEED26E114" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_DiscountRatefairvalueinputs" xlink:label="loc_cah_DiscountRatefairvalueinputs_4624195FED7275A03531F0BF295D5B55" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:to="loc_cah_DiscountRatefairvalueinputs_4624195FED7275A03531F0BF295D5B55" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TerminalGrowthRatefairvalueinputs" xlink:label="loc_cah_TerminalGrowthRatefairvalueinputs_BBED1F57FA2101FA7C17F0BF53848EAE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_E5990839EA845C18A517F0AC3B8DAB1C" xlink:to="loc_cah_TerminalGrowthRatefairvalueinputs_BBED1F57FA2101FA7C17F0BF53848EAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_CD23C2AD4EA5D9210342F0AC3B8D5185" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0054BB8DB4C83882A955F0AC3B8BFA10" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_CD23C2AD4EA5D9210342F0AC3B8D5185" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_CC902528F885FE408289F0AC3B8EABD5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0054BB8DB4C83882A955F0AC3B8BFA10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_CC902528F885FE408289F0AC3B8EABD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3C9B4B70BAF755C3E8B6F0AC3B8E649B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0054BB8DB4C83882A955F0AC3B8BFA10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3C9B4B70BAF755C3E8B6F0AC3B8E649B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6852269481554733D78BF0AC3B8E1933" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0054BB8DB4C83882A955F0AC3B8BFA10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6852269481554733D78BF0AC3B8E1933" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DB75F51ECE7CDE4DC088F0AC3B8EDC1B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0054BB8DB4C83882A955F0AC3B8BFA10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_DB75F51ECE7CDE4DC088F0AC3B8EDC1B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_62E524DAED6EF2D5E7BDF0AC3B8EF2E5" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0054BB8DB4C83882A955F0AC3B8BFA10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_62E524DAED6EF2D5E7BDF0AC3B8EF2E5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7EEF33E3308C0CFF9EF8F0AC3BB5FEA8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7EEF33E3308C0CFF9EF8F0AC3BB5FEA8" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_B9C6252FF4C7777B323FF0AC3BB692B2" xlink:to="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:to="loc_cah_PharmaceuticalMember_CBF4CF333808D522B8B6F0AC3BB60DF4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:to="loc_cah_MedicalMember_FC5786C8E2A19119F1EAF0B0E4C4201B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalReportingUnitMember" xlink:label="loc_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_C46816D2C45D50961CF9F0AC3BB650DF" xlink:to="loc_cah_MedicalReportingUnitMember_B56D7152C2D54B3283A3F0AC3BB6B1D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_FA1B11D61F66C0250934F0AC3BB55709" xlink:to="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CarryingValue" xlink:label="loc_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:to="loc_cah_CarryingValue_888116A686E127767209F0AC3BB7D0F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_F2588BCF283992674D37F0AC3BB78969" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_F2588BCF283992674D37F0AC3BB78969" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:to="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_13BA183C7983F364309BF0AC3BB73B28" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:to="loc_us-gaap_Goodwill_13BA183C7983F364309BF0AC3BB73B28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers" xlink:label="loc_us-gaap_GoodwillTransfers_6FFD764F5AECF55AD9CAF0AC3BB8434B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:to="loc_us-gaap_GoodwillTransfers_6FFD764F5AECF55AD9CAF0AC3BB8434B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2E6D3078EE7A025B6970F0AC3BB81219" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2E6D3078EE7A025B6970F0AC3BB81219" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_C09182A99B662F1ACE43F0AC3BB8CD08" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_43F1836F46CF307E41D2F0AC3BB78AF4" xlink:to="loc_us-gaap_Goodwill_C09182A99B662F1ACE43F0AC3BB8CD08" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_DiscountRatefairvalueinputs" xlink:label="loc_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:to="loc_cah_DiscountRatefairvalueinputs_40806AFD7E809AB5C72FF0AC3BB8164F" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TerminalGrowthRatefairvalueinputs" xlink:label="loc_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_4FD78E8F28BFAD3D5881F0AC3BB76165" xlink:to="loc_cah_TerminalGrowthRatefairvalueinputs_23BC1CEE5562715BF5DDF0AE28D69E4D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BC109AE447BDA349C99E54B572466213" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BC109AE447BDA349C99E54B572466213" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_B2090E7940B1AAE6260F54B5724738C3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_IPRDTrademarksandOtherMember" xlink:label="loc_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_AA0974571E7994E9975554B57247953D" xlink:to="loc_cah_IPRDTrademarksandOtherMember_FA7D23649425372D6C9E54B57247C923" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0F77B1C680F0CC6B313054B57246656B" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_341C13AB83AE4DE2EB9754B57248994F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_05C784679318F949E8B154B57248DEC4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_341C13AB83AE4DE2EB9754B57248994F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BC109AE447BDA349C99E54B572466213" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2E4AE02350F9FBC4608D54B5724994B9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6935F7EDA742F276EEF954B5724AFDBF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6935F7EDA742F276EEF954B5724AFDBF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TrademarksAndPatentsMember" xlink:label="loc_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:to="loc_cah_TrademarksAndPatentsMember_DED567041DAED0EAD59954B5724B7A1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_157FADE0780FC02F1A7454B5724B2D0D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CADACD64612C58B5CBA54B5724A6B03" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_157FADE0780FC02F1A7454B5724B2D0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_24B4B37A7011A9CC480E54B57249EAF1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5FAF8F17962A69E0189C54B5724C5F61" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5FAF8F17962A69E0189C54B5724C5F61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6F052AF0DDF7B2B2883C54B5724E32FF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6F052AF0DDF7B2B2883C54B5724E32FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4B46954CB61C7BECD73554B5724F160D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_4B46954CB61C7BECD73554B5724F160D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_877DFACB3A755A1A397C54B5724FAB85" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_6FD82AD49CD96C358C5954B5724C9823" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_877DFACB3A755A1A397C54B5724FAB85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7AC511E9E6E439FF746354B572502B7F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BC109AE447BDA349C99E54B572466213" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_7AC511E9E6E439FF746354B572502B7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6419374624E47BCF85E154B57250B0F1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_BC109AE447BDA349C99E54B572466213" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6419374624E47BCF85E154B57250B0F1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6FA300D027EF36A3989854B5730F95B8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_6A51BA808B14BE5CB5F154B5730F5C42" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6FA300D027EF36A3989854B5730F95B8" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_6A51BA808B14BE5CB5F154B5730F5C42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3918E50312581254CE5C54B5730F00F2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6FA300D027EF36A3989854B5730F95B8" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3918E50312581254CE5C54B5730F00F2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_E433A2594E07F9D7423A54B5729A4A53" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_82E3B0CBDDD291D67FFD54B5729A84D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_E433A2594E07F9D7423A54B5729A4A53" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_82E3B0CBDDD291D67FFD54B5729A84D3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_F8A16CC3A45C284FB5E2F41CEEC4F13A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F8A16CC3A45C284FB5E2F41CEEC4F13A" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_A4CEA02549C0D604C72BF41CEEC55061" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_cah_OpioidLitigationAxis_A4CEA02549C0D604C72BF41CEEC55061" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_DBB1C8B8DBFB3A466304F41CEEC6E0DC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_A4CEA02549C0D604C72BF41CEEC55061" xlink:to="loc_cah_OpioidLitigationDomain_DBB1C8B8DBFB3A466304F41CEEC6E0DC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_A58116AAB9848210452AF41CEEC62CAB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_DBB1C8B8DBFB3A466304F41CEEC6E0DC" xlink:to="loc_cah_TotalOpioidLitigationMember_A58116AAB9848210452AF41CEEC62CAB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMatterAxis" xlink:label="loc_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMatterDomain" xlink:label="loc_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterAxis_7DD1D86D3887A7E16501F41CEEC7B05E" xlink:to="loc_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PatientRecoveryBusinessMember" xlink:label="loc_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:to="loc_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CareFusionMember" xlink:label="loc_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMatterDomain_35AE70288273B540EFBAF41CEEC706A7" xlink:to="loc_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_C025A73F1A84885225FEF41CEEC87E9A" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_C3E5A1F7DC4AA4146C5AF41CEEC9F2E0" xlink:to="loc_cah_PatientRecoveryBusinessMember_DB4E254CDB042A61943FF41CEEC762B7" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMattersAgreementAxis" xlink:label="loc_cah_TaxMattersAgreementAxis_79B8617B0215946E4221F41CEEC91C73" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_cah_TaxMattersAgreementAxis_79B8617B0215946E4221F41CEEC91C73" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TaxMattersAgreementDomain" xlink:label="loc_cah_TaxMattersAgreementDomain_2DE9FFE839CF4C0A1EE9F41CEEC94AA0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMattersAgreementAxis_79B8617B0215946E4221F41CEEC91C73" xlink:to="loc_cah_TaxMattersAgreementDomain_2DE9FFE839CF4C0A1EE9F41CEEC94AA0" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_TaxMattersAgreementDomain_2DE9FFE839CF4C0A1EE9F41CEEC94AA0" xlink:to="loc_cah_CareFusionMember_5EEAF98632560030255CF41CEEC83376" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_E7E83602742DB7CD93D2F41CEECA9EFE" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_526B6B1BA8E2A82392E4F41CEECB42CC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_94DA7388097DB18C327DF41CEECAFD02" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_526B6B1BA8E2A82392E4F41CEECB42CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_465B1C11F8D3E3866C82F41CEECB7F8A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_srt_RangeAxis_465B1C11F8D3E3866C82F41CEECB7F8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_4738CD2EF688A7096354F41CEECB29C4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_465B1C11F8D3E3866C82F41CEECB7F8A" xlink:to="loc_srt_RangeMember_4738CD2EF688A7096354F41CEECB29C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_183AEE2810F44A3B8630F41CEECB55B0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4738CD2EF688A7096354F41CEECB29C4" xlink:to="loc_srt_MinimumMember_183AEE2810F44A3B8630F41CEECB55B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9405C8C142DC57DFB5F5F41CEECC39B6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4738CD2EF688A7096354F41CEECB29C4" xlink:to="loc_srt_MaximumMember_9405C8C142DC57DFB5F5F41CEECC39B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_40EBBAA4EDB748FC8323F41CEEC498A4" xlink:to="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_478C05D095A546A78ADDF41CEECC9279" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_LitigationReserve_478C05D095A546A78ADDF41CEECC9279" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1CF479CE97515B47AEEFF41CEECCAEAC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1CF479CE97515B47AEEFF41CEECCAEAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_3D1884B79031C48C95DEF41CEECD4660" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_3D1884B79031C48C95DEF41CEECD4660" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_C2C62C6CE734F8D9AEE1F41CEECD8599" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_C2C62C6CE734F8D9AEE1F41CEECD8599" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_B0B9B79BD0A3063F3C0FF41CEECDA0DE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_B0B9B79BD0A3063F3C0FF41CEECDA0DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_403D0D324005B631B7A6F41CEECD8FFE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_403D0D324005B631B7A6F41CEECD8FFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OpenTaxYear" xlink:label="loc_us-gaap_OpenTaxYear_41102EB5AA992F5F14A4F41CEECD28BC" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_OpenTaxYear_41102EB5AA992F5F14A4F41CEECD28BC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_IndemnificationReceivable" xlink:label="loc_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_cah_IndemnificationReceivable_3C8CD2BE278932490394F41CEECD5017" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6D825953BC34692EF6A8F41CEECE75CF" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_E2959A316380909CF530F41CEECC1C1D" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6D825953BC34692EF6A8F41CEECE75CF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/Investments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1772762514221847A67254B572B331BB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock" xlink:label="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_360EE37B8B010574EAD454B572B35119" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1772762514221847A67254B572B331BB" xlink:to="loc_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock_360EE37B8B010574EAD454B572B35119" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/InvestmentsInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_DDAB2277A27B817FBFD7E5395EA542B1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="loc_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_DDAB2277A27B817FBFD7E5395EA542B1" xlink:to="loc_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:to="loc_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_AC4929FB91A2055D79CFE5395EA6B87E" xlink:to="loc_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_NaviOwnershipInterestDivestedMember" xlink:label="loc_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_7AE11CF3D7755A226D24E5395EA67A9B" xlink:to="loc_cah_NaviOwnershipInterestDivestedMember_E7E3A97E999011D94A6FE53961ED0963" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0802C9C5291E5B4D56E5E5395EA708EE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0802C9C5291E5B4D56E5E5395EA708EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_E030BC4AEF15BF1A37FFE5395EA7109C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0802C9C5291E5B4D56E5E5395EA708EE" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_E030BC4AEF15BF1A37FFE5395EA7109C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_F4CBDCB8065A7471BE52E5395EA845DA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_E030BC4AEF15BF1A37FFE5395EA7109C" xlink:to="loc_cah_NaviHealthMember_F4CBDCB8065A7471BE52E5395EA845DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_47E75A1F9BFC1B71961DE5395EA5CC4C" xlink:to="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_F921F7405EB8C5540632E5395EA81586" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_F921F7405EB8C5540632E5395EA81586" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PartnershipIndirectOwnership" xlink:label="loc_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_cah_PartnershipIndirectOwnership_7FBAEFA2FB406B66EA66E5395EA8771E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_61ED4C04EAE3743A08AAE5395EA9C6B4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_cah_PreTaxGainonDivestiture_61ED4C04EAE3743A08AAE5395EA9C6B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_49F65EF5B083BFEBC581E5395EA9037D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_49F65EF5B083BFEBC581E5395EA9037D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_16372A0C61EFB0D5A5B6E5395EA9479F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_16372A0C61EFB0D5A5B6E5395EA9479F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaap_EquityMethodInvestments_7706631CEF96B984FCCFE5395EA9ACD3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_0472ABA0C52E65B4F144E5395EA892B1" xlink:to="loc_us-gaap_EquityMethodInvestments_7706631CEF96B984FCCFE5395EA9ACD3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/Leases" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_A6AF0E21A5F8C63EEF8A54B5722C237B" xlink:type="locator" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LeasesTextBlock" xlink:label="loc_cah_LeasesTextBlock_2F3D5DAC78548145F8C754B5722C6318" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A6AF0E21A5F8C63EEF8A54B5722C237B" xlink:to="loc_cah_LeasesTextBlock_2F3D5DAC78548145F8C754B5722C6318" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_E6C306AB63194253D5F154B57412EE69" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_A1EDC58AD8087F60A5C254B5741287E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_E6C306AB63194253D5F154B57412EE69" xlink:to="loc_us-gaap_StatementTable_A1EDC58AD8087F60A5C254B5741287E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_037D7A6FEC299A79953454B5741360DA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_A1EDC58AD8087F60A5C254B5741287E0" xlink:to="loc_srt_RangeAxis_037D7A6FEC299A79953454B5741360DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_BE1B6377675E30BB87EE54B574132AFC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_037D7A6FEC299A79953454B5741360DA" xlink:to="loc_srt_RangeMember_BE1B6377675E30BB87EE54B574132AFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_41D7018FC9CFC02DB34554B574134397" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_BE1B6377675E30BB87EE54B574132AFC" xlink:to="loc_srt_MinimumMember_41D7018FC9CFC02DB34554B574134397" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9E4CBE35B1751755A2F754B57414DD2B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_BE1B6377675E30BB87EE54B574132AFC" xlink:to="loc_srt_MaximumMember_9E4CBE35B1751755A2F754B57414DD2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_A1EDC58AD8087F60A5C254B5741287E0" xlink:to="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_FCCF175EC352F5326FF454B57414738A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_FCCF175EC352F5326FF454B57414738A" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ReclassificationofdeferredrentinaccordancewithASC842" xlink:label="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_cah_ReclassificationofdeferredrentinaccordancewithASC842_EFDDFC675E0D8350549754B574148F0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_F7B6D405D2B014A39D2154B57414CE94" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_F7B6D405D2B014A39D2154B57414CE94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_3DA1EE631F009CB2C74054B574153B56" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_3DA1EE631F009CB2C74054B574153B56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2F5AAA372653C88F4BC854B574155D50" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2F5AAA372653C88F4BC854B574155D50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9142D1EFC988F5D39B8E54B5741582CB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_9142D1EFC988F5D39B8E54B5741582CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_4E2AB8DFA2FDAD492BCB54B574159D3F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_4E2AB8DFA2FDAD492BCB54B574159D3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_BA8E7B1AA40DD6F059EA54B574162FFD" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_BA8E7B1AA40DD6F059EA54B574162FFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_FDB21F279BA129DCB85B54B57416174C" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_FDB21F279BA129DCB85B54B57416174C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_664BCAC05EF0148BA37654B574169625" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D3C949E0C4CA552EB1D154B574146AB3" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_664BCAC05EF0148BA37654B574169625" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_A7A4321D330261DF2B75DFCE368549B5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_AEC1055506F264546AC0DFCE3685E7D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_A7A4321D330261DF2B75DFCE368549B5" xlink:to="loc_us-gaap_StatementTable_AEC1055506F264546AC0DFCE3685E7D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_AEC1055506F264546AC0DFCE3685E7D0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_38B8A642CA03F9D6EFD3DFD2EA61D6DE" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OperatingLeaseMember" xlink:label="loc_cah_OperatingLeaseMember_E34D01A6715D76FD6318DFCE368668C8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:to="loc_cah_OperatingLeaseMember_E34D01A6715D76FD6318DFCE368668C8" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_FinanceLeaseMember" xlink:label="loc_cah_FinanceLeaseMember_EBEA08A5E7C7CD8017C1DFCE36863438" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_97F38B43F07C7D520BF6DFD3CEF7A8AD" xlink:to="loc_cah_FinanceLeaseMember_EBEA08A5E7C7CD8017C1DFCE36863438" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_AEC1055506F264546AC0DFCE3685E7D0" xlink:to="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_74D5C3CB637D9330808ADFCE3686F4F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_74D5C3CB637D9330808ADFCE3686F4F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0A311B57F67D3A468219DFCE3687895B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0A311B57F67D3A468219DFCE3687895B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear_9D90CD6C4E5569F12B02DFCE36877893" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_BF47C274771D90F4B9A4DFCE3687C467" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_BF47C274771D90F4B9A4DFCE3687C467" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_81536AC8ACE2C8707394DFCE3687822C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_81536AC8ACE2C8707394DFCE3687822C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearTwo_F7A00DC0D623F9A875CCDFCE36875400" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2BF3CD0269BFEAC885A9DFCE36874B0D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2BF3CD0269BFEAC885A9DFCE36874B0D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_732CA9DAEF4C50B9DC15DFCE3688DD10" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_732CA9DAEF4C50B9DC15DFCE3688DD10" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearThree_720EB612E522837409F7DFCE3688AAA5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_F5BC9EA3A12107F2BEB1DFCE3688F056" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_F5BC9EA3A12107F2BEB1DFCE3688F056" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1CE0721BA2AF5D6A89D5DFCE3688AAA3" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1CE0721BA2AF5D6A89D5DFCE3688AAA3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFour_ADA17BFDE6A52BECF05ADFCE36884845" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4DB07100E60E208FC760DFCE368930F9" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4DB07100E60E208FC760DFCE368930F9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_12282AB053528E31E669DFCE36896DAE" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_12282AB053528E31E669DFCE36896DAE" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueYearFive_00285EC4D1A2FA89D940DFCE36892305" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1E850B123630AAC20BBADFCE3689E57C" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1E850B123630AAC20BBADFCE3689E57C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5A0E50F281FF088179EDDFCE368923E8" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5A0E50F281FF088179EDDFCE368923E8" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive_704B46AB03440DFE9D62DFCE368942A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1B6718F45A2E24E7A4DADFCE368A4010" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1B6718F45A2E24E7A4DADFCE368A4010" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_59707F8F8145EE4142B0DFCE368A3854" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_59707F8F8145EE4142B0DFCE368A3854" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLeaseLiabilityPaymentsDue" xlink:label="loc_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_TotalLeaseLiabilityPaymentsDue_0073F1DEAAF898E10A29DFCE368A1F71" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount_1FD1293BDBF01A01C3DEDFCE368A63F5" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount_63623F506A87F3E1518EDFCE368AFC78" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLeaseLiabilityNotYetCommencedAmount" xlink:label="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_TotalLeaseLiabilityNotYetCommencedAmount_7C9FDD582B3AA1CCA3A2DFCE368A284B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OperatingLeaseImputedInterest" xlink:label="loc_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_OperatingLeaseImputedInterest_BD62BC40427C9C542BCADFCE368B6EBF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_FinanceLeaseImputedInterest" xlink:label="loc_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_FinanceLeaseImputedInterest_2122CBD806D2935E6FAFDFCE368B1FCC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_TotalLeaseLiabilityUndiscountedExcessAmount_18461131D34097AEBCDADFCE368BD2AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_C1EE3F16678C6E96571BDFCE368C22AA" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_OperatingLeaseLiability_C1EE3F16678C6E96571BDFCE368C22AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_D9EBE2D6419FBCC40EAEDFCE368C8FAC" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_us-gaap_FinanceLeaseLiability_D9EBE2D6419FBCC40EAEDFCE368C8FAC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLeaseLiability" xlink:label="loc_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ADE892F938E8BCDBE112DFCE36866BAF" xlink:to="loc_cah_TotalLeaseLiability_770AA737F61774441128DFCE368C3E57" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_EDF5AA60D2F2280721F954B5744ACF13" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_94AFB79F8C0E184A92A054B5744A36D8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EDF5AA60D2F2280721F954B5744ACF13" xlink:to="loc_us-gaap_OperatingLeaseCost_94AFB79F8C0E184A92A054B5744A36D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_39EC19F0065690383A4654B5744A1E3B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EDF5AA60D2F2280721F954B5744ACF13" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_39EC19F0065690383A4654B5744A1E3B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalFinanceLeaseCost" xlink:label="loc_cah_TotalFinanceLeaseCost_08E918EDD992C5AEC7BE54B5744BFFA6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EDF5AA60D2F2280721F954B5744ACF13" xlink:to="loc_cah_TotalFinanceLeaseCost_08E918EDD992C5AEC7BE54B5744BFFA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_075384FA59BBB7C218AB54B5744BBB56" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EDF5AA60D2F2280721F954B5744ACF13" xlink:to="loc_us-gaap_VariableLeaseCost_075384FA59BBB7C218AB54B5744BBB56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_01C2A963775A3C23B7FD54B5744B4B4D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EDF5AA60D2F2280721F954B5744ACF13" xlink:to="loc_us-gaap_LeaseCost_01C2A963775A3C23B7FD54B5744B4B4D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_85655E9F78E1A8F6A4A0DFCE369B9CC1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9DC42AADE10B905F4B3FE018CD1FAFD8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_85655E9F78E1A8F6A4A0DFCE369B9CC1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9DC42AADE10B905F4B3FE018CD1FAFD8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_025214D2EF1B987AACAEE0186FB84CDC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_85655E9F78E1A8F6A4A0DFCE369B9CC1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_025214D2EF1B987AACAEE0186FB84CDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_D1A0AAE37C08E5FDD5A6E019ADDC2615" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_85655E9F78E1A8F6A4A0DFCE369B9CC1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_D1A0AAE37C08E5FDD5A6E019ADDC2615" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_F12BD083BC0163E1851DDFCE369C726D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_85655E9F78E1A8F6A4A0DFCE369B9CC1" xlink:to="loc_us-gaap_OperatingLeaseLiability_F12BD083BC0163E1851DDFCE369C726D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaap_FinanceLeaseLiability_6F00892AD59E88CB4608DFCE369D62CE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_85655E9F78E1A8F6A4A0DFCE369B9CC1" xlink:to="loc_us-gaap_FinanceLeaseLiability_6F00892AD59E88CB4608DFCE369D62CE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_C8FE86708ABEE7064167E017BB43843E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_85655E9F78E1A8F6A4A0DFCE369B9CC1" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_C8FE86708ABEE7064167E017BB43843E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_88A24DE02377AE112637E018013545B9" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_85655E9F78E1A8F6A4A0DFCE369B9CC1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_88A24DE02377AE112637E018013545B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4DC80B5C67A3ACA82DA3E01918DC74B2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_85655E9F78E1A8F6A4A0DFCE369B9CC1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4DC80B5C67A3ACA82DA3E01918DC74B2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_CCA74F3ED8C3C9C2E443E54A8E63AED3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_CCA74F3ED8C3C9C2E443E54A8E63AED3" xlink:to="loc_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_36ABEE5B9CB433B6A46EE54A8E645045" xlink:to="loc_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ASC842Member" xlink:label="loc_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_D9396F91870737CC638BE54A8E6460DD" xlink:to="loc_cah_ASC842Member_AAAD6ED1AAADE39E9279E54A8E65878B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_14E4ADEF8ACAD9492AF0E54A8E633A30" xlink:to="loc_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_Impactofadoptionofnewaccountingstandard" xlink:label="loc_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_89DDAEDF3E55231A13C6E54A8E6514FF" xlink:to="loc_cah_Impactofadoptionofnewaccountingstandard_9A07949970571CA59C57E54A8E651EEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_112C8196F5AE25EC7937E54A8E6B954F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_CCA74F3ED8C3C9C2E443E54A8E63AED3" xlink:to="loc_us-gaap_OperatingLeasePayments_112C8196F5AE25EC7937E54A8E6B954F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_874BE262747B11205060E54A8E6BBF42" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_CCA74F3ED8C3C9C2E443E54A8E63AED3" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_874BE262747B11205060E54A8E6BBF42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_055D48742928B34DE06FE54A8E6BD77C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_CCA74F3ED8C3C9C2E443E54A8E63AED3" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_055D48742928B34DE06FE54A8E6BD77C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1E549B6F897231CF24E8E54A8E6CC3A5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_CCA74F3ED8C3C9C2E443E54A8E63AED3" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1E549B6F897231CF24E8E54A8E6CC3A5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_F634197A652253A6434754B5730B0BCB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_E93F4B4DE28306F30A7C54B5730BEA34" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F634197A652253A6434754B5730B0BCB" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_E93F4B4DE28306F30A7C54B5730BEA34" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LeasesSupplementalBalanceSheetInformationTableTextBlock" xlink:label="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_C4613A309E78FDD6831E54B5730C17A8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F634197A652253A6434754B5730B0BCB" xlink:to="loc_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock_C4613A309E78FDD6831E54B5730C17A8" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_LeasePaymentsTableTextBlock" xlink:label="loc_cah_LeasePaymentsTableTextBlock_45C9E05255D38D5F724354B5730C0221" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F634197A652253A6434754B5730B0BCB" xlink:to="loc_cah_LeasePaymentsTableTextBlock_45C9E05255D38D5F724354B5730C0221" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_C4B929E72E459EB5495054B5730C2869" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_F634197A652253A6434754B5730B0BCB" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_C4B929E72E459EB5495054B5730C2869" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings" xlink:type="extended">
    <link:loc xlink:href="cah-20200331.xsd#cah_LongTermObligationsandOtherShortTermBorrowingsAbstract" xlink:label="loc_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_D55E8878B3AAEB96DDB454B5728784D2" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_CF848043C4BDA48A275F54B57287A0D5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_D55E8878B3AAEB96DDB454B5728784D2" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_CF848043C4BDA48A275F54B57287A0D5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:href="cah-20200331.xsd#cah_LongTermObligationsandOtherShortTermBorrowingsAbstract" xlink:label="loc_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_716A8B8EEE12896F9C0AF431BDF24B38" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_716A8B8EEE12896F9C0AF431BDF24B38" xlink:to="loc_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:to="loc_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_BEE883A2EB52F132DCDDF431BDF295C7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A2.4Notesdue2020Member" xlink:label="loc_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A2.4Notesdue2020Member_EB79FA573B1C8037ED50F431BDF3739D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A2.616Notesdue2022Member" xlink:label="loc_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A2.616Notesdue2022Member_67ABC7BD0FACCC67BC40F431BDF49845" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.41Notesdue2027Member" xlink:label="loc_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A3.41Notesdue2027Member_755C656736EFA1095CF2F431BDF4415D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CommittedReceivablesSalesFacilityProgramMember" xlink:label="loc_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.6Notesdue2043Member" xlink:label="loc_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A4.6Notesdue2043Member_F6AD2A225AC9B7B8329CF431BDF46D42" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.9Notesdue2045Member" xlink:label="loc_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A4.9Notesdue2045Member_D7049842879B090E079EF431BDF40ADC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.368Notesdue2047Member" xlink:label="loc_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A4.368Notesdue2047Member_682FBB1622EF5484BECEF431BDF5D498" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.2Notesdue2023Member" xlink:label="loc_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_A3.2Notesdue2023Member_92CA37C07C182755D7DAF431BDF595A9" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_FloatingRateNotesdue2022Member" xlink:label="loc_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_DB188ABD7D109E4CDB2FF431BDF3888E" xlink:to="loc_cah_FloatingRateNotesdue2022Member_3D4E6073E073340AAFE0F431BDF52C6F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:to="loc_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_6A0C1DC7C70DFE4B6559F431BDF6969D" xlink:to="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaap_CommercialPaperMember_102C09CDDA82463BB622F431BDF6398C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:to="loc_us-gaap_CommercialPaperMember_102C09CDDA82463BB622F431BDF6398C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_C17C591F641ED29844C7F431BDF6A5A1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_C17C591F641ED29844C7F431BDF6A5A1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ShortTermCreditFacilitiesMember" xlink:label="loc_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:to="loc_cah_ShortTermCreditFacilitiesMember_5D2D264A965A2FB40805F431BDF7998F" xlink:type="arc" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_BD27F02B1B98F22A9712F431BDF61E41" xlink:to="loc_cah_CommittedReceivablesSalesFacilityProgramMember_43DF4678DE307C6FF380F431BDF4CD57" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_AA9980ED09417AA2E837F431BDF211CB" xlink:to="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLongTermandShortTermObligations" xlink:label="loc_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:to="loc_cah_TotalLongTermandShortTermObligations_D511064D90F3D106DC56F431BDF75BCC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_42E1866A0C4889BE85A2F431BDF8CFAD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_42E1866A0C4889BE85A2F431BDF8CFAD" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_NotesPayableRepurchased" xlink:label="loc_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:to="loc_cah_NotesPayableRepurchased_3BB639496ACE94AF78B8F431BDF8C333" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_C76C2D52C6090AE00C66F431BDF8899B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_C76C2D52C6090AE00C66F431BDF8899B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_A3AAABE8255DB2D0731BF431BDF85E23" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_021B066E057BEC4C65D9F431BDF795FF" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_A3AAABE8255DB2D0731BF431BDF85E23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_106718626323AA1E457CF431BDF9F1D5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_716A8B8EEE12896F9C0AF431BDF24B38" xlink:to="loc_us-gaap_AccountsPayableCurrent_106718626323AA1E457CF431BDF9F1D5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_C18656C5D0114EAEBA0D54B572EE0502" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_0ADA0A97F6B407D68DBE54B572EE146C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_C18656C5D0114EAEBA0D54B572EE0502" xlink:to="loc_us-gaap_DebtInstrumentTable_0ADA0A97F6B407D68DBE54B572EE146C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0ADA0A97F6B407D68DBE54B572EE146C" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_598D0653F6F1B49F9C9954B572EF6665" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_B37FCEDF2C56A44678A654B572EF7AF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_D75C1C72C2A9C0F5E63B54B572EFD829" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0ADA0A97F6B407D68DBE54B572EE146C" xlink:to="loc_us-gaap_DebtInstrumentAxis_D75C1C72C2A9C0F5E63B54B572EFD829" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_D75C1C72C2A9C0F5E63B54B572EFD829" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A2.4Notesdue2020Member" xlink:label="loc_cah_A2.4Notesdue2020Member_FC9FAFF9C1D873060F6E54B572F0BFA2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A2.4Notesdue2020Member_FC9FAFF9C1D873060F6E54B572F0BFA2" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.625Notesdue2021Member" xlink:label="loc_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A4.625Notesdue2021Member_A2818AC1CDFC363E756954B572F0DC61" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A2.616Notesdue2022Member" xlink:label="loc_cah_A2.616Notesdue2022Member_30E1914BFA7B23EB818654B572F046F3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A2.616Notesdue2022Member_30E1914BFA7B23EB818654B572F046F3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.2Notesdue2022Member" xlink:label="loc_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A3.2Notesdue2022Member_D28A792B42CBD5A544DE54B572F08139" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_FloatingRateNotesdue2022Member" xlink:label="loc_cah_FloatingRateNotesdue2022Member_E765FF24DB0FD577FFD654B572F18056" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_FloatingRateNotesdue2022Member_E765FF24DB0FD577FFD654B572F18056" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.2Notesdue2023Member" xlink:label="loc_cah_A3.2Notesdue2023Member_C8AA75CB0C83B397A0F454B572F1FDED" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A3.2Notesdue2023Member_C8AA75CB0C83B397A0F454B572F1FDED" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.079Notesdue2024Member" xlink:label="loc_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A3.079Notesdue2024Member_3D9C5410AC358BE387ED54B572F16230" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.5Notesdue2025Member" xlink:label="loc_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A3.5Notesdue2025Member_EF9F3F1D8B380737E06154B572F1286B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.75Notesdue2026Member" xlink:label="loc_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A3.75Notesdue2026Member_7DC117D38D5DAD59916054B572F1D109" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A3.41Notesdue2027Member" xlink:label="loc_cah_A3.41Notesdue2027Member_BF4B36A073A9FC98277454B572F1A651" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A3.41Notesdue2027Member_BF4B36A073A9FC98277454B572F1A651" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.6Notesdue2043Member" xlink:label="loc_cah_A4.6Notesdue2043Member_13A1A0EC9FD087439C9154B572F2E472" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A4.6Notesdue2043Member_13A1A0EC9FD087439C9154B572F2E472" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.5Notesdue2044Member" xlink:label="loc_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A4.5Notesdue2044Member_021193765AC31BA2ACD554B572F2EEE3" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.9Notesdue2045Member" xlink:label="loc_cah_A4.9Notesdue2045Member_224ECEE59CBC32B28BF854B572F237CB" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A4.9Notesdue2045Member_224ECEE59CBC32B28BF854B572F237CB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A4.368Notesdue2047Member" xlink:label="loc_cah_A4.368Notesdue2047Member_1C5097DA638F5BF4809E54B572F29E56" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A4.368Notesdue2047Member_1C5097DA638F5BF4809E54B572F29E56" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_A7.0Debenturesduefiscal2027Member" xlink:label="loc_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9D73B0A9CB4C18E955BD54B572F003E9" xlink:to="loc_cah_A7.0Debenturesduefiscal2027Member_FC383242A4529DE0DFEF54B572F27F9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0ADA0A97F6B407D68DBE54B572EE146C" xlink:to="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaap_NotesPayable_C7ECB9634C734C695E2754B572F39640" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:to="loc_us-gaap_NotesPayable_C7ECB9634C734C695E2754B572F39640" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaap_OtherBorrowings_4417D77D0723449A240354B572F36BF6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:to="loc_us-gaap_OtherBorrowings_4417D77D0723449A240354B572F36BF6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalLongTermandShortTermObligations" xlink:label="loc_cah_TotalLongTermandShortTermObligations_2A25A96E0C651C34ED3D54B572F3C5B4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:to="loc_cah_TotalLongTermandShortTermObligations_2A25A96E0C651C34ED3D54B572F3C5B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_BC9CD27C4D51BFAFB00254B572F334B8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_BC9CD27C4D51BFAFB00254B572F334B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_315C698DB158DF0412C654B572F3D146" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_560F6872FD215252FE5A54B572F2A055" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_315C698DB158DF0412C654B572F3D146" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables" xlink:type="extended">
    <link:loc xlink:href="cah-20200331.xsd#cah_LongTermObligationsandOtherShortTermBorrowingsAbstract" xlink:label="loc_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_39FF4C5869B1DA52981054B573061941" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_5714B8C36B499D26349554B57306E5E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract_39FF4C5869B1DA52981054B573061941" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_5714B8C36B499D26349554B57306E5E4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeverance" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_F1D2CD5A6D3F84BEC5A154B573122CE7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02B006E87C729154207854B57312079C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_F1D2CD5A6D3F84BEC5A154B573122CE7" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_02B006E87C729154207854B57312079C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_4012E43AE6E029B1F1E854B57323E398" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_C6F7B385E0D8F295BDB554B5732435DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_4012E43AE6E029B1F1E854B57323E398" xlink:to="loc_us-gaap_SeveranceCosts1_C6F7B385E0D8F295BDB554B5732435DD" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_EE55AEC1E6A8D053169A54B57324F99E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_4012E43AE6E029B1F1E854B57323E398" xlink:to="loc_cah_FacilityExitAndOtherCosts_EE55AEC1E6A8D053169A54B57324F99E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_4AF93B481539780DB8D154B57324EA22" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_4012E43AE6E029B1F1E854B57323E398" xlink:to="loc_us-gaap_RestructuringCharges_4AF93B481539780DB8D154B57324EA22" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_E714E7A4818B3013288F54B573BB71A8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_010C7BA8EE528A9C1A3F54B573BC9653" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_E714E7A4818B3013288F54B573BB71A8" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_010C7BA8EE528A9C1A3F54B573BC9653" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_010C7BA8EE528A9C1A3F54B573BC9653" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_FE25BD6A16E9AB07FBCE54B573BC3855" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="loc_us-gaap_EmployeeSeveranceMember_6F419679033CEF0DC53E54B573BEEDC5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:to="loc_us-gaap_EmployeeSeveranceMember_6F419679033CEF0DC53E54B573BEEDC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_44451552D5961426377F54B573BE82C9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_115B09E06BC94D0F30A754B573BD9D9E" xlink:to="loc_us-gaap_FacilityClosingMember_44451552D5961426377F54B573BE82C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_E7311B1092A0B59157C654B573BE3121" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_010C7BA8EE528A9C1A3F54B573BC9653" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_E7311B1092A0B59157C654B573BE3121" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_E7311B1092A0B59157C654B573BE3121" xlink:to="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_0A43E9224AA4F10B739554B573BFEFC9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:to="loc_us-gaap_RestructuringReserve_0A43E9224AA4F10B739554B573BFEFC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_E59B59EAE07CA0A8C51754B573BF0369" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:to="loc_us-gaap_RestructuringCosts_E59B59EAE07CA0A8C51754B573BF0369" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_909254ABE38CE9F044D754B573C23CCF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:to="loc_us-gaap_PaymentsForRestructuring_909254ABE38CE9F044D754B573C23CCF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_8B1863C8287F7F22265D54B573C25A04" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_8A725C3CA00852A5FCAC54B573BEB8EF" xlink:to="loc_us-gaap_RestructuringReserve_8B1863C8287F7F22265D54B573C25A04" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails" xlink:type="extended">
    <link:loc xlink:href="cah-20200331.xsd#cah_NarativeAbstract" xlink:label="loc_cah_NarativeAbstract_3F7E6CC6F73167DF204BE54904D2504C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_NarativeAbstract_3F7E6CC6F73167DF204BE54904D2504C" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:to="loc_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_4643982B3B81D92B171AE54904D804BC" xlink:to="loc_us-gaap_RestructuringPlanDomain_4831081FD7D0241FF698E54904D83183" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_BBC064383ED311BC5C81E54904DE373C" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_A853B8733426DE06FC4FE54904DFFBFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_46EF4D49661F7F55C949E54904D708D0" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="loc_us-gaap_RestructuringCosts_DEE46D26AE1A661D779DE54904DF3E0E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:to="loc_us-gaap_RestructuringCosts_DEE46D26AE1A661D779DE54904DF3E0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_E936532B5239FB46B6D6E54904E0C8EF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:to="loc_us-gaap_SeveranceCosts1_E936532B5239FB46B6D6E54904E0C8EF" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_FacilityExitAndOtherCosts" xlink:label="loc_cah_FacilityExitAndOtherCosts_FD21F4D57465CE7A260AE54904E099EF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_BDD2BE909FBDCEE728AAE54904DF3EDE" xlink:to="loc_cah_FacilityExitAndOtherCosts_FD21F4D57465CE7A260AE54904E099EF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesAbstract" xlink:label="loc_us-gaap_RestructuringChargesAbstract_F24A708587D7BFB5D15F54B573D0B79F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_FAAE087FBD03E659681054B573D1CB04" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_F24A708587D7BFB5D15F54B573D0B79F" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_FAAE087FBD03E659681054B573D1CB04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_BABA3C256D192E597E1954B573D165FF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_F24A708587D7BFB5D15F54B573D0B79F" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_BABA3C256D192E597E1954B573D165FF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_AE2B78A5BB79BE534CD254B574BE0FE1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_240FC838588340E85E2E54B574BEB2AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_AE2B78A5BB79BE534CD254B574BE0FE1" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_240FC838588340E85E2E54B574BEB2AF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_D3B8720CA7A76B0ACA1754B5738BC256" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_BA8F8A995E3107EB0BB854B5738B1A71" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_D3B8720CA7A76B0ACA1754B5738BC256" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_BA8F8A995E3107EB0BB854B5738B1A71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_BA8F8A995E3107EB0BB854B5738B1A71" xlink:to="loc_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_12AB9A57064B59F9611254B5738BA4C6" xlink:to="loc_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_199F4D76491B1EBD53A854B5738C0EFC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:to="loc_us-gaap_OperatingSegmentsMember_199F4D76491B1EBD53A854B5738C0EFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_0FEEDB9E29B4C9EECC6554B5738D84FA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_A3B5502CC944E0CBCA0454B5738CBE37" xlink:to="loc_us-gaap_CorporateNonSegmentMember_0FEEDB9E29B4C9EECC6554B5738D84FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_02D1632F0EC41C31C64E54B5738D8B74" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_BA8F8A995E3107EB0BB854B5738B1A71" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_02D1632F0EC41C31C64E54B5738D8B74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8DF7FA24C9868575277954B5738E2AD4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_02D1632F0EC41C31C64E54B5738D8B74" xlink:to="loc_us-gaap_SegmentDomain_8DF7FA24C9868575277954B5738E2AD4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_F6A60870A13D9D2C6D1454B5738EBCAC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8DF7FA24C9868575277954B5738E2AD4" xlink:to="loc_cah_PharmaceuticalMember_F6A60870A13D9D2C6D1454B5738EBCAC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_F0C17FD9FC9D7F3D9ECD54B5738EEB46" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8DF7FA24C9868575277954B5738E2AD4" xlink:to="loc_cah_MedicalMember_F0C17FD9FC9D7F3D9ECD54B5738EEB46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2F3AE1C0F35A2E7284C754B5738FB109" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_BA8F8A995E3107EB0BB854B5738B1A71" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2F3AE1C0F35A2E7284C754B5738FB109" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_1E9BE57AEA100886DD0D54B5738FAC7C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2F3AE1C0F35A2E7284C754B5738FB109" xlink:to="loc_us-gaap_Assets_1E9BE57AEA100886DD0D54B5738FAC7C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_883B0CDC05991BE09E0BFFE671603CF6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_883B0CDC05991BE09E0BFFE671603CF6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_GownRecallAxis" xlink:label="loc_cah_GownRecallAxis_86D171530DAA8D7D92FDFFE671604FF0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:to="loc_cah_GownRecallAxis_86D171530DAA8D7D92FDFFE671604FF0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_GownRecallDomain" xlink:label="loc_cah_GownRecallDomain_4D59EACF887DFFD8E553FFE67160BE3C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GownRecallAxis_86D171530DAA8D7D92FDFFE671604FF0" xlink:to="loc_cah_GownRecallDomain_4D59EACF887DFFD8E553FFE67160BE3C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallMemberDomain" xlink:label="loc_cah_SterileSurgicalGownRecallMemberDomain_82F545B334D9414C6A1EFFE671617689" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_GownRecallAxis_86D171530DAA8D7D92FDFFE671604FF0" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_82F545B334D9414C6A1EFFE671617689" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallAxis" xlink:label="loc_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:to="loc_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SterileSurgicalGownRecallDomain" xlink:label="loc_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SterileSurgicalGownRecallAxis_AE8358B302A5B75959A2FFE671617277" xlink:to="loc_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SterileSurgicalGownRecallDomain_FA80E2D1818799CF7F94FFE671618B3D" xlink:to="loc_cah_SterileSurgicalGownRecallMemberDomain_82F545B334D9414C6A1EFFE671617689" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationAxis" xlink:label="loc_cah_OpioidLitigationAxis_48BD150E7BBE0D483692FFE67162CC71" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:to="loc_cah_OpioidLitigationAxis_48BD150E7BBE0D483692FFE67162CC71" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_OpioidLitigationDomain" xlink:label="loc_cah_OpioidLitigationDomain_5D453D224BACDF6228FCFFE671625E29" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationAxis_48BD150E7BBE0D483692FFE67162CC71" xlink:to="loc_cah_OpioidLitigationDomain_5D453D224BACDF6228FCFFE671625E29" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TotalOpioidLitigationMember" xlink:label="loc_cah_TotalOpioidLitigationMember_5D35312F6606291A6099FFE67162C321" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_OpioidLitigationDomain_5D453D224BACDF6228FCFFE671625E29" xlink:to="loc_cah_TotalOpioidLitigationMember_5D35312F6606291A6099FFE67162C321" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_D5D7EA61A7A68F811360FFE671634A00" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_NaviHealthMember" xlink:label="loc_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7129BFC3B27DA713EB1CFFE671630CEC" xlink:to="loc_cah_NaviHealthMember_B2BD67993299E5F7B801FFE67163CA06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3CFBACABC987AEB80DABFFE67160A9FA" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_5D74690D9B0BCA1A5BA5FFE6727CA99D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_5D74690D9B0BCA1A5BA5FFE6727CA99D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRecallExpense" xlink:label="loc_us-gaap_InventoryRecallExpense_9F9B46AAB25E9D04C77DFFE671643860" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:to="loc_us-gaap_InventoryRecallExpense_9F9B46AAB25E9D04C77DFFE671643860" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PreTaxGainonDivestiture" xlink:label="loc_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_41057C37895138496AECFFE671632D53" xlink:to="loc_cah_PreTaxGainonDivestiture_97E8E3FCF2EF8EE60906FFE671699595" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_259B721DA53B18F9406CFFE6716968BC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_883B0CDC05991BE09E0BFFE671603CF6" xlink:to="loc_us-gaap_NumberOfOperatingSegments_259B721DA53B18F9406CFFE6716968BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_B50276A8E96752CFBB12FFE671690B4D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_883B0CDC05991BE09E0BFFE671603CF6" xlink:to="loc_us-gaap_NumberOfReportableSegments_B50276A8E96752CFBB12FFE671690B4D" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ProjectCostsOnInvestmentAndOtherSpending" xlink:label="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_78902826542842099364FFE6716A6511" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_883B0CDC05991BE09E0BFFE671603CF6" xlink:to="loc_cah_ProjectCostsOnInvestmentAndOtherSpending_78902826542842099364FFE6716A6511" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_A9DB042D7ED7C1F4C3B354B572FA8F50" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_A9DB042D7ED7C1F4C3B354B572FA8F50" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:to="loc_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_5F517DC7F0C0BEFDF4F354B572FA873B" xlink:to="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PharmaceuticalDistributionandSpecialtyMember" xlink:label="loc_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:to="loc_cah_PharmaceuticalDistributionandSpecialtyMember_392BF655411B72DE2FA454B572FB6EF4" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_NuclearPrecisionHealthServicesMember" xlink:label="loc_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:to="loc_cah_NuclearPrecisionHealthServicesMember_7A47EB6881C51ECE8C8154B572FB310C" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicaldistributionandproductsMember" xlink:label="loc_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:to="loc_cah_MedicaldistributionandproductsMember_650B3EAAEE9F328379F254B572FC3953" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_CardinalHealthAtHomeMember" xlink:label="loc_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_D77A1858C593FE2C1A0A54B572FBC5CB" xlink:to="loc_cah_CardinalHealthAtHomeMember_E9AFA5C73814660F6D6054B572FCCA50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_8D5DFA567CFAA6BEA5BA54B572FC9F3E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:to="loc_srt_ConsolidationItemsAxis_8D5DFA567CFAA6BEA5BA54B572FC9F3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_E8903B72DDF342852C3554B572FCE846" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_8D5DFA567CFAA6BEA5BA54B572FC9F3E" xlink:to="loc_srt_ConsolidationItemsDomain_E8903B72DDF342852C3554B572FCE846" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_3B510D895AD21B702F1F54B572FD3F2B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_E8903B72DDF342852C3554B572FCE846" xlink:to="loc_us-gaap_OperatingSegmentsMember_3B510D895AD21B702F1F54B572FD3F2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4AFB280C2BDBEE85DBC454B572FDD44E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_E8903B72DDF342852C3554B572FCE846" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4AFB280C2BDBEE85DBC454B572FDD44E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_D1C0F14460D636B819CD54B572FD870A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_D1C0F14460D636B819CD54B572FD870A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_E8E8F1BBDA5A2470F22754B572FEBAC6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_D1C0F14460D636B819CD54B572FD870A" xlink:to="loc_us-gaap_SegmentDomain_E8E8F1BBDA5A2470F22754B572FEBAC6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_4FB7E28BF217E7669ADD54B572FE52F1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_E8E8F1BBDA5A2470F22754B572FEBAC6" xlink:to="loc_cah_PharmaceuticalMember_4FB7E28BF217E7669ADD54B572FE52F1" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_E140E185A1750224F02954B572FF4CAB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_E8E8F1BBDA5A2470F22754B572FEBAC6" xlink:to="loc_cah_MedicalMember_E140E185A1750224F02954B572FF4CAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_D121979964B0ED5BDA3E54B572FF83EF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_C0218D9B600822F85F9E54B572FA2E83" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_D121979964B0ED5BDA3E54B572FF83EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_A5C3853D1A1C2635448854B572FF1E10" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_D121979964B0ED5BDA3E54B572FF83EF" xlink:to="loc_us-gaap_Revenues_A5C3853D1A1C2635448854B572FF1E10" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_340E7F983C852A26ADA454B573C9CEEE" xlink:type="locator" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable" xlink:label="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_340E7F983C852A26ADA454B573C9CEEE" xlink:to="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_5D8AC3BC449AA6E2C5F654B573CA7A8A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:to="loc_srt_ConsolidationItemsAxis_5D8AC3BC449AA6E2C5F654B573CA7A8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_D44B0226EB5695D34F1A54B573CA71B5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5D8AC3BC449AA6E2C5F654B573CA7A8A" xlink:to="loc_srt_ConsolidationItemsDomain_D44B0226EB5695D34F1A54B573CA71B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_669D71B85888A42E5C4554B573CAEB20" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_D44B0226EB5695D34F1A54B573CA71B5" xlink:to="loc_us-gaap_OperatingSegmentsMember_669D71B85888A42E5C4554B573CAEB20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_18E324CAEB7D6454BD2154B573CB8638" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_D44B0226EB5695D34F1A54B573CA71B5" xlink:to="loc_us-gaap_CorporateNonSegmentMember_18E324CAEB7D6454BD2154B573CB8638" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_285B66E4F591B80A449E54B573CB2FA0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:to="loc_srt_StatementGeographicalAxis_285B66E4F591B80A449E54B573CB2FA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_F5F94D8705F09F8D60B354B573CB0681" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_285B66E4F591B80A449E54B573CB2FA0" xlink:to="loc_srt_SegmentGeographicalDomain_F5F94D8705F09F8D60B354B573CB0681" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:label="loc_country_US_AAB354A69C6256CB74C454B573CCE43D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_F5F94D8705F09F8D60B354B573CB0681" xlink:to="loc_country_US_AAB354A69C6256CB74C454B573CCE43D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember" xlink:label="loc_us-gaap_NonUsMember_26B4A6CFBA6DF9853A3554B573CC89E6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_F5F94D8705F09F8D60B354B573CB0681" xlink:to="loc_us-gaap_NonUsMember_26B4A6CFBA6DF9853A3554B573CC89E6" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems" xlink:label="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable_B9B245DC56BABDEA60AC54B573C9E013" xlink:to="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_7FDF5254F723F8B3BE1054B573CCC5CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems_8BD92313A8F203BE898B54B573CCFE4E" xlink:to="loc_us-gaap_Revenues_7FDF5254F723F8B3BE1054B573CCC5CD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_2EF918591ADC49FAC8BF54B5731AB37D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2EF918591ADC49FAC8BF54B5731AB37D" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5A617C7D6366D6E148C454B5731BCCDB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5A617C7D6366D6E148C454B5731BCCDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_105A3EDEBECF482607CD54B5731B7764" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5A617C7D6366D6E148C454B5731BCCDB" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_105A3EDEBECF482607CD54B5731B7764" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srt_ConsolidationItemsAxis_C49765D7076EE9A69EBE54B5731C5B37" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:to="loc_srt_ConsolidationItemsAxis_C49765D7076EE9A69EBE54B5731C5B37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srt_ConsolidationItemsDomain_8E9ABDAA9839F7829B3754B5731C5E3D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_C49765D7076EE9A69EBE54B5731C5B37" xlink:to="loc_srt_ConsolidationItemsDomain_8E9ABDAA9839F7829B3754B5731C5E3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaap_OperatingSegmentsMember_41A0C3D208EDD8632BAB54B5731C9DD7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_8E9ABDAA9839F7829B3754B5731C5E3D" xlink:to="loc_us-gaap_OperatingSegmentsMember_41A0C3D208EDD8632BAB54B5731C9DD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="loc_us-gaap_CorporateNonSegmentMember_D5CC591FD9D32830B9E454B5731CA7F7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_8E9ABDAA9839F7829B3754B5731C5E3D" xlink:to="loc_us-gaap_CorporateNonSegmentMember_D5CC591FD9D32830B9E454B5731CA7F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_F80452500E1D7E2476E354B5731C104A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_F80452500E1D7E2476E354B5731C104A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_9D7D788291CB906D175E54B5731DF26B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_F80452500E1D7E2476E354B5731C104A" xlink:to="loc_us-gaap_SegmentDomain_9D7D788291CB906D175E54B5731DF26B" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_PharmaceuticalMember" xlink:label="loc_cah_PharmaceuticalMember_0E252F95F1B54A38D9E754B5731DBFA0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9D7D788291CB906D175E54B5731DF26B" xlink:to="loc_cah_PharmaceuticalMember_0E252F95F1B54A38D9E754B5731DBFA0" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_MedicalMember" xlink:label="loc_cah_MedicalMember_8BF2850BC3DD3DDA905054B5731DE807" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9D7D788291CB906D175E54B5731DF26B" xlink:to="loc_cah_MedicalMember_8BF2850BC3DD3DDA905054B5731DE807" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_D656B8B90A14D889220154B5731BB80A" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_C2191181F373BD7F2F9954B5731D91DA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_193C55312E1C78FFA84454B5731DF94D" xlink:to="loc_us-gaap_OperatingIncomeLoss_C2191181F373BD7F2F9954B5731D91DA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_FB80BD6DFA5AA1B452DD54B574AEC557" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_AB6D6F96E6BADB4BCBB754B574AFDFA9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_FB80BD6DFA5AA1B452DD54B574AEC557" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_AB6D6F96E6BADB4BCBB754B574AFDFA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_7B1C1071141F7CB1121F54B574AFCF8C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_FB80BD6DFA5AA1B452DD54B574AEC557" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_7B1C1071141F7CB1121F54B574AFCF8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6A25D45750B214223F1F54B574AF0B43" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_FB80BD6DFA5AA1B452DD54B574AEC557" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_6A25D45750B214223F1F54B574AF0B43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_90D5AC20E95589A8588C54B574AFCBB2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_FB80BD6DFA5AA1B452DD54B574AEC557" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_90D5AC20E95589A8588C54B574AFCBB2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9FBC6F92D5847453EE5B54B57437AEDD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_DA340920142EF32733C654B57437F958" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9FBC6F92D5847453EE5B54B57437AEDD" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_DA340920142EF32733C654B57437F958" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B62835E0AAE8353635E054B572340118" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0FD42F0284AA24EFA1CF54B572341D97" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_B62835E0AAE8353635E054B572340118" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0FD42F0284AA24EFA1CF54B572341D97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_4C7141C629126F6D90CD54B572351CFD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0FD42F0284AA24EFA1CF54B572341D97" xlink:to="loc_us-gaap_AwardTypeAxis_4C7141C629126F6D90CD54B572351CFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DF55E393E5B5162266E054B5723523DD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4C7141C629126F6D90CD54B572351CFD" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DF55E393E5B5162266E054B5723523DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_A155E3A35FB7E688834354B57236BB86" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DF55E393E5B5162266E054B5723523DD" xlink:to="loc_us-gaap_EmployeeStockOptionMember_A155E3A35FB7E688834354B57236BB86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2E68C935903C64DEC90254B5723636A7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DF55E393E5B5162266E054B5723523DD" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2E68C935903C64DEC90254B5723636A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_48B8B5E0C2B48C27982854B5723646FD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_DF55E393E5B5162266E054B5723523DD" xlink:to="loc_us-gaap_PerformanceSharesMember_48B8B5E0C2B48C27982854B5723646FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_DB157F47705650D894F254B57236DCC8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0FD42F0284AA24EFA1CF54B572341D97" xlink:to="loc_srt_RangeAxis_DB157F47705650D894F254B57236DCC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_3764A05CA431B195D1C854B572374B85" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_DB157F47705650D894F254B57236DCC8" xlink:to="loc_srt_RangeMember_3764A05CA431B195D1C854B572374B85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_79C57E6D1A933DE48D4F54B572370C90" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3764A05CA431B195D1C854B572374B85" xlink:to="loc_srt_MinimumMember_79C57E6D1A933DE48D4F54B572370C90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_CCC9EE75F4A34369941E54B5723704CD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3764A05CA431B195D1C854B572374B85" xlink:to="loc_srt_MaximumMember_CCC9EE75F4A34369941E54B5723704CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0FD42F0284AA24EFA1CF54B572341D97" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_VestingPeriodinyearsforShares" xlink:label="loc_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_cah_VestingPeriodinyearsforShares_977DC2C38D4FE0172D6754B572388306" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_054DA05A0FDCD448C6C054B5723896BB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_054DA05A0FDCD448C6C054B5723896BB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_02EC143328DA47675B8554B57238E121" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_02EC143328DA47675B8554B57238E121" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1B58DF4E816EFC0F956054B572398D78" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1B58DF4E816EFC0F956054B572398D78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_EFB1CFDF211EA29AA24A54B572394068" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_EFB1CFDF211EA29AA24A54B572394068" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_ExercisablePeriodOfPlansInYears" xlink:label="loc_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_cah_ExercisablePeriodOfPlansInYears_5A1E4657CDAACB79B26054B5723A9568" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1B7A0DE3E93FA891DB6154B5723AAC02" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_A46F23D898243CEF78FF54B572388926" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1B7A0DE3E93FA891DB6154B5723AAC02" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8183A030F2A73DD34D2754B573E8FCC6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BA8052E2CF04CE20BD2A54B573E95FF5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8183A030F2A73DD34D2754B573E8FCC6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BA8052E2CF04CE20BD2A54B573E95FF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_BB7EDB546B106A73A80554B573E9C4CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BA8052E2CF04CE20BD2A54B573E95FF5" xlink:to="loc_us-gaap_AwardTypeAxis_BB7EDB546B106A73A80554B573E9C4CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65879B2351871DFDE57854B573E93AD4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_BB7EDB546B106A73A80554B573E9C4CF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65879B2351871DFDE57854B573E93AD4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_58212119842F6E6A6EE354B573EA9754" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65879B2351871DFDE57854B573E93AD4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_58212119842F6E6A6EE354B573EA9754" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_BA8052E2CF04CE20BD2A54B573E95FF5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_93753D0E6E083CE9B72854B573EAF5CA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_93753D0E6E083CE9B72854B573EAF5CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0057E2485D617F3BE16454B573EA114E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0057E2485D617F3BE16454B573EA114E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60C5D3939408812594EB54B573EB2C0F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60C5D3939408812594EB54B573EB2C0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_472CED317DCE97C429B354B573EB4AE1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_472CED317DCE97C429B354B573EB4AE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_36C9C01D539AF720C75254B573EBC407" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_17A9F85762BFD77D9F9254B573EA9CC8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_36C9C01D539AF720C75254B573EBC407" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8C2B888345CEB5D19F3654B5743EC63C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8C2B888345CEB5D19F3654B5743EC63C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_959C61B0FEC9B57FEC6654B5743E8380" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_959C61B0FEC9B57FEC6654B5743E8380" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9D1331D44B6224384DD454B5743FA729" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9D1331D44B6224384DD454B5743FA729" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_E00A1BB4A56281BDB73D54B5743F1139" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_E00A1BB4A56281BDB73D54B5743F1139" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5F04EFD6C86939DC056354B5743F4D1B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_5F04EFD6C86939DC056354B5743F4D1B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3B36B2A55F49DA91809454B5743F5E87" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_92A0F5D84212D4B884E754B5743E589B" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3B36B2A55F49DA91809454B5743F5E87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1F5DC52850DEA19039BC54B574408048" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8C2B888345CEB5D19F3654B5743EC63C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1F5DC52850DEA19039BC54B574408048" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8C2B888345CEB5D19F3654B5743EC63C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CF3A5527D81F72CCFA7654B57440B58A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CF3A5527D81F72CCFA7654B57440B58A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_D7408C3CBE290C55F78454B57441BFE2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_D7408C3CBE290C55F78454B57441BFE2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3380B0B724BD6C10A51554B57441D033" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3380B0B724BD6C10A51554B57441D033" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_A6A75555A3675868E53654B57441C745" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_A6A75555A3675868E53654B57441C745" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9281E6ACEA0CE745AFD254B5744213B1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9281E6ACEA0CE745AFD254B5744213B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C85A98BB83AF4D8C7A1554B574422A8D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_847853A9396B6845740D54B57440FCD5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C85A98BB83AF4D8C7A1554B574422A8D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_03E885E026FFD8BEFD8254B5721F1007" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_462B6E3D998D260B3FA854B5722019EE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_03E885E026FFD8BEFD8254B5721F1007" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_462B6E3D998D260B3FA854B5722019EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_54135A12AA3C4FF51A1654B5722000BA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_462B6E3D998D260B3FA854B5722019EE" xlink:to="loc_us-gaap_AwardTypeAxis_54135A12AA3C4FF51A1654B5722000BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F718DA7685EC3CC0BC1154B57220B591" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_54135A12AA3C4FF51A1654B5722000BA" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F718DA7685EC3CC0BC1154B57220B591" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_06A2F6A293A1851C7A4E54B57221A867" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_F718DA7685EC3CC0BC1154B57220B591" xlink:to="loc_us-gaap_PerformanceSharesMember_06A2F6A293A1851C7A4E54B57221A867" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_462B6E3D998D260B3FA854B5722019EE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_C9D9A121D26898E6B40254B572228BF3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_C9D9A121D26898E6B40254B572228BF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7A68E48636BC1D38815A54B5722322AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7A68E48636BC1D38815A54B5722322AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F3428041D22685DC69754B572236F6B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_5F3428041D22685DC69754B572236F6B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_B494025A34EDB61E86E454B57224697B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_B494025A34EDB61E86E454B57224697B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D3325994D23BC206A6BC54B5722469A7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_D3325994D23BC206A6BC54B5722469A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_CA53AA5D5441A31010FE54B57225662F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_E23531CDB1465662AC2254B572225D41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_CA53AA5D5441A31010FE54B57225662F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4704093ACDCBC1CB49BB54B5722594A4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4704093ACDCBC1CB49BB54B5722594A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_FCECC6B08AF38667BEE954B572261033" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_FCECC6B08AF38667BEE954B572261033" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_23C867DD3BBBBECCCD4F54B57226A895" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_23C867DD3BBBBECCCD4F54B57226A895" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_FB185533383BE84B3C5C54B5722652A7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_FB185533383BE84B3C5C54B5722652A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C3A4565473AE6AF4B4C154B57227A2B1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5841554403E31AFD700654B5722586AB" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C3A4565473AE6AF4B4C154B57227A2B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D6A98376C152C192E56254B57227B97C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_D6A98376C152C192E56254B57227B97C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0447D92BF695E6CEC59B54B572284422" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0447D92BF695E6CEC59B54B572284422" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_B3E2A19C12533A899C1554B572283248" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6C1BCE07CAC0F25C59D054B57222BB58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_B3E2A19C12533A899C1554B572283248" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_640BB90BFACE4092B8A854B572AA01E7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7B268795E5365EEE4A6054B572AAB30E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_640BB90BFACE4092B8A854B572AA01E7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7B268795E5365EEE4A6054B572AAB30E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_C2720E84975FF2716F5254B572AB01B9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7B268795E5365EEE4A6054B572AAB30E" xlink:to="loc_us-gaap_AwardTypeAxis_C2720E84975FF2716F5254B572AB01B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7F6B4DA2FF4E4244260254B572AB58FA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_C2720E84975FF2716F5254B572AB01B9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7F6B4DA2FF4E4244260254B572AB58FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_615031608A7F86D4ABEB54B572AB620B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7F6B4DA2FF4E4244260254B572AB58FA" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_615031608A7F86D4ABEB54B572AB620B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_398DF7A77C8B2B14EB6954B572AB6151" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7F6B4DA2FF4E4244260254B572AB58FA" xlink:to="loc_us-gaap_EmployeeStockOptionMember_398DF7A77C8B2B14EB6954B572AB6151" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6671A968DDE312C2B91154B572ACD46E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7B268795E5365EEE4A6054B572AAB30E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6671A968DDE312C2B91154B572ACD46E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_DD92188B8A6F62AEEE2E54B572ACA17B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6671A968DDE312C2B91154B572ACD46E" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_DD92188B8A6F62AEEE2E54B572ACA17B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_14F7EA1DA3901B3FE5C654B572AC8B5E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6671A968DDE312C2B91154B572ACD46E" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_14F7EA1DA3901B3FE5C654B572AC8B5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6671A968DDE312C2B91154B572ACD46E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5A0272CD08257C50E23754B572ADAF14" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5A0272CD08257C50E23754B572ADAF14" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7E17B0078728FDBA1F0354B572ADDD99" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7E17B0078728FDBA1F0354B572ADDD99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_06E2CAF7A030E9A3BC8254B572AEAEAF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_06E2CAF7A030E9A3BC8254B572AEAEAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_B70DE556EFE57A33942854B572AE2FF1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_B70DE556EFE57A33942854B572AE2FF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9C5952387F26EA62BE754B572AECB9B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_F0C99DC43A16E5FB692154B572AD6E0E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_D9C5952387F26EA62BE754B572AECB9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6671A968DDE312C2B91154B572ACD46E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0B700A689F53464F356654B572AF7090" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0B700A689F53464F356654B572AF7090" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_27C2A133CC21AA51787F54B572AF5D37" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_27C2A133CC21AA51787F54B572AF5D37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3FD4503EFFB44C74FDE454B572AF3444" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3FD4503EFFB44C74FDE454B572AF3444" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2D67339673A9F0E01FB454B572AFF61D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2D67339673A9F0E01FB454B572AFF61D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_493F4C46D5985908928154B572AFAFB0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_CF67CB9CA64795C2185754B572AE5EFE" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_493F4C46D5985908928154B572AFAFB0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A0FD15E8F9203DF8317C54B57290B07D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_A0FD15E8F9203DF8317C54B57290B07D" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF" xlink:to="loc_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_75D973FB12F49918458354B57290F135" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ADD284ADD83BD5B2B4A854B572910583" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ADD284ADD83BD5B2B4A854B572910583" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_072DAA107E78A25ADCD254B57292F1E7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:to="loc_us-gaap_EmployeeStockOptionMember_072DAA107E78A25ADCD254B57292F1E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_90CD2ABA7453EDE8E0CF54B572920B58" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3D2304E87B9EBF81916754B572910F3D" xlink:to="loc_us-gaap_PerformanceSharesMember_90CD2ABA7453EDE8E0CF54B572920B58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_47B4BE9AD5F7B25AFD6E54B5729071DF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_973C13C0899F0850ADD954B57293647A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_CD3A0B896E8B4DA4371F54B57292073C" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_973C13C0899F0850ADD954B57293647A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BE63940D77704F58B42354B5742EF3C1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_891A6886E12F06396CD254B5742F82CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BE63940D77704F58B42354B5742EF3C1" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_891A6886E12F06396CD254B5742F82CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B254308C2DB12D56C9D754B5742F12E9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BE63940D77704F58B42354B5742EF3C1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_B254308C2DB12D56C9D754B5742F12E9" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_AdditionalStockOptionPlanDataTableTextBlock" xlink:label="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_C9F035C67ED3DD3D4D8354B5742FE521" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BE63940D77704F58B42354B5742EF3C1" xlink:to="loc_cah_AdditionalStockOptionPlanDataTableTextBlock_C9F035C67ED3DD3D4D8354B5742FE521" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_AC43B8F7D226B444484C54B5742F95DD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BE63940D77704F58B42354B5742EF3C1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_AC43B8F7D226B444484C54B5742F95DD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_7085F3EA8C92B45F5D1E54B5742F6F9D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_BE63940D77704F58B42354B5742EF3C1" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_7085F3EA8C92B45F5D1E54B5742F6F9D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_4471D56BF1FE79FF306D54B572C3B0FD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1245D4A192F09A84B81F54B572C388D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4471D56BF1FE79FF306D54B572C3B0FD" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1245D4A192F09A84B81F54B572C388D4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_185EA6F495254252DCEE54B7CE23131D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_185EA6F495254252DCEE54B7CE23131D" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2F12E969A8971A14CEBB54B7CE24386B" xlink:to="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2815251BDBBDD36AC13A54B7CE242F65" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2815251BDBBDD36AC13A54B7CE242F65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_066C67D4399E2CCE092F54B7CE2530AC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_066C67D4399E2CCE092F54B7CE2530AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8C5C635E03234F16D7D654B7CE25976B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_8C5C635E03234F16D7D654B7CE25976B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F114CAC7833A47AAC20D54B7CE2537A3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_A777C32E4FE3F61B93E454B7CE2474CF" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F114CAC7833A47AAC20D54B7CE2537A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_BB1A11D82E77DCCC252154B7CE236F3E" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_F7C0759FFE4E28220C9B54B7CE25AADC" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EEDAB9457CFDAF44029454B7CE260F07" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_EEDAB9457CFDAF44029454B7CE260F07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D88FFB71B158066FCAAB54B7CE263B03" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_D88FFB71B158066FCAAB54B7CE263B03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_DDF007A8B79F35BE993154B7CE2B5EF8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_DDF007A8B79F35BE993154B7CE2B5EF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7CAC2F317B1FCD0A883D54B7CE2CF90A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7CAC2F317B1FCD0A883D54B7CE2CF90A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_D2C92B576076480C005A54B7CE2C0C51" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_1AA17B97D209C248E3AD54B7CE2500D6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_D2C92B576076480C005A54B7CE2C0C51" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_51204B4F98675143AAD154B574C75880" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_51204B4F98675143AAD154B574C75880" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6109B93260FF17B1F6E654B574C7AEEA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6109B93260FF17B1F6E654B574C7AEEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_56FEBB3F462EFC49598A54B574C8F099" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6109B93260FF17B1F6E654B574C7AEEA" xlink:to="loc_us-gaap_EquityComponentDomain_56FEBB3F462EFC49598A54B574C8F099" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_58301B1564AE68AEE22754B574C820CC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_56FEBB3F462EFC49598A54B574C8F099" xlink:to="loc_us-gaap_TreasuryStockMember_58301B1564AE68AEE22754B574C820CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_EB5CE592A948769CF35754B574C7B806" xlink:to="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_045D18BFB8DC2EB5C28354B574C92B98" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_045D18BFB8DC2EB5C28354B574C92B98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_D4CF059169F01009598454B574CA5332" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_D4CF059169F01009598454B574CA5332" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38655F808B7037A10D8754B574CA5EAE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38655F808B7037A10D8754B574CA5EAE" xlink:type="arc" />
    <link:loc xlink:href="cah-20200331.xsd#cah_TreasuryStockAcquiredShares" xlink:label="loc_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_2D8F33FE969E31167E7E54B574C87E22" xlink:to="loc_cah_TreasuryStockAcquiredShares_F77B12378D5B99A7807654B574CA34A0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cardinal.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_A53A3F08BBDEB09D4F7254B5729E3565" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E6B91BBD1237C9AF1CCD54B5729E6139" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_A53A3F08BBDEB09D4F7254B5729E3565" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E6B91BBD1237C9AF1CCD54B5729E6139" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>chart-84be621792a45ea38bb.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 chart-84be621792a45ea38bb.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( 0H# 2(  A$! Q$!_\0
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MV<]$^'NJ:]I4]K=>'?"URGPFC@U0"^CM)&^(WB0W+-'XCO8YP#^OKX1_M#_
M+X_VVNWGP(^-_P (?C3:>%[Y-,\377PF^)7@SXC6_AW4I7N4BT_79O!^M:PF
MDWLK6=UY5M?FWEF%O,8E<1.5]BK^6B[T7]F+]A/_ (*P:1X,^ G_  3Z\<_L
M;>-_&7[(_P"U%X4^$?QE^%.L?!SPA^RG^TKX4^"GPJ\-?&OQ%K/CGX'>$[:3
MQ3KGB;X;^*Y?#?AW2_$.NGPUX@GOKHR7\WB'13;2V6)\)/VXO^"KGCG]E/\
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M#UI'H>H0>*_!GC#X6?M _#C4OB)X6\4+%9?N/'7AB]T'4[N[TK6K'3OV1HH
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MP/9^*?$_CG2;'0;B7Q[9:E9Z=KNG>*M+L=,N],U[2]-U33XX)[*(U\;>$?\
M@B?^RUH?P;_:D^$_C?XF?M4?'?7OVO?AOH?P;^+7QZ^/GQNF^)GQ^3X1>$S<
MMX.^&W@_QMJGAN'2?"WA3PO->WM[9VEIX7GN-7U.[EU7Q/<ZY?I:S6W["44
M9NC:5:Z%I.F:-9&5K/2=/L=,M3.XDG-MI]I#9P&:0*@DE,,"&1PBAWW,%4'
MTJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 9("R@ 9.^,_@
MLBL3SZ $_P N:_CA\/\ _!$;XX_##]FCPG^UK\&OV9_A=H/_  5;_9O_ &\O
MC[^TEX)TSQ!/\*=1B_:5^"_B_P"/WC*Z@^$WQ#\87^H:UX.M7\2_!KQ!9:K\
M//$FJ7UAXI^&NM:3966DZKX.U?4+V]M?[(:* /XZOC?_ ,$L_P!J;XB?MT_M
M"7?B/]FC]ISXI_L[_MO?'_\ 9^_:)GUWPQ_P4;3]G7X#?!RWTCPO\,C\0- _
M:9_9_P#"5SXDO/B/\3?@EXN\!6^I_"G7/ ^C>-;/Q0\'A2"PUW2(_"[30_>N
M@_\ !,_X^Z=_P6HUGXU-9Z5:_P#!/&T\0^*/V_/#=A:WWASS?^'A7Q$^">A?
MLF^*+&?PXVIR>(7-OX#TG6/C3!XBGT)=&MO%VO1K:ZW<:F)=/M/Z'\#(.!D<
M X&0/0'M2T ?QL?\$X?^"2O[5_[.WQE^$'PW^+W[/O[0&OZ+^QO'^UG<?#_]
MICQC_P %#)O$7[,^M3_%'PW\4/"OP]U#]FC]C"T;6O\ A$->^*/ASXAS:3\8
M=*\8Q_#_ $K0)(]>\03:QJ^JZK:Z'=?5/[-W_!-_]K#PAX,_X()>&O%?PNM?
M"]W^Q]^S!^W?\,/VF+N?QAX(U&+X5^*_CM\!-'\%>!K24:/XBOY?%L&O^*X)
MH[R?P+_PD-K9&U^V:I-;0F&=OZ?<#).!D]3CD_4TN!Z=.GM0!_&G^SY_P3R_
MX*4_%71O^";G[/WQX_9<@_9Q^'O[%7['G_!1/]BOQE\91\;_ (6?$!_$6M_M
M!?LZP?"+P%\7_#/A'PEJDFOVG@.[ETO2ETE99;OQ7<:S>:O)J_AOP_HFDZ=K
M.M>R_P#!)+]BCXZ_L>^.?#OQE_;#_9Z_:"^$&F_L0_L5^)_A/=_';XW_ /!1
MRY_:/^'&M_V'I_AAO&VF?LU_ #2[;5-&^%?[.NJ^%_AW:_$.*W\1:KX/G\$W
MUIX6\&:9X5U?_A';C5K#^L; '0#J3T[GJ?J>]<GX\\!^#?B?X*\6?#GXA>&=
M&\9>!/'?A[5_"?C/PCXBL8=3\/\ BCPSK]E-IFMZ!KNF7 :WU+2-7TZXGL-2
ML+E7M[VSGFMKA)(971@#\R?^"&/PX\3?"W_@DQ^PYX<\7V,NF:[K/P;3XG3Z
M9<*Z76EV7QJ\7>*?C+HNE7D<H66&]TW0O'NF6=Y#+'#+#<Q2Q200.K0I^L=0
M6MK:V-M;V=E;06=G:016UK:VL,=O;6UO;QK#!!!!"J10PPQ(D444:+''&BHB
MJJ@">@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **X:]^)GP_TV\NM/O_&7ARTO;*>2UN[6XU6VBGM[
MB%MDL,T;.&22-@5=&&5(P:J_\+9^&G_0]>%O_!S:?_%T >AT5YY_PMGX:?\
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M?M"_]%>\8?\ ?_3?_E91_P -0?M"_P#17O&'_?\ TW_Y65X4L4KH\B12O'&
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MX+12J#&LP+1.H,+$!9@2HS"Y("2C]VQ("L20#TO@?_D=?!W_ &-7AW_T\6=
M'ZX5X/\ &C]HGP#\"9/#L7C6#Q%,WB9-4DT[^PM*AU(*ND-8)=?:C+?V7DDG
M4;?R0OF;P),[-@W>\5^5'_!2C_C]^#__ %[>.O\ T?X4H ]O_P"'A/P(_P"?
M+XA?^$O:?_+VC_AX3\"/^?+XA?\ A+VG_P O:_$^B@#]L/\ AX3\"/\ GR^(
M7_A+VG_R]H_X>$_ C_GR^(7_ (2]I_\ +VOQ/HH _I%^$/Q>\*?&OPM/XO\
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MX)W_ /1WWP@_[_\ B_\ ^9*O[@/[+TW_ )\++_P$MO\ XU1_9>F_\^%E_P"
MEM_\:H _A_\ ^'I/_!.__H[[X0?]_P#Q?_\ ,E7Z0?L-?\%K/^"5'PO\,>/[
M/QQ^W/\  W0+K5O$NF7EA!?7_BN"2XMK?18[:6=!+X40-&)RT65+$,CA@HVE
MOZ8/[+TW_GPLO_ 2V_\ C5*-,T\=+&S'TM;<?RBH _(;_A_]_P $</\ I()\
M /\ P;>)?_F8K\S[S_@L=_P2UDO+R1/VY_@4R27EY(C+>>-,,DEU,Z,,^#!P
MRL&''0CH<@?U5?V=8?\ /E:?^ MO_P#&J3^S-._Y\;/_ ,!+?_XU0!_*;_P^
M+_X)<?\ 1\OP+_\  SQG_P#,;1_P^+_X)<?]'R_ O_P,\9__ #&U_5E_9FG?
M\^-G_P" EO\ _&J/[,T[_GQL_P#P$M__ (U0!_*;_P /B_\ @EQ_T?+\"_\
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M (U1_9>F_P#/A9?^ EM_\:H _A__ .'I/_!._P#Z.^^$'_?_ ,7_ /S)4?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
***** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>chart-90453b3d6ed050ecbdc.jpg
<TEXT>
begin 644 chart-90453b3d6ed050ecbdc.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( 0H# 2(  A$! Q$!_\0
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\Y/V^O\
M@H)_PQQ?? [X6?#/X#>._P!K']J[]IWQ#XKT'X!?LV_#K7_#?@[4_%EI\/=#
M@\2?$3QGXK\?>+F/AKX?_#_P1I-YIIUSQ-JL%V$O=7TZ"*S-JNIW^F_HW7X
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M;7?A;K^D:*UMIVB77@'1$TK5/"WBW3?&6BZE+?WMW<P&>+2VTW]1:* /P_\
M&/\ P2YL? ?A7]B;]EWX%V?Q!\4_!S1?^"@]C^WG^V+\<_B[\1['QO\ $WXC
M^+/A;#K_ ,6=)U;XC:IJT^E:QX^\>?&7]H"W^$UIJ<^BZ!%HFE^$_"&NW6H6
MU@T.GKJ/[?J"% .,XY(& 6/+$#W.3^-+10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*W>:V_:ONU?"?_!/+_DA.J_]E(\3?^FWP]7W90 4444 %%%% !1110 4444
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M_P D)U7_ +*1XF_]-OAZONROA/\ X)Y?\D)U7_LI'B;_ --OAZONR@ HHHH
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M'\-0Z(X'C?4" Z*^#_PC5_R-P.#VR,<<5^0OD0=!;PDG@ 01DDG@  )DDG@
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MONROA/\ X)Y?\D)U7_LI'B;_ --OAZONR@ HHHH **** "BBB@ K\^_VE_\
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M/VY_@4R27EY(C+>>-,,DEU,Z,,^#!PRL&''0CH<@?U5?V=8?\^5I_P" MO\
M_&J3^S-._P"?&S_\!+?_ .-4 ?RF_P##XO\ X)<?]'R_ O\ \#/&?_S&T?\
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=** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>chart-63966054a2b856539df.jpg
<TEXT>
begin 644 chart-63966054a2b856539df.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( 0H# 2(  A$! Q$!_\0
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M))_,Y-%% "8'OUSU/7\^GMT]J0(H)(SDG)Y/)Z9///  &<X  '  #J* $P,
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MQ&VLR:L4\;?M^_\ !5/X=_LQ?M1^!9?%.C_%;XS_ +*W_!2[1_V5_C!^U?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH/@A#XU/AWP3X;'Q$G6ZT+5M+@G\\\<?\$W?$_C_ ./?[37QI\0?&[PCK?\
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M$T3PKI>JZ5JP!_4"/VMM1(R/!%@03@$>(;D@GTS_ &7UI?\ AK74QU\#V//
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MZ=H_QI\:?%SQ/\*UU/5--\6Z5>>&;_V;_@G!8>#M(^$GC#X%>$/&C:9I&O\
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M4H]7OO"+:S-X">^D\/W>HQBXN-,DF>VF#S6SQFTN+B"7^N;^S-/_ .?&S_\
M 6W_ /C5']F:=_SXV?\ X"6__P :H _D<T[_ (*C?\$=M&\/:#X1T?\ :G_9
M2T?PEX5U73==\+^%=(\-7VE>&/#.N:-J;:UI&M>'?#VG?#FVT;0M7TK6G?6-
M-U32K&TO[#5G;4[6XBOF,YO6_P#P59_X)$V=AIFEV?[77[,MII>B>*+CQOHN
MF6FEZY;:=H_C6\O]5U6[\9:58P> ([73?%MWJFO:[J5UXFLH8-<N=0UO6+Z>
M_DNM4OYKC^M7^S-._P"?&S_\!+?_ .-4?V9IW_/C9_\ @);_ /QJ@#^4T?\
M!8K_ ();@8'[<OP+ '  N_&> /3_ )$VOTT@_P""_G_!'&.&%#_P4%_9_)2*
M-#C5O$V,J@!QGPN#C([@'U /%?K]_9FG?\^-G_X"6_\ \:I?[.L/^?*T_P#
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M #&U_5E_9FG?\^-G_P" EO\ _&J/[,T[_GQL_P#P$M__ (U0!_*;_P /B_\
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M ,7_ /S)4?\ #TG_ ()W_P#1WWP@_P"__B__ .9*O[@/[+TW_GPLO_ 2V_\
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3 "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>chart-b4b418d5d2515afb95c.jpg
<TEXT>
begin 644 chart-b4b418d5d2515afb95c.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( 0H# 2(  A$! Q$!_\0
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MG0_"%E_P4-^%%M^R1X'_ &XOAEH?Q'_9Z_9Z_:Q\<?#'6/@M\(O$7[2WQ\\
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M?BE\8[OPYX\\%77C'X31_ _6_#7A;Q?<^+_$FA>+=?\ "5I?7OB:[]6\ ?\
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MXTG5K7X$? ;X _LS^.O$NFR(%AG.I?%OX0?$'1[ZXB5UGOO#4SF>8C*_J10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 $ ]1GZUG:5I&E:'9)INBZ;I^DZ?'+=SQV.F65KI]FD]_>7&H7TR6MG%#
M LMY?W5U>W4BQA[B[N)[F9GGFDD;1HH **** "BBB@ H(!Z@''3-%% &=I6D
M:5H5DFFZ+IFGZ1I\<MW/'8Z796VGV<<]_>3ZA>S1VMG%# DMY?75S>W4BQA[
MB[N)[F9GGFED;1HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBOEN?\ :J\(0330MX;\4%H9IH6*C1RI:&5XF*YU'."4)&><$9 .10!]
M245\K?\ #5_@_P#Z%OQ3^6C?_+&C_AJ_P?\ ]"WXI_+1O_EC0!]4T5\K?\-7
M^#_^A;\4_EHW_P L:T=(_:>\*:QJVEZ1!X>\2Q3:KJ-CIL,LPTGR8Y;ZZBM8
MY)?+OW?RT>56DV*S[0=JLV 0#Z8KY3_:5_::_P"&>IO!\/\ PAA\6?\ "5Q:
M[)N&OC1?L/\ 8KZ4F,'2-4^T_:?[3SG,'E>1C$GF?)]65^5'_!2C_C]^#_\
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M_P"1U\'?]C5X=_\ 3Q9T ?KA7Y4?\%*/^/WX/_\ 7MXZ_P#1_A2OU7K\J/\
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M^T=?">CW7B"UN==\2?&SP9\*_$VO^#;K5)[+PW9>'+JY/B#Q')=7/F 'WO\
M"K]JCX&_&KQ_X\^&'PZ\6ZAJWC3X<)?S^(=-U/P=XR\,6=]9:+XKOO 'B;4O
M!FN>)="TO0_B!I/@WXAZ9J/P[\;:IX,U#6K+PIXZLI_#.L36]]Y'G?5W@?\
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MB69F)+,S$EF8G)+,22222222<T ?M7_P3R_Y(3JO_92/$W_IM\/5]V5\)_\
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MW(T=E+JNEI<MJ%L ?T@?\-A?LV_]%5T7_P %_B+_ .4M'_#87[-O_15-%_\
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M4K[X?^)K/Q+:Z/=PV.I36<%_ MI=7$ NH87%_9VCLSP$2 QJZ@<%@W%?RI?
M3X@7_P 5?@=\'?B;JESX<NM6^('PP\#^,-8G\'3W\_A1M;U[P[87VMQ^'I-3
M2/4O[*MM7EOK2WAU%!?6A@>SN]T]N[M^X_\ P3;)/@_XHY)/_%7:+U_[%]:
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M[+TW_GPLO_ 2V_\ C5*-,T\=+&S'TM;<?RBH _(;_A_]_P $</\ I()\ /\
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M6/\ PAO"QQHSL>P!-?U)_P!F:=_SXV?_ ("6_P#\:H_LS3_^?&S_ / 6W_\
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M+;SX0^(/#'PX\2:]\:_!GP>^,UWXI\/:G9?$GQO^SAXBC\)_&'0;WP1I\?\
M;W@>"TURU\4KX%U/5;W4?^$QT[P)XLO[ZR\*X\.6_B+[DK\Z/A5^R9\7O"/[
M06G>(?%OC/X>ZG\!_A=X\_:;^+'P<T[1--\31?%+4O'/[5_C#5?&7BRV^(]S
MJCS>&(-(^&TWC3XE:'X7U'PW/<ZEXUT[Q/H=WKMIX9N_"]['XI_1>@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
' "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>chart-c5eb687c6be4546d867.jpg
<TEXT>
begin 644 chart-c5eb687c6be4546d867.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( 0H# 2(  A$! Q$!_\0
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MWB#7WU#6K._U*UO8K^X /U>HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLLW+M='X$_L_:OXFTF^G\$> (-66SUJWL-;7Q;=QZAIFEQF[;3[&.R;]CJ*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "DR/?\C_ (4M?D1?:_KPOKX#7=<
M%]?  :SJ@  O)P  +L     #@  #@4 ?KMD>_P"1_P *,CW_ "/^%?C_ /\
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M#S_PJ-,_^/5_.KD^I_,T9/J?S- ']%7_  TE\ _^BP?#S_PJ-,_^/4?\-)?
M/_HL'P\_\*C3/_CU?SJY/J?S-&3ZG\S0!_3AX3\:>$_'>F/K7@WQ%H_B?28[
MR;3Y-1T2^@U"S2]MTADGM6GMV9!/$D\+R1D[E65"1AA73U\)_P#!/,D_ G5<
MG/\ Q<CQ-U_[!OAZONR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *_'*__ ./^_P#^O^__ /2R>OV-K\<K_P#X_P"__P"O^_\
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M+_9'A<L77&Y H\/%O,7<NZ/&\;ERHW+D'[7'[2!.!\5-;)PQP-)\+$@*,LQ
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MQBXO)S)<SB.,2RN(T"_U;?V9IW_/C9_^ EO_ /&J/[,T[_GQL_\ P$M__C5
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M/VY_@4R27EY(C+>>-,,DEU,Z,,^#!PRL&''0CH<@?U5?V=8?\^5I_P" MO\
M_&J3^S-._P"?&S_\!+?_ .-4 ?RF_P##XO\ X)<?]'R_ O\ \#/&?_S&T?\
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=** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>chart-d47fafa037625ec1989.jpg
<TEXT>
begin 644 chart-d47fafa037625ec1989.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( 0H# 2(  A$! Q$!_\0
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M\/:QX=U[1_IWPG^PM^VWH7[8O_"-:E\ ?"FI?LU:=_P6@^)W_!2"7X_O\7_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHH) ZD#ZT %%)D>H_,49'J/S% "
MT4F1ZC\Q1D>H_,4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 (?ZC]2*_-[5_CU\5[75]6M8/%(C@MM5U.V@3^QM"?9#;W
M]S#"FY]-9VV11HNYF+-C+$DDU^D)Z?BO\Q7X_:__ ,A[7?\ L.:U_P"G2[H
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M4%RS98_3E?'/["/_ ";IX;_[&#QG_P"I)?5]C4 %%%% !1110 4444 %%%%
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M?R!=:WJMWKNL73M-+---<ZKK-_>:IJ-Q/+++=WUQ)/.[L$V '\7J?$CXA?\
M#(_V'_A;_CO[#%\0U\:I\03\4/VK?^%:M\6V_8._X2,_";_A(_[4/Q:7]O!/
MC5&+QO!LNI-^S9_PU1.+9?AR=#)\!'^WGX*7=Q?^)?A+?W=IJ^GW=_>^ [^[
MT_Q"MLOB'3[N]ATJZNK#Q"ED%LD\065Q-+:ZZEDJV:ZO#>K:(EL(E&%YTV=W
MG3;MV_/FOG?YGG;R=W+^=^^W_?\ ._?;O-^>NS^&G_)1? O_ &-N@?\ IRMZ
M /UAK\O_ /@I5_R#_@Y_V$/''_I%X;K]0*_+_P#X*5?\@_X.?]A#QQ_Z1>&Z
M /Y/?B 8K/\ X*J^ (+.7QQKWB7QI\*(O"5H8(/B9X<U'X*>'KWPAJ\5[\4?
MAUJL2ZK\#_B7\+X]2C,OQ)\+^/M&MK_PO\6;C3-24^*;]?"6AP=+\$-6^'?@
M[]C/Q;\/?C5XJ^)^I:9JOQ'_ &V+&]D-]\1M?^,/C+P1X#_:0\:CQ;K;:KX.
M@A\<:P]GX<O]+U;QK>:!-IVH7?@Z^UJXT6.+2EF6T_4$Q1&9+@QH;B.":UCG
M*J94MKB:VN+BV20C>EO/<65E//"K"*:>SM)9$:2V@:."6PLI]2T[6)K:*75=
M'COXM)U%PS7>FQZI%:P:BMC,6S;&]@LK6"X>,+(T$"P!UA:5) #^<_3K3XDV
MNG?L977@W6]6\0>+K+QK>^%/@SI$T/[1^BG4_"GAC]N&_P!7\3?%O]GZ%]*N
MO"47PM^(WP!U2Y\'W?@C]I#Q!%K?@']GCPYH5]!JGBW3[ZQOKO\ 0'_@G_XO
M^,_BKXJ?MIWGQO\ AG\5_AUXPUKQ[\&/&-WIGQ"7PL-"\-MKGPJ\FS^'/@9O
M#/B[Q1!+X?\ ">A6VCKIEV#$^K:>PU_76L_$^KZCHFG_ *?F><^:#<3D3D&<
M&>4B<CH9@7/FD8&#)NQ@ =!478#LN0HSPH))(4=%R22< 9)R>: /W2_81_Y-
MT\-_]C!XS_\ 4DOJ^QJ^.?V$?^3=/#?_ &,'C/\ ]22^K[&H **** "BBB@
MHHHH *1NA^A_E2TC=#]#_*@#\M_BW>WD?Q-\<HEY>HB^(;H*B7ETB*/(MCA4
M2944<]% 'M7D=[XQT[3=7T#P_J7BVST_7_%<NIP^%M"O_$T5EK7B:;1;'^T]
M9B\.Z3<ZA%J&N2Z3IO\ I^IQZ5;7;6%D1<W0BA(<^I_%[_DJ'CO_ +&*Z_\
M1%M7X/\ [;7@GQ$G_!17]A'XG^"_@1XG^+'B^QET7P[9:CXE^&VD^-?@SINB
M:'\0]4\2^)->T/XDV^KZ=XD_9L^-/P?T35M3^*2^,-3CG\!?$;P_!X=\/ZAI
M/B+5O#T=O8 'ZXVGQ9\"ZA;:W>6'Q6\$W]GX9U*UT;Q+>67Q-\-W=GX:UF^N
M396.C>([NW\12VV@:Q?7BM9V6E:Q+9:C>7:M:VUM+<*T8Z4>)(CJTN@CQ'&=
M>M["/5I]!'B%3KL&DS7+V4.JSZ*+_P#M6'2IKV.2SBU.6S2PEO$>UCN&N$:,
M?S%Z+^SG;:1^R?\ M/?"'4?V8?VJ?%7PLU67P9IOPG\3_$+]AGX)ZO\ M(^!
M/VE=>^&OQ[TGXE^+?$OPL\":;H-C\?/A_P"'=0U[PSX"\&?''5;+XHW/@?QE
M\9->\:>#_'-UI?AF+QMX8^C?V+?A%^T9X&_;PU+Q9\4_@%_85[XK\-7]_P")
M?%&K_"F+Q/9?"?X;3_LE?LV>'? OACP%^VO?:U<>*/'U[:?%GP5XJ^"?B']G
M_4H]1M-)TWPOJ/Q;G1=9UBZ\5:V ?T#Z1?WQU?2 ;Z_(.K:4"#?7A!!U&U!!
M!G(((X((((X(Q7Z]CI^+?S-?CSH__(8TC_L+Z3_Z<;6OV&'3\6_F: /@7_@H
M5JNJZ3\+/!L^DZIJ>E3R?$*VBDGTO4;W39I(CX:\0N8I)K&>"1XBZJYC9BA=
M58KN52/R('C/QHQ"KXQ\8,S$!5'BGQ 223@  :CDDG@ <DU^M'_!1K_DD_@O
M_LHUM_ZB_B.OP2_:#T*/Q1\"/C-X:FLO'NI0^(/A?XWT:;3_ (6V]G>?$F]@
MU+P_>VL]KX$L-0O=.L=4\530R.ND:-=W]I!KEP1HLDZ#4 & /;!\5M2-IIFH
M#XI:A]@UH*=%OF^(URMEK(=MB?V/=MKRV^K;W^1!ITMR7<A5!8@5J#QUXN)G
M \;^*BUK(T5TH\7ZV3:2K$D[178&J$VLJP21SM%<^5(L$D<[*(G1V_FE\%_#
M[4]8^$'[(GB'P_\ !'6H/%OPU\:>.H/V>O"^E?L<_P!M?L]_%^_\2_%WX%ZC
MKWQ#\?\ AWXDP>(/$/[)FOZIH>E>*M0LO$6G#P=H%A;>!O$_C#P/XDM;:]M_
M"VM^F?$WP-\4!K?[=UA^RO\ L\?%E?!7Q9\):+X=^*O]JZ8_P"\:Z3+H^N?'
MZ]^+5GX7U_X@:GJ>E_M"^/?BG:ZCIGBEOC'X=U;6M?L?AG\1-*^&_AQI;C0_
M"^EZ: ?T'Q^./%\L:2Q>-?%<L4J)+%+%XMUV6*6*10\<L4L>IM'+%(C*\<D;
M,DB,KHS*P)_7'_@GCJVJZM\./'<VK:KJFJS1>/5BBEU34KW4I8HO^$9T5_*B
MEOI[B2.+>S/Y:,J;V9]NYB3_ #_?LSMKQ_9R^ "^*/#-YX,\10?!+X466L^%
M-0GM;B^T&_T[P'H.G2V%V]D%MXK@):1W$MB$2?2FN#I5['%?V-U&O[Y?\$X?
M^2:>/O\ LH"_^HOH= 'Z)GI^*_S%?C]K_P#R'M=_[#FM?^G2[K]@3T_%?YBO
MQ^U__D/:[_V'-:_].EW0!DT444 %=O\ #/\ Y*+X$_[&W0/_ $Y6]<17;_#/
M_DHO@3_L;= _].5O0!^L-?E__P %*O\ D'_!S_L(>./_ $B\-U^H%?E__P %
M*O\ D'_!S_L(>./_ $B\-T ?E/1110 4444 ?NE^PC_R;IX;_P"Q@\9_^I)?
M5]C5\<_L(_\ )NGAO_L8/&?_ *DE]7V-0 4444 %%%% !1110 5^??[3'_!5
M+_@GM^QW\1D^$7[37[5OPJ^#7Q)E\.:7XLC\'^,;_6+;5V\.:W-?VVE:N(K'
M1;^'['?3Z7?QPMY^\M:RAD4;2WZ"56EL[6=M\UM!*^ NZ2"*1L#.!N=&.!DX
M&<"@#^7_ .)/_!9[_@E7K7C[Q;JVG?MV? BYL=1UF:ZM9X[WQDR20R06X!#+
MX-*MAE9"49E+*VUF7:S<.?\ @L3_ ,$MB03^W)\"B1T)N_&1(^A/@S(_"OZL
M_P"S-/\ ^?&S_P# 6W_^-4?V9IW_ #XV?_@);_\ QJ@#^4S_ (?$_P#!+;C_
M (SE^!7'3_2_&? P1@?\4;TP2,=,$CH<4?\ #XK_ ();CI^W+\"O_ OQGZ8_
MZ$WT 'T '85_5G_9FG?\^-G_ . EO_\ &J/[,T[_ )\;/_P$M_\ XU0!_*WI
MG_!8_P#X):0ZGIDTO[='P)CBAU/39I9&O/&@5(HKZWDD=B/!A.U$5G;C[JG&
M3@']*A_P7^_X(X#_ )R"? #J?^8MXE[DG_H6*_7K^S-._P"?&S_\!+?_ .-4
MO]G6'_/E:?\ @+;_ /QJ@#^;;]MW_@MI_P $HOB;\./"^D^"?VZ_@7KVI6'C
MBVU*YL[+4/%<\\=B/#^NVKW3+%X4<+%'<7%O$Q9E.^>,*&RQ7\QO^'I/_!._
M_H[[X0?]_P#Q?QZ$?\4EP1V-?W G3-//6QLS];6W/\XJ3^R]-_Y\++_P$MO_
M (U0!_#\G_!4C_@G=&NR/]KWX/QIM";(YO%T:% 00I1/"*KM! (7&T$ @9 -
M._X>E?\ !/'Y?^,P/A%\G"?Z3XP^0!BP"?\ %)_( Q+ +@!B6'))K^W_ /LO
M3?\ GPLO_ 2V_P#C5']EZ;_SX67_ ("6W_QJ@#^( _\ !4G_ ()X$DG]K_X0
MDDDDFX\7DDDY))/A+))/))Y)Y-?IC^P__P %LO\ @E'\,? 7C#3/&W[=7P+T
M'4-2\:'4+2SO=0\5P32V2^']'M!<J)?":*T3W,,\*E&8AX)0ZH-A?^D[^R]-
M_P"?"R_\!+;_ .-4HTS3QTL;,?2UMQ_**@#\A3_P7^_X(X'_ )R"? #J/^8M
MXE[$'_H6*_-G6?\ @LA_P2SN-8UBXA_;I^!,L,^KZK/#(EYXT*R0S:A<RQ2+
MGP8#MDC=77@':PR <@?U0_V=8?\ /E:?^ MO_P#&J3^S-._Y\;/_ ,!+?_XU
M0!_*;_P^+_X)<?\ 1\OP+_\  SQG_P#,;1_P^+_X)<?]'R_ O_P,\9__ #&U
M_5E_9FG?\^-G_P" EO\ _&J/[,T[_GQL_P#P$M__ (U0!_*;_P /B_\ @EQ_
MT?+\"_\ P,\9_P#S&UU?@7_@LU_P2NTKQKX2U.]_;J^!,-GI_B/2+VZF>]\9
M*L5O;7L,TKLS>#@JA40G+,JC^)E&2/ZA_P"S-._Y\;/_ ,!+?_XU1_9FG_\
M/C9_^ MO_P#&J /R&_X?_?\ !'#_ *2"? #_ ,&WB7_YF*^!?VZO^"T__!*S
MXHV7PRC\#?MQ_ _7WT2]\62:FMC?^*IS:IJ%KH:6C2^5X5?:)GM9E7=C)0XS
M@X_IT_LZP_Y\K3_P%M__ (U2'3-//6QLS];6W/\ .*@#^'[_ (>D_P#!._\
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3 "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>chart-f71680c275d85d55b02.jpg
<TEXT>
begin 644 chart-f71680c275d85d55b02.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #( 0H# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK_V4CQ-_Z;?#U?=E !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^&I-;-I?SZ3#=P::[0:QJ^JI;"RAO[U(8K$6D.+F5I(Y'*LH!_0M_P $\O\
MDA.J_P#92/$W_IM\/5]V5\)_\$\O^2$ZK_V4CQ-_Z;?#U?=E !1110 4444
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MA#P+J/@'Q+=^&KW5/%=[8:A<6=MIMRUU9QZ%>7<<#KJ5C?1JJW$:2AHT1R5
M+E<J?S8_X:Y_:/) 'Q5ULDD  :5X6)))P  /#Y))/  !)/ &:^Z?^"D7_(A_
M#7_L=]0_]1J_K^:S_@HAK.JZ'^RCXZN]&^)]I\)KNXUOP7ILGB"^\7ZY\-[7
M7[+4==2"\^'+_%+P[IVIZC\+9?B%'CP]9>/7AM=-TR_EM=*U75-*T_7;B^A
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M\/Z_IUWI&MZ)JPL+_2]6TN_B:"\T_4+*X=X;FUN8F*212*1T=2LB(Z_I8/\
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M"DMW:27GP@,=U:,!;>.@<7=MD9F\*$9'FY&>WK@CJ#CE_P#AP#_P1P_Z1]_
M#_P4^)?_ )IZ4?\ ! +_ ((X#I_P3Z_9_P#QTCQ&?Y^)C0!^='GP?\_%M_X%
M6W_QZCSX/^?BV_\  JV_^/5^C'_#@/\ X(X_](^OV?O_  3>(O\ YI:/^' ?
M_!''_I'U^S]_X)O$7_S2T ?G/Y\'_/Q;?^!5M_\ 'J//@_Y^+;_P*MO_ (]7
MZ,?\. _^"./_ $CZ_9^_\$WB+_YI:/\ AP'_ ,$<?^D?7[/W_@F\1?\ S2T
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MITNETC08(_!-LVLZTIM;?;"\5R[/&W_!0C]G_P %>%O&_C[S/&?B[P!X+O\
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MY=>LO%'B/QA\#]7\-^([.XT^6QLI8-/T#X7:K8:H]Y<>?+?:AISVUF\!O'B
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H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6834823120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">1. Basis of Presentation and Summary of Significant Accounting Policies</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis of Presentation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">References to "we," "our," and similar pronouns is in this Quarterly Report on Form 10-Q for the quarter ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our fiscal year ends on June 30. References to fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in these condensed consolidated financial statements are to the fiscal years ending or ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements have been prepared in accordance with the United States Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. To conform to the current year presentation, certain prior year amounts have been reclassified.&#160;In addition, financial results presented for this fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (the "</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K"). </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Adopted Financial Accounting Standards</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Derivatives and Hedging </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2018, the </span><span style="font-family:Arial Narrow;font-size:10pt;">Financial Accounting Standards Board ("FASB")</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a benchmark interest rate for hedge accounting purposes. This guidance is effective beginning the first quarter of fiscal 2020 and must be applied on a prospective basis. The adoption did not have a material impact on our consolidated financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Leases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal 2020 and elected the transition option which allows us to apply the guidance prospectively. The adoption resulted in the recognition of lease liabilities in the amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$422 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. See </span><a href="#s37977FB1689852A6888EFF6B57032648" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 5</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for additional information regarding leases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Issued Financial Accounting Standards Not Yet Adopted</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This&#160;guidance will be effective for us in the first quarter of fiscal 2021. We are currently evaluating the impact of this amended guidance but do not expect the adoption to have a material impact on our consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6857717296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="num">$ (237)<span></span>
</td>
<td class="nump">$ 342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits, interest and penalties accrued</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate Reconciliation, Percent</a></td>
<td class="nump">26.80%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="nump">22.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated range of decrease in unrecognized tax benefits within the next 12 months</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Estimated range of decrease in unrecognized tax benefits within the next 12 months</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Internal Revenue Service (IRS) [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open Tax Year</a></td>
<td class="text">2008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember', window );">Patient Recovery Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IndemnificationReceivable', window );">Indemnification Receivable</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TaxMatterAxis=cah_CareFusionMember', window );">CareFusion [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_IndemnificationReceivable', window );">Indemnification Receivable</a></td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="nump">5,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">$ 468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_IndemnificationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_IndemnificationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TaxMatterAxis=cah_PatientRecoveryBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TaxMatterAxis=cah_CareFusionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TaxMatterAxis=cah_CareFusionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6857885712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents</a></td>
<td class="nump">$ 2,329<span></span>
</td>
<td class="nump">$ 2,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">9,019<span></span>
</td>
<td class="nump">8,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">12,808<span></span>
</td>
<td class="nump">12,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">1,692<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">25,848<span></span>
</td>
<td class="nump">25,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,299<span></span>
</td>
<td class="nump">2,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Goodwill and other intangibles, net</a></td>
<td class="nump">11,378<span></span>
</td>
<td class="nump">11,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,623<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">41,148<span></span>
</td>
<td class="nump">40,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">21,984<span></span>
</td>
<td class="nump">21,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term obligations and other short-term borrowings</a></td>
<td class="nump">508<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">2,179<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">24,671<span></span>
</td>
<td class="nump">24,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term obligations, less current portion</a></td>
<td class="nump">6,754<span></span>
</td>
<td class="nump">7,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred income taxes and other liabilities</a></td>
<td class="nump">8,517<span></span>
</td>
<td class="nump">2,945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred shares, without par value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Authorized&#8212;500 thousand shares, Issued&#8212;none</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common shares, without par value:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Authorized&#8212;755 million shares, Issued&#8212;327 million shares at March 31, 2020 and June 30, 2019, respectively</a></td>
<td class="nump">2,774<span></span>
</td>
<td class="nump">2,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">656<span></span>
</td>
<td class="nump">5,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Common shares in treasury, at cost: 35 million shares and 28 million shares at March 31, 2020 and June 30, 2019, respectively</a></td>
<td class="num">(2,086)<span></span>
</td>
<td class="num">(1,790)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(141)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Cardinal Health, Inc. shareholders' equity</a></td>
<td class="nump">1,203<span></span>
</td>
<td class="nump">6,328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">1,206<span></span>
</td>
<td class="nump">6,330<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 41,148<span></span>
</td>
<td class="nump">$ 40,963<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6835664016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ReclassificationofdeferredrentinaccordancewithASC842', window );">Reclassification of deferred rent in accordance with ASC 842</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Operating Leases, Future Minimum Payments Due, Next Twelve Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Operating Leases, Future Minimum Payments, Due in Two Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">Operating Leases, Future Minimum Payments, Due in Three Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">Operating Leases, Future Minimum Payments, Due in Four Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">Operating Leases, Future Minimum Payments, Due in Five Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Operating Leases, Future Minimum Payments, Due Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ReclassificationofdeferredrentinaccordancewithASC842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of deferred rent in accordance with ASC 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ReclassificationofdeferredrentinaccordancewithASC842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6858922432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Schedule of Future Lease Payments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityNotYetCommencedAmount', window );">Less: leases not yet commenced (1)</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLeaseLiability', window );">Total Lease Liability</a></td>
<td class="nump">504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_OperatingLeaseMember', window );">Operating Leases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount', window );">Less: leases not yet commenced (1)</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OperatingLeaseImputedInterest', window );">Less: imputed interest</a></td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_FinanceLeaseMember', window );">Finance Leases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount', window );">Less: leases not yet commenced (1)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FinanceLeaseImputedInterest', window );">Less: imputed interest</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FinanceLeaseImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Imputed Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FinanceLeaseImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Finance Lease Liability Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Liability Payments Remainder Of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Liability Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OperatingLeaseImputedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Imputed Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OperatingLeaseImputedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityNotYetCommencedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Not Yet Commenced, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityNotYetCommencedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total undiscounted Lease Liability Payments Due for both operating and financing leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Lease Liability Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_OperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_OperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cah_FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6837613168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $</a></td>
<td class="nump">$ 93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares) | shares</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares) | shares</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 51.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">42.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share) | $ / shares</a></td>
<td class="nump">60.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in usd per share) | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 45.88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $</a></td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6839482544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit related to share-based compensation</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ExercisablePeriodOfPlansInYears', window );">Exercisable period of plans (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_VestingPeriodinyearsforShares', window );">Vesting Period in years for Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Target performance goal (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ExercisablePeriodOfPlansInYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The instrument's contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ExercisablePeriodOfPlansInYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_VestingPeriodinyearsforShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vesting Period in years for Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_VestingPeriodinyearsforShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6843408000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill by Reportable Segment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,663</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,715</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,378</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(34</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(34</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,658</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,681</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,339</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:25%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:19%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted- Average Remaining Amortization Period (Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,544</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,746</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,798</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>674</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>329</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>345</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,604</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>730</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>874</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,822</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,805</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,017</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,844</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,805</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,039</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,562</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,517</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,045</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>672</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>295</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>377</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,602</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>616</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>986</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,836</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,408</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6843306720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">13. Segment Information</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operations are principally managed on a products and services basis and are comprised of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>two</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, this segment also distributes a broad range of national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Revenue</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>34,899</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>31,146</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>213</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>215</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>35,112</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>31,361</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (3)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,539</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,431</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>512</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>440</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4,051</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,871</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39,163</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>35,232</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39,157</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>35,228</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>103,612</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>95,888</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>642</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>628</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>104,254</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>96,516</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (3)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10,483</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10,339</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,508</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,339</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11,991</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11,678</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>116,245</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>108,194</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>116,233</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>108,181</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services."</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present revenue by geographic area:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>38,073</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>34,230</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,090</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,002</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39,163</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>35,232</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39,157</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>35,228</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>113,053</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>105,190</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,192</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,004</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>116,245</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>108,194</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>116,233</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>108,181</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Segment Profit</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general and administrative ("SG&amp;A") expenses. Segment SG&amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial, and customer care shared services, human resources, information technology, and legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We do not allocate the following items to our segments: last-in first-out, or ("LIFO"), inventory charges/(credits); surgical gown recall costs; restructuring and employee severance; amortization and other acquisition-related costs; impairments and (gain)/loss on disposal of assets; litigation (recoveries)/charges, net; state opioid assessment related to prior fiscal years; other (income)/expense, net; interest expense, net; loss on extinguishment of debt; and provision for income taxes. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$17 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for both the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$37 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$36 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the opioid litigation as discussed further in </span><a href="#s054B3015E6505AB9825D03C656BE42ED" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which was retained at Corporate. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the surgical gown recall as discussed further in </span><a href="#s054B3015E6505AB9825D03C656BE42ED" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$95 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> which was retained at Corporate. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the naviHealth divestiture, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$508 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which was retained at Corporate. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present segment profit by reportable segment and Corporate:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>534</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>536</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>178</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>155</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>712</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>691</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(150</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(259</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>562</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,394</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,388</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>543</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>479</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,937</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,867</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(6,305</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(115</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings/(loss)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4,368</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,752</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents total assets for each reportable segment and Corporate at: </span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:16pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, <br/>2020</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#d1d1d1;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22,508</span></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#d1d1d1;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22,446</span></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15,445</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,284</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,195</span></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,233</span></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>41,148</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>40,963</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6834694752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:26%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Estimated fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7,211</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Carrying amount</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7,262</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,031</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>28
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "a20q310q033120form10-q.htm": {
   "axisCustom": 5,
   "axisStandard": 27,
   "contextCount": 255,
   "dts": {
    "calculationLink": {
     "local": [
      "cah-20200331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cah-20200331_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "a20q310q033120form10-q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cah-20200331_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cah-20200331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cah-20200331.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 561,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 14,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 19
   },
   "keyCustom": 48,
   "keyStandard": 331,
   "memberCustom": 46,
   "memberStandard": 37,
   "nsprefix": "cah",
   "nsuri": "http://www.cardinal.com/20200331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Page",
     "role": "http://www.cardinal.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105100 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107100 - Disclosure - Investments",
     "role": "http://www.cardinal.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cah:LeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108100 - Disclosure - Leases",
     "role": "http://www.cardinal.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cah:LeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110100 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings",
     "role": "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111100 - Disclosure - Commitments, Contingent Liabilities and Litigation",
     "role": "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation",
     "shortName": "Commitments, Contingent Liabilities and Litigation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112100 - Disclosure - Income Taxes",
     "role": "http://www.cardinal.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113100 - Disclosure - Fair Value Measurements",
     "role": "http://www.cardinal.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115100 - Disclosure - Financial Instruments",
     "role": "http://www.cardinal.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116100 - Disclosure - Shareholders' Equity",
     "role": "http://www.cardinal.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117100 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc.",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001000 - Statement - Condensed Consolidated Statements of Earnings",
     "role": "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
     "shortName": "Condensed Consolidated Statements of Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118100 - Disclosure - Segment Information",
     "role": "http://www.cardinal.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119100 - Disclosure - Share-Based Compensation",
     "role": "http://www.cardinal.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2201201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Restructuring and Employee Severance (Tables)",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables",
     "shortName": "Restructuring and Employee Severance (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308301 - Disclosure - Leases (Tables)",
     "role": "http://www.cardinal.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310301 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)",
     "role": "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313301 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315301 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316301 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "role": "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317301 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318301 - Disclosure - Segment Information (Tables)",
     "role": "http://www.cardinal.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319301 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "I2020Q1ASC842",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2401402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "I2020Q1ASC842",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403402 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails",
     "shortName": "Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403403 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails",
     "shortName": "Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403404 - Disclosure - Restructuring and Employee Severance Narative (Details)",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails",
     "shortName": "Restructuring and Employee Severance Narative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:GoodwillTransfers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405403 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405404 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Other Intangible Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003000 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cah:PartnershipIndirectOwnership",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407401 - Disclosure - Investments Investments (Details)",
     "role": "http://www.cardinal.com/role/InvestmentsInvestmentsDetails",
     "shortName": "Investments Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cah:PartnershipIndirectOwnership",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "D2020Q1SD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:ReclassificationofdeferredrentinaccordancewithASC842",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408402 - Disclosure - Leases (Details)",
     "role": "http://www.cardinal.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "D2020Q1SD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:ReclassificationofdeferredrentinaccordancewithASC842",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Leases Schedule of Lease Costs (Details)",
     "role": "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails",
     "shortName": "Leases Schedule of Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:LeasesSupplementalBalanceSheetInformationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Leases Supplemental Balance Sheet Information (Details)",
     "role": "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:LeasesSupplementalBalanceSheetInformationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:LeasePaymentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Leases Supplemental Cash Flow Information (Details)",
     "role": "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:LeasePaymentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408406 - Disclosure - Leases Schedule of Future Lease Payments (Details)",
     "role": "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails",
     "shortName": "Leases Schedule of Future Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:TotalLongTermandShortTermObligations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410402 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "D2020Q2NotesPayable_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:RepaymentsOfNotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)",
     "role": "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails",
     "shortName": "Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411401 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)",
     "role": "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
     "shortName": "Commitments, Contingent Liabilities and Litigation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "I2020Q3SD_srt_LitigationCaseAxis_cah_OpioidLawsuitsStateDomain_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember",
      "decimals": "0",
      "lang": null,
      "name": "cah:LossContingencyLawsuitsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412401 - Disclosure - Income Taxes (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413402 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)",
     "role": "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
     "shortName": "Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415402 - Disclosure - Financial Instruments (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
     "shortName": "Financial Instruments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:CarryingAmountofLongTermandotherShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415403 - Disclosure - Financial Instruments Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings (Details)",
     "role": "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails",
     "shortName": "Financial Instruments Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "cah:CarryingAmountofLongTermandotherShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsForRepurchaseOfCommonStock",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416402 - Disclosure - Shareholders' Equity (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails",
     "shortName": "Shareholders' Equity (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:TreasuryStockAcquiredAverageCostPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q2",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416403 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)",
     "role": "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417402 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417403 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)",
     "role": "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails",
     "shortName": "Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:GainLossRelatedToLitigationSettlement",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418402 - Disclosure - Segment Information (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418403 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
     "shortName": "Segment Information (Revenue by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418404 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails",
     "shortName": "Segment Information (Segment Profit by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004000 - Statement - Condensed Consolidated Statements of Shareholders' Equity",
     "role": "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418405 - Disclosure - Segment Information Revenue From External Customers By Geographic Areas (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails",
     "shortName": "Segment Information Revenue From External Customers By Geographic Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD_srt_StatementGeographicalAxis_country_US",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418406 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)",
     "role": "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
     "shortName": "Segment Information (Assets by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419402 - Disclosure - Share-Based Compensation (Narrative) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
     "shortName": "Share-Based Compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419403 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails",
     "shortName": "Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3QTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419404 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2019Q4",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419405 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
     "shortName": "Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "cah:AdditionalStockOptionPlanDataTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419406 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419407 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)",
     "role": "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
     "shortName": "Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005000 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": "-6",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103100 - Disclosure - Restructuring and Employee Severance",
     "role": "http://www.cardinal.com/role/RestructuringAndEmployeeSeverance",
     "shortName": "Restructuring and Employee Severance",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "a20q310q033120form10-q.htm",
      "contextRef": "FD2020Q3YTD",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 84,
   "tag": {
    "cah_A2.4Notesdue2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.4% Notes due 2020",
        "label": "2.4% Notes due 2020 [Member]",
        "terseLabel": "2.4% Notes due 2020 [Member]"
       }
      }
     },
     "localname": "A2.4Notesdue2020Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A2.616Notesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.616% Notes due 2022",
        "label": "2.616% Notes due 2022 [Member]",
        "terseLabel": "2.616% Notes due 2022 [Member]"
       }
      }
     },
     "localname": "A2.616Notesdue2022Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.079Notesdue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.079% Notes due 2024",
        "label": "3.079% Notes due 2024 [Member]",
        "terseLabel": "3.079% Notes due 2024 [Member]"
       }
      }
     },
     "localname": "A3.079Notesdue2024Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.2Notesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.2% Notes due 2022",
        "label": "3.2% Notes due 2022 [Member]",
        "terseLabel": "3.2% Notes due 2022 [Member]"
       }
      }
     },
     "localname": "A3.2Notesdue2022Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.2Notesdue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.2% Notes due 2023",
        "label": "3.2% Notes due 2023 [Member]",
        "terseLabel": "3.2% Notes due 2023 [Member]"
       }
      }
     },
     "localname": "A3.2Notesdue2023Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.41Notesdue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.41% Notes due 2027",
        "label": "3.41% Notes due 2027 [Member]",
        "terseLabel": "3.41% Notes due 2027 [Member]"
       }
      }
     },
     "localname": "A3.41Notesdue2027Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.5Notesdue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.5% Notes due 2025",
        "label": "3.5% Notes due 2025 [Member]",
        "terseLabel": "3.5% Notes due 2025 [Member]"
       }
      }
     },
     "localname": "A3.5Notesdue2025Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A3.75Notesdue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.75% Notes due 2026",
        "label": "3.75% Notes due 2026 [Member]",
        "terseLabel": "3.75% Notes due 2026 [Member]"
       }
      }
     },
     "localname": "A3.75Notesdue2026Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.368Notesdue2047Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.368% Notes due 2047",
        "label": "4.368% Notes due 2047 [Member]",
        "terseLabel": "4.368% Notes due 2047 [Member]"
       }
      }
     },
     "localname": "A4.368Notesdue2047Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.5Notesdue2044Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.5% Notes due 2044",
        "label": "4.5% Notes due 2044 [Member]",
        "terseLabel": "4.5% Notes due 2044 [Member]"
       }
      }
     },
     "localname": "A4.5Notesdue2044Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.625Notesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.625% Notes due 2021",
        "label": "4.625% Notes due 2021 [Member]",
        "terseLabel": "4.625% Notes due 2021 [Member]"
       }
      }
     },
     "localname": "A4.625Notesdue2021Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.6Notesdue2043Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.6% Notes due 2043",
        "label": "4.6% Notes due 2043 [Member]",
        "terseLabel": "4.6% Notes due 2043 [Member]"
       }
      }
     },
     "localname": "A4.6Notesdue2043Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A4.9Notesdue2045Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.9% Notes due 2045",
        "label": "4.9% Notes due 2045 [Member]",
        "terseLabel": "4.9% Notes due 2045 [Member]"
       }
      }
     },
     "localname": "A4.9Notesdue2045Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_A7.0Debenturesduefiscal2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "7.0% Debentures due fiscal 2027",
        "label": "7.0% Debentures due fiscal 2027 [Member]",
        "terseLabel": "7.0% Debentures due fiscal 2027 [Member]"
       }
      }
     },
     "localname": "A7.0Debenturesduefiscal2027Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_ASC842Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASC 842",
        "label": "ASC 842 [Member]",
        "terseLabel": "ASC 842"
       }
      }
     },
     "localname": "ASC842Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_AdditionalStockOptionPlanDataTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A disclosure of additional data related to all stock option activity",
        "label": "Additional Stock Option Plan Data [Table Text Block]",
        "terseLabel": "Schedule of Additional Data Related to Stock Option Activity"
       }
      }
     },
     "localname": "AdditionalStockOptionPlanDataTableTextBlock",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_AlamedaCountyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Alameda County [Member]",
        "label": "Alameda County [Member]",
        "terseLabel": "Alameda County [Member]"
       }
      }
     },
     "localname": "AlamedaCountyMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Amortizationandotheracquisitionrelatedcosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Amortization and other acquisition-related costs",
        "terseLabel": "Amortization and other acquisition-related costs"
       }
      }
     },
     "localname": "Amortizationandotheracquisitionrelatedcosts",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_CVSHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CVS Health [Member]",
        "label": "CVS Health [Member]",
        "terseLabel": "CVS Health"
       }
      }
     },
     "localname": "CVSHealthMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CardinalHealthAtHomeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cardinal Health At Home [Member]",
        "label": "Cardinal Health At Home [Member]",
        "terseLabel": "Cardinal Health At Home [Member]"
       }
      }
     },
     "localname": "CardinalHealthAtHomeMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CareFusionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CareFusion [Member]",
        "label": "CareFusion [Member]",
        "terseLabel": "CareFusion [Member]"
       }
      }
     },
     "localname": "CareFusionMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CarryingAmountofLongTermandotherShortTermBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying Amount of Long-Term and other Short-Term Borrowings",
        "label": "Carrying Amount of Long-Term and other Short-Term Borrowings",
        "terseLabel": "Carrying Amount of Long-Term and other Short-Term Borrowings"
       }
      }
     },
     "localname": "CarryingAmountofLongTermandotherShortTermBorrowings",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_CarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying Value of Reporting Unit",
        "label": "Carrying Value",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingValue",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_CashComponentForSettlementFrameworkTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash Component For Settlement Framework, Term",
        "label": "Cash Component For Settlement Framework, Term",
        "terseLabel": "Cash Component For Settlement Framework, Term"
       }
      }
     },
     "localname": "CashComponentForSettlementFrameworkTerm",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cah_ClassActionLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class Action Lawsuits [Member]",
        "label": "Class Action Lawsuits [Member]",
        "terseLabel": "Class Action Lawsuits [Member]"
       }
      }
     },
     "localname": "ClassActionLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_CommittedReceivablesSalesFacilityProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Committed receivables sales facility program that exists largely to provide liquidity by selling interests in trade receivables.",
        "label": "Committed Receivables Sales Facility Program [Member]",
        "terseLabel": "Committed Receivables Sales Facility Program [Member]"
       }
      }
     },
     "localname": "CommittedReceivablesSalesFacilityProgramMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount",
        "label": "Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount",
        "terseLabel": "Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount"
       }
      }
     },
     "localname": "DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_DiscountRatefairvalueinputs": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discount Rate, fair value inputs",
        "label": "Discount Rate, fair value inputs",
        "terseLabel": "Discount Rate, fair value inputs"
       }
      }
     },
     "localname": "DiscountRatefairvalueinputs",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_ExercisablePeriodOfPlansInYears": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The instrument's contractual term.",
        "label": "Exercisable period of plans, in years",
        "terseLabel": "Exercisable period of plans (in years)"
       }
      }
     },
     "localname": "ExercisablePeriodOfPlansInYears",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cah_FacilityExitAndOtherCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.",
        "label": "Facility Exit and Other Costs",
        "terseLabel": "Facility Exit and Other Costs"
       }
      }
     },
     "localname": "FacilityExitAndOtherCosts",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_FinanceLeaseImputedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finance Lease Imputed Interest",
        "label": "Finance Lease Imputed Interest",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseImputedInterest",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_FinanceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finance Lease",
        "label": "Finance Lease [Member]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_FloatingRateNotesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Floating Rate Notes due 2022",
        "label": "Floating Rate Notes due 2022 [Member]",
        "terseLabel": "Floating Rate Notes due 2022 [Member]"
       }
      }
     },
     "localname": "FloatingRateNotesdue2022Member",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_GownRecallAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gown Recall [Axis]",
        "label": "Gown Recall [Axis]",
        "terseLabel": "Gown Recall [Axis]"
       }
      }
     },
     "localname": "GownRecallAxis",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_GownRecallDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Gown Recall [Axis]",
        "label": "Gown Recall [Domain]",
        "terseLabel": "Gown Recall [Domain]"
       }
      }
     },
     "localname": "GownRecallDomain",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_IPRDTrademarksandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Includes in process investigation of new knowledge useful in developing new product or service or new process or techniques or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for the improvements to existing product or process and rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "IPR&amp;D,TrademarksandOther [Member]",
        "terseLabel": "IPR&amp;D, trademarks and other"
       }
      }
     },
     "localname": "IPRDTrademarksandOtherMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Impactofadoptionofnewaccountingstandard": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "impact of adoption of new accounting standard",
        "label": "impact of adoption of new accounting standard",
        "terseLabel": "New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31)"
       }
      }
     },
     "localname": "Impactofadoptionofnewaccountingstandard",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_IndemnificationReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indemnification receivable from Patient recovery related to certain pre-acquisition tax exposures and transaction taxes.",
        "label": "Indemnification Receivable",
        "terseLabel": "Indemnification Receivable"
       }
      }
     },
     "localname": "IndemnificationReceivable",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LawsuitTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lawsuit Type [Axis]",
        "label": "Lawsuit Type [Axis]",
        "terseLabel": "Lawsuit Type [Axis]"
       }
      }
     },
     "localname": "LawsuitTypeAxis",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_LawsuitTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Lawsuit Type [Axis]",
        "label": "Lawsuit Type [Domain]",
        "terseLabel": "Lawsuit Type [Domain]"
       }
      }
     },
     "localname": "LawsuitTypeDomain",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease Liabilities established as a Result of the adoption of ASC 842",
        "label": "Lease Liabilities established as a Result of the adoption of ASC 842",
        "terseLabel": "Lease Liabilities established as a Result of the adoption of ASC 842"
       }
      }
     },
     "localname": "LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LeasePaymentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Table Text Block] for Lease Payments [Table]",
        "label": "Lease Payments [Table Text Block]",
        "terseLabel": "Leases Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "LeasePaymentsTableTextBlock",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LeasesSupplementalBalanceSheetInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]",
        "label": "LeasesSupplementalBalanceSheetInformation [Table Text Block]",
        "terseLabel": "Leases Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "LeasesSupplementalBalanceSheetInformationTableTextBlock",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LeasesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Leases [Text Block]",
        "label": "Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LeasesTextBlock",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cah_LesseeFinanceLeaseLiabilityNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Finance Lease Liability Not Yet Commenced, Amount",
        "label": "Lessee Finance Lease Liability Not Yet Commenced, Amount",
        "terseLabel": "Less: leases not yet commenced (1)"
       }
      }
     },
     "localname": "LesseeFinanceLeaseLiabilityNotYetCommencedAmount",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due After Year Five",
        "label": "Lessee Lease Liability Payments Due After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Five",
        "label": "Lessee Lease Liability Payments Due Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Four",
        "label": "Lessee Lease Liability Payments Due Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Three",
        "label": "Lessee Lease Liability Payments Due Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Due Year Two",
        "label": "Lessee Lease Liability Payments Due Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Lease Liability Payments Remainder Of Fiscal Year",
        "label": "Lessee Lease Liability Payments Remainder Of Fiscal Year",
        "terseLabel": "Remainder of 2020"
       }
      }
     },
     "localname": "LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LesseeOperatingLeaseLiabilityNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee Operating Lease Liability Not Yet Commenced, Amount",
        "label": "Lessee Operating Lease Liability Not Yet Commenced, Amount",
        "terseLabel": "Less: leases not yet commenced (1)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityNotYetCommencedAmount",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_LongTermObligationsandOtherShortTermBorrowingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-Term Obligations and Other Short-Term Borrowings [Abstract]",
        "label": "Long-Term Obligations and Other Short-Term Borrowings [Abstract]"
       }
      }
     },
     "localname": "LongTermObligationsandOtherShortTermBorrowingsAbstract",
     "nsuri": "http://www.cardinal.com/20200331",
     "xbrltype": "stringItemType"
    },
    "cah_LossContingencyLawsuitsNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Lawsuits, Number",
        "label": "Loss Contingency, Lawsuits, Number",
        "verboseLabel": "Loss Contingency, Lawsuits, Number"
       }
      }
     },
     "localname": "LossContingencyLawsuitsNumber",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_MaximumQuarterlyPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved.",
        "label": "Maximum Quarterly Payment",
        "terseLabel": "Maximum quarterly payment"
       }
      }
     },
     "localname": "MaximumQuarterlyPayment",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_MedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical [Member]",
        "label": "Medical Member",
        "terseLabel": "Medical"
       }
      }
     },
     "localname": "MedicalMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_MedicalReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical Reporting Unit [Member]",
        "label": "Medical Reporting Unit [Member]",
        "terseLabel": "Medical Reporting Unit [Member]"
       }
      }
     },
     "localname": "MedicalReportingUnitMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_MedicaldistributionandproductsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical distribution and products [Member]",
        "label": "Medical distribution and products [Member]",
        "terseLabel": "Medical distribution and products [Member]"
       }
      }
     },
     "localname": "MedicaldistributionandproductsMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NarativeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Narative [Abstract]",
        "label": "Narative [Abstract]"
       }
      }
     },
     "localname": "NarativeAbstract",
     "nsuri": "http://www.cardinal.com/20200331",
     "xbrltype": "stringItemType"
    },
    "cah_NaviHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "naviHealth [Member]",
        "label": "naviHealth [Member]",
        "terseLabel": "naviHealth [Member]"
       }
      }
     },
     "localname": "NaviHealthMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NaviOwnershipInterestDivestedMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Navi Ownership Interest Divested [Member]",
        "label": "Navi Ownership Interest Divested [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NaviOwnershipInterestDivestedMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Netproceedstaxwithholdingsfromsharebasedcompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.",
        "label": "Net proceeds/(tax withholdings) from share-based compensation",
        "terseLabel": "Net proceeds/(tax withholdings) from share-based compensation"
       }
      }
     },
     "localname": "Netproceedstaxwithholdingsfromsharebasedcompensation",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_NotesPayableRepurchased": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Principal Amount of Notes Payable Repurchased during the year",
        "label": "Notes Payable Repurchased",
        "terseLabel": "Notes Payable Repurchased"
       }
      }
     },
     "localname": "NotesPayableRepurchased",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_NuclearPrecisionHealthServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nuclear Precision Health Services [Member]",
        "label": "Nuclear Precision Health Services [Member]",
        "terseLabel": "Nuclear Precision Health Services [Member]"
       }
      }
     },
     "localname": "NuclearPrecisionHealthServicesMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_NumberofStateAttorneysGeneralfilinglawsuits": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of State Attorneys General filing lawsuits",
        "label": "Number of State Attorneys General filing lawsuits",
        "terseLabel": "Number of State Attorneys General filing lawsuits"
       }
      }
     },
     "localname": "NumberofStateAttorneysGeneralfilinglawsuits",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cah_OperatingLeaseImputedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease Imputed Interest",
        "label": "Operating Lease Imputed Interest",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "OperatingLeaseImputedInterest",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_OperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Lease",
        "label": "Operating Lease [Member]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Lawsuits [Member]",
        "label": "Opioid Lawsuits [Member]",
        "terseLabel": "Opioid Lawsuits [Member]"
       }
      }
     },
     "localname": "OpioidLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLawsuitsStateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Lawsuits State and Political Subdivisions [Domain]",
        "label": "Opioid Lawsuits State [Domain]",
        "terseLabel": "Opioid Lawsuits State [Domain]"
       }
      }
     },
     "localname": "OpioidLawsuitsStateDomain",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLitigationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Litigation",
        "label": "Opioid Litigation [Axis]",
        "terseLabel": "Opioid Litigation [Axis]"
       }
      }
     },
     "localname": "OpioidLitigationAxis",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_OpioidLitigationCuyahogaandSummitCountiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Litigation, Cuyahoga and Summit Counties",
        "label": "Opioid Litigation, Cuyahoga and Summit Counties [Member]",
        "terseLabel": "Opioid Litigation, Cuyahoga and Summit Counties [Member]"
       }
      }
     },
     "localname": "OpioidLitigationCuyahogaandSummitCountiesMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLitigationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Litigation [Domain]",
        "label": "Opioid Litigation [Domain]",
        "terseLabel": "Opioid Litigation [Domain]"
       }
      }
     },
     "localname": "OpioidLitigationDomain",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidLitigationlessCuyahogaandSummitCountiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Litigation, less Cuyahoga and Summit Counties",
        "label": "Opioid Litigation, less Cuyahoga and Summit Counties [Member]",
        "terseLabel": "Opioid Litigation, less Cuyahoga and Summit Counties [Member]"
       }
      }
     },
     "localname": "OpioidLitigationlessCuyahogaandSummitCountiesMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_OpioidTotalSettlementCuyahogaandSummitCounties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid Total Settlement, Cuyahoga and Summit Counties",
        "label": "Opioid Total Settlement, Cuyahoga and Summit Counties",
        "terseLabel": "Opioid Total Settlement, Cuyahoga and Summit Counties"
       }
      }
     },
     "localname": "OpioidTotalSettlementCuyahogaandSummitCounties",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_OtherJurisdictionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Jurisdictions [Member]",
        "label": "Other Jurisdictions [Member]",
        "terseLabel": "Other Jurisdictions [Member]"
       }
      }
     },
     "localname": "OtherJurisdictionsMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PartnershipIndirectOwnership": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Partnership Indirect Ownership",
        "label": "Partnership Indirect Ownership",
        "terseLabel": "Partnership Indirect Ownership"
       }
      }
     },
     "localname": "PartnershipIndirectOwnership",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_PatientRecoveryBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Patient Recovery Business [Member]",
        "label": "Patient Recovery Business [Member]",
        "terseLabel": "Patient Recovery Business"
       }
      }
     },
     "localname": "PatientRecoveryBusinessMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PharmaceuticalDistributionandSpecialtyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmaceutical Distribution and Specialty [Member]",
        "label": "Pharmaceutical Distribution and Specialty [Member]",
        "terseLabel": "Pharmaceutical Distribution and Specialty [Member]"
       }
      }
     },
     "localname": "PharmaceuticalDistributionandSpecialtyMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PharmaceuticalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmaceutical [Member]",
        "label": "Pharmaceutical Member",
        "terseLabel": "Pharmaceutical"
       }
      }
     },
     "localname": "PharmaceuticalMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PlaintiffTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plaintiff Type [Axis]",
        "label": "Plaintiff Type [Axis]",
        "terseLabel": "Plaintiff Type [Axis]"
       }
      }
     },
     "localname": "PlaintiffTypeAxis",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_PlaintiffTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Plaintiff Type [Axis]",
        "label": "Plaintiff Type [Domain]",
        "terseLabel": "Plaintiff Type [Domain]"
       }
      }
     },
     "localname": "PlaintiffTypeDomain",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_PreTaxGainonDivestiture": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pre-Tax Gain on Divestiture",
        "label": "Pre-Tax Gain on Divestiture",
        "terseLabel": "Pre-Tax Gain on Divestiture"
       }
      }
     },
     "localname": "PreTaxGainonDivestiture",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_PrivatePartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Private Parties [Member]",
        "label": "Private Parties [Member]",
        "terseLabel": "Private Parties [Member]"
       }
      }
     },
     "localname": "PrivatePartiesMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from divestitures and disposal of property and equipment and held for sale assets",
        "label": "Proceeds from divestitures and disposal of property and equipment and held for sale assets",
        "terseLabel": "Proceeds from divestitures and disposal of property and equipment and held for sale assets"
       }
      }
     },
     "localname": "Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from sales of available-for-sale securities and other investments.",
        "label": "Proceeds from sale of available-for-sale securities and other investments",
        "terseLabel": "Proceeds from return of investments"
       }
      }
     },
     "localname": "Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ProductLiabilityLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product Liability Lawsuits [Member]",
        "label": "Product Liability Lawsuits [Member]",
        "terseLabel": "Product Liability Lawsuits"
       }
      }
     },
     "localname": "ProductLiabilityLawsuitsMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_ProjectCostsOnInvestmentAndOtherSpending": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.",
        "label": "Project Costs On Investment And Other Spending",
        "terseLabel": "Project costs on investment and other spending"
       }
      }
     },
     "localname": "ProjectCostsOnInvestmentAndOtherSpending",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_Purchaseofavailableforsalesecuritiesandotherinvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow from purchases of available-for-sale securities and other investments.",
        "label": "Purchase of available-for-sale securities and other investments",
        "negatedLabel": "Purchase of investments"
       }
      }
     },
     "localname": "Purchaseofavailableforsalesecuritiesandotherinvestments",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_ReclassificationofdeferredrentinaccordancewithASC842": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reclassification of deferred rent in accordance with ASC 842",
        "label": "Reclassification of deferred rent in accordance with ASC 842",
        "terseLabel": "Reclassification of deferred rent in accordance with ASC 842"
       }
      }
     },
     "localname": "ReclassificationofdeferredrentinaccordancewithASC842",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Line Items] for Segment Revenue from External Customers by Geographic Area [Table]",
        "label": "Segment Revenue from External Customers by Geographic Area [Line Items]",
        "terseLabel": "Segment Revenue from External Customers by Geographic Area [Line Items]"
       }
      }
     },
     "localname": "SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_SegmentRevenuefromExternalCustomersbyGeographicAreaTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Segment Revenue from External Customers by Geographic Area [Table]",
        "label": "Segment Revenue from External Customers by Geographic Area [Table]",
        "terseLabel": "Segment Revenue from External Customers by Geographic Area [Table]"
       }
      }
     },
     "localname": "SegmentRevenuefromExternalCustomersbyGeographicAreaTable",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_Sharesthatwouldbeantidilutiveasaresultofnetloss": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "shares that would be antidilutive as a result of net loss",
        "label": "shares that would be antidilutive as a result of net loss",
        "terseLabel": "shares that would be antidilutive as a result of net loss"
       }
      }
     },
     "localname": "Sharesthatwouldbeantidilutiveasaresultofnetloss",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cah_ShortTermCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other short-term credit facilities and an unsecured line of credit",
        "label": "Short Term Credit Facilities Member",
        "terseLabel": "Short Term Credit Facilities Member"
       }
      }
     },
     "localname": "ShortTermCreditFacilitiesMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_SterileSurgicalGownRecallAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sterile Surgical Gown Recall [Axis] [Axis]",
        "label": "Sterile Surgical Gown Recall [Axis]",
        "terseLabel": "Sterile Surgical Gown Recall [Axis]"
       }
      }
     },
     "localname": "SterileSurgicalGownRecallAxis",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_SterileSurgicalGownRecallDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Sterile Surgical Gown Recall [Axis] [Axis]",
        "label": "Sterile Surgical Gown Recall [Domain]",
        "terseLabel": "Sterile Surgical Gown Recall [Domain]"
       }
      }
     },
     "localname": "SterileSurgicalGownRecallDomain",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_SterileSurgicalGownRecallMemberDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sterile Surgical Gown Recall [Member] [Domain]",
        "label": "Sterile Surgical Gown Recall [Member] [Domain]",
        "terseLabel": "Sterile Surgical Gown Recall [Member] [Domain]"
       }
      }
     },
     "localname": "SterileSurgicalGownRecallMemberDomain",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TaxMatterAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax Matter [Axis]",
        "label": "Tax Matter [Axis]",
        "terseLabel": "Tax Matter [Axis]"
       }
      }
     },
     "localname": "TaxMatterAxis",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_TaxMatterDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Tax Matter [Axis]",
        "label": "Tax Matter [Domain]",
        "terseLabel": "Tax Matter [Domain]"
       }
      }
     },
     "localname": "TaxMatterDomain",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TaxMattersAgreementAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax Matters Agreement [Axis]",
        "label": "Tax Matters Agreement [Axis]",
        "terseLabel": "Tax Matters Agreement [Axis]"
       }
      }
     },
     "localname": "TaxMattersAgreementAxis",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cah_TaxMattersAgreementDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Tax Matters Agreement [Axis]",
        "label": "Tax Matters Agreement [Domain]",
        "terseLabel": "Tax Matters Agreement [Domain]"
       }
      }
     },
     "localname": "TaxMattersAgreementDomain",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TerminalGrowthRatefairvalueinputs": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Terminal Growth Rate, fair value inputs",
        "label": "Terminal Growth Rate, fair value inputs",
        "terseLabel": "Terminal Growth Rate, fair value inputs"
       }
      }
     },
     "localname": "TerminalGrowthRatefairvalueinputs",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cah_TotalFinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Finance Lease Cost",
        "label": "Total Finance Lease Cost",
        "totalLabel": "Total finance lease cost"
       }
      }
     },
     "localname": "TotalFinanceLeaseCost",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Lease Liability",
        "label": "Total Lease Liability",
        "terseLabel": "Total Lease Liability"
       }
      }
     },
     "localname": "TotalLeaseLiability",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityNotYetCommencedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Lease Liability Not Yet Commenced, Amount",
        "label": "Total Lease Liability Not Yet Commenced, Amount",
        "terseLabel": "Less: leases not yet commenced (1)"
       }
      }
     },
     "localname": "TotalLeaseLiabilityNotYetCommencedAmount",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total undiscounted Lease Liability Payments Due for both operating and financing leases",
        "label": "Total Lease Liability Payments Due",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "TotalLeaseLiabilityPaymentsDue",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Lease Liability Undiscounted Excess Amount",
        "label": "Total Lease Liability Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "TotalLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalLongTermandShortTermObligations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Long-Term and Short-Term Obligations",
        "label": "Total Long-Term and Short-Term Obligations",
        "terseLabel": "Total Long-Term and Short-Term Obligations"
       }
      }
     },
     "localname": "TotalLongTermandShortTermObligations",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cah_TotalOpioidLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Opioid Litigation",
        "label": "Total Opioid Litigation [Member]",
        "terseLabel": "Total Opioid Litigation [Member]"
       }
      }
     },
     "localname": "TotalOpioidLitigationMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TotalOpioidLitigationnetoftaxMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total Opioid Litigation, net of tax",
        "label": "Total Opioid Litigation, net of tax [Member]",
        "terseLabel": "Total Opioid Litigation, net of tax [Member]"
       }
      }
     },
     "localname": "TotalOpioidLitigationnetoftaxMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TrademarksAndPatentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, and the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Trademarks And Patents Member",
        "terseLabel": "Trademarks, trade names and patents"
       }
      }
     },
     "localname": "TrademarksAndPatentsMember",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cah_TreasuryStockAcquiredShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Treasury Stock Acquired Shares",
        "label": "Treasury Stock Acquired Shares",
        "terseLabel": "Treasury Stock Acquired Shares"
       }
      }
     },
     "localname": "TreasuryStockAcquiredShares",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cah_VestingPeriodinyearsforShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vesting Period in years for Shares",
        "label": "Vesting Period in years for Shares",
        "terseLabel": "Vesting Period in years for Shares"
       }
      }
     },
     "localname": "VestingPeriodinyearsforShares",
     "nsuri": "http://www.cardinal.com/20200331",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r129",
      "r142",
      "r143",
      "r144",
      "r145",
      "r147",
      "r149",
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r129",
      "r142",
      "r143",
      "r144",
      "r145",
      "r147",
      "r149",
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case Type"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r161",
      "r243",
      "r245",
      "r465"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r256",
      "r258",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r463",
      "r466"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r256",
      "r258",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r463",
      "r466"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r161",
      "r243",
      "r245",
      "r465"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r246",
      "r256",
      "r258",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r463",
      "r466"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r246",
      "r256",
      "r258",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r463",
      "r466"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r157",
      "r158",
      "r243",
      "r244",
      "r464",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r157",
      "r158",
      "r243",
      "r244",
      "r464",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r41",
      "r46",
      "r47",
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r42",
      "r46",
      "r47",
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gain/(Loss) on Derivatives, net of tax"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r18",
      "r44",
      "r45",
      "r46",
      "r448",
      "r474",
      "r478"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r43",
      "r46",
      "r47",
      "r92",
      "r93",
      "r94",
      "r333",
      "r469",
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income/(Loss)",
        "verboseLabel": "AOCI Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r96",
      "r97",
      "r98",
      "r99",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r308",
      "r309",
      "r310",
      "r311",
      "r422",
      "r423",
      "r424",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r260",
      "r283",
      "r294"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total share-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r81",
      "r181",
      "r188"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r43",
      "r46",
      "r47",
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r86",
      "r137",
      "r144",
      "r151",
      "r166",
      "r327",
      "r334",
      "r375",
      "r427",
      "r446"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r39",
      "r86",
      "r166",
      "r327",
      "r334",
      "r375"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r262",
      "r285"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r349",
      "r352"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r255",
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r255",
      "r257",
      "r319",
      "r320"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r23",
      "r83"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and equivalents at end of period",
        "periodStartLabel": "Cash and equivalents at beginning of period",
        "terseLabel": "Cash and equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r78",
      "r376"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase/(decrease) in cash and equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": {
     "auth_ref": [
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments",
        "terseLabel": "Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r210",
      "r211",
      "r212",
      "r221"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments, Contingent Liabilities and Litigation"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends declared per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r92",
      "r93"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Common shares, without par value:"
       }
      }
     },
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common shares, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "terseLabel": "Common shares, issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Authorized\u2014755 million shares, Issued\u2014327 million shares at March 31, 2020 and June 30, 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r50",
      "r52",
      "r53",
      "r61",
      "r439",
      "r458"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r50",
      "r52",
      "r60",
      "r325",
      "r338",
      "r438",
      "r457"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income/(loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153",
      "r155"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r67",
      "r420"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold",
        "verboseLabel": "Cost of Goods and Services Sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap [Member]"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Obligations and Other Short-Term Borrowings"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r428",
      "r429",
      "r445"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r374"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r31",
      "r88",
      "r233",
      "r236",
      "r237",
      "r238",
      "r386",
      "r387",
      "r389",
      "r444"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Estimated range of decrease in unrecognized tax benefits within the next 12 months"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.",
        "label": "Deferred Tax and Other Liabilities, Noncurrent",
        "terseLabel": "Deferred income taxes and other liabilities"
       }
      }
     },
     "localname": "DeferredTaxAndOtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r81",
      "r132"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": {
     "auth_ref": [
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.",
        "label": "Derivative Assets (Liabilities), at Fair Value, Net",
        "terseLabel": "Forward contracts"
       }
      }
     },
     "localname": "DerivativeAssetsLiabilitiesAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r350",
      "r351",
      "r355",
      "r359"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r347",
      "r350",
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r354",
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r341",
      "r342",
      "r344"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "Derivative Liability, Notional Amount"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r340",
      "r343",
      "r344",
      "r347",
      "r348",
      "r353",
      "r355",
      "r361",
      "r362",
      "r364"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "verboseLabel": "Developed technology and other"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r255",
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r239",
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedTerseLabel": "Dividends"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Earnings/(loss) per common share attributable to Cardinal Health, Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r115",
      "r117",
      "r118",
      "r120"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share Attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r376"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rates changes on cash and equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Tax benefit related to share-based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee- Related Costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options",
        "verboseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r97",
      "r105",
      "r107",
      "r121",
      "r170",
      "r232",
      "r239",
      "r290",
      "r291",
      "r292",
      "r310",
      "r311",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r469",
      "r470",
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity Method Investment, Ownership Percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r24",
      "r138",
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Facility Exit and Other Costs"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r365",
      "r366",
      "r367",
      "r371"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring",
        "verboseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r366",
      "r410",
      "r411",
      "r412"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r365",
      "r366",
      "r368",
      "r369",
      "r372"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r247",
      "r248",
      "r253",
      "r254",
      "r366",
      "r410"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r247",
      "r248",
      "r253",
      "r254",
      "r366",
      "r411"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2",
        "verboseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r366",
      "r412"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r410",
      "r411",
      "r412"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r370",
      "r372"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r394",
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "verboseLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance Lease, Liability, Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2020"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r396",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Finance Lease, Principal Payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r395",
      "r399",
      "r408"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "cah_TotalFinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated annual amortization of intangible assets - Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization of intangible assets - Year Four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization of intangible assets - Year Three"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization of intangible assets - Year Two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r182",
      "r184",
      "r187",
      "r191",
      "r421",
      "r425"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r187",
      "r425"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Intangible"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r182",
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "verboseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r187",
      "r421"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Net Intangible"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r247",
      "r358"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract [Member]"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "negatedTerseLabel": "Impairments and (gain)/loss on disposal of assets, net"
       }
      }
     },
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedLabel": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Litigation (recoveries)/charges, net"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r81",
      "r226",
      "r227"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on Extinguishment of Debt",
        "verboseLabel": "Gain (Loss) on Extinguishment of Debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r174",
      "r175",
      "r426"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r176"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "negatedTerseLabel": "Foreign currency translation adjustments and other"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r177"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Goodwill, Transfers"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r66",
      "r86",
      "r137",
      "r143",
      "r147",
      "r150",
      "r153",
      "r166",
      "r375"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r347",
      "r360"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r89",
      "r137",
      "r143",
      "r147",
      "r150",
      "r153"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Earnings/(loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r55",
      "r62",
      "r96",
      "r101",
      "r102",
      "r103",
      "r104",
      "r110",
      "r112",
      "r113",
      "r433",
      "r435",
      "r440",
      "r454"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r55",
      "r62",
      "r96",
      "r101",
      "r102",
      "r103",
      "r104",
      "r110",
      "r112",
      "r113",
      "r114",
      "r440",
      "r454",
      "r456",
      "r459"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Income (Loss) from Continuing Operations, Per Diluted Share"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r255",
      "r257"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r299",
      "r305",
      "r306",
      "r312",
      "r314",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r87",
      "r106",
      "r107",
      "r135",
      "r297",
      "r313",
      "r315",
      "r461"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income Tax Expense (Benefit)",
        "verboseLabel": "Provision for/(benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Increase in accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Increase in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other accrued liabilities and operating items, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedTerseLabel": "Increase in trade receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r183",
      "r190"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r190"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Net Intangible"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r183",
      "r190"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Gross Intangible, Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r180",
      "r185"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Net Intangible, Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "terseLabel": "Goodwill and other intangibles, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r56",
      "r131",
      "r385",
      "r388",
      "r441"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Internal Revenue Service (IRS) [Member]"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r37"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "verboseLabel": "Inventory, Net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRecallExpense": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.",
        "label": "Inventory Recall Expense",
        "terseLabel": "Inventory Recall Expense"
       }
      }
     },
     "localname": "InventoryRecallExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Investment Holdings [Line Items]",
        "terseLabel": "Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "InvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for investment holdings.  This includes the information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.",
        "label": "Investment Holdings, Schedule of Investments [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentHoldingsScheduleOfInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentHoldingsTable": {
     "auth_ref": [
      "r480",
      "r481",
      "r482",
      "r483"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.",
        "label": "Investment Holdings [Table]",
        "terseLabel": "Investment Holdings [Table]"
       }
      }
     },
     "localname": "InvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r365"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r406",
      "r408"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2020"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r21",
      "r86",
      "r166",
      "r375",
      "r431",
      "r451"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r30",
      "r86",
      "r166",
      "r328",
      "r334",
      "r335",
      "r375"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r32",
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated Litigation Liability"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term obligations, less current portion",
        "verboseLabel": "Long-term Debt and Lease Obligation"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Current portion of long-term obligations and other short-term borrowings",
        "verboseLabel": "Long-term Debt and Lease Obligation, Current"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r31",
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermPurchaseCommitmentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Long-term Purchase Commitment, Period",
        "terseLabel": "Long-term Purchase Commitment, Period"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss Contingency Accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Loss Contingency, New Claims Filed, Number"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Loss Contingency, Number of Plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossOnSaleOfInvestments": {
     "auth_ref": [
      "r64",
      "r65",
      "r81",
      "r434",
      "r460"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.",
        "label": "Loss on Sale of Investments",
        "terseLabel": "Loss on Sale of Investments"
       }
      }
     },
     "localname": "LossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r36",
      "r86",
      "r166",
      "r375",
      "r430",
      "r450"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Noncontrolling Interest, Ownership Percentage by Parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by/(used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r78",
      "r79",
      "r82"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r48",
      "r51",
      "r58",
      "r82",
      "r86",
      "r96",
      "r101",
      "r102",
      "r103",
      "r104",
      "r106",
      "r107",
      "r111",
      "r137",
      "r143",
      "r147",
      "r150",
      "r153",
      "r166",
      "r375",
      "r436",
      "r455"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings/(loss) attributable to Cardinal Health, Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r48",
      "r51",
      "r106",
      "r107",
      "r330",
      "r337"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Less: Net earnings attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPrinciplesEarlyAdoptionMember": {
     "auth_ref": [
      "r100",
      "r103"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents a group of guidance that has been adopted early.",
        "label": "New Accounting Principles, Early Adoption [Domain]",
        "terseLabel": "New Accounting Principles, Early Adoption [Domain]"
       }
      }
     },
     "localname": "NewAccountingPrinciplesEarlyAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementEarlyAdoptionAxis": {
     "auth_ref": [
      "r100",
      "r103"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The financial statement line items and the effect of the guidance on financial statement line items by guidance implemented if the entity elects earlier application.",
        "label": "New Accounting Pronouncement, Early Adoption [Axis]",
        "terseLabel": "New Accounting Pronouncement, Early Adoption [Axis]"
       }
      }
     },
     "localname": "NewAccountingPronouncementEarlyAdoptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r95",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r103",
      "r119",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r308",
      "r309",
      "r310",
      "r311",
      "r422",
      "r423",
      "r424",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Financial Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US [Member]"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r239",
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r13",
      "r429",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OpenTaxYear": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tax year that remains open to examination under enacted tax laws, in CCYY format.",
        "label": "Open Tax Year",
        "terseLabel": "Open Tax Year"
       }
      }
     },
     "localname": "OpenTaxYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r137",
      "r143",
      "r147",
      "r150",
      "r153"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating earnings",
        "totalLabel": "Operating earnings/(loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r400",
      "r408"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities",
        "verboseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r397",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r405",
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r404",
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r390",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months",
        "terseLabel": "Operating Leases, Future Minimum Payments Due, Next Twelve Months"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r390",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Five Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Five Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r390",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Four Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r390",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Three Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r390",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due in Two Years"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": {
     "auth_ref": [
      "r390",
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due Thereafter",
        "terseLabel": "Operating Leases, Future Minimum Payments, Due Thereafter"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r145",
      "r147",
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r29"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities",
        "verboseLabel": "Other Accrued Liabilities, Current"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherBorrowings": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.",
        "label": "Other Borrowings",
        "terseLabel": "Other Borrowings"
       }
      }
     },
     "localname": "OtherBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Axis]",
        "terseLabel": "Other Comprehensive Income Location [Axis]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Domain]",
        "terseLabel": "Other Comprehensive Income Location [Domain]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r46",
      "r54",
      "r377",
      "r379",
      "r383"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "verboseLabel": "Other comprehensive loss, before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax",
        "terseLabel": "Net unrealized loss on derivative instruments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r49",
      "r52",
      "r54",
      "r59",
      "r232",
      "r377",
      "r382",
      "r383",
      "r437",
      "r456"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive income/(loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income/(loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r49",
      "r52",
      "r325",
      "r326",
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense) [Member]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Payments for Repurchase of Common Stock",
        "terseLabel": "Payments for Repurchase of Common Stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r76",
      "r199"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Payments and other adjustments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends on common shares"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of subsidiaries, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Share Units",
        "verboseLabel": "Performance Share Unit"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Preferred shares, without par value:"
       }
      }
     },
     "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred shares, issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r14"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Authorized\u2014500 thousand shares, Issued\u2014none"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from Divestiture of Businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/InvestmentsInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Net change in short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r48",
      "r51",
      "r77",
      "r86",
      "r96",
      "r106",
      "r107",
      "r137",
      "r143",
      "r147",
      "r150",
      "r153",
      "r166",
      "r325",
      "r329",
      "r331",
      "r337",
      "r338",
      "r375",
      "r442"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings/(loss)",
        "totalLabel": "Net earnings/(loss)",
        "verboseLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r25",
      "r195"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Lease Arrangement, Type [Axis] (Deprecated 2020-01-31)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r9",
      "r10",
      "r195",
      "r453"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r9",
      "r194"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Lease Arrangement, Type [Domain] (Deprecated 2020-01-31)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r63",
      "r173"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for bad debts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r16",
      "r22",
      "r452",
      "r479"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Loss [Rollforward]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r46",
      "r47",
      "r54",
      "r377",
      "r381",
      "r383"
     ],
     "calculation": {
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified to earnings"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Loss [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r144",
      "r147"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Assets by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r143",
      "r147"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r143",
      "r147"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Segment Profit by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r142",
      "r147"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Reduction of long-term obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayments of Notes Payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of fair value of reporting unit in excess of carrying amount.",
        "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount",
        "terseLabel": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount"
       }
      }
     },
     "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Share Units",
        "verboseLabel": "Restricted Share Unit"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Employee Severance"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeverance"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r81",
      "r198",
      "r203",
      "r207"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring and employee severance",
        "totalLabel": "Total restructuring and employee severance"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Additions",
        "verboseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r199",
      "r204"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r17",
      "r239",
      "r293",
      "r449",
      "r473",
      "r478"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r97",
      "r105",
      "r107",
      "r170",
      "r290",
      "r291",
      "r292",
      "r310",
      "r311",
      "r469",
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas [Table Text Block]"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r57",
      "r86",
      "r128",
      "r129",
      "r142",
      "r148",
      "r149",
      "r156",
      "r157",
      "r161",
      "r166",
      "r375",
      "r442"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenue",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r403",
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r403",
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r46",
      "r382",
      "r383"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings Compared to the Respective Carrying Amount"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of Total Share-based Compensation Expense by Type of Award"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r365",
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r182",
      "r186",
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r182",
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of Future Lease Payments"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r178",
      "r179"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r178",
      "r179"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r190",
      "r192"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Transactions Related to Performance Share Units Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r201",
      "r202",
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r201",
      "r202",
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Summary of Restructuring and Employee Severance"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r199",
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r137",
      "r140",
      "r146",
      "r178"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r262",
      "r285"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Transactions Related to Restricted Share Units Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r265",
      "r277",
      "r279"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Transactions Under the Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r33",
      "r84",
      "r122",
      "r123",
      "r229",
      "r230",
      "r231",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r124",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r142",
      "r143",
      "r144",
      "r145",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r153",
      "r161",
      "r462"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r124",
      "r126",
      "r127",
      "r137",
      "r141",
      "r147",
      "r151",
      "r152",
      "r153",
      "r154",
      "r156",
      "r160",
      "r161",
      "r162"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationNarrativeDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Distribution, selling, general and administrative expenses",
        "verboseLabel": "Selling, General and Administrative Expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r81",
      "r198",
      "r203",
      "r207"
     ],
     "calculation": {
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "verboseLabel": "Employee-related costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails",
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Canceled and forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (in shares)",
        "periodStartLabel": "Nonvested at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Restricted Share Units",
        "verboseLabel": "Performance Share Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (in usd per share)",
        "periodStartLabel": "Nonvested at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value per Share",
        "verboseLabel": "Weighted-Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable at end of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Canceled and forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled and forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of outstanding options at period end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r267",
      "r285"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period (in usd per share)",
        "periodStartLabel": "Outstanding at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price per Common Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r259",
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Target performance goal (as a percent)",
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails",
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of exercisable options at period end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r124",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r142",
      "r143",
      "r144",
      "r145",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r153",
      "r161",
      "r178",
      "r197",
      "r200",
      "r208",
      "r462"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Operating and Reportable Segment"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails",
      "http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails",
      "http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r35",
      "r92",
      "r93",
      "r94",
      "r97",
      "r105",
      "r107",
      "r121",
      "r170",
      "r232",
      "r239",
      "r290",
      "r291",
      "r292",
      "r310",
      "r311",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r469",
      "r470",
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "verboseLabel": "Statement of Stockholders' Equity"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r121",
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/LeasesDetails",
      "http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails",
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r14",
      "r15",
      "r232",
      "r239"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r14",
      "r15",
      "r232",
      "r239",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r14",
      "r15",
      "r239",
      "r261",
      "r278"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r15",
      "r19",
      "r20",
      "r86",
      "r163",
      "r166",
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "terseLabel": "Total Cardinal Health, Inc. shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r86",
      "r92",
      "r93",
      "r94",
      "r97",
      "r105",
      "r166",
      "r170",
      "r239",
      "r290",
      "r291",
      "r292",
      "r310",
      "r311",
      "r323",
      "r324",
      "r336",
      "r375",
      "r377",
      "r378",
      "r383",
      "r470",
      "r471"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r85",
      "r239",
      "r242"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r384",
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r384",
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r384",
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "TaxCreditCarryforwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury shares acquired, average price per share (in usd per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r34",
      "r240"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock",
        "verboseLabel": "Treasury Shares"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r34",
      "r240"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Treasury, balance at end of period (in shares)",
        "negatedPeriodStartLabel": "Treasury, balance at beginning of period (in shares)",
        "terseLabel": "Common shares in treasury"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r15",
      "r232",
      "r239"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedLabel": "Treasury shares acquired (in shares)",
        "negatedTerseLabel": "Treasury Stock, Shares, Acquired"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity",
      "http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r34",
      "r240",
      "r241"
     ],
     "calculation": {
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Common shares in treasury, at cost: 35 million shares and 28 million shares at March 31, 2020 and June 30, 2019, respectively",
        "negatedPeriodEndLabel": "Treasury, balance at end of period",
        "negatedPeriodStartLabel": "Treasury, balance at beginning of period"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r96",
      "r97",
      "r98",
      "r99",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r308",
      "r309",
      "r310",
      "r311",
      "r422",
      "r423",
      "r424",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r296",
      "r303"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r300"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized tax benefits, interest and penalties accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r401",
      "r408"
     ],
     "calculation": {
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Employee stock options, restricted share units, and performance share units (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r109",
      "r114"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted-average common shares\u2013diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r108",
      "r114"
     ],
     "calculation": {
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average common shares\u2013basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings",
      "http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted-average number of common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611133-123010"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611322-123010"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r495": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r496": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r497": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r498": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r499": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r500": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>a20q310q033120form10-q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cah="http://www.cardinal.com/20200331"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cah-20200331.xsd" xlink:type="simple"/>
    <context id="FD2020Q3YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="I2020Q3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="FD2019Q3QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FI2019Q2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="I2020Q1ASC842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalReportingUnitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cah:IPRDTrademarksandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cah:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-01</instant>
        </period>
    </context>
    <context id="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="I2018Q1navi_srt_OwnershipAxis_cah_NaviOwnershipInterestDivestedMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">cah:NaviOwnershipInterestDivestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cah:NaviHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-01</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_RangeAxis_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_RangeAxis_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="D2020Q1SD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cah:OperatingLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="D2020Q1SD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cah_ASC842Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cah:ASC842Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.75Notesdue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.4Notesdue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.5Notesdue2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.4Notesdue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.625Notesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A7.0Debenturesduefiscal2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.079Notesdue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.5Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="D2020Q2NotesPayable_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.4Notesdue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cah:ShortTermCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:CommittedReceivablesSalesFacilityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.2Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A3.41Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.6Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.9Notesdue2045Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A4.368Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:FloatingRateNotesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cah:A2.616Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:GownRecallAxis">cah:SterileSurgicalGownRecallMemberDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="I2020Q3SD_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-04</instant>
        </period>
    </context>
    <context id="I2020Q3SD_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-04</instant>
        </period>
    </context>
    <context id="D2020Q3Litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-04</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_LitigationCaseAxis_cah_OpioidLitigationCuyahogaandSummitCountiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationnetoftaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="I2020Q3SD_srt_LitigationCaseAxis_cah_OpioidLawsuitsStateDomain_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsStateDomain</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-04</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_MajorCustomersAxis_cah_CVSHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cah:CVSHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationlessCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:GownRecallAxis">cah:SterileSurgicalGownRecallMemberDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="D2020Q3Litigation_us-gaap_LossContingenciesByNatureOfContingencyAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-04</endDate>
        </period>
    </context>
    <context id="I2020Q3SD_cah_LawsuitTypeAxis_cah_ClassActionLawsuitsMember_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:LawsuitTypeAxis">cah:ClassActionLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cah:PlaintiffTypeAxis">cah:PrivatePartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-04</instant>
        </period>
    </context>
    <context id="D2020Q3Litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:AlamedaCountyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-04</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:OpioidLitigationlessCuyahogaandSummitCountiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="D2020Q3Litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cah:ProductLiabilityLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cah:OtherJurisdictionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-04</endDate>
        </period>
    </context>
    <context id="FI2020Q3_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:OpioidLitigationAxis">cah:TotalOpioidLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:PatientRecoveryBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_cah_TaxMatterAxis_cah_CareFusionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3_cah_TaxMatterAxis_cah_CareFusionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cah:TaxMatterAxis">cah:CareFusionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:CardinalHealthAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:MedicaldistributionandproductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:PharmaceuticalDistributionandSpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cah:NuclearPrecisionHealthServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cah:MedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_srt_StatementGeographicalAxis_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FD2020Q3YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000721371</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="StateAG">
        <measure>cah:StateAG</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="plaintiff">
        <measure>cah:plaintiff</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="lawsuit">
        <measure>cah:lawsuit</measure>
    </unit>
    <unit id="segment">
        <measure>cah:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="FD2020Q3YTD"
      id="Fact-9237862606A7BCA7298C54B51AE07017-wk-Fact-9237862606A7BCA7298C54B51AE07017">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="FD2020Q3YTD"
      id="Fact-F43BC75F0FEEA99FCC2B54B51ADD906E-wk-Fact-F43BC75F0FEEA99FCC2B54B51ADD906E">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="FD2020Q3YTD"
      id="Fact-6825393F2FDC51908B4954B51ADE3D4B-wk-Fact-6825393F2FDC51908B4954B51ADE3D4B">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="FD2020Q3YTD"
      id="Fact-39ADC9C92D7DCE3D05CF54B51ADEFA5B-wk-Fact-39ADC9C92D7DCE3D05CF54B51ADEFA5B">2020</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey
      contextRef="FD2020Q3YTD"
      id="Fact-2062A61CD15B024629D254B51AE0A31C-wk-Fact-2062A61CD15B024629D254B51AE0A31C">0000721371</dei:EntityCentralIndexKey>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="Fact-879C99B0F2503F832D5D54B51B102DC8-wk-Fact-879C99B0F2503F832D5D54B51B102DC8"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="Fact-0EFF2BDBB542E828E0E854B51AE6A7B0-wk-Fact-0EFF2BDBB542E828E0E854B51AE6A7B0"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="Fact-3F994A80D98FE166839E54B51AE557D6-wk-Fact-3F994A80D98FE166839E54B51AE557D6"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="-6"
      id="Fact-BBAB922100EACD20D1A454B51AB76D80-wk-Fact-BBAB922100EACD20D1A454B51AB76D80"
      unitRef="shares">755000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="FI2020Q3"
      decimals="-6"
      id="Fact-8F54C790D5AB93D684C054B51AAF69E7-wk-Fact-8F54C790D5AB93D684C054B51AAF69E7"
      unitRef="shares">755000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q4"
      decimals="-6"
      id="Fact-0F67C8D846509D56081754B51AAD9C11-wk-Fact-0F67C8D846509D56081754B51AAD9C11"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2020Q3"
      decimals="-6"
      id="Fact-29AE64265F2AF29C555A54B51AAF3017-wk-Fact-29AE64265F2AF29C555A54B51AAF3017"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:NumberOfReportableSegments
      contextRef="FD2020Q3YTD"
      decimals="0"
      id="Fact-9AE083E3A9FB667853FF54B51AC2153D-wk-Fact-9AE083E3A9FB667853FF54B51AC2153D"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2019Q4"
      decimals="-3"
      id="Fact-60DA7A6D0AAC9E20CF1A54B51AADF650-wk-Fact-60DA7A6D0AAC9E20CF1A54B51AADF650"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="FI2020Q3"
      decimals="-3"
      id="Fact-4D0A8A5601A0C8A584AF54B51AAEADA7-wk-Fact-4D0A8A5601A0C8A584AF54B51AAEADA7"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="FI2019Q4"
      decimals="-3"
      id="Fact-9D69251144C5272F051654B51AADCC87-wk-Fact-9D69251144C5272F051654B51AADCC87"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="FI2020Q3"
      decimals="-3"
      id="Fact-08AF18ADEA6CAD384B3554B51AAC86F0-wk-Fact-08AF18ADEA6CAD384B3554B51AAC86F0"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:TreasuryStockShares
      contextRef="FI2019Q4"
      decimals="-6"
      id="Fact-7BF09B7B5CAD1A07E1B054B51AAF36B1-wk-Fact-7BF09B7B5CAD1A07E1B054B51AAF36B1"
      unitRef="shares">28000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="FI2020Q3"
      decimals="-6"
      id="Fact-F06165CBBED17D09494754B51AACA15D-wk-Fact-F06165CBBED17D09494754B51AACA15D"
      unitRef="shares">35000000</us-gaap:TreasuryStockShares>
    <dei:DocumentType
      contextRef="FD2020Q3YTD"
      id="d55290718e2756-wk-Fact-A5C2F86E3AA1AF5C57CA54B51B083BCB">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="FD2020Q3YTD"
      id="d55290718e2773-wk-Fact-3B0812E189A157AE0C6654B51B07061E">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="FD2020Q3YTD"
      id="d55290718e2783-wk-Fact-194F46A3F823EF98863A54B51B062094">2020-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="FD2020Q3YTD"
      id="d55290718e2803-wk-Fact-EA565CE478F626B6E29054B51AD9681E">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="FD2020Q3YTD"
      id="d55290718e2816-wk-Fact-9AB61F136A9A9A0CA7A254B51A7E0935">1-11373</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="FD2020Q3YTD"
      id="d55290718e2823-wk-Fact-8746B1620FE198E829C054B51AFD6F55">Cardinal Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="FD2020Q3YTD"
      id="d55290718e2849-wk-Fact-45392805751A6C675F4954B51ADAA499">OH</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="FD2020Q3YTD"
      id="d55290718e2879-wk-Fact-63609306CCEADCBDAFC654B51ADFE708">31-0958666</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="FD2020Q3YTD"
      id="d55290718e2957-wk-Fact-7F7AB032B60061F288D654B51ADF1CC6">7000 Cardinal Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="FD2020Q3YTD"
      id="d55290718e2967-wk-Fact-291A356CF2AEFA00D77854B51ADE9E11">Dublin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="FD2020Q3YTD"
      id="d55290718e2977-wk-Fact-AD8BEDE4BD2128B3EBD554B51AD3A46F">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="FD2020Q3YTD"
      id="d55290718e2987-wk-Fact-1C3EBFAAC500D828C1A254B51AD8623C">43017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="FD2020Q3YTD"
      id="d55290718e3085-wk-Fact-200B95C353A475BBCF7554B51ADF7B8C">(614)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="FD2020Q3YTD"
      id="d55290718e3095-wk-Fact-D341E35D62260A0EA63054B51ADB896F">757-5000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="FD2020Q3YTD"
      id="d55290718e3178-wk-Fact-CF100CBFE9D64709E18854B51AC8024B">Common shares (without par value)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="FD2020Q3YTD"
      id="d55290718e3183-wk-Fact-0546DD73738FB3C51A9854B51AC778D6">CAH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="FD2020Q3YTD"
      id="d55290718e3188-wk-Fact-E09BFE8975167A1C978454B51AC759BC">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="FD2020Q3YTD"
      id="d55290718e3193-wk-Fact-99E0283978A2E811CBAF54B51B26495B">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="FD2020Q3YTD"
      id="d55290718e3207-wk-Fact-0E7140A906FC9B7762BB54B51A7F76E0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="FD2020Q3YTD"
      id="d55290718e3240-wk-Fact-F748EE4E670BE20DEA9454B51B2A1E67">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="FD2020Q3YTD"
      id="d55290718e3291-wk-Fact-3531CC31569026AC2FFB54B51B2A888F">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="FD2020Q3YTD"
      id="d55290718e3322-wk-Fact-93ECEFF218BD622191D354B51A7EE8E1">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="FD2020Q3YTD"
      id="d55290718e3364-wk-Fact-7AF0E7550DA025809BB654B51B02D589">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="I2020Q3"
      decimals="0"
      id="d55290718e3382-wk-Fact-EF46847575DA4A041B3554B51B2377AA"
      unitRef="shares">291986422</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e2937-wk-Fact-B5678807817E002A2C5254B51ACDCA6C"
      unitRef="usd">39157000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e2956-wk-Fact-1CCE01CC0FAB05B634D054B51AAD948A"
      unitRef="usd">35228000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e2975-wk-Fact-95BB44ACFE0A3C8D473654B51AA5FF98"
      unitRef="usd">116233000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e2995-wk-Fact-2D6DD524F1EBD75BAFA054B51AA8777B"
      unitRef="usd">108181000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e3010-wk-Fact-C89690A278F35814348254B51AC2BB05"
      unitRef="usd">37272000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e3029-wk-Fact-C58DF660935EDDFB43C954B51AA2B2DE"
      unitRef="usd">33464000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e3048-wk-Fact-30A224BFBEC760DBBD1354B51ADA1114"
      unitRef="usd">110955000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e3068-wk-Fact-9E3FF4DDBFCA6B5CB7C954B51B012265"
      unitRef="usd">103021000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e3088-wk-Fact-4118215C16A561B788EB54B51B19D085"
      unitRef="usd">1885000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e3107-wk-Fact-3C213EABD9DBDAACA5D854B51AEC7BBE"
      unitRef="usd">1764000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e3126-wk-Fact-AAD4CE138DEEEF77CC0F54B51A81630C"
      unitRef="usd">5278000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e3146-wk-Fact-3F03E0677B006461518054B51B0ACB11"
      unitRef="usd">5160000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e3330-wk-Fact-F1280C73126656C973ED54B51A9FBA9C"
      unitRef="usd">1165000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e3349-wk-Fact-3AB3B9B158C893B109A554B51AA62DA2"
      unitRef="usd">1097000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e3368-wk-Fact-C5F41C052A5CAA15D74754B51AE3A76E"
      unitRef="usd">3435000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e3388-wk-Fact-3718D3E045514DEA725354B51B073C49"
      unitRef="usd">3315000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:RestructuringCharges
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e3408-wk-Fact-CDD23AFADBFEF20CF0C854B51B130038"
      unitRef="usd">-6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e3428-wk-Fact-D12C27E0834E4710F68054B51ABA0B0B"
      unitRef="usd">53000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e3447-wk-Fact-9EF350966CEAF3367B0F54B51AF25715"
      unitRef="usd">80000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e3467-wk-Fact-DC1310CD717A52D67B3D54B51AEE96B6"
      unitRef="usd">97000000</us-gaap:RestructuringCharges>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e3487-wk-Fact-8D6AFCDF057859D9B6DE54B51B1A4C81"
      unitRef="usd">130000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e3506-wk-Fact-FFACB6CEC5105828FB2254B51B2192F9"
      unitRef="usd">154000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e3525-wk-Fact-4C18BD900DE70D5A57D354B51AABCDEA"
      unitRef="usd">395000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <cah:Amortizationandotheracquisitionrelatedcosts
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e3545-wk-Fact-C74667F4FA2345E604B454B51AA48B27"
      unitRef="usd">468000000</cah:Amortizationandotheracquisitionrelatedcosts>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e3565-wk-Fact-EA706E4D9F2D1B15B80654B51AEAA01C"
      unitRef="usd">1000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e3585-wk-Fact-2FE6D337637D8F3E9D9254B51B0F4FD3"
      unitRef="usd">-11000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e3604-wk-Fact-3F237E8C094C4D20E87554B51AE6B03E"
      unitRef="usd">-7000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e3624-wk-Fact-4258B5E0825630CFC45754B51ABA8334"
      unitRef="usd">492000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e3646-wk-Fact-C58F46D1036CF11CB39554B51AA5A96B"
      unitRef="usd">-35000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e3665-wk-Fact-6B6D0B306B30DE64D5D154B51A7FD9A5"
      unitRef="usd">-17000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e3684-wk-Fact-8A4BC8D191A614D4B11C54B51AFFC113"
      unitRef="usd">-5729000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e3704-wk-Fact-D2372DF3B7903BCC3C9954B51AA78942"
      unitRef="usd">-20000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e3724-wk-Fact-214140D02A180F197B4954B51A8F21D9"
      unitRef="usd">562000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e3743-wk-Fact-DF69602F2038573D567154B51B043599"
      unitRef="usd">432000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e3762-wk-Fact-0D29BC4669F150A7E4BD54B51AA61445"
      unitRef="usd">-4368000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e3783-wk-Fact-7336E4EDFE2DAA666FCC54B51A8823BF"
      unitRef="usd">1752000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e3885-wk-Fact-ACB2BA5C8E31A83F001C54B51ABF49A7"
      unitRef="usd">-19000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e3904-wk-Fact-72628D183A60CB34B99F54B51AB7DBA8"
      unitRef="usd">13000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e3924-wk-Fact-DCE43C99C2E08BF4E10054B51ABB0227"
      unitRef="usd">-21000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e3944-wk-Fact-34936A6785BAA8949D5254B51A9F33FB"
      unitRef="usd">-13000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e3964-wk-Fact-6B77C77920BAABD2A59054B51A80BD8B"
      unitRef="usd">60000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e3983-wk-Fact-C7C543F2798DB575AB0054B51A8CEE79"
      unitRef="usd">75000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e4002-wk-Fact-3CAE29399BE4FE27715754B51AA7C525"
      unitRef="usd">189000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e4022-wk-Fact-C846E2E1581C4AEC0E6B54B51A91E362"
      unitRef="usd">227000000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e4042-wk-Fact-FD435428437A218052EC54B51AA56CA2"
      unitRef="usd">-5000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e4061-wk-Fact-CB1A0E64377CA6969A2C54B51AA9E7B8"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e4080-wk-Fact-5F9B3DE83DE70A97FD6454B51AA69642"
      unitRef="usd">-9000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e4100-wk-Fact-13EB6853A5D82CF9B36854B51B20E343"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e4120-wk-Fact-CB138D4E4575F46ED54A54B51B26B0E4"
      unitRef="usd">478000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e4139-wk-Fact-3A6787092D6E9ABB9FF454B51A856FD6"
      unitRef="usd">370000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e4158-wk-Fact-57DA495F244616B33DFA54B51B1ABF6C"
      unitRef="usd">-4587000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e4179-wk-Fact-9000324042B2C60A5A8A54B51AFEEE66"
      unitRef="usd">1512000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e4281-wk-Fact-2547B3EC90BC7B32789C54B51AF028B0"
      unitRef="usd">127000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e4300-wk-Fact-43BDD7AE624BEA480B6C54B51AA288B2"
      unitRef="usd">74000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e4319-wk-Fact-F243BE4C240FCCAAE51454B51B139C87"
      unitRef="usd">-237000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e4340-wk-Fact-DB9104E46BCF02DAC24E54B51AE4E1B1"
      unitRef="usd">342000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e4360-wk-Fact-EB709ACC766503B2370C54B51AC127E0"
      unitRef="usd">351000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e4379-wk-Fact-2DB02FE7A9D905403B8061C9D4E58E9A"
      unitRef="usd">296000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e4398-wk-Fact-F078490E78EE8F83C79754B51AA13A98"
      unitRef="usd">-4350000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e4419-wk-Fact-67590E840E811BAA718E54B51ABE7580"
      unitRef="usd">1170000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e4522-wk-Fact-0E6B894266D67A681EA754B51B10F1D9"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e4542-wk-Fact-A81364456FEA3E37EBBA54B51B0B1906"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e4561-wk-Fact-69248AD84D3E8B62216254B51AC58F9B"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e4582-wk-Fact-25C2752A6A28A1DCDD1954B51AC77D31"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e4608-wk-Fact-35EF6B3029BEDC008B5054B51AAECB0B"
      unitRef="usd">350000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e4627-wk-Fact-33B1AB25C580C3A0D03454B51AFE9FFF"
      unitRef="usd">296000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e4646-wk-Fact-105C2CDA654CB50A699A54B51AD31834"
      unitRef="usd">-4352000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e4667-wk-Fact-42887B037229FD92376954B51A820B65"
      unitRef="usd">1169000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="FD2020Q3QTD"
      decimals="2"
      id="d55354548e4851-wk-Fact-35B7388269F954955FFF54B51AA4B5E1"
      unitRef="usdPerShare">1.20</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="FD2019Q3QTD"
      decimals="2"
      id="d55354548e4870-wk-Fact-4DC02757D3A3F5D76FEA54B51AA69EA6"
      unitRef="usdPerShare">0.99</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="FD2020Q3YTD"
      decimals="2"
      id="d55354548e4889-wk-Fact-BAAE7044E8133D6FD2B854B51B1CC35D"
      unitRef="usdPerShare">-14.84</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="FD2019Q3YTD"
      decimals="2"
      id="d55354548e4910-wk-Fact-D079ABA865704BE9C72654B51B0BE160"
      unitRef="usdPerShare">3.89</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="FD2020Q3QTD"
      decimals="2"
      id="d55354548e4925-wk-Fact-31525DD9F24C571C700A54B51AC5418E"
      unitRef="usdPerShare">1.19</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="FD2019Q3QTD"
      decimals="2"
      id="d55354548e4944-wk-Fact-663244E0C075DB4674D654B51AC5A554"
      unitRef="usdPerShare">0.99</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="FD2020Q3YTD"
      decimals="2"
      id="d55354548e4963-wk-Fact-347F63DCD1F9E111706354B51A86D6D7"
      unitRef="usdPerShare">-14.84</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="FD2019Q3YTD"
      decimals="2"
      id="d55354548e4984-wk-Fact-5EF65F8234B4FBC2137D54B51AB7236E"
      unitRef="usdPerShare">3.88</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e5168-wk-Fact-0B26D6B638400FB2D18454B51B21CD14"
      unitRef="shares">292000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e5187-wk-Fact-556A52112788EC9E118654B51A8B31D9"
      unitRef="shares">298000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e5206-wk-Fact-F2F36F531E2C061568FA54B51A8E1510"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e5226-wk-Fact-5535B20D9FD47662E0D254B51AAC6E51"
      unitRef="shares">301000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55354548e5246-wk-Fact-3C5E39C3EF23C07BA0ED54B51A99B73A"
      unitRef="shares">294000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55354548e5265-wk-Fact-74BC951CA67E200BA9E754B51AFCDAED"
      unitRef="shares">299000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55354548e5284-wk-Fact-F6D925A67782C67F989554B51A86E258"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55354548e5304-wk-Fact-526E27FF304324D2092354B51B2388DA"
      unitRef="shares">302000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="FD2020Q3QTD"
      decimals="INF"
      id="d55354548e5412-wk-Fact-B0D5CE26FB5D366931C554B51ABB6EB2"
      unitRef="usdPerShare">0.4811</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="FD2019Q3QTD"
      decimals="INF"
      id="d55354548e5431-wk-Fact-9213FD1FAE619687826054B51AA68A05"
      unitRef="usdPerShare">0.4763</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="FD2020Q3YTD"
      decimals="4"
      id="d55354548e5450-wk-Fact-93C72551129C7F04D8CF54B51AC0A27E"
      unitRef="usdPerShare">1.4433</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="FD2019Q3YTD"
      decimals="4"
      id="d55354548e5470-wk-Fact-97EDBBC7E9722965E88254B51B125FC8"
      unitRef="usdPerShare">1.4289</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55363777e2936-wk-Fact-EB709ACC766503B2370C54B51AC127E0"
      unitRef="usd">351000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55363777e2955-wk-Fact-2DB02FE7A9D905403B8061C9D4E58E9A"
      unitRef="usd">296000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55363777e2974-wk-Fact-F078490E78EE8F83C79754B51AA13A98"
      unitRef="usd">-4350000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55363777e2995-wk-Fact-67590E840E811BAA718E54B51ABE7580"
      unitRef="usd">1170000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55363777e3174-wk-Fact-7D774844018D9680179A54B51AC4E30A"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55363777e3194-wk-Fact-09ACDDE1CD29B089F5CF54B51AC0D399"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55363777e3213-wk-Fact-A13CBA778A366EC741E254B51AC60D17"
      unitRef="usd">-35000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55363777e3234-wk-Fact-B80BE59A5735A5E2F6DE54B51AC756F3"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55363777e3255-wk-Fact-89E549543DFDB5A5B40654B51AC2C248"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55363777e3275-wk-Fact-38DAD721AF41EB04D52454B51ABD00C6"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55363777e3295-wk-Fact-3A5BBB66429EA44DFDD654B51AC168B4"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55363777e3316-wk-Fact-DEE5E053C64DD10019F354B51AC62235"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55363777e3337-wk-Fact-3E440F9346445BDB592254B51AA4E8B0"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55363777e3357-wk-Fact-5093EFC34D0C3C462CD654B51AA4B7BC"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55363777e3376-wk-Fact-18042220F0F0E4E46DAE54B51AA504F4"
      unitRef="usd">-62000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55363777e3397-wk-Fact-8F1CA99B30778D61112D54B51AC5ACD5"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55363777e3500-wk-Fact-C9779B5A61999B40C04B54B51AA5270E"
      unitRef="usd">313000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55363777e3519-wk-Fact-CAAA1D20E10EB2CB2E8254B51AA44A00"
      unitRef="usd">308000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55363777e3538-wk-Fact-23070D0FB1FFC7800A5D54B51AC648CE"
      unitRef="usd">-4412000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55363777e3559-wk-Fact-B0A3F743D5770BA7638E54B51AC796D1"
      unitRef="usd">1151000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55363777e3662-wk-Fact-0E6B894266D67A681EA754B51B10F1D9"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55363777e3682-wk-Fact-A81364456FEA3E37EBBA54B51B0B1906"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55363777e3701-wk-Fact-69248AD84D3E8B62216254B51AC58F9B"
      unitRef="usd">2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55363777e3722-wk-Fact-25C2752A6A28A1DCDD1954B51AC77D31"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55363777e3748-wk-Fact-3EE138256991C8DEEAE154B51AC65ED8"
      unitRef="usd">312000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55363777e3767-wk-Fact-950E900CBD816DDE5BA054B51AC44399"
      unitRef="usd">308000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55363777e3786-wk-Fact-594F72D11F950DFDCE0054B51AC517B7"
      unitRef="usd">-4414000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55363777e3807-wk-Fact-5C6FBCF5A2EDA00D8DBA54B51AC215D2"
      unitRef="usd">1150000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e2888-wk-Fact-BD7C186A5B42F120F70A54B51AFD69A7"
      unitRef="usd">2329000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e2907-wk-Fact-D0E1A50DDE1CDF6E806154B51AEF1C21"
      unitRef="usd">2531000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e2922-wk-Fact-26987694F7920A2C1C8154B51AEF107D"
      unitRef="usd">9019000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e2941-wk-Fact-15866CC2F16CA7CAE9EB54B51B000A83"
      unitRef="usd">8448000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e2961-wk-Fact-E5212BB22D8EA27AC4F554B51AF95410"
      unitRef="usd">12808000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e2980-wk-Fact-39F782F57463F137835954B51AF094EB"
      unitRef="usd">12822000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3000-wk-Fact-8E54BA4D272CD872FEA954B51AF234A1"
      unitRef="usd">1692000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3019-wk-Fact-AA3A15F110F1588AE1BC54B51AEA9993"
      unitRef="usd">1946000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3039-wk-Fact-B808FBBBE7A37082601F54B51AFA9FB5"
      unitRef="usd">25848000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3058-wk-Fact-B68643127FFD6C7DF87854B51AE8EF8D"
      unitRef="usd">25747000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3119-wk-Fact-03305930E7ADF95AD4E054B51AFF81C3"
      unitRef="usd">2299000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3138-wk-Fact-BA15BAC9545515E7854954B51AF176B0"
      unitRef="usd">2356000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3158-wk-Fact-D04779526CB3D8BD087154B51AE70ED3"
      unitRef="usd">11378000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3177-wk-Fact-5FF107B511EC235C95DC54B51AE47EEE"
      unitRef="usd">11808000000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3198-wk-Fact-1BE368FF3E1E18FA60DB54B51AEBBFEE"
      unitRef="usd">1623000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3217-wk-Fact-D960C964B7B84A12CE4E54B51AE600E6"
      unitRef="usd">1052000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3242-wk-Fact-79192C98474F73FFBB6B54B51AF8130A"
      unitRef="usd">41148000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3261-wk-Fact-917DCA0680103C02A25754B51AFF2750"
      unitRef="usd">40963000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3404-wk-Fact-D1A68742AD7F613C6B6154B51AE7DDC5"
      unitRef="usd">21984000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3423-wk-Fact-CA129F3B526FC941592F54B51AE6675E"
      unitRef="usd">21535000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3438-wk-Fact-F497BA391D56252F1F4E54B51AECCD3B"
      unitRef="usd">508000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3457-wk-Fact-4F45C093DE0583F7701154B51AFE64C8"
      unitRef="usd">452000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3477-wk-Fact-F91393ABDEFFB8070D8854B51AEF505B"
      unitRef="usd">2179000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3496-wk-Fact-5E8A36BF6954F3A5CB0454B51AE42712"
      unitRef="usd">2122000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3516-wk-Fact-50D5D07A35AEA5DD798854B51AF1ABC1"
      unitRef="usd">24671000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3535-wk-Fact-C40225AF49A6AB17DFAF54B51AE67A39"
      unitRef="usd">24109000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3596-wk-Fact-576A5B650BA3491CB7A154B51AEBFBEF"
      unitRef="usd">6754000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3615-wk-Fact-044D800023AE5C22DF8254B51B003CF2"
      unitRef="usd">7579000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3636-wk-Fact-2A600DD5A9E4BFAC8A5954B51AF8C618"
      unitRef="usd">8517000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3655-wk-Fact-6ED392447DEABC07A94A54B51AED3454"
      unitRef="usd">2945000000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:PreferredStockValue
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3804-wk-Fact-CD866A916DC83598888C54B51AEE7D0F"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3823-wk-Fact-F577A7066F5EB61E2A6554B51AEAF3C9"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3896-wk-Fact-93B663D7958916A99DCC54B51AED2E25"
      unitRef="usd">2774000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3915-wk-Fact-0B28CDE8C0990B0ED01254B51AFFDDFA"
      unitRef="usd">2763000000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3935-wk-Fact-1C8B0F6E877AFB616BAD54B51AE9E8FF"
      unitRef="usd">656000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e3954-wk-Fact-4D8F2C4C77E010FB294954B51AEBCE9D"
      unitRef="usd">5434000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e3982-wk-Fact-FE94123580EB7859BF5454B51AFF83B1"
      unitRef="usd">2086000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e4002-wk-Fact-22670B103CB3CDF93B8854B51AE85B7D"
      unitRef="usd">1790000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e4023-wk-Fact-DD48F6F2B68FA6273F1854B51AFFDBE6"
      unitRef="usd">-141000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e4043-wk-Fact-6DDF835225D29A2EA00154B51AEC5CC5"
      unitRef="usd">-79000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e4064-wk-Fact-4959005A72B6A6AEEAD054B51AFF5CD4"
      unitRef="usd">1203000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e4083-wk-Fact-A6C46A9EE011C35AF05954B51AF80493"
      unitRef="usd">6328000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e4104-wk-Fact-24EC0E0E2909CE943C1954B51AEEA465"
      unitRef="usd">3000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e4123-wk-Fact-D875E3AB39F0149E297154B51AEEFDD9"
      unitRef="usd">2000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e4143-wk-Fact-CDE916D192DECAFCFB8B54B51AED2F88"
      unitRef="usd">1206000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e4162-wk-Fact-CE3156BD577214A8851554B51AE7B0EE"
      unitRef="usd">6330000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55361983e4187-wk-Fact-85176B163BC170C900A854B51AEAFE90"
      unitRef="usd">41148000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55361983e4206-wk-Fact-CA86463B26FF04489FF754B51AF95BC5"
      unitRef="usd">40963000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e3240-wk-Fact-DD562D82CB0C77CE143D54B51B078DEB"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e3259-wk-Fact-9CA7A75C444F9CA1EE3454B51A9F5715"
      unitRef="usd">2752000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e3278-wk-Fact-86A1B978EA8078F9678154B51A9C0637"
      unitRef="usd">449000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e3293-wk-Fact-2F86E23BC371B675671F54B51AA3DA8B"
      unitRef="shares">-35000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e3313-wk-Fact-52FC7BB269DDF874694F54B51B03D67A"
      unitRef="usd">-2099000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55388091e3333-wk-Fact-15F84A46B97B6467D1F154B51AA205A1"
      unitRef="usd">-103000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e3354-wk-Fact-BD8F2549F18F501FB1B854B51AA1DC53"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q2"
      decimals="-6"
      id="d55388091e3373-wk-Fact-240FC41A74E50611D38254B51A9FD9CA"
      unitRef="usd">1002000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55388091e3423-wk-Fact-35EF6B3029BEDC008B5054B51AAECB0B"
      unitRef="usd">350000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e3499-wk-Fact-F4BF95A589E7E5A0FA3C54B51B003B56"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55388091e3518-wk-Fact-EB709ACC766503B2370C54B51AC127E0"
      unitRef="usd">351000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55388091e3629-wk-Fact-3E440F9346445BDB592254B51AA4E8B0"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55388091e3670-wk-Fact-98058F24B57403A1D2A554B51AA14125"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e3705-wk-Fact-CC147F59BA55A1EAE1F454B51AA2E8DB"
      unitRef="usd">22000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e3758-wk-Fact-FF6CC19E3054286885EC54B51B045A84"
      unitRef="usd">13000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55388091e3818-wk-Fact-1EB948E80544A399F68054B51A9FFFF5"
      unitRef="usd">35000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:Dividends
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e3873-wk-Fact-7377D6D650A37E9AE8E854B51A9B5A6D"
      unitRef="usd">142000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55388091e3970-wk-Fact-1D9697C4A7231DD498B554B51B040A6A"
      unitRef="usd">142000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e4026-wk-Fact-61F58D55EE71DD1934F754B51AA0E634"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2020Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e4103-wk-Fact-C1B1A2F9C0D7A909B89654B51AA1DB7A"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55388091e4123-wk-Fact-C316279E628FD8ACB54254B51A9E3BCF"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e4144-wk-Fact-2F03BAA068955DAFB57254B51A9E0D89"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e4163-wk-Fact-5D1633A1DB160AADACB654B51AA0BC1A"
      unitRef="usd">2774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e4182-wk-Fact-7254B4EA33B6AA05381D54B51A9D46E5"
      unitRef="usd">656000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e4197-wk-Fact-8927D94E05ECFF64945054B51A9E6031"
      unitRef="shares">35000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e4217-wk-Fact-E7A21D525234B88AD08154B51AA1C4BC"
      unitRef="usd">2086000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55388091e4237-wk-Fact-C4594A4A3F705968274A54B51AA2F9B9"
      unitRef="usd">-141000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e4258-wk-Fact-0A599A035C1050EA6D5154B51AA2F035"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55388091e4277-wk-Fact-CDE916D192DECAFCFB8B54B51AED2F88"
      unitRef="usd">1206000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e4484-wk-Fact-F2C1844C6B044D151D3A54B51ADEF9A2"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e4503-wk-Fact-D2B520B24EDF13E96FCD54B51ADA71DE"
      unitRef="usd">2728000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e4522-wk-Fact-F0EBFF255B567F32FF1D54B51ADCEA7A"
      unitRef="usd">5233000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e4537-wk-Fact-2BDFF02382E3368BDBFA54B51AD2E8E6"
      unitRef="shares">29000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e4557-wk-Fact-9F196462D9D101B9291454B51ADED637"
      unitRef="usd">1795000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55388091e4577-wk-Fact-10A076A527A4CA16D92854B51AD96408"
      unitRef="usd">-123000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q2_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e4598-wk-Fact-77307A87C431DBF3AC5C54B51AE30AB4"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q2"
      decimals="-6"
      id="d55388091e4617-wk-Fact-69F1B5F92E8FA1C966EE54B51AD9C690"
      unitRef="usd">6043000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55388091e4667-wk-Fact-33B1AB25C580C3A0D03454B51AFE9FFF"
      unitRef="usd">296000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e4743-wk-Fact-8CD3F083BFC9FDD02D4154B51AE01FEC"
      unitRef="usd">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55388091e4762-wk-Fact-2DB02FE7A9D905403B8061C9D4E58E9A"
      unitRef="usd">296000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55388091e4873-wk-Fact-5972AE41296E201FA3E154B51ADFA25E"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55388091e4913-wk-Fact-E52DD5239EA0A6A85B7F54B51AE2FDC9"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e4947-wk-Fact-D42A53F2411CA753CEC254B51AE3457D"
      unitRef="usd">20000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      id="d55388091e4987-wk-Fact-3282C2AFC1E2DC63960F54B51ADBFAF6"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e5000-wk-Fact-463D1DC5765EFA224EFE54B51AE2200C"
      unitRef="usd">2000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55388091e5060-wk-Fact-640C051BF781F0957AD454B51ADBBB12"
      unitRef="usd">22000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:Dividends
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e5115-wk-Fact-2E3BE44C1A0E58BD319E54B51ADD0EAD"
      unitRef="usd">143000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55388091e5212-wk-Fact-0F725AB52B1B60CF479E54B51AE1B91A"
      unitRef="usd">143000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e5268-wk-Fact-DA9DC3CCA01A63A43C3B54B51ADD9DBE"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2019Q3QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e5344-wk-Fact-AD912F65EC830C162B7654B51ADBB02B"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55388091e5363-wk-Fact-AF862B2B4D22AD801EAD54B51ADE10A7"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e5383-wk-Fact-245D4717586334139C1054B51ABD62A8"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e5402-wk-Fact-850F0322FE427CCE3C9D54B51AB0F458"
      unitRef="usd">2748000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e5421-wk-Fact-1F6A194ECD8211D1774254B51ABBFAD0"
      unitRef="usd">5386000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e5436-wk-Fact-3BA664087DBE3EF7FFCC54B51AB83928"
      unitRef="shares">29000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e5456-wk-Fact-6E13B2F5DA6D6565B9FC54B51AB9AC33"
      unitRef="usd">1793000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55388091e5476-wk-Fact-A6A91FE527666F04C87354B51AAFA609"
      unitRef="usd">-111000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e5497-wk-Fact-ED1858A430E8A8EA7CDB54B51ABF1F0C"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q3"
      decimals="-6"
      id="d55388091e5516-wk-Fact-17A626A1D528A488BC0254B51AB69F38"
      unitRef="usd">6232000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e5722-wk-Fact-013581B0FE00157B462F54B51B008921"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e5741-wk-Fact-D1ABDCE5C2E420A992B154B51B0A482D"
      unitRef="usd">2763000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e5760-wk-Fact-E0E610827D00B8F0FFD654B51B0EC683"
      unitRef="usd">5434000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e5775-wk-Fact-D7CF5207F2EADC82381F54B51B0CE70D"
      unitRef="shares">-28000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e5795-wk-Fact-B298E012AA250F46144754B51B0A6FE6"
      unitRef="usd">-1790000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55388091e5815-wk-Fact-B8CF12806FC87C9F1A0B54B51B0D115A"
      unitRef="usd">-79000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e5836-wk-Fact-0D13DA5E17B25D84183754B51B0B922F"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55388091e5855-wk-Fact-CE3156BD577214A8851554B51AE7B0EE"
      unitRef="usd">6330000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55388091e5905-wk-Fact-105C2CDA654CB50A699A54B51AD31834"
      unitRef="usd">-4352000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e5982-wk-Fact-3CDE91D9155E99908FD754B51B05A0E5"
      unitRef="usd">2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55388091e6001-wk-Fact-F078490E78EE8F83C79754B51AA13A98"
      unitRef="usd">-4350000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55388091e6113-wk-Fact-E96553D6611AB0CA951B54B51B051314"
      unitRef="usd">-62000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55388091e6154-wk-Fact-72494495C740F7B9BE4354B51B01E840"
      unitRef="usd">-62000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e6189-wk-Fact-44BB3B24C5F81FCF6CD654B51B023066"
      unitRef="usd">11000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e6242-wk-Fact-C89888EF6B3898F6C8A654B51B02D42C"
      unitRef="usd">54000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55388091e6302-wk-Fact-0CFA1B30BFDF644E835D54B51B00B116"
      unitRef="usd">65000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e6337-wk-Fact-14AB8329CAD5365EE4F354B51B0F4F92"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e6375-wk-Fact-28AB96A847ED06D1C33554B51B0D6C36"
      unitRef="shares">7000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e6390-wk-Fact-75844EB611179C54B15D54B51B0D3D07"
      unitRef="usd">350000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55388091e6451-wk-Fact-74D3B12AD2E710ABEBFA54B51B02D142"
      unitRef="usd">350000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:Dividends
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e6507-wk-Fact-4B0A41F25245E55F503954B51B0DA9D0"
      unitRef="usd">426000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55388091e6604-wk-Fact-17B02B541B419A9E9D2654B51B0AAE7A"
      unitRef="usd">426000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e6660-wk-Fact-3467C2984775A4E71E9054B51B05D1C8"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e6736-wk-Fact-E780FE7D34A745CBC82454B51B0513A0"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55388091e6756-wk-Fact-949F08435683B2D52E5954B51B09C897"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e6777-wk-Fact-2F03BAA068955DAFB57254B51A9E0D89"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e6796-wk-Fact-5D1633A1DB160AADACB654B51AA0BC1A"
      unitRef="usd">2774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e6815-wk-Fact-7254B4EA33B6AA05381D54B51A9D46E5"
      unitRef="usd">656000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e6830-wk-Fact-8927D94E05ECFF64945054B51A9E6031"
      unitRef="shares">35000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e6850-wk-Fact-E7A21D525234B88AD08154B51AA1C4BC"
      unitRef="usd">2086000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55388091e6870-wk-Fact-C4594A4A3F705968274A54B51AA2F9B9"
      unitRef="usd">-141000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e6891-wk-Fact-0A599A035C1050EA6D5154B51AA2F035"
      unitRef="usd">3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55388091e6910-wk-Fact-CDE916D192DECAFCFB8B54B51AED2F88"
      unitRef="usd">1206000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e7117-wk-Fact-AB556C772901698D4C9054B51AC0E9DE"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e7136-wk-Fact-6DCEAE7555A18B1925CB54B51AB0AB51"
      unitRef="usd">2730000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e7155-wk-Fact-B69B00E063982FABD25454B51AAF90D7"
      unitRef="usd">4645000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e7170-wk-Fact-D06F50FC648919C1AC7654B51AB68520"
      unitRef="shares">18000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e7190-wk-Fact-7A58CEDABF7AC285095254B51ABDDCEC"
      unitRef="usd">1224000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55388091e7210-wk-Fact-6D4A0BC4E0C70393868C54B51AACE936"
      unitRef="usd">-92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e7231-wk-Fact-5811541612ABD1C1ECCE54B51ABA5EFD"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2018Q4"
      decimals="-6"
      id="d55388091e7250-wk-Fact-00C142A5D3ADEC768C6C54B51ABBFC37"
      unitRef="usd">6059000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55388091e7300-wk-Fact-42887B037229FD92376954B51A820B65"
      unitRef="usd">1169000000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e7376-wk-Fact-E6FA7D98926C449C9D3754B51AB7C8CA"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55388091e7395-wk-Fact-67590E840E811BAA718E54B51ABE7580"
      unitRef="usd">1170000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55388091e7506-wk-Fact-8FDDDF603D57A741920154B51AAC7CB6"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55388091e7547-wk-Fact-719B9B2B8B7ACA6C6B6154B51AC1CFA7"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e7582-wk-Fact-D38973670C8C03D597EC54B51ABC6AA3"
      unitRef="usd">18000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e7622-wk-Fact-DB3B9967EFCF1E55156354B51AADB03C"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e7636-wk-Fact-D8D4E5D1E33FA11F45A854B51AC19E9D"
      unitRef="usd">31000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55388091e7696-wk-Fact-53DA43E1A9BCC2BF45B054B51AB91321"
      unitRef="usd">49000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d55388091e7771-wk-Fact-67B50102B67EDEEF3EC354B51AB813DF"
      unitRef="shares">12000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e7786-wk-Fact-A18C9E8CA1955F4501F954B51ABE9A2B"
      unitRef="usd">600000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55388091e7847-wk-Fact-D90329078A87441BCC3254B51ABCA990"
      unitRef="usd">600000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:Dividends
      contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e7903-wk-Fact-A262364F8D7386D83A0B54B51AAC8983"
      unitRef="usd">429000000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55388091e8000-wk-Fact-FCAC390DE628BB5ECB2054B51ABC88BD"
      unitRef="usd">429000000</us-gaap:Dividends>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e8056-wk-Fact-26F9C275287F14986E8754B51AAEFE6A"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e8132-wk-Fact-3E27135BE35AB5DEDE1D54B51AB5601B"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55388091e8151-wk-Fact-672F4EE66C9F8C26EDFE54B51AAC61AB"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e8171-wk-Fact-245D4717586334139C1054B51ABD62A8"
      unitRef="shares">327000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-6"
      id="d55388091e8190-wk-Fact-850F0322FE427CCE3C9D54B51AB0F458"
      unitRef="usd">2748000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-6"
      id="d55388091e8209-wk-Fact-1F6A194ECD8211D1774254B51ABBFAD0"
      unitRef="usd">5386000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e8224-wk-Fact-3BA664087DBE3EF7FFCC54B51AB83928"
      unitRef="shares">29000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-6"
      id="d55388091e8244-wk-Fact-6E13B2F5DA6D6565B9FC54B51AB9AC33"
      unitRef="usd">1793000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55388091e8264-wk-Fact-A6A91FE527666F04C87354B51AAFA609"
      unitRef="usd">-111000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember"
      decimals="-6"
      id="d55388091e8285-wk-Fact-ED1858A430E8A8EA7CDB54B51ABF1F0C"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q3"
      decimals="-6"
      id="d55388091e8304-wk-Fact-17A626A1D528A488BC0254B51AB69F38"
      unitRef="usd">6232000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e2887-wk-Fact-F078490E78EE8F83C79754B51AA13A98"
      unitRef="usd">-4350000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e2907-wk-Fact-67590E840E811BAA718E54B51ABE7580"
      unitRef="usd">1170000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3004-wk-Fact-AB10504BC20D202C007054B51B24ABF8"
      unitRef="usd">688000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3023-wk-Fact-378C032EEE30E328F77A54B51AC80CF1"
      unitRef="usd">759000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3043-wk-Fact-D6C1A865C1D170A83F3554B51AD23183"
      unitRef="usd">0</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3062-wk-Fact-60C9378BD5D570DC4B6954B51B1EB6C3"
      unitRef="usd">2000000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3082-wk-Fact-3F237E8C094C4D20E87554B51AE6B03E"
      unitRef="usd">-7000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3101-wk-Fact-4258B5E0825630CFC45754B51ABA8334"
      unitRef="usd">492000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3122-wk-Fact-5F9B3DE83DE70A97FD6454B51AA69642"
      unitRef="usd">-9000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3141-wk-Fact-13EB6853A5D82CF9B36854B51B20E343"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3161-wk-Fact-44B495E6052B0036080154B51AC86701"
      unitRef="usd">68000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3180-wk-Fact-48956753B0718B00419254B51B2A81AB"
      unitRef="usd">64000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3201-wk-Fact-82411A5B74B8CE11D2AF54B51ACBA196"
      unitRef="usd">86000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3220-wk-Fact-661A93DE87A3CDF49D5C54B51B230F8D"
      unitRef="usd">59000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3281-wk-Fact-C475A01364865A8F52DD54B51ACDC9E0"
      unitRef="usd">653000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3301-wk-Fact-CD93C7D5EE3A7E9A3DCC54B51B1FDF94"
      unitRef="usd">156000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3322-wk-Fact-2559D6A037C48C30070E54B51ACB7A4B"
      unitRef="usd">8000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3342-wk-Fact-B21EF344325BCC48807C54B51ACF964A"
      unitRef="usd">345000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3363-wk-Fact-4A95DD12A709CD4051F554B51AD08397"
      unitRef="usd">448000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3382-wk-Fact-A7E73438BCCF1D8E7D4D54B51AD0D6BE"
      unitRef="usd">846000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3402-wk-Fact-C9A6C83D0C57DB60030B54B51AC9EC44"
      unitRef="usd">-5425000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3421-wk-Fact-04C80DA9BB4264E63B9254B51B27CD90"
      unitRef="usd">-309000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3441-wk-Fact-5036AAA5DBADB76585F854B51AD19825"
      unitRef="usd">1720000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3460-wk-Fact-E22C1DB80AD19B8B658754B51B2A527E"
      unitRef="usd">2216000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3562-wk-Fact-C97B54C1515B976F247954B51B21A09F"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3581-wk-Fact-F1B80EBD33EBA375E40C54B51ACBF693"
      unitRef="usd">38000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3602-wk-Fact-BE3F43ADEA2F650A1AC854B51ACE9235"
      unitRef="usd">239000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3622-wk-Fact-F5FBE63559E3A6A07AF654B51B2A0715"
      unitRef="usd">192000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3644-wk-Fact-7A413CF7DC50F269630B54B51B1D0E2B"
      unitRef="usd">18000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Purchaseofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3664-wk-Fact-B86DDE486B12CC239E1654B51B25DA3A"
      unitRef="usd">11000000</cah:Purchaseofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3685-wk-Fact-101E8D21FA197DEF097354B51B2467D2"
      unitRef="usd">6000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3704-wk-Fact-F393066FAB2780F1077554B51B1DE7B0"
      unitRef="usd">3000000</cah:Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments>
    <cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3724-wk-Fact-D9F0DD6BF00F4A77317454B51ACE2199"
      unitRef="usd">2000000</cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets>
    <cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3743-wk-Fact-3B12EB17030908350D7F54B51B203547"
      unitRef="usd">749000000</cah:Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3763-wk-Fact-E16094A6EC2127CED04554B51B20A76B"
      unitRef="usd">-249000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3783-wk-Fact-C56A935D6934EE83E31A54B51B26382C"
      unitRef="usd">511000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3885-wk-Fact-45B87C94ABE60FC96C9B54B51B222DF9"
      unitRef="usd">-2000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3905-wk-Fact-66FCBB99EB4C3AE2453354B51B210599"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3925-wk-Fact-972708A0473D504BE1D054B51B1F52D8"
      unitRef="usd">888000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3945-wk-Fact-1F5FCD85313EEF9C854154B51ACFAA68"
      unitRef="usd">2000000</us-gaap:RepaymentsOfLongTermDebt>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e3966-wk-Fact-2F45A97FF4CDC882D4AD54B51A8160C7"
      unitRef="usd">-4000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <cah:Netproceedstaxwithholdingsfromsharebasedcompensation
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e3986-wk-Fact-CAD091C65CFB0F9E82B754B51ACC4E05"
      unitRef="usd">-13000000</cah:Netproceedstaxwithholdingsfromsharebasedcompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e4007-wk-Fact-5078A2FE6F1EAB822AAF54B51B26414E"
      unitRef="usd">428000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e4027-wk-Fact-EFA0CE3249D21EDBD15F54B51B1D6564"
      unitRef="usd">435000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e4048-wk-Fact-74D3B12AD2E710ABEBFA54B51B02D142"
      unitRef="usd">350000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e4068-wk-Fact-D90329078A87441BCC3254B51ABCA990"
      unitRef="usd">600000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e4090-wk-Fact-6B71FC5490BB490CDC4B54B51B293E73"
      unitRef="usd">-1672000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e4110-wk-Fact-2B2CB097D5BDCDDB993B54B51ACC5B2D"
      unitRef="usd">-1050000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e4172-wk-Fact-A4A3660014780D04E1E254B51AD13CED"
      unitRef="usd">-1000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e4192-wk-Fact-728D27ED6E72E5B9F1CA54B51B21D97A"
      unitRef="usd">-2000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55373487e4254-wk-Fact-27A962EC96EB31A2AE2954B51B20F872"
      unitRef="usd">-202000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55373487e4274-wk-Fact-13429B6EDBCC43F2625554B51B22F1D4"
      unitRef="usd">1675000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55373487e4294-wk-Fact-D0E1A50DDE1CDF6E806154B51AEF1C21"
      unitRef="usd">2531000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2018Q4"
      decimals="-6"
      id="d55373487e4313-wk-Fact-0ABF0DEA7E181F12A18754B51AC74C13"
      unitRef="usd">1763000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55373487e4338-wk-Fact-BD7C186A5B42F120F70A54B51AFD69A7"
      unitRef="usd">2329000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="FI2019Q3"
      decimals="-6"
      id="d55373487e4357-wk-Fact-D51BA1D542000AB5560F54B51B1DDBA8"
      unitRef="usd">3438000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-3B2CD0A042E450EB379E54B51B4DC504-0-wk-Fact-C23337D5E250A7D8134554B51A9A0235">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;1. Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;References to "we," "our," and similar pronouns is in this Quarterly Report on Form 10-Q for the quarter ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our fiscal year ends on June 30. References to fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; in these condensed consolidated financial statements are to the fiscal years ending or ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our condensed consolidated financial statements have been prepared in accordance with the United States Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. To conform to the current year presentation, certain prior year amounts have been reclassified.&#160;In addition, financial results presented for this fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (the "&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; Form 10-K"). &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recently Adopted Financial Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;"&gt;Derivatives and Hedging &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In October 2018, the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Financial Accounting Standards Board ("FASB")&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a benchmark interest rate for hedge accounting purposes. This guidance is effective beginning the first quarter of fiscal 2020 and must be applied on a prospective basis. The adoption did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal 2020 and elected the transition option which allows us to apply the guidance prospectively. The adoption resulted in the recognition of lease liabilities in the amount of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$422 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. See &lt;/span&gt;&lt;a href="#s37977FB1689852A6888EFF6B57032648" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 5&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for additional information regarding leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recently Issued Financial Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This&#160;guidance will be effective for us in the first quarter of fiscal 2021. We are currently evaluating the impact of this amended guidance but do not expect the adoption to have a material impact on our consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-FC0CC9F5436B0CF59D9D54B51B4DD211-0-wk-Fact-7D3C2DDAE5CB14D9F34F54B51A9B022A">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;References to "we," "our," and similar pronouns is in this Quarterly Report on Form 10-Q for the quarter ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our fiscal year ends on June 30. References to fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; in these condensed consolidated financial statements are to the fiscal years ending or ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our condensed consolidated financial statements have been prepared in accordance with the United States Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. To conform to the current year presentation, certain prior year amounts have been reclassified.&#160;In addition, financial results presented for this fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (the "&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; Form 10-K"). &lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-18B451B2F1E1E77922FE54B51B4DF5EE-0-wk-Fact-0ECBB04057259D59F25654B51A9A5D48">&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recently Adopted Financial Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;"&gt;Derivatives and Hedging &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In October 2018, the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Financial Accounting Standards Board ("FASB")&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a benchmark interest rate for hedge accounting purposes. This guidance is effective beginning the first quarter of fiscal 2020 and must be applied on a prospective basis. The adoption did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal 2020 and elected the transition option which allows us to apply the guidance prospectively. The adoption resulted in the recognition of lease liabilities in the amount of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$422 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. See &lt;/span&gt;&lt;a href="#s37977FB1689852A6888EFF6B57032648" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 5&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for additional information regarding leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Recently Issued Financial Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This&#160;guidance will be effective for us in the first quarter of fiscal 2021. We are currently evaluating the impact of this amended guidance but do not expect the adoption to have a material impact on our consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842
      contextRef="I2020Q1ASC842"
      decimals="-6"
      id="d55375279e2834-wk-Fact-893FDD43AA38FC6C4CAA54B51A9BAFAB"
      unitRef="usd">422000000</cah:LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-2035394A40273F2E8D3054B51B4DB3BA-0-wk-Fact-72F70BD1F3AF7F573F0154B51A8CAFAD">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;2. Restructuring and Employee Severance&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes restructuring and employee severance:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total restructuring and employee severance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;70&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total restructuring and employee severance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;97&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, vendor transition fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Restructuring and employee severance during both the three and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; was primarily related to enterprise-wide cost-saving measures. The income during the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; was due to changes in estimates for severance previously accrued.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes activity related to liabilities associated with restructuring and employee severance:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Related Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility Exit&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;and Other Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;57&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;67&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Payments and other adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;66&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-036B3693A63687D8F6F154B51B4DD8C7-0-wk-Fact-3EF5A221EBC3A489692E54B51A8B9998">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes restructuring and employee severance:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;24&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total restructuring and employee severance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;70&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;33&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total restructuring and employee severance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;80&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;97&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, vendor transition fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55388671e2900-wk-Fact-8E1432A2D9B36B53031754B51A93C814"
      unitRef="usd">-15000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55388671e2920-wk-Fact-30E748BE5B754031A15B54B51A94DA1D"
      unitRef="usd">29000000</us-gaap:SeveranceCosts1>
    <cah:FacilityExitAndOtherCosts
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55388671e2935-wk-Fact-7DB7E5F3CA0D9D6939DE54B51A9966AA"
      unitRef="usd">9000000</cah:FacilityExitAndOtherCosts>
    <cah:FacilityExitAndOtherCosts
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55388671e2954-wk-Fact-7E97D700EB46BC531C8F54B51A93EC99"
      unitRef="usd">24000000</cah:FacilityExitAndOtherCosts>
    <us-gaap:RestructuringCharges
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55388671e2979-wk-Fact-CDD23AFADBFEF20CF0C854B51B130038"
      unitRef="usd">-6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55388671e2999-wk-Fact-D12C27E0834E4710F68054B51ABA0B0B"
      unitRef="usd">53000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55388671e3141-wk-Fact-2485CB1FF0F32D6BD35954B51ACA11C2"
      unitRef="usd">47000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55388671e3160-wk-Fact-69F8B74A653B01BCA27B54B51AC908F0"
      unitRef="usd">70000000</us-gaap:SeveranceCosts1>
    <cah:FacilityExitAndOtherCosts
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55388671e3175-wk-Fact-8C1847879FAE0061B62F54B51ACA0482"
      unitRef="usd">33000000</cah:FacilityExitAndOtherCosts>
    <cah:FacilityExitAndOtherCosts
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55388671e3194-wk-Fact-C9E2BEFBB5AFFDA645F254B51ACBA305"
      unitRef="usd">27000000</cah:FacilityExitAndOtherCosts>
    <us-gaap:RestructuringCharges
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55388671e3219-wk-Fact-9EF350966CEAF3367B0F54B51AF25715"
      unitRef="usd">80000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55388671e3238-wk-Fact-DC1310CD717A52D67B3D54B51AEE96B6"
      unitRef="usd">97000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-2E8D4C6EC2FC0F11396054B51B48129D-0-wk-Fact-7EBC2C8310843AD5BF2754B51A8B3101">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes activity related to liabilities associated with restructuring and employee severance:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Related Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Facility Exit&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;and Other Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Additions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;57&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;67&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Payments and other adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;66&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;81&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d55388671e3403-wk-Fact-9374612369B64518B56C54B51AEA95A9"
      unitRef="usd">64000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d55388671e3422-wk-Fact-1EC0606BD071E079F13D54B51AECD835"
      unitRef="usd">8000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55388671e3441-wk-Fact-200209B7EFF702F1744654B51AE89CEC"
      unitRef="usd">72000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCosts
      contextRef="FD2020Q3YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d55388671e3457-wk-Fact-64FD1944C2F72AFFF44854B51AE92653"
      unitRef="usd">57000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="FD2020Q3YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d55388671e3476-wk-Fact-A478B474AD324F0E997D54B51AEA35A2"
      unitRef="usd">10000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55388671e3495-wk-Fact-605448ADFBA0727B91E654B51AECF951"
      unitRef="usd">67000000</us-gaap:RestructuringCosts>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2020Q3YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d55388671e3516-wk-Fact-C62FBA4A3DEEFC3F409154B51AEBCD6E"
      unitRef="usd">55000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2020Q3YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d55388671e3536-wk-Fact-6EAF200CDF97F8AB9A1C54B51AEA02D9"
      unitRef="usd">3000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55388671e3556-wk-Fact-F013728926B003766D4E54B51AE94E0F"
      unitRef="usd">58000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q3_us-gaap_RestructuringCostAndReserveAxis_us-gaap_EmployeeSeveranceMember"
      decimals="-6"
      id="d55388671e3583-wk-Fact-1FAA037A3C0C2D58318B54B51AEB66CB"
      unitRef="usd">66000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q3_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember"
      decimals="-6"
      id="d55388671e3602-wk-Fact-C396340CA2A70933B0B554B51AE8CB34"
      unitRef="usd">15000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55388671e3621-wk-Fact-9A40EC4BF9E19C7100B054B51AED9BAC"
      unitRef="usd">81000000</us-gaap:RestructuringReserve>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-B9AAA695C3EF59E20A7454B51B4ED97A-0-wk-Fact-9C042C70FA1EDB21769554B51B21A6C4">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;3. Goodwill and Other Intangible Assets&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the carrying amount of goodwill by segment and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:47%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,663&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,715&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,378&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,681&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,339&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Primarily due to the risks and uncertainties to the business from both the Recalls and the COVID-19 pandemic, we elected to bypass the qualitative assessment and perform interim goodwill impairment testing for the Medical Unit during the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. The carrying value of this reporting unit at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$10.1 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, of which &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$4.2 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; was goodwill. The fair value of the reporting unit was estimated to be approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; percent in excess of its carrying value, using a combination of the income-based approach (using a discount rate of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;8.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; percent and a terminal growth rate of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; percent), and the market-based approach.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Other Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize other intangible assets by class at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,746&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,798&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;329&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,604&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;730&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;874&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,822&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,805&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,017&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,844&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,805&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,039&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,045&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;295&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;377&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,602&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;616&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;986&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,836&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,858&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,430&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Total amortization of intangible assets was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$129 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$133 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March 31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$385 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$399 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. Estimated annual amortization of intangible assets for the remainder of fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; through &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2024&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; is as follows: &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$134 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$442 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$408 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$358 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$328 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-428EC5B21E53D0B0807054B51B4DDA13-0-wk-Fact-AE8D5293857D00EB7A1554B51B270653">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the carrying amount of goodwill by segment and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:47%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:20%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:11%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:12%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,663&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,715&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,378&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Goodwill acquired, net of purchase price adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign currency translation adjustments and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(34&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,658&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,681&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;8,339&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55397340e2860-wk-Fact-9E2D5463F5BD7135147754B51ABC3795"
      unitRef="usd">2663000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2019Q4_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55397340e2879-wk-Fact-BE15B290B5EF4C7D7DE154B51ABA9519"
      unitRef="usd">5715000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55397340e2898-wk-Fact-9D36BB887BD0C84BFA7054B51ABBB4F7"
      unitRef="usd">8378000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTransfers
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55397340e2914-wk-Fact-B4704929F44957BC1E8A54B51AB90260"
      unitRef="usd">-5000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55397340e2934-wk-Fact-FB513EB8578B0F8CDC1F54B51AB9295B"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55397340e2953-wk-Fact-2B4F456CE8032017719954B51AB9E390"
      unitRef="usd">-5000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55397340e2975-wk-Fact-272A62F0C4D1F9BA58AB54B51AAEF20F"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q3YTD_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55397340e2994-wk-Fact-4B4E69E6F4B81AA6407C54B51AAEF953"
      unitRef="usd">-34000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55397340e3014-wk-Fact-0E11A8143120509BD94F54B51AB9DE44"
      unitRef="usd">-34000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55397340e3041-wk-Fact-683C5AF325D76D696C9654B51ABA7C04"
      unitRef="usd">2658000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55397340e3060-wk-Fact-66859FDEF84036089A7E54B51AB6826E"
      unitRef="usd">5681000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e3079-wk-Fact-C7E07246F08963044A3354B51ABAEA3A"
      unitRef="usd">8339000000</us-gaap:Goodwill>
    <cah:CarryingValue
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalReportingUnitMember"
      decimals="-8"
      id="d55397340e3111-wk-Fact-C8E849B25B94BFC96605EB0B1E8CE237"
      unitRef="usd">10100000000</cah:CarryingValue>
    <us-gaap:Goodwill
      contextRef="FI2020Q3_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalReportingUnitMember"
      decimals="-8"
      id="d55397340e3115-wk-Fact-4595A8473CEB32428559EAD956F63347"
      unitRef="usd">4200000000</us-gaap:Goodwill>
    <us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
      contextRef="FI2020Q3"
      decimals="2"
      id="d55397340e3119-wk-Fact-AD32C5B19431B525FE43E62BC85AE0C4"
      unitRef="number">0.10</us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount>
    <cah:DiscountRatefairvalueinputs
      contextRef="FD2020Q3YTD"
      decimals="3"
      id="d55397340e3124-wk-Fact-DA55A9A8B57DF763F811EB0CBD071602"
      unitRef="number">0.085</cah:DiscountRatefairvalueinputs>
    <cah:TerminalGrowthRatefairvalueinputs
      contextRef="FD2020Q3YTD"
      decimals="2"
      id="d55397340e3128-wk-Fact-A2598F2A2DE6A3CADC8CF0ACB9EB1DB8"
      unitRef="number">0.02</cah:TerminalGrowthRatefairvalueinputs>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-2D37680A57CE5FBD6F3C54B51B4E5E07-0-wk-Fact-DF5096EA23AC28F4DE7C54B51AA85AE0">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables summarize other intangible assets by class at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="14"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted- Average Remaining Amortization Period (Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,544&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,746&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,798&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;674&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;329&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;345&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,604&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;730&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;874&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,822&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,805&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,017&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5,844&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2,805&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,039&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;N/A&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:14%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Intangible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Indefinite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;IPR&amp;amp;D, trademarks and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total indefinite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Definite-life intangibles:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Customer relationships&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,517&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,045&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Trademarks, trade names and patents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;672&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;295&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;377&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Developed technology and other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,602&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;616&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;986&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total definite-life intangibles&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,836&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,408&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5,858&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2,428&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,430&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember"
      decimals="-6"
      id="d55397340e3413-wk-Fact-A960D2CC4B7C7A74E97F54B51A9C91F4"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q3_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember"
      decimals="-6"
      id="d55397340e3451-wk-Fact-A960D2CC4B7C7A74E97F54B51A9C91F4"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e3477-wk-Fact-189E51B2AEA682835DEC54B51A9A3217"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e3515-wk-Fact-189E51B2AEA682835DEC54B51A9A3217"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d55397340e3690-wk-Fact-BF0B5C2292362B4F4D1A54B51A9CEC6E"
      unitRef="usd">3544000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d55397340e3709-wk-Fact-7EAF3BBF98752DDD878C54B51A9D980F"
      unitRef="usd">1746000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d55397340e3728-wk-Fact-31A55655725AF10248AE54B51A9E87CF"
      unitRef="usd">1798000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="FD2020Q3YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      id="d55397340e3748-wk-Fact-814510111174754E0DCC54B51A933062">P13Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d55397340e3759-wk-Fact-A318E469B916D15FF60F54B51A9DF05D"
      unitRef="usd">674000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d55397340e3778-wk-Fact-46C272FC37D8E470F05E54B51A9ED954"
      unitRef="usd">329000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d55397340e3797-wk-Fact-6FCDAE74B3ADC6B6240F54B51A9EF6A5"
      unitRef="usd">345000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="FD2020Q3YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      id="d55397340e3817-wk-Fact-C2D32B164ACA254D65D354B51A94242B">P13Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d55397340e3828-wk-Fact-FE6112E9F5BF4413223F54B51A9C9D4B"
      unitRef="usd">1604000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d55397340e3847-wk-Fact-6C056C4E95A47F8A31C354B51A9A2802"
      unitRef="usd">730000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q3_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d55397340e3866-wk-Fact-E43316CBDF1F39579B2454B51A9D69FC"
      unitRef="usd">874000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="FD2020Q3YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      id="d55397340e3886-wk-Fact-A4CD034E49FF2CB0F9A054B51A9B3A39">P11Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e3897-wk-Fact-F6418AD1C9C5928792C554B51A9C016B"
      unitRef="usd">5822000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e3916-wk-Fact-7DA35B595EC9DDCF929F54B51A936FD7"
      unitRef="usd">2805000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e3935-wk-Fact-375229C4F5C05C9F403E54B51A94A431"
      unitRef="usd">3017000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="FD2020Q3YTD"
      id="d55397340e3955-wk-Fact-0388697F6B0A16A6617E54B51A9BFD30">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e3972-wk-Fact-B58B650EC206FE4BF32154B51A92FFE9"
      unitRef="usd">5844000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e3991-wk-Fact-7DA35B595EC9DDCF929F54B51A936FD7"
      unitRef="usd">2805000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e4010-wk-Fact-DF9023B3C900129EC19254B51A9BBAAE"
      unitRef="usd">3039000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember"
      decimals="-6"
      id="d55397340e4255-wk-Fact-CBB2E79823FF155209FF54B51AAC6F40"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_cah_IPRDTrademarksandOtherMember"
      decimals="-6"
      id="d55397340e4293-wk-Fact-CBB2E79823FF155209FF54B51AAC6F40"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55397340e4309-wk-Fact-E61530679C07470AF70354B51AC07FC4"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55397340e4347-wk-Fact-E61530679C07470AF70354B51AC07FC4"
      unitRef="usd">22000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d55397340e4492-wk-Fact-F75EE4315EC2FD1BBC2154B51AC0D7B0"
      unitRef="usd">3562000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d55397340e4511-wk-Fact-6C2B259DA0A633E2836554B51AAE6439"
      unitRef="usd">1517000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember"
      decimals="-6"
      id="d55397340e4530-wk-Fact-69CA400469FD20C71A3A54B51AABBA5F"
      unitRef="usd">2045000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d55397340e4551-wk-Fact-0FA43F71938C97E50CE254B51ABD449F"
      unitRef="usd">672000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d55397340e4570-wk-Fact-D0858B709AA071A32ADD54B51AAD594A"
      unitRef="usd">295000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cah_TrademarksAndPatentsMember"
      decimals="-6"
      id="d55397340e4589-wk-Fact-5FBB1BC47741F2C2C8A654B51ABCED8B"
      unitRef="usd">377000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d55397340e4610-wk-Fact-6CEB79941F3FFF0CE69A54B51AC04EB9"
      unitRef="usd">1602000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d55397340e4629-wk-Fact-8B3BBA792D9680BA225754B51ABCCFD3"
      unitRef="usd">616000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-6"
      id="d55397340e4648-wk-Fact-76B8884B359940E3032554B51ABDA437"
      unitRef="usd">986000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55397340e4669-wk-Fact-2EC53CFC62D2BA6E4C3C54B51ABD96CD"
      unitRef="usd">5836000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55397340e4688-wk-Fact-18EAE26518A0B50C9F2454B51AC4FB7E"
      unitRef="usd">2428000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55397340e4707-wk-Fact-585DA04721449349DA8254B51AAD39C5"
      unitRef="usd">3408000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55397340e4734-wk-Fact-9CA9ED538358611A696F54B51ABDA8F2"
      unitRef="usd">5858000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55397340e4753-wk-Fact-18EAE26518A0B50C9F2454B51AC4FB7E"
      unitRef="usd">2428000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55397340e4772-wk-Fact-1A7362C68134E6FC48EF54B51ABAF87C"
      unitRef="usd">3430000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55397340e4800-wk-Fact-DD35D15212C44B59990F54B51B235092"
      unitRef="usd">129000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55397340e4804-wk-Fact-C2D7DA6FD1EB6C0D53E754B51B20AB43"
      unitRef="usd">133000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55397340e4816-wk-Fact-709D1581693A22214C4A54B51AA75015"
      unitRef="usd">385000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55397340e4821-wk-Fact-0F0BE5BFB1F2C07B2E7A54B51B22BEB3"
      unitRef="usd">399000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e4846-wk-Fact-90B0DBACB4EF0F342FCC54B51AA8D888"
      unitRef="usd">134000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e4850-wk-Fact-93A1F8C4D63A789ED03854B51AA9F1C8"
      unitRef="usd">442000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e4854-wk-Fact-232F19BC72A2C7F2F22A54B51B21C0D3"
      unitRef="usd">408000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e4858-wk-Fact-054C35274AE3B0F6FE3754B51B1FA7F3"
      unitRef="usd">358000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55397340e4862-wk-Fact-83615130CA238216CBA054B51AA88A5C"
      unitRef="usd">328000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-0B8FAF2D61B103EAE81D54B51B4EABFA-0-wk-Fact-6FCEC92FAA2868333EA054B51A904DDC">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;4. Investments&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In August 2018, we sold our &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;98 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; ownership interest in naviHealth Holdings, LLC ("naviHealth") to investor entities controlled by Clayton, Dubilier &amp;amp; Rice in exchange for cash proceeds of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$737 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (after adjusting for certain fees and expenses) and a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;44 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; equity interest in a partnership that owns &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;100 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of the equity interest of naviHealth. We also have certain call rights to reacquire naviHealth. We are accounting for this investment using the equity method of accounting and on a one-month reporting lag.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we recognized a pre-tax gain of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$508 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; related to this divestiture in impairments and (gain)/loss on disposal of assets in our condensed consolidated statements of earnings/(loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The carrying value of this investment was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$330 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$334 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; as of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. During the three and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, our proportionate share of naviHealth&#x2019;s net loss, which was recorded in other (income)/ expense, net in the condensed consolidated statements of earnings/(loss), was immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="I2018Q1navi_srt_OwnershipAxis_cah_NaviOwnershipInterestDivestedMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="2"
      id="d55391894e2758-wk-Fact-8DD8A040D7113622D0EC54B51A8E5F61"
      unitRef="number">0.98</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="D2019Q1Navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d55391894e2762-wk-Fact-A5CE0920F58E27AD659854B51A900787"
      unitRef="usd">737000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="2"
      id="d55391894e2766-wk-Fact-B1F83B5133096EA51E5454B51A8E5EC0"
      unitRef="number">0.44</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <cah:PartnershipIndirectOwnership
      contextRef="I2018Q1navi_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="2"
      id="d55391894e2770-wk-Fact-C597732D506FC98536D554B51A91E5FE"
      unitRef="number">1</cah:PartnershipIndirectOwnership>
    <cah:PreTaxGainonDivestiture
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d55391894e2785-wk-Fact-A66B8111D0F733B8A69454B51A8F2287"
      unitRef="usd">508000000</cah:PreTaxGainonDivestiture>
    <us-gaap:EquityMethodInvestments
      contextRef="FI2020Q3_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d55391894e2792-wk-Fact-1CAE451EDC56DC615D1154B51A90B2B5"
      unitRef="usd">330000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="FI2019Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d55391894e2796-wk-Fact-CF742F295EEB6A2ABC2E54B51A8FF8D4"
      unitRef="usd">334000000</us-gaap:EquityMethodInvestments>
    <cah:LeasesTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-0F700B5A6822366EC7EC54B51B4EFBAE-0-wk-Fact-340B2B904ED4F86574E154B51B23B5BB">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;5. Leases&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We primarily have operating leases for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Beginning July 1, 2019, operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our condensed consolidated balance sheet at commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our lease agreements include leases that contain lease components and non-lease components. For all asset classes, we have elected to account for both of these provisions as a single lease component.  We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the condensed consolidated financial statements at or for the three and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in the three and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; was not material. In addition, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing 1) whether any contracts are leases or contain leases, 2) lease classification and 3) initial direct costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our leases have remaining lease terms from less than &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;1 year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; up to approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;23 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the components of lease cost:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Variable lease cost&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Primarily includes payments for property taxes, maintenance and insurance. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes supplemental balance sheet information related to leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;469&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;Current portion of operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;Long-term operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;381&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;490&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Current portion of finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our condensed consolidated balance sheet. Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our condensed consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables summarizes supplemental cash flow information related to leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Financing cash flows paid for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Non-cash right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;New operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;154&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;New finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amended lease standard adoption impact as of July 1, 2019 &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Includes the effect of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$22 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our operating leases had a weighted-average remaining lease term of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;6.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; years and a weighted-average discount rate of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2.8 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Future lease payments under non-cancellable leases as of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; were as follows:&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;                          &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Remainder of 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;113&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;119&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;77&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;173&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;173&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total future lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;537&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;553&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: leases not yet commenced &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: imputed interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;490&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;504&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The future minimum rental payments for operating leases&#160;having initial or remaining non-cancelable lease terms in excess of one year at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; for fiscal &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; through &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2024&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and thereafter were as follows: &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$126 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$100 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$76 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$54 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$33 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$94 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;.&lt;/span&gt;&lt;/div&gt;</cah:LeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="FI2020Q3_srt_RangeAxis_srt_MinimumMember"
      id="d55406474e2768-wk-Fact-149523CBE92BA64CFB3254B51B242160">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="FI2020Q3_srt_RangeAxis_srt_MaximumMember"
      id="d55406474e2772-wk-Fact-E8E00571A7B505E3669754B51B27014C">P23Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-173B01AD0315A2C8802B54B51B4E0AB6-0-wk-Fact-3CB09E2252B753A3E44054B51B2A9CE4">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes the components of lease cost:&lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:22%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;31&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;92&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total finance lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Variable lease cost&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;37&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Primarily includes payments for property taxes, maintenance and insurance. &lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55406474e2883-wk-Fact-60673AC53C7D7E063E0A54B51AF26177"
      unitRef="usd">31000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55406474e2897-wk-Fact-6D2A1BE124587A0C8A8A54B51AF28194"
      unitRef="usd">92000000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55406474e2944-wk-Fact-2910123C93A15ADF34C454B51AF1FC12"
      unitRef="usd">1000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55406474e2958-wk-Fact-109E63D3E2B1EB4FD6D154B51AEF5598"
      unitRef="usd">9000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <cah:TotalFinanceLeaseCost
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55406474e2978-wk-Fact-0001F669F3AF4796886F54B51AF15983"
      unitRef="usd">1000000</cah:TotalFinanceLeaseCost>
    <cah:TotalFinanceLeaseCost
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55406474e2992-wk-Fact-15072FFC704E8C11E4EA54B51AEFBCE5"
      unitRef="usd">9000000</cah:TotalFinanceLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55406474e3014-wk-Fact-154676E5356448B8F9EE54B51AEE77F4"
      unitRef="usd">5000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55406474e3028-wk-Fact-FC996E61CD02653BAA7954B51AF2571D"
      unitRef="usd">17000000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55406474e3053-wk-Fact-C34538FA49F58E176A3A54B51AF1C0DB"
      unitRef="usd">37000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55406474e3067-wk-Fact-5D23F7A609635D58681154B51AEF444F"
      unitRef="usd">118000000</us-gaap:LeaseCost>
    <cah:LeasesSupplementalBalanceSheetInformationTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-31777E1D67404630656F54B51B4FDE38-0-wk-Fact-A3E671A5D8A88CCC496354B51B0D13C5">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes supplemental balance sheet information related to leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;469&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;Current portion of operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;109&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;&#160;Long-term operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;381&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;490&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;height:17px;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Current portion of finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</cah:LeasesSupplementalBalanceSheetInformationTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3155-wk-Fact-717C12B21F6CC4D08566E01224936888"
      unitRef="usd">469000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3191-wk-Fact-0707FDF1136E865C82F6E012253F4A6A"
      unitRef="usd">109000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3211-wk-Fact-55BCF7AEBCF69F22D4F8E01224BD3082"
      unitRef="usd">381000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3231-wk-Fact-A1E6C17FD87D760DDF4C54B51AC01451"
      unitRef="usd">490000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3293-wk-Fact-8A0177B6EAD626BDBB32E01224E6D8EA"
      unitRef="usd">13000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3335-wk-Fact-5B45F313784567877AA7E01224558581"
      unitRef="usd">4000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3355-wk-Fact-6ED37342CDF3736A3826E0122514D1F1"
      unitRef="usd">10000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3380-wk-Fact-16D4A11AAE04C2725E0C54B51AC336FC"
      unitRef="usd">14000000</us-gaap:FinanceLeaseLiability>
    <cah:LeasePaymentsTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-19A865949873EB0B44B054B51B4E79E8-0-wk-Fact-2B698AA366CCC04AA4FA54B51B043611">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following tables summarizes supplemental cash flow information related to leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:27%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Financing cash flows paid for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Non-cash right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;New operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;154&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;New finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amended lease standard adoption impact as of July 1, 2019 &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;400&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Includes the effect of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;$22 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt; from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance. &lt;/span&gt;&lt;/div&gt;</cah:LeasePaymentsTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55406474e3486-wk-Fact-1FF6F6E0A65E7283B5AB54B51AA0412B"
      unitRef="usd">95000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55406474e3501-wk-Fact-F3DBE81607A7C36F018254B51AA0E82B"
      unitRef="usd">4000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55406474e3541-wk-Fact-F6918C6F7F45CCF78A6254B51AA10B05"
      unitRef="usd">154000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55406474e3561-wk-Fact-A05332FCCE9C0940EEFF54B51AA05D5E"
      unitRef="usd">17000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <cah:Impactofadoptionofnewaccountingstandard
      contextRef="D2020Q1SD_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cah_ASC842Member"
      decimals="-6"
      id="d55406474e3585-wk-Fact-35283208ABA32FDFFBF754B51AA0D695"
      unitRef="usd">400000000</cah:Impactofadoptionofnewaccountingstandard>
    <cah:ReclassificationofdeferredrentinaccordancewithASC842
      contextRef="D2020Q1SD"
      decimals="-6"
      id="d55406474e3603-wk-Fact-70D0394C1E5C3C142E1A54B51A7F1779"
      unitRef="usd">22000000</cah:ReclassificationofdeferredrentinaccordancewithASC842>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="FI2020Q3"
      id="d55406474e3612-wk-Fact-8456AA7248535BF5C2D354B51B23CBBE">P6Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="FI2020Q3"
      decimals="3"
      id="d55406474e3616-wk-Fact-11BD9F8570C224DFE87F54B51A7F7899"
      unitRef="number">0.028</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-D86209777F7DD08B59C754B51B4E92E3-0-wk-Fact-29163A09E7757811515A54B51B278092">&lt;div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Future lease payments under non-cancellable leases as of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; were as follows:&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;                          &lt;/span&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Remainder of 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;29&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;30&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;113&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;119&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;99&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;77&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;54&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;55&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;173&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;173&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total future lease payments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;537&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;553&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: leases not yet commenced &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;sup style="vertical-align:top;line-height:120%;font-size:5pt"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: imputed interest&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;43&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;490&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;504&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d55406474e3727-wk-Fact-CB1DFFA82AB74F8B212D54B51AE0F329"
      unitRef="usd">29000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d55406474e3746-wk-Fact-FC6DF462D71A78F04DFE54B51AE15759"
      unitRef="usd">1000000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3765-wk-Fact-DC44398BB148A7D93D6A54B51AE3DBC9"
      unitRef="usd">30000000</cah:LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d55406474e3781-wk-Fact-67C49839B414199908B854B51AE230F4"
      unitRef="usd">113000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d55406474e3800-wk-Fact-82A76946AEF0993CD68E54B51AE41D9D"
      unitRef="usd">6000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <cah:LesseeLeaseLiabilityPaymentsDueYearTwo
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3819-wk-Fact-7CA435206A8950632C6154B51AE46A4B"
      unitRef="usd">119000000</cah:LesseeLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d55406474e3840-wk-Fact-5CF450A201BBAB8DFA5C54B51AE0A5BE"
      unitRef="usd">95000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d55406474e3859-wk-Fact-C82D947322B193E6D20454B51ADF26D2"
      unitRef="usd">4000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <cah:LesseeLeaseLiabilityPaymentsDueYearThree
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3878-wk-Fact-D440E73262ACE2CB40C854B51AE53FBF"
      unitRef="usd">99000000</cah:LesseeLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d55406474e3899-wk-Fact-F9C630E400069C0235FD54B51AE7C8D9"
      unitRef="usd">73000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d55406474e3918-wk-Fact-D45F80C4DB048F41D66D54B51AE3A965"
      unitRef="usd">4000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <cah:LesseeLeaseLiabilityPaymentsDueYearFour
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3937-wk-Fact-F0188ED92B9DA9D4779754B51ADC034E"
      unitRef="usd">77000000</cah:LesseeLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d55406474e3958-wk-Fact-034BEA3F04C525CAE40454B51AE0392D"
      unitRef="usd">54000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d55406474e3977-wk-Fact-007E5C80364F77129E0954B51ADD925C"
      unitRef="usd">1000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <cah:LesseeLeaseLiabilityPaymentsDueYearFive
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e3996-wk-Fact-7BC4920E9C20B71B36C354B51ADBD270"
      unitRef="usd">55000000</cah:LesseeLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d55406474e4017-wk-Fact-24E4F19326D9D2F938BF54B51AE291A7"
      unitRef="usd">173000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d55406474e4036-wk-Fact-0F82301524221228422254B51AE75E03"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e4055-wk-Fact-2A5E641B2F179A578A6E54B51AE56C0C"
      unitRef="usd">173000000</cah:LesseeLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d55406474e4076-wk-Fact-A838CC9ED69DAC73709754B51AE1710E"
      unitRef="usd">537000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d55406474e4095-wk-Fact-92DA04C43388454478DF54B51AE71902"
      unitRef="usd">16000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <cah:TotalLeaseLiabilityPaymentsDue
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e4114-wk-Fact-339B6E40FCAFD57C337B54B51AE31AE1"
      unitRef="usd">553000000</cah:TotalLeaseLiabilityPaymentsDue>
    <cah:LesseeOperatingLeaseLiabilityNotYetCommencedAmount
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d55406474e4139-wk-Fact-7BA2981E23928BEAA86954B51AE44323"
      unitRef="usd">4000000</cah:LesseeOperatingLeaseLiabilityNotYetCommencedAmount>
    <cah:LesseeFinanceLeaseLiabilityNotYetCommencedAmount
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d55406474e4158-wk-Fact-F4371FDFEA2295E1EAFF54B51ADD2288"
      unitRef="usd">0</cah:LesseeFinanceLeaseLiabilityNotYetCommencedAmount>
    <cah:TotalLeaseLiabilityNotYetCommencedAmount
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e4177-wk-Fact-7C41E5D57C3758FEE4A454B51AE8B204"
      unitRef="usd">4000000</cah:TotalLeaseLiabilityNotYetCommencedAmount>
    <cah:OperatingLeaseImputedInterest
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d55406474e4198-wk-Fact-9A9211425AC0F961306E54B51AE87871"
      unitRef="usd">43000000</cah:OperatingLeaseImputedInterest>
    <cah:FinanceLeaseImputedInterest
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d55406474e4217-wk-Fact-18E6865F1525974CDE1A54B51ADDF7C5"
      unitRef="usd">2000000</cah:FinanceLeaseImputedInterest>
    <cah:TotalLeaseLiabilityUndiscountedExcessAmount
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e4236-wk-Fact-21B003D0AAC15C69CEFE54B51AE3914A"
      unitRef="usd">45000000</cah:TotalLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_OperatingLeaseMember"
      decimals="-6"
      id="d55406474e4262-wk-Fact-5134E564BC1EB77B714D54B51ADC70D2"
      unitRef="usd">490000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="FI2020Q3_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cah_FinanceLeaseMember"
      decimals="-6"
      id="d55406474e4281-wk-Fact-D69B5329534D9DA2B6D954B51AE2E314"
      unitRef="usd">14000000</us-gaap:FinanceLeaseLiability>
    <cah:TotalLeaseLiability
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55406474e4300-wk-Fact-F24DC858FCB7D0EEFBD854B51AE34933"
      unitRef="usd">504000000</cah:TotalLeaseLiability>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55406474e4335-wk-Fact-5BDFC3A1686B1ED760B054B51A7FFD9A"
      unitRef="usd">126000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55406474e4339-wk-Fact-57F12B10BCAEDFFFB8D654B51B2989E4"
      unitRef="usd">100000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55406474e4344-wk-Fact-DCE5995520BBE9E2F97954B51B22107F"
      unitRef="usd">76000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55406474e4348-wk-Fact-2E8E6B739775003C52BC54B51B0D31F1"
      unitRef="usd">54000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55406474e4352-wk-Fact-C8FB2AABFA729C12234A54B51B2413F5"
      unitRef="usd">33000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55406474e4356-wk-Fact-0E28B44946A3B30B2EAE54B51A81ADCE"
      unitRef="usd">94000000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-DCA53FBDCD5F146A651D54B51B4F3130-0-wk-Fact-784723F619F9FCAF720654B51A889747">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-weight:bold;"&gt;6. Long-Term Obligations and Other Short-Term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Long-Term Debt and Other Short-Term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we had total long-term obligations, including the current portion and other short-term borrowings, of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;text-align:right;vertical-align:bottom;"&gt;&lt;span&gt;$7.3 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;text-align:right;vertical-align:bottom;"&gt;&lt;span&gt;$8.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. Interest is paid pursuant to the terms of the obligations. These obligations are effectively subordinated to the liabilities of our subsidiaries, including trade payables of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$22.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$21.5 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In November 2019, we repaid the full principal of the 2.4% Notes due 2019 at maturity for &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$450 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;"&gt;we early repurchased&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$247 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;2.616% Notes due 2022&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$11 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;  of the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;3.2% Notes due 2022&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$20 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of the  &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Floating Rate Notes due 2022&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$104 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;3.41% Notes due 2027&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;4.6% Notes due 2043&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of the  &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;4.9% Notes due 2045&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$35 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;4.368% Notes due 2047&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;. &lt;/span&gt;&lt;span style="font-family:Arial Narrow;"&gt;The repurchases were paid for with available cash and other short-term borrowings. In connection with the early debt repurchases, we recorded a&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$9 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;"&gt;loss on extinguishment of debt.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes long-term obligations and other short-term borrowings at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.76543209876543%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:59%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions) (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2.4% Notes due 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;450&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.625%&#160;Notes due 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;504&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2.616% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;834&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,079&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.2% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;236&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;247&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Floating Rate Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;321&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;340&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.2% Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;551&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.079% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;815&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;781&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.5% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;413&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;402&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.75% Notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;530&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;494&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.41% Notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,215&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.6% Notes due 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;340&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;346&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.5% Notes due 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.9% Notes due 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;441&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;445&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.368% Notes due 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;560&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;594&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;7.0%&#160;Debentures due 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;124&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;124&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other Obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7,262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: current portion of long-term obligations and other short-term borrowings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;452&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#160;&#160;&#160;Long-term obligations, less current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6,754&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7,579&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Maturities are presented on a calendar year basis. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Other Financing Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;commercial paper program backed by a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$2.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;revolving credit facility. We also have a&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$1.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&#160;committed receivables sales facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#x201c;CHF&#x201d;) through September 30, 2022. CHF was organized for&lt;/span&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. &lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;"&gt;Our revolving credit and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter through December 2020, a consolidated net leverage ratio of no more than 4.00-to-1. The maximum permitted ratio will reduce to 3.75-to-1 in March 2021 and as of the end of every quarter thereafter.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;"&gt;As of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;"&gt;, we were in compliance with this financial covenant.&lt;/span&gt;</us-gaap:DebtDisclosureTextBlock>
    <cah:TotalLongTermandShortTermObligations
      contextRef="FI2020Q3"
      decimals="-8"
      id="d55401591e2751-wk-Fact-0BC2E3599948DA6740B954B51A895C8E"
      unitRef="usd">7300000000</cah:TotalLongTermandShortTermObligations>
    <cah:TotalLongTermandShortTermObligations
      contextRef="FI2019Q4"
      decimals="-8"
      id="d55401591e2755-wk-Fact-7C934709BB9D643F238254B51A8F0334"
      unitRef="usd">8000000000.0</cah:TotalLongTermandShortTermObligations>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2020Q3"
      decimals="-8"
      id="d55401591e2761-wk-Fact-46E9531AEBC449D692BD54B51A89DD83"
      unitRef="usd">22000000000.0</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="FI2019Q4"
      decimals="-8"
      id="d55401591e2766-wk-Fact-20C1DD835ED6A7DD3DCEF1DCF74B8C21"
      unitRef="usd">21500000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="D2020Q2NotesPayable_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member"
      decimals="-6"
      id="d55401591e2781-wk-Fact-E24DF376B679FCCF4D5E54B51A8A6EAE"
      unitRef="usd">450000000</us-gaap:RepaymentsOfNotesPayable>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member"
      decimals="-6"
      id="d55401591e2800-wk-Fact-53B8739CC66E373345ED54B51A89BC7F"
      unitRef="usd">247000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member"
      decimals="-6"
      id="d55401591e2809-wk-Fact-DFD8179652FF6D5B5F2954B51A8BAE70"
      unitRef="usd">11000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member"
      decimals="-6"
      id="d55401591e2817-wk-Fact-EADC97498F00DBEFBEE054B51A8D0DAA"
      unitRef="usd">20000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member"
      decimals="-6"
      id="d55401591e2826-wk-Fact-E2861A83CEB441726BD754B51A8E652E"
      unitRef="usd">104000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member"
      decimals="-6"
      id="d55401591e2834-wk-Fact-ABCBE72BAAAC001D57C554B51A8C4356"
      unitRef="usd">6000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member"
      decimals="-6"
      id="d55401591e2842-wk-Fact-F31F37ABFFC5EF52E2AA54B51A8D4E7A"
      unitRef="usd">5000000</cah:NotesPayableRepurchased>
    <cah:NotesPayableRepurchased
      contextRef="FD2020Q3YTD_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member"
      decimals="-6"
      id="d55401591e2851-wk-Fact-176107B635169649FB3754B51A8D22E7"
      unitRef="usd">35000000</cah:NotesPayableRepurchased>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55401591e2864-wk-Fact-5F9B3DE83DE70A97FD6454B51AA69642"
      unitRef="usd">-9000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-42519092354AF2CA3B7154B51B4F542F-0-wk-Fact-A2D73F9C957D01F1784D54B51A8BDD07">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table summarizes long-term obligations and other short-term borrowings at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.76543209876543%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:59%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:18%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions) (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2.4% Notes due 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;450&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.625%&#160;Notes due 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;504&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2.616% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;834&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,079&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.2% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;236&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;247&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Floating Rate Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;321&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;340&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.2% Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;573&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;551&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.079% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;815&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;781&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.5% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;413&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;402&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.75% Notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;530&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;494&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;3.41% Notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,215&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,318&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.6% Notes due 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;340&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;346&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.5% Notes due 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.9% Notes due 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;441&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;445&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;4.368% Notes due 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;560&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;594&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;7.0%&#160;Debentures due 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;124&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;124&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other Obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7,262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Less: current portion of long-term obligations and other short-term borrowings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;452&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&#160;&#160;&#160;Long-term obligations, less current portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6,754&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;7,579&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Maturities are presented on a calendar year basis. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member"
      decimals="-6"
      id="d55401591e2950-wk-Fact-69DF84C99F3E481D632A54B51AF8ACB9"
      unitRef="usd">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.4Notesdue2020Member"
      decimals="-6"
      id="d55401591e2969-wk-Fact-6D9D7D6C8CF545C8705A54B51A7FABB3"
      unitRef="usd">450000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member"
      decimals="-6"
      id="d55401591e2984-wk-Fact-C126CF7120E4EB5D880954B51A83B8C9"
      unitRef="usd">504000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.625Notesdue2021Member"
      decimals="-6"
      id="d55401591e3003-wk-Fact-56A514E8AC59AC67896A54B51AF83DA5"
      unitRef="usd">508000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member"
      decimals="-6"
      id="d55401591e3023-wk-Fact-B8D3F9C58044035623DA54B51AEFCDE3"
      unitRef="usd">834000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A2.616Notesdue2022Member"
      decimals="-6"
      id="d55401591e3042-wk-Fact-D37A30A4490DDB811C9554B51AF0E94E"
      unitRef="usd">1079000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member"
      decimals="-6"
      id="d55401591e3062-wk-Fact-B7D8AFF0B5E77C786A0D54B51A85F85D"
      unitRef="usd">236000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2022Member"
      decimals="-6"
      id="d55401591e3081-wk-Fact-640A56A99B867DC5811A54B51AEE397F"
      unitRef="usd">247000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member"
      decimals="-6"
      id="d55401591e3101-wk-Fact-2A24B6294227CF8EE68654B51AFA7AE0"
      unitRef="usd">321000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_FloatingRateNotesdue2022Member"
      decimals="-6"
      id="d55401591e3120-wk-Fact-9F7C9FF898024EFF47F054B51AFA8DE1"
      unitRef="usd">340000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member"
      decimals="-6"
      id="d55401591e3140-wk-Fact-83CFA5DA0356624A7C0754B51AF08702"
      unitRef="usd">573000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.2Notesdue2023Member"
      decimals="-6"
      id="d55401591e3159-wk-Fact-99BBA8FBAC77694E871954B51AF10F5A"
      unitRef="usd">551000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member"
      decimals="-6"
      id="d55401591e3179-wk-Fact-138996D5A02CEA08E19E54B51AEDB5A4"
      unitRef="usd">815000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.079Notesdue2024Member"
      decimals="-6"
      id="d55401591e3198-wk-Fact-E94B95BEFBAA234B4DBF54B51A848133"
      unitRef="usd">781000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member"
      decimals="-6"
      id="d55401591e3218-wk-Fact-0BC7871F75E0A9A4E6E554B51A81164B"
      unitRef="usd">413000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.5Notesdue2025Member"
      decimals="-6"
      id="d55401591e3237-wk-Fact-5EB9DEA1C648E8FF453254B51A856926"
      unitRef="usd">402000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member"
      decimals="-6"
      id="d55401591e3257-wk-Fact-D30E214F960C1088B05854B51AEE88F1"
      unitRef="usd">530000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.75Notesdue2026Member"
      decimals="-6"
      id="d55401591e3276-wk-Fact-15597F4F683F2CD27A8054B51AFC9373"
      unitRef="usd">494000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member"
      decimals="-6"
      id="d55401591e3296-wk-Fact-C2AA5C33E75A02BCEB3454B51AF28C09"
      unitRef="usd">1215000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A3.41Notesdue2027Member"
      decimals="-6"
      id="d55401591e3315-wk-Fact-CF7FE6B5EFCF39B8E16454B51A84165D"
      unitRef="usd">1318000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member"
      decimals="-6"
      id="d55401591e3336-wk-Fact-45C1F7BBA5B6C5C8AEE154B51AFAC586"
      unitRef="usd">340000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.6Notesdue2043Member"
      decimals="-6"
      id="d55401591e3355-wk-Fact-3AC82D6FB37124BC7EC954B51AF2C4D5"
      unitRef="usd">346000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member"
      decimals="-6"
      id="d55401591e3375-wk-Fact-C5A9EF27AA16BF4B34ED54B51AF9E8CE"
      unitRef="usd">342000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.5Notesdue2044Member"
      decimals="-6"
      id="d55401591e3394-wk-Fact-32D9E3E7D9A406FC488F54B51AF94747"
      unitRef="usd">342000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member"
      decimals="-6"
      id="d55401591e3414-wk-Fact-F7855EA8B0E17321759454B51A8435D7"
      unitRef="usd">441000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.9Notesdue2045Member"
      decimals="-6"
      id="d55401591e3433-wk-Fact-02E7E9C8EEF993D8CAD654B51A839722"
      unitRef="usd">445000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member"
      decimals="-6"
      id="d55401591e3453-wk-Fact-F674C763678F593FE08254B51AEEADEA"
      unitRef="usd">560000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A4.368Notesdue2047Member"
      decimals="-6"
      id="d55401591e3472-wk-Fact-7EF12C52947C74501B7954B51AEE73CF"
      unitRef="usd">594000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2020Q3_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member"
      decimals="-6"
      id="d55401591e3492-wk-Fact-9699D5007CD5EAF4394754B51A849AA3"
      unitRef="usd">124000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="FI2019Q4_us-gaap_DebtInstrumentAxis_cah_A7.0Debenturesduefiscal2027Member"
      decimals="-6"
      id="d55401591e3511-wk-Fact-CACE11EBA70119B41B2F54B51A81436C"
      unitRef="usd">124000000</us-gaap:NotesPayable>
    <us-gaap:OtherBorrowings
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55401591e3531-wk-Fact-F92A91457FE871234BDD54B51AF8B733"
      unitRef="usd">14000000</us-gaap:OtherBorrowings>
    <us-gaap:OtherBorrowings
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55401591e3550-wk-Fact-7047502C41F68032420254B51A8034F7"
      unitRef="usd">10000000</us-gaap:OtherBorrowings>
    <cah:TotalLongTermandShortTermObligations
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55401591e3570-wk-Fact-876E2D6CDB4B8D100E8154B51A833BDA"
      unitRef="usd">7262000000</cah:TotalLongTermandShortTermObligations>
    <cah:TotalLongTermandShortTermObligations
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55401591e3589-wk-Fact-BADC2BDBA626C0961C4554B51A82B842"
      unitRef="usd">8031000000</cah:TotalLongTermandShortTermObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55401591e3609-wk-Fact-F497BA391D56252F1F4E54B51AECCD3B"
      unitRef="usd">508000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55401591e3628-wk-Fact-4F45C093DE0583F7701154B51AFE64C8"
      unitRef="usd">452000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55401591e3653-wk-Fact-576A5B650BA3491CB7A154B51AEBFBEF"
      unitRef="usd">6754000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55401591e3672-wk-Fact-044D800023AE5C22DF8254B51B003CF2"
      unitRef="usd">7579000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2020Q3_us-gaap_CreditFacilityAxis_us-gaap_CommercialPaperMember"
      decimals="-6"
      id="d55401591e3693-wk-Fact-F2DECE937EB8F0EA036B54B51A892FC0"
      unitRef="usd">2000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2020Q3_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember"
      decimals="-6"
      id="d55401591e3697-wk-Fact-F6D1E663806E8024631954B51A8AA975"
      unitRef="usd">2000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="FI2020Q3_us-gaap_CreditFacilityAxis_cah_ShortTermCreditFacilitiesMember_us-gaap_DebtInstrumentAxis_cah_CommittedReceivablesSalesFacilityProgramMember"
      decimals="-6"
      id="d55401591e3701-wk-Fact-6D80E77A338B3C75D1E054B51A8DCBBC"
      unitRef="usd">1000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-AEA7B073026C37E0D25354B51B4F4DD5-0-wk-Fact-CD4937FC2CBFC67A0E5854B51B109149">&lt;div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:16pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;7. Commitments, Contingent Liabilities and Litigation&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Generic Sourcing Venture with CVS Health Corporation ("CVS Health")&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In July 2014, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. Due to the achievement of predetermined milestones, we are required to make quarterly payments of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$45.6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; to CVS Health for the remainder of the initial term.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We become involved from time to time in disputes, litigation and regulatory matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We are named from time to time in &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;qui tam&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;qui tam&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information have led, and may in the future lead, to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;From time to time, we determine that products we manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions can lead to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, action by regulators and product liability claims and lawsuits, including class actions. Even absent an &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates. Except as otherwise disclosed in this footnote, it is not possible for us to reasonably estimate the amount of any possible loss or range of possible losses in the matters described below. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our condensed consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;"&gt;Opioid Lawsuits and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Pharmaceutical wholesale distributors, including us, have been named as defendants in over &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;3,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; lawsuits relating to the distribution of prescription opioid pain medications. The lawsuits seek equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as public nuisance, negligence and unjust enrichment as well as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. These lawsuits also name pharmaceutical manufacturers, retail pharmacy chains and other entities as defendants.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;States &amp;amp; Political Subdivisions&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;2,700&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; of these lawsuits have been filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The vast majority of these lawsuits were filed in U.S. federal court and have been transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#x201c;MDL&#x201d;).  &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In January 2020, the complaints of the Cabell County, West Virginia and the City of Huntington, West Virginia were remanded to U.S. District Court in West Virginia.  A trial date has been set in August 2020.  In addition, the complaints of San Francisco, California and the Cherokee Nation have been remanded to their original district courts, but no trial dates have been set.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In addition, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;25&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; state attorneys general have filed lawsuits against distributors, including us, in various state courts.  A trial in New York for cases brought by the New York State Attorney General and Nassau and Suffolk counties was scheduled to begin in March 2020, but was deferred due to the COVID-19 pandemic. Trial is scheduled to begin in October 2020 for a case brought by the Ohio State Attorney General and trial on a case brought by certain West Virginia political subdivisions is scheduled for March 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Additionally, we have received requests from a multi-state task force of state attorneys general, as well as separate civil investigative demands, subpoenas or requests for information from these and other state attorneys general offices and governmental authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In October 2019, we agreed in principle to a global settlement framework with a leadership group of state attorneys general that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions (the "Settlement Framework"). This Settlement Framework is subject to contingencies and uncertainties as to final terms, but is the basis for our negotiation of definitive terms and documentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The Settlement Framework includes (1) a cash &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;component&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, pursuant to which we would pay up to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.56 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; over &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;eighteen years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, (2) development and participation in a program for  distribution of opioid abuse treatment medications for a period of ten years, and (3) industry-wide changes to be specified to controlled substance anti-diversion programs. Definitive terms for a settlement pursuant to the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. In connection with these matters, we have &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.56 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; accrued at March 31, 2020, included in deferred income taxes and other liabilities in the condensed consolidated balance sheets, which represents the cash component. We are unable to reasonably estimate the liability or cost associated with the other components of the Settlement Framework, the potential distribution of treatment medications and any incremental costs for changes to our controlled substance anti-diversion program that we may agree to. We continue to negotiate the definitive terms of the Settlement Framework. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In the nine months ended March 31, 2020, we along with two other national distributors entered into a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$215 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; settlement with two Ohio counties, Cuyahoga and Summit, to resolve all claims in the first bellwether trial in the MDL, which had been set for trial for October 2019. In connection with this settlement, we incurred &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$66 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; within litigation (recoveries)/charges, net during the nine months ended March 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In connection with these matters, we recorded a total pre-tax charge of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$5.14 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; after tax) during the nine months ended March 31, 2020 in litigation (recoveries)/charges, net, in the condensed consolidated statement of earnings for the cash component. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We will regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual. We continue to strongly dispute the allegations made in these lawsuits and reaching an agreement in principle on a global settlement framework is not an admission of liability or wrongdoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Private Plaintiffs&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The Settlement Framework does not address claims by private plaintiffs, which includes unions and other health and welfare funds, &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;hospital systems and other healthcare providers, businesses and individuals. Private plaintiffs had brought approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;400&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; lawsuits as of May 4, 2020. Of these, &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;105&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs. We will continue to vigorously defend ourselves in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Department of Justice Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;We have received grand jury subpoenas issued on behalf of the District Courts for the Eastern District of New York and the District of Columbia seeking documents and, in the District of Columbia, testimony, related to our anti-diversion policies and procedures, and our distribution of certain controlled substances. We are cooperating with these requests.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Cordis Product Liability Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;As of May 4, 2020, we are named as a defendant in &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;309&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;3,924&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. Another &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;29&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; lawsuits involving similar claims by approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;34&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. We are vigorously defending ourselves in these lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, we had a total of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$466 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; accrued for losses and legal defense costs related to the Cordis IVC filter lawsuits, net of estimated insurance recoveries. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range to be approximately &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$900 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, net of estimated insurance recoveries.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Shareholder Securities Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In August 2019, the Louisiana Sheriffs' Pension &amp;amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. The complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. We believe that the claims asserted in this complaint are without merit and intend to vigorously defend against them. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Surgical Gown Recalls&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In January 2020, we issued a voluntary recall for &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;9.1 million&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; AAMI Level 3 surgical gowns and two voluntary field actions (a recall of some packs and a corrective action allowing overlabeling of other packs) for 2.9 million Presource Procedure Packs containing affected gowns (together, the "Recalls"). These Recalls were necessary &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;because we discovered in December 2019 that one of our FDA-registered suppliers in China had shifted production of some gowns to unapproved sites with uncontrolled manufacturing environments. Because of this, we could not assure sterility of the gowns. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In connection with these Recalls, in the nine months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;March 31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, we recorded total charges of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$95 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;, of which &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$55 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; is within cost of products sold and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$40 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; is within SG&amp;amp;A in the condensed consolidated statements of earnings/(loss). In our condensed consolidated balance sheet at March 31, 2020, we had &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$38 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; reserved within inventories, net, and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;$55 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt; included in other accrued liabilities related to this charge.  This charge represents our best estimate of costs for the Recalls and includes inventory write-off costs and certain remediation and supply disruption costs, such as costs to replace recalled products. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. The amount of ultimate loss may differ materially from this accrual. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In addition to the charge for the nine months ended March 31, 2020, the Recalls may have other negative impacts, which could include: government investigations and enforcement actions by the U.S. Food and Drug Administration or other regulators or U.S. or international governmental bodies (possibly resulting in the suspension or revocation of the authority to produce, distribute and sell products and other civil or criminal sanctions); losses due to patient claims, including product liability claims and lawsuits; and customer claims unrelated to their direct costs from the supply disruption. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Other Civil Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Generic Pharmaceutical Antitrust Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;In December 2019, pharmaceutical distributors including us were added as defendants in a civil multidistrict litigation consisting of multiple individual and class action lawsuits filed by indirect purchasers of generic drugs, such as hospitals and retail pharmacies. The plaintiffs allege that pharmaceutical distributors encouraged manufacturers to increase prices, provided anti-competitive pricing information to manufacturers and informed manufacturers that they wished to maintain current customer allocations for the purpose of avoiding price erosion. We intend to vigorously defend ourselves in these matters. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;"&gt;Blood Pressure Medication Recall Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Many participants in the pharmaceutical supply chain, including manufacturers, repackagers (including us), distributors (including us), and retailers have been named as defendants in Multidistrict Litigation in the U.S. District Court for the District of New Jersey (the &#x201c;Blood Pressure Medication Recall MDL&#x201d;), which was created in February 2019. The claims arise out of a series of recalls of generic blood pressure medications due to alleged impurities in active pharmaceutical ingredients. We intend to vigorously defend ourselves in these matters.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LongtermPurchaseCommitmentPeriod
      contextRef="FD2020Q3YTD_srt_MajorCustomersAxis_cah_CVSHealthMember"
      id="d55409962e2756-wk-Fact-B0D0493B0E52079CE4B454B51B0C85D0">P10Y</us-gaap:LongtermPurchaseCommitmentPeriod>
    <cah:MaximumQuarterlyPayment
      contextRef="FD2020Q3YTD_srt_MajorCustomersAxis_cah_CVSHealthMember"
      decimals="-5"
      id="d55409962e2760-wk-Fact-94C2A466E1C9E6EEDCF354B51B0FAA97"
      unitRef="usd">45600000</cah:MaximumQuarterlyPayment>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q3SD_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d55409962e2806-wk-Fact-E021A5FFC4929D5C255C54B51B0C39A0"
      unitRef="number">3000</cah:LossContingencyLawsuitsNumber>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q3SD_srt_LitigationCaseAxis_cah_OpioidLawsuitsStateDomain_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d55409962e2816-wk-Fact-E2472C2FD2C5370D83A554B51B0DEA93"
      unitRef="number">2700</cah:LossContingencyLawsuitsNumber>
    <cah:NumberofStateAttorneysGeneralfilinglawsuits
      contextRef="I2020Q3SD_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d55409962e2826-wk-Fact-8D5EDA93E8E6FF8E037C54B51B10A78D"
      unitRef="StateAG">25</cah:NumberofStateAttorneysGeneralfilinglawsuits>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember"
      decimals="-7"
      id="d55409962e2843-wk-Fact-5FFC1971F9D31BF771EB54B51B07910D"
      unitRef="usd">5560000000</us-gaap:LitigationReserve>
    <cah:CashComponentForSettlementFrameworkTerm
      contextRef="FD2020Q3YTD_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember"
      id="d55409962e2847-wk-Fact-CA8E8EEC260DEBF35FD654B51B0E13F1">P18Y</cah:CashComponentForSettlementFrameworkTerm>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q1_srt_LitigationCaseAxis_cah_OpioidLitigationlessCuyahogaandSummitCountiesMember"
      decimals="-7"
      id="d55409962e2851-wk-Fact-5FFC1971F9D31BF771EB54B51B07910D"
      unitRef="usd">5560000000</us-gaap:LitigationReserve>
    <cah:OpioidTotalSettlementCuyahogaandSummitCounties
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55409962e2859-wk-Fact-D1765D640457DB68A4AA54B51B0EA1DE"
      unitRef="usd">215000000</cah:OpioidTotalSettlementCuyahogaandSummitCounties>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q3YTD_srt_LitigationCaseAxis_cah_OpioidLitigationCuyahogaandSummitCountiesMember"
      decimals="-6"
      id="d55409962e2863-wk-Fact-71F828C2464664426B8654B51B108A43"
      unitRef="usd">-66000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q3YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-6"
      id="d55409962e2870-wk-Fact-4074F71F4572CF3082B854B51B0B8528"
      unitRef="usd">-5630000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q3YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationnetoftaxMember"
      decimals="-6"
      id="d55409962e2874-wk-Fact-4BD128957D98CF90040D54B51B10F8A1"
      unitRef="usd">-5140000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q3SD_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d55409962e2887-wk-Fact-F05CE517D6D623308ED3E1811BEADAE9"
      unitRef="lawsuit">400</cah:LossContingencyLawsuitsNumber>
    <cah:LossContingencyLawsuitsNumber
      contextRef="I2020Q3SD_cah_LawsuitTypeAxis_cah_ClassActionLawsuitsMember_cah_PlaintiffTypeAxis_cah_PrivatePartiesMember_srt_LitigationCaseAxis_cah_OpioidLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d55409962e2891-wk-Fact-DC67CE161EA97FB0275054B51B0F830E"
      unitRef="lawsuit">105</cah:LossContingencyLawsuitsNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="D2020Q3Litigation_us-gaap_LossContingenciesByNatureOfContingencyAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d55409962e2907-wk-Fact-96B6FFB7B4816969D9D454B51B116B33"
      unitRef="lawsuit">309</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="D2020Q3Litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_AlamedaCountyMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d55409962e2911-wk-Fact-BE9949E7B9A82BDDE6CA54B51B0AE624"
      unitRef="plaintiff">3924</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="D2020Q3Litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d55409962e2915-wk-Fact-4237C7DE4C97FEBE8C7F54B51B104343"
      unitRef="lawsuit">29</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="D2020Q3Litigation_srt_LitigationCaseAxis_cah_ProductLiabilityLawsuitsMember_srt_StatementGeographicalAxis_cah_OtherJurisdictionsMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember"
      decimals="0"
      id="d55409962e2919-wk-Fact-B77F475FE5D176CD2AA754B51B0A5F97"
      unitRef="plaintiff">34</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="FI2020Q3_srt_RangeAxis_srt_MinimumMember"
      decimals="-6"
      id="d55409962e2930-wk-Fact-256CF8EC9955AA71165954B51B0D764B"
      unitRef="usd">466000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="FI2020Q3_srt_RangeAxis_srt_MaximumMember"
      decimals="-6"
      id="d55409962e2934-wk-Fact-5598CA08763CAE642D0E54B51B105474"
      unitRef="usd">900000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:InventoryRecallExpense
      contextRef="FD2020Q3YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain"
      decimals="-6"
      id="d55409962e2965-wk-Fact-1A86236C670FA586A29154B51B0ED102"
      unitRef="usd">95000000</us-gaap:InventoryRecallExpense>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="FD2020Q3YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain"
      decimals="-6"
      id="d55409962e2969-wk-Fact-99336BCAC5265656600654B51B0ABF85"
      unitRef="usd">55000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="FD2020Q3YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain"
      decimals="-6"
      id="d55409962e2973-wk-Fact-DBDEE4599B890F4E355954B51B0FE685"
      unitRef="usd">40000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:InventoryNet
      contextRef="FI2020Q3_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain"
      decimals="-6"
      id="d55409962e2977-wk-Fact-AFD49B57CB98132521F354B51B0C7047"
      unitRef="usd">38000000</us-gaap:InventoryNet>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="FI2020Q3_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain"
      decimals="-6"
      id="d55409962e2982-wk-Fact-B5FAE13621BBCF652EC854B51B094256"
      unitRef="usd">55000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-EEEB26D000FD0FF6C5EA54B51B4F85C5-0-wk-Fact-C7BFCDAEDDEE8941DA9754B51A893ED8">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;8. Income Taxes&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Fluctuations in our provision for/(benefit from) income taxes as a percentage of pretax earnings (&#x201c;effective tax rate&#x201d;) are generally due to changes in international and U.S. state effective tax rates resulting from our business mix and discrete items. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Opioid Settlement Framework&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; pre-tax charge for the opioid litigation, during the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; we recorded a tax benefit of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$487 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which is net of unrecognized tax benefits of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$468 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the U.S. Tax Cuts and Jobs Act ("Tax Act"). Further, it is possible that the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See &lt;/span&gt;&lt;a href="#s8AD44EFDC5135A2C93CB707A0F4CCE02" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for more information regarding these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Effective Tax Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the three months ended&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;and&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the effective tax rate was&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;26.8&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; percent and&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;20.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;percent, respectively. The increase in the effective tax rate from the prior period was &lt;/span&gt;&lt;span style="color:#000000;font-family:Arial Narrow;font-size:10pt;"&gt;primarily due to changes in discrete tax items and jurisdictional mix.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;and&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the effective tax rate was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;5.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;percent and&#160;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;22.6&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&#160;percent, respectively.  The decrease in the effective tax rate from fiscal 2019 to fiscal 2020 was primarily due to the net tax effects of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;the Settlement Framework.  &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Unrecognized Tax Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we had &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$919 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$456 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of unrecognized tax benefits, respectively. The &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; balances include &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$772 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$303 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of unrecognized tax benefits, respectively, that if recognized, would have an impact on the effective tax rate. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we had &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$137 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$122 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, accrued for the payment of interest and penalties related to unrecognized tax benefits, which we recognize in the provision for/(benefit from) income taxes in the condensed consolidated statements of earnings/(loss). These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of IRS and other audit issues, &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is between &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;zero&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and a net decrease of up to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$350 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, exclusive of penalties and interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;"&gt;Other Tax Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2008&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including IRS challenges to our international transfer pricing for the periods from 2008 to 2014, and it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), a subsidiary of Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$173 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$165 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, and is included in other assets in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition under the purchase agreement. The indemnification receivable was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$18 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$22 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, and is included in other assets in the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Future adjustments to the financial statements may be necessary as final tax regulations related to U.S. Tax Reform are issued. We will assess any impact as additional guidance is issued.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:LitigationReserve
      contextRef="FI2020Q3_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-7"
      id="d55413243e2749-wk-Fact-C827D709C763425D03DB54B51A88875B"
      unitRef="usd">5630000000</us-gaap:LitigationReserve>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="FD2020Q3YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-6"
      id="d55413243e2761-wk-Fact-7230EA700241F1F8918C54B51A87BD2B"
      unitRef="usd">-487000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="FI2020Q3_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-6"
      id="d55413243e2765-wk-Fact-4FCB10BF91AD0D13034054B51A87502E"
      unitRef="usd">468000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2020Q3QTD"
      decimals="3"
      id="d55413243e2789-wk-Fact-01BA2776369D9207C6BE54B51A8816D3"
      unitRef="number">0.268</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2019Q3QTD"
      decimals="3"
      id="d55413243e2793-wk-Fact-DD56625A8904CED45E6054B51A8AFEBE"
      unitRef="number">0.200</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2020Q3YTD"
      decimals="3"
      id="d55413243e2815-wk-Fact-82538175F53CC6D699BA54B51A8A6D48"
      unitRef="number">0.052</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="FD2019Q3YTD"
      decimals="3"
      id="d55413243e2819-wk-Fact-E251B4E4C6963D13977D54B51A8BB32A"
      unitRef="number">0.226</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55413243e2840-wk-Fact-B85D73606C7939B57FE954B51A8EBEAD"
      unitRef="usd">919000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55413243e2844-wk-Fact-6EBF8C0B00379729DEF2E1285D422880"
      unitRef="usd">456000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55413243e2857-wk-Fact-C88C341DFB9362BA9E1D54B51A88023D"
      unitRef="usd">772000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55413243e2861-wk-Fact-98458148AC76AFA9363BE128D24823EE"
      unitRef="usd">303000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55413243e2876-wk-Fact-40FCE5C055A1AEFFA81A54B51A8B2C57"
      unitRef="usd">137000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55413243e2880-wk-Fact-FD7E8DB15020819F909354B51A8A2DF6"
      unitRef="usd">122000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="FI2020Q3_srt_RangeAxis_srt_MinimumMember"
      decimals="-6"
      id="d55413243e2891-wk-Fact-C2705F220CD3515ECB3054B51A89B5EA"
      unitRef="usd">0</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="FI2020Q3_srt_RangeAxis_srt_MaximumMember"
      decimals="-6"
      id="d55413243e2895-wk-Fact-A3F93B9831A9998A560954B51A87031E"
      unitRef="usd">350000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:OpenTaxYear
      contextRef="FD2020Q3QTD_srt_RangeAxis_srt_MinimumMember_us-gaap_IncomeTaxAuthorityAxis_us-gaap_InternalRevenueServiceIRSMember"
      id="d55413243e2905-wk-Fact-02410FD87281CEBF97F054B51A8CD491">2008</us-gaap:OpenTaxYear>
    <cah:IndemnificationReceivable
      contextRef="FI2020Q3_cah_TaxMatterAxis_cah_CareFusionMember"
      decimals="-6"
      id="d55413243e2912-wk-Fact-DA4A0939B682249FBE4054B51A8A6419"
      unitRef="usd">173000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="FI2019Q4_cah_TaxMatterAxis_cah_CareFusionMember"
      decimals="-6"
      id="d55413243e2916-wk-Fact-F578E75BE509975E08FA54B51A879A7B"
      unitRef="usd">165000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="FI2020Q3_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember"
      decimals="-6"
      id="d55413243e2931-wk-Fact-E4970FDF0EEB181977C454B51A8A894C"
      unitRef="usd">18000000</cah:IndemnificationReceivable>
    <cah:IndemnificationReceivable
      contextRef="FI2019Q4_cah_TaxMatterAxis_cah_PatientRecoveryBusinessMember"
      decimals="-6"
      id="d55413243e2935-wk-Fact-21514D2926A043637CE354B51A87E127"
      unitRef="usd">22000000</cah:IndemnificationReceivable>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-3F862220C2F0F3511DC254B51B4F2568-0-wk-Fact-2CB425C6EB7D863CE86954B51A9A7D30">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;9. Fair Value Measurements&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;647&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;647&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;170&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;170&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;The fair value of interest rate swaps, foreign currency contracts, commodity contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the condensed consolidated balance sheets.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-63C2F2612879A6E0161454B51B4F48E3-0-wk-Fact-2703BAD0E8206E26477454B51A9E43CE">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;647&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;647&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;170&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;170&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:10%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Level&#160;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;297&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other investments (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;118&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Forward contracts (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;The fair value of interest rate swaps, foreign currency contracts, commodity contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the condensed consolidated balance sheets.</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3044-wk-Fact-4177FE15403B2396930D54B51ACF5DF7"
      unitRef="usd">647000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3063-wk-Fact-F8AE24940C2BB0BBF13154B51ACD99BC"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3082-wk-Fact-A531C885AE0854C4C7B054B51ACEC2E6"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3102-wk-Fact-B07DD9D2484518F3CB3954B51ACE133D"
      unitRef="usd">647000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3117-wk-Fact-739AFDDABCE1CC45641454B51ACC6F30"
      unitRef="usd">96000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3136-wk-Fact-A12910F2D5457BBD73E054B51AC965D1"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3155-wk-Fact-B26E0E38D4E6BBF4422B54B51ACC8679"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3175-wk-Fact-AC74E3BB9261595DE62354B51ACD23DD"
      unitRef="usd">96000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3195-wk-Fact-9E606EB3C7C5F052FB0C54B51AC98A73"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3214-wk-Fact-223A62BA8E65C7F1F5A854B51ACA4FA3"
      unitRef="usd">170000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3233-wk-Fact-874D2CB42B657D6159B454B51ACC884F"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2020Q3_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3253-wk-Fact-3355794C6F41C663B8F454B51ACBBED7"
      unitRef="usd">170000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3548-wk-Fact-0F84D4DD99AE3296A07154B51A80FE8F"
      unitRef="usd">297000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3567-wk-Fact-596BC5A2C56521B73ABA54B51B19625D"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3586-wk-Fact-9B536B22A45AB70E80A454B51B218A00"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="FI2018Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3606-wk-Fact-FF3D1C921AB3BAE69E7C54B51B24779E"
      unitRef="usd">297000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3621-wk-Fact-C57DBE0667B5A449A5E054B51A910000"
      unitRef="usd">118000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3640-wk-Fact-DD2B6905E86F3DBDC47854B51A91E324"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3659-wk-Fact-2D9492C6527B92B44AD754B51A8FE14C"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3679-wk-Fact-C13B0FD54FF2B38E803254B51A922444"
      unitRef="usd">118000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3699-wk-Fact-73D8D1B46D584134544654B51A909E27"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3718-wk-Fact-9657D4A53587C630C62454B51A8F57B7"
      unitRef="usd">53000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3737-wk-Fact-667F475675469E29F98954B51A912D3C"
      unitRef="usd">0</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="FI2019Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-6"
      id="d55421030e3757-wk-Fact-1B88FD3D6E189A1E9CCD54B51A91C734"
      unitRef="usd">53000000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-70E496C87DD5F1C7F30A54B51B4F7F55-0-wk-Fact-914DC504A1829D3CCC5D54B51AD24F98">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;10. Financial Instruments&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to fair value through earnings at the end of each period. We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are rated investment grade or better. We do not have significant exposure to any one counterparty and we believe the risk of loss is remote. Additionally, we do not require collateral under these agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Interest Rate Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes in interest rates. In addition, we enter into interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Currency Exchange Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce volatility in earnings, cash flow and net investments in certain subsidiaries to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Commodity Price Risk Management&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Fair Value Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense in the condensed consolidated statements of earnings. For the three and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, there was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; gain or loss recorded to interest expense as changes in the market value of our derivative instruments offset changes in the market value of the underlying debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, no new pay-floating interest rate swaps were executed. In connection with the debt redemption  as described in &lt;/span&gt;&lt;a href="#sC01B26F4270953278E0B2F0FA5E5852A" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 6&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, two pay-floating interest rate swaps with notional amounts of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$200 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; matured in the second quarter of fiscal 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of other comprehensive income/(loss) and reclassified into earnings in the &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we entered into forward interest rate swaps with a total notional amount of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$200 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; to hedge probable, but not firmly committed, future transactions associated with our debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Gains and losses recognized in accumulated other comprehensive loss and reclassified into earnings were immaterial for the three and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. All gains and losses currently included within accumulated other comprehensive loss associated with our foreign exchange forward contracts that are expected to be reclassified into net earnings within the next 12 months are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Net Investment Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In August 2019, we entered into a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;&#xa5;64.0 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$600 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;) cross-currency swap maturing in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In September 2018, we entered into a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;&#x20ac;200 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$233 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;) cross-currency swap maturing in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive loss until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings.&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Economic (Non-Designated) Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. We recorded a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$8 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; expense during the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively. The principal currencies managed through foreign currency contracts are the euro, Canadian dollar, British pound, Japanese yen, and Chinese renminbi.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The carrying amounts of cash and equivalents, trade receivables, accounts payable and other accrued liabilities at &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; approximate fair value due to their short-term maturities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:26%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Estimated fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7,211&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,065&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Carrying amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7,262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55416729e2780-wk-Fact-AD19C04A41A94AEC80AC54B51AA57EC3"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount
      contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember"
      decimals="-6"
      id="d55416729e2804-wk-Fact-1053ED9A8CA33FEAC1C054B51AD28D24"
      unitRef="usd">200000000</cah:DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CashFlowHedgingMember"
      decimals="-6"
      id="d55416729e2829-wk-Fact-522E21F8F49AD4E220EE54B51ACEE1EA"
      unitRef="usd">200000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-6"
      id="d55416729e2857-wk-Fact-C7638E4E29FD4AE84E6B54B51ACF6CB6"
      unitRef="jpy">64000000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2020Q3_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-6"
      id="d55416729e2861-wk-Fact-83A15CB947A060B6B89F54B51AD187B2"
      unitRef="usd">600000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-6"
      id="d55416729e2868-wk-Fact-D526AE510231D806874454B51AA3ECDB"
      unitRef="eur">200000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="FI2019Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_CurrencySwapMember"
      decimals="-6"
      id="d55416729e2872-wk-Fact-9D70F4DC0981FA9BAC8054B51AC8AADF"
      unitRef="usd">233000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="FD2020Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember"
      decimals="-6"
      id="d55416729e2888-wk-Fact-9F8AEBC21689F245E51054B51AD0770B"
      unitRef="usd">-7000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="FD2019Q3YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember_us-gaap_IncomeStatementLocationAxis_us-gaap_OtherNonoperatingIncomeExpenseMember"
      decimals="-6"
      id="d55416729e2892-wk-Fact-A029E17225F1F55C753C54B51AA3FA9F"
      unitRef="usd">-8000000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-19DA682266FFD3F0868254B51B508DB4-0-wk-Fact-7BCE65CE307DE6BE530154B51ACF7878">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:43%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:26%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Estimated fair value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7,211&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,065&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Carrying amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;7,262&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8,031&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="FI2020Q3_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-6"
      id="d55416729e3000-wk-Fact-9D30B9B2ECE9975B501D54B51AC1E146"
      unitRef="usd">7211000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="FI2019Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member"
      decimals="-6"
      id="d55416729e3019-wk-Fact-5E5AFAC1D3BC81CE4FB654B51AB08D15"
      unitRef="usd">8065000000</us-gaap:DebtInstrumentFairValue>
    <cah:CarryingAmountofLongTermandotherShortTermBorrowings
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55416729e3034-wk-Fact-F06326DCBCE66A30CB8454B51AB088D3"
      unitRef="usd">7262000000</cah:CarryingAmountofLongTermandotherShortTermBorrowings>
    <cah:CarryingAmountofLongTermandotherShortTermBorrowings
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55416729e3053-wk-Fact-5852226AE5E3DDC3B94854B51AAF0C91"
      unitRef="usd">8031000000</cah:CarryingAmountofLongTermandotherShortTermBorrowings>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-2243CEB78CC4CB88476854B51B500922-0-wk-Fact-B1982CA5FA460EBF9D0454B51AFBE75B">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;11. Shareholders' Equity&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we repurchased &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;7.3 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; common shares having an aggregate cost of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$350 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.  The average price paid per common share was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$48.00&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. These repurchases were made under an accelerated share repurchase ("ASR") program, which began on &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;August&#160;20, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and was completed on &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;December&#160;4, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;During the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we repurchased &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;11.5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; common shares having an aggregate cost of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$600 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. The average price paid per common share was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$52.32&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We funded the repurchases with available cash and short-term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gain/(Loss) on&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Derivatives,&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprehensive&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive loss, before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(57&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive loss, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(130&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(141&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d55424723e2762-wk-Fact-E49486C423693175141B54B51AE4649C"
      unitRef="shares">7300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55424723e2766-wk-Fact-74D3B12AD2E710ABEBFA54B51B02D142"
      unitRef="usd">350000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="2"
      id="d55424723e2770-wk-Fact-C596FCC85962378A16DB54B51AE127C8"
      unitRef="usdPerShare">48.00</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <cah:TreasuryStockAcquiredShares
      contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="-5"
      id="d55424723e2794-wk-Fact-56A34E8B7DACC10294FC54B51AE2E26D"
      unitRef="shares">11500000</cah:TreasuryStockAcquiredShares>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55424723e2798-wk-Fact-D90329078A87441BCC3254B51ABCA990"
      unitRef="usd">600000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="FD2019Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember"
      decimals="2"
      id="d55424723e2802-wk-Fact-9C231AF5B47D86A4C69D54B51AE51258"
      unitRef="usdPerShare">52.32</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-FF6EF8A2FEA500E32B9054B51B50B3CF-0-wk-Fact-827497D03AA82817CB0A54B51AE4C57B">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:16%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:15%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Gain/(Loss) on&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Derivatives,&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Accumulated Other&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprehensive&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Balance at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(95&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;16&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(79&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive loss, before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(22&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(57&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Amounts reclassified to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Other comprehensive loss, net of tax&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(35&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(62&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(130&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(11&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(141&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e2941-wk-Fact-5B54A947EFBD717E673D54B51B118A90"
      unitRef="usd">-95000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e2961-wk-Fact-AAD30A35F05C7429185C54B51B126855"
      unitRef="usd">16000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2019Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e2980-wk-Fact-A3EB249D21ED5C6323B854B51B2633BF"
      unitRef="usd">-79000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e2997-wk-Fact-CCBBA030CB3FF1DFBA9554B51AA275CA"
      unitRef="usd">-35000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e3017-wk-Fact-1C1C9629427C1F98B33A54B51AA4F8B7"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55424723e3037-wk-Fact-86A7BBA93AFFF759A7CE54B51B1BA19F"
      unitRef="usd">-57000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e3059-wk-Fact-D4635A2A07CF52A2853554B51A88C440"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e3078-wk-Fact-243C80AEE697367C1A7654B51AA4F50D"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-6"
      id="d55424723e3098-wk-Fact-7BB592B87C926646CB5F54B51A87704D"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e3120-wk-Fact-AF04F91587175ACDDF1754B51A8723C6"
      unitRef="usd">-35000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e3140-wk-Fact-5E701692EAFEFC172F9354B51B1223CC"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="FD2020Q3YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e3160-wk-Fact-E8D56A7FA19C524BBEB054B51A900516"
      unitRef="usd">-62000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e3187-wk-Fact-D816F62218451721D23D54B51AA6878C"
      unitRef="usd">-130000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e3207-wk-Fact-80FF37689761E59475A854B51A8E909E"
      unitRef="usd">-11000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="FI2020Q3_us-gaap_StatementEquityComponentsAxis_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"
      decimals="-6"
      id="d55424723e3227-wk-Fact-2FAB4B569AB9C979248A54B51B13A8CF"
      unitRef="usd">-141000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-1FA098C00422BFC8EE2554B51B50122A-0-wk-Fact-9D8129D2C5DABCEA320F54B51B030AD3">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;12. Earnings Per Share Attributable to Cardinal Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average common shares&#x2013;basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;298&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock options, restricted share units and performance share units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-average common shares&#x2013;diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;294&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;299&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average common shares&#x2013;basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;301&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock options, restricted share units and performance share units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-average common shares&#x2013;diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;302&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;7 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; (&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;2 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of which were anti-dilutive as a result of the year-to-date net loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive were &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;6 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; during both the three months and the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-248DC63518384E29A52854B51B50AD83-0-wk-Fact-4B22FF1CBB4628F4F48554B51B04E8AE">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average common shares&#x2013;basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;292&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;298&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock options, restricted share units and performance share units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-average common shares&#x2013;diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;294&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;299&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:70%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average common shares&#x2013;basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;301&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock options, restricted share units and performance share units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-average common shares&#x2013;diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;293&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;302&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55428392e2830-wk-Fact-0B26D6B638400FB2D18454B51B21CD14"
      unitRef="shares">292000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55428392e2844-wk-Fact-556A52112788EC9E118654B51A8B31D9"
      unitRef="shares">298000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55428392e2890-wk-Fact-40BF9DB5D5A0E28A68E654B51A868F2C"
      unitRef="shares">2000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55428392e2904-wk-Fact-D49C018021FF1964259E54B51A858CE5"
      unitRef="shares">1000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55428392e2919-wk-Fact-3C5E39C3EF23C07BA0ED54B51A99B73A"
      unitRef="shares">294000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55428392e2933-wk-Fact-74BC951CA67E200BA9E754B51AFCDAED"
      unitRef="shares">299000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55428392e3022-wk-Fact-F2F36F531E2C061568FA54B51A8E1510"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55428392e3036-wk-Fact-5535B20D9FD47662E0D254B51AAC6E51"
      unitRef="shares">301000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55428392e3082-wk-Fact-C10882DD0B920FFC2F9754B51AFCEB69"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55428392e3096-wk-Fact-257B3B89F8587BA6054B54B51AFE1DC0"
      unitRef="shares">1000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55428392e3111-wk-Fact-F6D925A67782C67F989554B51A86E258"
      unitRef="shares">293000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55428392e3125-wk-Fact-526E27FF304324D2092354B51B2388DA"
      unitRef="shares">302000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55428392e3140-wk-Fact-48D455F9A31C6FF315FD54B51B039F3E"
      unitRef="shares">4000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55428392e3148-wk-Fact-693F81673B332CCC726754B51B04EDBE"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <cah:Sharesthatwouldbeantidilutiveasaresultofnetloss
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55428392e3161-wk-Fact-D4F22345D5D7B7E632DE54B51B034379"
      unitRef="shares">2000000</cah:Sharesthatwouldbeantidilutiveasaresultofnetloss>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55428392e3168-wk-Fact-6325C9A92A956A26788154B51B06A135"
      unitRef="shares">6000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-E665B3A49B67D80F1C1254B51B50AA3C-0-wk-Fact-9072B05275E067C849BF54B51B286C33">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;13. Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our operations are principally managed on a products and services basis and are comprised of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;two&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; operating segments, which are the same as our reportable segments: Pharmaceutical and Medical. The factors for determining the reportable segments include the manner in which management evaluates performance for purposes of allocating resources and assessing performance combined with the nature of the individual business activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers; and repackages generic pharmaceuticals and over-the-counter healthcare products. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Our Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. In addition to distributing Cardinal Health branded products, this segment also distributes a broad range of national brand products and provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers in the United States and Canada. This segment also distributes medical products to patients' homes in the United States through our Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present revenue for each reportable segment and disaggregated revenue within our two reportable segments and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;34,899&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;31,146&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;215&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;35,112&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;31,361&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,539&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,431&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;512&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;440&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4,051&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,871&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39,163&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;35,232&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39,157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;35,228&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;103,612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;95,888&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;642&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;104,254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;96,516&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10,483&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10,339&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,339&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11,991&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11,678&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;116,245&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;108,194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;116,233&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;108,181&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services."&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present revenue by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:3%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;38,073&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;34,230&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,090&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,002&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39,163&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;35,232&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39,157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;35,228&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:3%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;113,053&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;105,190&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,192&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,004&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;116,245&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;108,194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;116,233&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;108,181&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;"&gt;Segment Profit&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We evaluate segment performance based on segment profit, among other measures. Segment profit is segment revenue, less segment cost of products sold, less segment distribution, selling, general and administrative ("SG&amp;amp;A") expenses. Segment SG&amp;amp;A expenses include share-based compensation expense as well as allocated corporate expenses for shared functions, including corporate management, corporate finance, financial, and customer care shared services, human resources, information technology, and legal and compliance, including certain litigation defense costs. Corporate expenses are allocated to the segments based on headcount, level of benefit provided and other ratable allocation methodologies. The results attributable to noncontrolling interests are recorded within segment profit.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We do not allocate the following items to our segments: last-in first-out, or ("LIFO"), inventory charges/(credits); surgical gown recall costs; restructuring and employee severance; amortization and other acquisition-related costs; impairments and (gain)/loss on disposal of assets; litigation (recoveries)/charges, net; state opioid assessment related to prior fiscal years; other (income)/expense, net; interest expense, net; loss on extinguishment of debt; and provision for income taxes. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In addition, certain investment spending, certain portions of enterprise-wide incentive compensation and other spending are not allocated to the segments. Investment spending generally includes the first-year spend for certain projects that require incremental investments in the form of additional operating expenses. Because approval for these projects is dependent on executive management, we retain these expenses at Corporate. Investment spending within Corporate was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$17 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for both the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$37 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$36 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the opioid litigation as discussed further in &lt;/span&gt;&lt;a href="#s054B3015E6505AB9825D03C656BE42ED" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we recognized a pre-tax charge of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$5.63 billion&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; during the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which was retained at Corporate. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the surgical gown recall as discussed further in &lt;/span&gt;&lt;a href="#s054B3015E6505AB9825D03C656BE42ED" style="font-family:Arial Narrow;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;Note 7&lt;/span&gt;&lt;/a&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, we recognized a pre-tax charge of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$95 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; during the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; which was retained at Corporate. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;In connection with the naviHealth divestiture, we recognized a pre-tax gain of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$508 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; during the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which was retained at Corporate. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present segment profit by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;534&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;536&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment profit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;712&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(259&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total operating earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;432&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,394&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,388&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;543&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment profit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,937&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,867&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(6,305&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(115&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total operating earnings/(loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4,368&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents total assets for each reportable segment and Corporate at: &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:16pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#d1d1d1;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22,508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#d1d1d1;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22,446&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15,445&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,284&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,195&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,233&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;41,148&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;40,963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:16pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="FD2020Q3YTD"
      decimals="0"
      id="d55446147e2741-wk-Fact-D631E556B9E4628A959C54B51B269C22"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-3582EC9A3968ED118D3E54B51B504461-0-wk-Fact-C0E8F7578BC3D19F78AB54B51ACBAE39">&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;34,899&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;31,146&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;213&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;215&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;35,112&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;31,361&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,539&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,431&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;512&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;440&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;4,051&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,871&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39,163&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;35,232&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39,157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;35,228&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:48%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:23%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical Distribution and Specialty Solutions (1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;103,612&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;95,888&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nuclear and Precision Health Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;642&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;628&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;104,254&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;96,516&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical distribution and products (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10,483&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;10,339&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Cardinal Health at-Home Solutions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,339&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;padding-left:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11,991&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;11,678&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;116,245&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;108,194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;116,233&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;108,181&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Products and services offered by our Specialty Solutions division are referred to as &#x201c;specialty pharmaceutical products and services."&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:24px;"/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top"&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember"
      decimals="-6"
      id="d55446147e2878-wk-Fact-FE6E48F8FA9170174CFD54B51AA89F54"
      unitRef="usd">34899000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember"
      decimals="-6"
      id="d55446147e2897-wk-Fact-0702439432E07F81379754B51AAB7B16"
      unitRef="usd">31146000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember"
      decimals="-6"
      id="d55446147e2912-wk-Fact-B1C60E9B690B1A18A1FA54B51AA92169"
      unitRef="usd">213000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember"
      decimals="-6"
      id="d55446147e2931-wk-Fact-30FA082C5458E10B606754B51AAE75F1"
      unitRef="usd">215000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55446147e2951-wk-Fact-DBAC790408518EF5ACD954B51AA96752"
      unitRef="usd">35112000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55446147e2970-wk-Fact-46479CF5E898CBE02A6254B51AAB5867"
      unitRef="usd">31361000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember"
      decimals="-6"
      id="d55446147e2990-wk-Fact-24E13E820102EF5C3C8654B51AABDA94"
      unitRef="usd">3539000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember"
      decimals="-6"
      id="d55446147e3009-wk-Fact-44134564C9EABE7E938654B51AA9E31D"
      unitRef="usd">3431000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember"
      decimals="-6"
      id="d55446147e3029-wk-Fact-31FF3C900127A0AEAF2E54B51AA98730"
      unitRef="usd">512000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember"
      decimals="-6"
      id="d55446147e3048-wk-Fact-7FB1FF074D060720F07D54B51AA9A2BC"
      unitRef="usd">440000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55446147e3068-wk-Fact-FFC5B1459CC785A51D7054B51AA8828A"
      unitRef="usd">4051000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55446147e3087-wk-Fact-2DDFD0A4834E8430651F54B51AAB71F6"
      unitRef="usd">3871000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d55446147e3107-wk-Fact-38556B57205319D998F354B51AAEAC2F"
      unitRef="usd">39163000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d55446147e3126-wk-Fact-FC4B0B47AB536C8C4C3754B51AAA7EC2"
      unitRef="usd">35232000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e3146-wk-Fact-2F7D81D8B9DBC5D66F5454B51AAFCB38"
      unitRef="usd">-6000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e3166-wk-Fact-C9D1F2F69E015692955F54B51AAE7B39"
      unitRef="usd">-4000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55446147e3192-wk-Fact-B5678807817E002A2C5254B51ACDCA6C"
      unitRef="usd">39157000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55446147e3211-wk-Fact-1CCE01CC0FAB05B634D054B51AAD948A"
      unitRef="usd">35228000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember"
      decimals="-6"
      id="d55446147e3327-wk-Fact-B2FCE6406AA7F56A141554B51AE6D7DC"
      unitRef="usd">103612000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_PharmaceuticalDistributionandSpecialtyMember"
      decimals="-6"
      id="d55446147e3346-wk-Fact-0081754E6BE7145D466354B51B1AD527"
      unitRef="usd">95888000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember"
      decimals="-6"
      id="d55446147e3361-wk-Fact-3382591D5CCDBAC219D554B51A9D0310"
      unitRef="usd">642000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember_us-gaap_SubsegmentsAxis_cah_NuclearPrecisionHealthServicesMember"
      decimals="-6"
      id="d55446147e3380-wk-Fact-C4004E11024DBC88C01054B51AC01AB1"
      unitRef="usd">628000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55446147e3400-wk-Fact-DCEA624298CD56FDC4F354B51B1AB304"
      unitRef="usd">104254000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55446147e3419-wk-Fact-D44E8637AEE1CCB480105FBD13F4439B"
      unitRef="usd">96516000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember"
      decimals="-6"
      id="d55446147e3439-wk-Fact-5A7688B9CAB4E47E96CF54B51A9B5D75"
      unitRef="usd">10483000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_MedicaldistributionandproductsMember"
      decimals="-6"
      id="d55446147e3458-wk-Fact-EFB2BB865981886822DD54B51AC562AE"
      unitRef="usd">10339000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember"
      decimals="-6"
      id="d55446147e3478-wk-Fact-7B6B6BF3E6C3562358B954B51B1D83C0"
      unitRef="usd">1508000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember_us-gaap_SubsegmentsAxis_cah_CardinalHealthAtHomeMember"
      decimals="-6"
      id="d55446147e3497-wk-Fact-9E07AA89C7BDA1D4728D54B51B1D0D13"
      unitRef="usd">1339000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55446147e3517-wk-Fact-C786DEC2E9B577D2A14154B51B1C8C00"
      unitRef="usd">11991000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55446147e3536-wk-Fact-540BC91BDF23EA619B025FBD13E97CCB"
      unitRef="usd">11678000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d55446147e3556-wk-Fact-0B4D03A0D4234274C53E54B51AA0B01E"
      unitRef="usd">116245000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d55446147e3575-wk-Fact-F63C16D145731C60EDAB54B51A9D575A"
      unitRef="usd">108194000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e3595-wk-Fact-B8C17E2C80FB84FF7BDF54B51A9F8121"
      unitRef="usd">-12000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e3615-wk-Fact-7D33EA3DC209B17A73DF54B51A9E015E"
      unitRef="usd">-13000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55446147e3641-wk-Fact-95BB44ACFE0A3C8D473654B51AA5FF98"
      unitRef="usd">116233000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55446147e3660-wk-Fact-2D6DD524F1EBD75BAFA054B51AA8777B"
      unitRef="usd">108181000000</us-gaap:Revenues>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-46948AC38F093158875054B51B503826-0-wk-Fact-7D8536D4F56C36EBB1B354B51B26681A">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present revenue by geographic area:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:3%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;38,073&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;34,230&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,090&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,002&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39,163&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;35,232&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;39,157&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;35,228&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:3%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;113,053&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;105,190&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;International&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,192&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,004&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&#160;&#160;Total segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;116,245&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;108,194&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;116,233&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;108,181&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;padding-left:0px;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD_srt_StatementGeographicalAxis_country_US"
      decimals="-6"
      id="d55446147e3817-wk-Fact-0F32505F1BFA5363425754B51AD0B00E"
      unitRef="usd">38073000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD_srt_StatementGeographicalAxis_country_US"
      decimals="-6"
      id="d55446147e3836-wk-Fact-B9908D823ADAE0E8EF4D54B51AD2168A"
      unitRef="usd">34230000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-6"
      id="d55446147e3851-wk-Fact-1D43CA95F55FFF46F44D54B51AD0606A"
      unitRef="usd">1090000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-6"
      id="d55446147e3870-wk-Fact-9CB0ACCCF02FD9B66D5054B51AAAD4E8"
      unitRef="usd">1002000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d55446147e3890-wk-Fact-38556B57205319D998F354B51AAEAC2F"
      unitRef="usd">39163000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d55446147e3909-wk-Fact-FC4B0B47AB536C8C4C3754B51AAA7EC2"
      unitRef="usd">35232000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e3929-wk-Fact-2F7D81D8B9DBC5D66F5454B51AAFCB38"
      unitRef="usd">-6000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e3949-wk-Fact-C9D1F2F69E015692955F54B51AAE7B39"
      unitRef="usd">-4000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55446147e3975-wk-Fact-B5678807817E002A2C5254B51ACDCA6C"
      unitRef="usd">39157000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55446147e3994-wk-Fact-1CCE01CC0FAB05B634D054B51AAD948A"
      unitRef="usd">35228000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-6"
      id="d55446147e4111-wk-Fact-C12E5C5142A13631F5F454B51A9CB3F8"
      unitRef="usd">113053000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD_srt_StatementGeographicalAxis_country_US"
      decimals="-6"
      id="d55446147e4130-wk-Fact-F65DFAE1BE566186F00254B51AA298CE"
      unitRef="usd">105190000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-6"
      id="d55446147e4145-wk-Fact-B28087BA80A2FD4E718C54B51A9FDCB4"
      unitRef="usd">3192000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD_srt_StatementGeographicalAxis_us-gaap_NonUsMember"
      decimals="-6"
      id="d55446147e4164-wk-Fact-1BAEC1A20D6EE1B9584654B51A9F926F"
      unitRef="usd">3004000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d55446147e4184-wk-Fact-0B4D03A0D4234274C53E54B51AA0B01E"
      unitRef="usd">116245000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d55446147e4203-wk-Fact-F63C16D145731C60EDAB54B51A9D575A"
      unitRef="usd">108194000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e4223-wk-Fact-B8C17E2C80FB84FF7BDF54B51A9F8121"
      unitRef="usd">-12000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e4243-wk-Fact-7D33EA3DC209B17A73DF54B51A9E015E"
      unitRef="usd">-13000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55446147e4269-wk-Fact-95BB44ACFE0A3C8D473654B51AA5FF98"
      unitRef="usd">116233000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55446147e4288-wk-Fact-2D6DD524F1EBD75BAFA054B51AA8777B"
      unitRef="usd">108181000000</us-gaap:Revenues>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55446147e4316-wk-Fact-C6FBC924F04260EBEFE754B51ACA7A3D"
      unitRef="usd">17000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55446147e4328-wk-Fact-78D5EE6340EE20121BA454B51ACF664D"
      unitRef="usd">37000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <cah:ProjectCostsOnInvestmentAndOtherSpending
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55446147e4332-wk-Fact-B526CF4C12F7493E870D54B51A849685"
      unitRef="usd">36000000</cah:ProjectCostsOnInvestmentAndOtherSpending>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="FD2020Q3YTD_cah_OpioidLitigationAxis_cah_TotalOpioidLitigationMember"
      decimals="-6"
      id="d55446147e4357-wk-Fact-4074F71F4572CF3082B854B51B0B8528"
      unitRef="usd">-5630000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:InventoryRecallExpense
      contextRef="FD2020Q3YTD_cah_GownRecallAxis_cah_SterileSurgicalGownRecallMemberDomain"
      decimals="-6"
      id="d55446147e4377-wk-Fact-1A86236C670FA586A29154B51B0ED102"
      unitRef="usd">95000000</us-gaap:InventoryRecallExpense>
    <cah:PreTaxGainonDivestiture
      contextRef="FD2019Q3YTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cah_NaviHealthMember"
      decimals="-6"
      id="d55446147e4393-wk-Fact-A66B8111D0F733B8A69454B51A8F2287"
      unitRef="usd">508000000</cah:PreTaxGainonDivestiture>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-468CE5C2553002CCDAE054B51B50AA12-0-wk-Fact-47365AF44E28366F383F54B51AC959E0">&lt;div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables present segment profit by reportable segment and Corporate:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;534&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;536&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;178&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;155&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment profit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;712&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;691&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(150&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(259&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total operating earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;562&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;432&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,394&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,388&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;543&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;479&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Total segment profit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1,937&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,867&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(6,305&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(115&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total operating earnings/(loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;(4,368&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;1,752&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55446147e4523-wk-Fact-D12C08DE622B935FFD5854B51AE80C24"
      unitRef="usd">534000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55446147e4542-wk-Fact-DBCA9DC3185A0E61633F54B51AFED1FA"
      unitRef="usd">536000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55446147e4557-wk-Fact-716A3963185A8AD3EF4954B51AFF26C3"
      unitRef="usd">178000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55446147e4576-wk-Fact-B9EBA376E0298DEE252654B51AEC2DAB"
      unitRef="usd">155000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d55446147e4596-wk-Fact-CADF19DC7DE5D6D6AF0554B51AFADD2B"
      unitRef="usd">712000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d55446147e4615-wk-Fact-38551D860599E9EF357354B51AE7AC8B"
      unitRef="usd">691000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e4635-wk-Fact-A274487488E9F94F03B354B51B0253FA"
      unitRef="usd">-150000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3QTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e4655-wk-Fact-D5396A5873232190429954B51AFCCBE6"
      unitRef="usd">-259000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55446147e4681-wk-Fact-214140D02A180F197B4954B51A8F21D9"
      unitRef="usd">562000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55446147e4700-wk-Fact-DF69602F2038573D567154B51B043599"
      unitRef="usd">432000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55446147e4815-wk-Fact-D4100987A70F33F10B7954B51AE13747"
      unitRef="usd">1394000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55446147e4834-wk-Fact-ADA9F2645AF9E6FAB81254B51ADD6690"
      unitRef="usd">1388000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55446147e4849-wk-Fact-FA7847D2928B6A3A3A5954B51ADE38B6"
      unitRef="usd">543000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55446147e4868-wk-Fact-F04C54AB50FEB563DC8B54B51ADC9A20"
      unitRef="usd">479000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d55446147e4888-wk-Fact-8457B98EFC1A0DBCFF4654B51AEB960A"
      unitRef="usd">1937000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember"
      decimals="-6"
      id="d55446147e4907-wk-Fact-CEB224BE84042A2B067154B51AE077F6"
      unitRef="usd">1867000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e4927-wk-Fact-6ECDE70A77EC76EB700E54B51AE2BCFE"
      unitRef="usd">-6305000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3YTD_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e4947-wk-Fact-CF1E89CADB9D87EA91A054B51ADEE500"
      unitRef="usd">-115000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55446147e4973-wk-Fact-0D29BC4669F150A7E4BD54B51AA61445"
      unitRef="usd">-4368000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55446147e4993-wk-Fact-7336E4EDFE2DAA666FCC54B51A8823BF"
      unitRef="usd">1752000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-2CE2FCA7EB50243553A554B51B51D529-0-wk-Fact-0651B07792AA9E48526054B51B2AA684">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;The following table presents total assets for each reportable segment and Corporate at: &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:16pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, &lt;br/&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, &lt;br/&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#d1d1d1;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;22,508&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#d1d1d1;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;22,446&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Medical&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;15,445&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;15,284&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Corporate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3,195&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;3,233&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#d1d1d1;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;41,148&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;40,963&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:Arial Narrow;font-size:16pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55446147e5083-wk-Fact-3FF201C6DC8FBC28919054B51A9B3BB6"
      unitRef="usd">22508000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_PharmaceuticalMember"
      decimals="-6"
      id="d55446147e5102-wk-Fact-D9EC9D09347EDCD797C054B51A9B0FE3"
      unitRef="usd">22446000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55446147e5117-wk-Fact-52167F23051D344B3E1954B51A930184"
      unitRef="usd">15445000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_cah_MedicalMember"
      decimals="-6"
      id="d55446147e5136-wk-Fact-DB5DA84A1B021A5266F654B51A929B86"
      unitRef="usd">15284000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2020Q3_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e5156-wk-Fact-7790429EB6F161D7607B54B51A932CEA"
      unitRef="usd">3195000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember"
      decimals="-6"
      id="d55446147e5175-wk-Fact-0A6FAF7026FDD43497CD54B51A949154"
      unitRef="usd">3233000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55446147e5200-wk-Fact-79192C98474F73FFBB6B54B51AF8130A"
      unitRef="usd">41148000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55446147e5219-wk-Fact-917DCA0680103C02A25754B51AFF2750"
      unitRef="usd">40963000000</us-gaap:Assets>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-7D7CB86523F846B3350754B51B51B055-0-wk-Fact-425B74E90FB73467B07754B51A82EC53">&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"&gt;14. Share-Based Compensation&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;We maintain stock incentive plans (collectively, the &#x201c;Plans&#x201d;) for the benefit of certain of our officers, directors and employees. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table provides total share-based compensation expense by type of award:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Restricted share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock option expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Performance share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Restricted share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock option expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Performance share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The total tax benefit related to share-based compensation was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$5 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$4 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the three months ended &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively, and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$12 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$13 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; for the &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;"&gt;nine months ended&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;2019&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Restricted share units granted under the Plans generally vest in equal annual installments over &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to restricted share units under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;42.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;60.13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&lt;/span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;45.88&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$93 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;two years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Employee stock options granted under the Plans generally vest in equal annual installments over &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; and are exercisable for &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all stock option transactions under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercise Price per&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Common Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Outstanding at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;63.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Outstanding at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;64.02&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercisable at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;63.96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$1 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which is expected to be recognized over a weighted-average period of less than &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables provide additional detail related to stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of outstanding options at period end&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of exercisable options at period end&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of outstanding options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of exercisable options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"&gt;Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;Performance share units vest over a &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;three&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;zero&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; to &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;240 percent&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Performance&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Share Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;43.68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;48.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;50.76&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;51.94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;At &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized was &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;$29 million&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;, which is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;&lt;span&gt;two years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt; if targets are achieved.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-D791A697838E7563DC2154B51B5201F4-0-wk-Fact-45E9B20C878702FE11CE54B51B1AA3BB">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table provides total share-based compensation expense by type of award:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Restricted share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;17&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock option expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Performance share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;27&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;23&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nine Months Ended March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Restricted share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;53&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;47&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Employee stock option expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Performance share unit expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Total share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;64&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q3QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d55443014e2880-wk-Fact-81BDCA2081AD2A1D417254B51A8F438A"
      unitRef="usd">20000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q3QTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d55443014e2899-wk-Fact-7770A060B29D96AF7F0A54B51A8F08C2"
      unitRef="usd">17000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q3QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d55443014e2914-wk-Fact-606FB73F0146AD86A89B54B51A922327"
      unitRef="usd">1000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q3QTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d55443014e2933-wk-Fact-96A3BF1896316BE91AB654B51A91FABC"
      unitRef="usd">2000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q3QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d55443014e2953-wk-Fact-251862DAA90ACA327AC754B51A92D65D"
      unitRef="usd">6000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q3QTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d55443014e2972-wk-Fact-5DF7EF1F5AF57275179754B51A8E5C68"
      unitRef="usd">4000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55443014e2997-wk-Fact-F31A720F5D778B8496DB54B51A923820"
      unitRef="usd">27000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55443014e3016-wk-Fact-D638018CEAC7A5BDB7F554B51A8E9843"
      unitRef="usd">23000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d55443014e3135-wk-Fact-D43318356557120D36DB54B51AC4AFD7"
      unitRef="usd">53000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d55443014e3154-wk-Fact-0890EE0DA48300176DD254B51AACD487"
      unitRef="usd">47000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d55443014e3169-wk-Fact-0FDD741EF47221630CE154B51AAA9208"
      unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d55443014e3188-wk-Fact-0A2A9DC7BDBBD1B4798D54B51AAB1356"
      unitRef="usd">8000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d55443014e3208-wk-Fact-26E89E6BDED25570A0CF54B51AC2A14E"
      unitRef="usd">12000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d55443014e3227-wk-Fact-89C73458E74E7E2508CC54B51AC5BEC2"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55443014e3252-wk-Fact-13EE0878A2F70C64904C54B51AC4EF32"
      unitRef="usd">68000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55443014e3271-wk-Fact-B951A0AE54C54ABA0A5E54B51AC4EFB2"
      unitRef="usd">64000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="FD2020Q3QTD"
      decimals="-6"
      id="d55443014e3287-wk-Fact-DB01B3D2C6910C722A6654B51ADA6E8B"
      unitRef="usd">5000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="FD2019Q3QTD"
      decimals="-6"
      id="d55443014e3291-wk-Fact-EB8D9E3A61F200AA5CBF54B51ADBCDD6"
      unitRef="usd">4000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55443014e3306-wk-Fact-4597EFC27239149A309154B51ADAFDB3"
      unitRef="usd">12000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="FD2019Q3YTD"
      decimals="-6"
      id="d55443014e3310-wk-Fact-7D4CCA082D2A6515F2C254B51AD90572"
      unitRef="usd">13000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      id="d55443014e3333-wk-Fact-795D6DDE0C81DCD708B354B51AD956C9">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-3797D492C5F7D5DC755154B51B512033-0-wk-Fact-8197A2B73BC62D19CDC154B51B19DD19">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to restricted share units under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:24%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51.65&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;42.58&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;60.13&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&lt;/span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;45.88&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d55443014e3410-wk-Fact-98CC13635E877D0BF95454B51B1C9267"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d55443014e3429-wk-Fact-E3BF258BD1A88B0694F754B51B1E562A"
      unitRef="usdPerShare">51.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d55443014e3444-wk-Fact-BBBB5AB2B76EDEC2565C54B51B1EB33E"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d55443014e3458-wk-Fact-8DF0E0D97F54292E0A0554B51B1F040F"
      unitRef="usdPerShare">42.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d55443014e3478-wk-Fact-395C073D201B6E0CAC5854B51B1CDFCE"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d55443014e3493-wk-Fact-87A203F7B1566E2D502C54B51B1EAD2B"
      unitRef="usdPerShare">60.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d55443014e3513-wk-Fact-38B6EEB9FD3B90B4F8AB54B51B1C3415"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      id="d55443014e3527-wk-Fact-22ED5EE499B5F49F4B2554B51B1BB868"
      unitRef="usdPerShare"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d55443014e3546-wk-Fact-6B93F3112992DF97C76A54B51B1C4664"
      unitRef="shares">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="d55443014e3565-wk-Fact-4A158FE95D6680F6E35854B51B1EAF70"
      unitRef="usdPerShare">45.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-6"
      id="d55443014e3584-wk-Fact-7607A631780891474FE454B51AD36D6B"
      unitRef="usd">93000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember"
      id="d55443014e3588-wk-Fact-FCB0BC93E3E44946062554B51B1320D4">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d55443014e3598-wk-Fact-D97A6DBDD88DF6DB329054B51AD22372">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <cah:ExercisablePeriodOfPlansInYears
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d55443014e3602-wk-Fact-6D32A3BB41D11C58403254B51AD36815">P10Y</cah:ExercisablePeriodOfPlansInYears>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-5B9F84347EB9C7AD37BE54B51B514B41-0-wk-Fact-0926BDCA8BE50C824E0E54B51A824F2A">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all stock option transactions under the Plans:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;"/&gt;&lt;td style="width:13%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercise Price per&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Common Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Outstanding at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;63.78&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Outstanding at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;64.02&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Exercisable at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;63.96&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="FI2019Q4"
      decimals="-6"
      id="d55443014e3689-wk-Fact-0E3D6DB281224BEF14B554B51B0FF53B"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="FI2019Q4"
      decimals="2"
      id="d55443014e3708-wk-Fact-B48D171DF33B72A0F77254B51B0E3414"
      unitRef="usdPerShare">63.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55443014e3723-wk-Fact-CD4F947DA5C0B83E0AB954B51B03D6DA"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="FD2020Q3YTD"
      decimals="2"
      id="d55443014e3737-wk-Fact-63ECACAD020D7CAB427954B51B1178E7"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55443014e3757-wk-Fact-790C59687B1E890B776954B51AFCEBBF"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="FD2020Q3YTD"
      decimals="2"
      id="d55443014e3771-wk-Fact-F6E2361E73F5EBB3C20654B51AFA78B5"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="FD2020Q3YTD"
      decimals="-6"
      id="d55443014e3791-wk-Fact-B08427703308ADA6FC1154B51B12F48E"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="FD2020Q3YTD"
      decimals="2"
      id="d55443014e3805-wk-Fact-7E5501013664A376E15F54B51B066ADD"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55443014e3825-wk-Fact-154E80348E64A5B03E6954B51B13B204"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="FI2020Q3"
      decimals="2"
      id="d55443014e3844-wk-Fact-240D406ED9BE78AA84C054B51AFA80E0"
      unitRef="usdPerShare">64.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="FI2020Q3"
      decimals="-6"
      id="d55443014e3859-wk-Fact-69EFDB8E3DE6208703FF54B51B0F6DD4"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="FI2020Q3"
      decimals="2"
      id="d55443014e3878-wk-Fact-4FA3E2C206322260BCB554B51AFE2791"
      unitRef="usdPerShare">63.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d55443014e3905-wk-Fact-0FE0A1D84FC05F63E2B854B51AD98F26"
      unitRef="usd">1000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d55443014e3909-wk-Fact-F51D2576739F5A1618ED54B51B19D99D">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <cah:AdditionalStockOptionPlanDataTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-A7D6AACD9935863F4F6454B51B510723-0-wk-Fact-FF3415E6615F4DB42D9C54B51A7FC104">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following tables provide additional detail related to stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:17%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of outstanding options at period end&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Aggregate intrinsic value of exercisable options at period end&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:58%;"/&gt;&lt;td style="width:21%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;March&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;June&#160;30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of outstanding options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:justify;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Weighted-average remaining contractual life of exercisable options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</cah:AdditionalStockOptionPlanDataTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d55443014e3992-wk-Fact-65C65E28515B84669A3654B51A8676B4"
      unitRef="usd">9000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d55443014e4011-wk-Fact-E12E9C5928E4C3675A4754B51ADA6E87"
      unitRef="usd">10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d55443014e4026-wk-Fact-83E5B4CCE9FE45B1B3D954B51A82A8FD"
      unitRef="usd">9000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-6"
      id="d55443014e4045-wk-Fact-B2A55AD186A35D0D6E8C54B51AD82BE2"
      unitRef="usd">10000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d55443014e4125-wk-Fact-A7E1B27E7F0CF3BAF9DA54B51B19BBCC">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d55443014e4135-wk-Fact-9922B56A821AB718127254B51B138D2A">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d55443014e4146-wk-Fact-A39FF8B836CC56DA857454B51B13CAC1">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="FD2019Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      id="d55443014e4156-wk-Fact-2C8227FC2DD153F64D9C54B51B193575">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <cah:VestingPeriodinyearsforShares
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="INF"
      id="d55443014e4201-wk-Fact-4544F660527CB1DA1BBC54B51ADB6E0D"
      unitRef="number">3</cah:VestingPeriodinyearsforShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="FD2020Q3YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d55443014e4205-wk-Fact-FF697DE9623D5209C79354B51A815E47"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="FD2020Q3YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d55443014e4209-wk-Fact-786A321FA80375C3CD3154B51B13635E"
      unitRef="number">2.40</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="FD2020Q3YTD"
      id="TextSelection-65D46D637BCE9A83572454B51B51337F-0-wk-Fact-1695DE7C8F83BB6A7A9454B51AD07161">&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"&gt;The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:51%;"/&gt;&lt;td style="width:19%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:2%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;td style="width:25%;"/&gt;&lt;td style="width:1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;"&gt;(in millions, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Performance&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Share Units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Grant Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Value per Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Nonvested at June 30, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;51.45&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;0.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;43.68&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;48.40&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;Canceled and forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;(0.1&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;"&gt;&lt;span&gt;50.76&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;text-indent:12px;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;Nonvested at March 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;1.3&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;$&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"&gt;&lt;div style="text-align:right;font-size:8pt;"&gt;&lt;span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"&gt;&lt;span&gt;51.94&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="font-family:inherit;font-size:10pt;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d55443014e4319-wk-Fact-6A64A8CA5EA1DB8984B254B51AC52664"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2019Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d55443014e4338-wk-Fact-EE358B7852C45EEFB06454B51AD20365"
      unitRef="usdPerShare">51.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d55443014e4353-wk-Fact-BD86E6607175E751EDE654B51AA7B1CB"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d55443014e4367-wk-Fact-052BC0CE470B87A0C6E254B51B0BED62"
      unitRef="usdPerShare">43.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d55443014e4387-wk-Fact-F5BF4C66AED0618E187854B51AC4C49C"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d55443014e4402-wk-Fact-A5D77F3F37C30B36CD2954B51A912EA4"
      unitRef="usdPerShare">48.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d55443014e4422-wk-Fact-B0E2E9DE4FFDBB3CFBB254B51B1F7260"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d55443014e4437-wk-Fact-F79ED58B169B150BC47A54B51AC385A2"
      unitRef="usdPerShare">50.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="d55443014e4457-wk-Fact-E39F92C2EE8D08E1BD8B54B51AABA9DE"
      unitRef="shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="2"
      id="d55443014e4476-wk-Fact-B80F42C575DA7DDAC0FF54B51AE69533"
      unitRef="usdPerShare">51.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="FI2020Q3_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-6"
      id="d55443014e4512-wk-Fact-138733F917EEC78BD56154B51AD26FEA"
      unitRef="usd">29000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="FD2020Q3YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      id="d55443014e4516-wk-Fact-24DB0572748EE776365A54B51AD12EFB">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6604284352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">9. Fair Value Measurements</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>647</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>647</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>96</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>96</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>170</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>170</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div>The fair value of interest rate swaps, foreign currency contracts, commodity contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the condensed consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6604284352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasesTextBlock', window );">Leases</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">5. Leases</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We primarily have operating leases for corporate offices, distribution facilities, vehicles, and equipment. We determine if an arrangement is a lease at inception by evaluating whether the arrangement conveys the right to use an identified asset and whether we obtain substantially all of the economic benefits from and have the ability to direct the use of the asset. Our lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Beginning July 1, 2019, operating lease right-of-use assets and corresponding operating lease liabilities are recognized in our condensed consolidated balance sheet at commencement date based on the present value of lease payments over the lease term. Operating lease expense for operating lease assets is recognized on a straight-line basis over the lease term. As most of our leases do not provide an implicit rate, we use our collateralized incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate if it is readily determinable. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our lease agreements include leases that contain lease components and non-lease components. For all asset classes, we have elected to account for both of these provisions as a single lease component.  We also, from time to time, sublease portions of our real estate property, resulting in sublease income. Sublease income and the related assets and cash flows are not material to the condensed consolidated financial statements at or for the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We also have elected to apply a practical expedient for short-term leases whereby we do not recognize a lease liability and right-of-use asset for leases with a term of less than 12 months. Short-term lease expense recognized in the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was not material. In addition, we elected the package of three practical expedients permitted under the transition guidance, which include the carry forward of our leases without reassessing 1) whether any contracts are leases or contain leases, 2) lease classification and 3) initial direct costs. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our leases have remaining lease terms from less than </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>1 year</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> up to approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>23 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Our lease terms may include options to extend or terminate the lease when it is reasonably certain and there is a significant economic incentive to exercise that option. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the components of lease cost:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:51%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>31</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>92</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization of right-of-use assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Variable lease cost</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>37</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>118</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Primarily includes payments for property taxes, maintenance and insurance. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes supplemental balance sheet information related to leases:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>469</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Current portion of operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>109</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Long-term operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>381</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>490</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease right-of-use assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Current portion of finance lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term finance lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Operating leases are included in other assets, other accrued liabilities, and deferred income taxes and other liabilities in our condensed consolidated balance sheet. Finance leases are included in property and equipment, net, current portion of long-term obligations and other short-term borrowings, and long-term obligations, less current portion in our condensed consolidated balance sheet. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarizes supplemental cash flow information related to leases:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating cash flows paid for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Financing cash flows paid for finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>154</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amended lease standard adoption impact as of July 1, 2019 </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>400</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes the effect of </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$22 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our operating leases had a weighted-average remaining lease term of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>6.5</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> years and a weighted-average discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>2.8 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Future lease payments under non-cancellable leases as of </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> were as follows:</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">                          </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:51%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Remainder of 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>113</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>119</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>99</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>73</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>77</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>54</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>55</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>173</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>173</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>537</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>553</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: leases not yet commenced </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>45</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>490</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>504</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">As of </span><span style="font-family:Arial Narrow;font-size:8pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the condensed consolidated balance sheets. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The future minimum rental payments for operating leases&#160;having initial or remaining non-cancelable lease terms in excess of one year at </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;"> for fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> through </span><span style="font-family:Arial Narrow;font-size:10pt;">2024</span><span style="font-family:Arial Narrow;font-size:10pt;"> and thereafter were as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$126 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$100 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$76 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$54 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$33 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$94 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6837947216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 8,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DiscountRatefairvalueinputs', window );">Discount Rate, fair value inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TerminalGrowthRatefairvalueinputs', window );">Terminal Growth Rate, fair value inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 129<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
<td class="nump">$ 385<span></span>
</td>
<td class="nump">$ 399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</a></td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization of intangible assets - Year Two</a></td>
<td class="nump">442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization of intangible assets - Year Three</a></td>
<td class="nump">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization of intangible assets - Year Four</a></td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated annual amortization of intangible assets - Year Five</a></td>
<td class="nump">328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalReportingUnitMember', window );">Medical Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CarryingValue', window );">Carrying Value</a></td>
<td class="nump">10,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying Value of Reporting Unit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DiscountRatefairvalueinputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, fair value inputs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DiscountRatefairvalueinputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TerminalGrowthRatefairvalueinputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Terminal Growth Rate, fair value inputs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TerminalGrowthRatefairvalueinputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fair value of reporting unit in excess of carrying amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6857024960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>34,899</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>31,146</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>213</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>215</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>35,112</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>31,361</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (3)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,539</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,431</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>512</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>440</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4,051</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,871</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39,163</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>35,232</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39,157</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>35,228</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical Distribution and Specialty Solutions (1) (2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>103,612</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>95,888</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nuclear and Precision Health Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>642</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>628</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>104,254</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>96,516</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical distribution and products (3)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10,483</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10,339</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cardinal Health at-Home Solutions</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,508</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,339</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11,991</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11,678</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>116,245</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>108,194</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (4)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>116,233</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>108,181</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Products and services offered by our Specialty Solutions division are referred to as &#8220;specialty pharmaceutical products and services."</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(3)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division.</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(4)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas [Table Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present revenue by geographic area:</span></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>38,073</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>34,230</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,090</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,002</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39,163</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>35,232</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>39,157</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>35,228</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/><td style="width:3%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>113,053</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>105,190</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">International</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,192</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,004</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;Total segment revenue</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>116,245</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>108,194</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate (1)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total revenue</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>116,233</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>108,181</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Segment Profit by Reportable Segment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present segment profit by reportable segment and Corporate:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>534</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>536</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>178</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>155</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>712</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>691</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(150</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(259</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>562</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,394</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,388</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>543</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>479</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total segment profit</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,937</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,867</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(6,305</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(115</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total operating earnings/(loss)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(4,368</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,752</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Assets by Reportable Segment</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table presents total assets for each reportable segment and Corporate at: </span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:16pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, <br/>2020</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, <br/>2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#d1d1d1;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22,508</span></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#d1d1d1;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22,446</span></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15,445</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>15,284</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Corporate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,195</span></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#d1d1d1;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,233</span></span></div></td><td style="vertical-align:bottom;background-color:#d1d1d1;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total assets</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>41,148</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>40,963</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:16pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6836968208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">$ 72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee- Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility Exit and Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Additions</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments and other adjustments</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="nump">$ 15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6836531440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">$ 1,002<span></span>
</td>
<td class="nump">$ 6,043<span></span>
</td>
<td class="nump">$ 6,330<span></span>
</td>
<td class="nump">$ 6,059<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="num">(38)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">1,206<span></span>
</td>
<td class="nump">6,232<span></span>
</td>
<td class="nump">1,206<span></span>
</td>
<td class="nump">6,232<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss, before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(130)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Gain/(Loss) on Derivatives, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss, before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(103)<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive loss, before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">$ (141)<span></span>
</td>
<td class="num">$ (111)<span></span>
</td>
<td class="num">$ (141)<span></span>
</td>
<td class="num">$ (111)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6837885952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details) - Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Forward contracts</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=117331979&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6858789312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Revenue by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 39,157<span></span>
</td>
<td class="nump">$ 35,228<span></span>
</td>
<td class="nump">$ 116,233<span></span>
</td>
<td class="nump">$ 108,181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">39,163<span></span>
</td>
<td class="nump">35,232<span></span>
</td>
<td class="nump">116,245<span></span>
</td>
<td class="nump">108,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">35,112<span></span>
</td>
<td class="nump">31,361<span></span>
</td>
<td class="nump">104,254<span></span>
</td>
<td class="nump">96,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">4,051<span></span>
</td>
<td class="nump">3,871<span></span>
</td>
<td class="nump">11,991<span></span>
</td>
<td class="nump">11,678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember', window );">Pharmaceutical Distribution and Specialty [Member] | Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">34,899<span></span>
</td>
<td class="nump">31,146<span></span>
</td>
<td class="nump">103,612<span></span>
</td>
<td class="nump">95,888<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember', window );">Nuclear Precision Health Services [Member] | Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="nump">642<span></span>
</td>
<td class="nump">628<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember', window );">Medical distribution and products [Member] | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">3,539<span></span>
</td>
<td class="nump">3,431<span></span>
</td>
<td class="nump">10,483<span></span>
</td>
<td class="nump">10,339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeMember', window );">Cardinal Health At Home [Member] | Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 512<span></span>
</td>
<td class="nump">$ 440<span></span>
</td>
<td class="nump">$ 1,508<span></span>
</td>
<td class="nump">$ 1,339<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_PharmaceuticalDistributionandSpecialtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_NuclearPrecisionHealthServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_MedicaldistributionandproductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cah_CardinalHealthAtHomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6834828512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">10. Financial Instruments</span><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We utilize derivative financial instruments to manage exposure to certain risks related to our ongoing operations. The primary risks managed through the use of derivative instruments include interest rate risk, currency exchange risk, and commodity price risk. We do not use derivative instruments for trading or speculative purposes. While the majority of our derivative instruments are designated as hedging instruments, we also enter into derivative instruments that are designed to hedge a risk, but are not designated as hedging instruments. These derivative instruments are adjusted to fair value through earnings at the end of each period. We are exposed to counterparty credit risk on all of our derivative instruments. Accordingly, we have established and maintain strict counterparty credit guidelines and only enter into derivative instruments with major financial institutions that are rated investment grade or better. We do not have significant exposure to any one counterparty and we believe the risk of loss is remote. Additionally, we do not require collateral under these agreements.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Interest Rate Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are exposed to the impact of interest rate changes. Our objective is to manage the impact of interest rate changes on cash flows and the market value of our borrowings. We utilize a mix of debt maturities along with both fixed-rate and variable-rate debt to manage changes in interest rates. In addition, we enter into interest rate swaps to further manage our exposure to interest rate variations related to our borrowings and to lower our overall borrowing costs.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Currency Exchange Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We conduct business in several major international currencies and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce volatility in earnings, cash flow and net investments in certain subsidiaries to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments and anticipated foreign currency revenue and expenses.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commodity Price Risk Management</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are exposed to changes in the price of certain commodities. Our objective is to reduce earnings and cash flow volatility associated with forecasted purchases of these commodities to allow management to focus its attention on business operations. Accordingly, we enter into derivative contracts when possible to manage the price risk associated with certain forecasted purchases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We enter into pay-floating interest rate swaps to hedge the changes in the fair value of fixed-rate debt resulting from fluctuations in interest rates. These contracts are designated and qualify as fair value hedges. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps is directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt are adjusted to market value at the end of each period with any resulting gain or loss recorded in interest expense in the condensed consolidated statements of earnings. For the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, there was </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>no</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> gain or loss recorded to interest expense as changes in the market value of our derivative instruments offset changes in the market value of the underlying debt.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, no new pay-floating interest rate swaps were executed. In connection with the debt redemption  as described in </span><a href="#sC01B26F4270953278E0B2F0FA5E5852A" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 6</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, two pay-floating interest rate swaps with notional amounts of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$200 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> matured in the second quarter of fiscal 2020. </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Cash Flow Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We enter into derivative instruments to hedge our exposure to changes in cash flows attributable to interest rate, foreign currency and commodity price fluctuations associated with certain forecasted transactions. These derivative instruments are designated and qualify as cash flow hedges. Accordingly, the gain or loss on the derivative instrument is reported as a component of other comprehensive income/(loss) and reclassified into earnings in the </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we entered into forward interest rate swaps with a total notional amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$200 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to hedge probable, but not firmly committed, future transactions associated with our debt.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Gains and losses recognized in accumulated other comprehensive loss and reclassified into earnings were immaterial for the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. All gains and losses currently included within accumulated other comprehensive loss associated with our foreign exchange forward contracts that are expected to be reclassified into net earnings within the next 12 months are immaterial.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Net Investment Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We hedge the foreign currency risk associated with certain net investment positions in foreign subsidiaries. To accomplish this, we enter into cross-currency swaps that are designated as hedges of net investments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In August 2019, we entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>&#165;64.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$600 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">) cross-currency swap maturing in 2022.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In September 2018, we entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>&#8364;200 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$233 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">) cross-currency swap maturing in 2023.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Cross-currency swaps designated as net investment hedges are marked-to-market using the current spot exchange rate as of the end of the period, with gains and losses included in the foreign currency translation component of accumulated other comprehensive loss until the sale or substantial liquidation of the underlying net investments. To the extent the cross-currency swaps designated as net investment hedges are not highly effective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Economic (Non-Designated) Hedges</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We enter into foreign currency contracts to manage our foreign exchange exposure related to sales transactions, intercompany financing transactions and other balance sheet items subject to revaluation that do not meet the requirements for hedge accounting treatment. Accordingly, these derivative instruments are adjusted to current market value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability. The settlement of the derivative instrument and the remeasurement adjustment on the foreign currency denominated asset or liability are both recorded in other (income)/expense, net. We recorded a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$7 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$8 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> expense during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. The principal currencies managed through foreign currency contracts are the euro, Canadian dollar, British pound, Japanese yen, and Chinese renminbi.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Fair Value of Financial Instruments</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The carrying amounts of cash and equivalents, trade receivables, accounts payable and other accrued liabilities at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> approximate fair value due to their short-term maturities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the estimated fair value of our long-term obligations and other short-term borrowings compared to the respective carrying amounts at:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:26%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Estimated fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7,211</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Carrying amount</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7,262</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,031</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The fair value of our long-term obligations and other short-term borrowings is estimated based on either the quoted market prices for the same or similar issues or other inputs derived from available market information, which represents a Level 2 measurement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6843355856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract', window );"><strong>Long-Term Obligations and Other Short-Term Borrowings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Obligations and Other Short-Term Borrowings</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-weight:bold;">6. Long-Term Obligations and Other Short-Term Borrowings</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Long-Term Debt and Other Short-Term Borrowings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had total long-term obligations, including the current portion and other short-term borrowings, of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;text-align:right;vertical-align:bottom;"><span>$7.3 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;text-align:right;vertical-align:bottom;"><span>$8.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. </span><span style="font-family:Arial Narrow;font-size:10pt;">All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. Interest is paid pursuant to the terms of the obligations. These obligations are effectively subordinated to the liabilities of our subsidiaries, including trade payables of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$22.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$21.5 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In November 2019, we repaid the full principal of the 2.4% Notes due 2019 at maturity for </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$450 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span><span style="font-family:Arial Narrow;font-size:10pt;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;">we early repurchased</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$247 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">2.616% Notes due 2022</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$11 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">  of the </span><span style="font-family:Arial Narrow;font-size:10pt;">3.2% Notes due 2022</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$20 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the  </span><span style="font-family:Arial Narrow;font-size:10pt;">Floating Rate Notes due 2022</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$104 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">3.41% Notes due 2027</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$6 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">4.6% Notes due 2043</span><span style="font-family:Arial Narrow;font-size:10pt;">, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the  </span><span style="font-family:Arial Narrow;font-size:10pt;">4.9% Notes due 2045</span><span style="font-family:Arial Narrow;font-size:10pt;">, and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$35 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of the </span><span style="font-family:Arial Narrow;font-size:10pt;">4.368% Notes due 2047</span><span style="font-family:Arial Narrow;font-size:10pt;">. </span><span style="font-family:Arial Narrow;">The repurchases were paid for with available cash and other short-term borrowings. In connection with the early debt repurchases, we recorded a</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$9 million</span></span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;">loss on extinguishment of debt.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes long-term obligations and other short-term borrowings at:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.76543209876543%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions) (1)</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.4% Notes due 2019</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>450</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.625%&#160;Notes due 2020</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>504</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>508</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.616% Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>834</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,079</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2% Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>236</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>247</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Floating Rate Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>321</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>340</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2% Notes due 2023</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>573</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>551</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.079% Notes due 2024</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>815</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>781</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.5% Notes due 2024</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>413</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>402</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.75% Notes due 2025</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>530</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>494</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.41% Notes due 2027</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,215</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,318</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.6% Notes due 2043</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>340</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>346</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.5% Notes due 2044</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>342</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>342</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.9% Notes due 2045</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>441</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>445</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.368% Notes due 2047</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>560</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>594</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7.0%&#160;Debentures due 2026</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>124</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>124</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other Obligations</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>14</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7,262</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,031</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: current portion of long-term obligations and other short-term borrowings</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>508</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>452</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;&#160;&#160;Long-term obligations, less current portion</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6,754</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7,579</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Maturities are presented on a calendar year basis. </span></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Financing Arrangements</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to cash and equivalents and operating cash flow, other sources of liquidity include a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;commercial paper program backed by a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$2.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;revolving credit facility. We also have a&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$1.0 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;">&#160;committed receivables sales facility. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (&#8220;CHF&#8221;) through September 30, 2022. CHF was organized for</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Narrow;font-size:10pt;">the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors. </span></div><span style="font-family:Arial Narrow;">Our revolving credit and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter through December 2020, a consolidated net leverage ratio of no more than 4.00-to-1. The maximum permitted ratio will reduce to 3.75-to-1 in March 2021 and as of the end of every quarter thereafter.</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span><span style="font-family:Arial Narrow;">As of </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;">, we were in compliance with this financial covenant.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Obligations and Other Short-Term Borrowings [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LongTermObligationsandOtherShortTermBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6840501136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Reconciliation of Common Shares Used to Compute Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:70%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>292</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>298</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units and performance share units</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>294</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>299</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:70%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>293</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>301</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units and performance share units</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>293</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>302</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6832910016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee-related costs</a></td>
<td class="num">$ (15)<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total restructuring and employee severance</a></td>
<td class="num">$ (6)<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FacilityExitAndOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FacilityExitAndOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6857617312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">5,822<span></span>
</td>
<td class="nump">5,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,805<span></span>
</td>
<td class="nump">2,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 3,017<span></span>
</td>
<td class="nump">3,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Intangible, Total other intangible assets</a></td>
<td class="nump">$ 5,844<span></span>
</td>
<td class="nump">5,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Intangible, Total other intangible assets</a></td>
<td class="nump">3,039<span></span>
</td>
<td class="nump">3,430<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember', window );">IPR&amp;D, trademarks and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net Intangible</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">3,544<span></span>
</td>
<td class="nump">3,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,746<span></span>
</td>
<td class="nump">1,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 1,798<span></span>
</td>
<td class="nump">2,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember', window );">Trademarks, trade names and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">$ 674<span></span>
</td>
<td class="nump">672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 345<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Intangible</a></td>
<td class="nump">$ 1,604<span></span>
</td>
<td class="nump">1,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">730<span></span>
</td>
<td class="nump">616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Intangible</a></td>
<td class="nump">$ 874<span></span>
</td>
<td class="nump">$ 986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cah_IPRDTrademarksandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cah_TrademarksAndPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6837897376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Segment Profit by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">$ 562<span></span>
</td>
<td class="nump">$ 432<span></span>
</td>
<td class="num">$ (4,368)<span></span>
</td>
<td class="nump">$ 1,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">712<span></span>
</td>
<td class="nump">691<span></span>
</td>
<td class="nump">1,937<span></span>
</td>
<td class="nump">1,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">534<span></span>
</td>
<td class="nump">536<span></span>
</td>
<td class="nump">1,394<span></span>
</td>
<td class="nump">1,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="nump">543<span></span>
</td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating earnings</a></td>
<td class="num">$ (150)<span></span>
</td>
<td class="num">$ (259)<span></span>
</td>
<td class="num">$ (6,305)<span></span>
</td>
<td class="num">$ (115)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6840379216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss', window );">shares that would be antidilutive as a result of net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Sharesthatwouldbeantidilutiveasaresultofnetloss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>shares that would be antidilutive as a result of net loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Sharesthatwouldbeantidilutiveasaresultofnetloss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6835566080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Narrative) (Details)<br> &#8364; in Millions, &#165; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2018 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative Liability, Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 64,000<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">$ 233<span></span>
</td>
<td class="nump">&#8364; 200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Fair Value Hedging | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount', window );">Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense) [Member] | Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivatives, Hedge Discontinuances, Hedging Instrument Matured, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DerivativesHedgeDiscontinuancesHedgingInstrumentMaturedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6836910480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments Investments (Details) - naviHealth [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Aug. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PartnershipIndirectOwnership', window );">Partnership Indirect Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from Divestiture of Businesses</a></td>
<td class="nump">$ 737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 330<span></span>
</td>
<td class="nump">$ 334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=cah_NaviOwnershipInterestDivestedMember', window );">Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling Interest, Ownership Percentage by Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PartnershipIndirectOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Partnership Indirect Ownership</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PartnershipIndirectOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PreTaxGainonDivestiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Tax Gain on Divestiture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PreTaxGainonDivestiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=cah_NaviOwnershipInterestDivestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=cah_NaviOwnershipInterestDivestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6834548736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, authorized</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="nump">755,000<span></span>
</td>
<td class="nump">755,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, issued</a></td>
<td class="nump">327,000<span></span>
</td>
<td class="nump">327,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Common shares in treasury</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6856315360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cardinal Health, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000721371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">OH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-0958666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Cardinal Place<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">43017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(614)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">757-5000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common shares (without par value)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CAH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">291,986,422<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6835621248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance Lease, Principal Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member', window );">ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Impactofadoptionofnewaccountingstandard', window );">New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31)</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Impactofadoptionofnewaccountingstandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>impact of adoption of new accounting standard</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Impactofadoptionofnewaccountingstandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cah_ASC842Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6843387904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Employee Severance</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">2. Restructuring and Employee Severance</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes restructuring and employee severance:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(15</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>70</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>33</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>80</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>97</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, vendor transition fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.</span></div></td></tr></table><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Restructuring and employee severance during both the three and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was primarily related to enterprise-wide cost-saving measures. The income during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was due to changes in estimates for severance previously accrued.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Related Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility Exit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">and Other Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>72</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>57</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>67</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(55</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(58</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>66</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>81</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6859223792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingent Liabilities and Litigation (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 04, 2020 </div>
<div>StateAG </div>
<div>plaintiff </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,808.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,808.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,822.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidTotalSettlementCuyahogaandSummitCounties', window );">Opioid Total Settlement, Cuyahoga and Summit Counties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.0<span></span>
</td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="nump">5,729.0<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,272.0<span></span>
</td>
<td class="nump">33,464.0<span></span>
</td>
<td class="nump">110,955.0<span></span>
</td>
<td class="nump">103,021.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,165.0<span></span>
</td>
<td class="nump">$ 1,097.0<span></span>
</td>
<td class="nump">3,435.0<span></span>
</td>
<td class="nump">$ 3,315.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other Accrued Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,179.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,179.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,122.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsStateDomain', window );">Opioid Lawsuits State [Domain] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number</a></td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLitigationlessCuyahogaandSummitCountiesMember', window );">Opioid Litigation, less Cuyahoga and Summit Counties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CashComponentForSettlementFrameworkTerm', window );">Cash Component For Settlement Framework, Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,560.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLitigationCuyahogaandSummitCountiesMember', window );">Opioid Litigation, Cuyahoga and Summit Counties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsMember', window );">Opioid Lawsuits [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NumberofStateAttorneysGeneralfilinglawsuits', window );">Number of State Attorneys General filing lawsuits | StateAG</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember', window );">Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Loss Contingency, New Claims Filed, Number | lawsuit</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cah_CVSHealthMember', window );">CVS Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermPurchaseCommitmentPeriod', window );">Long-term Purchase Commitment, Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_MaximumQuarterlyPayment', window );">Maximum quarterly payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember', window );">Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Loss Contingency, New Claims Filed, Number | lawsuit</a></td>
<td class="nump">309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">466.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">466.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cah_AlamedaCountyMember', window );">Alameda County [Member] | Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Loss Contingency, Number of Plaintiffs | plaintiff</a></td>
<td class="nump">3,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember', window );">Other Jurisdictions [Member] | Product Liability Lawsuits | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Loss Contingency, Number of Plaintiffs | plaintiff</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PlaintiffTypeAxis=cah_PrivatePartiesMember', window );">Private Parties [Member] | Opioid Lawsuits [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number | lawsuit</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember', window );">Class Action Lawsuits [Member] | Private Parties [Member] | Opioid Lawsuits [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LossContingencyLawsuitsNumber', window );">Loss Contingency, Lawsuits, Number | lawsuit</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember', window );">Total Opioid Litigation, net of tax [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,140.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,630.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated Litigation Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,630.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,630.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain', window );">Sterile Surgical Gown Recall [Member] [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRecallExpense', window );">Inventory Recall Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Goods and Services Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other Accrued Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CashComponentForSettlementFrameworkTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Component For Settlement Framework, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CashComponentForSettlementFrameworkTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LossContingencyLawsuitsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Lawsuits, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LossContingencyLawsuitsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_MaximumQuarterlyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Quarterly Payment for pharmaceutical sourcing venture if certain milestones are achieved.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_MaximumQuarterlyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NumberofStateAttorneysGeneralfilinglawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of State Attorneys General filing lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NumberofStateAttorneysGeneralfilinglawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidTotalSettlementCuyahogaandSummitCounties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Opioid Total Settlement, Cuyahoga and Summit Counties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidTotalSettlementCuyahogaandSummitCounties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRecallExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRecallExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermPurchaseCommitmentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermPurchaseCommitmentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsStateDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLawsuitsStateDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLitigationlessCuyahogaandSummitCountiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLitigationlessCuyahogaandSummitCountiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLitigationCuyahogaandSummitCountiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLitigationCuyahogaandSummitCountiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_OpioidLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_OpioidLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cah_ProductLiabilityLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cah_CVSHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cah_CVSHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=cah_ProductLiabilityLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cah_AlamedaCountyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cah_AlamedaCountyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cah_OtherJurisdictionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PlaintiffTypeAxis=cah_PrivatePartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PlaintiffTypeAxis=cah_PrivatePartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LawsuitTypeAxis=cah_ClassActionLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationnetoftaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6856896576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details) - Performance Share Units<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Performance Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares) | shares</a></td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares) | shares</a></td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 51.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">43.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share) | $ / shares</a></td>
<td class="nump">48.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled and forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">50.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 51.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $</a></td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6838188112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Share Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6838353424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in the Balance of Accumulated Other Comprehensive Loss by Component and in Total</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:38%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Currency</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Translation</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain/(Loss) on</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Derivatives,</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprehensive</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(95</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(79</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(35</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(57</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(35</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(62</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(130</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(11</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(141</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6723426048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Costs</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes the components of lease cost:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:51%;"/><td style="width:1%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>31</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>92</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization of right-of-use assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease cost</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Variable lease cost</span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total lease cost</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>37</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>118</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Primarily includes payments for property taxes, maintenance and insurance. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock', window );">Leases Supplemental Balance Sheet Information</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes supplemental balance sheet information related to leases:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating lease right-of-use assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>469</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Current portion of operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>109</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#160;&#160;&#160;Long-term operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>381</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total operating lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>490</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Finance lease right-of-use assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Current portion of finance lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Long-term finance lease liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total finance lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeasePaymentsTableTextBlock', window );">Leases Supplemental Cash Flow Information</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following tables summarizes supplemental cash flow information related to leases:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:27%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Operating cash flows paid for operating leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>95</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Financing cash flows paid for finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Non-cash right-of-use assets obtained in exchange for lease obligations:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New operating leases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>154</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">New finance leases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>17</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amended lease standard adoption impact as of July 1, 2019 </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>400</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Includes the effect of </span><span style="font-family:Arial Narrow;font-size:8pt;"><span>$22 million</span></span><span style="font-family:Arial Narrow;font-size:8pt;"> from reclassifying deferred rent as an offset to the lease right-of-use asset in accordance with the transition guidance. </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Lease Payments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Future lease payments under non-cancellable leases as of </span><span style="font-family:Arial Narrow;font-size:10pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;"> were as follows:</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">                          </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:51%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Operating Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Finance Leases</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Remainder of 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>113</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>119</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>95</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>99</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>73</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>77</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>54</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>55</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>173</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>173</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total future lease payments</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>537</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>553</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: leases not yet commenced </span><span style="font-family:Arial Narrow;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span><span style="font-family:Arial Narrow;font-size:8pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: imputed interest</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>45</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total lease liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>490</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>14</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>504</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">As of </span><span style="font-family:Arial Narrow;font-size:8pt;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:8pt;">, we had certain leases that were executed but did not have control of the underlying assets; therefore, the lease liabilities and right-of-use assets are not recorded in the condensed consolidated balance sheets. </span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasePaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Lease Payments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasePaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeasesSupplementalBalanceSheetInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for LeasesSupplementalBalanceSheetInformation [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeasesSupplementalBalanceSheetInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6834759696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">14. Share-Based Compensation</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We maintain stock incentive plans (collectively, the &#8220;Plans&#8221;) for the benefit of certain of our officers, directors and employees. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides total share-based compensation expense by type of award:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>27</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>53</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>68</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The total tax benefit related to share-based compensation was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$5 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$4 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$12 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$13 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Restricted Share Units</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Restricted share units granted under the Plans generally vest in equal annual installments over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>three years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Restricted share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:52%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Restricted Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51.65</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>42.58</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>60.13</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>45.88</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$93 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>two years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Stock Options</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Employee stock options granted under the Plans generally vest in equal annual installments over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>three years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and are exercisable for </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>ten years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> from the grant date. All stock options are exercisable at a price equal to the market value of the common shares underlying the option on the grant date.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all stock option transactions under the Plans:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:57%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Stock</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercise Price per</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Common Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>63.78</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Exercised</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Outstanding at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>64.02</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercisable at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>63.96</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$1 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of less than </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>one year</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables provide additional detail related to stock options:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of outstanding options at period end</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercisable options at period end</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:58%;"/><td style="width:21%;"/><td style="width:2%;"/><td style="width:19%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in years)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of outstanding options</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of exercisable options</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Performance Share Units</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Performance share units vest over a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>three</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">-year performance period based on achievement of specific performance goals. Based on the extent to which the targets are achieved, vested shares may range from </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>zero</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>240 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the target award amount. Performance share units accrue cash dividend equivalents that are payable upon vesting of the awards.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:51%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Performance</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51.45</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>43.68</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>48.40</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>50.76</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>51.94</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance share units not yet recognized was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$29 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is expected to be recognized over a weighted-average period of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>two years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> if targets are achieved.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6835516304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Total Share-based Compensation Expense by Type of Award</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table provides total share-based compensation expense by type of award:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>20</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>27</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Restricted share unit expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>53</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock option expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Performance share unit expense</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total share-based compensation</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>68</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Transactions Under the Plans</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all stock option transactions under the Plans:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:57%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Stock</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercise Price per</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Common Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Outstanding at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>63.78</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Exercised</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Outstanding at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1.5px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>64.02</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Exercisable at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>63.96</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_AdditionalStockOptionPlanDataTableTextBlock', window );">Schedule of Additional Data Related to Stock Option Activity</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables provide additional detail related to stock options:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:58%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of outstanding options at period end</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Aggregate intrinsic value of exercisable options at period end</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:58%;"/><td style="width:21%;"/><td style="width:2%;"/><td style="width:19%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in years)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of outstanding options</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average remaining contractual life of exercisable options</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5</span></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Transactions Related to Restricted Share Units Under the Plans</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to restricted share units under the Plans:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:52%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:24%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Restricted Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51.65</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>42.58</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>60.13</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span></span><br/></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>45.88</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of Transactions Related to Performance Share Units Under the Plans</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes all transactions related to performance share units under the Plans (based on target award amounts):</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:51%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:25%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions, except per share amounts)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Performance</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Share Units</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-Average</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Grant Date Fair</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Value per Share</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Nonvested at June 30, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>51.45</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>43.68</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>48.40</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Canceled and forfeited</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(0.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>50.76</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;text-indent:12px;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nonvested at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>51.94</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_AdditionalStockOptionPlanDataTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A disclosure of additional data related to all stock option activity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_AdditionalStockOptionPlanDataTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6714928256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance Narative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee-related costs</a></td>
<td class="num">$ (15)<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_FacilityExitAndOtherCosts', window );">Facility Exit and Other Costs</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_FacilityExitAndOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Facility exit and other costs primarily consist of lease termination costs, accelerated depreciation, equipment relocation costs, project consulting fees and costs associated with restructuring our delivery of information technology infrastructure services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_FacilityExitAndOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6834760496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">8. Income Taxes</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Fluctuations in our provision for/(benefit from) income taxes as a percentage of pretax earnings (&#8220;effective tax rate&#8221;) are generally due to changes in international and U.S. state effective tax rates resulting from our business mix and discrete items. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Opioid Settlement Framework</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In connection with the </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> pre-tax charge for the opioid litigation, during the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> we recorded a tax benefit of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$487 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, which is net of unrecognized tax benefits of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$468 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, reflecting our current assessment of the estimated future deductibility of the amount that may be paid. We have made reasonable estimates and recorded amounts based on management's judgment and our current understanding of the Tax Act; however, these estimates require significant judgment since the definitive settlement terms and documentation, including provisions related to deductibility, under the Settlement Framework have not been negotiated and the U.S. tax law governing deductibility was changed by the U.S. Tax Cuts and Jobs Act ("Tax Act"). Further, it is possible that the tax authorities could challenge our interpretation of the Tax Act or the estimates and assumptions used to assess the future deductibility of these benefits. The actual amount of the tax benefit related to uncertain tax positions may differ materially from these estimates. See </span><a href="#s8AD44EFDC5135A2C93CB707A0F4CCE02" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 7</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for more information regarding these matters.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Effective Tax Rate</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the three months ended&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;and&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the effective tax rate was&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>26.8</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent and&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>20.0</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;percent, respectively. The increase in the effective tax rate from the prior period was </span><span style="color:#000000;font-family:Arial Narrow;font-size:10pt;">primarily due to changes in discrete tax items and jurisdictional mix.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;and&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, the effective tax rate was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>5.2</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;percent and&#160;</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>22.6</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">&#160;percent, respectively.  The decrease in the effective tax rate from fiscal 2019 to fiscal 2020 was primarily due to the net tax effects of </span><span style="font-family:Arial Narrow;font-size:10pt;">the Settlement Framework.  </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Unrecognized Tax Benefits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$919 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$456 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of unrecognized tax benefits, respectively. The </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> balances include </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$772 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$303 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of unrecognized tax benefits, respectively, that if recognized, would have an impact on the effective tax rate. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we had </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$137 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$122 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, accrued for the payment of interest and penalties related to unrecognized tax benefits, which we recognize in the provision for/(benefit from) income taxes in the condensed consolidated statements of earnings/(loss). These balances are gross amounts before any tax benefits and are included in deferred income taxes and other liabilities in the condensed consolidated balance sheets. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">It is reasonably possible that there could be a change in the amount of unrecognized tax benefits within the next 12 months due to activities of the U.S. Internal Revenue Service ("IRS") or other taxing authorities, possible settlement of IRS and other audit issues, </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">reassessment of existing unrecognized tax benefits or the expiration of statutes of limitations. We estimate that the range of the possible change in unrecognized tax benefits within the next 12 months is between </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>zero</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and a net decrease of up to </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$350 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, exclusive of penalties and interest.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Tax Matters</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We file income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions and various foreign jurisdictions. With few exceptions, we are subject to audit by taxing authorities for fiscal years </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>2008</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> through the current fiscal year. Tax laws are complex and subject to varying interpretations. Tax authorities have challenged some of our tax positions, including IRS challenges to our international transfer pricing for the periods from 2008 to 2014, and it is possible that they will challenge others. These challenges may adversely affect our effective tax rate or tax payments.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We are a party to a tax matters agreement with CareFusion Corporation ("CareFusion"), a subsidiary of Becton, Dickinson and Company. Under the tax matters agreement, CareFusion is obligated to indemnify us for certain tax exposures and transaction taxes prior to our fiscal 2010 spin-off of CareFusion. The indemnification receivable was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$173 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$165 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and is included in other assets in the condensed consolidated balance sheets.</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">As a result of the acquisition of the Patient Recovery Business, Medtronic plc is obligated to indemnify us for certain tax exposures and transaction taxes related to periods prior to the acquisition under the purchase agreement. The indemnification receivable was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$18 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$22 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and is included in other assets in the condensed consolidated balance sheet.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Future adjustments to the financial statements may be necessary as final tax regulations related to U.S. Tax Reform are issued. We will assess any impact as additional guidance is issued.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6843387904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock', window );">Investments</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">4. Investments</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In August 2018, we sold our </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>98 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> ownership interest in naviHealth Holdings, LLC ("naviHealth") to investor entities controlled by Clayton, Dubilier &amp; Rice in exchange for cash proceeds of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$737 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (after adjusting for certain fees and expenses) and a </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>44 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> equity interest in a partnership that owns </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>100 percent</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of the equity interest of naviHealth. We also have certain call rights to reacquire naviHealth. We are accounting for this investment using the equity method of accounting and on a one-month reporting lag.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we recognized a pre-tax gain of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$508 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> related to this divestiture in impairments and (gain)/loss on disposal of assets in our condensed consolidated statements of earnings/(loss).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The carrying value of this investment was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$330 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$334 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> as of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. During the three and </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, our proportionate share of naviHealth&#8217;s net loss, which was recorded in other (income)/ expense, net in the condensed consolidated statements of earnings/(loss), was immaterial.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment holdings.  This includes the information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>255</ContextCount>
  <ElementCount>379</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>84</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Condensed Consolidated Statements of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CondensedConsolidatedStatementsOfEarnings</Role>
      <ShortName>Condensed Consolidated Statements of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003000 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004000 - Statement - Condensed Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CondensedConsolidatedStatementsOfShareholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005000 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Restructuring and Employee Severance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeverance</Role>
      <ShortName>Restructuring and Employee Severance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2105100 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2107100 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2110100 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2111100 - Disclosure - Commitments, Contingent Liabilities and Litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation</Role>
      <ShortName>Commitments, Contingent Liabilities and Litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2113100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2115100 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2116100 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2117100 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc.</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2118100 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2119100 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2201201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Restructuring and Employee Severance (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</Role>
      <ShortName>Restructuring and Employee Severance (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeverance</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssets</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2308301 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/Leases</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2310301 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowings</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2313301 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2315301 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstruments</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2316301 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquity</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2317301 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthInc</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2318301 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2319301 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2401402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeRecentFinancialAccountingStandardsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceActivityRelatedToRestructuringAndEmployeeSeveranceCostsDetails</Role>
      <ShortName>Restructuring and Employee Severance (Activity Related to Restructuring and Employee Severance Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2403403 - Disclosure - Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceLiabilitiesAssociatedWithRestructuringAndEmployeeSeveranceActivitiesDetails</Role>
      <ShortName>Restructuring and Employee Severance (Liabilities Associated with Restructuring and Employee Severance Activities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2403404 - Disclosure - Restructuring and Employee Severance Narative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceNarativeDetails</Role>
      <ShortName>Restructuring and Employee Severance Narative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/RestructuringAndEmployeeSeveranceTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfGoodwillByReportableSegmentDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2405403 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2405404 - Disclosure - Goodwill and Other Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/GoodwillAndOtherIntangibleAssetsTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2407401 - Disclosure - Investments Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/InvestmentsInvestmentsDetails</Role>
      <ShortName>Investments Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LeasesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Leases Schedule of Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesScheduleOfLeaseCostsDetails</Role>
      <ShortName>Leases Schedule of Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Leases Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Leases Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2408406 - Disclosure - Leases Schedule of Future Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LeasesScheduleOfFutureLeasePaymentsDetails</Role>
      <ShortName>Leases Schedule of Future Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2410402 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/LongTermObligationsAndOtherShortTermBorrowingsSummaryOfDebtDetails</Role>
      <ShortName>Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2411401 - Disclosure - Commitments, Contingent Liabilities and Litigation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigationDetails</Role>
      <ShortName>Commitments, Contingent Liabilities and Litigation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/CommitmentsContingentLiabilitiesAndLitigation</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2412401 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/IncomeTaxes</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2413402 - Disclosure - Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FairValueMeasurementsFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements (Fair Value of Assets and Liabilities Measured on a Recurring Basis) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2415402 - Disclosure - Financial Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2415403 - Disclosure - Financial Instruments Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/FinancialInstrumentsSummaryOfEstimatedFairValueOfLongTermObligationsAndOtherShortTermBorrowingsDetails</Role>
      <ShortName>Financial Instruments Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2416402 - Disclosure - Shareholders' Equity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>Shareholders' Equity (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquityTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2416403 - Disclosure - Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareholdersEquityChangesInAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Shareholders' Equity (Changes in the Accumulated Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareholdersEquityTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2417402 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncNarrativeDetails</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2417403 - Disclosure - Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncReconciliationOfCommonSharesUsedToComputeBasicAndDilutedEpsDetails</Role>
      <ShortName>Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/EarningsPerShareAttributableToCardinalHealthIncTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2418402 - Disclosure - Segment Information (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2418403 - Disclosure - Segment Information (Revenue by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationRevenueByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Revenue by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2418404 - Disclosure - Segment Information (Segment Profit by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationSegmentProfitByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Segment Profit by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2418405 - Disclosure - Segment Information Revenue From External Customers By Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationRevenueFromExternalCustomersByGeographicAreasDetails</Role>
      <ShortName>Segment Information Revenue From External Customers By Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2418406 - Disclosure - Segment Information (Assets by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/SegmentInformationAssetsByReportableSegmentDetails</Role>
      <ShortName>Segment Information (Assets by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/SegmentInformationTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2419402 - Disclosure - Share-Based Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2419403 - Disclosure - Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfTotalShareBasedCompensationExpenseByTypeOfAwardDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Total Share-Based Compensation Expense by Type of Award) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2419404 - Disclosure - Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllStockOptionTransactionsUnderPlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2419405 - Disclosure - Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAdditionalDataRelatedToStockOptionsDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2419406 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToRestrictedShareUnitsUnderPlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Transactions Related to Restricted Share Units Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="a20q310q033120form10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2419407 - Disclosure - Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardinal.com/role/ShareBasedCompensationScheduleOfAllTransactionsRelatedToPerformanceShareUnitsUnderPlansDetails</Role>
      <ShortName>Share-Based Compensation (Schedule of All Transactions Related to Performance Share Units Under the Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cardinal.com/role/ShareBasedCompensationTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="a20q310q033120form10-q.htm">a20q310q033120form10-q.htm</File>
    <File>a20q310q33120exhibit311.htm</File>
    <File>a20q310q33120exhibit312.htm</File>
    <File>a20q310q33120exhibit321.htm</File>
    <File>a20q310q33120exhibit991.htm</File>
    <File>cah-20200331.xsd</File>
    <File>cah-20200331_cal.xml</File>
    <File>cah-20200331_def.xml</File>
    <File>cah-20200331_lab.xml</File>
    <File>cah-20200331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>chart-63966054a2b856539df.jpg</File>
    <File>chart-84be621792a45ea38bb.jpg</File>
    <File>chart-90453b3d6ed050ecbdc.jpg</File>
    <File>chart-b4b418d5d2515afb95c.jpg</File>
    <File>chart-c5eb687c6be4546d867.jpg</File>
    <File>chart-d47fafa037625ec1989.jpg</File>
    <File>chart-f71680c275d85d55b02.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6834688544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc.<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share Attributable to Cardinal Health, Inc.</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:13pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">12. Earnings Per Share Attributable to Cardinal Health, Inc.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table reconciles the number of common shares used to compute basic and diluted earnings per share attributable to Cardinal Health, Inc.:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:70%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>292</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>298</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units and performance share units</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>294</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>299</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:70%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted-average common shares&#8211;basic</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>293</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>301</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Effect of dilutive securities:</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee stock options, restricted share units and performance share units</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Weighted-average common shares&#8211;diluted</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>293</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>302</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>4 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>7 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>2 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> of which were anti-dilutive as a result of the year-to-date net loss).</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive were </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>6 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> during both the three months and the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6836181024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 5,729<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_ProjectCostsOnInvestmentAndOtherSpending', window );">Project costs on investment and other spending</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember', window );">naviHealth [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_PreTaxGainonDivestiture', window );">Pre-Tax Gain on Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember', window );">Total Opioid Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Gain (Loss) Related to Litigation Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_GownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain', window );">Sterile Surgical Gown Recall [Member] [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRecallExpense', window );">Inventory Recall Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_PreTaxGainonDivestiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Tax Gain on Divestiture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_PreTaxGainonDivestiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_ProjectCostsOnInvestmentAndOtherSpending">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment spending at the Corporate level. Investment spending generally includes the first year spend for certain projects that require incremental investments in the form of additional operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_ProjectCostsOnInvestmentAndOtherSpending</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRecallExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRecallExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cah_NaviHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_OpioidLitigationAxis=cah_TotalOpioidLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_GownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_GownRecallAxis=cah_SterileSurgicalGownRecallMemberDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6829008160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Narrative) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury Stock, Shares, Acquired</a></td>
<td class="num">(7.3)<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury shares acquired, average price per share (in usd per share)</a></td>
<td class="nump">$ 48.00<span></span>
</td>
<td class="nump">$ 52.32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TreasuryStockAcquiredShares', window );">Treasury Stock Acquired Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TreasuryStockAcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Acquired Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TreasuryStockAcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6835493264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of Additional Data Related to Stock Options) (Details) - Stock Options - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of outstanding options at period end</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of exercisable options at period end</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6836227888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information (Assets by Reportable Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 41,148<span></span>
</td>
<td class="nump">$ 40,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">22,508<span></span>
</td>
<td class="nump">22,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">15,445<span></span>
</td>
<td class="nump">15,284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 3,195<span></span>
</td>
<td class="nump">$ 3,233<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6723908032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Schedule of Lease Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalFinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalFinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Finance Lease Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalFinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6856622848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings/(loss)</a></td>
<td class="num">$ (4,350)<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">688<span></span>
</td>
<td class="nump">759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on Sale of Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairments and (gain)/loss on disposal of assets, net</a></td>
<td class="nump">7<span></span>
</td>
<td class="num">(492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on Extinguishment of Debt</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for bad debts</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Increase in trade receivables</a></td>
<td class="num">(653)<span></span>
</td>
<td class="num">(156)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(345)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase in accounts payable</a></td>
<td class="nump">448<span></span>
</td>
<td class="nump">846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other accrued liabilities and operating items, net</a></td>
<td class="nump">5,425<span></span>
</td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,720<span></span>
</td>
<td class="nump">2,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of subsidiaries, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property and equipment</a></td>
<td class="num">(239)<span></span>
</td>
<td class="num">(192)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Purchaseofavailableforsalesecuritiesandotherinvestments', window );">Purchase of investments</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments', window );">Proceeds from return of investments</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets', window );">Proceeds from divestitures and disposal of property and equipment and held for sale assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">749<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by/(used in) investing activities</a></td>
<td class="num">(249)<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net change in short-term borrowings</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Reduction of long-term obligations</a></td>
<td class="num">(888)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation', window );">Net proceeds/(tax withholdings) from share-based compensation</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends on common shares</a></td>
<td class="num">(428)<span></span>
</td>
<td class="num">(435)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="num">(350)<span></span>
</td>
<td class="num">(600)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,672)<span></span>
</td>
<td class="num">(1,050)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rates changes on cash and equivalents</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase/(decrease) in cash and equivalents</a></td>
<td class="num">(202)<span></span>
</td>
<td class="nump">1,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents at beginning of period</a></td>
<td class="nump">2,531<span></span>
</td>
<td class="nump">1,763<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and equivalents at end of period</a></td>
<td class="nump">$ 2,329<span></span>
</td>
<td class="nump">$ 3,438<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Netproceedstaxwithholdingsfromsharebasedcompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow/(outflow) associated with the amount received from holders exercising their stock options and paid by the company to satisfy an employee's income tax withholding obligation when shares are withheld from settlement of a share-based award to cover taxes. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Netproceedstaxwithholdingsfromsharebasedcompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from divestitures and disposal of property and equipment and held for sale assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of available-for-sale securities and other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Purchaseofavailableforsalesecuritiesandotherinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from purchases of available-for-sale securities and other investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Purchaseofavailableforsalesecuritiesandotherinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6847180512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings/(loss)</a></td>
<td class="nump">$ 351<span></span>
</td>
<td class="nump">$ 296<span></span>
</td>
<td class="num">$ (4,350)<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income/(loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments and other</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax', window );">Net unrealized loss on derivative instruments, net of tax</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income/(loss), net of tax</a></td>
<td class="num">(38)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income/(loss)</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="num">(4,412)<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to Cardinal Health, Inc.</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">$ 308<span></span>
</td>
<td class="num">$ (4,414)<span></span>
</td>
<td class="nump">$ 1,150<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6858547200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLongTermandShortTermObligations', window );">Total Long-Term and Short-Term Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.4Notesdue2020Member', window );">2.4% Notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of Notes Payable</a></td>
<td class="nump">$ 450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member', window );">2.616% Notes due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member', window );">3.41% Notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember', window );">Committed Receivables Sales Facility Program [Member] | Short Term Credit Facilities Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member', window );">4.6% Notes due 2043 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member', window );">4.9% Notes due 2045 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member', window );">4.368% Notes due 2047 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member', window );">3.2% Notes due 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member', window );">Floating Rate Notes due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_NotesPayableRepurchased', window );">Notes Payable Repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_NotesPayableRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal Amount of Notes Payable Repurchased during the year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_NotesPayableRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLongTermandShortTermObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Long-Term and Short-Term Obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLongTermandShortTermObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.4Notesdue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.4Notesdue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_CommittedReceivablesSalesFacilityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cah_ShortTermCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>74
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MKC_\+L(N&+NS_]CX+-@V\.LNVB]02P,$%     @ XDFK4)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M2XKF[V3_7I19VK52#26-O[6_EVOS>^_:_PR3 [ +P$= U?>S -4%J.\!WM,
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M+"MM-7QW7N7E;./#XR:QQ[*^--5UWIX]MS=E=NO.U9W'X?[Z?U!+ P04
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M7Q>GW_F=WE3YH?L-X_#\0\K'_P%02P,$%     @ XDFK4,L!W#DJ!   -Q0
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M%8>.9:,Q,C5 9B;L(!K&O+C>0EEH7(8P-C7 9L89KB43%XJ[ 1K'*M:.-UX
MSHP37(-:DD(Q-5+53Z!KY6!X:@1/SG$ML4A&B[F1JOXEQ;&O-*:GEC4GA9SE
ML^CQ79TT<98#E8Y$*1(\'+>4MCF.)U.MMZNO53<<;#RTWD^_GFDXKF'M&_6T
MG<ZP?H:9CM0^Y\WQ7+7>:]UU=3D>V1SJNK.]R?!#;_)D\_W]IK"';KA,^NMF
M.LJ:;KKZ,A_3!?>SPO7_4$L#!!0    ( .))JU#XQ)>EM $  -(#   8
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL?5-A;]P@#/TKB!]0<MRMZTY)I%ZG
M:I,VZ=1I[6<N<1)4""F02_?O9TB:IFVV+X"-W_.S,>E@[*-K #QYUJIU&6V\
M[_:,N:(!+=R%Z:#%F\I8+3R:MF:NLR#*"-**\22Y9%K(EN9I]!UMGIK>*]G"
MT1+7:RWLGP,H,V1T0U\<=[)N?'"P/.U$#;_ _^Z.%BTVLY120^ND:8F%*J/7
MF_UA%^)CP+V$P2W.)%1R,N8Q&-_+C"9!$"@H?& 0N)WA!I0*1"CC:>*D<\H
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M3RPH18N7<9=MW(?QYGH[P=8!? +P&;"/>=B8*"K_(KS(4VL&8L?>=R(\\>;
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MG7_9V/]6:P=>RN[&CU#O/]AB"&A=.'[T9S./V6PX/:0?1)9O7/T"4$L#!!0
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MV&PHJ'PX?L:S'<=L-+SIIA_$YF^<_P502P,$%     @ XDFK4(4W(I>S 0
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M/YMQS$;#83?](#9_X_P#4$L#!!0    ( .))JU#$2ZDFM@$  -(#   9
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MIO+)<!3AFS-O7/92TG2?DXL76C#'&4,WF-V*($Y]+4%C)8[T'SJ-T_=1A_M
MWV_IR7\$TJA &@32OUI,;UJ,8;)XD2Q:)(L(W-\4B6$>;HJ0S<5)T&UXL@95
M:NS#N&RRZU0\TG#Q?^#S2'UANN6]06=EW?,)E]PH9<%92>Z<E\Y-\1H(:*S?
M/KB]GM_R'%@U+&-*UO^*\C=02P,$%     @ XDFK4"4^#K#! 0  -P0  !D
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M\PF7W"AEP:62W+E<.M?%ZT) 8_WTP<WU_);GA57#TJ9D_5>4?P!02P,$%
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MM19"@TDEN#-=;<U[M!@,:FVW>[.7TU1.AA;#_."0Y=4K_@!02P,$%     @
MXDFK4+ )0L"X 0  T@,  !D   !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL
M;5/M;ML@%'T5Q .4F*1)%MF6FD[3)FU2U&G=;V)?VZC@ZP&.N[<?8-?S.O\!
M[N6<<S^XI .:%]L ./*J56LSVCC7G1BS10-:V#OLH/4W%1HMG#=-S6QG0)21
MI!7CF\V>:2%;FJ?1=S%YBKU3LH6+(;;76IC?9U X9#2A;XXG63<N.%B>=J*&
M[^!^=!?C+3:KE%)#:R6VQ$"5T8?D=-X%? 0\2QCLXDQ")5?$EV!\*3.Z"0F!
M@L(%!>&W&SR"4D'(I_%KTJ1SR$!<GM_4/\7:?2U78>$1U4]9NB:C1TI*J$2O
MW!,.GV&JYYZ2J?BO< /EX2$3'Z- 9>-*BMXZU).*3T6+UW&7;=R'\69_/]'6
M"7PB\)EPC''8&"AF_E$XD:<&!V+&WG<B/'%RXKXW17#&5L0[G[SUWEO.]X>4
MW8+0A#F/&+[ )#.">?4Y!%\+<>;_T?DZ?;N:X3;2MTMZ<E@7V*T*[*+ [I\2
MC^]*7,-\>!>$+7JJP=1QFBPIL&_C)"^\\\ ^\/@F?^'CM'\3II:M)5=T_F5C
M_RM$!SZ5S9T?H<9_L-E04+EP//BS&<=L-!QVTP]B\S?._P!02P,$%     @
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M/K#)D5#Z8.[0ML.:#8XW[?B"V/2,LT]02P,$%     @ XDFK4#)I=DFS 0
MT@,  !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&UL;5-M;YLP$/XKEG]
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M+Z>IG PM^OG!P<NKE_\!4$L#!!0    ( .))JU!8;(].[@$  &8%   9
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MA]YL<+@8MTWM7HVM/QI&=M-4(_-H+?\"4$L#!!0    ( .))JU!8'<%.F@$
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M:P-..,VAM38 \K(KO,H.'_IL*&A#W-[BWHW7/1K!]M-+9O/O5/T 4$L#!!0
M   ( .))JU"^O//%3 (  "('   9    >&PO=V]R:W-H965T<R]S:&5E=#,T
M+GAM;(U578^;,!#\*XCWGODRR44$Z2"I6JF53G=J^^P0)Z SF-I.<OWWM0WA
MB&VE?0GV9F9V9PWK[$+9&Z\Q%MY[2SJ^]FLA^A4 O*IQB_@#[7$G_SE0UB(A
MM^P(>,\PVFM22T 4!"EH4=/Y>:9CSRS/Z$F0IL//S..GMD7L3X$)O:S]T+\&
M7IIC+50 Y%F/CO@5BQ_],Y,[,*GLFQ9WO*&=Q_!A[3^%JVVJ\!KPL\$7/EM[
MRLF.TC>U^;I?^X$J"!-<":6 Y..,2TR($I)E_!XU_2FE(L[75_7/VKOTLD,<
MEY3\:O:B7OM+W]OC SH1\4(O7_#H!_K>:/X;/F,BX:H2F:.BA.M?KSIQ0=M1
M19;2HO?AV73Z>1GUKS0W(1H)T420N>\1XI$0?Q"2NX1D)"3_FP&.!&AD (-W
MW<P-$BC/&+UX;'@=>J3>NG %Y7%5*JA/1_\G^\EE])S'09J!LQ(:,<6 B688
MN+B%;&Q(."& +&"J(G)54406/;I-4-H(N#1J^*?(]J[(39FQLUFQYL?S# %T
M"R1.@40+)#?=-EI9#)A48SJ-^11"HQLV)GHTNF%#$B/3UH8L K<;Z'0#'6Z,
M0RD&#)SE, HM;424&%YL2!P;7APJ"[>7U.DE=7@Q*BU2^V2,3Z6T(="H=&-#
MEH%AQH8\FF; [ -O,3OJ:<N]BIXZH5[1670:Z$^1&A!&O A79>B(;^0%,,SK
M#_GA]OB.V+'IN+>C0HXE/3P.E HL*P\>Y G4\L*:-@0?A%HNY)H-8WO8"-J/
M-Q*8KL7\+U!+ P04    " #B2:M0!JV<O'\"  !!"0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6R55EV/FS 0_"N(]QX8PD<B@I1<5;52*YVN:OOL
M$">@,YC:3G+]][6-0R$L$GT)MC,[LVMVL+,;XV^B)$0Z[S5MQ-8MI6PWGB>*
MDM18/+&6-.J?$^,UEFK*SYYH.<%'$U13+_#]V*MQU;AY9M9>>)ZQBZ150UZX
M(RYUC?F?/:'LMG61>U]XK<ZEU M>GK7X3+X3^:-]X6KF]2S'JB:-J%CC<'+:
MNCNTV:.U#C"(GQ6YB<'8T:4<&'O3DR_'K>OKC @EA=046#VNY)E0JIE4'K\M
MJ=MKZL#A^,[^R12OBCE@09X9_54=9;EU4]<YDA.^4/G*;I^)+2AR'5O]5W(E
M5,%U)DJC8%287Z>X",EJRZ)2J?%[]ZP:\[Q9_GL8'!#8@* /"+I:.B&3^4<L
M<9YQ=G-XM_DMUN\8;0*U-X5>-%MA_E/)"[5ZS4/D9]Y5$UG,OL,$ PSJ$9YB
M[R4"2&(?3,)#-$,0@CF&AB <$00PP0HD6!F"U8@@?"BRP\0&TQA,,J,1@1H1
MH+%ZT.@PT4 C3F"-&-2( 8WH02.>:'R(4E@D 4420"1^$$DF(NG,&TU!C130
MF-F)-4BP7MX2R(<;WU_0%!8T>F.K&9D9?Z$%?6%!0YEH9CL0Z+$="A:TA@6-
M>R.:T8&MB,(%W6%!HUV+9V1@PR+ L?Y,%R/8CRCZCQ:![88@OTU:9&JXN41A
MOR'(<),.F3IN\)D>R\"60Y#G)AV23CLDG)&!C8G62QID/?G8HL<^] 8G6$WX
MV9S=PBG8I3$7A\%J?S_8!>8$_ ?O+A??,#]7C7 .3*ISU)QV)\8D4:GX3ZK6
M4MUG^@DE)ZF'B1KS[E#O)I*U]L+B];>F_"]02P,$%     @ XDFK4.R+\/H[
M @  N08  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&ULC559CYLP$/XK
MB/>NN;,;$:3-4;52*T6[:OOLP"2@-9C:3MC^^]J&L,18:5_ 'KYCQL>0=I2]
M\1) ..\U:?C*+85HEPCQO(0:\P?:0B._'"FKL9!3=D*\98 +3:H)"CPO036N
M&C=+=6S/LI2>!:D:V#.'G^L:LS]K(+1;N;Y[#;Q4IU*H ,K2%I_@%<2/=L_D
M#(TJ155#PRO:. R.*_?97^X2A=> GQ5T?#)V5"4'2M_4Y&NQ<CV5$!#(A5+
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M7O8-;S_0HG7-?#+\HUC_ U!+ P04    " #B2:M08-8<?I<#  "&$   &0
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MG10:6AY1<R5P1\_$X3$$T(E-.L2>W-!<IC5"1<RQ1PCTHUM" 9W$D0(;#OF
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MVDXS,Y=#OQH,+;JQ%Y/I@U#^!U!+ P04    " #B2:M0W.'U:.<!   ]!0
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MP3)SEB!1Z.B,!*98((H=:XG [(DEK;.C=P8;GVV)L)D09E\"1+1R;!<"4RP
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MA5)*4]V*BQ0#52J*"1>X&+!H0K=B]!A@SRW]:^8CHZE>Q<0PA$R"77",#)^
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M6!]+*;*614G)XO?FF>3U\]SR?YCA!K0UH)V!FON:@=,:.)\&[E4#MS5PQ\[
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M8AU-+(;1-NT2PS#-(0SC:?L:P_BX0R'J4 @(G"# "8B-UUY[?+$@ ^6;(&Z
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MJ$7):H?#<>,^^>N=[^D$@_A50BM&:T=;V3/VIC??#AO7TXJ 0BXU!5&/"^R
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MBX(?9'N:JO.Z_R#07TAQUA\[@ML7E^5O4$L#!!0    ( .))JU"W!;\8$P(
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MA$:50U5#PRO:. R.2_?97VQ3A=> 'Q5T?+)W5"9[2M_4X<MAZ7HJ("!0"*6
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M>@(=*14@0_<>9-2E?/7& X&C4-M4[ED_^_N#H.WPK*'Q;<W_ %!+ P04
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M=D62&K1;3=!HBD9#8S"!+Q$5)\1$8JL  D*-(=>(S(\@&GB$'"V-(Z4Q/$&
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MV792*J$G[]_I97$0R;9O9&*GZMM0WY?M8;EM*'GL_@CP^G\CYO\ 4$L#!!0
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M1R:&$SXF74O031AN5;OC]3U7]A=02P,$%     @ XDFK4 "\6!MH @  =@@
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M]WSHA,- LF[L\M[TJ5'\!5!+ P04    " #B2:M0W-)P*2,"  !F!@  &0
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M7O^JCNJR#HLP.+(3O=;JA=\_LZ&@+ R&ZK^R&ZLUW&2B-0Z\EO8W.%REXLW
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M)-$(>Q,EO2>M:!$O2228DP;%!A-4&'AQNH("-;G'!"AJ@2( *O7"%1(L7AP
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MU.H'$%D>.;%U5E!J4)5\W(,#+<Q8W1\ FUO%*8\;F6^"H2(!'&^TN.+)Q;=
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MN/S\K]%Z\^I-R(HZKI;-!>!<C^&'8@;TY\>79\+.DO:F\4'UEKSSIGT8Y\"
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M@7DJOC5:C*U*F95\]$BSV_%@^@=* .)(5FJ9\FXEQP6YS8OIS'")/1Q\ZF(
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M?;S0="FAMRK.B9N\N*D_B\7N,#/.&6.3"AZI?RR8!-^P ,U%_8@ R8@3UR:
M9()#()BE L.I%1V1@NDA)7=H@^!=,XKI09\LW/M87Z\ZO3WD6: @0]A>U#_+
MSHJ:D7N ,DRI M:U)0<ME/-0\G=XW:L8DB6T6TI^B9J"BKBV^S5AV+*_9>A#
M!@QYA/2;'B2L+W%*&0U;I4V']6LVC1Y*/> [8EM+7)>; MKF6_ZZ0D$+HT:/
M,42R8C<8<7?XZ+I(KO'6QX: QV ,27V-"4X9L;JZ%NTA=DZ(6HSTT1 [A;\
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M57!";(%P05QLX5LR&M_6)8VWFKGATA"L5:,D4<^*;+2@#5Y)A#">6^BP_,I
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M['C;6*T"T0W*MN<:(;)_M#*)LSHHD5IR>:DY$C9RK=YW8K<:;]"E@FA]K4K
MXNIAEMF2_ (84)<"'\3EU$NI*+Z#=KPPQF2<I%7UG6A[WK*79GX&NZ[\(PQ\
MW8:4K,RK> LT )FWQS]AIL657@15F6R@\ZX]*H!)5U+1@L@PR*#?O!84M6I+
MPDJ_)0Y9RFY]R+U7"J=BBFK^1,&_QM;?V.C^V/Z5YG1F'3 [!W-W7@23:;@X
M1146NAA-Y\%'X77XYB7H0@PF( MJ&AB/)@$6 &JY4]023&;A:#3&MB?SD3[^
MJ_H0]:YCC;%).)N<PL_I9-1C1V?0_'0Z;+ 6-8)I.)R-H+7%R4B2I1IC/ U'
M\PD.=3P9F]T(#J>H&Z."/(4?_*YZYP6]-</4*GQOO'B2HO)].S<:3L(YS/Y%
M<#H+%XM%WZV;3\?!'$:\8^M&PVDXGDV#TWDX&\U[[MUH&$X7$_QG GNX>_=&
MX6RX@)_X=-L.CD;AZ>D(_YF?+%KV<#2:A^/I##I>A"-0'6N[."*+"I!L<Q_I
MS<F$UA/>78QHA2^](FN.($ QX2CAH?9MCV(PXJ*5E#0",%*0>#LE#Z?3P0%M
M][DM'V,D?,ON6:5D&"N >%=/RC#<$?>RT65]@_Q][<.$<7/,5JE-$9Q-$VJ0
M$LRI<N*31_FX3@'F>E*?$/XT2]G&0:,XK]?VTV3\L-.W,1JU-W=HW2GBZ(E,
MVKVT@&LLPN')A/GO>#)4>"!RUX_"X>D0?Z+&OQ_3&OW63*L^D]%H BR6#Q!P
M^]/Z7";PV9BJJD_W/[RCIQS>_RZ*4GHR, _$W,%("U$%]91ME4Z[T?27]![*
M9IC8(T(G>[.LUOFIP!*F9'AAD*+6IS[UHIC7GK&9>4AXPW 60NTT('74 DV^
M1U>/0CL_.+(2*-3@-!2Z^DHKS60A.>8Y.QFZ5CBT4G;,&ANWA6Z0E+<[<KK>
M5)D),U%X(>85HR"%UJ<<@X+!M<HK+KF9&N28U 3N07'A,+BKH#FCJH>!@WD;
M+^^R/,UO!8J B\Q(L.XF3;A#:XP2-V>!"SL5:086#>N)DPK=1GV&FD Z7Y$B
MAGN-+E&@ 04#92'Y:MJ.!+I<@^L"S6WO\A5.1SO6V;K6C%?.<ETGP([-KD4H
MB2#LTKF=6*BF)8$BBBES_(^DAQF[3AJ5VV.,+,3ZD,>@[X;H2CX\>'_Q[A,B
MH!C@>*D \/*0LRD1'MLI.*&*2="BOV)C7Z64=PJ!T&9!2A>#;7R%Q[/8VBG>
M*N1!XV,<JY@H:1=S!)/"2/R'&/IS]%(%16.MO;SD$D:<Y/2J5]'%5P(GI$K[
M&GPG&\N#,#QLY)]775$TKQIY"O*Q&FS\#?5<F.F="@W"@-]71A]5X&.!C>95
M2RM4]&^%S952CLI\2<9)E!<PFHJAA4 :X<K#B-"92>Z1Q4NL, 9=S+K8R;<O
MFJ.P4&HU3 '1)I$<+B,_ZJ"LP/3_$>L 7I6W:M>/K:7O25C4FC;>X'H8TZ=A
ML*HB =?J,-'.!-,MW1(V (Y*HJXX"2.Y=SDAN<D9%8;1*S5_V1JNXU\4.<>&
M-PGFCF/:]QNT=P55,0I@+61K,M_?:= :J-62B-*LQHFI*'!<JI)\Z)+;JE)2
M3DRE$8EFCW:68MTGSLS&P.9MBE>-G?%.Q,O8GF,N5NF4O?",GSB/++I/1'7
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M<4T8=730UAM'C'-$)+FR8S<"W:1^J6CS:@.+0@*"0?ZGL[<[&!Q%(R<#Q2*
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M=[W7'Q&JVQF'!>IW9B=M,?Z]?DZ[BP/E+_ZL533GO4LVB1[^C<,IT#QTPVM
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MGI\Y=YR(GGB#+M]N>^E[#\O+LMS^^7\#4$L#!!0    ( .))JU"-D3U AP(
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M.C;$$<JINC9;+)T>;,<?C7!WW*R:-0@/MN-/."0Y*SM^I_V6]'\#4$L#!!0
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M96_;X;LD#\YMWN>SZ9]Y5_\!4$L! A0#%     @ XDFK4!\CSP/     $P(
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M4$L! A0#%     @ XDFK4$:(YQS6 @  M@H  !@              ( !7Q$
M 'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( .))JU#D8WYE
MN@,  %81   8              "  6L4  !X;"]W;W)K<VAE971S+W-H965T
M-"YX;6Q02P$"% ,4    " #B2:M0SW,C'/P!    !@  &
M@ %;&   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ XDFK
M4*.,&.7D!@  5"D  !@              ( !C1H  'AL+W=O<FMS:&5E=',O
M<VAE970V+GAM;%!+ 0(4 Q0    ( .))JU#+ =PY*@0  #<4   8
M      "  :<A  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M" #B2:M0^,27I;0!  #2 P  &               @ $')@  >&PO=V]R:W-H
M965T<R]S:&5E=#@N>&UL4$L! A0#%     @ XDFK4 _).56U 0  T@,  !@
M             ( !\2<  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4
M Q0    ( .))JU" LL]0M0$  -(#   9              "  =PI  !X;"]W
M;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ XDFK4*JDBM6S 0
MT@,  !D              ( !R"L  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX
M;6Q02P$"% ,4    " #B2:M0?=WXPK0!  #2 P  &0              @ &R
M+0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( .))JU!5
M 1+\M0$  -(#   9              "  9TO  !X;"]W;W)K<VAE971S+W-H
M965T,3,N>&UL4$L! A0#%     @ XDFK4#*:>FZT 0  T@,  !D
M     ( !B3$  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .))JU#/YXP?M0$  -(#   9              "
M 2([  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ XDFK
M4,1+J2:V 0  T@,  !D              ( !#CT  'AL+W=O<FMS:&5E=',O
M<VAE970R,"YX;6Q02P$"% ,4    " #B2:M0<T1ZN+,!  #2 P  &0
M        @ '[/@  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0
M   ( .))JU#S+.5<P0$  #<$   9              "  >5   !X;"]W;W)K
M<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ XDFK4"4^#K#! 0  -P0
M !D              ( !W4(  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q0
M2P$"% ,4    " #B2:M05-Q?)\0!   W!   &0              @ '51
M>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( .))JU 53%UU
MX@$   $%   9              "  =!&  !X;"]W;W)K<VAE971S+W-H965T
M,C4N>&UL4$L! A0#%     @ XDFK4+ )0L"X 0  T@,  !D
M ( !Z4@  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " #B
M2:M0$)AS)+8!  #2 P  &0              @ '82@  >&PO=V]R:W-H965T
M<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( .))JU"8GN'?LP$  -(#   9
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M970S,BYX;6Q02P$"% ,4    " #B2:M06!W!3IH!  !: P  &0
M    @ '!5@  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (
M .))JU"^O//%3 (  "('   9              "  9)8  !X;"]W;W)K<VAE
M971S+W-H965T,S0N>&UL4$L! A0#%     @ XDFK4 :MG+Q_ @  00D  !D
M             ( !%5L  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"
M% ,4    " #B2:M0[(OP^CL"  "Y!@  &0              @ '+70  >&PO
M=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( .))JU#R]5RI[0(
M %T,   9              "  3U@  !X;"]W;W)K<VAE971S+W-H965T,S<N
M>&UL4$L! A0#%     @ XDFK4&#6''Z7 P  AA   !D              ( !
M86,  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " #B2:M0
M!Q[TYOP"  !'#   &0              @ $O9P  >&PO=V]R:W-H965T<R]S
M:&5E=#,Y+GAM;%!+ 0(4 Q0    ( .))JU#:&_N'5@(  .T'   9
M      "  6)J  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%
M  @ XDFK4(V6XIA4 @  /0@  !D              ( ![VP  'AL+W=O<FMS
M:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " #B2:M0_3.)5"4"  ""!@
M&0              @ %Z;P  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+
M 0(4 Q0    ( .))JU"&YT7U"@(  !P&   9              "  =9Q  !X
M;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ XDFK4-SA]6CG
M 0  /04  !D              ( !%W0  'AL+W=O<FMS:&5E=',O<VAE970T
M-"YX;6Q02P$"% ,4    " #B2:M0O,&),$4#   "$   &0
M@ $U=@  >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( .))
MJU"'N*W1M0,  %<2   9              "  ;%Y  !X;"]W;W)K<VAE971S
M+W-H965T-#8N>&UL4$L! A0#%     @ XDFK4)>/7G_R P  A!4  !D
M         ( !G7T  'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4
M    " #B2:M0&.7QZO0$   U'   &0              @ '&@0  >&PO=V]R
M:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( .))JU#^S4>+AP,  #\0
M   9              "  ?&&  !X;"]W;W)K<VAE971S+W-H965T-#DN>&UL
M4$L! A0#%     @ XDFK4"<+[S2M @  EPL  !D              ( !KXH
M 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " #B2:M0IGCS
MB- "   P"P  &0              @ &3C0  >&PO=V]R:W-H965T<R]S:&5E
M=#4Q+GAM;%!+ 0(4 Q0    ( .))JU#IO%^&VP$  -\$   9
M  "  9J0  !X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @
MXDFK4'$!BF-( @  ZP8  !D              ( !K)(  'AL+W=O<FMS:&5E
M=',O<VAE970U,RYX;6Q02P$"% ,4    " #B2:M0FWA%HJ0#  !]$0  &0
M            @ $KE0  >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4
M Q0    ( .))JU"W!;\8$P(  .<%   9              "  0:9  !X;"]W
M;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ XDFK4"\9L+Q+ @
M9P<  !D              ( !4)L  'AL+W=O<FMS:&5E=',O<VAE970U-BYX
M;6Q02P$"% ,4    " #B2:M0U8'J%:\"  #'"0  &0              @ '2
MG0  >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( .))JU!5
M#\D%DP,  )D0   9              "  ;B@  !X;"]W;W)K<VAE971S+W-H
M965T-3@N>&UL4$L! A0#%     @ XDFK4".ZB>#1 @  _PH  !D
M     ( !@J0  'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .))JU  O%@;: (  '8(   9              "
M 0:S  !X;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ XDFK
M4-S2<"DC @  9@8  !D              ( !I;4  'AL+W=O<FMS:&5E=',O
M<VAE970V-2YX;6Q02P$"% ,4    " #B2:M0U3*-XKL"  !="@  &0
M        @ '_MP  >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0
M   ( .))JU!?,?O]@ (  (\(   9              "  ?&Z  !X;"]W;W)K
M<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ XDFK4&=\CV:J:P  QL(!
M !0              ( !J+T  'AL+W-H87)E9%-T<FEN9W,N>&UL4$L! A0#
M%     @ XDFK4(V1/4"' @  6 X   T              ( !A"D! 'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " #B2:M04S2,Y24%  "0+   #P
M    @ $V+ $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ XDFK4!>M++HY
M @  7B@  !H              ( !B#$! 'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ XDFK4' MD!S\ 0  H2<  !,
M ( !^3,! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $P 3 #&%   )C8!
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6843402880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables present the fair values for assets and (liabilities) measured on a recurring basis at:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>647</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>647</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>96</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>96</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>170</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>170</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:46%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;2</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Level&#160;3</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other investments (1)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Forward contracts (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">The other investments balance includes investments in mutual funds, which are used to offset fluctuations in deferred compensation liabilities. These mutual funds invest in the equity securities of companies with both large and small market capitalization and high quality fixed income debt securities. The fair value of these investments is determined using quoted market prices.</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div>The fair value of interest rate swaps, foreign currency contracts, commodity contracts, and net investment hedges is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. The fair value of these derivative contracts, which are subject to master netting arrangements under certain circumstances, is presented on a gross basis in prepaid expenses and other, other assets, other accrued liabilities, and deferred income taxes and other liabilities within the condensed consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6858795120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Employee Severance (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Summary of Restructuring and Employee Severance</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes restructuring and employee severance:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Three Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(15</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>24</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:48%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:23%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Nine Months Ended March 31,</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related (1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>70</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other (2)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>33</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total restructuring and employee severance</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>80</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>97</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-related costs primarily consist of termination benefits provided to employees who have been involuntarily terminated, duplicate payroll costs and retention bonuses incurred during transition periods.</span></div></td></tr></table><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(2)</span></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility exit and other costs primarily consist of product distribution and lease contract termination costs, lease costs associated with vacant facilities, accelerated depreciation, equipment relocation costs, project consulting fees, vendor transition fees, costs associated with restructuring our delivery of information technology infrastructure services and certain other divestiture-related costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Activity Related to Liabilities Associated with Restructuring and Employee Severance</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes activity related to liabilities associated with restructuring and employee severance:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Employee-</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Related Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Facility Exit</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">and Other Costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>72</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>57</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>67</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Payments and other adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(55</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(58</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>66</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>15</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>81</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6843281376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Schedule of All Stock Option Transactions Under the Plans) (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Canceled and forfeited (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares) | shares</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period (in shares) | shares</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 63.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled and forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in usd per share) | $ / shares</a></td>
<td class="nump">64.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period (in usd per share) | $ / shares</a></td>
<td class="nump">$ 63.96<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6836790032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information Revenue From External Customers By Geographic Areas (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems', window );"><strong>Segment Revenue from External Customers by Geographic Area [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 39,157<span></span>
</td>
<td class="nump">$ 35,228<span></span>
</td>
<td class="nump">$ 116,233<span></span>
</td>
<td class="nump">$ 108,181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems', window );"><strong>Segment Revenue from External Customers by Geographic Area [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">38,073<span></span>
</td>
<td class="nump">34,230<span></span>
</td>
<td class="nump">113,053<span></span>
</td>
<td class="nump">105,190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems', window );"><strong>Segment Revenue from External Customers by Geographic Area [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">1,090<span></span>
</td>
<td class="nump">1,002<span></span>
</td>
<td class="nump">3,192<span></span>
</td>
<td class="nump">3,004<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems', window );"><strong>Segment Revenue from External Customers by Geographic Area [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">39,163<span></span>
</td>
<td class="nump">35,232<span></span>
</td>
<td class="nump">116,245<span></span>
</td>
<td class="nump">108,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems', window );"><strong>Segment Revenue from External Customers by Geographic Area [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="num">$ (6)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Segment Revenue from External Customers by Geographic Area [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_SegmentRevenuefromExternalCustomersbyGeographicAreaLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6856570832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income/(Loss)</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period (in shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Jun. 30, 2018</a></td>
<td class="nump">$ 6,059<span></span>
</td>
<td class="nump">$ 2,730<span></span>
</td>
<td class="nump">$ 4,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (92)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at beginning of period (in shares) at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at beginning of period at Jun. 30, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,224)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">1,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">1,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="num">(600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="num">(429)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(429)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2019</a></td>
<td class="nump">6,232<span></span>
</td>
<td class="nump">$ 2,748<span></span>
</td>
<td class="nump">5,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(111)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,793)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2018</a></td>
<td class="nump">6,043<span></span>
</td>
<td class="nump">$ 2,728<span></span>
</td>
<td class="nump">5,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at beginning of period (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at beginning of period at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,795)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="num">(143)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(143)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2019</a></td>
<td class="nump">$ 6,232<span></span>
</td>
<td class="nump">$ 2,748<span></span>
</td>
<td class="nump">5,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(111)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,793)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period (in shares) at Jun. 30, 2019</a></td>
<td class="nump">327.0<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Jun. 30, 2019</a></td>
<td class="nump">$ 6,330<span></span>
</td>
<td class="nump">$ 2,763<span></span>
</td>
<td class="nump">5,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at beginning of period (in shares) at Jun. 30, 2019</a></td>
<td class="num">(28.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at beginning of period at Jun. 30, 2019</a></td>
<td class="num">$ (1,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="num">(4,350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="num">(4,352)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="num">(350)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury shares acquired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="num">(426)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(426)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Mar. 31, 2020</a></td>
<td class="nump">327.0<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2020</a></td>
<td class="nump">$ 1,206<span></span>
</td>
<td class="nump">$ 2,774<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(141)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Mar. 31, 2020</a></td>
<td class="num">(35.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Mar. 31, 2020</a></td>
<td class="num">$ (2,086)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,086)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="nump">1,002<span></span>
</td>
<td class="nump">$ 2,752<span></span>
</td>
<td class="nump">449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at beginning of period at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="num">(142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at end of period (in shares) at Mar. 31, 2020</a></td>
<td class="nump">327.0<span></span>
</td>
<td class="nump">327.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2020</a></td>
<td class="nump">$ 1,206<span></span>
</td>
<td class="nump">$ 2,774<span></span>
</td>
<td class="nump">$ 656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (141)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury, balance at end of period (in shares) at Mar. 31, 2020</a></td>
<td class="num">(35.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury, balance at end of period at Mar. 31, 2020</a></td>
<td class="num">$ (2,086)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,086)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6829469280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Supplemental Balance Sheet Information (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6857319856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings Summary of Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Other Borrowings</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TotalLongTermandShortTermObligations', window );">Total Long-Term and Short-Term Obligations</a></td>
<td class="nump">7,262<span></span>
</td>
<td class="nump">8,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Long-term Debt and Lease Obligation, Current</a></td>
<td class="nump">508<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term Debt and Lease Obligation</a></td>
<td class="nump">6,754<span></span>
</td>
<td class="nump">7,579<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.4Notesdue2020Member', window );">2.4% Notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member', window );">4.625% Notes due 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">504<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member', window );">2.616% Notes due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">834<span></span>
</td>
<td class="nump">1,079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member', window );">3.2% Notes due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member', window );">Floating Rate Notes due 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member', window );">3.2% Notes due 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">573<span></span>
</td>
<td class="nump">551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.079Notesdue2024Member', window );">3.079% Notes due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">815<span></span>
</td>
<td class="nump">781<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.5Notesdue2025Member', window );">3.5% Notes due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.75Notesdue2026Member', window );">3.75% Notes due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">530<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member', window );">3.41% Notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">1,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member', window );">4.6% Notes due 2043 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.5Notesdue2044Member', window );">4.5% Notes due 2044 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member', window );">4.9% Notes due 2045 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">441<span></span>
</td>
<td class="nump">445<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member', window );">4.368% Notes due 2047 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">560<span></span>
</td>
<td class="nump">594<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member', window );">7.0% Debentures due fiscal 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes Payable</a></td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TotalLongTermandShortTermObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Long-Term and Short-Term Obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TotalLongTermandShortTermObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.4Notesdue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.4Notesdue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.625Notesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A2.616Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_FloatingRateNotesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.2Notesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.079Notesdue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.079Notesdue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.5Notesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.5Notesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.75Notesdue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.75Notesdue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A3.41Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.6Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.5Notesdue2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.5Notesdue2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.9Notesdue2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A4.368Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cah_A7.0Debenturesduefiscal2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6856827872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Earnings - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 39,157<span></span>
</td>
<td class="nump">$ 35,228<span></span>
</td>
<td class="nump">$ 116,233<span></span>
</td>
<td class="nump">$ 108,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">37,272<span></span>
</td>
<td class="nump">33,464<span></span>
</td>
<td class="nump">110,955<span></span>
</td>
<td class="nump">103,021<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">1,885<span></span>
</td>
<td class="nump">1,764<span></span>
</td>
<td class="nump">5,278<span></span>
</td>
<td class="nump">5,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Distribution, selling, general and administrative expenses</a></td>
<td class="nump">1,165<span></span>
</td>
<td class="nump">1,097<span></span>
</td>
<td class="nump">3,435<span></span>
</td>
<td class="nump">3,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and employee severance</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_Amortizationandotheracquisitionrelatedcosts', window );">Amortization and other acquisition-related costs</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairments and (gain)/loss on disposal of assets, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(492)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation (recoveries)/charges, net</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">5,729<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating earnings/(loss)</a></td>
<td class="nump">562<span></span>
</td>
<td class="nump">432<span></span>
</td>
<td class="num">(4,368)<span></span>
</td>
<td class="nump">1,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="nump">19<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on Extinguishment of Debt</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings/(loss) before income taxes</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="num">(4,587)<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for/(benefit from) income taxes</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings/(loss)</a></td>
<td class="nump">351<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="num">(4,350)<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings/(loss) attributable to Cardinal Health, Inc.</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="nump">$ 296<span></span>
</td>
<td class="num">$ (4,352)<span></span>
</td>
<td class="nump">$ 1,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Earnings/(loss) per common share attributable to Cardinal Health, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic (in shares)</a></td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="nump">$ 0.99<span></span>
</td>
<td class="num">$ (14.84)<span></span>
</td>
<td class="nump">$ 3.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income (Loss) from Continuing Operations, Per Diluted Share</a></td>
<td class="nump">$ 1.19<span></span>
</td>
<td class="nump">$ 0.99<span></span>
</td>
<td class="num">$ (14.84)<span></span>
</td>
<td class="nump">$ 3.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted-average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share</a></td>
<td class="nump">$ 0.4811<span></span>
</td>
<td class="nump">$ 0.4763<span></span>
</td>
<td class="nump">$ 1.4433<span></span>
</td>
<td class="nump">$ 1.4289<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_Amortizationandotheracquisitionrelatedcosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_Amortizationandotheracquisitionrelatedcosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6834694752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations and Other Short-Term Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract', window );"><strong>Long-Term Obligations and Other Short-Term Borrowings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt [Table Text Block]</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The following table summarizes long-term obligations and other short-term borrowings at:</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.76543209876543%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions) (1)</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.4% Notes due 2019</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>450</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.625%&#160;Notes due 2020</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>504</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>508</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">2.616% Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>834</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,079</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2% Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>236</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>247</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Floating Rate Notes due 2022</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>321</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>340</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.2% Notes due 2023</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>573</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>551</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.079% Notes due 2024</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>815</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>781</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.5% Notes due 2024</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>413</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>402</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.75% Notes due 2025</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>530</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>494</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">3.41% Notes due 2027</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,215</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,318</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.6% Notes due 2043</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>340</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>346</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.5% Notes due 2044</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>342</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>342</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.9% Notes due 2045</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>441</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>445</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">4.368% Notes due 2047</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>560</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>594</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">7.0%&#160;Debentures due 2026</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>124</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>124</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other Obligations</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>14</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>10</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>7,262</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>8,031</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Less: current portion of long-term obligations and other short-term borrowings</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>508</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>452</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#160;&#160;&#160;Long-term obligations, less current portion</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>6,754</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:middle;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>7,579</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><span style="font-family:Arial Narrow;font-size:8pt;">(1)</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Maturities are presented on a calendar year basis. </span></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LongTermObligationsandOtherShortTermBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Obligations and Other Short-Term Borrowings [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LongTermObligationsandOtherShortTermBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6843324704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Basis of Presentation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements include the accounts of all majority-owned or controlled subsidiaries, and all significant intercompany transactions and amounts have been eliminated. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">References to "we," "our," and similar pronouns is in this Quarterly Report on Form 10-Q for the quarter ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (this "Form 10-Q") refer to Cardinal Health, Inc. and its majority-owned or controlled subsidiaries unless the context requires otherwise.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our fiscal year ends on June 30. References to fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> in these condensed consolidated financial statements are to the fiscal years ending or ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Our condensed consolidated financial statements have been prepared in accordance with the United States Securities and Exchange Commission ("SEC") instructions to Quarterly Reports on Form 10-Q and include the information and disclosures required by accounting principles generally accepted in the United States ("GAAP") for interim financial reporting. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the condensed consolidated financial statements and accompanying notes. Actual amounts may differ from these estimated amounts. In our opinion, all adjustments necessary for a fair presentation of the condensed consolidated financial statements have been included. Except as disclosed elsewhere in this Form 10-Q, all such adjustments are of a normal and recurring nature. To conform to the current year presentation, certain prior year amounts have been reclassified.&#160;In addition, financial results presented for this fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> interim period are not necessarily indicative of the results that may be expected for the full fiscal year ending </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These condensed consolidated financial statements are unaudited and, accordingly, should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K for the fiscal year ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">June&#160;30, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> (the "</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> Form 10-K"). </span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Financial Accounting Standards</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Adopted Financial Accounting Standards</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Derivatives and Hedging </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In October 2018, the </span><span style="font-family:Arial Narrow;font-size:10pt;">Financial Accounting Standards Board ("FASB")</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> issued amended accounting guidance related to derivatives and hedging which permits the use of the Secured Overnight Financing Rate ("SOFR") Overnight Index Swap ("OIS") as a benchmark interest rate for hedge accounting purposes. This guidance is effective beginning the first quarter of fiscal 2020 and must be applied on a prospective basis. The adoption did not have a material impact on our consolidated financial statements.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:normal;">Leases</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In February 2016, the FASB issued amended accounting guidance that requires lessees to recognize most leases on the balance sheet as a lease liability and corresponding right-of-use asset. The guidance also requires disclosures that meet the objective of enabling financial statement users to assess the amount, timing and uncertainty of cash flows arising from leases. We adopted this guidance during the first quarter of fiscal 2020 and elected the transition option which allows us to apply the guidance prospectively. The adoption resulted in the recognition of lease liabilities in the amount of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$422 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and did not have a material impact on our results of operations, liquidity or debt covenant compliance under our current debt agreements. The majority of our lease spend relates to certain real estate with the remaining lease spend primarily related to vehicles and equipment. The adoption required certain changes to our systems and processes. See </span><a href="#s37977FB1689852A6888EFF6B57032648" style="font-family:Arial Narrow;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Note 5</span></a><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for additional information regarding leases.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Recently Issued Financial Accounting Standards Not Yet Adopted</span><span style="font-family:Arial Narrow;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In June 2016, the FASB issued amended accounting guidance that will require entities to measure credit losses on trade and other receivables, held-to-maturity debt securities, loans and other instruments using an "expected credit loss" model that considers historical experience, current conditions and reasonable supportable forecasts. This guidance also requires that credit losses on available-for-sale debt securities with unrealized losses be recognized as allowances rather than as deductions in the amortized cost of the securities. This&#160;guidance will be effective for us in the first quarter of fiscal 2021. We are currently evaluating the impact of this amended guidance but do not expect the adoption to have a material impact on our consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6856302720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Narrative, Recent Financial Accounting Standards) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jul. 01, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842', window );">Lease Liabilities established as a Result of the adoption of ASC 842</a></td>
<td class="nump">$ 422<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities established as a Result of the adoption of ASC 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6719429232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 8,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 8,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_DiscountRatefairvalueinputs', window );">Discount Rate, fair value inputs</a></td>
<td class="nump">8.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_TerminalGrowthRatefairvalueinputs', window );">Terminal Growth Rate, fair value inputs</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember', window );">Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 2,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,658<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember', window );">Medical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">5,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill, Transfers</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments and other</a></td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">5,681<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalReportingUnitMember', window );">Medical Reporting Unit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CarryingValue', window );">Carrying Value</a></td>
<td class="nump">10,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 4,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying Value of Reporting Unit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_DiscountRatefairvalueinputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount Rate, fair value inputs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_DiscountRatefairvalueinputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_TerminalGrowthRatefairvalueinputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Terminal Growth Rate, fair value inputs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_TerminalGrowthRatefairvalueinputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fair value of reporting unit in excess of carrying amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cah_MedicalReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cah_MedicalReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6834838832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">11. Shareholders' Equity</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>7.3 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$350 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.  The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$48.00</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. These repurchases were made under an accelerated share repurchase ("ASR") program, which began on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">August&#160;20, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and was completed on </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">December&#160;4, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">During the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, we repurchased </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>11.5 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> common shares having an aggregate cost of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$600 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The average price paid per common share was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$52.32</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">We funded the repurchases with available cash and short-term borrowings. The common shares repurchased are held in treasury to be used for general corporate purposes.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Accumulated Other Comprehensive Loss</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the balance of accumulated other comprehensive loss by component and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:38%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Currency</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Translation</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Unrealized</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gain/(Loss) on</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Derivatives,</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">net of tax</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated Other</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Comprehensive</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Loss</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(95</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(79</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(35</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(22</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(57</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amounts reclassified to earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Other comprehensive loss, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(35</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(62</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(130</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(11</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(141</span></span></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6604284352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingent Liabilities and Litigation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments, Contingent Liabilities and Litigation</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">7. Commitments, Contingent Liabilities and Litigation</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Commitments</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Generic Sourcing Venture with CVS Health Corporation ("CVS Health")</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">In July 2014, we established Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health for an initial term of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>10 years</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. Red Oak Sourcing negotiates generic pharmaceutical supply contracts on behalf of its participants. Due to the achievement of predetermined milestones, we are required to make quarterly payments of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$45.6 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> to CVS Health for the remainder of the initial term.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Legal Proceedings</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We become involved from time to time in disputes, litigation and regulatory matters.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We are named from time to time in </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> actions initiated by private third parties. In such actions, the private parties purport to act on behalf of federal or state governments, allege that false claims have been submitted for payment by the government and may receive an award if their claims are successful. After a private party has filed a </span><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</span><span style="font-family:Arial Narrow;font-size:10pt;"> action, the government must investigate the private party's claim and determine whether to intervene in and take control over the litigation. These actions may remain under seal while the government makes this determination. If the government declines to intervene, the private party may nonetheless continue to pursue the litigation on his or her own purporting to act on behalf of the government.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we become aware through employees, internal audits or other parties of possible compliance matters, such as complaints or concerns relating to accounting, internal accounting controls, financial reporting, auditing, or other ethical matters or relating to compliance with laws such as healthcare fraud and abuse, anti-corruption or anti-bribery laws. When we become aware of such possible compliance matters, we investigate internally and take appropriate corrective action. In addition, from time to time, we receive subpoenas or requests for information from various federal or state agencies relating to our business or to the business of a customer, supplier or other industry participants. Internal investigations, subpoenas or requests for information have led, and may in the future lead, to the assertion of claims or the commencement of legal proceedings against us or result in sanctions.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">From time to time, we determine that products we manufacture or market do not meet our specifications, regulatory requirements, or published standards. When we or a regulatory agency identify a potential quality or regulatory issue, we investigate and take appropriate corrective action. Such actions can lead to product recalls, costs to repair or replace affected products, temporary interruptions in product sales, action by regulators and product liability claims and lawsuits, including class actions. Even absent an </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">identified regulatory or quality issue or product recall, we can become subject to product liability claims and lawsuits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We accrue for contingencies related to disputes, litigation and regulatory matters if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because these matters are inherently unpredictable and unfavorable developments or resolutions can occur, assessing contingencies is highly subjective and requires judgments about future events. We regularly review contingencies to determine whether our accruals and related disclosures are adequate. The amount of ultimate loss may differ from these estimates. Except as otherwise disclosed in this footnote, it is not possible for us to reasonably estimate the amount of any possible loss or range of possible losses in the matters described below. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize income from the favorable outcome of litigation when we receive the associated cash or assets.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We recognize estimated loss contingencies for certain litigation and regulatory matters and income from favorable resolution of litigation in litigation (recoveries)/charges in our condensed consolidated statements of earnings.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;font-weight:bold;">Opioid Lawsuits and Investigations</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Pharmaceutical wholesale distributors, including us, have been named as defendants in over </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>3,000</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits relating to the distribution of prescription opioid pain medications. The lawsuits seek equitable relief and monetary damages based on a variety of legal theories including various common law claims, such as public nuisance, negligence and unjust enrichment as well as violations of controlled substance laws, the Racketeer Influenced and Corrupt Organizations Act and various other statutes. These lawsuits also name pharmaceutical manufacturers, retail pharmacy chains and other entities as defendants.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">States &amp; Political Subdivisions</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>2,700</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> of these lawsuits have been filed by counties, municipalities, cities and political subdivisions in various federal, state, and other courts. The vast majority of these lawsuits were filed in U.S. federal court and have been transferred for consolidated pre-trial proceedings in a Multi-District Litigation proceeding in the U.S. District Court for the Northern District of Ohio (the &#8220;MDL&#8221;).  </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In January 2020, the complaints of the Cabell County, West Virginia and the City of Huntington, West Virginia were remanded to U.S. District Court in West Virginia.  A trial date has been set in August 2020.  In addition, the complaints of San Francisco, California and the Cherokee Nation have been remanded to their original district courts, but no trial dates have been set.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>25</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> state attorneys general have filed lawsuits against distributors, including us, in various state courts.  A trial in New York for cases brought by the New York State Attorney General and Nassau and Suffolk counties was scheduled to begin in March 2020, but was deferred due to the COVID-19 pandemic. Trial is scheduled to begin in October 2020 for a case brought by the Ohio State Attorney General and trial on a case brought by certain West Virginia political subdivisions is scheduled for March 2021. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Additionally, we have received requests from a multi-state task force of state attorneys general, as well as separate civil investigative demands, subpoenas or requests for information from these and other state attorneys general offices and governmental authorities.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In October 2019, we agreed in principle to a global settlement framework with a leadership group of state attorneys general that is designed to resolve all pending and future opioid lawsuits and claims by states and political subdivisions (the "Settlement Framework"). This Settlement Framework is subject to contingencies and uncertainties as to final terms, but is the basis for our negotiation of definitive terms and documentation.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Settlement Framework includes (1) a cash </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">component</span><span style="font-family:Arial Narrow;font-size:10pt;">, pursuant to which we would pay up to </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.56 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> over </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>eighteen years</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, (2) development and participation in a program for  distribution of opioid abuse treatment medications for a period of ten years, and (3) industry-wide changes to be specified to controlled substance anti-diversion programs. Definitive terms for a settlement pursuant to the Settlement Framework continue to be negotiated, and there is no assurance that the necessary parties will agree to a definitive settlement agreement or that the contingencies to any agreement will be satisfied. In connection with these matters, we have </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.56 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> accrued at March 31, 2020, included in deferred income taxes and other liabilities in the condensed consolidated balance sheets, which represents the cash component. We are unable to reasonably estimate the liability or cost associated with the other components of the Settlement Framework, the potential distribution of treatment medications and any incremental costs for changes to our controlled substance anti-diversion program that we may agree to. We continue to negotiate the definitive terms of the Settlement Framework. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In the nine months ended March 31, 2020, we along with two other national distributors entered into a </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$215 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> settlement with two Ohio counties, Cuyahoga and Summit, to resolve all claims in the first bellwether trial in the MDL, which had been set for trial for October 2019. In connection with this settlement, we incurred </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$66 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> within litigation (recoveries)/charges, net during the nine months ended March 31, 2020. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with these matters, we recorded a total pre-tax charge of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.63 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> (</span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$5.14 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> after tax) during the nine months ended March 31, 2020 in litigation (recoveries)/charges, net, in the condensed consolidated statement of earnings for the cash component. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. We will regularly review these opioid litigation matters to determine whether our accrual is adequate. The amount of ultimate loss may differ materially from this accrual. We continue to strongly dispute the allegations made in these lawsuits and reaching an agreement in principle on a global settlement framework is not an admission of liability or wrongdoing.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Private Plaintiffs</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">The Settlement Framework does not address claims by private plaintiffs, which includes unions and other health and welfare funds, </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">hospital systems and other healthcare providers, businesses and individuals. Private plaintiffs had brought approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>400</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits as of May 4, 2020. Of these, </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>105</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> are purported class actions. The causes of action asserted by these plaintiffs are similar to those asserted by public plaintiffs. We will continue to vigorously defend ourselves in these matters.</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Department of Justice Investigations</span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">We have received grand jury subpoenas issued on behalf of the District Courts for the Eastern District of New York and the District of Columbia seeking documents and, in the District of Columbia, testimony, related to our anti-diversion policies and procedures, and our distribution of certain controlled substances. We are cooperating with these requests.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Cordis Product Liability Lawsuits</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">As of May 4, 2020, we are named as a defendant in </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>309</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> product liability lawsuits coordinated in Alameda County Superior Court in California involving claims by approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>3,924</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs that allege personal injuries associated with the use of Cordis OptEase and TrapEase inferior vena cava (IVC) filter products. Another </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>29</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> lawsuits involving similar claims by approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>34</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> plaintiffs are pending in other jurisdictions. These lawsuits seek a variety of remedies, including unspecified monetary damages. We are vigorously defending ourselves in these lawsuits.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">At </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we had a total of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$466 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> accrued for losses and legal defense costs related to the Cordis IVC filter lawsuits, net of estimated insurance recoveries. We believe there is a range of estimated losses with respect to these matters. Because no amount within the range is a better estimate than any other amount within the range, we have accrued the minimum amount in the range. We estimate the high end of the range to be approximately </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$900 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, net of estimated insurance recoveries.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Shareholder Securities Litigation</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In August 2019, the Louisiana Sheriffs' Pension &amp; Relief Fund filed a purported class action complaint against Cardinal Health and certain current and former officers and employees in the United States District Court for the Southern District of Ohio purportedly on behalf of all purchasers of our common shares between March 2015 and May 2018. The complaint alleges that the defendants violated Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 by making misrepresentations and omissions related to the integration of the Cordis business and inventory and supply chain problems within the Cordis business, and seeks to recover unspecified damages and equitable relief for the alleged misstatements and omissions. We believe that the claims asserted in this complaint are without merit and intend to vigorously defend against them. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Surgical Gown Recalls</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In January 2020, we issued a voluntary recall for </span><span style="font-family:Arial Narrow;font-size:10pt;">9.1 million</span><span style="font-family:Arial Narrow;font-size:10pt;"> AAMI Level 3 surgical gowns and two voluntary field actions (a recall of some packs and a corrective action allowing overlabeling of other packs) for 2.9 million Presource Procedure Packs containing affected gowns (together, the "Recalls"). These Recalls were necessary </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">because we discovered in December 2019 that one of our FDA-registered suppliers in China had shifted production of some gowns to unapproved sites with uncontrolled manufacturing environments. Because of this, we could not assure sterility of the gowns. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In connection with these Recalls, in the nine months ended </span><span style="font-family:Arial Narrow;font-size:10pt;">March 31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;">, we recorded total charges of </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$95 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;">, of which </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$55 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> is within cost of products sold and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$40 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> is within SG&amp;A in the condensed consolidated statements of earnings/(loss). In our condensed consolidated balance sheet at March 31, 2020, we had </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$38 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> reserved within inventories, net, and </span><span style="font-family:Arial Narrow;font-size:10pt;"><span>$55 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;"> included in other accrued liabilities related to this charge.  This charge represents our best estimate of costs for the Recalls and includes inventory write-off costs and certain remediation and supply disruption costs, such as costs to replace recalled products. Because loss contingencies are inherently unpredictable and unfavorable developments or resolutions can occur, the assessment is highly subjective and requires judgments about future events. The amount of ultimate loss may differ materially from this accrual. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In addition to the charge for the nine months ended March 31, 2020, the Recalls may have other negative impacts, which could include: government investigations and enforcement actions by the U.S. Food and Drug Administration or other regulators or U.S. or international governmental bodies (possibly resulting in the suspension or revocation of the authority to produce, distribute and sell products and other civil or criminal sanctions); losses due to patient claims, including product liability claims and lawsuits; and customer claims unrelated to their direct costs from the supply disruption. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Other Civil Litigation </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Generic Pharmaceutical Antitrust Litigation </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">In December 2019, pharmaceutical distributors including us were added as defendants in a civil multidistrict litigation consisting of multiple individual and class action lawsuits filed by indirect purchasers of generic drugs, such as hospitals and retail pharmacies. The plaintiffs allege that pharmaceutical distributors encouraged manufacturers to increase prices, provided anti-competitive pricing information to manufacturers and informed manufacturers that they wished to maintain current customer allocations for the purpose of avoiding price erosion. We intend to vigorously defend ourselves in these matters. </span></div><div style="line-height:120%;padding-bottom:0px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Blood Pressure Medication Recall Litigation </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;">Many participants in the pharmaceutical supply chain, including manufacturers, repackagers (including us), distributors (including us), and retailers have been named as defendants in Multidistrict Litigation in the U.S. District Court for the District of New Jersey (the &#8220;Blood Pressure Medication Recall MDL&#8221;), which was created in February 2019. The claims arise out of a series of recalls of generic blood pressure medications due to alleged impurities in active pharmaceutical ingredients. We intend to vigorously defend ourselves in these matters.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6834811440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:16pt;"><span style="font-family:Arial Narrow;font-size:13pt;color:#ee2724;font-style:normal;font-weight:bold;text-decoration:none;">3. Goodwill and Other Intangible Assets</span><span style="font-family:Arial Narrow;font-size:16pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;"> </span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Goodwill</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following table summarizes the changes in the carrying amount of goodwill by segment and in total:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Pharmaceutical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Balance at June 30, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,663</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,715</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cccccc;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,378</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Goodwill acquired, net of purchase price adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Foreign currency translation adjustments and other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>&#8212;</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>(34</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>(34</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Balance at March 31, 2020</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,658</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,681</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>8,339</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Primarily due to the risks and uncertainties to the business from both the Recalls and the COVID-19 pandemic, we elected to bypass the qualitative assessment and perform interim goodwill impairment testing for the Medical Unit during the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">. The carrying value of this reporting unit at </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$10.1 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, of which </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$4.2 billion</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> was goodwill. The fair value of the reporting unit was estimated to be approximately </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>10</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent in excess of its carrying value, using a combination of the income-based approach (using a discount rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>8.5</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent and a terminal growth rate of </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>2</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> percent), and the market-based approach.</span></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><span style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Other Intangible Assets</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">The following tables summarize other intangible assets by class at:</span></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:25%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:19%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">March&#160;31, 2020</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Weighted- Average Remaining Amortization Period (Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,544</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,746</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,798</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>674</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>329</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>345</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>13</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>1,604</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>730</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>874</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>11</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,822</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,805</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,017</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>12</span></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>5,844</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>2,805</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;"><span>3,039</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">N/A</span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:43%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">June&#160;30, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">(in millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Gross</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Accumulated</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Net</span></div><div style="text-align:center;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Intangible</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Indefinite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">IPR&amp;D, trademarks and other</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total indefinite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">&#8212;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Definite-life intangibles:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,562</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,517</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,045</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Trademarks, trade names and patents</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>672</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>295</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>377</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Developed technology and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>1,602</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>616</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>986</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cccccc;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">Total definite-life intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,836</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cccccc;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,408</span></span></div></td><td style="vertical-align:bottom;background-color:#cccccc;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;font-weight:bold;">Total other intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>5,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>2,428</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><span style="font-family:Arial Narrow;font-size:8pt;"><span>3,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:2.5px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:Arial Narrow;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">Total amortization of intangible assets was </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$129 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$133 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the three months ended </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March 31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively, and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$385 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$399 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> for the </span><span style="font-family:Arial Narrow;font-size:10pt;">nine months ended</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">March&#160;31, 2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2019</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, respectively. Estimated annual amortization of intangible assets for the remainder of fiscal </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2020</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> through </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">2024</span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> is as follows: </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$134 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$442 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$408 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">, </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$358 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"> and </span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;"><span>$328 million</span></span><span style="font-family:Arial Narrow;font-size:10pt;color:#000000;">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6835506224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share Attributable to Cardinal Health, Inc. (Reconciliation of Common Shares Used to Compute Basic and Diluted EPS) (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares&#8211;basic (in shares)</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Employee stock options, restricted share units, and performance share units (in shares)</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares&#8211;diluted (in shares)</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6839037568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments Summary of Estimated Fair Value of Long-term Obligations and Other Short-term Borrowings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cah_CarryingAmountofLongTermandotherShortTermBorrowings', window );">Carrying Amount of Long-Term and other Short-Term Borrowings</a></td>
<td class="nump">$ 7,262<span></span>
</td>
<td class="nump">$ 8,031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair value</a></td>
<td class="nump">$ 7,211<span></span>
</td>
<td class="nump">$ 8,065<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cah_CarryingAmountofLongTermandotherShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying Amount of Long-Term and other Short-Term Borrowings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cah_CarryingAmountofLongTermandotherShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cah_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>93
<FILENAME>0000721371-20-000043-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000721371-20-000043-xbrl.zip
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M18$"ZMQKW+E]W2Z"O10?=U857#*M0G7.Z:S*A-F<QF7AG<9R[#SC9VP*?U'
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M-.N5MT8AV*DH]=/P<[G8#^[+-Z?$A58D(V!5E#Q6 AX&-<_^A._66ZY/AJN
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MKY2XQPZU,F5;T<9@J<3GUG25>0ZLM)@5$+T<B%X $RZ6\-(:J,2QI*P(<R4
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MSXA+QBZ93?A"",1ZU)7PB!U5_GC/LJM8U[[QI3'']M@UY6-1,BS_R?=UH_#
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M#IAMHG.<K.RP21Y/ UOC)34P,@5-X!YV/4Y"Y5L$/W,N+HT$PH A'B*$Q;F
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M?89LOP&-3MO"C ?L5=C=,#$LEJ<5H9:&AW>M@#9,ST@":4[S)1+L(M!K4Y:
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MD(5F:C0"0L$K9_ZCQQ6UC+?BQU.7+.#+,>_TC^^-[P70CPE0$[ 7L-0H.T3
M 20NWI,0B(\__U8.!*BQ5=]\9L^G-V]JV-AP0N@8SA.NGD8!&QN 8 # 2'@[
M!].F!A)E^NO-WVC=MKIF7;<'#;MN=[KMEF'WZV:O83>Z \L8]'.RGYMW?_C
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MPAQQEU'7RQ(S4KB@N(CB(A7$G)U<I.#YK"76:)C;.@RB= (]6:X6_A-H\Y3
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M-Y;+^;O(Y>RG<CD[(I?SC\TP=%G%?+\20P1/9ML5C<J/1,.TA)D'U^"TT%5
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MO1#^S_QOPB=!D&"G&H'S>=*F/&?_K\@)0H*%K($?S>9:'UZQ',$'R&?@9DR
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M$CM_A$Q_9\QBF\?6UC"1('.*+P78>IE:\*&\#S%Y0WI0UG^LAG=[8&E1Z@1
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M^VQEF5</E4L'!H6K%<#5LQQ2KEXPZHS.>D;YFI:H0U),_S6"!W45ZKH@;+W
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M1&,^!NS^\8;QS "YN.LQWC)U QIJ?T5.@)< ,TCS%3E)B3,RS5^Y/FCIB_B
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M@HAI=!1M%G^-&I'1Q>21$@#.R'] D:1AEVVC_O9#['ED;;>;;RF+VL#%LA%
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MW_%R># VBUN?M-BN0%X J/IQ'/HR*9ZCZRP@/"]4U*WR'N4.Z$9AN.#QVV$
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MP:)ZXS5/1V9*O?(1L3#B<6LX#D52 <R<QP"HL>(-A'#:AVQ3Y6B!,QJY6A@
M;\")6GS "9]OAM.^<+ G3H;V^.1Z[$34)U,2!*QW^G)%/,H;HG]:.-[FY)-M
M^:!D0@Z9<%BQ[&O*A(^>%N<V-G&2BM[B0YF[OA.P>41]-P LQ.%O#A:!/K#I
M*C_H]W4Y%X:SL?2DYA4O\1.#%7$B1#PC"#"R3\9D*<<9WVNP@C_@J>R3TZR
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MGDZG;_4&NMGJ#P:#8;.)N3V<T%MZPZQOY1N^*,"+4=3MFM%4.3V*T!6A'R+
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MD*8,D+P' M%($@CRUZ3]5H2W</D%J<$GTW$1VZ['4K3].83VT'$?&\)UA83
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M3VI1HY.46W2406*F7WMZPJ5QPLX4P"L*P,(JRQ%4/M@!&A!+$2D2W2P AIV
M EYIB.^D*PR8 2+@!P/X_96 6JHK#G)?:\8(DDX1$E0!6RH!D E-3J0$M&PM
MH#;=ZI=& 5$)&"XG[$H!&%9UT]8YZ@#%AA%K(0@2V>/2)8@0;DS$.Y(2T+;W
M;\ ,<* CX='=AGLC_.R5+A^GB_#D]*4,O1;]"/NPPKGK8_96(S#FE1KA" %>
M8L((H=IJ*E$15E#$"=VHF'F.0T[J+L#BW'[%?A0'MJ,47$ KHSY2P(YQ?4PK
MP%,@L?,&$PL,-H0A4]H-BFBN33N ;S%*C]J?!=>Q KD(T1Y#='\IS2M-'PI
M$$+ A_]SQ!%F51$O5!00_RIC_Z3V/&L3O5%*1PJX1 K8&?&R$M/"0Z.DU!AP
M+BR#$");V/94&?LJV_ZT\?XV9[=>(N(O*1G@$BHNA[(A<1/BK8BW(MZ*>"OB
MK3A9;=[%!PF>"0\,T-+8ZFQXP?*@ *PM#R,YEYHJ!F6P/P@P()@=A:\!<>">
M6AX;C([2X B_C1_R/?HPG2U3D!>+V>C3PW(.V<?IN^DDMT=FT_$X_,F/>;/V
M;+XX:DOG5DM^HC,Q>A*ZZ>^G4%9P5DK!@"('@=/(:.3$.L!'%&@$^(X.Y_9"
M QBT&0.,<(YP[HJX?LE32+&H&I1CP($%7D/O#1< *%IZ"AD1YCSRNO4NP:35
M.. E^A5C)"$2QJ[RGU;R7P.%/2?84LZ!5IQAL2XUE,S"L\C_UOKJMCNCI9,:
M0(P<1+]/] ;&6Q%O1;P5\5;$6W'&-L G&?9YBMC!3]E\_OW&V$&2UI3:9#%-
M)H_4VO!7*[UV?FA]TBE'O7? 8\$8JEJ+.::%)(@QR[AB CJU&DFD(?#0-EJ+
M!?NC2F8Z=PSA" ;'BY>@8U5*+7DBSD$G775&7"@=[.B/8*("OQ(0Y[5&S#N%
M'>9.ZU6/4 TTE*#1N: %\!\0<?AG-IO>I/.[_)@%@NB'$Z*_LS&'"-R+!^[>
M<IP#6$W;DH@(906QV G-$(*L;$E(A9?Z2'*\'>?A$<J*HAR/='"9=+ S^E$E
MR!$UB%.DF$)"06NLA;(,+'"+&X&%E@1Y2Z&#B/Y#ZQ0>K1HU5KV;ZV3__,.S
MT..+.8<-]X%)9^&+AQ?]:Y:.%W=72<# 7Y.#;UESO_<*9W9TUNF&G=]K^.FA
M5[3#D>!],STY$;7>#PYB@2B3$AIAG5,.EIDCU-E&'\EG0L/'S=H\GJ[VBDO1
MS>CP:6CZ,K6VR*?K5T7ZW,MQQ5E5D2LI<!( HZV S%I'M0+E<!NR82#&J]BR
MXTFQD2U/PI;=S:J+5!I5T^/[%D75\81*XCFR$/K N]9;XT#)MA1RW1AW\FK=
M] @9RJ0+Q#O@U.;(WI&]HR)\%$58@%H'.<.\-IXJY*P"P JKRRF/"%*+#E:$
MV\L.!UU@Y&ZJPDM'[W=+/^7Z\>6_M:\S'DVRMV4:&@+?/+W )%S@VE>^SG+/
M_2N^])9[6;SLMRQ+)M-%-L_]J.&>!**<9WDL9K+<PG01?KD=3=+)=?XN\T5X
M8#E>YJ^/5]N9]6PXB>4_JX>KW_?_POF I]'MUR-=FV-\K]I[/I(SH'R#47[L
MJ]_K'SK)<3]^1+ 0K/Q-*]?[=38>%\_^[0UXL_P]+.:Z_'W#7GP<W8>[]B[[
MDOPZO4\;0OG+Z&9Q%WX,JRT0'6 ^3C_/L^_+'WYXBM\WZUA*+>5T>Z1E]1$8
M?_/#FP8I%<^19YZKO>[$DYHW4UR6(8[(;EFN[,RISW$?AK4/9QUEWB7U_\A)
MVRW+T"?AU'4@=9]W*[2TXE9NL$'_^Y!W+X_D%WS4[_CXW/?[HGZ4*]1)[A=)
M?!"L"01O?^G>57IJ]!QRDS;L)"*GT9*/JZ2M_KV;55K5[]G;3[,L_<?;]#8@
M\?MT_"7].L_UA+M9H7"F2VMOCIG"5EOO1%XA#(7*6Y &BTX98*RR+G]-VI*F
M^FI:.(VBNL7HBEIJ4]M$;+LF2M'VYQ#:0TO=FF*5$7B+Z0;;NWCBM"5)AS!2
M\;UOE_]MXB>_-G5_6YNZ;6:K'7''NJ3O]'W]6R765H_#:[BR^AYHO[N.MF@U
MRW<H";-Q^Y>0N\FNI[/E*.O<HY?EVN#:*63J3B&=C@-2LN2WNRQ[BI%7K!<\
M.7SPO*Q ^V$?5?M1N 3WWX]O_WV2/MR,PA[\Y>@^L N2B??I[/?19/7UTH?%
MM'Q@!=?E(RV)3?&BV.3/.'?@,T\](U&?>]E^3X&=7O9J$_JLZ<Y/(1-TA6R6
M7\P<-Z-)$EX_#H^_V#;TQ9+Q\Q9)-_#::E3VYW1V?;<2/1A>+2W&CMB)YRH(
M&<YU>//W?WN89,7A@_SP\U$/W7*LG0P(:CYOJ!:OOAL]P$'?US>8L^QFE[$3
M)1N9A]DLT$62+E']_24WC3FK:=WCA<?3[XI@;S$9S*3SNR2=W"39?SV,_DC'
M>[K4]EGPQ60J'[*6<Y:[02EPAH2HRMVTY08*IJ@FR$,$/ =%WIJW3*IF2G&X
M'6IRD_\_5]T/M3#A"^;3T?\C'3]D3S+8?EPE%[?1G^ *HS9'J76VYN+2>?$R
MV>&2R6!'[,M:SJH%#BH*K'706,^< *PH=74>&M3L@KP?]J'\A;2"?8K;[%!P
MWB3305@5;_[^<9;>9,DLN\["=?DTSN97R21;'-I/I,U]Z;"<EO7&(DP*SO+Z
M'XF 0@8:46$5</L4J[]66_XN6Q2VW-'DLKP"K8XXW7K"G178O;5P^@S,77%(
MJO9>D K&C FZ,C.*&^6DTT6G/@"4P'OBL"49*:X(:;72N7,X[*'!_>/DCW G
MIK-1.]*QHUC;6PBR"GR.(HBT1L@*IQ!7AGA:&*N2$M@8VU7N[-< O:/)/HBN
M1*OM!3HKXX8DRCJ*HEU!(ZK1E5AZ+I"GG##L(>8"TZ(EG0>2N$9#RN=!TY*@
MRD&#VNQ@U'V!U -K[L,L^YR.;I+LS\]YAME\Z2:>+L*.#4QQW%.885 ;*;N<
M.*6(11P9*SCR3I6X1)BHAO?E?;[/JQ#[L<TY>,5DJ^W%.J=&=@JL796!EX;*
M74%8&P2K%%:0>IC/6*!"* >U*=PJ2DK9,.=V 6%;(O)*$M9K$ YU.ONCQ(H!
M#FS<6WKBV@3'8'-YK;7C"G,@$ /0%])32:_I4^">1G B>B7:=<!TLDU&'*?:
M8W3N"D9:2R)@@A$,$??>,L.M%UP44E0X+QK!B=,(T !&3GCOP=A- S0.LNO.
MAL1-B+>B_V&4#[/IY["$K^O<Q<]Y-7",J#0D-ZS9OP '02XQ"&JT]9(J2US1
M4=1[ 4W#_BTW^<,XG2S4Y,:5^WS," NZ0C)F_?7,N=114.V*(5S3?A6D6AE)
M":60NESU+1VYD#/=B$J^#D.M9<]AVJ8W*:J[)Q!I_WLZO?DR&H^K.$L^:C>=
M_#Z*J72OE'DU:]4"PKFDB!F-K= 6"%ZFTG'@;$/F_;C>\I7=NIK9-7[(EU^>
MT/%",? *\WZG]'0*R%T5EY<&U%UQR6LME'V>R1IP")U!F :!:LM8#.'.N79P
MV59T!K:<]=,]7/;01ER&[\X7>.FR@)25@(3:82:\QPXZ*+QBP.H"B%K[)A!K
M0=%\:.7QDQ,0[H,F&ZW!SJ-I1_ @6"NJD@P8R8CF6A %D7'$%>!A +C&*/<=
MP=-:4@&@ TN[._-(UNY-D5EE(3PG! _:T+UBGAT=C;)A]^*LE'84#D2JXC8N
MH41&"L*)Y]A[K5FA<'@!,5";X\='TS (O(+'R.)X_?EW,^(<1T[%D5/G*+3O
M,XWNRIJU:B@)N34*, $@P 8@A2@O8W>(TT;<81MKMJ1:$G E69N&6<]8LU/#
M-;J8>-&S=0]IK8,\X\Y'(H_;[?.G4?II-!XM1D4=V&]WZ2R["\]EL_G__!\"
M0?Y#DH>V%U\O.2%KL*EY76&,WFY"[\(K&SBB["$ZKKCBT$:BEW[L7= ,NH+M
M2U]KYS6 %@UV=7T=OO]BGGQ.O^;M;$YTM0\.BY_?^7N 5Z+#_EL"2!7S@HH)
M3I"RW#.(#=/K1H+<6M,LQBONTH?553IZ51Z\DH+T.E>C4P1TZ>+TC)S32XK9
ME5$07C.*41!)CS5%S!M)()7(EU%TQFDC!6571FDKFQI>44Q[S2B],T\J:^3S
M=+:\?]/;9#S-OV@VNT^FG\+'+:<@U=K:)/.[\+>K/_@TS=\T?.N8.?88MK52
M"$\DUPI+:"E#%'GHU\DOQEC<Z#7U4]C^CV%S;?9IL>PL_'FT2,<_9>D\>U^=
MQ['U QK;MUV(J+]TC.T**5KEDQ%/J $26P>HP)YS  O=VCM&C&@94FT% X>6
M97;Y!GZ1&WU]/7O(;NH>NX%5+NPM!VNE#%Y"++'2UGFO!># BK(AAJ> -N3@
M*@ETM?6UN,K1#>,KR&/;[K[:Q;U%Z*Z E*RJ+7)"8:8]DY1XK*C1@)2U18A#
M="@@6ZO2A:UV1>T>( ?>\ZT]L;J78^M"<X4IK"$96&H!5Y@JIZBU7):BU4.E
M3:-MZBG%*;EBO,T1-=U,9(O=WWH,T5T1B6GEJR4 (:H\D8HI#;GU:NVK#3B5
M^R"R+7E*KB!H5</M)"*[::9>0C[B4#8D;D*\%?T/\/RT*9ISE8RS^7RM@1?!
MGW[ZE_=6L.NF,L^GP3(*M HF-#2:JS*90WOM_'X.YZ,IW>R*TS9S.WJN5O=7
M<^Z.<LQ@I1P#0JP(RB'"RE&#D/4"E?/BL/$-Q].^:&I)8>97M%6/<%2)3R#V
M;':;!>%VDXPFU]/[+%FD?]9G\\18SJOE(<.5/$2* 6 M5=(1[941:CT_2Q@&
M&P'8\C0^IG\& "\=R36+]P0-<L05A:VV/>^<$[E3F.ZJ#+TTK.X*35H)5^8L
MEH@0;IW2!G EB2I458L))>U!L[7XCB0Q;;!WE:!=JWGIBF.I9VL=Y!D/1Y'>
MH"QNJFG.EC7-AY8Q]EE%&>S"X^GWT*G\85::U_.<#>97R9?1XF[ZL$@^I[/D
MCW3\D,6:YMZO;S!GV;*\WS]SZQ385@\!R;/P^\U2NJ/UAK2C/E  5ON<\\4\
MG=P<\/;ED94D].-\_G"DKQULTRWEW;UU/NSK*!2U*FAC!6-*0F:-P%2*\%_9
MO]YQ"QJ!L[5@^6TQO?['?^2"I#V?X#^SV?0FG=_EUZ:X(CWV.D2ELX>8W!6"
MM;)A3SE7'##FJ=,,.J08+<=Y>VP:J6@[07!?W]^P(-A#S=],[^_#?8MJ?U3[
M>W^64>UO3W_FE*[V.;QV7,LUZ[;6CQ%/VO["2;I(VOV6/Z>SZ[L$PZLDUXU;
M^*)YFL2_/4RR!(/\/:&\2L(7_YP%"?U'-GZI=V7?=*Z][:!: J'$FC%LN:0B
M&$-*2FM*.\@BAQK=H%9B]AA&4"/ZRGEL Q7MH O#Y(X0E/6L0XV$L4X8("70
MP%D 4=D:WEK?&*CQ,@1;2X#@[?:([QP$>V@'_9HMTM$DNTFR=#89Q09(3X%7
MJX6#1FC@F1.<*Z\99%K90O9))WS#!UANK2MV5EU?/]P_C--%=F.SV]'UZ'AI
M@JP?\Z"'9(1>*+!VQ1&M?.G$"H\,,9P[ ('72)8SU9TV3MHV<-222*-7!/>B
M *6;F3Y'<.4EHTFRF&7I_&'V]2HW4:^G\\7W+1NJF);6]"%O_.;OI2$=S%0D
M'KD5DFAC7Z0^OU7/^/8E@A35R#SO)($(4P&<YH)*[2DI-7R!=:,-QL?BOI_$
MS :B3=7BQ?.MJ..0 SYF'N%?HJT^#&SO"&4"0 5EA!@'.I_AIK&Q7F*];A8G
MJ.8-76<7*+<V+IA+,& H;T;NGK.'FPU#+L<%4-.GBZ+"Z^G]YUEVETWF088G
MX^G\X-K"(VQ6AZ4Y ;6\!6N)\,PCS817#''LH5C[ZW1S:'CM.)953*9^&#\N
MJT!_"B?R+EN\O_V8_GF8J)^'#0N//4\4Y A]KUZ\"AUCB[8$_QE8H[/R_S))
M86<.(!4',&N#YDX1HA9)A9P"H.R[8:C9.$3E, YXC8ZP"P>TVTKV,BG@4(6A
MAS54JP:8)IV%+Q-^^-<L'2_NKI)P0_^Z\F 4]57_JZBLZI+%<.YN?'N&) A@
M-5>JI!( JGC0+A13SBD+2MV"&MLHDEZ:%<69K.9W'LU3 *\0.$DTL)MM^\[,
M!CWHL-DKL.^*;5'I#(H9PI1T#D!H,%4>5+U) )%X'VRWY#I@5QBU.5;EPK#=
MPS2 O#]&>&@V'8_#AR>C?+AT-E]$N_]5HAG6*H80<08XX) $TCA)L(%EE-,I
MPAHJ_\^CR33<PJ\_%EM_-,'<JE!^X7R[*WZC'7[I(-T5DW57G.#48:6Q]  2
M&;#)2S/<>6L;)40O8[*MU+DA8+(UU_JQRQ3./%=BJYT]W]JQY,@,T"M5?&_A
M7O/G&>OR6F HD75&>>.UT.LT>"\:?0.;NOF/D^OQ0[XU'U8]B]5B,1M]>ECD
M$TX_3A^K8T=7"7);O=6H_K[WJ9OZ_FGX:M"V_I (:%>^854:@7$84J8MY1Q!
MHH2@L*Q]YAJXQLCD8_%->_X#W&KJ0;_X9D]%"3VON7>Y;'.KRE-K;[Q,DWRM
M"M3>]G4F#+5AK_::*[_CXB_4$R.J@9V!+#G3D&%M( =& J#$NG&$D^"9&49J
M<G/"D F!5Y"TZE=]X8PO1*-J!YD=<\_TD)GZ3$0[\DZPHRJE30E& NL@YCT@
M1$CO>1' D50WDSY>SSMM#?0&5[+=RLVN\LY2L_INJ?26C[_R+A0?\%N6)9/I
M(F@EBVE^+($PYEEN\$R6*UWF4MZ.)NGD.G^7^2(\<)]-%O._/OY2M5T(BG?V
MMFS\B\ W3^\Y"?>\ME/76:ZDOV*OGE_/A@U;_K-ZN/K]A%_X-8=[A*]5>\M'
M; O*UX_R0U_]7O_,28ZS\2/6@F#%4<M[EUQGXW'Q[-_>!.4C_SVLY;K\?<-6
M?!S=AYOV+ON2_#J]3QNBZ3Z=_3Z:K+Y>^K"8E@^L)-WRD2^CF\5=^.NP'P4X
M@R$T3C_/L^_+'WYXBL,W:R.DUBEGNXFR^@B,O_GA38,FBN?(,\_57G?B^.IF
M(S#+$$?D!1VA.'/VN0^]V.,^7,H^=#0!X3 1]'BU^[S'!F,1T8Z4E1]/=#_)
MOMRW7G3Y;H5WK+CK&_;SOP]Z^S=__P4?]>L=?H?>_-V/<J5Y61Z;^"#,$PC>
M_M*16W3RKG&/=>5#E:W_?)@O1K=?CZ7A+_^]FU5JV^_9VT^S+/W'V_0V(.[[
M=/PE_3K/M8R[6:'/IDL#;FZ,-QI;JU@^'!-AI34@&'/".6&0+]6>M-^*\!8N
MOR U^&0Z+F+;]5B*MC^'T!XZ[M;81D;@+:8;8AO%$Y<C^XOO?;O\;Q.M^[4E
M_=O:DFXS3'3$'>NN5[%_Z]\JL;8Z-%[#E=7W0/O==;1%A5F^0TF8C=N_A-Q-
M=CV=+<?#YAZZ+-?ZUCXG4_<Y5?A(IK?);X]*<-R&.-DK]@ \N1#@>?F!]N,#
M5.U1X2S<?X^^_?=)^G S"OORE[:DY'8-9H""$KSL#7I&&M+M3\&VGWK&\=3Z
M9[6^KKYNE!CT9W5JF.:I\L#8*9O<-0RM%IJ,+27J/KIGGTZQ[_WRAW26+R'R
MI,4AK2*V;*44,5M@-FS2;MFXI_9_M]6\:-DJ8VGA/>J7L7SDIZU-C.(5N/ K
M\*1V]<?G:U?C<5_T<6_P#BXSA9<@WS#2>?GX)L_'^97P-K;CJ>?C81+6GKL7
M<O?':%*VJ9UOZ55UU.[3NT;67TH*:Y4L5LI ,6NG8RD&G2K9.8V2WX$;H>ZG
M#Y-%%!8]$1#52(L5]3\[UF(PY]L?!:"D\($?:)\ .V0&CNN[X/4-TH>/Y!E<
MAF?7$S?9G7>S+$M^#D_<S1,7#*^;9/-TC4%V"WWS=YV.T\EUEL\PL=EU=O\I
MFQ5; ^6Y.R9VO0> $$#"#",":GW$*4-6(*.!X=PX2/!J_)@&7%BGGYG[M]*8
M5C;OQNI5]/^*5_V_=0+)RF>2.U*GDSR?1/TYFJ__JO;>/R\/ME:%MII<LU]K
M,L2'VU4P=@P]E0IQW(MQ\OK9E^Y%#VB0RFH"L5%<<6H((3[\#)W#Q7 DZ2F'
MC:K:([9>:I,U#QBZ2EOM'A=),Y)F),T^D"8750L4IJ"67#@E@K+H)>.B:'PI
M#6"8=Y@TGT[_;(TY"6EUID7DS?[S9B]-T*US;$H>D57?2^0%<PAK@SG4C%/&
MH5_QB,)6B88-^FB<W6^%8=@"*3QZWU=;H+L,O,&TLZ/QSBYP.SCQ\D())2IB
M?5#$7F)0#"L&I<@;KC5B,A\)Q@F3Q!=>/&P95WO.]FV70 \>%X:N@#R)=A4)
M-!)H)-#>$RBN"!12+X@B+)BSFA'&+?2%*:L0H*HQ'+U#INP.4QW;IV)XFBEL
MD8@C$4<BOG0B?HF':37?2EOA$2720^$I@%Y#77155M :NL-XNK/Q\.:W;LVQ
M&*=>1NX<+'=NR),:&IENV(+=V)77'*T$>$.@XL11P""T6* RRFVE:;@)CLFN
MK0P8 F# 4>J.]NL\J.@R6R39L[459ZT]N'1Z[]CZ8NN'_JSOJ+CLCJU":G,_
M,76>:0R0U,X: (2FH+!5G-&@$;8,Y+9RQ^1= YX(1;L:]_++1]N&J4#;'(/5
M6;4_HN:BUMKW]45IUI_UQ;/LS_J&HIG(*IO=$^TE551(QQU5P"MLBG0 @#5E
M3S63#[/I[6CQK%K2+6<HC/I-Q%Z'G6X45EG23G,@E3&<,1K0AS '*S J Q%W
MC4&1.X"Q%1NA%Q@:4N7K,KH?KD0MO)^,PS6Y2B;9(F_,O4C_/'1B]BEWJ4MZ
M3I\7OK,RV^=-&.S"X^G'TX_,/\R%1^S'TS\U]CN4X,M0Y1+!CA#@)2:,$*JM
MIA(5J0^*.*$;5MBV5-K<+GN7+=[??DS_/-@^VZED3'0VT7:@N;3= '6D] $N
MO+>4OM71]B+'\ZJ7E12 "H\"JW,"L((6*5HF#Q.(&DU<=N'XC7EN'])9-GF:
MUQ;I_Q1IGYOD00\3X=S]Y_'T:Y:%%TZO_Y%\'J>3>9*?_Q^CQ=>UPV]5DIY\
M&2WN[K+Q37Z/DJQ\Y2+]\V3];$^B]"U[[Z-]1$(,\71 )'7V7NT4T>& KN6,
M,9!P3Z4.XD5!IQSTI"P6=,(V$K^6:=2K/HGV81:6^"%L\_1F67>];%^ATWEV
MDPNB((66$Q?:"L,>I3=8FRG7$9D=,!5ZL-:XODXRZY[@BZP0Y?6A\II6&1C>
MLR"RI<. $B28$-25Z5"$*D&Z(Z\/:*#R7+94F[6C$9M18G=2HG5L??$L^[.^
M2Y>9^Z8QBEH:(W1:$N%$D*%$82D]$Z"L'0[_;>Z0W8X0;27=L0\B<$C9CG;T
MQRA ^V:>'_<XW)<M<Q5CADNG+D-7I6R?-V&P"^]M.'37Z*>H-??@F'/++*-
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MM2%@P?K7U$ODA%?02,:<*Y58PR0X)7FVT>;J"I !ATYZ.$OO7;9(LB+"%D<
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MKE+<J8"0$L@@"OHJ-- 9XPKU55'G;8=IN.T4][-,6(A.Q$B>D3POB3QKU?<
M&$B0HA8KZPP/&BPK=%BMO<$G#;^TT2[I"E Y7-([:W[G<3#\+ELD61%@BT.1
M^[Z^.'RU/^N[].&K.TI3#"II2I 07 /,$9+>2H0Y6W7S5P(!S1K5MH'<5LZ6
MGZ;S#>-6H6QKW"J\@JQ-N=A9M3[BYJ+6VO?U17G6G_7%L^S/^H:BF_#:,#+F
M%;=22,0,(=)(BWEAZ7,C3*.A_8?9]':T>%8QZ59#CS;[,47])F+O4.S)*LF9
M<2J!$R3\#T*M%(>B#%$X3D4C-7$'[+5C%/ V"S2Z[_;J0=GJ,EP?+D4M7I^,
MPT6Y2B;9(IG>)HOTSRX-XNL8^0QVX7$L;SS]>/K#7'AD_GCZ$?O#7'AOQR_O
MFK%+0>4#$=Y:ZQG EG+%"93!G"HS=KG1C8S=;;FQN67V+EN\O_V8_KDQ[>%#
M.LLF3],<]G:<G*?!]4GR*)IH.>1V]3LAMQL\$J7( !<>I0BIVEUQ*+742 O-
ME5',,,T**6*@\:J1,W<L*1+9_JALW\-D.G?_>3S]FF7AA=/K?R2?Q^EDGN3'
M_4=0/M8>Q%6)>O)EM+B[R\8W^;5)LO*5B_3/;$LBWF4Z\]>9\I?C[XY!H@NX
M5SL%B:A 5?\*+"3'C ,C3&ZA2.[*5&S#E,(;4[%7G1/MPRPL\4/8YNG-LB![
MV<Y"I_/L)I<[0>BD^:>W98\<HUM8J\TM(C([8 CT8*UQ?1?+K S5F%5C+27C
MSAL/':60,ERX?:P&N-'@8@NSKGH$'9=:C]<\*-+K14!R((H/J_5-M<(21RUT
M&'L%H2=4B=*>EDYN+N ]B^)SG!8U.&+SPK 959^+7U\\R_ZL;R@R4U8RDV*K
M"'9026T,TD%FZF+D@I80H\V]QMN1F6TTN.U%+=J0TDZ7=R2999\?9M=WX:HD
MGV?3WV?I_=I[W*6X4<?H:; +[W'4</^HP=:U=E9S'\05C6D-<>&73DJ[I3)P
M#FN%29H"")!FW%GG/':F\(QJ ;'U._1,5]?_]3":-:9WG<X#2G?U@':W_61,
M:(O*R>EY0%3FI(+"2">,@I+28$P"Z&59H"@5THT"Q?1K#N2YG\Y^7=L$[V]K
M@>%NNUP9.,EDJD@&ET8&40T<X,+CZ<?3'[ B(&JYS58"C"3@0@E."-3&X'(6
MB%%2-CL5[*\(1#$>TY9W6Z8=_3$*1' SS^_(.!B -[%S6M_7%^.S_5E?7^*S
M+PG2(#LKBQHQA!GQPG(LF!58 5V6F@HI&MG<:XYKRW ^WG12U&;T]J)D:\1J
MK];:]_5%&=J?]<6S[,_ZXEGV9WT#T6T%J+6Y]T89+(%U# FMJ3,:E<F'1@C=
M2-A_6;>-:NE)7#X]2$1<-E/HDB.W8WPTV(7'($X\_1X'<5X2S[1*YD#,2X,X
M18)[2*1@3A2=WI7SCC4ZO3=GNBU)MAN.J)V:UYPB"!33<P<#ZXYMPF 7'D5Z
M//UX^L-<^.[,OYK$6JRD.8RUIPH?Q%5_$^P0AYAJAZG2U#KKH"W\,90!V,C>
M/;+"=T%S?O:^/%$;[#0G]!3SM%ZY@SQQCC$CO3"(.>M=F5_  O /Q7P+0#U)
MO<T%5'^_P#'M +.5@>2'W&"=CM/)=9:DB^3G='9]EV!XE>37Z0BTO,^6[;=!
MI\=XK3H/$6H)AYP*AC&!6!I8QEDL0TH\Q7@MZW95F[=J^/ $XS^N,-YBS\<#
MVI)AQ$\ISML R>E%>M<(I%,V4&>HHD4N_9<C;D0/*%)6H6A!@0<8(>\(XL8X
M;&1I^@!/:(,BFVK0CY/K\4.^$QM;L&^V98[.J'NK7%><M-E(-Q)J)-1(J'TG
M5 3DFE"A9PI*XHP5"$(+.2=E 9CVRC8*P#I$J$?+>*=76+#(JI%5^\"JIT\=
M1(A4KFJM&"- <*L==IY[;\HA!P)+U-#7-C2<:84KCM9GN]4LQ%UOS:NR%,\N
MC/=J/A')Y1+():IL)R-54I$J<Q!KY*E5S#+*J):^)%6I#&[4&CXBOV4+V!-P
MZM[AOBLN<>34R*F14R.G'IE36<6IBBD)O:.(,\8\($;P<F:,5PS(#MO!YQD7
M#$^9EQ%).I)T).E>DO1+'"WHFJ.=A8(*13!P0@FGN+%%CPWMH0>;YWIU@Z./
MG"/7:NI-]%9&7HV\VG->Q:#2?2%7##$%+46!7870!I0Q("8]/FE0O8TN@5<(
M1T)<YBM^MSR!]>/+?VM?)QQ']O8N6](71.";I_>9A/M<^\K767YTK_C26ZYI
M\;+?LBR93!?9/%E,\[L06'">Y5F_D^46YO9,<CN:I)/K_%WFI9R=__7Q:I?_
MK#:A^GW_1?[GPWPQNOUZI*,YQO>JO><CH@;E&XSRK5W]7O_020ZA\2-.@V"5
M +V\-LEU-AX7S_[M#7BS_#TLYKK\?<->?!S=A_-\EWU)?IW>IPVI]F5TL[@+
M/X;5%JBY#J20?IYGWY<__/ 4(V_6:;>U"J'M2;FKC\#XFQ_>-/!=/$>>>:[V
MNA-WUMQ,(UF&."(OZ [%@;+P+N=4(^(^#&L?SMIZMDOZ\S'6=SRY:])9^.3P
M!_^:I>/%75(N>)]W*XHSBENY?/++ZO)]"OIA^+#_/N3=RR/Y!1_U.SX^]_V^
MJ!_ENFF"  *)#X(U@>#M+]V[2D_MC$-NTH:=1.PTFNAQE;35OW>S2JOZ/7O[
M:9:E_WB;W@8D?I^.OZ1?Y[F><#<K%,YT:6#-">7:<$.1@YYBS[3RE".<)]EI
M39')7Y.VI*F^FA9.HZAN,6RBEMK4-A';KHE2M/TYA/;04K>:L1F!MYAN*+DK
MGC@R);W2$-Z!Z6^7_VWB)[\V)]=NVWF;'H$C[EB7])V^KW^KQ-KJ<7@-5U;?
M ^UWU]$6K6;Y#B5A-F[_$G(WV?5TMISWG#O'LEP;7#M>3-WQ4N$CF=XF)IW?
M)3[L_GQO*0&>7 /PO-1 ^[$ JG:F<,#MOS/?_OLD?;@9A=U8!W*')\3$BT*,
MP^V"ZKFGGI%O>[[CP1\V)(-V?<+\P(8K^^S%[J;N_H&0#>+_78!D\G-X_&Z>
MN(#4FZITO6ONC6/$Q)[R7%#ULEE.4SG9C29)>/TX/#[?DK>R>X.FKL5:3W;!
M<O._(T9_9[MW#>-RY'=A8R^,X31OWH"/I1Z9W\IY<CN;WB?3SUG.19/?DSQ*
M^\=H,<KFW\?V<+$]7#S]WFLC01W+%DE6%.]^]^UX.M^F>;2^WK.0WSX)28>L
MI;V<H@V+>2'#GF,B>(:$J$:->L %D<!QX9SP ALNRS;5$"O9R#+Z,)O>CA8_
MA5O1;%J&P*N:ENV2T$ZN,&USNNA>*>MGN9<#G7QV@:1RR1SR4EYBP1@2\%K/
M0QKX0I#P/PBU4AR*HN>A=IR*YG#B9QBCO3:'\ KR-HGBO!F"G;-$MN2RP!,D
M]5R&DGG"#8F;$&]%_\T0=9.GDZQB78MI,LN"[+@>C;-DTK1/\C_('[[.'1F?
M9]-\T-E-\NGK43P94<GJ_/H&<Y8M*PNPTXQ@L\^!!4;+*$F23FZ2]#ZO:_GG
M\H&!]2K?:OL_K\AC4"LP4AH""H@V".3&NP& KQH;:T24]@W3O[[_X>=QMJPI
MFMRHVC$<[!1XKH)(M-I4LW.]S#NMVIV*L?L&U%UQB7#5G8T+ S!RSF'@,!*>
M<[4RL(T QL-V<-F>Z<UIJ]W6.H?+_93K;LO2'^\_IZ/92KO.16FN1B?A6L[#
M>>>I9=.\94DRFOR1%3IX/^<N[RU&2057RPQ4@E&3]VD%2F"/Z0JN%F$H&GV_
M<D_8^\EO8:/?W_Y8;7"KDO.?V6QZ$XRAG'0%@NB'/GC&AF2X7"B>=H4/J\9F
M,6!DD'C:4DLYL(9H)E=:*'2:F?WAT\T1.MV78GTP%9^*MV]_3T>3OWQ72KF;
MT?SS-(BZ7-*E\WFVF%_E_J.!J:9["S]1&WKG$>8NZ*N2&!) EP\Y7@D_QS3
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M3*=68744K+<HW.& L3X8>SKHC==9=E/$LF;9XF$V:5?.=Q31^[JRF:!51VH
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MDTD>U,_;PR^O6<P-W$TE>(DL9*T=/'!046"M@\9ZY@1@12FN\] @N(DLFGX
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MB-//R?XZS39^&G;,CI.-NG%.QU/3""B?IDYU2?!YD6BYK5(I*VP,(0H0CX#
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M,1OWYEYBQF<['+HA3X>N^<M]8A_W)1GU;6_OBN?S[U>/9][6M^U=^LEP8"C
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M<A!6LYA4:JO!<)R9*QM#)-$!4@=(K0>DIN)*VXU0N\:-DGHR+@ (2)]'6G.
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M1#"&+/!##366E$L?D=+ESJ0.WOP<^O" ()KUO)\J()P!PU_T2;40%5<K$H0
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MT\&)*@T'X?U3,ALZ:.R@<0=HE+#SI70PV<%D!Y,=3*Z%20)@5=LGU!(@[.-
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M6GP:V&[&OR9?O0_CQWBIX%?N(8? S+8H-N3,]Z<L>5?^HSYGYWR_FM7)G96
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M-9P#QDV%B[U>5E'$O0_Y@+:'?"Z^ ?Z(I#%[%%$7? M[8<N^ /T9%.S9HX#
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MKF2&8'($5=-N)(8 SJ&B&M"0R!9NL9EBE;%'6Z_GC0I)$0YFN10<5:+.)7D
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MXX+.M3M#J8;I@M2-^FL%K,U%[26<ZU^Q6*7JBL!/)=WD54IN9C8WA=<*;2$
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MX!##4('K(?CC<_2,TZ1_;+)T&)CN)L#2RR"NS9'9$_30VNHI552BJ<!=M#I
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M>GFL$\D8&E8S0;PJCFU6T.\>]0I61F]QIUJYSC2[ILJ0>FPGVF0":PM[\O"
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M_U-FQ61H?U&3J4HCN3D\[?_R3&?:P#%$;\?E6L[;LNB%O;P>=V@H1LT(3%$
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MH?UW=RK3^<D]I8/FNE)UN@99\\ N8-D@"Q)(@ ;(AZ[80G(U/6 2!D$M=W$
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MSE+9]J%%;74]A_ [JIDK6:'0OL[67TSK:4@Z>GO.@]8<?$L=+%G2@Q@,?8Z
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M&-5GH=B\6K8^>'1L$L<,HX+SQ<>VY,,<T%VMDMINX*YNR;EXZMDQ!*"RZ9C
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ML2\DHT&>-/HQ&?7B:Z=P9ZQ=JZ>Z8=K5Q:.ZL9Y,C**+O=4<>WM_Z67=M[O
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MC>%-A50B8]).HS&=3NO3=EVJ<>/V<P-%'3>$E)K5 Q-4+E_VL.ORY8M>Q&@
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MY#"L2N,\";'XP6(5_O9%%@!/,/&2K54!'ER)&4G!0A%<"#HA%NC)#5>OB :
M!K8*KB)%)H  ("/!KJTX;?7QJ8X(9K6ZP)-B8ZX-E-"&4.QT>H.6U1(L=*',
MFK9'9+P,,DX/"!EW2V;T[LUER[OHZ=SV\^04W:X,0P[-$_W>VM@MH8I9:P;K
MY&@E8'6$:;08KB.<@60Q1!V,/-@.N/:%U!G,PWBDH-RV-*F2/@N@6Y,3L.*
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M][]26OTRZ5_]<NM%/C _0'C9,+^,:/X#4$L#!!0    ( .))JU#=U*5R,AH
M !&\   ;    83(P<3,Q,'$S,S$R,&5X:&EB:70Y.3$N:'1M[3UKD]NVM9^3
M7\&ZDS:=D;PO-XUW'<_8:^<FMWG5<9JY'R$2E."E  8@I55^_3T/  0E:KWK
M-'-[I_B0>$42P %PSL%YX]D?7GU__?9_?GA=K+IU4_SPT\MOOKXN'LU/3GZ^
MN#XY>?7V5?'5VV^_*9X\/CTKWEJAG>J4T:(Y.7G]W:/BT:KKVLN3D^UV^WA[
M\=C8Y<G;-R?8U9.3QA@G'U==]>CYQ\_PT?.//WJVDJ*"?S]Z]H?YO'AERGXM
M=5>45HI.5D7OE%X6/U?2W11GQ7P>O[PV[<ZJY:HKSD_/3XN?C;U1&Q&^Z%37
MR.>O;U=JH;IG)_P3!COQHSU;F&KW_%FE-H7K=HW\XE%M=#>OQ5HUN\NW:BU=
M\9W<%F_,6N@K>N?4K_+R[+3MKA!Z:/G\F2BT6$-;]_+TY=-7K\]/7YR>/_WK
MJU>?O?CR]9<O7K[Z_&^?7;Q^\OK5TT?/GYT(^(]:A?^%D1NEY7PE<2Z79^>G
MGUQU\K:;BT8M]64):R'M(0!I^U94%2S2O)%U=WG:WG)[I2MH2[_3 ;2Q:]%<
MA3:=:;'+6^RR$XM&%J5L&O_VBT>GC^BW:T49?C]\N=;"+I5F\$3?F?" =H^?
M;%75K2Z?/GW\V>G3B[_]]9.KA;&5M//2-(UHG;P,?Z1K@QT2W!;^JPKX!.#4
M7SRZP-7N*OR?C6\]V#S0Q<4G5^&C![U[,KR;Z'PC;:=*T7CX%J;KS/IJM#WG
ML-3IVJ>_^?O1(UZB<]Z?9,L-#%4W9GNY4A5L\P1^X).IO5)Z):WJ#EO\Z8]G
MGYU>/3O!%P%3]Q8AS^]?-;\$B^F3!TSPA56B*;X3UIKM?C/ZN65"7YBF@GX\
M"RR MLXF)D]8?$*4'Y__2_C3AX /S18(3@KE_P<X?K]1DP.#WCUD2=[UKE/U
M+AWFXL.@NYA&K1\[.*'IL'XCE\(BPA=?&KN%/^??&'.#O[_6-1XX*" 4'[2Q
M$[/X36O\PH%( 7*%TD6W4JZ03!^SXD]__/S\_/1J*V?TU]E5>&)ZN_^H=^&!
MT, ]%(PK;-%:HTVO76%E+6W1F>*:5@6@^4J*IEO-8#G*Q]1&=:YP_<*I2@FK
MI)L5O6ZD<P 4',$ -*P ]/-+KRP<K0:>VJT"V:GXOK=%K6#%EJ[8JFY%#7Z4
M90],#_JASE_?EBNAEQ)DI/5:.0>+/X,)ETU/>P03*EYHW0-<;V1K;%? YL#&
MK8NST_G?"]@PZK16#GAAL9,P-0G"1%7\=Z\EL]&+TQF(76=/BT_Q2[\J]"#V
MXU?H+S,:[Y=>6"#09@>3PB%=.N8_4NAH5XR6,YH*MH6Y6<2R_9:? ["?BL9
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M_C<<+/@-<^=@RXW\=I"'AB6A'87^,"8*1O4+ZU;&HM&)Y3P<45C/SSU$2E<
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M61#Q2%R-[C=OZ9FA,4N4-V))/U225^!V .C:)5+C#H<5[)@;O.W1J(4:)?K
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MB4!]UY<-IL*\&=8X3:\9@)<5=?W6HL5[\I-K.O]Y<UY2HFOQ@U>A\+N-L,J
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M.>@]"=X))VK9194:K5IB.P2CCZ(_O'.&7#@+Z<NA,)_W-C7E4H\0J/L=!K(
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M:AKZHQ4[LO%R#W T5O,;*=NH:%NNEY )-1/J;R;4L4:ZES-"Y]R0IA&#"Y-
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MNW'%USW"^7<AD\/;@/^M(4L"(3\*+&AAJMWSCY^=K+IU\_Q_ 5!+ P04
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M>H-]\\+*\()A*BM9%RL#9WFFQW0P&PI)9T4WNO.#>V'+WW]M(;E\XVXZ132
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M4$AW[S"WDJ66*(JX-!Q)9V%Z9\H@T"HU6%PJ2>W!'Z&/+TI;R&I4[ ]!NM^
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M4.$KPI>[\+S\(0NAQI>LV-2%U+/0>/Y0]*I)<"AGJQ US<M$Q*?\Y(PS+.1
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M 3WI]+P$(X4#=0)#2!R0@&!:K?L*& F&5)E#P><8G+(A$7Y4J'__[4!@>-F
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M2,?1C9G:C9&F#TF<1L:+8* PUM9R B"HW S*? <-.+]_XF4TH%>\AG+7?P_
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MY427?BYG*^E9AZHNH"['%#8:ND-%*8=,[)[NDZ=R&LQ.F".$(^T%"I@R@J@
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MH4,3$L<#/ P@3E P.<9*;%'%G71^R,O-+ATU1T'H<O)OT'[E\)1$$AL"!2&
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M)L[#HY,RA"4&$*<<Y@0K()3:D2H-T^U/8O163AA=DE&0&6I)_U#DDRR;+GW
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M$FE2=G<O<TK$[I<, 7%[4SC\J;E6 HR!RHC.!CC.J/>HO/'96\JY][;2.R@
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M#>B$T8^G"^-/&%],!2Y8LVKRN_LBNRWA^I*]600W,GM;BJ840;V-:#(]T=J
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M*#*85APY0=@XPZL8(FK2T*X=.C^"W$<58HU%W)>)I>/U+\2:0F"%I,JB$%
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M$Z- ,'#(<X\D6*^,(!77=& VQR$#XWDQN; AFQ/].:@/ 9AWM]O-=K'\O)O
ML%U?Q^/LZL_%S>W9^&(?[RP08FE6CV2.8Q'2%2><5AAC7.^"\LD5A#1VV#-A
M0_9A] .]]Y('#^D]6S'2RTL+CBQSH%)V2DI,F*+^,'#2&V)1\RA!SO4CK80]
M!SY,1=KO:?=_E2F1$$^['^5Z\;7\4"9FQY_;541B<;6]7=Q\+-??28]JT& U
M!17$>@=8N'C:"DO3F,^*+U3[YO55.5>@C*4?_3-H*HIS;Z>HB<1 YT?=U13
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M<!5ZBSIW+)!#PC?"+OJ<RW3)9GCZ.XJ HV&EK9  F@JM+4'NJ'!"-T^9]E:
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MI4YO7E164M@#QL-4[CPP5MXNUNN(Y8]R['(5FSC[[LO.G/JM1N')D\\7Q,D
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MN%8L\F:$<Z'R;V*<G)E*3#,Z_31BW*/27O^3O8+YN=QFZX/1LU=L%C3U,$N
MSWM*2D@<N, =SB;"B(G/(H;-6IY,^BMG+=RCX:9X\<QZ&UR?6R:D7VZ*^8,Q
M+WOO<I(6T+IV::@EQ"]?BE)T9AZRQ//TTY$MQU[=O+3$G6@>SL]9L6FV\3[F
M:[Z\XF@.-T$/H!; YU82ZB<,>&&,,4CZK3S"O)0"M-CD=\T_OSPSF;4I-"9A
M-R:/X0D/R0:F\T,#],].#]79ED<WHX_&J5QRCB'2+T]$$["M- <9H=E*MHX0
M<Q=2=LPR/X^\'<,^E3;[JF1&XM[4Q[S.JZ_Y @4Q=KG,(ABY;@@)@?%^.1!3
M*E0/1?WKEH-N6F^+AW:P'8VT_1M&DLF&\M2):9==UN1T2I$P.WF$+WFYE#BH
MS.$\%$<#_\O40$TF5-_.SK_A=58\U*Q8YZO^<-1/66N; ! FQ*? )<.%]I"%
MOM8;VBKV+*O-B3>@\V].!]-I<<KE3!BE6E"+1F99-QE%FN!17ML^P=HE[3+(
M^4S4S*1'5U[AUF=+5?%:6^]O/W#S_ ]O;^M%Q&*(7 R@ZT$/)VZ(8%]<FT9\
M52OTGI Y:^.KW?ZH^H!23^D4*%;3.;OL:JN<#+&C*-PKOB3T39WK>:J;AC]7
MM$V7*45E0\MEM<O6:(NSJGKB?_CW;+WC<63(&&*I&WC<$/3]Q(7#[?V(!(%0
M.7^S%D=6.*>'J:5IJN0JZ=H(O.IIVU5*QU"STRR)*YHFR[-4-5V?+BN;$<:D
M[^)_S)?9>DV_/^:;FAM+7882AD,WC6,2(1S0X=Y%A%@HM?&E:,*R?NU1.1TL
MI\>E>$M?DCXQP1J!.3F%DB;-[AW^9[1<D"1-'N>A0;I.G+OAK\.)J,K@LMZ^
MO_VY+%<UVJP^Y=778IG7G\KU:@%]1 CS,'0IC6 :I5[*>H.QY_J>7/T/#4,R
MHT;IRE6#K5FFM.BZP_P>G], E!,>'4;%Q&<D*N4$2)5#*SITGJ$+6F2 UGGH
MD0E'2N-=3K+H8K[F?WO7IY)SFVCU4&R*>EMEV^)K/HABXGG(]PC#J4]PQ!B,
M/3 8)SYC<AIER*AUO>IQWNSO4C3#[3E6M:#)%.MB.C8!W7*:9H)G.Y4>A9B[
MH'6&J9^'[IEVZF5Q2!N<B>KA^^U]7K7KSWPU'&P7>8UW5=6D7:2)VX@M\1+7
M(\C% 8)[H]"-J9P.:AJSKG\M/J<'Z!PA;%(R6XQRLJ=+KIC<C<BJG,QIT&E%
MW2X3=4'5##$\#S4SY4QII1=*1G/-_< F/^S]+2LVV6999.L/95TT^1[H2Z.@
MR^W"1V$840PA"6#HQ@ #0,,@#3D>!@@2'69&;%F,*09XS6)I#] 9$#J_#1C'
M+AXM0-NE@,(DZ_,8@&9=>AE,F.=+=#!^X+TFYZ-]]6E;+G__=)_QWHIVV_NR
M*OXS7RUB"!,08^QZ"60L31A.HL$H=0&1V6#6-&5YHWF/SJE;9#=.ML<F%T#H
M4BJF;".R*:=I!R);9#=.A\U!U^FTHF67B;J@8H88GH=^F7*FM-(+]37K;5WS
M&&8149+$+B2,!"1R/4!2XG<&@9N"--;5*T$SHVM5T>+2URE1&M4UR@*#9O3I
M[64*1].F#H>D+DFR.E]-DG5$0(^4N!$_,GMX*#>GU<]U,2 L!<R#%+@4,#=-
M!HMQZDH%3SIV+*M1!TT[;-)B4O2L;!P290_+6O[F$2U=H.CB:9D^L?/0)".>
MO#HO,\6.LBKU&I@D*4L#%,<L1EZ4^F[J>H,UFLB]EJAJ8UPU4@F,E-E35"$+
MQ.DKT,TD =$9;F2D1Y+-F<J.K!?7)$>)%5&Y^5SE6;VKGH[L+6#J^8Q0%/O0
MIR"A*<9I;PE@WW=EI$;E^V/*C%-LG&V/44YJE)@3DQG;I,E)S(#FN<B,*RXG
M&+D@+#K\S4-4M#PHS?4F.3'YF-?;:K?<[JIB<X>YI3L>, V;X($+/!KXB$;4
M]2 /FP#MPB7?\ZD/15_8TK)A;Y \@^7TN"8[!+I$TH5Q8X3;>0P@,ZZ4%OJ>
M;/[<U[S*N,M-YEX-%CAB<>HG(75)PA<>84K2L+<2^"$ALHER<E^WGA%"'Q[7
MY5.>OZGZ*C7+!IAL\ILD98+GT1:YDCQZ'I X^"([EE+6GM%P,3=-C;!Y"(@R
M^E?99CHLB-2_9-FR+8]"OQ=;M%FUB2&ML06E88@H!C1""7%#'T00#;88A%2T
MU*6Z!<NA_ #,:9"U69U=#M3E<6&2P<O:,1YY<@HR/6_B92;'X4^MHN2>QWS@
ML6QY;&<MY[$J'K*J6#_QWV_JHKM7L<Z;1Q*;U_.*35??J/WA&R=;+O,UEXIF
MUEOECU6^+-J_OW'R?^R*QS;5B,^*C2P>_:O'JOR/?+EM+>S6S05'YS;/NXL;
M'8JLKLOF4_RSWXKM/?_&<:3*/>/6U@47J:<&7K&Y+:N'SL0V7]YORG5Y]]3\
M<94-_RYWZO[B@-YS7F=;]L2D8J8G3%_STH /I<FQH;_ 6P2(03\-$A#Z,$Y<
MDB8$#*8H\KS%MBF_*1:0*AF0FF3V6,3W/]IZL<^'33.\\CY6Y:.AG^+EXE0U
M,M57R49Y-+ ZGGY)++D4%B9P'A&LG@L"2U])/D1%AF5%U5[()T6]7)?UKCI:
M9</(#U"$/2\$;A1"!D (6Y.!ER9N*OJDLI8-FW%943DM+N<(V&3;2)=8NC!V
MC) [CS%DQI720N>3W$9:WN>KW3I_?[LWCNHZWS:W0(]N#_S2[A3GJ_>;C_ER
M5S5C/<UXY/HY^[+./^??MRDGY_<%P00#F.((D!C%$*=)D P8 Y<!F0.B<9%9
M7X\.X_?&Z;QH(X4C/YS!$8<'V'M7G-87R6VN<9M4<)-LMJTIN<76^]%>[M!J
M5.>WUBFG\<IIW1K[0HC))KFTW3=)T\]CFIC(]Y=;C1.V@-#3HEEWP_9P+X;%
M-,+-CBA?G\:$>6Z0TC" ;D"\T VN58U5^J8]S1B@B(1K!KB1>''2)D>*STI*
M<"7T<.0+%\_L("DS,?W&D3KTTD!/4(TVGRT;N0SUCPZT>U2MWBR"B+* !#"*
M (M9&&(8P!Y!["9$*MG(I%W+D>)Q@/'QU=;2\$9'B[>/( 3%Q$H;R 9_X]*O
M'MKI,F\Y8+M*HU X9JXQYA9L&?3L;"AEFCVEK?8/O >C[T7-;04^3+S43Q-
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M(-%FU?Q/<R/\:[9N+VML<5953WSQ^O=LO<L7-(P\0I,P")@?)0&WSP9)HX0
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M"LUJZ67Z,8B^L/LSLY:>QX;1W$@I9STZ)6OPRN!HQF4_[\; @RG#?NK%!,7
MIRG  QH74ZFD+EL8IIB+I*)VZXT@-KW,@7\#\\4UZNV4YU7C[L(48+LUYJ'I
MUKU\6<MW%%9%-I)^S;X675+Z+WE3CF.1>BF)^.+%]R"D(8O3Q 6#"8Q<H6*^
M2A^VK(^;/1[GMPZ1Q&:&/$O7=X*L$B0G8"-S([ZS8Y4CM:T<&:Y$MFE>NGAF
M7T:9B>DW8M2AEP9Z@F2^ROESV7?%)G_+@^IZ$0 WC+$?)S $?A+ "-&]"GLD
M]*425$P8M+W+?BGCP?FMP>FT0&733XR0+9AO,C;/DIOO^A3;R281H.U2^HA)
MUN<1*IIUZ66"B'F^1(+ #U7^.?O^,X\PRPTION;UMMCNJGP!8YI0GV'F4990
M&KG0C7I+$(90J+Z0SO<MZQJ']:9Y8Z4!YO!A=@1-//Q1YNYZA#@&;7(R-2UC
MXG'C&,RIA8\J#(J$D6<\/A--ZO(S?5"I[4%IKK?(A9A#V<M^@;^YZT6_7G@A
M3&,/$!3Z*4B:LL71(.PP2N2NIJI;L2RZAPJSY0#-J7ML<N&C!I%B,>,X',HI
M\(&^/:HAWWCDAZ3/LG,A'M1G=!Y!H $_2M-]34V%NE"SR33>&TR;YW@BE% 8
MQ:&'69J"(5L-NFD@]22[AIG1=*C:8],4(A4NY93(,HVJ4G2 -;$6O>9'0(PT
M2)V7&NDX<D:.M+D16WZ6_Y$OM[BLM_7[S=M-$X$UMH92X)\>\TUS/++@2U[7
M2[PH#+PD\%P(_6A(KT)1"(1>=C%JT/H"M<795HJLF]5"L8=Z]/9JW:.568&9
M(EQD$3L!U[*KVH[F%J/S?N,<4#IH_^C!IPEIEEGY3D"WVE+XB.6A"S=53CE*
MWA(5UYULFSOK_&N^_M$Y];-W^8;'2NOU4_,H\7JWRNOVW]X65;UUGO*L'QEM
MSNTRKYK"M\YC1T_SD]Q4U=P9K_+FWU=MMDRV/AIB7<76YHME\_[[K9/MDV>.
MUB[Y=VZDSNL?-9?O8LUV=CUON-7GL, W[5)I<93()O3N^UC_U'EW"?M3OMQ5
MW1WMX<D+0E#J>7&,O#A-0,Q21F(:^C"DB&-*11_=,FC1G@X?@;QQ&IA'!0F<
M ]+)GIP1)_%B3J7QEIA'%&K#L5>YC9:XDQ^X?RW7C4#4W27=(*9QB !KDG-
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M!^IEXQU1>R/LF2_UUV'VC)K;C90;.F[9Q\</"\S J*QV?^2#16[YOXMUO4(
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M/KY8..LJ23P=G+K5N[J*\HQ%20: '\11F*<P!N.3\-0G,%89PSH&?89Q<#G
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MY?JRW'7O616-N$^@;&Z*[;I9?R[$\US557M3K(=\55V1+PRC8 4# GEKQ1
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M+'%N3/46V0TGP9:.[FEP[;CNZ7@DJWO:;,GL9?@XOHK>]?1A8UT>^X2 ($P
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MPONT+K<7WH,H]1YXPH5YI^;Z5)^9L<\0/S<F\G,X6LW>-]3D^C0O2 +Q"02
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MH,V5E9H!;RW%*J Y9*D?1 G-,YZ9<$@.A75$?:4C$^:MV\\3DC=B62380N7
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MCT_S-0TB*8N6.3=6WK#'O;T:AVP,#%0Z7DLTUAAVON:AZ99\X6,*;Z:K'RM
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M%(A)V<I<0.1SE3Q/9S.5!;I=R5,V7'N2I:SQIUE1>]YTS)(\34,<4$@(8(Q
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MB)-317GTYZ>$BBS(CL4^%?555=\*>?YRL^:-XF_%[651K_R(!#G__P02@$/
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M(F^.VJ/GP$EU,>!"X]U.>7ZA-?-9:MC'V]_J[DFZPQ?I%@!E-$#<]Y,X03Z
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M&5>^"43[PXZ#OP7AE;=>$/YR\P=O@*>N /I,G5< IR3I*8 N/S9DX*7[1V3
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M?[07I=T^IB='[4V.4B,_WLJ'.!X*O%W)%?^JN"^V]?I[T?_T1KZKOFP681J
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M%!-D*X+CS//+)<.Q.BRZ!+9-;AS/B>V4D0=:6.TYDD11@QFCJIHRE 8E<&%
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M?9_IK&W@_8-A9RV%]&$-[DV^+-\)?CS#"ZN+A!6ES)DRBT]2P*&!T%&B*4?
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M#HI_[:BD+\I5S_1N9AQ]R6WAK_B]E']X<WN73>;KAZ*C>WQ=&ZPX=JB@,&0
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ME=5T+M0^[)<O3Z\4M:R5OIAHLL5-1*3\5_ER_-=L^FBS^B%'#2,;CQ$8]Y
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ME. !()P21(VE5B@))/<5#M:C"[N"W05!GM?T[PC\ 9#PQ_S?9;>'K]\>.5+
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MLE)#+NP)[HYX<+BTZ(EX#R^5YSB^-1XM8 F%HP!#1$7\?V(B-A4N "0]!3_
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M]673;/JCR-M"W\?_N"L6V?2W>;&Z*\\1-E6\RS8;GS@?_W")&]TMZGH" 0B
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M1T8[B^N33^4<SE%OUY&:-NA&V 'B ;?"(Z1I\WHA"?)&8.(Y(8I*AG20]60
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MT 13:X9D4&=0+Q15LXOMIW"W_FL&$35K0;) O5.66FV)9U'+<P;*"PK>7?!
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M%8'KP5E ,RN4&%R$Z]Z@GE-F"<.(2TNETAQ3Q;0 ?X"/N*QK#_GT2#;F/CT
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MA%+8<NRM5U;A>A(4H[D%4'IAR0# YK4WN'U*U"^;]>W]S8F67$U?+01'AGH
M[W6@1%&I ZDF8:G..GJ<8GRD%W8, &Q'=MC*HWW@)^S^8_VY/,F)XR\47D,
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M)F9&?[+-0>]2):*'O7'U,9E78;TYO3L^W1Q_[U!5VM,O%EA3R]-EK!Y;J4(
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M"BJLM@@[3C4$29"5O.:0L2SK"I9YYDI-8$,;2+C3.-6_NWL4$GP?T=G&&24
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M_3@F=1>&U4['/11'F2JMO# ,D1I;94+.<6UKO?ZUW/RYOK1F[Y&.H]R&T4Z
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M-^6Q>Q+3;',#S4>DT4$ >'9+PK=HV0HXTYRT+8$B28:TH)5 ."*N&).9N>L
M6^3XC+AP5=%W;7#T%D%J57T0RZ_LR)^/VSH^#H[\LO6UX_?7S.Z][Z!\Q]H
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MNISNO;WUEUH_?,FYVL9XTGM>B\!H+9N(&L+T"2]X!D^HY[$034YZ*9N/B%M
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M1^@BA^_A.*(=Q88^PM[0,7D:350.O%BE UIM\[F)X>ORRJ31&V=#;QM-NS[
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M)6J)#DBEVS1YP,*6!(?U4.F-^F-E(3$)4I-F7DB_=+#H!<7$)>O>D7'&M$W
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MQZN/Y)7^Y2[Z?7-#?C0@'I_+OH[A)6P1^0)LUZ(#%O+("<JJD%;/X(BLNLH
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MV -3%5M9?A!%C9-3\H@+.R>#< II&B/HODN+EF9-?D\]3(X[=BOO)\.9;_"
MEHF^Q"B1)XH>(EEC9?NA3Z[C"5W#$1?8JQH.D928]PK<*RAXBS%T5:\@XCY<
M.")I\/XA<G;7Y 2.')5<_2G9NS90N35$/(ROKRO6 T<R7'K"DB43;&]^WA0W
M*RR&P["[S]@%?K@670WG*G1%6"J25:F&_KT_D'YZ4\\S#1_= *?OZ2$(N^;4
MB40]5>JU>VN^;21==YJ0DQ4A8NX%;\KX<PP%/T,\]6JP?V>_T)0Q%XM4P^RG
MX 2!#^@JS4^0E_BF R9GYC#=/@Y[0Y2,Q"VBF+>3[E'!L*<<YP3_1<HL<:V!
MPQWSAK,5CDD,0NGNT\XS2W^;249LQ INKC,VWTV$@+%Q1W;)7-!++0-?:/2
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MZ2XJQ_H.<<K]23U@R7R.61$6Y"/GM4R!TCQ"4A[!'_:2Y[F&"A]Y._'NQM?
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MH!591??IU% 8+\8_9JD1#TI^F!Z0/ O7N,+ED)<J1$*RD-&G6X>]0-9E3]G
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M+O!73Q$Q>+B;>IT*OM]$W;+V=ATF*&4F6QU9G_8,YG%(PD^(J9(9A\(V1K&
M'NLUX=H]U("JJS146^1R>L[&GWGL@Z7=(7N>-[3_]'WC\VJ!8[89Z%)E"-D
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M%J,-ZOL__7'Z'];"N_\ 4$L#!!0    ( .))JU")]7XUC3(  (HX   =
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M6]V-GRR^@Q6BJ)NTO]VFQ?E>%%D1Y?Z@$&0[+- !&6>A:)HQ9E,'@V*NO78
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M"+E> 9FB<5T.-@@AV\>H:BAZQ.MY ]4\QEM0)U-%?M=[<V"C.]<JYJI-LY?
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M SHFP8]K_3$?'/1UKZ2@X1SM\>H//;G 9X+,OL*=<\+U,J[3 7]?(<(?ZG7
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MCB3:_ :'=3J@E\ZN?O\72M4:O=$!:YP/ZH#[EQ5TC2>:(IB\N2!W_7\:WVA
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MWVN?](*C'3C6U'.%T/[UO>Y(3]??::[QX@^YYRFK(9SK2F%_PMP>YS8"9L?
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M)G IMNHJ565B+&QJB2]?6_/Z:5VNU"^=49/XSBG_AQLJY4%+O8_VS9CE9L5
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MU9<<#PF6<_]V@IUT4&0(CSN%1AUZ&N]LJ(,N]C7(U%[L!!U$MSVE-ZM@7";
M/@]H 4T'10SY$A["K04]9S'"0<F_<%LGB=C.JM$^/ \IA3B,X.W+W__AD$[?
M>C%_BKBT,12ZTF3%Z)9AQXM]76,3O5?.TY@T>3'CT[9XAF:E\W(=U,7B57Q\
M\?^-W=38[B]YG#Q GUBLF.S?,1S>-PS:E31S049E=?OZ9_C7/4+W,I-*7U5H
M!X6F9#B/#&QN3:6L5TY:LSFM>U!2.L7GWFAM77UM;GG1^1^(MFJZMN;/(0KA
MB4S\902$>->AWJI@\$#%X(D6@B+41V&7B44A^?*09G*VLR,BS14M&!TP3U&Q
M8;\*MNN6[O&I1&-9..I<=#.:ND)TQ<FPN?!NK&V$X]/NHUW# KXXAM3OHKX!
MKFEB1QC6N"D8;I1!\"(!;(S:28@>AH/8/E894=U$5WW2:^@D$B]B,P@\N91O
MBGM(F<JX!']TN$'@*&.P]^P'D23>].UE]<+N:OK\Q"H']6EM,M47(X.3"D%R
ML2<A"B5\)]B+8#7YC7KN!/E>&& V^G(E)IO$26)SH:OM8T3CSYC_82;BJYK'
M?7  6M7 -\:"!,![;&]QF^1TA&/]8^I7J&-!"/4'PR$B\N+8O"2QO9"KDJ:3
MS85AMV.'/,$_"CX#7E WYJ3R,#TH.Q@M<A,AAIDU'O.8Q<M>5S\E*>?ERV49
M9X^7(),M ^4I7F:Q;8W%O@_Y$M^FWIDA_VO3"4DZZ,]X)$&;&T%D5U?S-<X>
M3KOL05XNU8;33UZH@Z*#3I/,V&'/"D16H%+.2!.9(^4MI"P=9%'=_ATY1^;L
MJ8,NB+Y&KR/DO"F-AQELH-E_YU8S]2GR^5D(OKQ#N!UU:!)YHI6U=TH_7&*?
MVUJM/8C0L LB<QWTH$(BGF5772?U&?][V<^IZ/MW8$4?H:L'4+M<BH=F'1S8
M(W)FS^P"<2I]N_2I"=>F 7Z6)U>?_G4/MJ]D9("7)ERO8BT8.3N40B"H,WLP
ML'BFL7@.ZEQY:ZA_1+2ZI[JD=N"OL+AMTL\R":.Z/%N)MHX_1NG!H ^U:R$;
MN&,6R*!B)EM$]D.9"CP3'0X!-VZ/<JO-^!G".)2I/HU$G8^?H*GF\9;RS4*V
M5/4)YQ(]F-E(_3M!JH 2HV@05,2.THX*PQ0>INP9B?-72$CN*3/79JHENC__
MW UVMJ1^(JVV_!;3_KL2DZT)QQ(CSSCV?MXQVJ ZGO,\[J2CW6FI38_0RE\Z
MPI\OLHTF0AC_SDTAD&@W,4"\XJ)<#+&3I0T<^[H^S$I!KLK>@4A3IQ]5-_50
M-M]X_I/]RE/MRS]VOMIW12[\MB]DQP\D287'X"8EO]FC7ZK^#927<KKL=!")
MN@SV CU*6<;0 L ]1N)A<WK%)N,B8VPMVLTUB[L)VN2#07Y*VWS$X]M'J#B3
M<@X9EM@.)&2)/(& _JC+JHEC]5H8K@C:]GE&_>*3+/AA57><:6[,[?Z#H]ZY
M7O=ZUWN5W6":350$1I[$\R/=PJ0.7]Y=/+:8&9;3;IK^2+  7@G"E5W_@ \B
M@\^HJS2,G''<)9S;2)=/FH.,0_"VKJEW/CM^1[LEH5V"R]CAJ%O1LSLNLY04
MLU#W]8%=X[:3XU?^\<VUOY=E'E]V-?/X\:55ZRT/_OK;I9<!2R\1OR>WD&NX
M"-WC[\6^ NTO>5;<D3I)S\PQV%4'&7S209>L[NJ@_IVH#UX$;V:<_EYON_6_
M&7..GLU[&7QQE+:6\1MW ;X*WMZ)):B<-M'1"S51D9'*H-#.5[V+W+_9KWY]
MZ.%VTZT33LD[KJ]*/[YA-. O,8U#P&:#/[X:WJ2]3]7#GP^L(9I[^U$=M!!>
M>P?(FIS=:0LXSF =V1#X=NWM/655 2(E$6[>ON7-Y_CFL?9.KP0H>3N2VSCF
M;(%<'LJ]W?]FK%[TN"SZ,\3UZW<N^6S]Y7@AGZI0%]SDL)(Q![8#F2@,(EL'
M[+#%LEHC[<537#/X!-J;@A@'A033>:$)32/X,G;;?I24(@SP:.2;D$S>A8]^
M_6%HZ6L!YN?TR]FCLS6BB_%W \M'.'<0)FY\1S69PZC)RQ$?>^H[*9F-&S[/
M(0-&<_%7J)-XPD9.6P"R@WOC=5 :WYRZG/&&;:6XQDN>F":3V:0M9,MJ/BD<
MWO]:&*3-/[G:Y'Y9"JLDUK8*(HT$NG1SCEP1K^8J3F"[=="-L0B"7JYPL33&
M'=OQT*%Y1PX6+KSZZ_32FY?HCUV7G]] SV#84,G8J@==->0,YV552,^5RG/+
M^>72,W.QL?@S-L*"G[=D'XXY/=K&<GCQ;49FS4[3,&.X G<P4<?IH)MW;A)@
M_*2)BY4*KM'DM[[)T\.\&EJQ_;,\O"1D&EQ&&0=1,0]?"'_31[4?\:5G4)=$
MX\9$GR4/,FFRNW@@NK UN]+S229,*XLM"+&;W6LQ,!2[;<C*<?;^9;.WN4Z_
MU-^_4N!^.PSB[B0C;QA5+*U-.%%?<_$E.NB]^_^8"OHR->3R98IK2S81QW(O
MS/9)I&_&]CU!#9.P6)RJO>/)3>)6>V3$$YW*8A" DB5=H[6AZJIR;.,CL/%V
MX-T1T4+TX8AM;P'NAK879!Y%%)W^O$FAX2VF+;ZJX,"#8?PK^$?M[Q3#,^@K
M&@D.Z<#=!J+YCAP2+M5!YE,$1'%>4AU%@,#Q!92H6Q'8+E! --,\JEX7=<G(
M?IH=YH=,/K,3670L>8C2LRFND;?#Q4TTB_!V)BUE]2GM(7T-BY")C=HB[H>[
MT6*P!B6:S97,;MP9"P'GT/U=NT6 JV32+ <^S/SCS>B>@PW<.0/AA[:LN9'6
MK+U64D4QV&D:.VHX-^4$XT7!,WH&X1(;CB'L!(KN'@(_C^T'28B$4 ^]KLBI
MF<\@N.;I.4FMW<!;CG/^GIW3'N,5<1%A8X'L>&N[WG3#JB?O-C]YPB%PM\'[
M.94$2B[1L7T#'@R-7>]YVBXF^H(0,31"Q(P1:D8'!;H*W@Q@/Q,B)H\0,;/_
M(F<ZGW^84_KE=M;_H=?BV_K^=U6WA7S?YN]@(H0KB$O(4G30](1*H"4K=FE#
M!"_ROMR*X6"$,P0L)^X'@K6_-WP__=_OE)%K^/^7&,3@<ZO%F VAZ28T3K!_
MGH(\X:79CZT"7NARAOE(A'M> [Y6W.M>PT/^JMNLK;U<D7'O5!C@/$^D%G =
MW8<GW9DKC@97UWU8MO_*J][3,J]J2]&<CY>,;OUH*O_I5&12?M)OQA >+N02
M9A411+Q_%/=!3]\YK(G'C(K;@E';.^=BUD6 YU<"SV6G7_(Q%9FM>'9G-.?%
MSDT!A]9B(]HR+G,2+'>=6(8^49\$%PE+&H(YMM%4/;!2^=2UI5#:>*OC?DUV
M>$ASA&E??C-NBB:<IX3?@3<6--.,A8>Y][;&*.@9A9/I\=;$C%G<C=<_!)I\
M"/VDTA3B+PD%-=Q"I*T>4<*@A]Q?F("!?J*0EQ&1L[].4O0UT6K%F-43C9MJ
M %Y#G%X(>X/-2OX%<34_BQ:]V;^IGB;1>-B_&>FE>H) !3?5V04P[K+]6X9,
MGG8*@Q0CI_CF?,N8PJD0CD/OE-C&:;F\]*^+I4,?9M^1TO@U7,RR3<%M$J=0
M7?)PXTHYWPY>J2V"#<_()_MGY'69G@=<Z@ KL1)V1!*>B2V8Z[' #MPQ!E^'
MIA<EREE&GK.,U.D_+%O]4%H6Q;]"!\7$[K_(/AGX6@<]YH^W;\+A'W408BG3
M0;G!VJOE7&DN'Y\3IH/0NQ"^AZM N4A@WBR5D<0%BU0T/)(YU4D"'L.81<N&
MPWY$O.9J^<]WEOCEAC6]>7'=<!'R:,,?'_6F(90AD/U;5Y7BKX@.CN]&Q^;6
M$=I^KQ[6R7G+14()KR[S:=)!AFQ[20.YSO]9^]F90#3NW?1$3:X.RAJ^XA!0
M[3"V[]$)NS2G_6O_@7X3N.[2IQ;KKX?V?!IN9B!$*8#E(1?@]4KR7" EM+63
MDFL$ZK9W"S<JN69C9*3@[4BH.NE>:&#DW1'?'!/%@:' P+&-I<F,53O+<[Z^
M,A3]DTO64?R#^=7RXEKOJ#'F3]S?]O+[S[(P<) K7U;W+T'^#!"[B2^/>R2!
M$W(:CVLNW*@)P%;@SP #M:.#)XKL7'_"!&NOS:>YF;/AM:7'8E1Y%F-]]9ZS
M@LSI&X?O'HKY9/;SJ+IA"IP:LSA:6QAQS:Q6D,5E<L%2GUR8K&3-81>H<\!V
MKD)F!W_;C:\;,S',PM=$#[QE6,>?ZQ$]06MYRG9#>B<6HL@]X>@0YI9G/A9Z
MY$#,;FE)J+]M_HG-O_!E!>H(HGJHM@PPG\C5EMMX6Q=WN+&-2%UW,>B!N*94
M&R(]_\EM6$\A*?+,@0<A=FM<&TAF@-X8NKQ (38%YP)T4&I]7^#K*2?;5TZT
M79W5FA,*[T^5J^_)LXQ2-OW1\&U^P&KITKS91(T9MX%H_2Z33;"U*@W-D?-6
M!^F?,JD,:ZH_]C[5K@]W2P[,9B;:;HJ)VNJ1ML#SR,\=QP(7_*%(SBT5EY'&
MG_K@\&HQ8CE(I-WNW/5TI]4_MG;VON6NN*W_R0$G:PE?$SWYK628P,R&NDSN
MW[\*7FJD8'4"9MD;V/;<2CT,K)\O>_]G1ML9U;?K N+7EYB"K__QHH'G9/3A
M9\/I?=IKAPE7[.<#$X(H6N[0JCPG_T:)3O]9(!?WVD)^P<*H'OC\$SK(OPWQ
M($Y.B=)!+^/("!"#9:U:LL<S,6:*\G70VAKM0>[Q&-EG%;'@_!4=A,7F_=NB
M^=[P$^%U4C;AVD/<CD^8";&)=)$.^NP0AEL1DP3^-ZQ>3=FG*!H3#U;(O_6N
MC5C<L>;C\7/21:E90X-[:@IC#NB@1H?&5OOU#\;UO+1$"/Z/#6G_NJ'MOV[X
MIP]&T^!&!&,&&  ]'93RY?O:SVL9Q?PZ.F:;@L^/1+<-*WXKGJ=])#($YZ-?
M@Z=>:P\G*A^WWQ 72'*/'U\+@BYO?U;SV (;S$S^]CSD.IOVOU4G[]NNO#"'
M]=/5=;17JR"<+%:,T)#O",;:-)E*GM%!S<3!GA.U1R).FTQP58<,_HH@,YSP
MY5^[Q(_^;8"#M05E.DB:5D  "_<+KA $]5]ZO9/B(U+@/H-9GE34-;K[2?#U
MVB?4N1_."H<V]-7L'!?$DZTE:Q_4/^BX6<<_*K+=MCND]E<W:.O EHT&I \>
M"G$3RP!F@$0Y/XMO!@>4@5;%9!/7.-IY T++FDJX$N365&R%[K@:=^^#_<>B
MI>C6]6]&ZX^]JYFH:#/=[;E^,;LC,[@KUX?N:.+P]>:YE8]TT,"^$_N"]UGL
M"[9>=??\W;LE>OOV0I ^!$&.>EO,;V:M@/['N+44"OB@YZKO"D6=WTC;%;IM
MG='S109'XQ<Y^3\:7:'_F=<BJ_OR;:P%YH=^=TVS&8B;^ \%#:R,.JZQ:"W>
MT2OR1"ISI3Q*X/51M;,32%.RC+'%C^ORFYU]0 C";2K,J2<W,Q8U5WX(;;EX
M1L%WD"KH\X"4CK0-,699$NG X'Z4-1&D8O27-).-O#SF'!HI7H"*\RCS!>_8
MF@;<I0\.D$_RBGT1'21I#VD:\@'QUZOK9QJ#K%K/]F5,3.<ES0PM$743$8T&
M?H&H\_W#2,N=&T-L&([7;..T<&M;2JYC1X ;8J>D/=LD[>>J&,T>CE@(.IR*
M+QW!O3M$'N'L<RI2AJR%["329]-;ZIV+E!XF[--]2L.L&OHBD-+ M?<R(T3L
M;O C)=PC/9Z<7KRANG-*MF! ZR87]S]1=?-KWO*=1,N!6&$P9(-$I*$IC4/S
M^ZA.;/I^I*]Y,BN"T&7*7#(#825S-KTZG-+X&23(S0O* FX /XVSJLF'X]G[
M9PWZO@-9?IVR]0;X59^/\":2--]A_BBKY5?<F?-'L1&A@QEIQ>NT-W#G:.>E
M1>J*#D]^1C$-Y3][(K8&+'IG)6XK13A,NND@MA4=YKEC&\MC[<5-BVZ\]GQW
MI*]IH/!0:)-ZW2GG^42.\^!UX%H)R&MEF%$6$>+1&?X:\1_7*CQRBKU04MH4
M,Y?9/.!_@;-D9Q1"'U=$(JI=M:(^+_J%P%MOF';B!;#;LJ'?=)#)QV'DIVM*
M@1MNI7>FA(FWDW_O:\Q+&J( ,2K8!PXCQV?4YT$16J=.1D= _W6VW:X4Y:%B
M U"'VNU'_7G8LDKVQ\F==>CVMAAGAZ+MKZ<#EXJ+=AKN2AYJ+GM8EY1W3$/A
MM/<Q#(06FBWL'^I2EPA!N\8/[Q0[6*HDOJ?JXZL$+01'C@ZY=/Z)+O3VOB1C
M%W9]]^1!%6I^_<ZINO6A<VN?U"=O"#U/L6N2(<$7;\;P3;&PPXA#<WVY9%!V
MGD$ ? QYP*KY,UO64+CSRQ,5G(X!48EB$OJE<TUA&#\K]*^"VX#5,EN7.T[9
M>*(D-)I#0A+5566CONK'=P&WL5 PDE6KX)\V'+VW-^^E\[EI00LYAX%\R[6#
M#[T6'Q/,&4N@S?,0KD<TZD2P'K%2^62N&53^5:#R[L!M1HN=^FHB%9O=&O$E
MG51G[.AK+/AD:<0 <)/PJPW3!:<FDT0K+WED%QL&ZB"+6/N9]!I2__OP$N?Q
MUM&7!W#HDF$-!$]J=F!GZP'Y!EC>U8A#/?AJ;"^H4E6PTOGS.8NB!X9R%3R4
MGB63<):A]ROC*X& X5[*]F_ %R ^*7"(BFS'OO17U]['59V>_@]>3]$LV/R]
MKX6TN_!5Y218$9*#.2%52I\,+WY_V8P_J$'6M[@KI'G%<]"05G(:3@(Q2*N$
M]\Q69C4ER.S"7SM_92NRZA&1V6.- \79I? &,<M\Q+ZE!C797=3@O+I#:$+C
MP6%WHVF[\&[R7"P174-*<Z8"'P'PD\CL<3UL1X'27U(+TLJ9]GGG*73G*CEK
M(;P.%9\7QN@@HZD.D!+8(3PHYSN.6;QA%VSC?=\M7*9LWR2A+L>;T&7I!;?9
MS(. +"$_Y$Y@GHP+7Q[U>1JF=@/EJ(\JI(EF+F//- [Y(-P<+UG_F)+1:.:J
MV%Z0!"\F("8,J92FW4)IZ=AVA-OL&XUF@_173GO\00_USOVMYV[ ;C4]GFXT
MO?.))XF<?H+R4S!]S=?L?#F_P0!<4Q+(RV^:C<B6$_H!#@872>.SE+5E0Y@9
M.MR:/3AISTP8F@^RJ?F5(\7.B/NKS!.*4PC6QT#^&9%]D%5YLZIXOT(8I^&,
M,N::R=)Q&F;Y&&$TFS'D$9FHO\(N&39$YPPJ$WFMK(P"?$.VHDR &"IX67FI
M% ?;4M1N!RK-YIC&/*C!\R(C[T3KH(539*L=5^KIZ<)CRW,C6\F_VZ5S7+&O
MM:DB$SB*KH]WT$BT8[DG=W53EQ_$6,@U<78EOD;,$Q^G9='F5B=R6&;,WT%^
M0'Z3B8IA'UV\;GO?I,=W13&'3Q_IF:S)B/MIS=,\I>MXG2+W7#/MP?;69'@M
M,MPX9*B]2%T=R_%Z+70EI_\X/EY-,N%*O.%HL%C1KJ^H+2J/*0]"WM8[EZ!6
MDH+]5Q"S=8UM6SO6'*F*%Z8$)9VGN+32D._)-K 3ZI/IWR+M3VF-, #,PPIZ
M=D&Q.=K#OP [W6?2%L!,Q.=92<N0S^M3-)Y/!YO9M)]JBEH\[*LFI\HLIYD5
M<9M:[:]<+1MBAMHE>S(6LC<%]XJN:HOP3>P"U1H^:K@#9",BE;ROF9\J\DYI
M(%M0R3XYU=R,T&.YO0+YI GLAXBJ%&*'#Z?MM_,S/9T2&O!U'64^])L?9LZR
M,MPI?@I-D9VO;RS1O1NQ->J-VDK.!OB0]O8P:#ZCH;0CD\KA\R(7; E8C+IM
M1\7-E2$$ W'3"GK/4DOE=!+1'L^M(?,&?"17!5@@2I*<M;O V3Q6JX.LNL)
MNMK7(SVRQP41)&%6)<3:6/PE>3Z^FKV<14@]"YPR2C:_CWM@_T#5^4JIQ0A_
M?E]3)]!O+/1(I9+9?HKR5,SG^JAH;=T#U+M^LIS]W7!S:$O%W9C"@T&LYK/I
M%R./GGJWI',6T[^KO8Y3^SFO9KD2KBV[1!+B(S,3!J-AC613?#%[U"RTMZ5+
M8<-OVO@3["47.X-++SZ^R9;->PL'/45"DC#Z[>;$(R+S*C2'ZM433NPY]G
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M:-EH<GB5IM#A3VEX2)WY#1I.<T,'Q%',M3U>["4>OM 690O>E+E>VZX#:G7
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M5>C"'C2TZD34:(JK<'#T8E-11:+U;\7Q?Y_<$_-TS6?Q*B+GBQ2.5-5IFG1
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M'Z\#+/ /C#E<F=]28^<A'D\_3 +82%KTGHQ=!@A. .#6 @" _F5 _\I.?/6
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M[,5\H?,.X;ROZ@Q25HU&(C8R?/;P^J?=,U++V,WTBKVP3T.6@:;AJG8U1"A
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M2\GPB "WD"D>7H:\5%+-$*K?[_W<L/OT$<6:3'"A]HTU>:E[9>QD_%'DGZ;
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M'->GYCTA2(;*TR7CY%M[B)N"FA?C<Z.QUT0#;#UC-1U7>Z88:8QH7(FYH/^
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M6J8(H][BF@MD7!8)IK9P+V/.ZQ/V1//EX% '+7<-R[1+SC%"5#)R$FE],#)
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M6CU@#[81-#8U5*WWP&7RGG+XA1[0D55Z8%3W(W]]'7FO)>C?!'J H\':I1[
M7O4\_SRCV.+ UEG1=IB"NB%ND:I=&3%Z@&(9W2D^( ._VS(Q0@D+9(.3</A6
M0N6"[P?TP*P5V!321$RQCRMY6H)\CS;P7_N4#U,_IL8&H9;[[RF0Z?@OZ?)_
MW)0Y5-Q4>Z7.[_Q,RN7!$_DK!G&;MH3TR60RY>R'XD_2<8QW9C[$-$ <Z[7
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M+FAT;5!+ 0(4 Q0    ( .))JU"SH4'Z30@  +4S   ;              "
M ;<L @!A,C!Q,S$P<3,S,3(P97AH:6)I=#,Q,2YH=&U02P$"% ,4    " #B
M2:M0-NLXX58(  #--   &P              @ $]-0( 83(P<3,Q,'$S,S$R
M,&5X:&EB:70S,3(N:'1M4$L! A0#%     @ XDFK4!=$C1%&!0  ="$  !L
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M              "  =+: P!C86@M,C R,# S,S%?<')E+GAM;%!+ 0(4 Q0
M   ( .))JU"#2:%SG3H   ]    =              "  4=P! !C:&%R="TV
M,SDV-C U-&$R8C@U-C4S.61F+FIP9U!+ 0(4 Q0    ( .))JU!3I;1B)4D
M "1/   =              "  1^K! !C:&%R="TX-&)E-C(Q-SDR830U96$S
M.&)B+FIP9U!+ 0(4 Q0    ( .))JU")]7XUC3(  (HX   =
M  "  7_T! !C:&%R="TY,#0U,V(S9#9E9# U,&5C8F1C+FIP9U!+ 0(4 Q0
M   ( .))JU!XNP.LC30  ) Z   =              "  4<G!0!C:&%R="UB
M-&(T,3AD-60R-3$U869B.35C+FIP9U!+ 0(4 Q0    ( .))JU#CA4YNHS4
M "T[   =              "  0]<!0!C:&%R="UC-65B-C@W8S9B930U-#9D
M.#8W+FIP9U!+ 0(4 Q0    ( .))JU"H:! 8-3D   $_   =
M  "  >V1!0!C:&%R="UD-#=F869A,#,W-C(U96,Q.3@Y+FIP9U!+ 0(4 Q0
M   ( .))JU"_#V,<C"\  !$U   =              "  5W+!0!C:&%R="UF
L-S$V.#!C,C<U9#@U9#4U8C R+FIP9U!+!08     $0 1 +\$   D^P4    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
